Citrus Sinensis ID: 000757
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1299 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.413 | 0.721 | 0.593 | 0.0 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.330 | 0.605 | 0.429 | 2e-88 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.250 | 0.454 | 0.479 | 5e-87 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.226 | 0.644 | 0.541 | 1e-85 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.221 | 0.422 | 0.513 | 8e-85 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.257 | 0.439 | 0.476 | 4e-84 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.221 | 0.441 | 0.513 | 1e-83 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.270 | 0.691 | 0.434 | 7e-83 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.224 | 0.404 | 0.518 | 7e-83 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.267 | 0.894 | 0.439 | 3e-82 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/568 (59%), Positives = 407/568 (71%), Gaps = 31/568 (5%)
Query: 635 PPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFM 694
P + DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG ++
Sbjct: 93 PSSHDCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYL 151
Query: 695 KQSQVRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDY 753
+QSQV+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDY
Sbjct: 152 EQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDY 211
Query: 754 EVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEGVDVPKRRQKY-----GLSG 808
EV ++ YPG+P S P +G +G+ P G+ +P + G+
Sbjct: 212 EVTHISYPGIPSSSP----------NGDVTGD-----APGGLPIPINATTFANKSQGIGF 256
Query: 809 GMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSG 868
IAI+ LS FV ++L A ++ K+K + V +L S K GA + S
Sbjct: 257 RTIAIIALSGFV-LILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSA 315
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVA 928
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VA
Sbjct: 316 RSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVA 375
Query: 929 VKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 988
VK+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 376 VKLLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH 435
Query: 989 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFG
Sbjct: 436 -----EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 490
Query: 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1108
LAR A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+
Sbjct: 491 LAREAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMS 549
Query: 1109 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168
QP G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFM
Sbjct: 550 QPSGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFM 609
Query: 1169 GEVVQALKLVCNECDEAKEVGSASSSQD 1196
GEVVQALKL+ N+ DE G S +D
Sbjct: 610 GEVVQALKLIYNDADET--CGDYCSQKD 635
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 191/445 (42%), Positives = 252/445 (56%), Gaps = 16/445 (3%)
Query: 795 VDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQAEEVPQSLQT 852
+D P G+ +G ++ I V A V L W L + K A +V S +
Sbjct: 265 LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMS 324
Query: 853 SHVKPSGAAGLMVGS---GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILG 909
S + A M S G S S+ S S FS E+ KAT F +LG
Sbjct: 325 STARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLG 384
Query: 910 EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 969
EGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV ++G CI
Sbjct: 385 EGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD 444
Query: 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1029
R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED PR+IHRD
Sbjct: 445 RRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 501
Query: 1030 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY 1089
KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G L KSDV+
Sbjct: 502 KSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVF 560
Query: 1090 SYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPSLGNDVPFDS 1146
S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP LG +
Sbjct: 561 SFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESE 620
Query: 1147 VAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SSSQDDMSIDL 1202
+ ++ A CV+ RP MG++V+A + L + +G + +S+Q I L
Sbjct: 621 MFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNSAQQSAEIRL 680
Query: 1203 DSKVSTGSGQLPDPLQRHYSVPNYD 1227
+++ GS H S + D
Sbjct: 681 FRRMAFGSQNYSTDFFSHSSYNSRD 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 174/363 (47%), Positives = 234/363 (64%), Gaps = 37/363 (10%)
Query: 885 GSAKT-FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF 943
G++K F+ E+ + T F S ++GEGGFG VY G+L +G VA+K LK V +G REF
Sbjct: 352 GTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREF 411
Query: 944 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 1003
AEVE++SR+HHR+LV L+G CI EQ R L+YE +PN +++ HLHG K L W R+
Sbjct: 412 KAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRV 469
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+IA+GAA+ LAYLHED P++IHRD KSSNILL+ +F +V+DFGLAR D HIST
Sbjct: 470 RIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLAR-LNDTAQSHIST 528
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
RVMGTFGY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD +QP G+E+LV WARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 1124 LTSREGLER-----IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178
L E +E+ ++DP L ND V K+ A+ CV+ RP M +VV+AL
Sbjct: 589 LI--EAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--- 643
Query: 1179 CNECDEAKEVGSASSSQDDMSIDLDSKVSTG------SGQLPDPLQ--RHYSVPNYDLGL 1230
++DD+S DL + V G SGQ + ++ R S + DLG
Sbjct: 644 --------------DTRDDLS-DLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGT 688
Query: 1231 DTG 1233
+TG
Sbjct: 689 NTG 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 162/299 (54%), Positives = 202/299 (67%), Gaps = 5/299 (1%)
Query: 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFL 944
+A TF+ E+ AT NF LGEGGFG VY G LD G VAVK L R QG REFL
Sbjct: 70 AAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFL 129
Query: 945 AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDAR 1002
EV MLS LHH NLV LIG C + R LVYE +P GS+E HLH + DKE+ L W+ R
Sbjct: 130 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA--LDWNMR 187
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+KIA GAA+ L +LH+ ++P VI+RDFKSSNILL+ F PK+SDFGLA+ + H+S
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122
TRVMGT+GY APEYAMTG L VKSDVYS+GVV LEL++GRK +D P G++NLVAWARP
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
Query: 1123 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181
L R ++ DP L P ++ + A+ASMC+Q + RP + +VV AL + N+
Sbjct: 308 LFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 155/302 (51%), Positives = 204/302 (67%), Gaps = 14/302 (4%)
Query: 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 949
FS E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP----LGWDARLKI 1005
+SR+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH AP + W+ R+++
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH------APGRPVMTWETRVRV 440
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD-EESRHISTR 1064
A GAAR +AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STR
Sbjct: 441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500
Query: 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124
VMGTFGY+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560
Query: 1125 ---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181
E + ++DP LG + + ++ A+ CV+ RP M +VV+AL +
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEA 620
Query: 1182 CD 1183
D
Sbjct: 621 TD 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 165/346 (47%), Positives = 218/346 (63%), Gaps = 11/346 (3%)
Query: 883 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE 942
+ S + FS E+ AT F +LGEGGFG VY GVL D VAVK LK QG RE
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 943 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
F AEV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN ++ HLH + L W R
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAG--TPGLDWATR 528
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+KIA GAAR LAYLHED PR+IHRD KSSNILLE++F VSDFGLA+ A+D + HI+
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HIT 587
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122
TRVMGTFGY+APEYA +G L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARP
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 1123 LL---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179
LL T E + DP LG + + ++ A+ C++ RP M ++V+A +
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLA 707
Query: 1180 NE-CDEAKEVGSA---SSSQDDMSIDLDSKVSTGSGQL-PDPLQRH 1220
E +G + +S+Q I L +++ GS D L R+
Sbjct: 708 EEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDSLTRN 753
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 151/294 (51%), Positives = 206/294 (70%), Gaps = 6/294 (2%)
Query: 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 945
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 946 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1005
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1125
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 1126 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 162/373 (43%), Positives = 236/373 (63%), Gaps = 21/373 (5%)
Query: 809 GMIAIVVLSA-FVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGS 867
G+I VVL A FV + +C + K K + E++ S+ + P
Sbjct: 62 GLITGVVLGATFVLLGVCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKD-------- 113
Query: 868 GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKV 927
DS +L SS F+ ++ KAT NF + +LG+GGFG V+ GVL DGT V
Sbjct: 114 --DSNNLQQWSSSEI---GQNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLV 168
Query: 928 AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL 987
A+K LK QG REF AE++ +SR+HHR+LV L+G CI R LVYE +PN ++E HL
Sbjct: 169 AIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHL 228
Query: 988 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047
H +KE + W R+KIALGAA+ LAYLHED +P+ IHRD K++NIL++ + K++DF
Sbjct: 229 H--EKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADF 286
Query: 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107
GLARS++D ++ H+STR+MGTFGY+APEYA +G L KSDV+S GVV+LEL++GR+PVD
Sbjct: 287 GLARSSLDTDT-HVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDK 345
Query: 1108 TQPPGQEN-LVAWARPLLTS--REG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQ 1163
+QP ++ +V WA+PL+ +G + ++DP L ND + + ++ A A+ V+ +
Sbjct: 346 SQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAK 405
Query: 1164 HRPFMGEVVQALK 1176
RP M ++V+A +
Sbjct: 406 RRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 157/303 (51%), Positives = 202/303 (66%), Gaps = 12/303 (3%)
Query: 885 GSAKT-FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF 943
GS +T FS E+ + T F ILGEGGFG VY G L DG VAVK LK QG REF
Sbjct: 353 GSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREF 412
Query: 944 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 1003
AEVE++SR+HHR+LV L+G CI +Q R L+YE + N ++E HLHG K L W R+
Sbjct: 413 KAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRV 470
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+IA+G+A+ LAYLHED P++IHRD KS+NILL+ ++ +V+DFGLAR D H+ST
Sbjct: 471 RIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLAR-LNDTTQTHVST 529
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
RVMGTFGY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD TQP G+E+LV WARPL
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 1124 L---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180
L L +ID L V ++ A+ CV+ RP M +VV+AL
Sbjct: 590 LLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL----- 644
Query: 1181 ECD 1183
+CD
Sbjct: 645 DCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 166/378 (43%), Positives = 232/378 (61%), Gaps = 30/378 (7%)
Query: 852 TSHVKPSGAAGLMVGSGLDSASLSFGSSIATYT------------GSAKTFSASEIEKAT 899
++ +K A+ + S S S GSS A+++ + K FS SE++ AT
Sbjct: 6 SNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSAT 65
Query: 900 GNFDASRILGEGGFGLVYSGVLDD----------GTKVAVKVLKRVDQQGGREFLAEVEM 949
NF ++GEGGFG V+ G +D+ G +AVK L + QG RE+LAE+
Sbjct: 66 RNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINY 125
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
L +L H NLVKLIG C+EE+ R LVYE + GS+E+HL PL W+ R+++ALGA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
AR LA+LH ++ P+VI+RDFK+SNILL+ ++ K+SDFGLAR ++ H+STRVMGT
Sbjct: 186 ARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129
GY APEY TGHL VKSDVYS+GVV+LELLSGR+ +D QP G+ NLV WARP LT++
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 1189
L R++DP L K+A +A C+ + + RP M E+V+ ++ E KE
Sbjct: 305 LLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTME----ELHIQKE-- 358
Query: 1190 SASSSQDDMSIDLDSKVS 1207
AS Q + I +D+ ++
Sbjct: 359 -ASKEQQNPQISIDNIIN 375
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1299 | ||||||
| 255546109 | 1282 | conserved hypothetical protein [Ricinus | 0.646 | 0.655 | 0.657 | 0.0 | |
| 359484309 | 992 | PREDICTED: receptor-like serine/threonin | 0.681 | 0.892 | 0.629 | 0.0 | |
| 224122486 | 1156 | predicted protein [Populus trichocarpa] | 0.569 | 0.640 | 0.689 | 0.0 | |
| 357449795 | 1478 | Serine/threonine protein kinase PBS1 [Me | 0.554 | 0.487 | 0.688 | 0.0 | |
| 124360779 | 986 | Protein kinase [Medicago truncatula] | 0.554 | 0.730 | 0.688 | 0.0 | |
| 356545725 | 1270 | PREDICTED: uncharacterized protein LOC10 | 0.925 | 0.946 | 0.495 | 0.0 | |
| 356558353 | 1255 | PREDICTED: receptor-like serine/threonin | 0.553 | 0.572 | 0.691 | 0.0 | |
| 449436078 | 1050 | PREDICTED: receptor-like serine/threonin | 0.543 | 0.672 | 0.685 | 0.0 | |
| 224112136 | 664 | predicted protein [Populus trichocarpa] | 0.504 | 0.986 | 0.749 | 0.0 | |
| 297738662 | 1046 | unnamed protein product [Vitis vinifera] | 0.641 | 0.796 | 0.596 | 0.0 |
| >gi|255546109|ref|XP_002514114.1| conserved hypothetical protein [Ricinus communis] gi|223546570|gb|EEF48068.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1091 bits (2822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/911 (65%), Positives = 671/911 (73%), Gaps = 71/911 (7%)
Query: 444 APAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSP 503
P +P RHSP++ P P + PV +AS+ I + +SP
Sbjct: 254 VPVVSPTRELPRHSPSVLPGEPPAILPVPDVSHASSPPTSI-----------DRKKDRSP 302
Query: 504 VARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYD-IPMPPPVNHSPSKG-- 560
+A P P TP+ P D P+ S +P SY +P P NHS SKG
Sbjct: 303 IAAP--PDETPSHLPSADHSPTKGSFSAVAPSTHEPTGYTSYGLVPSSSPPNHSLSKGNH 360
Query: 561 -----------------------------------PVVPPSFIPTSRKRHYGPPPLN--- 582
PV PSF+PTSR+ HY PPP++
Sbjct: 361 TSASSPSIPFHKQNHSRTDFSSPAPAYSPPSKQQGPVASPSFLPTSRRTHYAPPPISPGS 420
Query: 583 SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPP------ 636
S SPSH P PV V +PSPSPT+ASG T++P+L P+ SPS P PP
Sbjct: 421 SASPSHFHFPKPVINVSPAPSPSPTAASGWTKMPILSPEVSPSGSSPRSPKMPPRPPVHA 480
Query: 637 ------NADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAA 690
N DCS+T+C EPYTNTPPGSPCGCV PMQVGLRLSVALYTFFPLVSELA EIA
Sbjct: 481 LPPPPPNEDCSSTVCVEPYTNTPPGSPCGCVLPMQVGLRLSVALYTFFPLVSELAQEIAT 540
Query: 691 GVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSY 749
GVFMKQSQVRI+GANAA +QP+KTVVL DLVPLGE+FDNTTA LT+ RFWHKQVVIK+S+
Sbjct: 541 GVFMKQSQVRIMGANAASQQPEKTVVLIDLVPLGERFDNTTAVLTFHRFWHKQVVIKASF 600
Query: 750 FGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNG--RATKPEGVDVPKRRQKYGLS 807
FGDYEVLYVRYPGLPPSP + S I IIDDGPYSGNN R KP GVDV KR +K GL
Sbjct: 601 FGDYEVLYVRYPGLPPSP-PSPSGITIIDDGPYSGNNNNARTIKPLGVDVHKRHRKDGLG 659
Query: 808 GGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGS 867
GMIAI+ LSA +A++LCSA AWVLL +++ Q PQ L S KPSG G ++GS
Sbjct: 660 AGMIAIISLSASLALILCSAVAWVLLVRHRGRMSQPTPTPQPLPPSGAKPSGTTGSVIGS 719
Query: 868 GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKV 927
GL SASLSFGSSIA YTGSAKTFS S+IE+AT NF+ASRILGEGGFG VYSGVL+DGTKV
Sbjct: 720 GLSSASLSFGSSIAPYTGSAKTFSISDIERATNNFNASRILGEGGFGRVYSGVLEDGTKV 779
Query: 928 AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL 987
AVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLIGIC EE+ARCLVYELIPNGSVESHL
Sbjct: 780 AVKVLKRDDHQGGREFLAEVEMLSRLHHRNLVKLIGICTEERARCLVYELIPNGSVESHL 839
Query: 988 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047
HG DKESAPL WDAR++IALGAAR LAYLHEDSSP VIHRDFKSSNILLEHDFTPKVSDF
Sbjct: 840 HGADKESAPLDWDARIRIALGAARGLAYLHEDSSPHVIHRDFKSSNILLEHDFTPKVSDF 899
Query: 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107
GLAR+AMDE++RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM
Sbjct: 900 GLARTAMDEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVVLELLTGRKPVDM 959
Query: 1108 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1167
QPPGQENLVAWARPLLTS+EGLE I DPSLG DVPFDSVAKVAAIASMCVQPEV +RPF
Sbjct: 960 LQPPGQENLVAWARPLLTSKEGLEIITDPSLGPDVPFDSVAKVAAIASMCVQPEVSNRPF 1019
Query: 1168 MGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYD 1227
MGEVVQALKLVCNECDEAKEVGS S S D+S+D+D++ S GSG + DP Q VPNYD
Sbjct: 1020 MGEVVQALKLVCNECDEAKEVGSRSPSW-DISVDMDAEASAGSGHMRDPFQNRTIVPNYD 1078
Query: 1228 LGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSE 1287
D R LS+S LFS+S R G++ S FRRYSSSGPLRTGRG+Q WQR+RRL G S SE
Sbjct: 1079 SEPDIERGLSMSDLFSTSVRYGRQASGSFRRYSSSGPLRTGRGKQLWQRMRRLTGESVSE 1138
Query: 1288 HGAVFSLWPGS 1298
HG +F +WP +
Sbjct: 1139 HGGIFRIWPAA 1149
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484309|ref|XP_003633096.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/997 (62%), Positives = 705/997 (70%), Gaps = 112/997 (11%)
Query: 400 PSNTALTPASHPSNIAPPPLFVPVL-----PSALPGKAPVSQSPISLPDAPAA----TPR 450
PSN ++P P PP L VP+ PSA KAP +++P+ P AP A P
Sbjct: 11 PSNPRMSP---PHYKTPPHLKVPITLPSVPPSASQRKAPDNKAPVWAPVAPIAPVAPVPD 67
Query: 451 GNFHRHSPAI------HPSMPGPLPPVAQKRNASNREAPIAEPIAPGP------FPPGNS 498
G R P HP MPG LPP A RN + +API+ PIAP P PP S
Sbjct: 68 GPPQRKWPQNPPSMHPHPVMPGLLPPSAHNRNKPDNKAPISTPIAPDPDVTPISTPPLAS 127
Query: 499 ---RQKSPVARPIIPGGTPTASPDP----------------------------------- 520
R++ PVA P P +PDP
Sbjct: 128 HWRRKQMPVAAP------PNRTPDPLSPVNHSPAKAPSIHNAMRHSNAPASLSTPQSPTN 181
Query: 521 ---DVPPSTPPLSVDGKRVGK-----PVAEPSYDIPMPPPVNHSP--SKGPVVPPSFIPT 570
P S+P +S G+ P SY IP P P + P S P PP +P
Sbjct: 182 KGSQSPASSPSMSFSKHHRGRNKITGPAPASSYLIPPPSPRHQGPVISPAPSHPPKSLPN 241
Query: 571 SRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQT-----ELPLLPPKS 622
+ H+ P PLN +SP+HSP P+ ++ +PSPSPT ++P L PK
Sbjct: 242 RTRTHHAPLPLNPGSRISPAHSPSPSSLTYPSPAPSPSPTLIYCHVCICTLQVPFLSPKI 301
Query: 623 SPSEPIRAFPP---------------PPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 667
SPS PP PPPN DCS +CTEP TNTPPGSPCGCV PMQV
Sbjct: 302 SPSR----LPPSSKMPAPPPVQALPPPPPNQDCSAIVCTEPNTNTPPGSPCGCVLPMQVQ 357
Query: 668 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAAE-QPDKTVVLTDLVPLGEKF 726
LRL+VALYTFFPLVSELA EIAAGVFM+QSQVRI+GANAA + +KT+VL DLVPLGEKF
Sbjct: 358 LRLNVALYTFFPLVSELAEEIAAGVFMRQSQVRIMGANAASPEAEKTIVLIDLVPLGEKF 417
Query: 727 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSG-- 784
DNTTAFLTYQRFW KQVVIK+ +FGDYEV+YV YPGLPPSPPSA SSI +ID+GPYSG
Sbjct: 418 DNTTAFLTYQRFWGKQVVIKNLFFGDYEVIYVNYPGLPPSPPSAPSSITMIDNGPYSGQG 477
Query: 785 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 844
NNGR P GVDV K R K+GLSG +IAI+VLSA VAVVLCSA AWV LFK C +
Sbjct: 478 NNGRTIHPLGVDVHKNRHKHGLSGSVIAIIVLSASVAVVLCSAVAWVFLFKKTD--CIGQ 535
Query: 845 EVPQ--SLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNF 902
VP +L S +P GAAG +VGS SASLSFGSSIATYTGSAKTFSA++IE+AT NF
Sbjct: 536 PVPTQAALVPSLARPPGAAGSVVGSAPSSASLSFGSSIATYTGSAKTFSAADIERATDNF 595
Query: 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
D SRILGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLI
Sbjct: 596 DDSRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREFLAEVEMLSRLHHRNLVKLI 655
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
GIC EE+ RCLVYELIPNGSVESHLHG DKE+APL W AR+K+ALGAAR LAYLHEDSSP
Sbjct: 656 GICTEERTRCLVYELIPNGSVESHLHGADKETAPLDWGARIKVALGAARGLAYLHEDSSP 715
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
RVIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDEE+RHISTRVMGTFGYVAPEYAMTGHL
Sbjct: 716 RVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEENRHISTRVMGTFGYVAPEYAMTGHL 775
Query: 1083 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
LVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLVAWARPLLTS+EGL+ +ID SLG+DV
Sbjct: 776 LVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVAWARPLLTSKEGLQTMIDLSLGSDV 835
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDL 1202
PFDSVAKVAAIASMCVQPEV HRPFMGEVVQALKLVCNECDE KE GS S SQ+D+S+DL
Sbjct: 836 PFDSVAKVAAIASMCVQPEVSHRPFMGEVVQALKLVCNECDETKEAGSKSGSQEDLSLDL 895
Query: 1203 DSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSS 1262
D+ VS+ SGQLPDP H+ V Y GLD LS+S LFS+SAR G++ S FRRYSSS
Sbjct: 896 DTGVSSASGQLPDPSHAHFPVSTYGSGLDAETGLSVSELFSTSARFGRQPSGSFRRYSSS 955
Query: 1263 GPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGSY 1299
GPLRTGR R FWQR+RR GGS SEHG +F L PGS+
Sbjct: 956 GPLRTGRARHFWQRMRRNSGGSVSEHGIMFRLRPGSH 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122486|ref|XP_002330493.1| predicted protein [Populus trichocarpa] gi|222872427|gb|EEF09558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1013 bits (2619), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/795 (68%), Positives = 612/795 (76%), Gaps = 55/795 (6%)
Query: 556 SPSKGPVVPPSFIPTSRKRHYGPPPL----NSVSPSHSPLPTPVSRVPTSPSPSPTSASG 611
S +GPV+PPSF+PTSR + Y PL +S + SH P PV V +PSP+ T+ASG
Sbjct: 366 SKQQGPVMPPSFLPTSRHKQYAFSPLGTPDSSNNASHYRYPKPVIIVSPTPSPTQTAASG 425
Query: 612 QTELPLLPPKSSPSEPIRAFPP------------PPPNADCSTTICTEPYTNTPPGSPCG 659
T++P L PK+SPS P PPPN DCSTT+CTEPYTNTPPGSPC
Sbjct: 426 WTKMPALSPKASPSGFSSRTPKMPPLPPLHTLPPPPPNEDCSTTVCTEPYTNTPPGSPCR 485
Query: 660 CVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANA-AEQPDKTVVLTD 718
CV PMQVGL +SVALYTFFPLVSELA EIAAGVFMKQ QVRIIGANA ++Q +KT+VL D
Sbjct: 486 CVLPMQVGLGVSVALYTFFPLVSELAQEIAAGVFMKQGQVRIIGANAPSQQLEKTIVLID 545
Query: 719 LVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIID 778
LVPLGE+FDN+TA LTY RFW KQVVI S+FGDYEVLYVRY GLPP PP A I IID
Sbjct: 546 LVPLGERFDNSTALLTYLRFWKKQVVINPSFFGDYEVLYVRYLGLPPPPPMAPFGIAIID 605
Query: 779 DGPYSGN--NGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKY 836
DGPYSGN N R KP GVDV KR++K GL+GG+IAI+ +S FVA+VL SA A LLFK+
Sbjct: 606 DGPYSGNDNNARMIKPLGVDVHKRKRKDGLAGGIIAIIAVSGFVALVLFSAVALALLFKH 665
Query: 837 KSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIE 896
+ HA Q V Q L S VKPSG AG ++GSGL SASLSF SSI YTGSAKTFS S+IE
Sbjct: 666 RDHASQPASVLQPLPPSVVKPSGIAGSLIGSGLSSASLSFASSIPAYTGSAKTFSKSDIE 725
Query: 897 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR 956
+AT +FDASRILGEGGFGLVYSGVL+DGTKVAVKVLKR DQQGGREFLAEVEMLSRLHHR
Sbjct: 726 RATSSFDASRILGEGGFGLVYSGVLEDGTKVAVKVLKRNDQQGGREFLAEVEMLSRLHHR 785
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHG--------------------------- 989
NLVKLIGIC EE +R LVYELI NGSVESHLHG
Sbjct: 786 NLVKLIGICTEECSRSLVYELIANGSVESHLHGSRLALSEFSYLDQESYLLDKESMFYNM 845
Query: 990 -----VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044
VDKESA L WDAR+KIALGAAR LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV
Sbjct: 846 NMLVWVDKESA-LNWDARIKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 904
Query: 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
SDFGLAR+A+DEE+RHIST+VMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKP
Sbjct: 905 SDFGLARTALDEENRHISTQVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 964
Query: 1105 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH 1164
VDM+QPPGQENLVAWARP LT++EGLE IIDP+L DVPFDSVAKVAAIASMCVQPEV H
Sbjct: 965 VDMSQPPGQENLVAWARPFLTTKEGLEVIIDPTLATDVPFDSVAKVAAIASMCVQPEVSH 1024
Query: 1165 RPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVP 1224
RPFM EVVQALKLV NECDEAKE+ S SSSQ D+SI +D++VS SGQL D L+ V
Sbjct: 1025 RPFMSEVVQALKLVSNECDEAKELDSRSSSQ-DLSIYMDAEVSAVSGQLRDSLRSQALVH 1083
Query: 1225 NYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGS 1284
NYD D R L SY FS+S G++ S RR SSGPL+TGRGR+ +QR+ RL G S
Sbjct: 1084 NYDSEPDIERGLVDSYFFSTSDGCGRQGSGSLRR-CSSGPLKTGRGRELFQRM-RLTGES 1141
Query: 1285 DSEHGAVFSLWPGSY 1299
SE G +F +WPGS+
Sbjct: 1142 VSERGTIFKMWPGSH 1156
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449795|ref|XP_003595174.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355484222|gb|AES65425.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2593), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/747 (68%), Positives = 589/747 (78%), Gaps = 27/747 (3%)
Query: 563 VPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLP 619
+PPSF+PT+R+RH P P+N + SP P+ +PVS+V +PSPS + T++P P
Sbjct: 735 IPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSPVSQVSPAPSPSFKTFPHSTKIPFHP 794
Query: 620 PK--------SSPSEPI----RAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 667
PK SP +PI +A PPPPPN DC + +C+EPYTN+PPG PC C+WPM+VG
Sbjct: 795 PKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLSFVCSEPYTNSPPGVPCMCIWPMRVG 854
Query: 668 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKF 726
LRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+GANAA +QPDKT L DLVPLGE+F
Sbjct: 855 LRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIMGANAATDQPDKTDALIDLVPLGEQF 914
Query: 727 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--G 784
DNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YPGLPPSPP SS+ +ID GPYS G
Sbjct: 915 DNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYPGLPPSPPLPPSSVNMIDGGPYSNNG 974
Query: 785 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 844
NNGR KP GVD+ KR+ + GLS G+IAI+ LS+F+A+VLCSAA + L+ K++ H +++
Sbjct: 975 NNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSFLAIVLCSAAVFALI-KFRDHVSESQ 1033
Query: 845 --EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNF 902
P+ S K G AG SAS SF SSIA Y GSAKTFS +EIEKAT NF
Sbjct: 1034 PTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFRSSIAAYAGSAKTFSMNEIEKATDNF 1091
Query: 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
SRILGEGGFGLVYSG L+DG+KVA KVLKR D G REFL+EVEMLSRLHHRNLVKLI
Sbjct: 1092 HPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDHHGDREFLSEVEMLSRLHHRNLVKLI 1151
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
GIC E RCLVYELIPNGSVESHLHGVD+E +PL W AR+KIALGAAR LAYLHEDSSP
Sbjct: 1152 GICTELSFRCLVYELIPNGSVESHLHGVDREKSPLDWSARIKIALGAARGLAYLHEDSSP 1211
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE++RHISTRVMGTFGYVAPEYAMTGHL
Sbjct: 1212 HVIHRDFKSSNILLENDFTPKVSDFGLARTAADEDNRHISTRVMGTFGYVAPEYAMTGHL 1271
Query: 1083 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
LVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLVAWARPLLTSREGLE IIDPSLG++V
Sbjct: 1272 LVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLVAWARPLLTSREGLEVIIDPSLGSNV 1331
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDL 1202
PFDSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEAKE GS SS++D S D
Sbjct: 1332 PFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEAKEAGSTSSNKDGSSSDF 1391
Query: 1203 DSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSS 1262
T + QLPD Q H + NYD G+D LS S +FSSSAR ++ S FRR+S S
Sbjct: 1392 ----YTVTEQLPDNFQSHSAAANYDFGVDIENGLSTSEIFSSSARFERQVSGSFRRHSYS 1447
Query: 1263 GPLRTGRGRQFWQRIRRLVGGSDSEHG 1289
GPLRTGR ++ W IR+L GGS SEHG
Sbjct: 1448 GPLRTGRSKRLWHIIRKLSGGSVSEHG 1474
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|124360779|gb|ABN08751.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/747 (68%), Positives = 589/747 (78%), Gaps = 27/747 (3%)
Query: 563 VPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLP 619
+PPSF+PT+R+RH P P+N + SP P+ +PVS+V +PSPS + T++P P
Sbjct: 243 IPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSPVSQVSPAPSPSFKTFPHSTKIPFHP 302
Query: 620 PK--------SSPSEPI----RAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVG 667
PK SP +PI +A PPPPPN DC + +C+EPYTN+PPG PC C+WPM+VG
Sbjct: 303 PKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLSFVCSEPYTNSPPGVPCMCIWPMRVG 362
Query: 668 LRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKF 726
LRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+GANAA +QPDKT L DLVPLGE+F
Sbjct: 363 LRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIMGANAATDQPDKTDALIDLVPLGEQF 422
Query: 727 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--G 784
DNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YPGLPPSPP SS+ +ID GPYS G
Sbjct: 423 DNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYPGLPPSPPLPPSSVNMIDGGPYSNNG 482
Query: 785 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAE 844
NNGR KP GVD+ KR+ + GLS G+IAI+ LS+F+A+VLCSAA + L+ K++ H +++
Sbjct: 483 NNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSFLAIVLCSAAVFALI-KFRDHVSESQ 541
Query: 845 --EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNF 902
P+ S K G AG SAS SF SSIA Y GSAKTFS +EIEKAT NF
Sbjct: 542 PTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFRSSIAAYAGSAKTFSMNEIEKATDNF 599
Query: 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
SRILGEGGFGLVYSG L+DG+KVA KVLKR D G REFL+EVEMLSRLHHRNLVKLI
Sbjct: 600 HPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDHHGDREFLSEVEMLSRLHHRNLVKLI 659
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
GIC E RCLVYELIPNGSVESHLHGVD+E +PL W AR+KIALGAAR LAYLHEDSSP
Sbjct: 660 GICTELSFRCLVYELIPNGSVESHLHGVDREKSPLDWSARIKIALGAARGLAYLHEDSSP 719
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE++RHISTRVMGTFGYVAPEYAMTGHL
Sbjct: 720 HVIHRDFKSSNILLENDFTPKVSDFGLARTAADEDNRHISTRVMGTFGYVAPEYAMTGHL 779
Query: 1083 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
LVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLVAWARPLLTSREGLE IIDPSLG++V
Sbjct: 780 LVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLVAWARPLLTSREGLEVIIDPSLGSNV 839
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDL 1202
PFDSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEAKE GS SS++D S D
Sbjct: 840 PFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEAKEAGSTSSNKDGSSSDF 899
Query: 1203 DSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSS 1262
T + QLPD Q H + NYD G+D LS S +FSSSAR ++ S FRR+S S
Sbjct: 900 ----YTVTEQLPDNFQSHSAAANYDFGVDIENGLSTSEIFSSSARFERQVSGSFRRHSYS 955
Query: 1263 GPLRTGRGRQFWQRIRRLVGGSDSEHG 1289
GPLRTGR ++ W IR+L GGS SEHG
Sbjct: 956 GPLRTGRSKRLWHIIRKLSGGSVSEHG 982
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545725|ref|XP_003541286.1| PREDICTED: uncharacterized protein LOC100816296 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 986 bits (2550), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 675/1362 (49%), Positives = 829/1362 (60%), Gaps = 160/1362 (11%)
Query: 1 MGLVMPVILQLVKLCVIGFAFTVQGSAGYGIPPSPAIIGGHFLLPRL-PVTFTLKP--HL 57
MG+V+ ++LQL C+I FA T Q G I PSPA LP + P TL P H
Sbjct: 1 MGVVLALMLQL---CIIAFAVTAQEFKGSIISPSPA------FLPVVPPGEETLGPIYHG 51
Query: 58 LGGHAPSPIELPTHS-----APPPVNIPSF-SPSTPAV-SAPFDMAPPPSLIPTNPVASP 110
G AP+ LP+ +P P N+ + SPS+PAV + PF PP + P+ SP
Sbjct: 52 EGSKAPN---LPSDGDGFVISPSPANLHVYHSPSSPAVPNGPF-YKPPKTFPPSTTAPSP 107
Query: 111 PSIT--------APPPVNMAPPPSLIP---TTPVASPPPITAPPLVNVLPA---PSLIPT 156
I +P + ++PP +++P PPP+ P P P PT
Sbjct: 108 QKIKDIEPSKSPSPSTIALSPPYAVVPLPSAVQGNKPPPVKTSPPQREAPTVRPPFSTPT 167
Query: 157 TPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKT 216
P +SS P SP S P H T + +N+ L
Sbjct: 168 APAPVAISSDRSPKISPVSQ---------------PIEHGHLTPDVDNRNANNSHLAESF 212
Query: 217 APSPASHPSNTALPP---ASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
+P+P + PS LP AS P++ P +N P +P+ + P ++
Sbjct: 213 SPAPGAVPSAN-LPKNSSASQPTENGTFPPKEGTNNG--HGLEPISPAPVAVNLPKES-- 267
Query: 274 PPASHPSNTAPPPASHPSKTAP----PPASHPSNTAPPPASHP--SNTAPPPASHPSNTA 327
P + P + + PP H P S P++ A PP ++ S + P H S
Sbjct: 268 PVSQPPEHASLPPIVHQRNANMGHNLKPVS-PASVAIPPTTYKITSMDSEPTTQHGS--- 323
Query: 328 PPPASHPSNTAPPPASHSSKT-APPPASHP--SNTALPPASHPSNPAIPPASHPSNTAIP 384
PP H N+ H+S+T +P P + P PP +HP P I P++ + P
Sbjct: 324 IPPNVHKRNSN---KGHTSETVSPEPVASPPWKVENSPPETHPIVPTITPSTLTAPVTSP 380
Query: 385 PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDA 444
P++ P PPL P++P A P K P +P+S P
Sbjct: 381 PSAFP-------------------------LKPPLVHPIVPVASPSKLP---APVSSP-- 410
Query: 445 PAATPRGNFHRH---SPAIHP--SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSR 499
TP +F+ +P + P P PLP V S +AP+A+ +R
Sbjct: 411 ---TPLRSFNWKKGGAPVVAPLSRNPKPLPAVIH----SPAQAPVAQ----------KAR 453
Query: 500 QKSPVARPIIPGGTPTASPDPDVPPSTPPLSV-----DGKRVGKPVAEPSYDIPMPPPVN 554
Q P+I +++ + PP +P S + +G P + S + PP
Sbjct: 454 QLHHAPEPLISSPKSSSNKEYHYPPLSPTSSFYKHPHTREIIGSP-SPASSSMVSPPTSK 512
Query: 555 HSPSKGPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASG 611
H + +PP P S +RH+ PP+N SVSP SP+ + +V +PSPS AS
Sbjct: 513 HQEA---AIPPLLPPRSGQRHHVSPPINSSSSVSPFSSPIHSNTGQVSPAPSPSIKFASH 569
Query: 612 QTELPLLPPKSSPSEPIRAFPP------------PPPNADCSTTICTEPYTNTPPGSPCG 659
T + PPK +PSE P PPPN DC +T+CTEPYTN+PPG PC
Sbjct: 570 PTGSTIFPPKVAPSESSSKRPKMPLLPQVQVLPPPPPNEDCISTVCTEPYTNSPPGEPCR 629
Query: 660 CVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTD 718
CVWPM+VGLRLSV+LYTFFPLVSELA EIA GVFMKQSQVRI+GANAA +QP+KTVVL D
Sbjct: 630 CVWPMRVGLRLSVSLYTFFPLVSELASEIATGVFMKQSQVRIMGANAADQQPEKTVVLID 689
Query: 719 LVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIID 778
LVPLGE+FDNTTAF T RFWHK V+IK+ YFGDY+VLYV YPGLPPSPP SS+ + +
Sbjct: 690 LVPLGEEFDNTTAFFTSDRFWHKMVIIKAFYFGDYDVLYVSYPGLPPSPPLPPSSLNMFN 749
Query: 779 DGPYS--GNNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKY 836
GPYS GNNGR KP GVD+ KR+QK GLS G+I+ + +S +AVVLC+AAAWV +FK+
Sbjct: 750 GGPYSTDGNNGRTIKPIGVDILKRQQKVGLSRGIISTIAVSVSLAVVLCAAAAWV-MFKF 808
Query: 837 KSHACQAEEVPQSLQ-TSHVKPSGAAGLM--VGSGLDSASLSFGSSIATYTGSAKTFSAS 893
+ H Q+ P+ L S K G AG + G+G+ S S SF SSIA YTGSAKTFS +
Sbjct: 809 RDHVSQSASTPRQLSPPSLTKEPGTAGSLRGAGAGVGSVSTSFRSSIAAYTGSAKTFSTN 868
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL 953
+I+KAT +F ASRILGEGGFGLVYSG+L+DGTKVAVKVLKR D G REFLAEVEMLSRL
Sbjct: 869 DIKKATDDFHASRILGEGGFGLVYSGILEDGTKVAVKVLKREDHHGDREFLAEVEMLSRL 928
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
HHRNLVKLIGICIE R LVYEL+PNGSVES+LHGVD+ ++PL W AR+KIALGAAR L
Sbjct: 929 HHRNLVKLIGICIENSFRSLVYELVPNGSVESYLHGVDRGNSPLDWGARMKIALGAARGL 988
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
AYLHEDSSPRVIHRDFKSSNILLE DFTPKVSDFGLAR+A DEE++HISTRVMGTFGYVA
Sbjct: 989 AYLHEDSSPRVIHRDFKSSNILLEDDFTPKVSDFGLARTATDEENKHISTRVMGTFGYVA 1048
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
PEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+Q PGQENLVAWARPLLTS+EG E +
Sbjct: 1049 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQAPGQENLVAWARPLLTSKEGCEAM 1108
Query: 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK-EVGSAS 1192
ID SLG DVPFDSVAKVAAIASMCVQPEV +RPFM EVVQALKLVC+ECDEAK E GS+S
Sbjct: 1109 IDQSLGTDVPFDSVAKVAAIASMCVQPEVSNRPFMSEVVQALKLVCSECDEAKEESGSSS 1168
Query: 1193 SSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEE 1252
S +D+S+DL +ST SGQL D Q S N+D G+D R L+ S +FSSSAR G+ E
Sbjct: 1169 FSLEDLSVDLALGISTVSGQLSDNFQSQLSGTNFDSGVDIERGLAASEIFSSSARFGRAE 1228
Query: 1253 SELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSL 1294
S FRR S SGPLRTGR RQ WQ IR L GS SEHG + L
Sbjct: 1229 SGSFRRNSYSGPLRTGRSRQLWQIIRSLSSGSVSEHGTMLKL 1270
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558353|ref|XP_003547471.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/749 (69%), Positives = 584/749 (77%), Gaps = 30/749 (4%)
Query: 564 PPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPP 620
PPS +PTS +RH+ PPP+N SVSPS + +PV++V +PSP + T++PL PP
Sbjct: 519 PPSPLPTSGQRHHAPPPMNTGSSVSPSSLHIQSPVNQVSPAPSPIFNISPHSTKIPLHPP 578
Query: 621 KSSPSEP------------IRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGL 668
K SPS P +A PPPPPN DC + +C+EPYT+TPPG+PC CVWPM+VGL
Sbjct: 579 KVSPSRPSSKIPKKPVRPRFQALPPPPPNEDCISVVCSEPYTSTPPGAPCKCVWPMKVGL 638
Query: 669 RLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFD 727
RLSV+LYTFFPLVSE A EIA GVFMKQSQVRI+GA+AA +QPDKT+V DLVPLGE+FD
Sbjct: 639 RLSVSLYTFFPLVSEFASEIATGVFMKQSQVRIMGADAANQQPDKTIVFIDLVPLGEEFD 698
Query: 728 NTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSG--N 785
NTTAFLT +RFWHKQVVIK+SYFGDY VLYV YPGLPPSPP SSI IID GPYSG N
Sbjct: 699 NTTAFLTSERFWHKQVVIKTSYFGDYVVLYVTYPGLPPSPPLPPSSISIIDGGPYSGGGN 758
Query: 786 NGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEE 845
NGR KP GVD+ KR+ + GLS G+IA++ LS F+ V LC AAA + FKY+ H Q
Sbjct: 759 NGRTIKPLGVDISKRQHRGGLSKGIIAVIALSVFLVVALCFAAA-LASFKYRDHVSQTPS 817
Query: 846 VPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDAS 905
P+ L P A ++ G L SAS SF SSIA YTGSAKT S ++IEKAT NF AS
Sbjct: 818 TPRILPPLTKAPGAAGSVVGGG-LASASTSFRSSIAAYTGSAKTLSMNDIEKATDNFHAS 876
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
R+LGEGGFGLVYSG+L+DGTKVAVKVLKR D QG REFL+EVEMLSRLHHRNLVKLIGIC
Sbjct: 877 RVLGEGGFGLVYSGILEDGTKVAVKVLKREDHQGNREFLSEVEMLSRLHHRNLVKLIGIC 936
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
E RCLVYELIPNGSVESHLHG DKE++PL W ARLKIALG+AR LAYLHEDSSP VI
Sbjct: 937 AEVSFRCLVYELIPNGSVESHLHGADKENSPLDWSARLKIALGSARGLAYLHEDSSPHVI 996
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRDFKSSNILLE+DFTPKVSDFGLAR+A DE +RHISTRVMGTFGYVAPEYAMTGHLLVK
Sbjct: 997 HRDFKSSNILLENDFTPKVSDFGLARTAADEGNRHISTRVMGTFGYVAPEYAMTGHLLVK 1056
Query: 1086 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 1145
SDVYSYGVV+LELL+GRKPVDM+QPPGQENLVAWARPLL+S EGLE +IDPSLG DVP D
Sbjct: 1057 SDVYSYGVVLLELLTGRKPVDMSQPPGQENLVAWARPLLSSEEGLEAMIDPSLGPDVPSD 1116
Query: 1146 SVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSK 1205
SVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEA+E GS+SSS D
Sbjct: 1117 SVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEARETGSSSSSVDLSHSR---- 1172
Query: 1206 VSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPL 1265
QL D LQ +S NYD G+D L S LFSSSAR G+ S FRR+S SGPL
Sbjct: 1173 ------QLSDNLQGQFSATNYDSGVDIENGLLASELFSSSARYGRRVSGSFRRHSYSGPL 1226
Query: 1266 RTGRGRQFWQRIRRLVGGSDSEHGAVFSL 1294
TGR ++ WQ IR+L GGS SEHG +F L
Sbjct: 1227 NTGRSKRLWQIIRKLSGGSVSEHGTMFKL 1255
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436078|ref|XP_004135821.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] gi|449489947|ref|XP_004158466.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2516), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/740 (68%), Positives = 574/740 (77%), Gaps = 34/740 (4%)
Query: 575 HYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSP-TSASGQTELPLLPPKSSPSEP------ 627
HY PPPL V SPSPSP SG T PPK+SPS+P
Sbjct: 328 HYAPPPL---------------VVHVSPSPSPHQKISGHTRRHFYPPKASPSKPSAKSPK 372
Query: 628 ---IRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSEL 684
I PPPPPN DC TT C EPYTNTPPGSPCGCVWPMQ+GLRLSV+LYTFFPLVSEL
Sbjct: 373 MSPIHTLPPPPPNEDCLTTQCIEPYTNTPPGSPCGCVWPMQIGLRLSVSLYTFFPLVSEL 432
Query: 685 AGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQV 743
A EIA GVF+KQSQVRIIGANAA +QPDKTV+L DLVPLGEKFDNTTAFLTYQRFWHK+V
Sbjct: 433 AAEIAVGVFVKQSQVRIIGANAANQQPDKTVILIDLVPLGEKFDNTTAFLTYQRFWHKKV 492
Query: 744 VIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPY--SGNNGRATKPEGVDVPKRR 801
IK+SYFG+YEVLYVRYPGLP SPPS S I ++ PY + N+ RA KP GVDV R+
Sbjct: 493 SIKASYFGNYEVLYVRYPGLPQSPPSGDSGI---ENEPYFSNSNDARAVKPIGVDVQNRQ 549
Query: 802 QKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAA 861
K LSGG+IAIV LS VAVVLC A AW+LLFK CQ + P +S KPSGA
Sbjct: 550 HKNKLSGGIIAIVALSTTVAVVLCVATAWILLFKRNDGLCQPKPTPHVSLSSLNKPSGAG 609
Query: 862 GLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 921
G ++ + SASLS GSSIA Y+GSAKTFSA +IE+AT NFD SRILGEGGFG VY G+L
Sbjct: 610 GSVMATMPSSASLSIGSSIAPYSGSAKTFSAPDIERATNNFDPSRILGEGGFGRVYRGIL 669
Query: 922 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981
+DGT+VAVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLIGIC EE++R LVYELIPNG
Sbjct: 670 EDGTEVAVKVLKRDDLQGGREFLAEVEMLSRLHHRNLVKLIGICTEERSRSLVYELIPNG 729
Query: 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041
SVESHLHGVDKE+APL W++R+KIALGAAR L+YLHEDSSPRVIHRDFKSSNILLEHDFT
Sbjct: 730 SVESHLHGVDKETAPLDWESRVKIALGAARGLSYLHEDSSPRVIHRDFKSSNILLEHDFT 789
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1101
PKVSDFGLAR+AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+G
Sbjct: 790 PKVSDFGLARTAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 849
Query: 1102 RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 1161
RKPVDM+QPPG+ENLV+WARPLLTS+EGL+ IID S+ ++VPF+++AKVAAIASMCVQPE
Sbjct: 850 RKPVDMSQPPGEENLVSWARPLLTSKEGLDVIIDKSIDSNVPFENIAKVAAIASMCVQPE 909
Query: 1162 VQHRPFMGEVVQALKLVCNECDEAKEVGS-ASSSQDDMSIDLDSKVSTGSGQLPDPLQRH 1220
V HRPFMGEVVQALKLVCN+C+ +E S A SS + +ID + ++ S + D
Sbjct: 910 VSHRPFMGEVVQALKLVCNQCNTTRETSSHAGSSPESSTIDTNDDEASSSRYMLDSFHSE 969
Query: 1221 YSVPNYDLGLDT-GRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRG-RQFWQRIR 1278
Y VPN GLD+ LS+S L ++S +GK+ES R SS P R G+G R FW+R+R
Sbjct: 970 YLVPNSFPGLDSIDTHLSISDLLNTSIGNGKQESRSLERCFSSSPHRIGKGKRNFWERMR 1029
Query: 1279 RLVGGSDSEHGAVFSLWPGS 1298
R G S SEHG W GS
Sbjct: 1030 RYSGNSISEHGMPTKTWSGS 1049
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112136|ref|XP_002332826.1| predicted protein [Populus trichocarpa] gi|222833257|gb|EEE71734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2491), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/666 (74%), Positives = 552/666 (82%), Gaps = 11/666 (1%)
Query: 637 NADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQ 696
+ADCS T+CTEPYTNTPPGSPCGCV PMQVGL +SVALYTFFPLVSELA EIA GVFMKQ
Sbjct: 7 SADCSATVCTEPYTNTPPGSPCGCVLPMQVGLSVSVALYTFFPLVSELAQEIATGVFMKQ 66
Query: 697 SQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEV 755
SQV IIGANAA +QP+KT++L DLVPLGE+FDNTTAF YQRFWHKQVVI S+FGDYEV
Sbjct: 67 SQVHIIGANAASQQPEKTIILVDLVPLGERFDNTTAFFIYQRFWHKQVVINPSFFGDYEV 126
Query: 756 LYVRYPGLPPSPPSASSSIGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAI 813
LYVRY GLPPSP A S I IIDDGPYSG NN R KP GVDV R+ K GL G+IAI
Sbjct: 127 LYVRYLGLPPSPHLAPSGIAIIDDGPYSGDDNNARTIKPLGVDV-HRKHKNGLGHGVIAI 185
Query: 814 VVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSAS 873
+ LS VA+VL SA AW LLF+++ A Q+E V Q L S VKPSG AG +VGSGL SAS
Sbjct: 186 IALSGVVALVLFSAVAWALLFRHRDRASQSETVLQPLPPSVVKPSGIAGSLVGSGLSSAS 245
Query: 874 LSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK 933
LSFGSSI Y GSAKTFS S+IE+AT +FDASRILGEGGFG VY GVL+DGTKVA+KVLK
Sbjct: 246 LSFGSSIPAYAGSAKTFSTSDIERATNSFDASRILGEGGFGRVYCGVLEDGTKVAIKVLK 305
Query: 934 RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKE 993
R DQQGGREFLAEVEMLSRLHHRNLVKLIGIC EE++R LVYELIPNGSVESHLHG
Sbjct: 306 RDDQQGGREFLAEVEMLSRLHHRNLVKLIGICTEERSRSLVYELIPNGSVESHLHG---- 361
Query: 994 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053
SA L WDAR+KIALGAAR LAYLHEDSSP VIHRDFKSSNILLEHDFTPKVSDFGLAR+A
Sbjct: 362 SASLDWDARIKIALGAARGLAYLHEDSSPCVIHRDFKSSNILLEHDFTPKVSDFGLARTA 421
Query: 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+DEE++HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQ
Sbjct: 422 LDEENQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQ 481
Query: 1114 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
ENLV WARPLLTS+EGL+ IIDPSLG+DVPFDSVAKVAAIASMCVQPEV +RPFMGEVVQ
Sbjct: 482 ENLVTWARPLLTSKEGLKLIIDPSLGSDVPFDSVAKVAAIASMCVQPEVSNRPFMGEVVQ 541
Query: 1174 ALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTG 1233
ALKLV NECDEAKE+ S SSSQ +SID+D++VS SGQL Q H V NYD D
Sbjct: 542 ALKLVSNECDEAKELDSRSSSQ-GLSIDMDAEVSAVSGQLRGAFQNHALVLNYDSEPDIE 600
Query: 1234 RRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFS 1293
R L +S L S+S G+E RR SSGPLR RGR+ +++ RL G + SE G +F
Sbjct: 601 RGLPVSDLLSTSVGYGREGCGSLRR-CSSGPLRKVRGRELLRKM-RLTGETVSERGTIFK 658
Query: 1294 LWPGSY 1299
+WPGS+
Sbjct: 659 MWPGSH 664
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738662|emb|CBI27907.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2487), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/992 (59%), Positives = 662/992 (66%), Gaps = 159/992 (16%)
Query: 400 PSNTALTPASHPSNIAPPPLFVPVL-----PSALPGKAPVSQSPISLPDAPAA----TPR 450
PSN ++P P PP L VP+ PSA KAP +++P+ P AP A P
Sbjct: 122 PSNPRMSP---PHYKTPPHLKVPITLPSVPPSASQRKAPDNKAPVWAPVAPIAPVAPVPD 178
Query: 451 GNFHRHSPAI------HPSMPGPLPPVAQKRNASNREAPIAEPIAPGP------FPPGNS 498
G R P HP MPG LPP A RN + +API+ PIAP P PP S
Sbjct: 179 GPPQRKWPQNPPSMHPHPVMPGLLPPSAHNRNKPDNKAPISTPIAPDPDVTPISTPPLAS 238
Query: 499 ---RQKSPVARPIIPGGTPTASPDP----------------------------------- 520
R++ PVA P P +PDP
Sbjct: 239 HWRRKQMPVAAP------PNRTPDPLSPVNHSPAKAPSIHNAMRHSNAPASLSTPQSPTN 292
Query: 521 ---DVPPSTPPLSVDGKRVGK-----PVAEPSYDIPMPPPVNHSP--SKGPVVPPSFIPT 570
P S+P +S G+ P SY IP P P + P S P PP +P
Sbjct: 293 KGSQSPASSPSMSFSKHHRGRNKITGPAPASSYLIPPPSPRHQGPVISPAPSHPPKSLPN 352
Query: 571 SRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEP 627
+ H+ P PLN +SP+HSP P+ ++ +PSPSPT+ SGQT +P L PK SPS
Sbjct: 353 RTRTHHAPLPLNPGSRISPAHSPSPSSLTYPSPAPSPSPTARSGQTMIPFLSPKISPSR- 411
Query: 628 IRAFPP---------------PPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSV 672
PP PPPN DCS +CTEP TNTPPGSPCGCV PMQV LRL+V
Sbjct: 412 ---LPPSSKMPAPPPVQALPPPPPNQDCSAIVCTEPNTNTPPGSPCGCVLPMQVQLRLNV 468
Query: 673 ALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAAE-QPDKTVVLTDLVPLGEKFDNTTA 731
ALYTFFPLVSELA EIAAGVFM+QSQVRI+GANAA + +KT+VL DLVPLGEKFDNTTA
Sbjct: 469 ALYTFFPLVSELAEEIAAGVFMRQSQVRIMGANAASPEAEKTIVLIDLVPLGEKFDNTTA 528
Query: 732 FLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSG--NNGRA 789
FLTYQRFW KQVVIK+ +FGDYEV+YV YPGLPPSPPSA SSI +ID+GPYSG NNGR
Sbjct: 529 FLTYQRFWGKQVVIKNLFFGDYEVIYVNYPGLPPSPPSAPSSITMIDNGPYSGQGNNGRT 588
Query: 790 TKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQ- 848
P GVDV K R K+GLSG +IAI+VLSA VAVVLCSA AWV LFK C + VP
Sbjct: 589 IHPLGVDVHKNRHKHGLSGSVIAIIVLSASVAVVLCSAVAWVFLFKKTD--CIGQPVPTQ 646
Query: 849 -SLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRI 907
+L S +P GAAG +VGS SASLSFGSSIATYTGSAKTFSA++IE+AT NFD SRI
Sbjct: 647 AALVPSLARPPGAAGSVVGSAPSSASLSFGSSIATYTGSAKTFSAADIERATDNFDDSRI 706
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
LGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLIGIC E
Sbjct: 707 LGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREFLAEVEMLSRLHHRNLVKLIGICTE 766
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
E+ RCLVYELIPNGSVESHLHG DKE+APL W AR+K+ALGAAR LAYLHEDSSPRVIHR
Sbjct: 767 ERTRCLVYELIPNGSVESHLHGADKETAPLDWGARIKVALGAARGLAYLHEDSSPRVIHR 826
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 1087
DFKSSNILLEHDFTPKVSDFGLAR+AMDEE+RHISTRVMGTFGYVAPEYAMTGHLL
Sbjct: 827 DFKSSNILLEHDFTPKVSDFGLARTAMDEENRHISTRVMGTFGYVAPEYAMTGHLL---- 882
Query: 1088 VYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSV 1147
ENLVAWARPLLTS+EGL+ +ID SLG+DVPFDSV
Sbjct: 883 --------------------------ENLVAWARPLLTSKEGLQTMIDLSLGSDVPFDSV 916
Query: 1148 AKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVS 1207
AKVAAIASMCVQPEV HRPFMGEVVQALKLVCNECDE KE
Sbjct: 917 AKVAAIASMCVQPEVSHRPFMGEVVQALKLVCNECDETKE-------------------- 956
Query: 1208 TGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRT 1267
+GQLPDP H+ V Y GLD LS+S LFS+SAR G++ S FRRYSSSGPLRT
Sbjct: 957 --AGQLPDPSHAHFPVSTYGSGLDAETGLSVSELFSTSARFGRQPSGSFRRYSSSGPLRT 1014
Query: 1268 GRGRQFWQRIRRLVGGSDSEHGAVFSLWPGSY 1299
GR R FWQR+RR GGS SEHG +F L PGS+
Sbjct: 1015 GRARHFWQRMRRNSGGSVSEHGIMFRLRPGSH 1046
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1299 | ||||||
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.565 | 0.660 | 0.599 | 1.6e-254 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.483 | 0.844 | 0.523 | 6.6e-162 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.336 | 0.617 | 0.429 | 8.2e-120 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.315 | 0.538 | 0.429 | 8.8e-115 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.293 | 0.559 | 0.446 | 1.4e-110 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.303 | 0.547 | 0.430 | 3.8e-105 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.237 | 0.422 | 0.481 | 8.2e-105 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.270 | 0.484 | 0.540 | 6.3e-104 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.273 | 0.5 | 0.452 | 1.2e-102 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.221 | 0.441 | 0.513 | 1.2e-101 |
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2159 (765.1 bits), Expect = 1.6e-254, Sum P(3) = 1.6e-254
Identities = 459/766 (59%), Positives = 534/766 (69%)
Query: 538 KPVAEPSYDIPMPPPV---NHSPSKGPVVPPSFIPTSRKRHYGP-PPL--NSVSPSHXXX 591
K +A+ P+PP + S KG + PP P S H+ P PP+ + +SP+H
Sbjct: 354 KKIADSPAPSPLPPHLISPKKSNRKGSMTPP---PQS---HHAPSPPIPDSLISPAHAPV 407
Query: 592 XXXXXXXXXXXXXXXXXXXGQTXXXXXXXXXXXXXX--IRAFXXXXXNADCSTTICTEPY 649
++AF N+DCS+TIC EPY
Sbjct: 408 SFSMKRISPALAPSPTQVFPLRSSSRPSKSRKFPLGPPLQAFPPPPPNSDCSSTICLEPY 467
Query: 650 TNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-E 708
TNTPPGSPCGCVWP+QV LRLS+ALY FFP+VSE A EI+AGVFMKQSQVRI+GANAA E
Sbjct: 468 TNTPPGSPCGCVWPIQVELRLSMALYDFFPMVSEFAREISAGVFMKQSQVRIMGANAASE 527
Query: 709 QPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRXXXXXXXXX 768
QP+K++VL DLVPLG+KFDN TA LTYQRFW K+V I FG Y+V+YVR
Sbjct: 528 QPEKSIVLIDLVPLGDKFDNMTAMLTYQRFWSKKVYIDEPIFGGYDVIYVRYPGLPASPP 587
Query: 769 XXXXXXXXXXXXXXXXNNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAA 828
NNGRA KP GVDVP++ +K L+GG IA++VLSA + LC
Sbjct: 588 TSGMTIIDQGPYSGN-NNGRAVKPLGVDVPRKPRKKELNGGSIAVIVLSAAAFIGLCFVI 646
Query: 829 AWVLLFK-YKSHACQAEEVPQSLQT--SHVKPSGAAGLMVGSGLDSASLSFGSSIATYTG 885
W L+F+ + ++ P + + S KPSG+A + GS S SLSF SSIA +T
Sbjct: 647 VWFLVFRRQRDRRRLSKRTPLARPSLPSLSKPSGSARSLTGSRFSSTSLSFESSIAPFTL 706
Query: 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 945
SAKTF+ASEI KAT NFD SR+LGEGGFG VY GV DDGTKVAVKVLKR DQQG REFLA
Sbjct: 707 SAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFLA 766
Query: 946 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1005
EVEMLSRLHHRNLV LIGICIE++ R LVYELIPNGSVESHLHG+DK S+PL WDARLKI
Sbjct: 767 EVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLKI 826
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTR 1064
ALGAAR LAYLHEDSSPRVIHRDFKSSNILLE+DFTPKVSDFGLAR+A+D+E +RHISTR
Sbjct: 827 ALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHISTR 886
Query: 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124
VMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLV+W RP L
Sbjct: 887 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPFL 946
Query: 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1184
TS EGL IID SLG ++ FDS+AKVAAIASMCVQPEV HRPFMGEVVQALKLV NECDE
Sbjct: 947 TSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLVSNECDE 1006
Query: 1185 AKEVGSASS-SQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGXXXXXXXXXX 1243
AKE+ S +S S+DD D ++ S G + R+ +PNYD DT
Sbjct: 1007 AKELNSLTSISKDDFRDDTQAESSCGDSSAR--MARYPLLPNYDSEPDT---ERGLSTSE 1061
Query: 1244 XXXXXGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHG 1289
G+ F R S+SGPL +GRG+ FWQ++RRL GS SEHG
Sbjct: 1062 MYTGSGR-----FERQSNSGPLTSGRGKSFWQKMRRLSTGSLSEHG 1102
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1544 (548.6 bits), Expect = 6.6e-162, Sum P(2) = 6.6e-162
Identities = 354/676 (52%), Positives = 434/676 (64%)
Query: 639 DCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQ 698
DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG +++QSQ
Sbjct: 97 DCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYLEQSQ 155
Query: 699 VRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLY 757
V+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDYEV +
Sbjct: 156 VKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDYEVTH 215
Query: 758 VRXXXXXXXXXXXXXXXXXXXXXXXXXNNGRAT--KPEGVDVPKRRQKY-----GLSGGM 810
+ NG T P G+ +P + G+
Sbjct: 216 I-----------------SYPGIPSSSPNGDVTGDAPGGLPIPINATTFANKSQGIGFRT 258
Query: 811 IAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLD 870
IAI+ LS FV +++ A +++ K+K + V +L S K GA + S
Sbjct: 259 IAIIALSGFVLILVLVGAISIIV-KWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARS 317
Query: 871 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVK 930
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VAVK
Sbjct: 318 SGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVK 377
Query: 931 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 990
+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 378 LLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-- 435
Query: 991 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFGLA
Sbjct: 436 ---EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 492
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110
R A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+QP
Sbjct: 493 REAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQP 551
Query: 1111 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170
G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFMGE
Sbjct: 552 SGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGE 611
Query: 1171 VVQALKLVCNECDEA-KEVGSASSSQDDMSIDL--DSKVSTGSGQLPDPLQRHYSVPNY- 1226
VVQALKL+ N+ DE + S S S D D S S P R+ ++
Sbjct: 612 VVQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWNLTPRLRYGQASSFI 671
Query: 1227 DLGLDTGXXXXXXXXXXXXXXXGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLV---GG 1283
+ +G + + + SGPLR R R+ + R+R + GG
Sbjct: 672 TMDYSSGPLEDMENRPHSASSIPRVGGLILP--NRSGPLRPMRSRRNFFRLRGSMSEHGG 729
Query: 1284 -SDSEHGAVFSLWPGS 1298
S S H LW G+
Sbjct: 730 PSSSRH-----LWSGN 740
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 8.2e-120, Sum P(3) = 8.2e-120
Identities = 195/454 (42%), Positives = 259/454 (57%)
Query: 786 NGRATKPEGVDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQA 843
N +P +D P G+ +G ++ I V A V L W L + K A
Sbjct: 257 NNPTLRPP-LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSG 315
Query: 844 EEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGS--SIATYTGSAKT-FSASEIEKATG 900
+V S +S + A M S AS GS S + G++K FS E+ KAT
Sbjct: 316 GDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATN 375
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
F +LGEGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV
Sbjct: 376 GFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVS 435
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
++G CI R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED
Sbjct: 436 IVGHCISGDRRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDC 492
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
PR+IHRD KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G
Sbjct: 493 HPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSG 551
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPS 1137
L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP
Sbjct: 552 KLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPK 611
Query: 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SS 1193
LG + + ++ A CV+ RP MG++V+A + L + +G + +S
Sbjct: 612 LGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNS 671
Query: 1194 SQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYD 1227
+Q I L +++ GS H S + D
Sbjct: 672 AQQSAEIRLFRRMAFGSQNYSTDFFSHSSYNSRD 705
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 8.8e-115, Sum P(3) = 8.8e-115
Identities = 184/428 (42%), Positives = 249/428 (58%)
Query: 805 GLSGGMIAIVVLSAFVAVVLCSAAAWVLLFK----YKSHACQAEEVPQSLQTSHVKPSGA 860
G+S G +A+V+L+ VV C L Y P+S ++ +K +
Sbjct: 332 GVSIG-VALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRS-DSALLKTQSS 389
Query: 861 AGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV 920
A L VG+ + + S + S + FS E+ AT F +LGEGGFG VY GV
Sbjct: 390 APL-VGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGV 448
Query: 921 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980
L D VAVK LK QG REF AEV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN
Sbjct: 449 LPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPN 508
Query: 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040
++ HLH L W R+KIA GAAR LAYLHED PR+IHRD KSSNILLE++F
Sbjct: 509 NNLYFHLHAAGTPG--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNF 566
Query: 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
VSDFGLA+ A+D + HI+TRVMGTFGY+APEYA +G L KSDV+S+GVV+LEL++
Sbjct: 567 HALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 625
Query: 1101 GRKPVDMTQPPGQENLVAWARPLL---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMC 1157
GRKPVD +QP G E+LV WARPLL T E + DP LG + + ++ A+ C
Sbjct: 626 GRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAAC 685
Query: 1158 VQPEVQHRPFMGEVVQALKLVCNE-CDEAKEVGSA---SSSQDDMSIDLDSKVSTGSGQL 1213
++ RP M ++V+A + E +G + +S+Q I L +++ GS
Sbjct: 686 IRHSATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNY 745
Query: 1214 P-DPLQRH 1220
D L R+
Sbjct: 746 STDSLTRN 753
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 1.4e-110, Sum P(3) = 1.4e-110
Identities = 182/408 (44%), Positives = 249/408 (61%)
Query: 785 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSH--ACQ 842
NNG T P P + + G +GG++AI V+ V + L W + +
Sbjct: 217 NNGNNTLPSSS--PGKSE-VG-TGGIVAIGVIVGLVFLSLFVMGVWFTRKRKRKDPGTFV 272
Query: 843 AEEVPQSLQTSHVKPSGAAGLMVGSG------LDSASLS---FGSSIATYTGSAKT-FSA 892
+P S +S P G+ ++ S + S S S + SS + + ++ FS
Sbjct: 273 GYTMPPSAYSS---PQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSY 329
Query: 893 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 952
E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE++SR
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH + + W+ R+++A GAAR
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGAARG 447
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGY 1071
+AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STRVMGTFGY
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGY 507
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL---TSRE 1128
+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL E
Sbjct: 508 MAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENE 567
Query: 1129 GLERIIDPSLG-NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
+ ++DP LG N +P + V A A+ CV+ RP M +VV+AL
Sbjct: 568 EFDELVDPRLGKNFIPGEMFRMVEAAAA-CVRHSAAKRPKMSQVVRAL 614
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 3.8e-105, Sum P(2) = 3.8e-105
Identities = 181/420 (43%), Positives = 242/420 (57%)
Query: 848 QSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKT-FSASEIEKATGNFDASR 906
Q Q+S G AG G S G+ + GS +T FS E+ + T F
Sbjct: 319 QQQQSSMGNSYGTAG---GGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKN 375
Query: 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
ILGEGGFG VY G L DG VAVK LK QG REF AEVE++SR+HHR+LV L+G CI
Sbjct: 376 ILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCI 435
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+Q R L+YE + N ++E HLHG K L W R++IA+G+A+ LAYLHED P++IH
Sbjct: 436 SDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIH 493
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD KS+NILL+ ++ +V+DFGLAR D H+STRVMGTFGY+APEYA +G L +S
Sbjct: 494 RDIKSANILLDDEYEAQVADFGLAR-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 552
Query: 1087 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REG-LERIIDPSLGNDVP 1143
DV+S+GVV+LEL++GRKPVD TQP G+E+LV WARPLL G L +ID L
Sbjct: 553 DVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYV 612
Query: 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLD 1203
V ++ A+ CV+ RP M +VV+AL +CD + G S+ I +
Sbjct: 613 EHEVFRMIETAAACVRHSGPKRPRMVQVVRAL-----DCDG--DSGDISNG-----IKIG 660
Query: 1204 SKVSTGSGQLPDPLQRHYSVP-NYDLGLDTGXXXXXXXXXXXXXXXGKE-ESELF--RRY 1259
+ SGQ + + + + D +++G G E E+ F RR+
Sbjct: 661 QSTTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNESETRPFNNRRF 720
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 8.2e-105, Sum P(2) = 8.2e-105
Identities = 153/318 (48%), Positives = 208/318 (65%)
Query: 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 949
FS E+ KATG F +LGEGGFG V+ GVL +GT+VAVK LK QG REF AEV+
Sbjct: 377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDT 436
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
+SR+HH++LV L+G C+ R LVYE +P ++E HLH + + L W+ RL+IA+GA
Sbjct: 437 ISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLH--ENRGSVLEWEMRLRIAVGA 494
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR--HISTRVMG 1067
A+ LAYLHED SP +IHRD K++NILL+ F KVSDFGLA+ D S HISTRV+G
Sbjct: 495 AKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVG 554
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-- 1125
TFGY+APEYA +G + KSDVYS+GVV+LEL++GR + ++LV WARPLLT
Sbjct: 555 TFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQSLVDWARPLLTKA 614
Query: 1126 -SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK--LVCNEC 1182
S E + ++D L + +A +AA A+ C++ RP M +VV+AL+ + +
Sbjct: 615 ISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRALEGEVALRKV 674
Query: 1183 DEAKEVGSASSSQDDMSI 1200
+E + SSS++ I
Sbjct: 675 EETGNSVTYSSSENPNDI 692
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.3e-104, Sum P(3) = 6.3e-104
Identities = 199/368 (54%), Positives = 251/368 (68%)
Query: 813 IVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSA 872
++++ + A VL A VL+ S A + E+ P + + VKP LD+
Sbjct: 306 LILIFSIAAGVLILAIITVLVIC--SRALREEKAPDPHKEA-VKPRN---------LDAG 353
Query: 873 SLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVL 932
S FG S+ + S + S E+++AT NF+++ ILGEGGFG VY G+L DGT VA+K L
Sbjct: 354 S--FGGSLP-HPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKL 410
Query: 933 KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYELIPNGSVESHLHGV 990
QG +EF E++MLSRLHHRNLVKL+G + L YEL+PNGS+E+ LHG
Sbjct: 411 TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGP 470
Query: 991 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
+ PL WD R+KIAL AAR LAYLHEDS P VIHRDFK+SNILLE++F KV+DFGLA
Sbjct: 471 LGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLA 530
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110
+ A + H+STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QP
Sbjct: 531 KQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 590
Query: 1111 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170
GQENLV W RP+L ++ LE ++D L P + +V IA+ CV PE RP MGE
Sbjct: 591 SGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGE 650
Query: 1171 VVQALKLV 1178
VVQ+LK+V
Sbjct: 651 VVQSLKMV 658
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 1.2e-102, Sum P(4) = 1.2e-102
Identities = 166/367 (45%), Positives = 222/367 (60%)
Query: 834 FKYKSHACQAEEVPQSLQTSHVKPSGAA-GLMVGSGLDSASLSFGSSIATYTGSAKT-FS 891
F Y + + P + SG + G G G + S S S GS +T F+
Sbjct: 285 FLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVM--GSGQTHFT 342
Query: 892 ASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 951
E+ T F ILGEGGFG VY G L+DG VAVK LK QG REF AEVE++S
Sbjct: 343 YEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIIS 402
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
R+HHR+LV L+G CI + R L+YE +PN ++E HLHG K L W R++IA+G+A+
Sbjct: 403 RVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGSAK 460
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
LAYLHED P++IHRD KS+NILL+ +F +V+DFGLA+ D H+STRVMGTFGY
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LNDSTQTHVSTRVMGTFGY 519
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REG 1129
+APEYA +G L +SDV+S+GVV+LEL++GRKPVD QP G+E+LV WARPLL G
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 1130 -LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV--CNECDEAK 1186
++D L + V ++ A+ CV+ RP M +VV+AL +
Sbjct: 580 DFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGN 639
Query: 1187 EVGSASS 1193
+VG +S+
Sbjct: 640 KVGQSSA 646
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 1.2e-101, Sum P(3) = 1.2e-101
Identities = 151/294 (51%), Positives = 206/294 (70%)
Query: 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 945
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 946 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1005
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1125
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 1126 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00016557001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (681 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1299 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-36 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-31 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-27 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-18 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-16 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-16 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 4e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-14 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-14 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-13 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-11 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-11 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 4e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-10 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-09 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-09 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-08 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-08 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 7e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 8e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 9e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 9e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-07 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-07 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 4e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 9e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-06 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-06 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-06 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 5e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 7e-06 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 7e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 7e-06 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 9e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 9e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 1e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 3e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-05 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 4e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 6e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 6e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 7e-05 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 7e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 8e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 8e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 9e-05 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 9e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 2e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 3e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 3e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 3e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 3e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 4e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 5e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 5e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 5e-04 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 6e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 6e-04 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 6e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 7e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 7e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 7e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 8e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 8e-04 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-04 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 8e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 9e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.001 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.001 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.001 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 0.001 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.001 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.001 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.001 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.002 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 0.002 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.002 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.002 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.002 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.002 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.002 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.002 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.002 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.002 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.002 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.003 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.003 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 0.003 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.003 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.003 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.003 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 0.003 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.003 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.003 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 0.003 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.004 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 0.004 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.004 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.004 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.004 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.004 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.004 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.004 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.004 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.004 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.004 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.004 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.004 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| COG3170 | 755 | COG3170, FimV, Tfp pilus assembly protein FimV [Ce | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 88/283 (31%), Positives = 129/283 (45%), Gaps = 41/283 (14%)
Query: 905 SRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 958
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
VKL+G+C EE+ +V E + G + S+L K L L AL AR + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES-RHISTRV----MGTFGYVA 1073
S IHRD + N L+ + K+SDFGL+R D++ R ++ M A
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM------A 171
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132
PE G KSDV+S+GV++ E+ + G +P PG N L + L +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRLPQ 224
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
P + ++ + C + + RP E+V+ L
Sbjct: 225 ----------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-56
Identities = 84/277 (30%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 906 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
KL+G+C EE+ +V E +P G + +L L L AL AR + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
S IHRD + N L+ + K+SDFGL+R + ++ + ++APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138
G KSDV+S+GV++ E+ + G +P PG N L L +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPK------ 225
Query: 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
P + ++ + C + + RP E+V+ L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 3e-53
Identities = 73/195 (37%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGIC 965
LGEGGFG VY G KVA+K++K+ D E L E+E+L +L+H N+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E LV E GS++ L + L D L+I L L YLH S +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 1026 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1083
HRD K NILL + K++DFGL++ + + ++GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 1084 VKSDVYSYGVVILEL 1098
KSD++S GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-53
Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 906 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
+ LGEG FG VY G L TKVAVK LK ++ EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+G+C + + +V E +P G + L K L L++AL A+ + YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV-----AP 1074
S +HRD + N L+ + K+SDFGL+R +++ G + AP
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKWMAP 173
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
E G KSDV+S+GV++ E+ + G +P P +++ E LE +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELL 217
Query: 1134 IDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
D G P + ++ + C + + RP E+V+ L
Sbjct: 218 ED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-50
Identities = 76/203 (37%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLI 962
R LG G FG VY G VAVK+LK+ + + + E+ +L RL H N+V+LI
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
++ LV E G L PL D KIAL R L YLH +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-YAMTGH 1081
+IHRD K NILL+ + K++DFGLA+ + + S ++T V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 1082 LLVKSDVYSYGVVILELLSGRKP 1104
K DV+S GV++ ELL+G+ P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 8e-50
Identities = 86/282 (30%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 960
+ LGEG FG VY G L T+VAVK LK + R +FL E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAY 1015
L+G+C EE+ LV E + G + +L E + L L A+ A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
L S + +HRD + N L+ D K+SDFGL+R D++ T ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134
G KSDV+S+GV++ E+ + G P PG N L L +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-----PGLSN--EEVLEYLRKGYRLPK-- 228
Query: 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P D ++ + C Q + + RP E+V+ L+
Sbjct: 229 -PEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIG 963
LGEG FG VY G VA+KV+K+ + RE L E+++L +L H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ +E LV E G + L + S +AR AL YLH S
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED---EAR-FYLRQILSALEYLH---SKG 117
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
++HRD K NILL+ D K++DFGLAR + ++T V GT Y+APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 1084 VKSDVYSYGVVILELLSGRKP 1104
D++S GV++ ELL+G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+LG G FG VY + D G +AVK L ++ E+ +LS L H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 963 GICIEEQARCL-VY-ELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLH 1017
G +E+ L ++ E + GS+ S L K P+ R +I G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQILEG----LAYLH 118
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
S ++HRD K +NIL++ D K++DFG A+ D E+ + V GT ++APE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
+D++S G ++E+ +G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 958
R LGEG FG V+ G +D VAVK LK R+ F E E+L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVD--------KESAPLGWDARLKIALG 1008
VK G+C E +V+E + +G + L HG D L L+IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
A + YL +S +HRD + N L+ +D K+ DFG++R + + M
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 1069 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++ PE M +SDV+S+GVV+ E+ + G++P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 87/293 (29%), Positives = 134/293 (45%), Gaps = 37/293 (12%)
Query: 905 SRILGEGGFGLVYSGVLD---DGT--KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 958
+ LGEG FG V D D T +VAVK L ++Q +F E+E+L L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 959 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
VK G+C + R L+ E +P+GS+ +L + + L + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVA 1073
S R IHRD + NIL+E + K+SDFGLA+ + E+ + + G F Y A
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWY-A 180
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLS-GRK-------PVDMTQPPGQENLVAWARPLLT 1125
PE T SDV+S+GV + EL + G + M + +V LL
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 1126 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178
E L R PS ++V +D + +C + E Q RP +++ + +
Sbjct: 241 EGERLPR--PPSCPDEV-YD-------LMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961
F R LG G FG V+ G+ + +VA+K+LK D ++F EV+ L RL H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
+C + ++ EL+ GS+ + L E L + + +A A +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1081
IHRD + NIL+ D KV+DFGLAR + +E ++S+ + + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 1082 LLVKSDVYSYGVVILELLS 1100
KSDV+S+G+++ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
+G+G FG V G G KVAVK LK D + FLAE +++ L H NLV+L+G+ ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
+V E + GS+ +L + A + +L AL + YL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 1087
D + N+L+ D KVSDFGLA+ + S ++ + APE KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFSTKSD 181
Query: 1088 VYSYGVVILELLS-GRKP 1104
V+S+G+++ E+ S GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 908 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G+GGFG VY G +VA+KV+K ++ + + E+++L + H N+VK G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 967 EEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
++ +V E GS++ + ES A + + L YLH +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTES----QIA--YVCKELLKGLEYLHSN---G 118
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
+IHRD K++NILL D K+ DFGL+ D ++R+ ++GT ++APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYD 175
Query: 1084 VKSDVYSYGVVILELLSGRKP 1104
K+D++S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGI 964
+G+G FG VY GVL T+VAVK + + FL E E+L + H N+VKLIG+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
C+++Q +V EL+P GS+ + L K+ L L+++L AA + YL S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT----FGYVAPEYAMTG 1080
IHRD + N L+ + K+SDFG++R EE I T G + APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 1081 HLLVKSDVYSYGVVILELLSG 1101
+SDV+SYG+++ E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-31
Identities = 146/608 (24%), Positives = 199/608 (32%), Gaps = 70/608 (11%)
Query: 62 APSPIELPTHSAPP-PVNIPSFSPSTPAV--SAPFDMAPPPSLIP----TNPVASPPSIT 114
A P PP P P+ S PA+ P P ++ +AS +
Sbjct: 2491 AAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGD 2550
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPP 174
PPP+ A PP + PPP AP PA + P A P S++ P
Sbjct: 2551 PPPPLPPAAPP---AAPDRSVPPPRPAPRPSE--PAVTSRARRPDAPPQSARPRAPVDDR 2605
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPP-PASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ P P PP +H PP P+ + P P + P
Sbjct: 2606 GDPRGPAPPSPL----PPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRV 2661
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
+ A ++PP P S S PPP AP +
Sbjct: 2662 SRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPL 2721
Query: 294 APPPAS----HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP--PASHSSK 347
P PA+ P+ A P P PP + P APP PA+ +
Sbjct: 2722 PPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPR 2781
Query: 348 TAPPPASHPSNTALPPASHPSNPAIPPAS-HPSNTAIPPASHPSNTAPPHASHPSNTALT 406
PA + + P +PA PPA+ A+PPA+ P+ PP T+
Sbjct: 2782 RLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPP------PTSAQ 2835
Query: 407 PASHPSNIAPPPLFVPVLPSALPG----KAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
P + P PPP +P+ S PG + P S+SP + P APA P R + +
Sbjct: 2836 PTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVS-RS 2894
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDV 522
+ LPP +R P P PP Q P +P P P P P +
Sbjct: 2895 TESFALPPDQPER----------PPQPQAPPPPQPQPQPPPPPQPQPPPPPP-PRPQPPL 2943
Query: 523 PPSTPPLSVDGKRVGKPVAEPSYDIPMPP-----------PVNHSPSKGPVVPPSFIPTS 571
P+T P EPS +P P P P P T
Sbjct: 2944 APTTDP---------AGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTP 2994
Query: 572 RKRHYGPPPLNSVSPS----HSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEP 627
+ ++S + S P PVS T P T S L + S E
Sbjct: 2995 PLTGHSLSRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEA 3054
Query: 628 IRAFPPPP 635
+ PP P
Sbjct: 3055 LDPLPPEP 3062
|
Length = 3151 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
R LG G FG V+ G+ ++ T VAVK LK ++FLAE +++ +L H L++L +C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
E+ +V EL+ GS+ +L G L + +A A +AYL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1083
HRD + N+L+ + KV+DFGLAR ++ R F + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFS 182
Query: 1084 VKSDVYSYGVVILELLS-GRKP 1104
+KSDV+S+G+++ E+++ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 73/205 (35%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLI 962
R LG G FG V+ G + TKVAVK LK G FL E +++ +L H LV+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
+C EE+ +V E + GS+ L E L + +A A +AYL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTG 1080
IHRD + NIL+ + K++DFGLAR D+E + R F + APE A G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYG 179
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
+KSDV+S+G+++ E+++ GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-29
Identities = 84/358 (23%), Positives = 128/358 (35%), Gaps = 24/358 (6%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL-HHR 956
++ R LGEG FG VY D VA+KVL + + FL E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N+VKL +E + LV E + GS+E L PL L I AL YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 1017 HEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTR----VMGTFGY 1071
H +IHRD K NILL K+ DFGLA+ D S +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 1072 VAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128
+APE + + SD++S G+ + ELL+G P + + + L E
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-----LKIILE 229
Query: 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV-QALKLVCNECDEAKE 1187
+ L P + + + + ++R + L +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 1188 VGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSS 1245
+ + L + L + D + +
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHN 347
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 20/211 (9%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRN 957
N+ ++G G FG+VY G+ L+ G VA+K L+++ ++ + + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD--ARL--KIALGAARAL 1013
+VK IG + ++ E NGS L + K+ P A ++ G L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQG----L 112
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
AYLHE VIHRD K++NIL D K++DFG+A + +++ S+ ++ V+GT ++A
Sbjct: 113 AYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDAS-VVGTPYWMA 167
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
PE SD++S G ++ELL+G P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 76/213 (35%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 908 LGEGGFGLVYSGV--LDDGT--KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 962
LG G FG V GV + G +VAVK LK+ G +EFL E ++++L H +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI-ALGAARALAYLHEDSS 1021
G+C E LV EL P G + +L + P + LK A A +AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL--KKRREIP---VSDLKELAHQVAMGMAYLESK-- 114
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 1079
+HRD + N+LL + K+SDFG++R A+ S + G + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKPV-DMTQP 1110
G KSDV+SYGV + E S G KP +M
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 20/211 (9%)
Query: 906 RILGEGGFGLVYSGV---LDDGTK--VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG VY GV + K VA+KVL+ + +E L E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+GIC+ Q L+ +L+P G + ++ +G L + A+ ++YL E
Sbjct: 73 RLLGICLSSQV-QLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 1020 SSPRVIHRDFKSSNILLEHDFTP---KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
R++HRD + N+L++ TP K++DFGLA+ +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 1077 AMTGHLLVKSDVYSYGVVILELLS-GRKPVD 1106
+ KSDV+SYGV + EL++ G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
+G G FGLV+ G + KVA+K + R +F+ E +++ +L H LV+L G+C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
CLV+E + +G + +L + + L + L +AYL + VIHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 1087
D + N L+ + KVSDFG+ R +D++ ST + +PE KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 1088 VYSYGVVILELLS-GRKPVD 1106
V+S+GV++ E+ S G+ P +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLV 959
+ +G+G FG VY L DG +K L + ++ + L EV++L +L+H N++
Sbjct: 6 KQIGKGSFGKVY---LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
K E+ C+V E G + + KE P + L + AL YLH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE---- 1075
+++HRD K NI L + K+ DFG+++ + T V GT Y++PE
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQN 177
Query: 1076 --YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y KSD++S G V+ EL + + P
Sbjct: 178 KPYN------YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 89/270 (32%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+LG+G FG V+ G L D T VAVK K + Q+ +FL+E +L + H N+VKLIG+C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+ Q +V EL+P G S L K+ L +K AL AA +AYL S I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRD + N L+ + K+SDFG++R D+ S + APE G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 1086 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 1145
SDV+SYG+++ E S + + PG N A RE +E+ S P D
Sbjct: 175 SDVWSYGILLWETFS----LGVCPYPGMTNQQA--------REQVEKGYRMSCPQKCPDD 222
Query: 1146 SVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
V + C + ++RP E+ + L
Sbjct: 223 ----VYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 905 SRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 959
R +GEG FG VY GV ++ VAVK K RE FL E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
KLIG+ E +V EL P G + S+L V+K S L + + + + ALAYL
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLA--SLILYSYQLSTALAYLE-- 124
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
S R +HRD + N+L+ K+ DFGL+R +++ES + +++ ++APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINF 182
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
SDV+ +GV + E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-27
Identities = 136/574 (23%), Positives = 179/574 (31%), Gaps = 76/574 (13%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDM--APPPSLIPTNPVASPPS 112
P L AP P S PPP P PS PAV++ APP S P PV
Sbjct: 2552 PPPLPPAAPPAA--PDRSVPPPRPAPR--PSEPAVTSRARRPDAPPQSARPRAPVDDRGD 2607
Query: 113 ITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPAS 172
P P + PP T PPP + P N P P A S
Sbjct: 2608 PRGPAPPSPLPP-----DTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVS 2662
Query: 173 PPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP----SNTA 228
P A R + + PP R A P ++ A P P+P P S T
Sbjct: 2663 RPRRARRL--GRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATP 2720
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
LPP ++ A P PA P + P TA PPA P
Sbjct: 2721 LPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPA---- 2776
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPP-PASHPS-----NTAPPPASHPSNTAPPPA 342
PP A S S +P PA P+ A PPA+ P+ PPP
Sbjct: 2777 ----AGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPT 2832
Query: 343 SHSSKTAPPPASHPSNTALP-------------------PASHPSNPAIPPASHPSNTAI 383
S + TAPPP P +LP PA+ P+ PA PP + A+
Sbjct: 2833 S-AQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAV 2891
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPD 443
++ P P P + P P P P P P Q P++
Sbjct: 2892 SRSTESFALPPDQPERPP----QPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTT 2947
Query: 444 APAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSP 503
PA + P + +PG + P P P
Sbjct: 2948 DPAGAGEPSGAVPQPWLGALVPGRVA-------VPRFRVPQPAPSREAPASSTPPLTGHS 3000
Query: 504 VARPIIPGGTPTASPDPDVPPST------PPLSVDGKRVGKPVAEPSYDI------PMPP 551
++R + + D PP + PP + S P+PP
Sbjct: 3001 LSRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEALDPLPP 3060
Query: 552 PVNHSPSKGPVVPPSFIPT--SRKRHYGPPPLNS 583
+ + P S +GPPPL++
Sbjct: 3061 EPHDPFAHEPDPATPEAGARESPSSQFGPPPLSA 3094
|
Length = 3151 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 908 LGEGGFGLVYSGVLDDGT----KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 962
LG+G FG+V G VAVK LK +FL E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLG--WDARLKIALGAARALAYLHEDS 1020
G+ + +V EL P GS+ L + D ++IA G + YL
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLE--- 114
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST---RVMGTFGYVAPEYA 1077
S R IHRD + NILL D K+ DFGL R+ E ++ +V F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 1078 MTGHLLVKSDVYSYGVVILELLS-GRKP 1104
T SDV+ +GV + E+ + G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 906 RILGEGGFGLVYSG----VLDDGT---KVAVKVLKR--VDQQGGREFLAEVEMLSRLHHR 956
LG G FG VY G +L G+ +VAVK L++ DQ+ +EFL E ++S +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP---LGWDARLKIALGAARAL 1013
N+VKL+G+C+ + + ++ EL+ G + S+L E L L I L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 1014 AYLHEDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMD------EESRHIS 1062
YL + IHRD + N L+ + D K+ DFGLAR E +
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
R M APE + G +SDV+S+GV++ E+L+ G++P
Sbjct: 177 VRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 27/219 (12%)
Query: 908 LGEGGFGLVYSGVL------DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 958
LGEG FG VY G L T VA+K LK Q +EF E E++S L H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIA 1006
V L+G+C +EQ C+++E + +G + L G + + L L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
+ A + YL SS +HRD + N L+ T K+SDFGL+R + + ++ +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++ PE + G +SD++S+GVV+ E+ S G +P
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLIGI 964
LG G FG+V+ G VA+K+++ +G +F+ E +++ +L H NLV+L G+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
C +++ +V E + NG + ++L + LG + L + A+ YL +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGH 1081
IHRD + N L+ D KVSDFGLAR +D++ T GT + PE
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 1082 LLVKSDVYSYGVVILELLSGRK 1103
KSDV+S+GV++ E+ S K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-26
Identities = 120/510 (23%), Positives = 148/510 (29%), Gaps = 31/510 (6%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPAS--HPSRTAPPPASHPSNTALPSKTA 217
S L + FP A A + A P P APP S + LP +
Sbjct: 2466 LSLLLGELFPGAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEP- 2524
Query: 218 PSPASHPSNTALPPA--SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
HP L S A P L APP A P PA PS+ A
Sbjct: 2525 VGEPVHPRMLTWIRGLEELASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTS 2584
Query: 276 ASHPSNTAPPPASHPSKTAP--PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
+ + P A + P + PP +H PP PS A P H
Sbjct: 2585 RARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHA---PDPPPPSPSPAANEPDPH 2641
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALP--------PASHPSNPAIPPASHP-SNTAIP 384
P T PPP AP S P P P A P ++ A P
Sbjct: 2642 PPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADP 2701
Query: 385 PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKA-PVSQSPISLPD 443
P P+ PHA + + +P P P+ G A P + + P
Sbjct: 2702 PPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPP 2761
Query: 444 APAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSP 503
A P +PA P P VA + +P P + P
Sbjct: 2762 TTAGPPAPAPPA-APAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPP 2820
Query: 504 VARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVV 563
A P P PT S P PP P +G VA P PS+ P
Sbjct: 2821 AASPAGPLPPPT-SAQPTAPPPPPGPPPPSLPLGGSVA------PGGDVRRRPPSRSPAA 2873
Query: 564 PPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSS 623
P+ R P VS S P + P P P PP+
Sbjct: 2874 KPAAPARPPVRRLARPA---VSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQ 2930
Query: 624 PSEPIRAFPPPPPNADCSTTICTEPYTNTP 653
P P P PP EP P
Sbjct: 2931 PPPPPPPRPQPPLAPTTDPAGAGEPSGAVP 2960
|
Length = 3151 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 908 LGEGGFGLVY----SGVLDDGTK--VAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961
LGEG FG V+ +L + K VAVK LK + ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 962 IGICIEEQARCLVYELIPNGSVESHL--HGVDKE---------SAPLGWDARLKIALGAA 1010
G+C E + +V+E + +G + L HG D + L L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
+ YL +S +HRD + N L+ K+ DFG++R + + R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREG 1129
++ PE + +SD++S+GVV+ E+ + G++P W + L++ E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP--------------WYQ--LSNTEA 233
Query: 1130 LERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEV 1171
+E I + G ++ P +V AI C Q E Q R + ++
Sbjct: 234 IECI---TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 38/287 (13%)
Query: 906 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 958
R LG+G FG+VY G+ T+VA+K + R EFL E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAARA 1012
V+L+G+ Q +V EL+ G ++S+L E+ P +++A A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+AYL + +HRD + N ++ D T K+ DFG+ R + + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131
APE G KSDV+S+GVV+ E+ + +P G N E L+
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSN-----------EEVLK 232
Query: 1132 RIIDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ID G D+P + K+ + MC Q + RP E+V +LK
Sbjct: 233 FVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
+ +G G +G+V S V G KVA+K + V D + L E+++L L H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 963 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
I +V EL+ E+ LH V K PL D R L YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------HISTRVMGTFGY 1071
S VIHRD K SNIL+ + K+ DFGLAR +E ++ TR Y
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-----Y 172
Query: 1072 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
APE ++ K+ D++S G + ELL RKP
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 34/262 (12%)
Query: 907 ILGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
I+GEG FG V G G KVAVK +K V Q FL E ++++LHH+NLV+L+G+
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV- 67
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
I +V EL+ G++ + L + + L+ +L A + YL S +++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRD + NIL+ D KVSDFGLAR S + + + APE K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKL-PVKWTAPEALKHKKFSSK 177
Query: 1086 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1144
SDV+SYGV++ E+ S GR P P ++ +E E ++ + P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKEC-VEKGYRMEPPE 220
Query: 1145 DSVAKVAAIASMCVQPEVQHRP 1166
A V + + C + E + RP
Sbjct: 221 GCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 93/295 (31%), Positives = 131/295 (44%), Gaps = 41/295 (13%)
Query: 906 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 959
R+LGEG FG V Y D G VAVK LKR Q + E+ +L L+H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 960 KLIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
K G C E + L+ E +P GS+ +L K L L A +AYLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHK--LNLAQLLLFAQQICEGMAYLH 124
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAP 1074
S IHRD + N+LL++D K+ DFGLA+ A+ E + R G F Y A
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWY-AV 179
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSG--------RKPVDMTQPP-GQENLVAWARPLLT 1125
E SDV+S+GV + ELL+ +K +M P GQ +V L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV----RLIE 235
Query: 1126 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180
E R+ P + P + V + C + E + RP ++ LK + +
Sbjct: 236 LLERGMRLPCP---KNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 37/274 (13%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGG-----REFLAEVEMLSRLH 954
+F+ +G+G FG+V+ V D V +K++D E + E +L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKLD 57
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAARA 1012
+++ +++ +V E NG + L P W ++I LG
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG---- 113
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
LA+LH S +++HRD KS N+ L+ K+ D G+A+ D + + + ++GT Y+
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYL 168
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132
+PE KSDV++ GVV+ E +G+ P D N A ++
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRGV----- 217
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
P V ++A + C+ + + RP
Sbjct: 218 -FPP-----VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+L+G+
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 966 IEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 1082
+HRD + N+L+ D KVSDFGL + A ST+ G + APE
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKF 176
Query: 1083 LVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ E+ S GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 959
+GEG +G VY G VA LK++ + +E + E+++L +L H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 960 KLIGICIEEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAY 1015
+L I + +V+E + + L G+ D ++++K L Y
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFT-ESQIKCYMKQLLEGLQY 115
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S ++HRD K SNIL+ +D K++DFGLAR S + RV+ T Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 1076 YAMTGHLLV-------KSDVYSYGVVILELLSGR 1102
LL+ + D++S G ++ EL G+
Sbjct: 172 ------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 960
+++G G FG V G L K VA+K LK R +FL E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+ + + ++ E + NGS++ L D + + + G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ISTRVMGTFGYVAP 1074
+HRD + NIL+ + KVSDFGL+R D E+ + I R + AP
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAP 177
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 1108
E SDV+S+G+V+ E++S G +P DM+
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 44/275 (16%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
LG G FG+V G VA+K++K EF+ E +++ +L H LV+L G+C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
++ +V E + NG + ++L K P L++ +AYL S + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS---QLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGHLLV 1084
D + N L++ KVSDFGL+R +D+E T +G+ + PE +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 1085 KSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID------PS 1137
KSDV+++GV++ E+ S G+ P + + E +E++ P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLRLYRPH 224
Query: 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 1172
L ++ KV AI C + + RP +++
Sbjct: 225 LASE-------KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ-QGGREFLA----EVEMLSRLHHRNLV 959
+LG G FG VY G+ LDDG AVK + D Q G+E + E+ +LS+L H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+ +G EE + EL+P GS+ L P+ +I LG L YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH-- 119
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 1078
+HRD K +NIL++ + K++DFG+A+ + E + G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKS-FKGSPYWMAPEVIAQ 175
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKP 1104
G + +D++S G +LE+ +G+ P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+G G FG VY+ V LD G +AVK ++ D + +E E+++L L H NLVK G+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 1022
+ + + E G++E L D + L LAYLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRIL------DEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV---MGTFGYVAPE---Y 1076
++HRD K +NI L+H+ K+ DFG A + + + V GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCA-VKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+D++S G V+LE+ +G++P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 73/216 (33%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGI 964
LG G FG V+ G + TKVA+K LK QG FLAE ++ +L H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+E ++ E + NGS+ L E L + + +A A +A++ +
Sbjct: 70 VTQEPIY-IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKNY--- 123
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 1082
IHRD +++NIL+ K++DFGLAR D E + R F + APE G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 180
Query: 1083 LVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENL 1116
+KSDV+S+G+++ E+++ GR P MT P +NL
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 960
R++G+G FG VY G L D AVK L R+ D + +FL E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L+GIC+ + LV ++P + + E+ + L A+ + YL +
Sbjct: 61 LLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTFGYVAPEYAM 1078
S + +HRD + N +L+ FT KV+DFGLAR D+E S H T ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 1079 TGHLLVKSDVYSYGVVILELLS 1100
T KSDV+S+GV++ EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/209 (37%), Positives = 109/209 (52%), Gaps = 29/209 (13%)
Query: 908 LGEGGFGLVYSGV--LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLI 962
LG+G FG V V D G A+KVLK+ + ++ L E +LSR++H +VKL
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 963 GICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIALGAARALAYLH 1017
E+ LV E P G + SHL G E AR +I L AL YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-----ERARFYAAEIVL----ALEYLH 110
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
S +I+RD K NILL+ D K++DFGLA+ E SR +T GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEVL 165
Query: 1078 M-TGHLLVKS-DVYSYGVVILELLSGRKP 1104
+ G+ K+ D +S GV++ E+L+G+ P
Sbjct: 166 LGKGY--GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 30/262 (11%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
LG G FG V+ G + TKVAVK LK FL E +++ +L H LV+L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
E+ +V E + GS+ L D E L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1085
D +S+NIL+ K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1086 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1144
SDV+S+G+++ EL++ GR P PG N RE LE+ ++ P
Sbjct: 184 SDVWSFGILLTELVTKGRVPY-----PGMNN-----------REVLEQ-VERGYRMPCPQ 226
Query: 1145 DSVAKVAAIASMCVQPEVQHRP 1166
D + + C + + + RP
Sbjct: 227 DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 908 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
E ++ E + G++ +L +++ L +A + A+ YL + + IH
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNA--VVLLYMATQISSAMEYLEKKN---FIH 127
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD + N L+ + KV+DFGL+R M ++ + APE +KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 1087 DVYSYGVVILELLS-GRKP---VDMTQ 1109
DV+++GV++ E+ + G P +D++Q
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-23
Identities = 79/273 (28%), Positives = 132/273 (48%), Gaps = 23/273 (8%)
Query: 907 ILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
++ G G Y G + +G + VK + V+ +E+ + +L H N+VKLIG+C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLC 752
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
E+ L++E I ++ L L W+ R KIA+G A+AL +LH SP V+
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
+ I+++ P + L + IS+ YVAPE T + K
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 1086 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 1145
SD+Y +G++++ELL+G+ P D + ++V WAR S L+ IDPS+ DV +
Sbjct: 859 SDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVN 916
Query: 1146 S--VAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ +V +A C + RP +V++ L+
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 906 RILGEGGFGLVYSGVL--DDGT--KVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNL 958
+ILGEG FG V G L DDG+ KVAVK +K +D E FL+E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 959 VKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAA 1010
+KLIG+C E + ++ + +G + S L P L LK + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE---SRHISTRVMG 1067
+ YL S+ IHRD + N +L D T V+DFGL++ + I+ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127
++A E KSDV+++GV + E+ + T PG EN
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVEN-----------H 222
Query: 1128 EGLERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
E + + GN + P D + ++ + C + + + RP ++ + L
Sbjct: 223 EIYDYLRH---GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 965
LG+G G+VY G A+K + + R+ L E++ L +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E +V E + GS L + K+ + IA + L YLH +I
Sbjct: 69 YKEGEISIVLEYMDGGS----LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--HII 122
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV------MGTFGYVAPEYAMT 1079
HRD K SN+L+ K++DFG+ S+ + + +GT Y++PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGI--------SKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1118
+D++S G+ +LE G+ P PPGQ +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 906 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGR---EFLAEVEMLSRLHHRN 957
R LGEG FG V Y D+ G +VAVK LK + GG + E+E+L L+H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHEN 67
Query: 958 LVKLIGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+VK GIC E+ L+ E +P+GS++ +L + + +LK A+ + + Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAP 1074
L S + +HRD + N+L+E + K+ DFGL ++ D+E + + + AP
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLS 1100
E + + SDV+S+GV + ELL+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HH 955
TG F+ ++GEG +G VY G VA+K++ + + E E +L + +H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 956 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
N+ G I++ LV EL GSV + G+ K+ L + I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
R LAYLHE+ +VIHRD K NILL + K+ DFG+ SA + + +GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV--SAQLDSTLGRRNTFIGTP 177
Query: 1070 GYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKPV-DM 1107
++APE +SDV+S G+ +EL G+ P+ DM
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRL-HH 955
+F +I+GEG F V + + A+K+L +++ ++ ++ E E+L+RL H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 956 RNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
++KL +++ V E PNG + ++ R A AL
Sbjct: 62 PGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRFYAAE-ILLALE 116
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------- 1066
YLH S +IHRD K NILL+ D K++DFG A+ +D S S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQI 172
Query: 1067 -----------GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT YV+PE SD+++ G +I ++L+G+ P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 954
N R LGEG FG V+ D VAVK LK ++F E E+L+ L
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDK----ESAP---LGWDARLKI 1005
H ++VK G+C+E +V+E + +G + L HG D E L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
A A + YL +S +HRD + N L+ + K+ DFG++R + +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
M ++ PE M +SDV+S GVV+ E+ + G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 906 RILGEGGFGLVYSG------VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHL--HGVD----------KESAPLGWDARLKIAL 1007
K G+C + +V+E + +G + L HG D + LG L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067
A + YL +S +HRD + N L+ + K+ DFG++R + + M
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++ PE M +SDV+S+GV++ E+ + G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 5e-22
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 963
LGEG +G+VY G VA+K ++ +++ G L E+ +L L H N+VKL+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 964 ICIEEQARCLVYELIPNGSVESHLHG-VDKESAPLGWDARL--KIALGAARALAYLHEDS 1020
+ E+ LV+E + L +DK PL L I R LAY H
Sbjct: 66 VIHTERKLYLVFEYC-----DMDLKKYLDKRPGPL--SPNLIKSIMYQLLRGLAYCH--- 115
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S R++HRD K NIL+ D K++DFGLAR+ R + V+ T Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV-TLWYRAPE----- 168
Query: 1081 HLLVKSDVYSYGV-------VILELLSGR 1102
+L+ S YS V + E+++G+
Sbjct: 169 -ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 7e-22
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 47/223 (21%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+GEG G VY G +VA+K + R+ +Q + E+ ++ H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 967 EEQARCLVYELIPNGS------------VESHLHGVDKESAPLGWDARLKIALGAARALA 1014
+V E + GS E + V +E + L
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL---------------QGLE 130
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
YLH S VIHRD KS NILL D + K++DFG A E+S+ S V+GT ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 1075 E------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
E Y K D++S G++ +E+ G P + +PP
Sbjct: 186 EVIKRKDYGP------KVDIWSLGIMCIEMAEGEPPY-LREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 906 RILGEGGFGLVYSGVL----DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 958
R LG G FG VY G+ D + VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAP--LGWDARLKIALGAARALAY 1015
V+LIG+ E R ++ EL+ G ++S L + P L L A A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 1016 LHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L E+ IHRD + N LL K++DFG+AR R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131
PE + G K+DV+S+GV++ E+ S G P PG+ N +E +E
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTN-----------QEVME 232
Query: 1132 RI-----IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ +DP G P V I + C Q + RP +++ ++
Sbjct: 233 FVTGGGRLDPPKGCPGP------VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 32/285 (11%)
Query: 905 SRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRN 957
SR LG+G FG+VY G+ + T+VA+K + R EFL E ++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAAR 1011
+V+L+G+ + Q ++ EL+ G ++S+L + E AP +++A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
+AYL+ + + +HRD + N ++ DFT K+ DFG+ R + + + + +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131
++PE G SDV+S+GVV+ E+ + + + P Q +++ + L
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQG---------MSNEQVLR 232
Query: 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+++ L D P + + + MC Q + RP E++ ++K
Sbjct: 233 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 907 ILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 960
++G G FG V G L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNIIH 69
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+ + + ++ E + NG+++S L D + + L+ G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMN 126
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 1077
+HRD + NIL+ + KVSDFGL+R D+ S T +G + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 1078 MTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIID 1135
SDV+SYG+V+ E++S G +P DM S + + I+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------------------SNQDVINAIE 225
Query: 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
P D + + C Q + RP G++V L
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 906 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 958
R LG+G FG+VY G D T+VAVK + R EFL E ++ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLK----IALGAARA 1012
V+L+G+ + Q +V EL+ +G ++S+L + + E+ P L+ +A A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+AYL ++ + +HRD + N ++ HDFT K+ DFG+ R + + + + ++
Sbjct: 132 MAYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132
APE G SD++S+GVV+ E+ S + + P Q L++ + L+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQG---------LSNEQVLKF 233
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
++D D P + +V + MC Q + RP E+V LK
Sbjct: 234 VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 907 ILGEGGFGLVY----SGVLDDGTK--VAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLV 959
LG G FG V+ G+ ++G + V VK L K D+ EF E++M +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHL----HGVDK-ESAPLGWDARLKIALGAARALA 1014
+L+G+C E + ++ E G ++ L +K + PL ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
+L S+ R +HRD + N L+ KVS L++ + E + ++ ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
E KSDV+S+GV++ E+ + G P L+ E L R+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----------------FYGLSDEEVLNRL 231
Query: 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
L VP +++ + + C + RP E+V AL
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
E+ +V E + GS+ L G + L + +A A +AY+ + +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1085
D +++NIL+ + KV+DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1086 SDVYSYGVVILELLS-GRKP 1104
SDV+S+G+++ EL + GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFL-------AEVEMLSRLHH 955
++G+G +G VY + + G +AVK + + + +E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
N+V+ +G E+ + E +P GS+ S L + L ++ G LAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAY 123
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S ++HRD K+ N+L++ D K+SDFG+++ + D + + G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 1076 YAMTGH--LLVKSDVYSYGVVILELLSGRKP 1104
+ K D++S G V+LE+ +GR+P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ LG G FG V+ G ++ TKVAVK LK + FL E ++ L H LV+L +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E+ ++ E + GS+ L E + + + A +AY+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YI 125
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1083
HRD +++N+L+ K++DFGLAR D E + R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFT 182
Query: 1084 VKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115
+KSDV+S+G+++ E+++ G+ P PG N
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPY-----PGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLV 959
R+LG+G FG L +D + V K L R+ ++ R+ L E+ +LS L H N++
Sbjct: 6 RVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62
Query: 960 KLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+++ + E G++ G E + W A++Y+
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYI 117
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H+ ++HRD K+ NI L K+ DFG+++ + E T V+GT Y++PE
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSPEL 172
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
KSD+++ G V+ ELL+ ++ D T P NLV +I+
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV-------------KIVQ- 215
Query: 1137 SLGNDVPFDSV--AKVAAIASMCVQPEVQHRPFMGEVV 1172
GN P SV +++ ++ +Q + + RP EV+
Sbjct: 216 --GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-21
Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 896 EKATGNFDASRILGEGGFGLVYS----GVL--DDGTKVAVKVLKR-VDQQGGREFLAEVE 948
E N + R +G+G FG V+ G+L + T VAVK+LK +F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 949 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------------SVESHLHGVDKESA- 995
+++ H N+VKL+G+C + CL++E + G + S H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 996 -----PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
PL +L IA A +AYL E + +HRD + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 1051 RS--AMD----EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
R+ + D E+ I R M PE +SDV++YGVV+ E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 906 RILGEGGFGLVYSGVLDDGTK----VAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLV 959
+++G G FG V SG L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNII 68
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L G+ + + +V E + NGS+++ L D + + L+ G A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL--- 122
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAM 1078
S +HRD + NIL+ + KVSDFGL+R D+ E+ + + + APE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 1079 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
SDV+SYG+V+ E++S G +P +M+ + ++ + E R+ P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----------QDVIKAIEEGYRL--P 229
Query: 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL-KLV 1178
+ P D A + + C Q + RP ++V L KL+
Sbjct: 230 A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 960
+++G G FG V+ G+L + VA+K LK + R +FL+E ++ + H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+ + + ++ E + NG+++ +L D E + L+ G A + YL S
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAMT 1079
+HRD + NIL+ + KVSDFGL+R D+ E + ++ + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137
SDV+S+G+V+ E++S G +P DM S + + I+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDM------------------SNHEVMKAINDG 226
Query: 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
P D + V + C Q + RP ++V L
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
LG G G+V + G +AVK ++ +++ ++ L E+++L + + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKE--SAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ E + GS++ L V LG KIA+ + L YLHE
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK-- 121
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
+IHRD K SNIL+ K+ DFG++ ++ ++ +GT Y+APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 1084 VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---PSLGN 1140
VKSD++S G+ ++EL +GR P PP P E L+ I++ P L +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY----PP-------ENDPPDGIFELLQYIVNEPPPRLPS 226
Query: 1141 DV 1142
Sbjct: 227 GK 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 908 LGEGGFGLVYSGVLDDGTK---VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIG 963
LG G FG V GV K VA+KVLK +++ R E + E E++ +L + +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1021
+C E +A LV E+ G + L G K+ + L ++++G + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMG----MKYLEGKN- 115
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 1079
+HRD + N+LL + K+SDFGL++ A+ + + R G + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
+SDV+SYG+ + E S G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 907 ILGEGGFGLVYSGVLDDGTKVAVK--VLKRVDQQGG----REFLAEVEMLSRLHHRNLVK 960
+LG+G +G VY G+ + G +AVK L + + EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+G C+++ + E +P GS+ S L PL K +AYLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----SAMDEESRHISTRVMGTFGYVAPEY 1076
V+HRD K +N++L + K+ DFG AR + ++ + GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
KSD++S G + E+ +G+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 908 LGEGGFGLVY----SGVL-----------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 951
LGEG FG V+ G+ VAVK+L+ V + +FL E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESA--------PLGWDARL 1003
RL + N+++L+G+C+ + C++ E + NG + L + ES + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+A+ A + YL +S +HRD + N L+ + +T K++DFG++R+ + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
R + ++A E + G SDV+++GV + E+ +
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 23/282 (8%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLH 954
GNF + +G+G F +VY + L DG VA+K ++ +D + ++ L E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H N++K + IE +V EL G + + K+ + K + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
++H S R++HRD K +N+ + K+ D GL R + + S ++GT Y++P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134
E KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKK-------IEKCD 224
Query: 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P L D ++ + S C+ P+ + RP + V+Q K
Sbjct: 225 YPPLPADH---YSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967
LG+G FG V+ G + TKVA+K LK FL E +++ +L H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1027
E+ +V E + GS+ L D + L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 1028 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1085
D +++NIL+ + K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1086 SDVYSYGVVILELLS-GRKP 1104
SDV+S+G+++ EL++ GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLI 962
+ LG G FG+V+ G KVA+K + +G +F+ E +++ +L H LV+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
G+C +++ +V E + NG + L+ + + L D L + + YL +S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG------YVAPEY 1076
IHRD + N L+ KVSDFG+ R +D+E + S + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTS-----SSGAKFPVKWSPPEV 172
Query: 1077 AMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+GV++ E+ + G+ P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 901 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 953
N + LG G FG V D KVAVK+LK RE L +E++++S L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 954 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+H N+V L+G C ++ E G + + L K + L + L + A+
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKG 153
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI---STRVMGTF 1069
+A+L +S IHRD + N+LL H K+ DFGLAR M+ +S ++ + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARL--PV 207
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++APE +SDV+SYG+++ E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 71/203 (34%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 908 LGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
LG+G FG V Y + D+ G VAVK L+ + R+F E+E+L L H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 963 GICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
G+C R LV E +P GS+ +L K L L A + + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 1077
S R +HRD + NIL+E + K+ DFGL + + ++ + R G F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 1078 MTGHLLVKSDVYSYGVVILELLS 1100
V SDV+S+GVV+ EL +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 907 ILGEGGFGLVYSGVLD--DGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+G+G FG V V DG + K + + ++ ++ ++EV +L L H N+V+
Sbjct: 7 TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 963 GICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH--E 1018
I+ + L V E G + + KE + + +I AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
D V+HRD K +NI L+ + K+ DFGLA+ + +S T V GT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKP 1104
KSD++S G +I EL + P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 8e-20
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 908 LGEGGFGLVY----SGVLDDGTK-------------VAVKVLKRVDQQGGR-EFLAEVEM 949
LGEG FG V+ G+ K VAVK+L+ + R +FL E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------- 1002
+SRL N+++L+ +CI C++ E + NG + L + + A D
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+ +A A + YL SS +HRD + N L+ ++T K++DFG++R+ + I
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
R + +++ E + G SDV+++GV + E+L+
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 908 LGEGGFGLVYSGVL-----DDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKL 961
LGE FG +Y G L D VA+K LK ++ Q EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 962 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1006
+G+ +EQ C+++E + G + L G K S G L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG--DFLHIA 130
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
+ A + YL SS +H+D + NIL+ K+SD GL+R + + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++ PE M G SD++S+GVV+ E+ S G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD---QQGGREFLAEVEMLSRLHHR 956
+F+ R++G+G FG V D K+ A+K + + + R L E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 1014
LV L +E+ LV +L+ G + HL E + I AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWIC-EIVLALE 114
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
YLH S +IHRD K NILL+ ++DF +A + ++T GT GY+AP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP 168
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
E V D +S GV E L G++P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 40/239 (16%)
Query: 908 LGEGGFGLVYSGVLDDGTK-----------------VAVKVLKRVDQQGGR-EFLAEVEM 949
LGEG FG V+ + + VAVK+L+ + R +FL EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAP----------- 996
LSRL N+++L+G+C++E C++ E + NG + L H +D +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 997 --LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054
+ + + L +AL A + YL SS +HRD + N L+ + T K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+ I R + ++A E + G SDV+++GV + E+L + QP G+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 908 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 963
LG+GGFG V + V G A K L KR+ ++ G + L E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDS 1020
+ CLV L+ G ++ H++ V + P A +I G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-RAIFYAAQIICG----LEHLHQR- 114
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
R+++RD K N+LL+ ++SD GLA + GT GY+APE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D ++ G + E+++GR P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 887 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREFL 944
A+ +E+ K ++LG G FG V+ G+ + +G + + V +K + + GR+
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 945 AEV--EMLS--RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1000
E+ ML+ L H +V+L+GIC + LV +L P GS+ H+ + L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVR---QHRDSLDPQ 109
Query: 1001 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060
L + A+ + YL E R++HR+ + NILL+ D +++DFG+A ++ ++
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPP 1111
+ ++A E + G +SDV+SYGV + E++S G +P +P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG+C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
++Q +V EL+ G + L E L +++ AA + YL S I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE---SKHCI 116
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1083
HRD + N L+ K+SDFG++R +E+ + ST M + APE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 1084 VKSDVYSYGVVILELLS 1100
+SDV+S+G+++ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHH 955
+ +GEG +G+V S G KVA+K + + Q F L E+++L R H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62
Query: 956 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
N++ ++ I I + +V EL+ E+ L+ + K + L D
Sbjct: 63 ENIIGILDI-IRPPSFESFNDVYIVQELM-----ETDLYKLIK-TQHLSNDHIQYFLYQI 115
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMG 1067
R L Y+H S V+HRD K SN+LL + K+ DFGLAR A D E H T +
Sbjct: 116 LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA-DPEHDHTGFLTEYVA 171
Query: 1068 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
T Y APE + K+ D++S G ++ E+LS R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 964
+GEG +G+VY G VA+K +K + G + L E+++L L+H N++KL+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 965 CIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ LV+E + ++ L + L + LA+ H S
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR----HISTRVMGTFGYVAPE--YA 1077
++HRD K N+L+ + K++DFGLARS R ++ TR Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTR-----WYRAPELLLG 172
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGR 1102
G+ D++S G + ELLS R
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 908 LGEGGFGLVYSG-VLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+GEG +G+V G VA+K K D+ + L EV++L +L H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+ LV+E + + L ++ L DA +A+AY H S +
Sbjct: 69 FRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNI 121
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
IHRD K NIL+ K+ DFG AR A+ T + T Y APE LLV
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPE------LLV 174
Query: 1085 KS-------DVYSYGVVILELLSGR 1102
DV++ G ++ ELL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 908 LGEGGFGLVY-----------------SGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEM 949
LGEG FG V+ + D VAVKVL+ +FL EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH-------GVDKESAPLGWDAR 1002
LSRL N+ +L+G+C + C++ E + NG + L G+ S L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
L +A A + YL S +HRD + N L+ ++T K++DFG++R+ + +
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
R ++A E + G KSDV+++GV + E+L+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-19
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 961
LGEG + +VY + G VA+K +K +++ ++ + E+++L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDS 1020
+ + + LV+E + E+ L V K+ + + A +K L R L YLH +
Sbjct: 68 LDVFGHKSNINLVFEFM-----ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
++HRD K +N+L+ D K++DFGLARS +R ++ +V+ T Y APE
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVV-TRWYRAPE----- 172
Query: 1081 HLLVKS-------DVYSYGVVILELLSGRKP 1104
LL + D++S G + ELL R P
Sbjct: 173 -LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVK-VLKRVDQQGGREFLAEVEMLSRLHHR 956
LGEG G V + T A+K + + ++ L E+E+
Sbjct: 1 EKIVELSRLGEGAGGSV-TKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 957 NLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
+VK G ++E + + E GS++S V K +G KIA + L+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG---- 1070
YLH ++IHRD K SNILL K+ DFG+ S + + GTF
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSF 168
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV--DMTQPPG 1112
Y+APE + SDV+S G+ +LE+ R P + P G
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-19
Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 14/208 (6%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKV----AVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG VY G+ + +G V A+K+L + EF+ E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+G+C+ + LV +L+P+G + ++H + +G L + A+ + YL E
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
R++HRD + N+L++ K++DFGLAR +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKPVD 1106
+SDV+SYGV I EL++ G KP D
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 906 RILGEGGFGLVYSGV-LDDGTK----VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG VY G+ + DG VA+KVL+ + +E L E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+GIC+ + LV +L+P G + + V + +G L + A+ ++YL E
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDY---VRENKDRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
R++HRD + N+L++ K++DFGLAR +E+ + + ++A E +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138
+SDV+SYGV + EL++ G KP D AR + E ER+ P +
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----------AREIPDLLEKGERLPQPPI 235
Query: 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
V I C + + RP E+V
Sbjct: 236 -------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 16/221 (7%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL 953
EI + + + + LG G FG V+ + TKVAVK +K FLAE ++ L
Sbjct: 2 EIPRESLKLE--KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
H LVKL + +E ++ E + GS+ L + PL + + A +
Sbjct: 59 QHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGM 115
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GY 1071
A++ + + IHRD +++NIL+ K++DFGLAR D E + R F +
Sbjct: 116 AFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKW 169
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQP 1110
APE G +KSDV+S+G++++E+++ GR P M+ P
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 908 LGEGGFGLVYS-GVLDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+GEG G+V+ + G VA+K L+R++ + L E++ L H +VKL+ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
LV E +P S L V + E PL + +AY+H +
Sbjct: 68 FPHGSGFVLVMEYMP-----SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
++HRD K +N+L+ D K++DFGLAR +EE R S +V T Y APE LL
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE------LL 172
Query: 1084 VKS-------DVYSYGVVILELLSGR 1102
+ D+++ G + ELL+G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 901 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL 953
N + LGEG FG V T VAVK+LK R+ L+E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDAR---------- 1002
+H +++KL G C ++ L+ E GS+ S L K + LG D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 1003 ---------LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053
+ A +R + YL E ++HRD + N+L+ K+SDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
+E+S ++ ++A E +SDV+S+GV++ E+++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 907 ILGEGGFGLVYSG-VLDDGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 961
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARLKIALGA 1009
+G C L E P+G++ L + ++ L L A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + ++ + MG
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTMGRL 185
Query: 1070 G--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++A E SDV+SYGV++ E++S
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
LG+G FG VY + G A K+++ ++ +F+ E+++LS H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
E ++ E G+++S + + L + AL +LH +VIH
Sbjct: 73 YENKLWILIEFCDGGALDSI---MLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--- 1083
RD K+ NILL D K++DFG++ + + +GT ++APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 1084 --VKSDVYSYGVVILELLSGRKP 1104
K+D++S G+ ++EL P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 8e-18
Identities = 76/229 (33%), Positives = 108/229 (47%), Gaps = 55/229 (24%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-------RVDQQGGREFLAEVEMLSR 952
++ + LG+G +G+V+ + D TK VA+K K D Q R F E+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAI-DRRTKEVVALK--KIFDAFRNATDAQ--RTF-REIMFLQE 62
Query: 953 L-HHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK----- 1004
L H N+VKL+ + E + LV+E + E+ LH V + A + L+
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIR--ANI-----LEDVHKR 110
Query: 1005 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM---DEESRH 1060
I +AL Y+H S VIHRD K SNILL D K++DFGLARS +
Sbjct: 111 YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV------VIL-ELLSGR 1102
+ T + T Y APE +L+ S Y+ GV IL E+L G+
Sbjct: 168 VLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-17
Identities = 87/375 (23%), Positives = 116/375 (30%), Gaps = 21/375 (5%)
Query: 80 PSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVA----- 134
P P + PP P P P P P P + + P
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL 237
Query: 135 -SPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHP-SNTARPP 192
SP P P + P++ PP HP SN +P
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPF 297
Query: 193 ASHPSRTAP---PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
S+ P P + P + PS++A P P LPPA PPP + +
Sbjct: 298 GLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQL 357
Query: 250 APPPASHP-YKTSPLP-ASHPSKTAPPPASHPSNTAP---PPASHPSKTAPPPASHPSNT 304
HP + P P PS PPPA P ++ P PP++HP P S P +
Sbjct: 358 PNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQS 417
Query: 305 AP--PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
P PP S + PP AS P H P A H + PA P +
Sbjct: 418 VPAQPPVLTQSQSLPPKAST----HPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPT 473
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVP 422
A + P + P L A P + PPP
Sbjct: 474 STPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPS 533
Query: 423 VLPSALPGKAPVSQS 437
P+ + + SQS
Sbjct: 534 PEPTVVNTPSHASQS 548
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 911 GGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRNLVKLIGICI 966
G +G V+ G A+KV+K+ D + L E ++LS+ +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 967 EEQARCLVYELIPNGSVESHLHGV---DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
++ LV E +P G + S L V D++ A R+ IA AL YLH S
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIAEIVL-ALEYLH---SNG 113
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI--------STRVMGTFGYVAPE 1075
+IHRD K NIL++ + K++DFGL S + R I R++GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGL--SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 1076 YAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1104
+L + D +S G ++ E L G P
Sbjct: 172 V-----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 956
++ R++G G FG+V+ D V +K + V+Q E LA E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHP 59
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N+++ +E++A +V E P G++ ++ + ++ L D L + AL ++
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHV 117
Query: 1017 HEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
H + ++HRD K+ NILL+ H K+ DFG+++ S+ + V+GT Y++PE
Sbjct: 118 H---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPE 171
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
KSD+++ G V+ EL S ++ + P
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 906 RILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKL 961
R +G G FG+V+S V D DG +VA+K + V Q + E++ML H N++
Sbjct: 6 RPIGYGAFGVVWS-VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDS 1020
+ I + ++S LH + PL D +K+ L R L YLH
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLH--- 120
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-T 1079
S ++HRD K N+L+ + K+ DFGLAR +ES+H++ V+ + Y APE M +
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGS 179
Query: 1080 GHLLVKSDVYSYGVVILELLSGR 1102
H D++S G + ELL R
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 907 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 961
++GEG FG V ++ DG K+ A+K+LK + R+F E+E+L +L HH N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 962 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1006
+G C + E P G++ L HG ++ L L+ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT---ASTLTSQQLLQFA 125
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
A + YL S + IHRD + N+L+ + K++DFGL+R E ++ + M
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVK-KTM 177
Query: 1067 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
G ++A E KSDV+S+GV++ E++S
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-17
Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 902 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 957
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V L + A CLV L+ G ++ H++ + + G + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----RAVFYAAEICCGLE 116
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ R+++RD K NILL+ ++SD GLA E + I RV GT GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGRV-GTVGYMAPEVV 173
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137
D ++ G ++ E+++G Q P Q+ R RE +ER++
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAG-------QSPFQQ------RKKKIKREEVERLV--- 217
Query: 1138 LGNDVPFDSVAKVAAIA-SMCVQ 1159
+V + K + A S+C
Sbjct: 218 --KEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 954
N+ ++LG+G FG VY +D G ++AVK + + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H +V+ G +++ + E +P GSV+ L K L K +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVE 118
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVA 1073
YLH S ++HRD K +NIL + K+ DFG ++ S + V GT +++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 1074 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKP 1104
PE ++G K+DV+S G ++E+L+ + P
Sbjct: 176 PE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 963
++GEG +G+V + G VA+K L+ D + ++ + E+ ML +L H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1021
+ ++ LV+E + + ++ D E P G D K R + + H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMTG 1080
+IHRD K NIL+ K+ DFG AR+ A E + T + T Y APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPE----- 170
Query: 1081 HLLVKS-------DVYSYGVVILELLSG 1101
LLV D+++ G ++ E+L+G
Sbjct: 171 -LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-17
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTK----VAVKVLKRVDQ-QGGREFLAEVEMLSRLHH 955
F ++LG G FG VY G+ + +G K VA+K L+ + +E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
++ +L+GIC+ + L+ +L+P G + L V + +G L + A+ + Y
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
L E R++HRD + N+L++ K++DFGLA+ +E + + ++A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVD 1106
+ +SDV+SYGV + EL++ G KP D
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-16
Identities = 85/354 (24%), Positives = 132/354 (37%), Gaps = 14/354 (3%)
Query: 74 PPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPV 133
P P P T A A + P + T ASP +P P + P PT P
Sbjct: 65 FEPPTGPPPGPGTEA-PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPP 123
Query: 134 ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPA 193
ASPPP AP L +L P ASP ++ A P A A+ A+ P ++ A
Sbjct: 124 ASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETA 183
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHP--SNTALPPASLPSKTA---PPPASHLSN 248
PS PPA P +T + + P S +A PA P ++A +S S+
Sbjct: 184 RAPS---SPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSS 240
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPP---ASHPSNTAPPPASHPSKTAPPPASHPSNTA 305
++ + P P+ P + N S ++ P PS +
Sbjct: 241 SSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSP 300
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
P S P+ ++P +S S++ +S S+++ + P P+ PS + PP +
Sbjct: 301 SSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPA 360
Query: 366 HPSNP--AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
PS+P P+ PS+ A A + + P+ P
Sbjct: 361 DPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRP 414
|
Length = 1352 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG------REFLAEVEMLSRLHHRNL 958
+ LG G F Y + GT +AVK + V E+ +++RL+H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAYL 1016
++++G E+ L E + GSV L G KE+ + + +L R L+YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 1017 HEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESR--HISTRVMGTFGY 1071
HE+ ++IHRD K +N+L++ +++DFG A + + +++GT +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+APE DV+S G VI+E+ + + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 908 LGEGGFGLVYSGVLD--DGTK-VAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLI 962
LG G FG V G+ K VAVK+LK + E L E ++ +L + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 963 GICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARALAYLHE 1018
GIC E ++ LV EL G + L H +K L ++++G + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL----VHQVSMG----MKYLEE 113
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1076
+ +HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 1077 AMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+GV++ E S G+KP
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 907 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 961
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 962 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1006
+G C L E P+G++ L + ++ L L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST---ASTLSSQQLLHFA 118
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
AR + YL + + IHRD + NIL+ ++ K++DFGL+R + ++ + M
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTM 170
Query: 1067 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
G ++A E SDV+SYGV++ E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-16
Identities = 96/435 (22%), Positives = 127/435 (29%), Gaps = 42/435 (9%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP----ASHPSNTAPPPASHPSKTA 294
AP S L P P P A P P P APP S +
Sbjct: 2462 APFSLSLLLGELFP--GAPVYRRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAI 2519
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
P P AS + PPP APP A S P PA
Sbjct: 2520 LPDEP-VGEPVHPRMLTWIRGLEELASDDAGDPPPPLP---PAAPPAAPDRSVPPPRPAP 2575
Query: 355 HPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNI 414
PS A+ S P PP S + P APP P A P
Sbjct: 2576 RPSEPAV--TSRARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDP------- 2626
Query: 415 APPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQK 474
PPP P + P + P P A R + R + + + PP +
Sbjct: 2627 -PPPSPSPA-ANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPR 2684
Query: 475 RNASNRE----APIAEPIAPGPFPPGNSRQKSPVARPIIPGGT--------PTASPDPDV 522
R A+ +A+P P P P A P+ PG A+P P
Sbjct: 2685 RRAARPTVGSLTSLADPPPPPPTPEPAPHALVS-ATPLPPGPAAARQASPALPAAPAPPA 2743
Query: 523 PPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLN 582
P+ P R +P P PP + + P+ S R P P +
Sbjct: 2744 VPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWD 2803
Query: 583 SVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCST 642
+ + + P + +P + SP+ + P PP PPPP +
Sbjct: 2804 P-ADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPG-------PPPPSLPLGGS 2855
Query: 643 TICTEPYTNTPPGSP 657
PP
Sbjct: 2856 VAPGGDVRRRPPSRS 2870
|
Length = 3151 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-16
Identities = 91/455 (20%), Positives = 133/455 (29%), Gaps = 30/455 (6%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPS--ITAPPPV--NMAPPPSLIPTTPVASP 136
P A A L + S + A V A PT P P
Sbjct: 16 EGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGP 75
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHP 196
P SL P ASP + P S PP P
Sbjct: 76 GTEAPANESRSTPTWSLSTLAP------------ASPAREGSPTPPGPSSPDPPPPTPPP 123
Query: 197 SRTAPPPAS-HPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPAS 255
+ P PA P PA+ P PA++ S A + L ++P +
Sbjct: 124 ASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETA 183
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNT 315
S PA P T P AS P S + + P + +S S++
Sbjct: 184 RA--PSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSS 241
Query: 316 APPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPA 375
+ P P+ P + N S+ + P
Sbjct: 242 SESSGCGWGPENECPLPRPAPITLPT--------RIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 376 SHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVS 435
PS + P S P+ ++P +S S++ + +S S+ + V P P ++P
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSP 353
Query: 436 QSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQK---RNASNREAPIAEPIAPGP 492
P D + R R + S P A+ A R+A P
Sbjct: 354 SRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPR 413
Query: 493 FPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP 527
P ++ S P TP+ P P PP P
Sbjct: 414 PSPLDAGAASGAFYARYPLLTPSGEPWPGSPPPPP 448
|
Length = 1352 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 902 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 957
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V L + A CLV L+ G ++ H++ + G+D + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM----GNPGFDEE-RAVFYAAEITCGLE 116
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ R+++RD K NILL+ ++SD GLA + E+ I RV GT GY+APE
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPE-- 171
Query: 1078 MTGHLLVKSDVYSY-------GVVILELLSGRKP 1104
+VK++ Y++ G +I E++ G+ P
Sbjct: 172 -----VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-16
Identities = 86/334 (25%), Positives = 113/334 (33%), Gaps = 15/334 (4%)
Query: 74 PPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPP---PSLIPT 130
P P S P++ +P P L P P AP + P
Sbjct: 217 QPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMP 276
Query: 131 TPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPAS-PPSNAARPPASHPSNTA 189
+ P P N L + PL S+A P + PPS +A P P
Sbjct: 277 HALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQP 336
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
PPA PPP + S P PS P++LP A P S L T
Sbjct: 337 LPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLP-T 395
Query: 250 APPPASHPYKTSPLPASHPSKTAP--PPASHPSNTAPPPASHPSKTAPP--PASHPSNTA 305
PP++HP +P S P ++ P PP S + PP AS + P P
Sbjct: 396 HHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQH 455
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP-----PPASHSSKTAPPPASHPSNTA 360
P + PPP+ S A PP + + P + P P
Sbjct: 456 PFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEP 515
Query: 361 LPPASHPSNPAIPPAS-HPSNTAIPPASHPSNTA 393
L A P +P PP S P T + SH S +A
Sbjct: 516 LDEAEEPESPPPPPRSPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 964
+G G +VY+ + L + KVA+K + +++ E EV+ +S+ +H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSS 1021
+ LV + GS L + K S P G IA + L YLH S
Sbjct: 68 FVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYA 1077
IHRD K+ NILL D + K++DFG+ SA + + +V +GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGV--SASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 1078 MTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
H K+D++S+G+ +EL +G P PP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYS-KYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVL--------KRVDQQGGREFLAEVEMLS 951
+F+ + LG G FG V K A+K+L K+V+ L E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQ 56
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
+ H LV L G ++ LV E +P G + SHL + P AR ++ L
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP---VARFYAAQVVL- 112
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-- 1066
AL YLH +++RD K N+LL+ D K++DFG A + + R
Sbjct: 113 ---ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTL 158
Query: 1067 -GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT Y+APE + G+ K+ D ++ G++I E+L+G P
Sbjct: 159 CGTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 35/292 (11%)
Query: 902 FDASRILGEGGFGLVYSGVL--DDGT--KVAVKVLKR--VDQQGGREFLAEVEMLSRLHH 955
F R+LG+G FG V L +DG+ KVAVK+LK EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 956 RNLVKLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL 1007
N++KLIG+ + +A+ ++ + +G + + L + +E L ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067
A + YL SS IHRD + N +L + T V+DFGL++ +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1126
++A E SDV+++GV + E+++ G+ P G EN + L
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVEN--SEIYNYLIK 230
Query: 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178
L++ P D + V + C PE + RP + L+L+
Sbjct: 231 GNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 908 LGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVK 960
LGE FG VY G L + VA+K LK + + EF E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 961 LIGICIEEQARCLVYELIPNG---------SVESHLHGVDKE---SAPLGWDARLKIALG 1008
L+G+ +EQ +++ + S S + D + + L + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
A + +L SS V+H+D + N+L+ K+SD GL R + + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 1069 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+++PE M G + SD++SYGVV+ E+ S G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 908 LGEGGFGLVY------SGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961
LG+GGFG V +G L K+ K LK+ ++G + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
+ CLV ++ G + H++ VD+E+ L +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1081
R+I+RD K N+LL++D ++SD GLA D +S+ + GT G++APE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 1082 LLVKSDVYSYGVVILELLSGRKP 1104
D ++ GV + E+++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQG---GREFLA----EVEMLSRLHHR 956
++G G FG VY G+ G +AVK L V R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N+V+ +G ++ + E +P GSV + L+ L + +I G L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKG----LNYL 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-------VMGTF 1069
H + +IHRD K +NIL+++ K+SDFG+++ E+ +ST+ + G+
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSV 176
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV-DMTQ 1109
++APE K+D++S G +++E+L+G+ P D TQ
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 4e-16
Identities = 93/391 (23%), Positives = 123/391 (31%), Gaps = 43/391 (10%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
+ P +P A AP P P + + P P + +P P
Sbjct: 186 GAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQ 245
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPA-PSLIPTTPLASPLSSKAFPPASPPSNAARP 180
S P A P P + P+ P SN +P
Sbjct: 246 PQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQ---------HPSSNPPQP 296
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAP 240
S P P + P + PS++A P P LPPA P
Sbjct: 297 FGLAQSQVPPLPL--------PSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKP 348
Query: 241 PPASHLSNTAPPPASHP-YKTSPLP-ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
PP + + HP + P P PS PPPA P ++ P +H +A PP
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLP---THHPPSAHPP- 404
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
P P S A PP S + PP AS P HS P A HP
Sbjct: 405 --PLQLMPQSQPLQSVPAQPPVLTQSQSLPPKAST----HPHSGLHSGPPQSPFAQHPFT 458
Query: 359 TALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
+ PA P PP+ S A PP + + P A S P PP
Sbjct: 459 SGGLPAIGP-----PPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGP--------GPP 505
Query: 419 LFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
L + +A +SP P +P+ P
Sbjct: 506 LPPIQIKEEPLDEAEEPESPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
FD LGEG +G VY + + G VA+KV+ V++ +E + E+ +L + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE-DLQEIIKEISILKQCDSPYIVK 62
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
G + +V E GSV + +K L + I + L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S + IHRD K+ NILL + K++DFG++ + + +T V+GT ++APE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
K+D++S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVL-----KRVDQQGGREFLAEVEMLSRLHHRNLVKL 961
+G G +G+V S + KVA+K + R+D + L E+++L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAI 69
Query: 962 IGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
I +VYEL+ ++ LH + + S L D R L Y+
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S V+HRD K SN+LL + K+ DFGLAR+ E T + T Y APE
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPE- 178
Query: 1077 AMTGHLLVKS-------DVYSYGVVILELLSGRKPV 1105
LL+ DV+S G + ELL GRKP+
Sbjct: 179 -----LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSRLHHRNLVKL 961
+G G FG V G G A V+K D+Q FL EV+ L+H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLH 1017
+G CIE LV E P G ++++L V + + D ++A A L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ IH D N L D + K+ D+GLA E+ ++APE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 1078 MTGH--LLV-----KSDVYSYGVVILEL 1098
LL KS+++S GV + EL
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 958
FD +GEG +G VY D G VA+K ++ +++ G A E+++L +L+HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 959 VKLIGICIEEQ----------ARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKI 1005
V L I ++Q A LV+E + + G +ES L ++ + +K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----SFMKQ 124
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
L L Y H+ + +HRD K SNILL + K++DFGLAR EESR + +V
Sbjct: 125 LL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 1066 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1105
+ T Y PE + + DV+S G ++ EL + +KP+
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 908 LGEGGFGLVYSGV--LDDGTKVAVK-VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG G G V S V + GT +A K V ++ L E++++ +V G
Sbjct: 13 LGAGNGGSV-SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+ E C+ E + GS L + K+ P+ + KIA+ L YL+ R+
Sbjct: 72 FLNENNICMCMEFMDCGS----LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
+HRD K SNIL+ K+ DFG++ E I+ +GT Y++PE G V
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 1085 KSDVYSYGVVILELLSGRKPVDM 1107
KSDV+S G+ I+EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 902 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 957
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V L + A CLV ++ G ++ H++ + G++ + AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFEEE-RALFYAAEILCGLE 116
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ ++RD K NILL+ ++SD GLA + ES I RV GT GY+APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ D + G +I E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-15
Identities = 90/349 (25%), Positives = 122/349 (34%), Gaps = 37/349 (10%)
Query: 110 PPSITAPPPVNMA----PPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
PPSI PP +A PP P P P P+P + + P P
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL 237
Query: 166 KAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
+ P P A++ P+ ++R P S PP +P P
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPP---------MPHALQQGPVFLQH 288
Query: 226 NTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP-PPASHPSNTAP 284
++ PP + P L + A P + P S L P + P PPA + P
Sbjct: 289 PSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKP 348
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 344
PP + + HP + P P PSN PPPA P ++ P
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGP---------SPFPQMPSNLPPPPALKPLSSLP----- 394
Query: 345 SSKTAPPPASHPSNTALPPASHP--SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
T PP++HP L P S P S PA PP S + P AS ++ S
Sbjct: 395 ---THHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSP 451
Query: 403 TA---LTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
A T P+ I PPP P+A P + SQ P S +
Sbjct: 452 FAQHPFTSGGLPA-IGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGC 499
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
LG+G FG VY + G A KV++ ++ +++ E+E+L+ +H +VKL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSSPRVI 1025
+ ++ E P G+V++ + +D+ + +++ I AL YLH S ++I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVICRQMLEALQYLH---SMKII 132
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL-- 1083
HRD K+ N+LL D K++DFG+ SA + ++ +GT ++APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 1084 ---VKSDVYSYGVVILELLSGRKP 1104
K+D++S G+ ++E+ P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 907 ILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRNL 958
LGEG FG V ++ + VAVK+LK ++ + ++E+EM+ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI------------- 1005
+ L+G+C +E +V E +G++ L + P G A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 1006 ---ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
A AR + +L +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
T ++APE +SDV+S+GV++ E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-15
Identities = 60/222 (27%), Positives = 82/222 (36%), Gaps = 15/222 (6%)
Query: 167 AFPPASPPSNAA-RPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
AF P A A+ P P A+ P+ AP PA+ P A P+ + A+ +
Sbjct: 362 AFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPP---AAPAAAPAAAAAARA 418
Query: 226 NTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP 285
A P P+ A A S P A P +P PA+ P+ A P A+ P A
Sbjct: 419 VAAAPARRSPAPEALAAARQASARGPGGAPAP---APAPAAAPAAAARPAAAGPRPVAAA 475
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA-----SHPSNTAPP 340
A+ P++ AP A P++ PPP PA + AP P+ P
Sbjct: 476 AAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPD 535
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTA 382
A + AP A P A P PP + S
Sbjct: 536 DAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLP 574
|
Length = 700 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 902 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 957
F R+LG+GGFG V + V G A K L KR+ ++ G L E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V L + A CLV ++ G ++ H++ + G+D + I AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAI-FYAAELCCGLE 116
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ R+++RD K NILL+ ++SD GLA E + RV GT GY+APE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRV-GTVGYMAPEVI 173
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
D + G +I E++ G+ P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 23/280 (8%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHHR 956
NF + +G G F VY L D VA+K + + +D + ++ + E+++L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N++K + IE+ +V EL G + + K+ + K + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
KSD++S G ++ E+ + + P L + + +E+ P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP-----------FYGDKMNLFSLCQKIEQCDYP 226
Query: 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
L + K+ + SMC+ P+ RP +G V Q K
Sbjct: 227 PLPTE---HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G G +G VY + G VA+KV+K E+ ML H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSSPR 1023
+V E GS++ PL + L+IA + LAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ---VTRGPL---SELQIAYVCRETLKGLAYLHET---G 121
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPEYA---M 1078
IHRD K +NILL D K++DFG++ + + I+ R +GT ++APE A
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
G K D+++ G+ +EL QPP
Sbjct: 178 KGGYDGKCDIWALGITAIELAEL-------QPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-15
Identities = 88/393 (22%), Positives = 109/393 (27%), Gaps = 21/393 (5%)
Query: 30 GIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAV 89
P P P LP G P P P+ PA
Sbjct: 2718 ATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAA 2777
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLP 149
P + P + S PS P A P ASP PP + P
Sbjct: 2778 GPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPP-TSAQP 2836
Query: 150 APSLIPTTPLASPLSSK-AFPPASPPSN--AARPPASHPSNTARPPASHPSRTAPPPASH 206
P P L + P +R PA+ P+ ARPP +R A ++
Sbjct: 2837 TAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTE 2896
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
ALP P P PP P PPP PPP P +P
Sbjct: 2897 S--FALP----PDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQP-PLAPTTDP 2949
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
+ P A P P PS AP ++ P S+
Sbjct: 2950 AGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRV--SSW 3007
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
A A H T PPP S PP + S+ S + P
Sbjct: 3008 ASSLALH-EETDPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEALDPLPPEPHDPF 3066
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPPL 419
+H + A P A S S PPPL
Sbjct: 3067 AHEPDPATPEAGA-------RESPSSQFGPPPL 3092
|
Length = 3151 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 78/225 (34%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 887 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 942
A+ FS + EK F R +G G FG VY + VA+K + +Q ++
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 943 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
+ EV L +L H N ++ G + E LV E GS S + V K+ PL
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA-SDILEVHKK--PLQEVEI 117
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
I GA + LAYLH S IHRD K+ NILL T K++DFG A S + + +
Sbjct: 118 AAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSFV- 172
Query: 1063 TRVMGTFGYVAPE--YAM-TGHLLVKSDVYSYGVVILELLSGRKP 1104
GT ++APE AM G K DV+S G+ +E L+ RKP
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 51/217 (23%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVK---------VLKRVDQQGGREFLAEVEMLSRLHHRN 957
+GEG +G+V+ + G VA+K V+K++ L E+ ML +L H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-------LREIRMLKQLKHPN 61
Query: 958 LVKLIGICIEEQARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
LV LI + ++ LV+E + +E + GV + KI +A+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQAVN 114
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGY 1071
+ H IHRD K NIL+ K+ DFG AR D+ + +++TR Y
Sbjct: 115 FCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166
Query: 1072 VAPEYAMTGHLLVKS-------DVYSYGVVILELLSG 1101
APE LLV DV++ G V ELL+G
Sbjct: 167 RAPE------LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 952
E E +LG+G +G+VY+ L ++A+K + D + + E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-----VDKESAPLGWDARLKIAL 1007
L HRN+V+ +G E + E +P GS+ + L D E + + ++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFG----LARSAMDEESRHIS 1062
L YLH++ +++HRD K N+L+ + K+SDFG LA E+
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET---- 168
Query: 1063 TRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQP 1110
GT Y+APE G+ +D++S G I+E+ +G+ P +++ +P
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 900 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHH 955
NF + +G G F VY + L DG VA+K + +D + + + E+++L +L+H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
N++K IE+ +V EL G + + K+ + K + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
+H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135
KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKK-------IEQCDY 225
Query: 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
P L +D + + + + +MC+ P+ + RP
Sbjct: 226 PPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 31/213 (14%)
Query: 906 RILGEGGFGLVY-----SGVLDDGTKVAVKVLK--------RVDQQGGREFLAEVEMLSR 952
++LG+G FG V+ +G D G A+KVLK RV + R+ LAEV
Sbjct: 2 KVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----- 55
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+H +VKL E L+ + + G + + L KE D + +A A A
Sbjct: 56 -NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALA 110
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L +LH S +I+RD K NILL+ + K++DFGL++ ++D E + S GT Y+
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 1073 APEYA-MTGHLLVKSDVYSYGVVILELLSGRKP 1104
APE GH +D +S+GV++ E+L+G P
Sbjct: 166 APEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 53/219 (24%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRL-HHRN 957
LG+G FG VY + G VA+K +K+ +F L EV+ L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHPN 59
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLKIALGAARALAY 1015
+VKL + E V+E +E +L+ + D++ P I + LA+
Sbjct: 60 IVKLKEVFRENDELYFVFEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR-----HISTRVMGTFG 1070
+H+ HRD K N+L+ K++DFGLAR SR ++STR
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----W 163
Query: 1071 YVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1102
Y APE +L++S D+++ G ++ EL + R
Sbjct: 164 YRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-15
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 906 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL--- 961
R LG G GLV+S V D +VAVK + D Q + L E++++ RL H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 962 -----------IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGA 1009
+G E + +V E +E+ L V E PL + ARL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEY-----METDLANV-LEQGPLSEEHARL-FMYQL 123
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMG- 1067
R L Y+H S V+HRD K +N+ + D K+ DFGLAR +D H G
Sbjct: 124 LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGL 179
Query: 1068 -TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
T Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 901 NFDASRILGEGGFGLVYSGV---LDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLH- 954
++ + LG+G +G+V S + VA+K + V + + L E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 955 HRNLVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GA 1009
H+N+ L + I L EL+ E+ LH + + PL DA + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLT-DAHFQSFIYQI 114
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMG 1067
L Y+H S V+HRD K N+L+ D K+ DFGLAR S E+ T +
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 1068 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1105
T Y APE ++ K+ DV+S G ++ ELL GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 908 LGEGGFGLVYSGVLDDG---TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+G G FG V G ++ G +V VK L+ Q +FL E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1021
C E LV E P G ++ +L K + D ++A A L +LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL-MTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA--MT 1079
IH D N LL D T K+ D+GL+ + E+ ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 1080 GHLLV-----KSDVYSYGVVILELLS-GRKP 1104
G+LLV +S+V+S GV I EL G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 908 LGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
LG GGFG V V A+K +K+ V+ +E E+L +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+++ ++ E G + + L + AR IA A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHNRG--- 113
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHL 1082
+I+RD K N+LL+ + K+ DFG A+ +S + GT YVAPE + G+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 1083 LVKSDVYSYGVVILELLSGRKP 1104
D +S G+++ ELL+GR P
Sbjct: 171 FS-VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-14
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 7/224 (3%)
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
+ A+ P P A+ P+ AP PA+ + A PA+ + A+ P++ +P P +
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAA--AARAVAAAPARRSPAPEA 432
Query: 278 HPSNTAPPPASHPSKTAPP--PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ AP PA+ P+ A P A+ P A A+ P+ AP A P+
Sbjct: 433 LAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPA 492
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPS--NPAIPPASHPSNTAIPPASHPSNTA 393
+ PPP PA + A S +PA T P +
Sbjct: 493 DDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPR 552
Query: 394 PPHASHPSNTALTPASHPSNIAPP-PLFVPVLPSALPGKAPVSQ 436
A+ P P + S + P L + LP + Q
Sbjct: 553 AAAATEPVVAPRPPRASASGLPDMFDGDWPALAARLPVRGLAQQ 596
|
Length = 700 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 906 RILGEGGFGLVYSGVL---DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRN 957
+ LGEG FG V G L D KVAVK +K R + + +FL+E + H N
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPN 61
Query: 958 LVKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGA 1009
+++LIG+C++ ++ + +G + S L P ++ K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
A + YL SS IHRD + N +L + V+DFGL++ + +
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115
++A E KSDV+S+GV + E+ + G+ P PG EN
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 901 NFDASRILGEGGFGLVYS-GVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 957
+F + LG+G +G VY L D A+K L + Q+ + + E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
++ ++ C+V E P G + + K+ + +I + R L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
E +++HRD KS+NILL + K+ D G+++ ++++ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
KSD++S G ++ E+ + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-14
Identities = 67/337 (19%), Positives = 95/337 (28%), Gaps = 33/337 (9%)
Query: 129 PTTPVASPPPITAPPLV-NVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSN 187
P P P V +PAP + + A P A+ +
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAA 419
Query: 188 TARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
R A P PPA+ AP PA + + PP S +
Sbjct: 420 ATRAEA--PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSA 477
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
+ A P P + A PA+ + AP A+ P+ A P
Sbjct: 478 SAPASDAPPDAAFEPAP---RAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARP 534
Query: 308 PASHPSNTAPPPASH----------------PSNTAPPPASHPSNTAPPPASHSSKTAPP 351
P P+ AP + S+ A+ A P A + K A P
Sbjct: 535 PT--PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA--APKPAAP 590
Query: 352 PASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
+ T A+ P A A+ PP P + + ++
Sbjct: 591 RVAVQVPTPRARAATGDAPPNGAAR------AEQAAESRGAPPPWEDIPPDDYVPLSADE 644
Query: 412 SNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
P FVPV S P V+ P P P T
Sbjct: 645 GFGGPDDGFVPVFDSG-PDDVRVAPKPADAPAPPVDT 680
|
Length = 830 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 965
+G+G FG VY + VA+KV+ + + E + E++ LS+ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
++ ++ E GS L + L I L YLHE+ I
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRD K++NILL + K++DFG++ S+ +T V GT ++APE K
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR-NTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 1086 SDVYSYGVVILELLSGRKP 1104
+D++S G+ +EL G P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 57/282 (20%)
Query: 908 LGEGGFGLVYSGVLDD-GTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH-RNLVKLIG- 963
+G G FG V + GT +AVK ++ VD++ + L +++++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 964 --------ICIEEQARCL--VYELIPNGSVESHLHGVDKESAP---LGWDARLKIALGAA 1010
IC+E L Y+ + + V K P LG KIA+
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYV---------YEVLKSVIPEEILG-----KIAVATV 117
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
+AL YL E+ ++IHRD K SNILL+ + K+ DFG++ +D ++ TR G
Sbjct: 118 KALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRP 172
Query: 1071 YVAPEYAMTGHLL---VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127
Y+APE V+SDV+S G+ + E+ +G+ P W
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF---- 217
Query: 1128 EGLERIID---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
+ L +++ P L N + ++C+ + RP
Sbjct: 218 DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--QQGGREFLA---EVEMLSRLHH 955
++ + +GEG FG +Y + + V+K +D + +E A EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIY--LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHL---HGVD-KESAPLGWDARLKIALGAAR 1011
N+V E +V E G + + GV E L W ++I+LG
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG--- 113
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
L ++H+ +++HRD KS NI L + K+ DFG+AR D S ++ +GT
Sbjct: 114 -LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPY 167
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
Y++PE K+D++S G V+ EL + + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-14
Identities = 53/215 (24%), Positives = 82/215 (38%), Gaps = 4/215 (1%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPS 219
A P ++ A P A P AA P A+ P+ A P A P+ A+ + A P++ +P+
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAA--PAAAPAAAAAARAVAAAPARRSPA 429
Query: 220 PASHPSNTALPPASLPSKTAPP--PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P + + AP PA+ + A P A+ P + A+ P++ AP A
Sbjct: 430 PEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAP 489
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 337
P++ PPP PA + AP S P A + +
Sbjct: 490 APADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAP 549
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
AP A+ + P S + LP PA+
Sbjct: 550 APRAAAATEPVVAPRPPRASASGLPDMFDGDWPAL 584
|
Length = 700 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH---RNLVKL 961
++G G +G VY G + G VA+K++ + EV +LS+L N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 1018
G ++ ++ E GSV + + ++ P+ A I++ AL Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPI---AEKYISVIIREVLVALKYIHK 119
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
VIHRD K++NIL+ + K+ DFG+A +++ S ST V GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 1079 TGHLL-VKSDVYSYGVVILELLSGRKP 1104
G K+D++S G+ I E+ +G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-14
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRN 957
+ +G G +G+V S + G KVA+K + + L E+++L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 958 LVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA-RA 1012
++ + I A +V +L+ ES LH + PL + ++ L R
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLLRG 119
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMGTFG 1070
L Y+H S VIHRD K SN+L+ D ++ DFG+AR + H T + T
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 1071 YVAPE--YAMTGHLLVKSDVYSYGVVILELLSGRKPV 1105
Y APE ++ + D++S G + E+L GR+ +
Sbjct: 177 YRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 901 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRLHHRNL 958
D +GEG G+V + G +VAVK + QQ RE L EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNI 78
Query: 959 VKLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAY 1015
V++ + +V E + G++ +H +++ A + L +AL++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALSF 130
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH + VIHRD KS +ILL D K+SDFG E R S ++GT ++APE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE 185
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+ D++S G++++E++ G P +PP Q
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPY-FNEPPLQ 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-14
Identities = 91/450 (20%), Positives = 135/450 (30%), Gaps = 23/450 (5%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
P A S L S +A A A T PPP
Sbjct: 21 FPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPP----GPG 76
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
PA+ T S + +P P+ P P T PPPAS P + P
Sbjct: 77 TEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPT-PPPASPPP-SPAPDL 134
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
S P P+ + P + P+ A AS P + + A
Sbjct: 135 SEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPP 194
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALP 429
P+ PPA+ + ++ + P + + A + S+ + S+
Sbjct: 195 PSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSS-------ESSGC 247
Query: 430 GKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIA 489
G P ++ P+ P AP P R A + P P A ++ +P P +
Sbjct: 248 GWGPENECPLPRP-APITLPT----RIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSS 302
Query: 490 PGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP-PSTPPLSVDGKRVGKPVAEPSYDIP 548
PG P +S + S + + + S + + R P P P
Sbjct: 303 PGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADP 362
Query: 549 MPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSP-SPSPT 607
P PS+ P P + +R + P R SP
Sbjct: 363 SSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAA 422
Query: 608 SASGQTELPLLPPKSSPSEPIRAFPPPPPN 637
S + PLL P P PPPPP
Sbjct: 423 SGAFYARYPLLTPSGEPWPGS---PPPPPG 449
|
Length = 1352 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 9e-14
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 906 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQG--GREFLAEVEMLSRLHHRNLVKLI 962
+G G +G V S G KVA+K L R Q + E+ +L + H N++ L+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 963 GICIEEQARCLVYELIPNGSVE--------SHLHGVD----KESAPLGWDARLKIALGAA 1010
+ P S+E +HL G D + L D +
Sbjct: 81 DV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
R L Y+H S +IHRD K SNI + D K+ DFGLAR DE + +++TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 1071 YVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR 1102
Y APE + H D++S G ++ ELL+G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 908 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 963
LG+GGFG V + V + G A K L KR+ ++ G + L E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ CLV L+ G ++ H++ V + G + I A LH S
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHLHSM-D 115
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
+++RD K N+LL+ ++SD GLA D ++ T+ GT GY+APE
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 1084 VKSDVYSYGVVILELLSGRKP 1104
D ++ G I E+++GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-13
Identities = 96/371 (25%), Positives = 124/371 (33%), Gaps = 25/371 (6%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
PP P AL P S + P + P+ HP +
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQR- 236
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKT---APPPASHPSNTAPPPASHPSNTAP 317
LP+ HP + P + HP + PP H P HPS+ P
Sbjct: 237 --LPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP 294
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
P + PP PS P + S++A P P LPPA PS P I P
Sbjct: 295 QPFGLAQSQVPPLPL-PSQAQPHSHTPPSQSALQPQQPPREQPLPPA--PSMPHIKP--- 348
Query: 378 PSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
P T IP + S+ PPH PS PSN+ PPP P+ S+LP P S
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGPSPF----PQMPSNLPPPPALKPL--SSLPTHHPPSAH 402
Query: 438 PISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGN 497
P L P + P + P + S P P + ++ P P A PF G
Sbjct: 403 PPPLQLMPQSQPLQSVPAQPPVLTQSQSLP-PKASTHPHSGLHSGPPQSPFAQHPFTSGG 461
Query: 498 SRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVD---GKRVGKPVAEPSYDIPMPPPVN 554
+ P + A+P S PP S G G P I P
Sbjct: 462 ---LPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPLDE 518
Query: 555 HSPSKGPVVPP 565
+ P PP
Sbjct: 519 AEEPESPPPPP 529
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLHHRN 957
F+ +GEG +G+VY G VA+K ++ +++ G L E+ +L L H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 958 LVKLIGICIEEQARC--LVYELIPNGSVESHLHG-VDKESAPLGWDARLK-IALGAARAL 1013
+V+L + + + LV E E L +D P ++++K + L R L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFS-ESQVKCLMLQLLRGL 121
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
YLHE+ +IHRD K SN+LL K++DFGLAR ++ ++ +V+ T Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVV-TLWYRA 176
Query: 1074 PE--YAMTGHLLVKSDVYSYGVVILELLSGR 1102
PE T + D+++ G ++ ELL+ +
Sbjct: 177 PELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 906 RILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 959
RILG G FG + G L +K VA+ L+ D+Q R FLAE L + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIV 69
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L G+ +V E + NG+++S L K L + + G A + YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFG-LARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
+H+ + +L+ D K+S F L E+ + + + APE
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS--EAIYTTMSGKSPVLWAAPEAIQ 181
Query: 1079 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 1108
H SDV+S+G+V+ E++S G +P DM+
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
LG+G FG VY + G A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
E ++ E G+V++ + +++ PL + AL YLHE+ ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH----- 1081
RD K+ NIL D K++DFG+ SA + + +GT ++APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 1082 LLVKSDVYSYGVVILELLSGRKP 1104
K+DV+S G+ ++E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSR-LHHRNLVKLIG- 963
LG G +G+V + GT +AVK ++ V+ Q + L ++++ R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 964 --------ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
IC+E L + + G+ LG KIA+ +AL Y
Sbjct: 69 LFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S VIHRD K SN+L+ + K+ DFG++ +D ++ T G Y+APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TIDAGCKPYMAPE 173
Query: 1076 Y----AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 1114
VKSDV+S G+ ++EL +GR P D + P Q+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 908 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHH-RNLVKLIG- 963
+G G G VY G +AVK ++R ++ + L +++++ + H +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 964 --------ICIEEQARCL------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
IC+E + CL + IP LG K+ +
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIP--------------EDILG-----KMTVAI 123
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
+AL YL E VIHRD K SNILL+ K+ DFG++ +D +++ TR G
Sbjct: 124 VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCA 178
Query: 1070 GYVAPEY----AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y+APE +++DV+S G+ ++EL +G+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 908 LGEGGFGLVYSGV---LDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 957
LGEG FG V LD TKVAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLH-----GVDKESAP-------LGWDARLKI 1005
++ L+G C ++ ++ E G++ +L G++ P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++APE +SDV+S+GV++ E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-13
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P A+ + + A PA+ P A+ P+ A P A+ + APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P+ A P A+ P + + P+ AP + P AP PA S+ A
Sbjct: 423 PAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASA--A 476
Query: 350 PPPASHPSNTALPPAS 365
P PA+ P+ L P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGI 964
+G G +G V + G +VAVK L R Q + E+ +L + H N++ L+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKES----APLGWDARLKIALGAARALAYLHEDS 1020
++ E + + +HL G D + L D + R L Y+H
Sbjct: 85 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 1081 -HLLVKSDVYSYGVVILELLSGR 1102
H D++S G ++ ELL+GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 908 LGEGGFGLVYSGVL--------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 957
LGEG FG V D VAVK+LK + + ++E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLGWDARLKI 1005
++ L+G+C +E ++ E G++ L L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
A AR + YL S R IHRD + N+L+ D K++DFGLAR D + ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++APE +SDV+S+G+++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRV------DQQGGRE-------FLAEVEML-SRL 953
LG G FG VY V + LK + + RE ++EV ++ +L
Sbjct: 8 LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
H N+V+ +E +V +LI + H + + ++ + I + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
YLH++ R++HRD +NI+L D ++DFGLA+ E T V+GT Y
Sbjct: 127 RYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSREGLER 1132
PE K+DV+++G ++ ++ QPP N+++ A + +E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLATKI------VEA 228
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1171
+ +P L + + V + + C+ P+ + RP + +V
Sbjct: 229 VYEP-LPEGMYSE---DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRL---HHRN 957
+GEG +G VY L+ G VA LK+V E L E+ +L +L H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVA---LKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 958 LVKLIGIC-IEEQARC----LVYELIPNGSVESHLHG-VDKESAP-LGWDARLKIALGAA 1010
+V+L+ +C R LV+E V+ L + K P L + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
R + +LH S R++HRD K NIL+ D K++DFGLAR E + T V+ T
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLW 171
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y APE + D++S G + EL R+P
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-13
Identities = 58/217 (26%), Positives = 74/217 (34%), Gaps = 12/217 (5%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P A A + PP AARP A P+ A P A P+ A PA + A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAA--PAAPAAPAAPAPAGAAAAPAEASAAPA--- 644
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
+P HP + A+P AS P A + APPPA P A A P
Sbjct: 645 PGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAP------AAPAAPAGAAP 698
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH-PSNTAPPPASH 333
P+ A PPA A P + P + PP P + A PA
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P AP PA+ + PP + +
Sbjct: 759 PPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
|
Length = 824 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G+G G VY+ + + G +VA+K + Q + E+ ++ H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 138
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1087 DVYSYGVVILELLSGRKP 1104
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-13
Identities = 43/206 (20%), Positives = 60/206 (29%), Gaps = 8/206 (3%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
PA + PPA S A P + P+ A P+ + A ++ A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAA------RPAAPAAPAAPAAPAPAGAAAAPAEASAAP 643
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P + P + + PA+ P P A A P
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPA 702
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P+ A PPA + A P + P + + P P P A
Sbjct: 703 PAPAATPPAGQADDPAAQPPQAAQGASAPSPA-ADDPVPLPPEPDDPPDPAGAPAQPPPP 761
Query: 350 PPPASHPSNTALPPASHPSNPAIPPA 375
P PA + A PP S PS
Sbjct: 762 PAPAPAAAPAAAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-13
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 908 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+GEG G+V + G +VAVK + QQ EV ++ HH N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 967 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+V E + G+ + +H +++ A + L RAL+YLH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLSVLRALSYLHNQG--- 138
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
VIHRD KS +ILL D K+SDFG E + S ++GT ++APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYG 196
Query: 1084 VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+ D++S G++++E++ G P +PP Q
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY-FNEPPLQ 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-12
Identities = 58/224 (25%), Positives = 77/224 (34%), Gaps = 19/224 (8%)
Query: 94 DMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSL 153
P + PVA P A P AP P+ P P A+P A V PA
Sbjct: 371 GAGPATAAAA--PVAQPAPAAAAPAA-AAPAPAAPPAAPAAAPAAAAAARAVAAAPARRS 427
Query: 154 IPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALP 213
LA+ + A P P+ A P A+ P+ ARP A+ P A A+ P+ A
Sbjct: 428 PAPEALAAARQASARGPGGAPAPAPAPAAA-PAAAARPAAAGPRPVAAAAAAAPARAAPA 486
Query: 214 SKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
+ AP+ P LPP + + PA ++ P PA+ P
Sbjct: 487 AAPAPADDDPPPWEELPPE--------FASPAPAQPDAAPAGWVAESIPDPATAD----P 534
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
A AP A P A P PP + S
Sbjct: 535 DDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVKL 961
LGEG FG VY + G VA LK++ ++ F L E+++L +L H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 962 IGICIEE-----QARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALA 1014
I + +E + R VY + P ++ L G+ + S L ++++K L +
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENPSVKLT-ESQIKCYMLQLLEGIN 129
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE---------ESRHISTRV 1065
YLHE+ ++HRD K++NIL+++ K++DFGLAR T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 1066 MGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGR 1102
+ T Y PE + T + D++ G V E+ + R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 907 ILGEGGFGLVYSG-VLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
ILG G G VY L +AVKV+ + + ++ ++E+E+L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E + E + GS++ ++ E LG +IA+ + L YL S ++
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLW---SLKI 116
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
+HRD K SN+L+ K+ DFG++ ++ I+ +GT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGI 172
Query: 1085 KSDVYSYGVVILELLSGRKP 1104
SDV+S G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 908 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+GEG G+V + V G VAVK + QQ EV ++ H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 967 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+V E + G+ + +H +++ A + L +AL+ LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLKALSVLH---AQG 136
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
VIHRD KS +ILL HD K+SDFG E R S ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 1084 VKSDVYSYGVVILELLSGRKPVDMTQPP 1111
+ D++S G++++E++ G P +PP
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY-FNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 908 LGEGGFGLVYSGVL-------DDGTKVAVKVLKRVDQQGGREFLAEVE---MLSRLHHRN 957
LG+G F +Y GVL G V V+ +V R+ LA E ++S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
LVKL G+C+ +V E + G ++ LH +K + L W +L +A A AL YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 1018 EDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFG 1070
+ +++H + NIL+ + P K+SD G+ + + E R +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIP 169
Query: 1071 YVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128
++APE G L + +D +S+G +LE+ S G+E L L+S E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLST-----LSSSE 214
Query: 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175
D + +P A++A + + C + RP +++ L
Sbjct: 215 KERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 908 LGEGGFGLVYS----GVLDDGTK----VAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 957
LGEG FG V G+ D K VAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA----------- 1006
++ L+G C ++ ++ E G++ +L + P G + IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 1007 -----LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061
AR + YL +S + IHRD + N+L+ + K++DFGLAR + +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
+T ++APE +SDV+S+GV++ E+ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-12
Identities = 46/195 (23%), Positives = 68/195 (34%), Gaps = 6/195 (3%)
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
A+ P P A+ P+ AP PA+ P+ A PA+ A A+ ++ +P P +
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAA--AARAVAAAPARRSPAPEA 432
Query: 355 HPSNTALPPASHPSNPAIP--PASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPS 412
+ PA PA+ P+ A P A+ P A A+ P+ A A P+
Sbjct: 433 LAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPA 492
Query: 413 NIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVA 472
+ PPP LP AP + P A P P A
Sbjct: 493 DDDPPPW--EELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPA 550
Query: 473 QKRNASNREAPIAEP 487
+ A+ P
Sbjct: 551 PRAAAATEPVVAPRP 565
|
Length = 700 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 963
++G+G +G+V S + G KVA+K + V + L E+++L L H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 964 ICIEEQAR-----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
I + R +V+EL+ ES LH V K + L + RAL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPEYA 1077
+ V HRD K NIL D K+ DFGLAR A ++ I T + T Y APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 176
Query: 1078 MTGHLLVKS----DVYSYGVVILELLSGR 1102
+ G K D++S G + E+L+G+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+G G FGLV S G VA+K + + + E+++L L H N++ L I
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 965 CIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
I V EL+ + LH + S PL R L Y+H S
Sbjct: 78 FISPLEDIYFVTELL-----GTDLHRL-LTSRPLEKQFIQYFLYQILRGLKYVH---SAG 128
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
V+HRD K SNIL+ + K+ DFGLAR + + ++STR Y APE +T
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 1084 -VKSDVYSYGVVILELLSGRKPV 1105
V+ D++S G + E+L G KP+
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHR 956
T ++ +G+G +G VY DG+ AVK+L + E AE +L L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 957 NLVKLIGI------CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1010
N+VK G+ + Q LV EL GSV + G+ L I GA
Sbjct: 80 NVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
L +LH + R+IHRD K +NILL + K+ DFG+ SA +R +GT
Sbjct: 139 LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTSTRLRRNTSVGTPF 193
Query: 1071 YVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 1110
++APE + DV+S G+ +EL G P+ P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 908 LGEGGFGLVYSGVLDDGTKV--AVKVLKRV---DQQGGREFLAEVE--MLSRLHHRNLVK 960
LG+G FG VY V D +KVLK + + A E +LS+L H +VK
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 961 LIGICIEEQARCLVYELIP----NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+E A C++ E + +E H S + +++ LG + Y+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG----VHYM 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H+ R++HRD K+ NI L+++ K+ DFG++R M S ++T GT Y++PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEA 176
Query: 1077 AMTGHLLVKSDVYSYGVVILEL 1098
KSD++S G ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 906 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 961
R+LG+G FG V + + + G AVKVLK+ + Q E + E +LS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 962 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+ C + R V E + G + H+ + AR A AL +LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAA-EITSALMFLHDKG 116
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
+I+RD K N+LL+H+ K++DFG+ + + ++ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVD 1106
D ++ GV++ E+L G P +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 78/270 (28%), Positives = 115/270 (42%), Gaps = 28/270 (10%)
Query: 887 AKTFSASEIEKATGNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKRVDQQGG---RE 942
A+ F + EK F R +G G FG VY + + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 943 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
+ EV L +L H N ++ G + E LV E + S L V K+ PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEI 117
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 170
Query: 1063 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVA 1118
+GT ++APE + G K DV+S G+ +EL + P+ +M ++
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 1119 WARPLLTSR---EGLERIIDPSLGNDVPFD 1145
P L S E +D L +P D
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCL-QKIPQD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 911 GGFGLVY-SGVLDDGTKVAVKVLKRVDQQGGRE---FLAE-VEMLSRLHHRNLVKLIGIC 965
G FG VY + G A+KVLK+ D + AE M+ + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+ LV E + G S + K L D + + LH+ +I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRD K N+L++ K++DFGL+R+ + + + +GT Y+APE +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDYLAPETILGVGDDKM 173
Query: 1086 SDVYSYGVVILELLSGRKPVDMTQP 1110
SD +S G VI E L G P P
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-12
Identities = 73/237 (30%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLHH 955
F R +G G FG VY D V +K++ G + + + EV+ L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
N ++ G + E LV E + S L V K+ PL I GA + LAY
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAY 140
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S +IHRD K+ NILL K++DFG A A S +GT ++APE
Sbjct: 141 LH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 1076 YAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVAWARPLLTSRE 1128
+ G K DV+S G+ +EL + P+ +M ++ P L S E
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 908 LGEGGFGLVYSGVLDDGTK-VAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLIG 963
+G G FG VY + VAVK + +Q ++ + EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
++E LV E + S L V K+ PL I GA + LAYLH S
Sbjct: 89 CYLKEHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHN 141
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT---G 1080
+IHRD K+ NILL K++DFG A + S +GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
K DV+S G+ +E L+ RKP
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 72/261 (27%), Positives = 111/261 (42%), Gaps = 32/261 (12%)
Query: 893 SEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 951
S + G F+ ++G G +G VY G + G A+KV+ V + E E+ ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLK 67
Query: 952 RL-HHRNLVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK 1004
+ HHRN+ G I+ + LV E GSV + + W A
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064
I R LA+LH + +VIHRD K N+LL + K+ DFG+ SA + +
Sbjct: 126 ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNT 180
Query: 1065 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPV-DM----------T 1108
+GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 1109 QPPGQENLVAWARPLLTSREG 1129
PP + W++ + EG
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEG 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 57/226 (25%)
Query: 909 GEGGFGLVYSGVL---DDGTKVAVKVLK-RVDQQGGREFLA--EVEMLSRLHHRNLVKLI 962
G G +G VY DG + A+K K +Q G A E+ +L L H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 963 GICIEEQARC--LVYE-------------------LIPNGSVESHLHGVDKESAPLGWDA 1001
+ +E + L+++ IP V+S L
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW------------- 115
Query: 1002 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEE 1057
+I G + YLH + V+HRD K +NIL+ + K+ D GLAR +
Sbjct: 116 --QILNG----VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAP 165
Query: 1058 SRHIST--RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLS 1100
+ ++ V+ T Y APE + K+ D+++ G + ELL+
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-12
Identities = 44/220 (20%), Positives = 66/220 (30%), Gaps = 3/220 (1%)
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
P A+ P PA+ A P + P + + A A+ P+ +P
Sbjct: 371 GAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPA-AAAAARAVAAAPARRSPA 429
Query: 308 PASHPSNTAPPPASHPSNTAPP--PASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
P + + AP PA+ P+ A P A+ A A+ P+ A A
Sbjct: 430 PEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAP 489
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P++ PP PA + AP S A P
Sbjct: 490 APADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAP 549
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMP 465
+ A P A A+ F PA+ +P
Sbjct: 550 APRAAAATEPVVAPRPPRASASGLPDMFDGDWPALAARLP 589
|
Length = 700 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQGGREF 943
S KT + ++ +G+G +G V+ VL+ +G+K AVK+L + E
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEI 61
Query: 944 LAEVEMLSRLH-HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPL 997
AE +L L H N+VK G+ ++ + LV EL GSV + G K +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 998 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057
I A L +LH + + IHRD K +NILL + K+ DFG+ SA
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTS 176
Query: 1058 SRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 1110
+R +GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 907 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLI 962
I+G GGFG VY D G A+K L KR+ + G L E MLS + + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 963 GICIEEQAR---CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 1017
+ + +L+ G + HL HGV E+ + A +I LG L ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA--EIILG----LEHMH 114
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
V++RD K +NILL+ ++SD GLA ++ H S +GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 1078 MTGHLLVKS-DVYSYGVVILELLSGRKP 1104
G S D +S G ++ +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
+GEG +G+VY G VA+K ++ + G A E+ +L L+H N+V+L+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL--KIALGAARALAYLHEDSS 1021
E LV+E + + ++ ++ +S+P G D L + +AY H S
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG- 1080
RV+HRD K N+L++ + K++DFGLAR A R + V+ T Y APE +
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D++S G + E+++ R+P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 45/219 (20%)
Query: 907 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
I+G GGFG VY D G A+K L KR+ + G E LA L+ R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA-------LNERIMLSLVS 52
Query: 964 -------ICIE-----EQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIA 1006
+C+ C + +L+ G + HL HGV E + R +I
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-----EMRFYATEII 107
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
LG L ++H V++RD K +NILL+ ++SD GLA ++ H S +
Sbjct: 108 LG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---V 156
Query: 1067 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT GY+APE G S D +S G ++ +LL G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-12
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 44/194 (22%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVK 960
+G+G FG V+ VA LK+V + +E F L E+++L L H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 961 LIGICIEE---QARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
LI IC + R LV+E + + A L + +K L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEF------------CEHDLAGLLSNKNVKFTLSEIKK 123
Query: 1013 --------LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRH-I 1061
L Y+H +++HRD K++NIL+ D K++DFGLAR S +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 1062 STRVMGTFGYVAPE 1075
+ RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-11
Identities = 41/192 (21%), Positives = 56/192 (29%), Gaps = 2/192 (1%)
Query: 199 TAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA-PPPASHLSNTAPPPASHP 257
AP A A S P A+ P+ A P A A A ++ AP P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 258 YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+ P + P + PA+ P P A A P P+ A
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAPAAT 708
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
PPA + A P + P + PP + P P P +
Sbjct: 709 PPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAA 768
Query: 378 PSNTAIPPASHP 389
A PP+
Sbjct: 769 APAAAPPPSPPS 780
|
Length = 824 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 54/223 (24%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
+GEG +G+VY G G VA+K ++ ++ G A E+ +L L H N+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 965 CIEEQARCLVYEL-----------IPNGS------VESHLHGVDKESAPLGWDARLKIAL 1007
++E L++E +P G V+S+L+ +
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI----------------- 110
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-- 1065
+ + + H S RV+HRD K N+L+++ K++DFGLAR+ I RV
Sbjct: 111 --LQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------GIPVRVYT 159
Query: 1066 --MGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPV 1105
+ T Y APE + D++S G + E+ + +KP+
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 908 LGEGGFGLVYSG----VLDDG----TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
LG+G F ++ G V D G T+V +KVL + + F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
G+C+ +V E + GS++++L +K + W +L++A A AL +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 1020 SSPRVIHRDFKSSNILL--EHDF---TP---KVSDFGLARSAMDEESRHISTRVMGTFGY 1071
+ H + + N+LL E D P K+SD G++ + + +E + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERI----PW 170
Query: 1072 VAPE-YAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQP 1110
V PE +L + +D +S+G + E+ SG KP+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 901 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEVEMLSR 952
NF+ R+LG G +G V+ G D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 953 LHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALG 1008
+ R LV L + L+ + + G + +HL+ + ES R+ IA
Sbjct: 61 VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE-----VRVYIA-E 113
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMG 1067
AL +LH+ +I+RD K NILL+ + ++DFGL++ +EE R S G
Sbjct: 114 IVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCG 168
Query: 1068 TFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP 1104
T Y+APE GH D +S GV+ ELL+G P
Sbjct: 169 TIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 908 LGEGGFGLVYS----GVLDD----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 957
LGEG FG V G+ D VAVK+LK + + ++E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA------------RLKI 1005
++ L+G C ++ ++ E G++ +L +D +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + + +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++APE +SDV+S+GV++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRV----DQQGGREF-LAEVEMLSRLHHRNLVKL 961
+GEG +G V+ + VA LKRV D +G L E+ +L L H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 962 IGICIEEQARCLVYELIP----------NGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
+ ++ LV+E NG ++ + + +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-------------VKS-FMFQLLK 110
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
LA+ H S V+HRD K N+L+ + K++DFGLAR A R S V+ T Y
Sbjct: 111 GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWY 165
Query: 1072 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1105
P+ L S D++S G + EL + +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-11
Identities = 53/212 (25%), Positives = 72/212 (33%), Gaps = 7/212 (3%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P P + P PAS + P+ A P A P+ A PA + AP A
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
+ P + P + PA+ P P A + A P P+
Sbjct: 649 APE--HHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 359 TALPPASHPSNPAIPPASHP-SNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
A PPA +PA P +A PA+ PP P + A PA P AP
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
P P+A P +P S+ D +
Sbjct: 766 P---AAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-11
Identities = 39/193 (20%), Positives = 57/193 (29%), Gaps = 7/193 (3%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
AP A A + P + A P A AP + P A + AP P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAP----AAPAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P + P + PA+ P P A A P P+
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPA 704
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
A PPA + A P + P + ++ +P P + P + PP
Sbjct: 705 PAATPPAGQADDPAAQPPQAAQGASAPSPA--ADDPVPLPPEPDDPPDPAGAPAQPPPPP 762
Query: 396 HASHPSNTALTPA 408
+ + A P
Sbjct: 763 APAPAAAPAAAPP 775
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-11
Identities = 48/211 (22%), Positives = 65/211 (30%), Gaps = 11/211 (5%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
V P P A PA S P + P+ A P + +
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPA-------APAAPAAPAAPAPAGAAAAPAEA 639
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
++ P+ P HP + A+P + PA+ P P A A P
Sbjct: 640 SAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAP 698
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH-PSNTAPPPASH 311
P + PA A P + P + PP P + A PA
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
P AP PA+ P+ A PP S PS
Sbjct: 759 PPPPAPAPAAAPA--AAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 908 LGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 965
+G+G FG V+ G+ + KV A+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+++ ++ E + GS L E PL I + L YLH S + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH---SEKKI 123
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
HRD K++N+LL K++DFG+A D + + +GT ++APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSK 181
Query: 1086 SDVYSYGVVILELLSGRKPVDMTQP 1110
+D++S G+ +EL G P P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 908 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 964
+G+G FG VY G+ D+ TK VA+K++ + + E + E+ +LS+ + + G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
++ ++ E + GS L + PL I + L YLH S R
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH---SERK 122
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDF 180
Query: 1085 KSDVYSYGVVILELLSGRKPVDMTQP 1110
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 905 SRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGRE-----FLAEVEMLSRLH 954
S +L EG FG ++ G+L D +V VK +K E L E +L L
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLS 66
Query: 955 HRNLVKLIGICIEEQARCLVYELIPN-GSVESHL----HGVDKESAPLGWDARLKIALGA 1009
H+N++ ++ +CIE+ V N G+++ L G L + +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM--------DEESRHI 1061
A ++YLH VIH+D + N +++ + K++D L+R D E+R +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++A E + SDV+S+GV++ EL++
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 957
G F+ ++G G +G VY G + G A+KV+ V E E+ ML + HHRN
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 958 LVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
+ G I+ + LV E GSV + + W A I R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L++LH+ +VIHRD K N+LL + K+ DFG+ SA + + +GT +
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYW 177
Query: 1072 VAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPVDMTQP 1110
+APE KSD++S G+ +E+ G P+ P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 46/134 (34%), Positives = 73/134 (54%), Gaps = 10/134 (7%)
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
K+++ R LAYL E +++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 107 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA-WARP 1122
+GT Y++PE H V+SD++S G+ ++EL GR P+ PP + L A + RP
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI---PPPDAKELEAIFGRP 217
Query: 1123 LLTSREGLERIIDP 1136
++ EG I P
Sbjct: 218 VVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 910 EGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRNLVKLIGI 964
EG +G+VY G VA+K LK ++ G F L E+ +L +L H N+V + +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQHPNIVTVKEV 72
Query: 965 CIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSS 1021
+ +V E VE L + + + +K + L +A+LH++
Sbjct: 73 VVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1081
++HRD K+SN+LL + K+ DFGLAR T+++ T Y APE
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPE------ 176
Query: 1082 LLV-------KSDVYSYGVVILELLSGRKPV 1105
LL+ D++S G + ELL+ +KP+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-11
Identities = 84/332 (25%), Positives = 143/332 (43%), Gaps = 57/332 (17%)
Query: 844 EEVPQSLQTSHVKPSGAAG--LMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 900
E++ + +H G +G M LD S ++ A + ++I ++
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERS-HNNNAGEDEDEEKMIDNDINRSPNK 66
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
++ I+G G FG+VY + +D KVA+K + + Q RE L ++ L+H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINII 122
Query: 960 KLIGICIEEQAR--------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGA 1009
L E + +V E IP +V ++ + + + PL L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL-- 179
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAM--DEESRHISTRVM 1066
RALAY+H S + HRD K N+L++ + T K+ DFG A++ + +I +R
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 1067 GTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILE------LLSGRKPVDMTQPPGQEN 1115
Y APE + T H+ D++S G +I E + SG+ VD
Sbjct: 236 ----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILGYPIFSGQSSVD--------Q 279
Query: 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSV 1147
LV + L T E + ++P+ D+ F V
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYA-DIKFPDV 310
|
Length = 440 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
KI++ R L YL E ++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
+GT Y++PE H V+SD++S G+ ++E+ GR P+ E +
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216
Query: 1124 LTSREGLERIIDPSLGNDVP 1143
++E + D P
Sbjct: 217 GEAKESHRPV--SGHPPDSP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-11
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 922 DDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYE 976
G +VA+K+L+ + + F E + +RL+H N+V L+ G V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036
+P ++ L L ++ L ALA H ++HRD K NI++
Sbjct: 60 YVPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 1037 -EHDFTP--KVSDFGLAR-----SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDV 1088
+ P KV DFG+ D + +T V+GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 1089 YSYGVVILELLSGRKPV 1105
Y++G++ LE L+G++ V
Sbjct: 173 YAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 957
NF +GEG +G+VY G VA+K ++ + G A E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYL 1016
+VKL+ + E LV+E + + ++ + PL +K L + LA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL---PLIKSYLFQLLQGLAFC 116
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S RV+HRD K N+L+ + K++DFGLAR A R + V+ T Y APE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 1077 AM-TGHLLVKSDVYSYGVVILELLSGR 1102
+ + D++S G + E+++ R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 906 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGREF-LAEVEMLSRL-HHRNLVK 960
++LG+G FG V L ++ AVKVLK+ + Q E + E +L+ H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 961 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L C + + R V E + G + H+ + P +I LG L +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHER 115
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
+I+RD K N+LL+ + K++DFG+ + + ++ GT Y+APE ++
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-ILS 169
Query: 1080 GHLLVKS-DVYSYGVVILELLSGRKPVD 1106
+ D ++ GV++ E+L+G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 12/228 (5%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 139
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 1087 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLLTSREGLERI 1133
D++S G++ +E++ G P P L+A P L + E L I
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-11
Identities = 39/136 (28%), Positives = 54/136 (39%), Gaps = 8/136 (5%)
Query: 276 ASHPSNTAPPPASHPSKT-APPPASHPSNT-APPPASHPSNTAPPPASHPSNTAPPPASH 333
A P+ A A KT A P A+ P+ A+ P+ A P A+ + APP A+
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
P+ A P A AP A + A+ A P A P P ++ A
Sbjct: 423 PAPVAAPAA-----AAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPE-PAVASAA 476
Query: 394 PPHASHPSNTALTPAS 409
P A+ P+ LTP
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-11
Identities = 83/408 (20%), Positives = 115/408 (28%), Gaps = 55/408 (13%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P A+ PS A PA+ P+ A PA+ + AP PA P+ PP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA--------APQPAPAPAPAPAPP 442
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
+ + A S AP P+ A P + PA P A PA+ P+
Sbjct: 443 SPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAP-------APAAAPA 495
Query: 391 NTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPR 450
A P A ++ A T I A K I LP+A R
Sbjct: 496 APAAPAAPAGADDAATLRERWPEI-----------LAAVPKRSRKTWAILLPEATVLGVR 544
Query: 451 GN----FHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEP----------IAPGPFPPG 496
G+ A NA +AE + P P G
Sbjct: 545 GDTLVLGFSTGGLAR--------RFASPGNAEVLVTALAEELGGDWQVEAVVGPAPGAAG 596
Query: 497 NSRQKSPVAR-PIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNH 555
+P + P P A P P + P A H
Sbjct: 597 GEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKH 656
Query: 556 SPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTEL 615
P P + +P+ P + +P+P+ T +GQ +
Sbjct: 657 VAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADD 716
Query: 616 PLLPPKSSPSEPIRAFP------PPPPNADCSTTICTEPYTNTPPGSP 657
P P + P P PP D P PP +P
Sbjct: 717 PAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAP 764
|
Length = 824 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-----RVDQQGGREFLAEVEMLSRL 953
+ + + +G G FG V+ V D ++ A+KV+ R+ Q+ + E +L +
Sbjct: 2 DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEV 58
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
H +++L +++ ++ E +P G + S+L + S G L A AL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCAL 114
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
YLH S +++RD K NILL+ + K++DFG A+ D + + GT Y+A
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLA 166
Query: 1074 PE-YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 1112
PE GH D ++ G++I E+L G P P G
Sbjct: 167 PEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 956
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 957 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+ + C + R V E + G + H+ V K P +I++G L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 1074
LH +I+RD K N++L+ + K++DFG+ + M + ++TR GT Y+AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAP 170
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
E D ++YGV++ E+L+G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 908 LGEGGFGLVYSGVLDDGT--KVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 963
+G G +G V S D KVAVK L R Q R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 964 ICIEEQARCLVYELIPNGSVE--------SHLHGVDKES----APLGWDARLKIALGAAR 1011
+ P S+E ++L G D + L + + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L Y+H S +IHRD K SN+ + D ++ DFGLAR A DE + +++TR Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 1072 VAPEYAMTG-HLLVKSDVYSYGVVILELLSGR 1102
APE + H D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-11
Identities = 34/140 (24%), Positives = 52/140 (37%), Gaps = 10/140 (7%)
Query: 204 ASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPL 263
A P+ A + A A P A+ ++ A PA A P A+ +P
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPA----AAPAAAASAPAAPP 418
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
A+ P+ A P A+ P + + P+ AP + P AP PA
Sbjct: 419 AAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--V 472
Query: 324 SNTAPPPASHPSNTAPPPAS 343
++ AP PA+ P+ P
Sbjct: 473 ASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G+G G VY+ + + G +VA+K + Q + E+ ++ + N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLH---SNQVIH 138
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1087 DVYSYGVVILELLSGRKP 1104
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-11
Identities = 43/202 (21%), Positives = 62/202 (30%), Gaps = 9/202 (4%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P+ A P+ + P + A P+ A A P+ A PA + AP A+
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNT 304
P + P + PA+ P P A A P P+
Sbjct: 650 --PEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAPA 706
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
A PPA + A P + P + PP PP + PP
Sbjct: 707 ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPD-----DPPDPAGAPAQPPPP 761
Query: 365 SHPSNPAIPPASHPSNTAIPPA 386
P+ A PA+ P +
Sbjct: 762 PAPAPAA-APAAAPPPSPPSEE 782
|
Length = 824 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR----VDQQGGREFLAEVEMLSR------LH 954
++LG+G FG V+ L A+K LK+ +D E M+ +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD------VECTMVEKRVLSLAWE 54
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H L L ++ V E + G + H+ K P +I G L
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQ 110
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
+LH S +++RD K NILL+ D K++DFG+ + M +++ + GT Y+AP
Sbjct: 111 FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAP 165
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
E + D +S+GV++ E+L G+ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-11
Identities = 47/263 (17%), Positives = 58/263 (22%), Gaps = 31/263 (11%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
A + + P + AS P PS K P P P +
Sbjct: 84 APSVGPDSDLSQKTSTFSPCQS-GYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPES 142
Query: 227 TALPPA------------------SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHP 268
P + PP L PP + + P P
Sbjct: 143 QPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQ--P 200
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
PP HP P AP P P P P P
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLP---PQLPQQPPPLQQPQFPGLSQQMPP 257
Query: 329 PPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASH 388
PP P PP A PP + T P N +PP P +
Sbjct: 258 PPPQPPQQQQQPPQP----QAQPPPQNQ-PTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQ 312
Query: 389 PSNTAPPHASHPSNTALTPASHP 411
P L+
Sbjct: 313 GQQRGPQF--REQLVQLSQQQRE 333
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 907 ILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEML----------SRLHH 955
+LG G FG V ++ A+K LK+ D R+ EVE L + H
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RD---EVESLMCEKRIFETANSERH 61
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
LV L C + + C V E G + H+H D S P + LG L
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLG----LQ 115
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
YLHE+ ++++RD K N+LL+ + K++DFGL + M R ST GT ++AP
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEFLAP 170
Query: 1075 EYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1104
E L S D + GV+I E+L G P
Sbjct: 171 EV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE--------------FLAEVEMLSR 952
LGEG +G V G VA+K +K ++ L E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAAR 1011
+ H N++ L+ + +E LV +++ S L V L ++++K I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLT-ESQVKCILLQILN 130
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-----AMDEESRHI---ST 1063
L LH+ +HRD +NI + K++DFGLAR D S+
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 1064 RVMG----TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
M T Y APE M + D++S G + ELL+G KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232
|
Length = 335 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-11
Identities = 54/235 (22%), Positives = 73/235 (31%), Gaps = 25/235 (10%)
Query: 53 LKPHLLGGHA--PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP 110
+P GG A + P P P+ + PA A P + VA+
Sbjct: 363 FRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAA 422
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
P+ +P P +A P +P P AP PA + A P
Sbjct: 423 PARRSPAPEALAAARQASARGPGGAPAPAPAPAAA---PAAA--------------ARPA 465
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASH-PSNTALPSKTAPSPASHPSNTAL 229
A+ P A A+ P+ A A P+ PPP P A P+ P A
Sbjct: 466 AAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAES 525
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P P+ P A AP A P + P PP + S
Sbjct: 526 IPD--PATADPDDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-10
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 9/136 (6%)
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
P A+ + A PA+ P A+ P+ A P A+ + APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
P+ A P A+ P + + ++ AP + P A PA ++ A
Sbjct: 423 PAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--VASAA 476
Query: 372 IPPASHPSNTAIPPAS 387
PA+ P+ + P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-10
Identities = 43/221 (19%), Positives = 59/221 (26%), Gaps = 17/221 (7%)
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 331
P P + P PAS + P+ A P A P+ A PA + AP A
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 332 SHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
+ P + + PA+ P P A A P P+
Sbjct: 649 APE--HHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 392 TAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG 451
A P A + A P + P P + P+ LP P P
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPS--------------PAADDPVPLPPEPDDPPDP 751
Query: 452 NFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGP 492
P P+ P A + E
Sbjct: 752 AGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPS 792
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-10
Identities = 40/227 (17%), Positives = 54/227 (23%), Gaps = 22/227 (9%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
P A+ P + P + P P A P P A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAP-----------AGAAAAPAE 638
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+S A P + P + PA+ P A
Sbjct: 639 ASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-------PPPAPAPAAPA 691
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
A P P+ A PPA + A P S + PP
Sbjct: 692 APAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDD---- 747
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
PP + PPP + AP A PS + +
Sbjct: 748 PPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-10
Identities = 79/408 (19%), Positives = 118/408 (28%), Gaps = 40/408 (9%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKT---APPPASHPSNTAPPPASHPSNTAPPPA 320
A+ PS A PA+ P+ A PA+ + AP PA P+ PP+ + A
Sbjct: 395 AAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAP 454
Query: 321 SHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP-- 378
S P AP P+ A P + + APP A P+ PA+ + A+
Sbjct: 455 SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATLRE 514
Query: 379 -----------SNTAIPPASHPSNTAPP---------HASHPSNTALTPASHPSNIAP-- 416
+ P T ++ + +
Sbjct: 515 RWPEILAAVPKRSRKTWAILLPEATVLGVRGDTLVLGFSTGGLARRFASPGNAEVLVTAL 574
Query: 417 -PPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKR 475
L A+ G AP + P ++ P R + P P A
Sbjct: 575 AEELGGDWQVEAVVGPAPGAAGGEGPPAPASSGPPEEAARPAAP-----AAPAAPAAPAP 629
Query: 476 NASNRE-APIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGK 534
+ A + APG P + + V G A P + PP
Sbjct: 630 AGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAA 689
Query: 535 RVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPP---LNSVSPSHSPL 591
A P+ P P +P G P+ P + P + V P
Sbjct: 690 PAAPAGAAPAQPAPAPAA---TPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPD 746
Query: 592 PTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNAD 639
P + P P + + PP S PSE P+ D
Sbjct: 747 DPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 991 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
++S PL D L+ + A+ + +L +S IHRD + N+LL K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
R M++ + + ++APE V+SDV+SYG+++ E+ S G+ P
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 900 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKR-----VDQQGGREFLAEVEMLSRL 953
+F +G+GG+G V+ + D G VA+K +K+ +++ R L E ++L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTT 58
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAAR 1011
LVKL+ +++ L E +P G + L+ GV E + A + A+ A
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L Y IHRD K N L++ K++DFGL++ + + V+G+ Y
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDY 164
Query: 1072 VAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWA---- 1120
+APE Y T D +S G ++ E L G P + P ENL W
Sbjct: 165 MAPEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
Query: 1121 RPLLTSRE 1128
RP+
Sbjct: 219 RPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 908 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+GEG G+V + G +VAVK++ QQ EV ++ H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+ ++ E + G++ + L + + +AL YLH S VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 1027 RDFKSSNILLEHDFTPKVSDFGL-ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1085
RD KS +ILL D K+SDFG A+ + D R ++GT ++APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTE 197
Query: 1086 SDVYSYGVVILELLSGRKP 1104
D++S G++++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-10
Identities = 51/228 (22%), Positives = 73/228 (32%), Gaps = 30/228 (13%)
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
A+ P P A+ P+ AP PA+ P+ A PA+ + A A+ P+
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAA--AAAARAVAAAPA------RR 426
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P+ A+ A S A P+ P+ A A+ P +A P
Sbjct: 427 SPAPEALAAARQASARGPGGAPAPAPAPAAA---PAAAARPAAAGPRPVAAAAAAAPARA 483
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIA 485
+ AP P + P SPA P VA I
Sbjct: 484 APAAAPAPADDDPPPWEELPPEFA-------SPAPAQPDAAPAGWVA---------ESIP 527
Query: 486 EPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDG 533
+P P + +P A P A+ +P V P P S G
Sbjct: 528 DPATADPDDAFETLAPAPAAAPAPR---AAAATEPVVAPRPPRASASG 572
|
Length = 700 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
+G+G G V++ + + G +VA+K + Q + E+ ++ L + N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026
+V E + GS+ + + A + R +AL +LH + +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHAN---QVIH 138
Query: 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1086
RD KS N+LL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1087 DVYSYGVVILELLSGRKP 1104
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 900 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLH 954
+F+ +++G G FG V+ V D T A+KVL++ D + AE ++L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
+VKL +E+ LV E +P G + + L + K+ P AR IA AL
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVL-ALD 115
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1050
+H IHRD K NIL++ D K++DFGL
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 1051 ---RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
R ++ R + +GT Y+APE ++ D +S GV++ E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 961
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHMKHENVIGL 79
Query: 962 IGICIEEQAR---CLVYELIP-NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+ + + + Y ++P G+ L +K L D + + L Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIH 135
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ +IHRD K N+ + D K+ DFGLAR E + ++ TR Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 1078 MTG-HLLVKSDVYSYGVVILELLSGR 1102
+ H D++S G ++ E+L+G+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 908 LGEGGFGLVYSG-VLDDGTKVAVKVLKR----VDQQGGREFLAEVEMLSRL-HHRNLVKL 961
+GEG F V G A+K +K+ ++Q L E++ L RL H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 962 IGICIEEQARCL----------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
I + + + L +YELI PL +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----RKR-------PLPEKRVKSYMYQLLK 111
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTF 1069
+L ++H + + HRD K NIL+ D K++DFG R + + +ISTR
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTR----- 162
Query: 1070 GYVAPEYAMT-GHLLVKSDVYSYGVVILELLS 1100
Y APE +T G+ K D+++ G V E+LS
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 905 SRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNL 958
SR+LG G G V + + DG AVKV VD +G E AEV L ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKV---VDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 959 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1006
VK C E+ A+ LV + G + + K + +
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAG 146
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
L + L +H S +IHRD KS+NILL + K+ DFG ++ S +
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
GT YVAPE K+D++S GV++ ELL+ ++P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 908 LGEGGFG---LVYSGVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+GEG FG LV S +DG + +K + ++ + E EV +LS + H N+V+
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 963 GICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLHE 1018
E +V + G + ++ + E L W ++ + AL ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE 1075
+++HRD KS NI L D T K+ DFG+AR S ++ ++ +GT Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPE 171
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS 1100
KSD+++ G V+ E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-10
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 15/145 (10%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A +P A+ + + A PA+ P A+ P+ A P A+ +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAP---------VAQAAAAPAPAAAPAAAASA 413
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
APP A+ + A P A+ P + PA+ P+ A PA P+ AP + P + AP
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAP---AAAPAAAPAAVALAPAP-PAQAAPETVAIPVRVAPE 469
Query: 297 PASHPSNTAPPPASHPSNTAPPPAS 321
PA ++ AP PA+ P+ P
Sbjct: 470 PA--VASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-10
Identities = 34/143 (23%), Positives = 55/143 (38%), Gaps = 15/143 (10%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
+P A+ + A P A +PA+ P A+ P+ A P A+ +
Sbjct: 365 KPAAAAEA--AAPAEKKTPARP----EAAAPAAAP---VAQAAAAPAPAAAPAAAASAPA 415
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
APP A+ P + A+ P + + P++ AP + P AP PA
Sbjct: 416 APPAAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA 471
Query: 310 SHPSNTAPPPASHPSNTAPPPAS 332
++ AP PA+ P+ P
Sbjct: 472 --VASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLA---EVEMLSRLH 954
N+ ++LG+G FG VY D G ++AVK ++ + + +E A E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 955 HRNLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
H +V+ G + R L E +P GS++ L K L + K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--------- 1063
++YLH S ++HRD K +NIL + K+ DFG S+ + T
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFG--------ASKRLQTICLSGTGMK 167
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
V GT +++PE K+D++S G ++E+L+ + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 908 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 964
+G+G FG V+ G+ D+ T+ VA+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
++ ++ E + GS L + + LK L + L YLH S +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH---SEKK 122
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDS 180
Query: 1085 KSDVYSYGVVILELLSGRKPVDMTQP 1110
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-10
Identities = 98/465 (21%), Positives = 144/465 (30%), Gaps = 30/465 (6%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
SP + R S+T P ++ S P++ PS+ ++
Sbjct: 74 TSPLKSTKRQREKPASDTEEPERVTAKKSKTQELSRPNS---PSEGEGEGEGEGESSDSR 130
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
+ + P + ++ P P S + P PS PP A+
Sbjct: 131 SVNEEGSSDPKDIDQDNRSSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALA 190
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
PP PS A PP P P P P S S + P +P
Sbjct: 191 PSAPPPT---PSAQAVPPQGSPIAAQPAP-------QPQQPSPLSLISAPSLHPQRLPSP 240
Query: 351 PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASH 410
P P + P+ + P S + PP H P HPS ++
Sbjct: 241 HPPLQPQTASQQSPQPPAPSSRHPQS-SHHGPGPPMPHALQQGPVFLQHPS------SNP 293
Query: 411 PSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPP 470
P VP LP + P P PR +P++ P P P
Sbjct: 294 PQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTP 353
Query: 471 VAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLS 530
+ Q N S++ P + P PFP S P P P +S PPS P
Sbjct: 354 IPQLPNQSHKHPPHLQ--GPSPFPQMPSNLPPP------PALKPLSSLPTHHPPSAHPPP 405
Query: 531 VDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSP 590
+ +P+ P+ P K P S + + + P + + P
Sbjct: 406 LQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQ--SPFAQHPFTSGGLP 463
Query: 591 LPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPP 635
P +PTS +P AS ++ P SS P PP
Sbjct: 464 AIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPP 508
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 50/212 (23%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 908 LGEGGFGLVYSGVLDD---------GTKVAVKVLKRVDQQGGRE----FLAEVEMLSRLH 954
LG G +Y+G+L+ + +KV+ +V R+ F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H+++V L G+C+ + +V E + G ++ +H ++S L + K+A A AL+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 1015 YLHEDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMG 1067
YL ED ++H + + NILL + + P K+SD G+ + + + +
Sbjct: 120 YL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VE 170
Query: 1068 TFGYVAPEYAM-TGHLLVKSDVYSYGVVILEL 1098
++APE + +L + +D +S+G + E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 916 VYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971
+Y G+ ++ +V ++ K+ +G E++ L R+ N++K+ G I+
Sbjct: 36 IYKGIFNN-KEVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID---- 89
Query: 972 CLVYELIPNGSVE------SHLHGV-DKESAPLGWDARLKIALGAARALAYLHE-DSSPR 1023
+ + +P S+ +L V DKE L + +L +A+ + L L++ + P
Sbjct: 90 --IVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY-----VAPEYAM 1078
+++ S + L+ ++ K+ GL + ++++ M F Y + EY
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKMLNDIFSEY-- 199
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+K D+YS GVV+ E+ +G+ P +
Sbjct: 200 ----TIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-10
Identities = 41/202 (20%), Positives = 57/202 (28%), Gaps = 4/202 (1%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P P + + P PAS + P+ A P A P+ A ++ AP P
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPA--GAAAAPAEASAAPAPG 646
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
P + P + PA+ P A A P P+
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV-LPSAL 428
A PPA + A P + P + L P P P+
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 429 PGKAPVSQSPISLPDAPAATPR 450
P AP + P S P
Sbjct: 766 PAAAPAAAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 954
N+ ++LG+G FG VY +D G ++A K ++ + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 955 HRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
H +V+ G C+ ++A + E +P GSV+ L K L K
Sbjct: 63 HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILE 117
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFG 1070
++YLH S ++HRD K +NIL + K+ DFG ++ R V GT
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+++PE K+DV+S G ++E+L+ + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-10
Identities = 51/281 (18%), Positives = 78/281 (27%), Gaps = 19/281 (6%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A P + + + P P + + S A + +
Sbjct: 357 AFEPAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAV-----TGAAGAALA 411
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
A A+ APP A P T+ AP PA + + PP
Sbjct: 412 PKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPP 471
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
S ++ A + P P + A PA+ S + AP A+ P
Sbjct: 472 ADSGSASAPASDAPPDAAFEPAP---RAAAPSAATPAAVPDARAPAAASREDAPAAAAPP 528
Query: 357 SNTALPPASHPSNPAIPPASHPS------NTAIPPASHPSNTAPPHASHPSNTALTPASH 410
+ A PP + PA + N + +S A A + A P
Sbjct: 529 APEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKP- 587
Query: 411 PSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG 451
A P + V V + + AA RG
Sbjct: 588 ----AAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRG 624
|
Length = 830 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDD--GTK--VAVKVLKR--VDQQGGRE-FLAEVEMLSRL 953
+F+ +LG+G FG V +L + GT A+K+LK+ + Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 954 HHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+ + C + R V E + G + H+ V K P +IA+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1071
L +LH S +I+RD K N++L+ + K++DFG+ + + +TR GT Y
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDY 167
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+APE D +++GV++ E+L+G+ P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGG---REFLAEVEMLSRLHHRNLVKLIG 963
+GEG +G+VY D T + + K R++Q+ + E+ +L + H N+V+L
Sbjct: 10 IGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL-KIAL-GAARALAYLHEDS 1020
+ E+ LV+E + + ++ H+ +S+P + RL K L R +AY H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-----DSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 1021 SPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 1078
S RV+HRD K N+L++ K++DFGLAR A R + V+ T Y APE +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 1079 TGHLLVKSDVYSYGVVILELLSGR 1102
+ H D++S G + E+++ +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
LGEG + VY G G VA+K + R++ + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 965 CIEEQARCLVYELIPNG---SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
++ LV+E + ++ G+ + L L R LAY H+
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQR-- 122
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--- 1078
RV+HRD K N+L+ K++DFGLAR A S+ S V+ T Y P+ +
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 1079 --TGHLLVKSDVYSYGVVILELLSGR 1102
+ L D++ G + E+ +GR
Sbjct: 180 EYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 957
NF LGEG + VY G G VA+K + +D + G A E+ ++ L H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHEN 59
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAY 1015
+V+L + E LV+E + + ++ ++ D D + +A+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
HE+ RV+HRD K N+L+ K++DFGLAR A S V+ T Y AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPD 170
Query: 1076 YAMTGHLLVKS-DVYSYGVVILELLSGR 1102
+ S D++S G ++ E+++GR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA---EVEMLSRLH 954
N+ ++LG G FG VY D G ++AVK + Q+ +E A E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 955 HRNLVKLIGICI---EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
H +V+ G C+ EE+ + E +P GS++ L K L + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-------- 1063
++YLH S ++HRD K +NIL + K+ DFG S+ I T
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG--------ASKRIQTICMSGTGI 166
Query: 1064 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
V GT +++PE K+DV+S ++E+L+ + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRV----DQQGGREFLAEVEMLSRLHHRN 957
++LG+GG+G V+ G A+KVLK+ +Q+ AE +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAY 1015
+V LI L+ E + G + HL G+ E + + + +AL +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH+ +I+RD K NILL+ K++DFGL + ++ E + ++ GT Y+APE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPE 170
Query: 1076 YAM-TGHLLVKS-DVYSYGVVILELLSGRKP 1104
M +GH K+ D +S G ++ ++L+G P
Sbjct: 171 ILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-09
Identities = 32/132 (24%), Positives = 51/132 (38%), Gaps = 8/132 (6%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASH--PSNTAPPPASHPSKTAPPPASHPSNT 304
+ A A KT P + AP + P+ A P A+ + APP A+ P+
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
A P A+ P + + P+ AP + + AP PA ++ A PA
Sbjct: 427 AAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--VASAAPAPA 480
Query: 365 SHPSNPAIPPAS 376
+ P+ + P
Sbjct: 481 AAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIG 963
+G G FG V + T VA V+K + EFL + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 964 ICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAYLHE 1018
C+E LV+E G ++S+L H + + L ++A A + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 1076
+ +H D N L D T KV D+G+ S E+ ++APE
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 1077 AMTGHLLVK-----SDVYSYGVVILELL 1099
G L+ S+V++ GV + EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 908 LGEGGFGLVYSGVLDDGTKV--AVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG+G +G VY VL T V A+K ++ +D+ + + E+++L + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E A + E + GS++ L+ + + D +I + L +L E+ + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1083
IHRD K +N+L+ + K+ DFG+ S S ++ +G Y+APE +G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 1084 -----VKSDVYSYGVVILELLSGRKP 1104
V+SDV+S G+ ILE+ GR P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
LGEG + VY G +G VA+KV+ R+ ++ G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
++ LV+E + + +DK L + R L+Y+H+ +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQY----MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 1083
+HRD K N+L+ K++DFGLAR+ H + + T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 1084 VKSDVYSYGVVILELLSG 1101
D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGT--KVAVKVLKR---VDQQGGREFLAEVEMLSRLHH 955
+F+ R LG G FG V + VA+K ++ + Q+ +E ++L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
V L G +E LV E + G + L + +G +I L Y
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEY 146
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
L S +++RD K N+LL+ D K++DFG A+ ++R + + GT Y+APE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTR--TYTLCGTPEYIAPE 198
Query: 1076 YAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134
+ GH +D ++ G+ I E+L G PP N PLL ++ LE II
Sbjct: 199 ILLNVGHGKA-ADWWTLGIFIYEILVG-------CPPFYAN-----EPLLIYQKILEGII 245
|
Length = 340 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 906 RILGEGGFGLVYSGVLDD--GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKL 961
+ +G G G+V + D G VAVK L R +Q + E+ +L ++H+N++ L
Sbjct: 27 KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 962 IGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+ + +EE Q LV EL+ + +D E R+ L + L
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE--------RMSYLL--YQMLCG 135
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
+ S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPE 192
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSG 1101
+ D++S G ++ EL+ G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 54/244 (22%)
Query: 900 GNFDASRILGEGGFGLVYSGVLDD---GTKVAVKVLKRVDQQGG----REFLAEVEMLSR 952
+D R++G+GG G VY D +VA+K + R D + FL E ++ +
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAAD 58
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIP----------------NGSVESHLHGVDKESAP 996
L H +V + IC + VY +P S+ L +K S
Sbjct: 59 LIHPGIVPVYSICSDGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELA--EKTSVG 113
Query: 997 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056
A L I + Y+H S V+HRD K NILL + D+G A E
Sbjct: 114 ----AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 1057 ESRHIST----------------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
E + +++GT Y+APE + +D+Y+ GV++ ++L+
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 1101 GRKP 1104
P
Sbjct: 227 LSFP 230
|
Length = 932 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 51/266 (19%), Positives = 79/266 (29%), Gaps = 25/266 (9%)
Query: 109 SPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAF 168
P P V A P + A V +L P A+ +
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
PPA+P A ++ P + + A + A P AS P++ A
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPP-ADSGSASAPASDA 484
Query: 229 LPPA----SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P A + + A PA+ + +P A+ P+ A PP P+ AP
Sbjct: 485 PPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPT--PAAAAP 542
Query: 285 PPASHPSKTA----------------PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
+ + A A+ A P A+ P+ A
Sbjct: 543 AARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRAR 602
Query: 329 PPASH--PSNTAPPPASHSSKTAPPP 352
P+ A + S+ APPP
Sbjct: 603 AATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 18/144 (12%)
Query: 124 PPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPAS 183
P + A P P A+P++ A+ P+ AA P A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPE-----------AAAPAAAPVA----QAAAAPAPAAAPAAA 410
Query: 184 HPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP-PASLPSKTAPPP 242
+ A P A+ P+ A P A+ P+ + A + A P A P ++P + AP P
Sbjct: 411 ASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEP 470
Query: 243 ASHLSNTAPPPASHPYKTSPLPAS 266
A ++ AP PA+ P P
Sbjct: 471 AV--ASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH---HRNLVKL 961
+G G +G VY G VA+K ++ + G + EV +L RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 962 IGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ +C E LV+E + + + ++L V P + + R L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPE 1075
H + ++HRD K NIL+ K++DFGLAR S ++ T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPE 177
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPV 1105
+ D++S G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-09
Identities = 30/126 (23%), Positives = 43/126 (34%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P + +N+ + S P ++P S PS P +
Sbjct: 149 NPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPS 208
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
S P P+S S+T PP P+N +PPP P P +TA P +S T
Sbjct: 209 DSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATP 268
Query: 350 PPPASH 355
P
Sbjct: 269 APIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 31/134 (23%), Positives = 43/134 (32%)
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P P L + + A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
+ S+ P P+S S+T PP P+N +PPP P TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 358 NTALPPASHPSNPA 371
T P +
Sbjct: 266 ATPAPIGGITLDDD 279
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 931 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 990
V+ ++ Q+G L E +L ++H +++++ + C+V +P+ S + + + +
Sbjct: 94 VVLKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-L 147
Query: 991 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
K S PL D L I L YLH R+IHRD K+ NI + + D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110
+ + + + GT APE K+D++S G+V+ E+L+ + P
Sbjct: 205 QFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 1111 PGQENLVAWARPLLTSREGLERII 1134
E + + L +II
Sbjct: 262 STPEE------YVKSCHSHLLKII 279
|
Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 961
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVIGL 79
Query: 962 IGICIEEQARCLVYE---LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
+ + + + ++P +++ L + PL D + L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMP--YMQTDLQKI--MGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
S +IHRD K N+ + D K+ DFGLAR A E + ++ TR Y APE +
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 1079 TG-HLLVKSDVYSYGVVILELLSGR 1102
H D++S G ++ E+L+G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 30/129 (23%), Positives = 45/129 (34%)
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
P P + + + ++ A S P ++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPS 368
+ S+ P P+S S+T PP P+N +PPP + P P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 369 NPAIPPASH 377
P
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 901 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLSR 952
NF+ ++LG G +G V+ D G A+KVL++ V + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 953 LHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA- 1010
+ + + + +A+ L+ + + G + +HL+ D S + ++ G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEII 115
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
AL +LH+ +++RD K NILL+ + ++DFGL++ + EE + GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIE 171
Query: 1071 YVAPEY--AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y+APE GH D +S G++I ELL+G P
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-09
Identities = 54/238 (22%), Positives = 75/238 (31%), Gaps = 16/238 (6%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
A P +A P+ PA A D + PV + + A
Sbjct: 405 AAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDA-PVPAKANARASADSRC 463
Query: 122 APPPSLIPTTPV-ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
+ P AS P APP PAP + A PA+ A
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPS-KTAPSPASHPSNTALPPASLPSKTA 239
A+ P+ ARPP P+ AP + + AL + A S S+ A+ A
Sbjct: 524 AAAPPAPEARPPT--PAAAAPAARAGGAAAALDVLRNAGMRVS--SDRGARAAAAAKPAA 579
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P A P A + P A + P+ A + S+ APPP
Sbjct: 580 APAA-----APKPAAPRV----AVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 906 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 961
++LG+G FG ++ G A+K+LK+ + + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 962 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+ C V E + G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI------VSALDYLH-- 112
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
S ++++RD K N++L+ D K++DFGL + + + + + GT Y+APE
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLED 169
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKP 1104
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 958
++LG+G FG V +L G A+K+LK+ + + L E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 959 VKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 1015
L + R C V E G + HL V E + A + ALG Y
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------Y 110
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S V++RD K N++L+ D K++DFGL + + + + T GT Y+APE
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPE 165
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
D + GVV+ E++ GR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-09
Identities = 80/296 (27%), Positives = 101/296 (34%), Gaps = 22/296 (7%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVN 120
H P P +P PV + S + P PP +P+ + + +
Sbjct: 269 HGPGP-PMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQ 327
Query: 121 MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
PP P P S P I PP P P L + P P PSN P
Sbjct: 328 PQQPPREQPLPPAPSMPHIKPPPTT---PIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPP 384
Query: 181 PASHPSNTARPPASHPSRTAPPPAS-HPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
PA P ++ P HP PPP P + L S A P S + P AS
Sbjct: 385 PALKPLSSL--PTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTH---- 438
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPAS 299
P H P A HP+ + LPA PPP+ S A PP + P A
Sbjct: 439 PHSGLHSGPPQSPFAQHPFTSGGLPA-----IGPPPSLPTSTPAAPPRASSGSQPPGSAL 493
Query: 300 HPS-----NTAPPPASHPSNTAPPPASHPSNTAPPPAS-HPSNTAPPPASHSSKTA 349
S P P A P + PPP S P T SH+S++A
Sbjct: 494 PSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-09
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 3/183 (1%)
Query: 922 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981
D KV K + D++ +E+ L+ H +VK + L+ E G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041
+ + KE P ++ L + + L E S +++HRD KS+NI L
Sbjct: 151 DLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1101
K+ DFG ++ D S +++ GT Y+APE K+D++S GV++ ELL+
Sbjct: 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 1102 RKP 1104
+P
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-08
Identities = 52/266 (19%), Positives = 78/266 (29%), Gaps = 27/266 (10%)
Query: 73 APPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSL-IPTT 131
AP + S A +L P A+ + PP APP +
Sbjct: 382 APGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDD 441
Query: 132 PVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARP 191
P+ PA + + + A PPA S +A P + P + A
Sbjct: 442 AADGDAPV---------PAKANARASADSRCDERDAQPPADSGSASA-PASDAPPDAAFE 491
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA- 250
PA + A PA+ A A+ P+ A PP + A
Sbjct: 492 PAP-RAAAPSAATPAAVPDARA------PAAASREDAPAAAAPPAPEARPPTPAAAAPAA 544
Query: 251 ----PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
A + + + S A+ P+ A P A+ P+ A
Sbjct: 545 RAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPA--AAPAAAPKPAAPRVAVQVPTPRAR 602
Query: 307 PPASH--PSNTAPPPASHPSNTAPPP 330
P+ A + S APPP
Sbjct: 603 AATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-08
Identities = 48/269 (17%), Positives = 56/269 (20%), Gaps = 29/269 (10%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
+ P + + T P P SL TAP P
Sbjct: 86 SVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQ----PDPSLWG-TAPKPEP-----Q 135
Query: 251 PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
PP A PA A P + PP PP +
Sbjct: 136 PPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAP------QLPQPPQQVLPQGMPPRQA 189
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
PP P PP HP P + AP P P P
Sbjct: 190 AFPQQGPPEQ--PPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQ---LPQQPPPLQ 244
Query: 371 AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPG 430
+PP P P P P P P
Sbjct: 245 QPQFPGLSQQ--MPP---PPPQPPQQQQQPPQPQAQPPPQNQPTPHPG---LPQGQNAPL 296
Query: 431 KAPVSQSPISLPDAPAATPRGNFHRHSPA 459
P + L P RG R
Sbjct: 297 PPPQQPQLLPLVQQPQGQQRGPQFREQLV 325
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 31/117 (26%), Positives = 41/117 (35%), Gaps = 4/117 (3%)
Query: 228 ALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
+ + + A S + P S SP S PS P + S+ P P+
Sbjct: 162 DVATTNSDNSFPGEDADPASASPSDPPSS----SPGVPSFPSPPEDPSSPSDSSLPPAPS 217
Query: 288 SHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 344
S S T PP P+N +PPP P P +TA P S T P
Sbjct: 218 SFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 29/129 (22%), Positives = 43/129 (33%)
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
P P + +N+ ++ A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 342 ASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPS 401
+ S P P+S S+T P P+NP+ PP P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 402 NTALTPASH 410
T
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 901 NFDASRILGEGGFGLVY-----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLS 951
NF+ ++LG G +G V+ SG D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSG-HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 952 RLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA- 1009
+ + + + + L+ + I G + +HL ++ + ++I G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEI 114
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
AL +LH+ +I+RD K NILL+ + ++DFGL++ ++E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTI 170
Query: 1070 GYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1115
Y+AP+ GH D +S GV++ ELL+G P + G++N
Sbjct: 171 EYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVD---GEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-08
Identities = 64/281 (22%), Positives = 83/281 (29%), Gaps = 11/281 (3%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
T PVA + T AP + T PVAS A P V P P P+ +P
Sbjct: 317 TEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAP- 375
Query: 164 SSKAFPPASPPSNAARPPASH------PSNTARPPASHPSRTAPPPASHPSNTALPSKTA 217
+ + +P S + A P PA+ P A P A A
Sbjct: 376 APEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYA 435
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP-ASHPYKTSPLPASHPSKTAPPPA 276
P+P + A S AP T P A P P P P P
Sbjct: 436 PAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVVEPEPV 495
Query: 277 SHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSN 336
+ A PP + + A A P P S AP A+ P
Sbjct: 496 VEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAVPPV 555
Query: 337 TAPP---PASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
A P + K A + A P S ++ P
Sbjct: 556 EAAAAVSPLASGVKKATLATGAAATVAAPVFSLANSGGPRP 596
|
Length = 1355 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLH---HRNL 958
+GEG +G V+ L +G + LKRV Q G E + EV +L L H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 959 VKLIGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
V+L +C E LV+E + + + ++L V + P + + R L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ETIKDMMFQLLRGL 123
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
+LH S RV+HRD K NIL+ K++DFGLAR + T V+ T Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1105
PE + D++S G + E+ RKP+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 908 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 964
LGEG + VY G L D VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 965 CIEEQARCLVYELIPNGSVES--------HLHGVDKESAPLGWDARLKIAL-GAARALAY 1015
E++ LV+E + + ++H V K+ L R L Y
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV-------------KLFLFQLLRGLNY 119
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
H +V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPD 174
Query: 1076 YAM-TGHLLVKSDVYSYGVVILELLSGR 1102
+ + + D++ G + E+ +GR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-08
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 13/139 (9%)
Query: 151 PSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPPPASHPSN 209
P+ + + A P A+ P+ A A+ P+ A P A+ + APP A+ P+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
A P+ AP+ A + A+ A P A AP + P + +P PA +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQA----------APETVAIPVRVAPEPA--VA 473
Query: 270 KTAPPPASHPSNTAPPPAS 288
AP PA+ P+ P
Sbjct: 474 SAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 34/128 (26%), Positives = 50/128 (39%), Gaps = 4/128 (3%)
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
P A+ + + A PA+ P A+ P+ A P A+ S+ APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 356 PSNTALPPASHPSN-PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNI 414
P+ A P A+ P+ PA PA+ A P + P A P P + A P+
Sbjct: 423 PAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAA 482
Query: 415 APPPLFVP 422
P
Sbjct: 483 PAAARLTP 490
|
Length = 618 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-08
Identities = 33/148 (22%), Positives = 49/148 (33%), Gaps = 6/148 (4%)
Query: 265 ASHPSKTAPPPASHPSNTAPPPAS--HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
A HP+ P P P + AP ++ + TA PPPAS P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPP-ASHPSNPAIPPASHPSNT 381
++ + S+ A + P N+AL AS P+ +
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 382 AIP-PASHPSNTAPPHASHPSNTALTPA 408
A A++P + P AL A
Sbjct: 478 AYRWKATNPVEVKKEPVATPK--ALKKA 503
|
Length = 647 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 961 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 1015
L+G+ C + +R LV E + G + H+ K E + A + IAL +
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------F 111
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LHE +I+RD K N+LL+ D K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPE 166
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107
D ++ GV++ E+++GR P D+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 906 RILGEGGFGLVYSGVLDDGTKV-AVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKL 961
R++G G + V L ++ A+KV+K+ D + E + + + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 962 IGICIEEQARCL-VYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHE 1018
+ C + ++R V E + G + H+ K E + A + +AL YLHE
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
+I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILR 169
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKPVDM 1107
D ++ GV++ E+++GR P D+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-08
Identities = 57/248 (22%), Positives = 88/248 (35%), Gaps = 17/248 (6%)
Query: 78 NIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPP 137
IPS A P P+ T SPP PP P L P T
Sbjct: 322 KIPSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLK 381
Query: 138 PITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT--ARPPASH 195
P T+P IPT P +SP SSK+ + P+ P+ ++ PA
Sbjct: 382 PPTSP-----------IPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQV 430
Query: 196 PSRTAPP--PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
++ P P + + P+ +P+ + S + +S+P+ PA+ ++ A PP
Sbjct: 431 EAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPP 490
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
++ SP K PP + P+ A + + TA H +
Sbjct: 491 PANMRPLSPYAVYDDLK--PPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHA 548
Query: 314 NTAPPPAS 321
P P S
Sbjct: 549 QPKPRPLS 556
|
Length = 576 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
++D +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 1012
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHS 160
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ +IHRD K N+LL+ K++DFG MDE +GT Y+
Sbjct: 161 MG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMK-MDETGMVRCDTAVGTPDYI 210
Query: 1073 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 1104
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLH 954
+F+ LG G FG V G A+K LK ++ Q + E +L L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV--QHVAQEKSILMELS 76
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H +V ++ +E + E + G + +HL + + ++ L A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFE 132
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
YLH +I+RD K N+LL++ KV+DFG A+ D + + GT Y+AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 1075 EYAMT-GHLLVKSDVYSYGVVILELLSGRKP 1104
E + GH D ++ GV++ E ++G P
Sbjct: 185 EVIQSKGHGKA-VDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L +LH +I+RD K N+LL+ D K++DFG+ + M+ E + ++ GT Y
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 1072 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
+APE + G +S D +S+GV++ E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L +LH S +I+RD K N++L+ D K++DFG+ + + ++R ++ GT Y+
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
APE D +S+GV++ E+L G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 29/133 (21%), Positives = 43/133 (32%), Gaps = 2/133 (1%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
P P + +N+ + A S P +++P S PS P +
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 322 HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNT 381
S+ PPA + PP S S T P P P+ PP + + PS +
Sbjct: 208 SDSS--LPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 382 AIPPASHPSNTAP 394
A P
Sbjct: 266 ATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 27/127 (21%), Positives = 41/127 (32%)
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
P+ + +N+ + A S +++P S P +
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
S P P+S S+T PP P+ +PPP P P +TA P S T
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASAT 267
Query: 327 APPPASH 333
P
Sbjct: 268 PAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 30/129 (23%), Positives = 43/129 (33%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P P + + ++ A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
+ S+ P P+S S T PP P+N + PP P P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 391 NTAPPHASH 399
T P
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 908 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 964
LGEG + V+ G L + VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDSSPR 1023
+++ LV+E + + L + + +KI L R LAY H +
Sbjct: 73 VHTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHL 1082
V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 1083 LVKSDVYSYGVVILELLSGR 1102
+ D++ G + E+ SGR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 956
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 957 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+ + C + R V E + G + + V + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 1074
LH S +I+RD K N++L+ + K++DFG+ + M + ++T+ GT Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCGTPDYIAP 170
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
E D +++GV++ E+L+G+ P +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRN 957
F+ ++GEG +G+V TK V + K D + E L E++ML L N
Sbjct: 3 FEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW--DARLKIALGAARALAY 1015
+V+L LV+E + +E E P G + +A+ +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLEL------LEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
H++ ++HRD K N+L+ H+ K+ DFG AR+ + E S T + T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPE 171
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGR 1102
+ D++S G ++ EL G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGIC 965
LGEG + V+ G VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDSSPRV 1024
E+ LV+E + +S L L +KI + R L+Y H+ ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 1083
+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+ + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 1084 VKSDVYSYGVVILELLSGR 1102
D++ G ++ E+ +GR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 906 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 961
++LG+G FG V L +V A+KVLK+ + Q + + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 962 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+ C + + R V E + G + + K P +R A AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRF-YAAEVTLALMFLHRHG 116
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
VI+RD K NILL+ + K++DFG+ + + +T GT Y+APE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D ++ GV++ E+++G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 961 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 1015
L+G+ C + ++R V E + G + H+ K E + A + +AL +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------F 111
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LHE +I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVD---MTQPPGQ 1113
D ++ GV++ E+++GR P D M+ P Q
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-08
Identities = 48/263 (18%), Positives = 65/263 (24%), Gaps = 7/263 (2%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLI-PTTPLAS 161
P PV P + + P + P + P+ AP P
Sbjct: 336 PVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNE 395
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
PL P + AA PA P P P P
Sbjct: 396 PLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQST 455
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
P +T + A P P P P P +K A PP +
Sbjct: 456 FAPQSTYQTEQTYQQPAAQEPLYQ----QPQPVEQQPVVEPEPVVEETKPARPPLYYFEE 511
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
A + A P P S AP A+ P A S ++
Sbjct: 512 VEEKRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAVPPVEAAAAVSPLASGVKKA 571
Query: 342 ASHSSKTAPP--PASHPSNTALP 362
+ A P +N+ P
Sbjct: 572 TLATGAAATVAAPVFSLANSGGP 594
|
Length = 1355 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 36/113 (31%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
K+++ + L YL E +++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 107 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1116
+GT Y++PE H V+SD++S G+ ++E+ GR P+ PP + L
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI---PPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 57/220 (25%)
Query: 906 RILGEGGFGLVYSGVL--DDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHRNLVK 960
R++G+G +G V S V DG + +K L + RE A E ++LS+L H N+V
Sbjct: 6 RVVGKGSYGEV-SLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 961 --------------LIGIC--------IEEQARCLVYELIPNGSVESHLHGVDKESAPLG 998
++G C ++EQ +L+P E+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG----KLLP-------------ENQVVE 106
Query: 999 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058
W ++ A AL YLHE ++HRD K+ N+ L KV D G+AR + E
Sbjct: 107 WFVQI------AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQ 155
Query: 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILEL 1098
+++ ++GT Y++PE KSDV++ G + E+
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
LGEG + VY G+ +G VA+KV+ + + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 965 CIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
++ V+E + + H G+ + L R LAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ-- 122
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1081
++HRD K N+L+ + K++DFGLAR A S+ S+ V+ T Y P+ + G
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPD-VLLGA 178
Query: 1082 LLVKS--DVYSYGVVILELLSGR 1102
S D++ G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-08
Identities = 52/206 (25%), Positives = 73/206 (35%), Gaps = 15/206 (7%)
Query: 362 PPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFV 421
A+ P P A+ P+ A PA+ P+ AP A + A A+ P+ +P P +
Sbjct: 376 TAAAAPVAQPAPAAAAPAAAAPAPAAPPA--APAAAPAAAAAARAVAAAPARRSPAPEAL 433
Query: 422 PVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNRE 481
A + +P APAA P + A P+ GP P A A R
Sbjct: 434 AAARQASARGPGGAPAPAP---APAAAP-------AAAARPAAAGPRPVAAAAAAAPARA 483
Query: 482 APIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP-PLSVDGKRVGKPV 540
AP A P PP ++ P P A+P V S P P + D + +
Sbjct: 484 APAAAPAPADDDPP--PWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETL 541
Query: 541 AEPSYDIPMPPPVNHSPSKGPVVPPS 566
A P P + PP
Sbjct: 542 APAPAAAPAPRAAAATEPVVAPRPPR 567
|
Length = 700 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-08
Identities = 31/133 (23%), Positives = 42/133 (31%), Gaps = 4/133 (3%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
P P + + T + A S + P S ++P S S
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPS----SSPGVPSFPSPP 201
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P + P P+S S T PP P+N +PPP P P +TA P
Sbjct: 202 EDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 310 SHPSNTAPPPASH 322
S T P
Sbjct: 262 PSASATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 7/120 (5%)
Query: 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042
VE G + PL + + + AR + +L +S + IHRD + NILL +
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVV 212
Query: 1043 KVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
K+ DFGLAR + R R+ ++APE +SDV+S+GV++ E+ S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-08
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 906 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 960
+++G+G FG V + DG AVKVL++ + ++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARF-YAAEIASALGYLH--- 113
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +I+RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQ 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-08
Identities = 38/195 (19%), Positives = 52/195 (26%), Gaps = 13/195 (6%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
PP H T+ P P + P + P L PA Y+
Sbjct: 95 PAPPPPHARRTSEPELPRPGRRPYEGYGG--PRADDRPPGLPRQDQLPT--ARPAYPAYQ 150
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP- 318
P P + P PP A + S + P P +
Sbjct: 151 QRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAGRPEYDQRR 208
Query: 319 -PASHPSNTAPPPASHPSNT--APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPA 375
HP P ++ PP A H + P P +P PS P P A
Sbjct: 209 RDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIR--PSAPG-PLA 265
Query: 376 SHPSNTAIPPASHPS 390
+ P+ P
Sbjct: 266 AQPAPAPGPGEPTAR 280
|
Length = 617 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
+++ + +G G +G VY L G AVK++K E+ M+ H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYL 1016
G + + + E GS++ H + PL + L+IA + LAYL
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPL---SELQIAYVCRETLQGLAYL 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +HRD K +NILL + K++DFG+A ++ S +GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEV 177
Query: 1077 AM---TGHLLVKSDVYSYGVVILELLSGRKPV 1105
A G D+++ G+ +EL + P+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-08
Identities = 73/274 (26%), Positives = 100/274 (36%), Gaps = 22/274 (8%)
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPA-- 193
P T P +LPAP L P + + +S PS A P P HPS T PP
Sbjct: 553 PASTEPVHDQLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQ 612
Query: 194 SHPSRTAPP----------PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
SH T+ P P + P H P+ T
Sbjct: 613 SHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHI 672
Query: 244 SHLSNTAPPPASHPYKTSPLPASHPSKT---APPPASHPSNTAPPPASHPSKTAPPPASH 300
+ + P + +P P + PPA+ P P A+ + A PPA+
Sbjct: 673 PYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAA--TGRARPPAAA 730
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P PP A+ A PPA+ P A PPA+ P PP A+ + T PP P
Sbjct: 731 PGRARPPAAA--PGRARPPAAAPG-RARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQ 787
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP 394
P P+ P PP + P++ + P + P P
Sbjct: 788 QRPRGAPT-PQPPPQAGPTSMQLMPRAAPGQQGP 820
|
Length = 991 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-08
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 925 TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 984
K V+ + Q+GG E +L ++H ++++L G + CL+ +P +
Sbjct: 114 NKTCEHVVIKAGQRGGT--ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTD 168
Query: 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044
+ + K + + L I RA+ YLHE+ R+IHRD K+ NI + H +
Sbjct: 169 LYCYLAAKRNIAIC--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL 223
Query: 1045 SDFGLARSAMD-EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1102
DFG A +D +++ GT APE D++S G+V+ E+ +
Sbjct: 224 GDFGAACFPVDINANKYYGW--AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-08
Identities = 29/140 (20%), Positives = 42/140 (30%), Gaps = 7/140 (5%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
P A+ + A P P A+P A + A+P ++
Sbjct: 366 PAAAAEAAAPAEKKTPARPE---AAAPAAAPVAQAAAAPAPAAAPAAAAS--APAAPPAA 420
Query: 166 KAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
P + P+ AA A + A A P A P P S A P+
Sbjct: 421 APPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPA 480
Query: 226 NTALPPASLPSKTAPPPASH 245
A P A+ + T H
Sbjct: 481 --AAPAAARLTPTEEGDVWH 498
|
Length = 618 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-08
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 13/190 (6%)
Query: 923 DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 982
KV VK + GG+ E+++L + HR ++ LI + C+V +P
Sbjct: 118 QRKKVIVKAV-----TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK 169
Query: 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042
+ + VD+ S PL + + I ALAYLH +IHRD K+ NI L+
Sbjct: 170 CDLFTY-VDR-SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1102
+ DFG A GT +PE K+D++S G+V+ E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 1103 KPVDMTQPPG 1112
+ Q
Sbjct: 285 VTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-08
Identities = 47/249 (18%), Positives = 74/249 (29%), Gaps = 8/249 (3%)
Query: 184 HPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
N A PPA P P + P + P PPP+
Sbjct: 67 QQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPS 126
Query: 244 SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPP---ASHPSKTAPPPASH 300
A P + + P +PP PP A S P + +
Sbjct: 127 QPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPY 186
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
+ PP PS+ A P + APP P P + P + PS
Sbjct: 187 QPQSYPPNEPLPSSMAM---QPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQ 243
Query: 361 LPPA--SHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
PP+ + PP S ++ ++ + ++ ++PS A T ++ P
Sbjct: 244 PPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPMSSAP 303
Query: 419 LFVPVLPSA 427
+ S
Sbjct: 304 MSGGGSGSP 312
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 958
++LG+G FG V +L G A+K+L++ + + + E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA--ARALAYL 1016
L C V E G + HL +E AR GA AL YL
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF---YGAEIVSALEYL 111
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 166
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
D + GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-07
Identities = 32/172 (18%), Positives = 49/172 (28%), Gaps = 15/172 (8%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
A HP+ P P AP ++ + + P + P A P P+ P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
S L + +K + P A+ + P + + P
Sbjct: 418 TTSQLLAARQQLQRA-------QGATKAKKSEPAAA----SRARPVNSALERLASVRPAP 466
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
S PA A++P P + P A A KT A
Sbjct: 467 SALEKAPAK--KEAYRWKATNPVEVKKEPVATPK--ALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE--ESRHISTRVMGTF 1069
+ +LH S +IHRD K SNI+++ D T K+ DFGLAR+A + ++ TR
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1102
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 906 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 960
+++G+G FG V + DG+ AVKVL++ + ++ +AE +L L H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L + V + + G + HL +E L AR A A A+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARF-YAAEVASAIGYLH--- 113
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +I+RD K NILL+ ++DFGL + ++ E ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-07
Identities = 21/92 (22%), Positives = 34/92 (36%)
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
P+ + P S + TA A+ + +AP A A P + P+ AP
Sbjct: 26 DPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPK 85
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
P+ A A+ + A A+ P+ A
Sbjct: 86 PAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-07
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 16/136 (11%)
Query: 165 SKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+ A P+ PA+ P A+ P+ A P A+ + A P+ P+P +
Sbjct: 372 AAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAA 428
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
P A+ + A PA+ + P + +P + P + AP PA ++ A
Sbjct: 429 P-----AAAAPAAAPAAAPAA-----VALAPAPPAQAAPETVAIPVRVAPEPA--VASAA 476
Query: 284 PPPASHPSKTAPPPAS 299
P PA+ P+ P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-07
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 7/127 (5%)
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
+ A PA + P A+ ++ A+ P+ A P A+ + A P A+ P
Sbjct: 369 AAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPP----- 423
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPD 443
P + P+ AP A + A+ A P P V + P A S +P
Sbjct: 424 APVAAPAAAAPAAAPAAAPAAVALAPAPP-AQAAPETVAIPVRVAPEPAVASAAPAPAA- 481
Query: 444 APAATPR 450
APAA
Sbjct: 482 APAAARL 488
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-07
Identities = 53/211 (25%), Positives = 68/211 (32%), Gaps = 9/211 (4%)
Query: 88 AVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNV 147
AV P A P + PP A P AP P A+ P A
Sbjct: 586 AVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 148 LPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
A +A P +S + A P A P+ PA+ PA P
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 208 SNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASH 267
+ P A PP + +AP PA+ PP P + PA
Sbjct: 706 A-------ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P AP PA+ P+ A PP S PS+
Sbjct: 759 PPPPAPAPAAAPA--AAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-07
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 2/125 (1%)
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
+ + A P A+ + A P + + + + AP PA P+ PP+
Sbjct: 387 VAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA--APQPAPAPAPAPAPPSP 444
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
+ A S P AP P+ A P + APP A P+ PA+ ++
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 349 APPPA 353
A
Sbjct: 505 GADDA 509
|
Length = 824 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-07
Identities = 51/263 (19%), Positives = 63/263 (23%), Gaps = 23/263 (8%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
++ + ST D+ P PSL T P P AP P+
Sbjct: 94 SQKTSTFSPCQSGYEAST-DPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQPQPQTPAQK 152
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
+ + LP P P P AFP PP P
Sbjct: 153 MLSLEEVEAQLQQRQQAPQLPQP-PQQVLPQGMPPRQAAFPQQGPPE--------QPPGY 203
Query: 189 ARPPASHPSRTAPPPA-SHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
+PP HP + P PS P P P S+ PPP
Sbjct: 204 PQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPP----- 258
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
PP + P P + P P HP A P P P P
Sbjct: 259 ---PPQPPQQQQQPPQPQAQPPPQNQPTP-HPGLPQGQNAPLPPPQQPQ--LLPLVQQPQ 312
Query: 308 PASHPSNTAP-PPASHPSNTAPP 329
Sbjct: 313 GQQRGPQFREQLVQLSQQQREAL 335
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-07
Identities = 55/262 (20%), Positives = 78/262 (29%), Gaps = 11/262 (4%)
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
P ++ P + PA P + P+ + ++ P P HPS T PP
Sbjct: 553 PASTEPVHDQLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPP--- 609
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
+ + P + + + P P L N + P H P+ T
Sbjct: 610 -TTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQ 668
Query: 394 PPHASHPSNTALTPASHPSNIAP----PPLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
H + + P AP PP P P P P + A P
Sbjct: 669 IGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPT-PMRPPAAPPGRAQRPAAATGRARPP 727
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPII 509
R P + PG P A + A P PG + P P
Sbjct: 728 AAAPGRARPP--AAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPA 785
Query: 510 PGGTPTASPDPDVPPSTPPLSV 531
P P +P P PP P S+
Sbjct: 786 PQQRPRGAPTPQPPPQAGPTSM 807
|
Length = 991 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 906 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 961
++LG+G FG ++ G A+K+LK+ V + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 962 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1019
C V E G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------VSALDYLH-- 112
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
S V++RD K N++L+ D K++DFGL + + + + + GT Y+APE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 170
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKP 1104
D + GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-07
Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 901 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLHH 955
+F++ +++G G FG V D G A+K+L++ D +Q G AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-HIRAERDILVEADS 60
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARAL 1013
+VK+ ++ L+ E +P G + + L D E + A +A+ + L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------- 1050
+ IHRD K N+LL+ K+SDFGL
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 1051 -----RSAMDEES-----RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
S E+ R ++ +GT Y+APE M D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 1101 GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQP 1160
G P P QE + ++ +E L I P +VP AK + C
Sbjct: 232 GYPPFCSETP--QETY----KKVMNWKETL--IFPP----EVPISEKAKDLILRFCC--- 276
Query: 1161 EVQHR 1165
E +HR
Sbjct: 277 EWEHR 281
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
A+ +++L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++APE +SDV+SYG+++ E+ S G P
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 908 LGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+G G G+V Y VLD VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 963 GI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ +EE Q LV EL+ + +D E +++ + L +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE----------RMSYLLYQMLCGI 132
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 189
Query: 1077 AMTGHLLVKSDVYSYGVVILE------LLSGRKPVD 1106
+ D++S G ++ E L GR +D
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 45/246 (18%)
Query: 880 IATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVL--KRVDQ 937
++ Y +A+ + ++ +FD +++G G FG V+++ K Q
Sbjct: 25 LSRYEKAAEKITKLRMKAE--DFDVIKVIGRGAFG-------------EVQLVRHKSSKQ 69
Query: 938 QGGREFLAEVEMLSR------------LHHRN---LVKLIGICIEEQARCLVYELIPNGS 982
+ L++ EM+ R + H N +V+L +++ +V E +P G
Sbjct: 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129
Query: 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042
+ + + D P W AR A AL +H S IHRD K N+LL+
Sbjct: 130 LVNLMSNYD---IPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181
Query: 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILEL 1098
K++DFG MD +GT Y++PE + G+ + D +S GV + E+
Sbjct: 182 KLADFGTCMK-MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 1099 LSGRKP 1104
L G P
Sbjct: 241 LVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-07
Identities = 31/162 (19%), Positives = 45/162 (27%), Gaps = 6/162 (3%)
Query: 82 FSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITA 141
F P+ P PP P AS + AP P +P P ++P A
Sbjct: 359 FHPAAPLPEPE---VPPQ---SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPA 412
Query: 142 PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAP 201
PL + ++KA ++ ARP S A + +
Sbjct: 413 VPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKA 472
Query: 202 PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
P + + AL A KT A
Sbjct: 473 PAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 30/147 (20%), Positives = 36/147 (24%), Gaps = 1/147 (0%)
Query: 85 STPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPL 144
+ P+D +P P + P P A P + P PP
Sbjct: 41 QSGVAEFPWDPSPQAPP-PVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPA 99
Query: 145 VNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPA 204
LPA PT P N A P P+ AP
Sbjct: 100 TFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASG 159
Query: 205 SHPSNTALPSKTAPSPASHPSNTALPP 231
PS K S N PP
Sbjct: 160 QLPSQQQSAQKNDESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 38/179 (21%), Positives = 49/179 (27%), Gaps = 20/179 (11%)
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
PS APPP A P P P A A H + T P A+ P+ A
Sbjct: 51 PSPQAPPP------VAQLPQPLP-QPPPTQALQAL-PAGDQQQHNTPTGSPAANPPATFA 102
Query: 339 PPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHAS 398
P P +P NPA P P+ AP
Sbjct: 103 LPAGPAGPTIQTEP-GQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQ 160
Query: 399 HPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHS 457
PS + S + P G+ P Q+ + D A R +
Sbjct: 161 LPSQQQSAQKNDESQLQQQP----------NGETPPQQTDGAGDDESEALVRLREADGT 209
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 908 LGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+G+G FG V D ++ A+K +++ V + LAE +L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ LV I G + HL +E AR A AL LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTA-ELLCALENLHKFN--- 113
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
VI+RD K NILL++ + DFGL + M ++ + + GT Y+APE + GH
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPEL-LLGHGY 170
Query: 1084 VKS-DVYSYGVVILELLSGRKP 1104
K+ D ++ GV++ E+L+G P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 33/241 (13%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 956
+F+ + +G G +G VY ++ G A+KV+K + G +F E+ M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N+V G + + E GS++ H + PL ++ + L YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYL 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +HRD K +NILL + K++DFG++ ++ S +GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV 177
Query: 1077 AMT---GHLLVKSDVYSYGVVILELLSGRKPVD----------MT----QPPGQENLVAW 1119
A G D+++ G+ +EL + P+ MT QPP ++ + W
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237
Query: 1120 A 1120
+
Sbjct: 238 S 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-07
Identities = 36/127 (28%), Positives = 50/127 (39%), Gaps = 8/127 (6%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
A+ PS A PA+ P+ A PA+ AP PA+ +P PA P+ PP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAA---AAPAPAA-----APQPAPAPAPAPAPP 442
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ + A S P AP P+ A P + APP A P+ PA+ +
Sbjct: 443 SPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAA 502
Query: 336 NTAPPPA 342
A
Sbjct: 503 PAGADDA 509
|
Length = 824 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 4e-07
Identities = 66/367 (17%), Positives = 109/367 (29%), Gaps = 33/367 (8%)
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPP 174
AP + T P TA P LP S PT A P S P
Sbjct: 425 APDTTKSVI---FVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGT---PTGTT 478
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
S+ S S T + S T + ++ + A+ P+ P
Sbjct: 479 SSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPT----PIVIG 534
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP-----ASHPSNTAPPPASH 289
+ TA P + ++ + + SP+ ++ P A +
Sbjct: 535 VTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPT 594
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT--------APPPASHPSNTAP-P 340
+ P +SH + P ++ S T ++HP+ + P +H S +P P
Sbjct: 595 SQQPGIPSSSHST----PRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGP 650
Query: 341 PASHSSKTAPPPAS----HPSNTALPPASHPSNPAIPPASHPSNTAIPPAS-HPSNTAPP 395
+S+ + P S +P + N P A TA+P +
Sbjct: 651 GPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANST 710
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHR 455
+T + S +N + LP P +P T +
Sbjct: 711 TKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVP 770
Query: 456 HSPAIHP 462
P HP
Sbjct: 771 VPPTQHP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 9/201 (4%)
Query: 906 RILGEGGFG--LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
R++GEG FG L+ V D ++ + E +L+++ H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ +V E G + + + D L+ + + ++HE R
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
V+HRD KS NI L + K+ DFG AR + + T V GT YV PE
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTYV-GTPYYVPPEIWENMPYN 178
Query: 1084 VKSDVYSYGVVILELLSGRKP 1104
KSD++S G ++ EL + + P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
+++ +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 1012
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHS 160
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ + IHRD K N+LL+ K++DFG M++E +GT Y+
Sbjct: 161 MGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYI 210
Query: 1073 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 1104
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-07
Identities = 27/128 (21%), Positives = 41/128 (32%), Gaps = 3/128 (2%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP--PVNMAPPPS 126
P +A +P+ P +AP + P A+P + + P P APP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
+ A A P L P + + P + S AA PA+ P+
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVAS-AAPAPAAAPA 484
Query: 187 NTARPPAS 194
P
Sbjct: 485 AARLTPTE 492
|
Length = 618 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-07
Identities = 74/384 (19%), Positives = 123/384 (32%), Gaps = 33/384 (8%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
T S + P PP S PT A P S T + P
Sbjct: 428 TTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTS 487
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
PT+ S P +P+ TTP A+ +++ S NA P T
Sbjct: 488 PTSRTTSATPNA--------TSPTPAVTTPNATSPTTQK---TSDTPNATSPTPIVIGVT 536
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSN 248
+ T+ P A+ P ++ +P ++ P+ L S A H
Sbjct: 537 TTATSPPTGTTSVPNATSPQ----VTEESPVNNTNTPVVTSAPSVLTS--AVTTGQH--- 587
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS-HPSKTAPPPASHPSNTAPP 307
S P P PS + P S+ ++T P S HP+ PS P
Sbjct: 588 ---GTGSSPTSQQPGI---PSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSV---P 638
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
+H S +P P ++ P + ++ P + P A+ PS + + P
Sbjct: 639 STTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVP 698
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSA 427
+ + ++ + ++ ++T+P T A+ + P
Sbjct: 699 TVTSTGGKANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFT 758
Query: 428 LPGKAPVSQSPISLPDAPAATPRG 451
P PV+ ++P P P
Sbjct: 759 SP---PVTTKQATVPVPPTQHPDH 779
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 5e-07
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 942 EFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYELIPNGSVESHLHGVDKESAPLGW 999
+ + EV ++ L H+N+V+ I + + Q ++ E G + ++ K +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 1000 DARLKIALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDF--------------- 1040
A + I ALAY H + RV+HRD K NI L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 1041 --TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVIL 1096
K+ DFGL+++ E H +GT Y +PE + T KSD+++ G +I
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 1097 ELLSGRKP 1104
EL SG+ P
Sbjct: 235 ELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-07
Identities = 67/242 (27%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKV--AVKVL-KRVDQQGGR--EFLAEVEMLSRLHHR 956
F ++LG+G G V+ V GT A+KVL K+ + + L E E+L+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARA 1012
L L E CLV + P G + L E AR A A
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-----VARFYAAEVLL-A 115
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD----------------- 1055
L YLH +++RD K NILL +SDF L++ +
Sbjct: 116 LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 1056 ----------EESRHISTRVMGTFGYVAPEY-AMTGHLLVKSDV--YSYGVVILELLSGR 1102
EE S +GT Y+APE + GH S V ++ G+++ E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEMLYGT 229
Query: 1103 KP 1104
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 37/248 (14%)
Query: 890 FSASEIEKAT----GNFDASRILGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGG 940
F + EI +T + + +G G G+V Y +L+ VA+K L R +Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 941 REFLAEVEMLSRLHHRNLVKLIGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKES 994
+ E+ ++ ++H+N++ L+ + +EE Q +V EL+ + +D E
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE- 126
Query: 995 APLGWDARLKIALGAAR-ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053
R+ L + +LH S +IHRD K SNI+++ D T K+ DFGLAR+A
Sbjct: 127 -------RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+ + T + T Y APE + D++S G ++ E++ G PG
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-----VLFPGT 228
Query: 1114 ENLVAWAR 1121
+++ W +
Sbjct: 229 DHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-07
Identities = 37/139 (26%), Positives = 52/139 (37%), Gaps = 14/139 (10%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
A P A+ PS A PA+ P+ A PA+ AP+PA+ P
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAA---------APAPAAAP-----Q 430
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
PA P+ PP+ + A S P +P P+ A P + APP A P
Sbjct: 431 PAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAP 490
Query: 291 SKTAPPPASHPSNTAPPPA 309
+ PA+ + A
Sbjct: 491 AAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 29/147 (19%), Positives = 42/147 (28%), Gaps = 7/147 (4%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPAS----HPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
A HP+ P P P + AP ++ P+ PP PPPAS P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQ--APAVPPPPASAPQQAPAVPL 415
Query: 343 SHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
++ + S PA + P N+A+ + P
Sbjct: 416 PETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAP-A 474
Query: 403 TALTPASHPSNIAPPPLFVPVLPSALP 429
+N P AL
Sbjct: 475 KKEAYRWKATNPVEVKKEPVATPKALK 501
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 32/167 (19%), Positives = 51/167 (30%), Gaps = 14/167 (8%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P PL P PP S A+ + P+ PP + P A A+P
Sbjct: 361 PAAPLPEPEV----PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAP-QQAPAVPL 415
Query: 215 KTAPSPASHPSNTAL-PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
S + +K + P A+ + P + + L + P+ +A
Sbjct: 416 PETTSQLLAARQQLQRAQGATKAKKSEPAAA----SRARPVNSALE--RLASVRPAPSAL 469
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
A A++P + P + P A A T A
Sbjct: 470 EKAPAKKEAYRWKATNPVEVKKEPVATPK--ALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 37/180 (20%), Positives = 57/180 (31%), Gaps = 12/180 (6%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
A HP+ P P P + AP ++ + + P A P PPPAS P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVP---------PPPASAPQ 408
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
P ++ + + S A + P N+AL +
Sbjct: 409 QAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSA 468
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNA 477
P A KA +P+ + P ATP+ P + L A +R+
Sbjct: 469 LEKAPAKKEAYRWKA---TNPVEVKKEPVATPKALKKALEHEKTPELAAKLAAEAIERDP 525
|
Length = 647 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-07
Identities = 33/154 (21%), Positives = 37/154 (24%), Gaps = 15/154 (9%)
Query: 163 LSSKA--FPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNT------ALPS 214
S FP P A P A P +PP + + P NT A P
Sbjct: 40 SQSGVAEFPWD-PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPP 98
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
T PA T P N A P P + L AP
Sbjct: 99 ATFALPAGPAGPTIQTEPGQLYPVQVPVMVTQ-NPANSPLDQPAQQRALQQLQQRYGAP- 156
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
S P K N PP
Sbjct: 157 ----ASGQLPSQQQSAQKNDESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 37/184 (20%)
Query: 972 CLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFK 1030
C+V E + G + L K L D AR+ A AL YLH + ++HRD K
Sbjct: 77 CMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLK 128
Query: 1031 SSNILLEHDFTPKVSDFGLAR------------SAMDEESRHISTR-VMGTFGYVAPEYA 1077
N+L+ K++DFGL++ +++++R + V GT Y+APE
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP---------------VDMTQPPGQENLVAWARP 1122
+ D ++ G+++ E L G P D+ P G E L A A+
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQD 248
Query: 1123 LLTS 1126
L++
Sbjct: 249 LISR 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 31/133 (23%), Positives = 44/133 (33%), Gaps = 5/133 (3%)
Query: 293 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP 352
P P +N+ ++ A S P +++P S S P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 353 ASHPSNTALPPASHPSNPAIPPASH--PSNTAIPPASHPSNTAPPHASHPSNTAL-TPAS 409
+ S+ LPPA PP S P+N + PP P P +TA TP S
Sbjct: 206 SPSDSS--LPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPS 263
Query: 410 HPSNIAPPPLFVP 422
+ AP
Sbjct: 264 ASATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 9e-07
Identities = 21/82 (25%), Positives = 34/82 (41%)
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHS 345
P S + TA A+ + +AP A A P + P+ AP P+ A A+ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 346 SKTAPPPASHPSNTALPPASHP 367
+ A A+ P+ A+ P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-06
Identities = 67/265 (25%), Positives = 81/265 (30%), Gaps = 31/265 (11%)
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
PL PA PP A TAR PP A+ P+ A P A
Sbjct: 247 PLRGDIAAPAPPPVVGEG--ADRAPETARGA---TGPPPPPEAAAPNGAAAPPDGVWGAA 301
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPP--------PASHPYKTSPLPASHPSK-TA 272
+ ALP P P PA P P + PL + T
Sbjct: 302 LAGAPLALPAP--PDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTW 359
Query: 273 PPPAS--------HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
PP+S H A P + + A+ P P AP PAS P+
Sbjct: 360 TPPSSLEDLSAGRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPT 417
Query: 325 NTAPP-PASHPSNTAPPPASHSSKT----APPPASHPSNTALPPASHPSNPAIPPASHPS 379
P PAS P A P S + APPP P A PA + A A
Sbjct: 418 PAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDAL 477
Query: 380 NTAIPPASHPSNTAPPHASHPSNTA 404
PP ++ A HP
Sbjct: 478 RERRPPEPPGADLAELLGRHPDTAG 502
|
Length = 3151 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 960
+++G+G FG V DG AVKVL++ ++++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L + V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +++RD K NILL+ ++DFGL + + + +T GT Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQ 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D + G V+ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 901 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR 956
+F++ +++G G FG V D G A+K+L++ D ++ AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALA 1014
+VK+ +++ L+ E +P G + + L D E A + A +A+ A L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1050
+ IHRD K N+LL+ K+SDFGL
Sbjct: 122 F---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 1051 -------RSA--MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1101
R A + R ++ +GT Y+APE M D +S GV++ E+L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 1102 RKP 1104
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-06
Identities = 74/344 (21%), Positives = 90/344 (26%), Gaps = 28/344 (8%)
Query: 316 APPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPA 375
AP S P P P A P P P +P PPA
Sbjct: 2462 APFSLSLLLGELFP--GAPVYRRPAEARFPFAAGAAPD--------PGGGGPPDPDAPPA 2511
Query: 376 SHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVS 435
AI P P AS + PPP P P A P ++
Sbjct: 2512 PSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAG-DPPPPLPPAAPPAAPDRSVPP 2570
Query: 436 QSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPP 495
P P PA T R P P P PV + + P P P
Sbjct: 2571 PRPAPRPSEPAVTSRA----RRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDP 2626
Query: 496 GNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNH 555
SP P P PP P RV +P
Sbjct: 2627 PPP---SPSPAANEPDPHPPP---TVPPPERPRDDPAPGRVSRPRRARR---LGRAAQAS 2677
Query: 556 SPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTEL 615
SP + P + PP +P +P VS P P P +A+ Q
Sbjct: 2678 SPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHAL-VSATPLPPGP---AAARQASP 2733
Query: 616 PLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSPCG 659
L + P+ P P P P PP +P
Sbjct: 2734 ALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAA 2777
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-06
Identities = 59/249 (23%), Positives = 79/249 (31%), Gaps = 22/249 (8%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
PV + AP A P P P A+ P A P V A + PLA P
Sbjct: 257 PPPVVGEGADRAPETARGATGP---PPPPEAAAPNGAAAPPDGVWGAA--LAGAPLALP- 310
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+PP PA + + P P + P+
Sbjct: 311 --------APPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPP 362
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
S L K A P + A+ P+ P AP PAS P+
Sbjct: 363 SSLEDLSAGRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAP 420
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
P + +APPP + P +A P + APPP P A PA + A A
Sbjct: 421 TPVPA----SAPPPPATPLPSAEPGS--DDGPAPPPERQPPAPATEPAPDDPDDATRKAL 474
Query: 344 HSSKTAPPP 352
+ + PP
Sbjct: 475 DALRERRPP 483
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 25/115 (21%), Positives = 37/115 (32%), Gaps = 1/115 (0%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHP-Y 258
S S + A + S P +++ S PS P + S+ P P+S
Sbjct: 163 VATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSD 222
Query: 259 KTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
P P S + + PP + P S P P S + AP
Sbjct: 223 TPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-06
Identities = 52/275 (18%), Positives = 73/275 (26%), Gaps = 24/275 (8%)
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTAL 212
L+ P+ P++ A + S AA P S PP + +
Sbjct: 310 LLNGAPITEPVAVAAAATTATQSWAA------PVEPVTQTPPVASVDVPPAQPTVAWQPV 363
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
P P P+ P S ++ A L P + + PA P
Sbjct: 364 PGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAP 423
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNT-APPPASHPSNTAPPP-ASHPSNTAPPP 330
P P P A +T AP T P A P P P
Sbjct: 424 APEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQP 483
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNT----------------ALPPASHPSNPAIPP 374
P P +K A PP + +P P
Sbjct: 484 VEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPEPIKSS 543
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPAS 409
PS A+PP + +P + T T A+
Sbjct: 544 LKAPSVAAVPPVEAAAAVSPLASGVKKATLATGAA 578
|
Length = 1355 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-06
Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 7/80 (8%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
P S + TA A+ + +AP AP + + PPA+ P PA+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAA-------APAAKAPAAPAPAPPAAAAPAAPPKPAAAA 90
Query: 335 SNTAPPPASHSSKTAPPPAS 354
+ A P A ++ A PA+
Sbjct: 91 AAAAAPAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 24/159 (15%), Positives = 35/159 (22%), Gaps = 5/159 (3%)
Query: 220 PASHPSNTALPPASLPSKTAPPPASHLS-NTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
P+ + P A + P + PA++P T PA
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTP---TGSPAANPPATFALPAGP 107
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
T P N A P P+ AP PS
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQ 166
Query: 339 PPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
+ S+ P A + A+
Sbjct: 167 SAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-06
Identities = 25/109 (22%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
L S + APP A+ P+ PPPA+ P+ + P A + AP H
Sbjct: 43 LADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKRLTAQREQL 101
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
+ A P A AP + + A P A
Sbjct: 102 VARAAAPAAPEA--QAPAAPAERAAAENAARRLARAAAAAPRPRVPADA 148
|
Length = 484 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMG 1067
A+ + +L +S + IHRD + NILL + K+ DFGLAR + R R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
++APE ++SDV+S+GV++ E+ S G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 61/274 (22%)
Query: 902 FDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRN 957
F + LG G FG V + +D A+K L++ D + AE ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 1015
+V+L ++ V + IP G + S L G+ E + A L A+ + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------- 1050
IHRD K NIL++ D K++DFGL
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 1051 --------------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 1090
R A + R ++ ++GT Y+APE + D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 1091 YGVVILELLSGRKPVDMTQP-PGQENLVAWARPL 1123
GV++ E+L G+ P P Q ++ W L
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 29/221 (13%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+ + + T VAVK L ++ + E+ +L H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 1020
I + +V L+ GS E L E P L IA AL Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG--------YV 1072
S IHR K+S+ILL D +S + S + R RV+ F ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWL 175
Query: 1073 APEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110
+PE + G+ KSD+YS G+ EL +G P
Sbjct: 176 SPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054
+PL + + + AR + +L +S + IHRD + NILL + K+ DFGLAR
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 1055 DEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
+ R S R+ ++APE +SDV+S+GV++ E+ S
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-06
Identities = 30/144 (20%), Positives = 45/144 (31%), Gaps = 3/144 (2%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
A HP+ LP +P ++A P AS + AP A P + +P S PA
Sbjct: 358 AFHPA-APLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLP 416
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
T + + + + + P A S P ++ + PA AP
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAA--ASRARPVNSALERLASVRPAPSALEKAPA 474
Query: 341 PASHSSKTAPPPASHPSNTALPPA 364
A P P
Sbjct: 475 KKEAYRWKATNPVEVKKEPVATPK 498
|
Length = 647 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-06
Identities = 18/81 (22%), Positives = 29/81 (35%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
A + A A+ AP + + PPA+ P PA+ ++ A P A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 354 SHPSNTALPPASHPSNPAIPP 374
+ A PA+ + P
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 3e-06
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 6/120 (5%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
S L+ APP A+ P P PA+ P+ + P A + AP H +
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKRLTAQREQLV 102
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTAL 361
+ A P A AP + + A+ + A+ ++
Sbjct: 103 ARAAAPAAPEA--QAPAAPAERAAAENAARRLA---RAAAAAPRPRVPADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 908 LGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK------ 960
+G+G FG VY D ++ A+KVL + +E +A+ E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 961 ---LIGICIEEQARC---LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
++G+ Q LV + + G + HL KE A+ IA AL
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIA-ELVLALE 110
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
+LH+ +++RD K NILL+ + DFGL+++ + + + GT Y+AP
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAP 165
Query: 1075 EYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
E + K D +S GV++ E+ G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 61/272 (22%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD----QQGGREFLAEVEMLSRLHHR 956
F + +G G FG V D + A+K L++ D Q AE ++L+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-HVKAERDILAEADNE 61
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 1014
+VKL ++ V + IP G + S L G+ +E AR IA A+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELTCAIE 115
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1050
+H+ IHRD K NIL++ D K++DFGL
Sbjct: 116 SVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 1051 -----------------RSAMDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYG 1092
R + R ++ ++GT Y+APE TG+ + D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVG 231
Query: 1093 VVILELLSGRKPVDMTQPPG-QENLVAWARPL 1123
V++ E+L G+ P P Q ++ W L
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-06
Identities = 61/258 (23%), Positives = 78/258 (30%), Gaps = 16/258 (6%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
A PP + P + T P P ++ A+PP A + A P
Sbjct: 253 AAPAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVW-GAALAGAPLALPA 311
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN---TALPPASLPSKTAPPPASHLSNT 249
P AP + + + SP P P P+ T P LS
Sbjct: 312 PPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSA- 370
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP-P 308
H K + LP + + A+ P P AP PAS P+ P P
Sbjct: 371 ----GRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVP 424
Query: 309 ASHPSNTAPPPAS----HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
AS P A P S APPP P A PA A A PP
Sbjct: 425 ASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRERRPPE 484
Query: 365 SHPSNPAIPPASHPSNTA 382
++ A HP
Sbjct: 485 PPGADLAELLGRHPDTAG 502
|
Length = 3151 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-06
Identities = 45/227 (19%), Positives = 67/227 (29%), Gaps = 33/227 (14%)
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPD 443
A+ P P A+ P+ A PA+ P+ A P + A S +P +L
Sbjct: 376 TAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAA 435
Query: 444 APAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSP 503
A A+ RG +PA P P A P + +P
Sbjct: 436 ARQASARGPGGAPAPAPAP-AAAPAAAAR---------PAAAGPRPVAAAAAAAPARAAP 485
Query: 504 VARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVV 563
A P +P D PP P E + P P + V
Sbjct: 486 AAAP---------APADDDPP--------------PWEELPPEFASPAPAQPDAAPAGWV 522
Query: 564 PPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSAS 610
S + + +P+ +P P + +P P AS
Sbjct: 523 AESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRAS 569
|
Length = 700 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-06
Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 13/151 (8%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
A P+ A A P+ P A PA+ P A+ + A P A+ +
Sbjct: 363 AFKPAAAAEAAA--PAEKKTPARP----EAAAPAAAP---VAQAAAAPAPAAAPAAAASA 413
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
A P A+ P+ A P A+ P + + P+ A + P +AP
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPE 469
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
P P+ A +P D AT
Sbjct: 470 PAVASAAPAPAAAPAAARLTPTEEGDVWHAT 500
|
Length = 618 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
AR + +L +S +HRD + N+LL K+ DFGLAR M + +
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
++APE SDV+SYG+++ E+ S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-06
Identities = 32/124 (25%), Positives = 38/124 (30%), Gaps = 8/124 (6%)
Query: 256 HPYKTSPLP-ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN 314
Y PL A + P PA P A P A+ PS P PA PS A+
Sbjct: 344 TSYGQLPLELAVIEALLVPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIP 398
Query: 315 TAPPPAS--HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
P P P P + P P A ++ A P P T P I
Sbjct: 399 PKEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALI 458
Query: 373 PPAS 376
Sbjct: 459 ADGD 462
|
Length = 585 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKR---VDQQGGREFLAEVEMLSRLHH 955
+FD ++G G FG V V + T A+KV+K+ + Q+ F E ++LS +
Sbjct: 2 DFDVKSLVGRGHFGEVQV-VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD---KESAPLGWDARLKIALGAARA 1012
+ +L ++ LV E P G + S L+ + E + A L +A+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ Y +HRD K N+L++ K++DFG A + + S +GT Y+
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPDYI 170
Query: 1073 APEY--AMTGHLL----VKSDVYSYGVVILELLSGRKP 1104
APE M G V+ D +S GV+ E++ GR P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-06
Identities = 71/306 (23%), Positives = 92/306 (30%), Gaps = 42/306 (13%)
Query: 56 HLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITA 115
LL P+++ ++P + S +PS P P PS P PP+ +
Sbjct: 562 QLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWP---VPHPSQTP-----EPPTTQS 613
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
P AP +P P+ P P NVL P+ P PP
Sbjct: 614 HIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPT-----------------PHQPPQ 656
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
P + P P P NT LP + AP T PP P
Sbjct: 657 VEITPYKPTWTQIGHIPYQ------PSPTGA--NTMLPIQWAPG-------TMQPPPRAP 701
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP 295
+ PP A P A+ + A P A P + P AP
Sbjct: 702 TPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAP 761
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
A P+ P P APP AP P P A P + A P
Sbjct: 762 GRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQ--AGPTSMQLMPRAAPGQQG 819
Query: 356 PSNTAL 361
P+ L
Sbjct: 820 PTKQIL 825
|
Length = 991 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 5e-06
Identities = 19/82 (23%), Positives = 31/82 (37%)
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P S + TA A+ + +AP A + + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 291 SKTAPPPASHPSNTAPPPASHP 312
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-06
Identities = 27/131 (20%), Positives = 42/131 (32%), Gaps = 9/131 (6%)
Query: 168 FPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNT 227
+ AA P A+ + A P + + A + + AP PA P+
Sbjct: 387 VAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA--------APQPAPAPAPA 438
Query: 228 ALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
PP+ + A S AP P + P + PPA+ AP
Sbjct: 439 PAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAA-PEPTAAPAPAPPAAPAPAAAPAAP 497
Query: 288 SHPSKTAPPPA 298
+ P+ A
Sbjct: 498 AAPAAPAGADD 508
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-06
Identities = 33/123 (26%), Positives = 46/123 (37%), Gaps = 14/123 (11%)
Query: 86 TPAVSAPFDMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPSLIPTTPVASPPPITAPP 143
T P ++A +L+ P P P+ AP PV P PS P A+ P P
Sbjct: 344 TSYGQLPLELAVIEALLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIP-PKEP 402
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPP 203
+ P +P P+A P P +P S A+ P + P + P APP
Sbjct: 403 VRETAT-PPPVPPRPVAPP------VPHTPESAPKLTRAAIPVDEK-PKYTPP---APPK 451
Query: 204 ASH 206
Sbjct: 452 EEE 454
|
Length = 585 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-06
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 57/249 (22%)
Query: 901 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL 953
+F++ +++G G FG LV D G A+K L++ + +Q AE ++L+
Sbjct: 2 DFESIKVIGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVA-HVRAERDILAEA 58
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAAR 1011
+ +VKL +E L+ E +P G + + L D E + A +A+ +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA-------RSAMDEESRHIST- 1063
L Y IHRD K N+LL+ K+SDFGL R+ H
Sbjct: 119 KLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 1064 -----------------------RVM-----GTFGYVAPEYAMTGHLLVKSDVYSYGVVI 1095
R + GT Y+APE + + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 1096 LELLSGRKP 1104
E+L G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-06
Identities = 43/227 (18%), Positives = 58/227 (25%), Gaps = 19/227 (8%)
Query: 20 AFTVQGSAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNI 79
AF S G P + A P P A P +A
Sbjct: 362 AFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAA-PAAAAAARAVA 420
Query: 80 PSFSPSTPAVSA------PFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPV 133
+ + +PA A P + P A+ P+ A P P
Sbjct: 421 AAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPV-----AAA 475
Query: 134 ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPA 193
A+ P A P PA P P F +P A P + P
Sbjct: 476 AAAAPARAAPAAAPAPADDDPPPWEELPP----EFASPAPAQPDAAPAGWVAESIPDPAT 531
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAP 240
+ P A P+ P A + P PP + S
Sbjct: 532 ADPDDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 7e-06
Identities = 35/187 (18%), Positives = 51/187 (27%), Gaps = 31/187 (16%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
P P+ P + + PT VA P PP
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPP------------------- 401
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS 222
PPAS P A P ++ R + S A S+ P ++
Sbjct: 402 ------PPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSA 455
Query: 223 HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS--KTAPPPASHPS 280
++ PA + AP A++P + P + P K A P
Sbjct: 456 LERLASVRPAPSALEKAPAKK----EAYRWKATNPVEVKKEPVATPKALKKALEHEKTPE 511
Query: 281 NTAPPPA 287
A A
Sbjct: 512 LAAKLAA 518
|
Length = 647 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 26/151 (17%), Positives = 35/151 (23%), Gaps = 2/151 (1%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTA-PPPASHPSNTAPPPASHPSKTAPPP 297
PP A PP + + P T PA++P T PA T
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
P N A P P+ AP S+ + S
Sbjct: 116 PGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDES 174
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASH 388
P A + A+
Sbjct: 175 QLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-06
Identities = 43/226 (19%), Positives = 67/226 (29%), Gaps = 6/226 (2%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP--SNTALPPASLPSKTAPPP 242
NTA A P A P A P+ S++ ASH S +P
Sbjct: 5 SINTATKTAVQPE--ATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSS 62
Query: 243 ASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPS 302
A APP A +P +P + P T + P + A S +A
Sbjct: 63 APRQIQAAPPQALNPTAAAPQSSRGP--TLRELLALPEDDGETQAPESSPSARRLTRSEG 120
Query: 303 NTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
P + S+ PP + ++ PA+ ++ AL
Sbjct: 121 VARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAALF 180
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPA 408
S ++ + S + A P + P LT +
Sbjct: 181 KDDEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRS 226
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 7e-06
Identities = 56/260 (21%), Positives = 76/260 (29%), Gaps = 66/260 (25%)
Query: 45 PRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPT 104
PRL L+ LLG LP+ N + + TPA + AP P
Sbjct: 348 PRL----WLEVTLLG-------LLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPK 396
Query: 105 NPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVN---------VLPAPSLIP 155
A+ P + P PT P +PP A + +L L
Sbjct: 397 TKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPANAANAPPSLNLEELWQQILAKLELPS 456
Query: 156 TTPLAS-----------------------------PLSSKAF----------------PP 170
T L S PL +AF
Sbjct: 457 TRMLLSQQAELVSLDSNRAVIAVSPNWLGMVQSRKPLLEQAFAKVLGRSIKLNLESQSGS 516
Query: 171 ASPPSNAARPPASHPSNTAR-PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
AS + PP P A PP P+ TAPPP P ++ +PA P++++
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSP 576
Query: 230 PPASLPSKTAPPPASHLSNT 249
PP T P
Sbjct: 577 PPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 9e-06
Identities = 33/158 (20%), Positives = 42/158 (26%), Gaps = 24/158 (15%)
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHP 196
P PPL + T S A P ++ PS+ PS + P
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 197 SRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH 256
+ P PA + PP S S T P P PP +
Sbjct: 207 PSDSSLP----------------PAPSSFQSDTPPPSPESPTNPSP--------PPGPAA 242
Query: 257 PYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P S P P S + AP A
Sbjct: 243 PPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-06
Identities = 30/202 (14%), Positives = 48/202 (23%), Gaps = 20/202 (9%)
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP- 307
APPP + P + ++ PP + ++P+ P
Sbjct: 95 PAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAYQQRPE 154
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN--TALPPAS 365
P + P PP A + S + P + P +
Sbjct: 155 PGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAGRPEYDQRRRDYD 212
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
HP P ++ P P P V +
Sbjct: 213 HPRPDWDRPRRDRTDR---PEPPPGAGHVHRGG------------PGPPERDDAPVVPIR 257
Query: 426 SALPGKAPVSQSPISLPDAPAA 447
+ PG +P P P A
Sbjct: 258 PSAPGPLAAQPAPAPGPGEPTA 279
|
Length = 617 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 16/148 (10%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLIG 963
++L G VY + +K+ ++ G + EV +L L + L K++
Sbjct: 4 KLLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ L+ E I G + +KE IA A LA LH+
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKE----------DIAEQLAELLAKLHQLPLLV 109
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLAR 1051
+ H D NIL++ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 31/173 (17%), Positives = 45/173 (26%), Gaps = 12/173 (6%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPP-PSLIPTNPVASPPSITAPPPVN 120
A + P +P P + + ++ P P+ P + P
Sbjct: 416 ARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAA 475
Query: 121 MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
A P A+P AP + P L P +P A P + P
Sbjct: 476 AAAAP------ARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDP 529
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ P A AP A P A S + LP
Sbjct: 530 ATADP-----DDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMF 577
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-05
Identities = 32/177 (18%), Positives = 47/177 (26%), Gaps = 12/177 (6%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
P A P A A AP P P V +
Sbjct: 615 PAAPAAPAAPAAPAPAGAAAAPAEASAAPAP--------GVAAPEHHPKHVAVPDASDGG 666
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
P + A P PA P + + P A+PP+ A PA+ P
Sbjct: 667 DGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPA--PAATPPAGQADDPAAQPPQA 724
Query: 189 ARPPASHPSRTAP--PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
A+ ++ P P + P+ P P+ + +PP
Sbjct: 725 AQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSE 781
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-05
Identities = 20/82 (24%), Positives = 31/82 (37%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P S + TA A+ ++P A A P + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 302 SNTAPPPASHPSNTAPPPASHP 323
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-05
Identities = 19/75 (25%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
P S + A A+ + +A A P+ AP + A P PA+ + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAA--PAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 230 PPASLPSKTAPPPAS 244
P A + A PA+
Sbjct: 96 PAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-05
Identities = 20/82 (24%), Positives = 31/82 (37%)
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
P S T+ A+ + +AP A A P + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 313 SNTAPPPASHPSNTAPPPASHP 334
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-05
Identities = 51/259 (19%), Positives = 68/259 (26%), Gaps = 26/259 (10%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
P AS AP SK + P P
Sbjct: 514 PEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGK--------------PGETKEGEVGK 559
Query: 251 PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
P + +K S +P P HP + P ++A P S P
Sbjct: 560 KPGPAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLD 619
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P + P S S PPP PS+ P K+ PP S P +P
Sbjct: 620 IP-KSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS---------PKPPFDP 669
Query: 371 AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPG 430
+ + A+ T S ++ + P P LP LP
Sbjct: 670 KFKEKFYDD--YLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPR 727
Query: 431 KAPVSQSPISLPDAPAATP 449
PI PDA
Sbjct: 728 DEEFPFEPIGDPDAEQPDD 746
|
Length = 943 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 33/244 (13%)
Query: 871 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAV 929
S+S S SS A+ + + S SE+E+ +G G G VY + G A+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYAL 104
Query: 930 KVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 988
KV+ + R+ E+E+L ++H N+VK + ++ E + GS+E
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 989 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048
++ A D +I G +AYLH ++HRD K SN+L+ K++DFG
Sbjct: 165 ADEQFLA----DVARQILSG----IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 1049 LAR---SAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLS 1100
++R MD + + GT Y++PE T + D++S GV ILE
Sbjct: 214 VSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 1101 GRKP 1104
GR P
Sbjct: 269 GRFP 272
|
Length = 353 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (115), Expect = 1e-05
Identities = 49/153 (32%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 265 ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA---SHPSNTAPPPA---SHPSNTAPP 318
A+ K A A+ PS A+ P+K A PA + P+ A PA + P+ A P
Sbjct: 197 AAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAP 256
Query: 319 PA---SHPSNTAPPPASHPSNTAPPPASHSSKTAPPP--ASHPSNTALPPASHPSNPAIP 373
PA + P+ A PPA + A A + APP A+ P+ A PA + PA
Sbjct: 257 PAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPA-K 315
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
A+ P+ A PPA + T P A+ P A
Sbjct: 316 AAAPPAKAAAPPAK--AATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (115), Expect = 1e-05
Identities = 59/175 (33%), Positives = 77/175 (44%), Gaps = 39/175 (22%)
Query: 211 ALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSK 270
A K A A+ PS A+ P+K A PA A PPA A+ P+K
Sbjct: 198 AAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPA----KAAAPPAK--------AAAAPAK 245
Query: 271 TAPPPA---SHPSNTAPPPA---SHPSKTAPPPA---SHPSNTAPPPA---SHPSNTAPP 318
A PA + P+ A PPA + P+K A PPA + P+ A PPA + P+ A
Sbjct: 246 AAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAA 305
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP---ASHPSNTALPPASHPSNP 370
PA A+ P+ A PPA K A PP A+ P+ A PPA + P
Sbjct: 306 PAK--------AAAAPAKAAAPPA----KAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 20/86 (23%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
T P PA+ T + TAP PA P A S + AP
Sbjct: 174 TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------QANVDTAATPAPAA 227
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHP 356
+ P AP P + + P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 38/252 (15%), Positives = 66/252 (26%), Gaps = 17/252 (6%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSK--TA 217
++P SS P +SP S+ P + + P S L +
Sbjct: 388 SNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGT---PGSKSDRVGAVLLRRMNIK 444
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P+ AS P + P +S L PP + +
Sbjct: 445 PTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKC---GEESGHLPNNPFFNKLKLT 501
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPP--ASHPSNTAPPPASHPSNTAPPPASHPS 335
S+ P T P P+ S + S + P +P+ + A+ S
Sbjct: 502 L-SSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLS 560
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
+ ALP + + S ++++P +
Sbjct: 561 FNRSVSDIEGERIGRYNLLPTRIPALPFKAEST------TSSRRSSSLPSPTGVIGFPGS 614
Query: 396 HASHPSNTALTP 407
L P
Sbjct: 615 VPRFDHENLLPP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-05
Identities = 45/198 (22%), Positives = 58/198 (29%), Gaps = 7/198 (3%)
Query: 60 GHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPV 119
G AP AP P + A +AP A P A + AP
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
P + + PA P A + A P P+ AA
Sbjct: 649 APEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAAT 708
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
PPA + A P + P + LP + P PA P A
Sbjct: 709 PPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAG-----APAQPPPPPA 763
Query: 240 PPPASHLSNTAPPPASHP 257
P PA+ + A PP S P
Sbjct: 764 PAPAA--APAAAPPPSPP 779
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-05
Identities = 27/149 (18%), Positives = 40/149 (26%), Gaps = 10/149 (6%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP--PASHPSKTAPPPAS 299
PA+ L PP S S + P+ PP + P P P+ P S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPPPASHSSKTAPPPASHPS 357
T + + + P + + PA + + AP
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPA 386
A P P P A+ A
Sbjct: 481 WKATNPVEVKKEPVATP------KALKKA 503
|
Length = 647 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-05
Identities = 63/280 (22%), Positives = 97/280 (34%), Gaps = 20/280 (7%)
Query: 199 TAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPY 258
TAP +PS+ P S + A P +P+K P A PP
Sbjct: 310 TAPLTPMEELLAKIPSQRVPPKES---DAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAV 366
Query: 259 KTSPL-PASHPSKTAPPPASHP-SNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTA 316
PL P + PP + P ++ P +S PA +P AS+
Sbjct: 367 VPRPLSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVE 426
Query: 317 PPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPAS 376
P + P + + P + S TAP S + +S P+ P PA+
Sbjct: 427 PAQV--EAKKTRPLSPYARYEDLKPPTSPSPTAPTGV---SPSVSSTSSVPAVPDTAPAT 481
Query: 377 HPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQ 436
++ A PP ++ P + + L P + PS AP P + + K S
Sbjct: 482 AATDAAAPPPANMR----PLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVV-KVGNSA 536
Query: 437 SPISLPDA-----PAATPRGNFHRHSPAIHPSMPGPLPPV 471
P +L D P P + + P+ P P P +
Sbjct: 537 PPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPVL 576
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-05
Identities = 20/83 (24%), Positives = 31/83 (37%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
P S + TA A+ + +AP A A P + P +P P+ A A+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 279 PSNTAPPPASHPSKTAPPPASHP 301
+ A A+ P+ A P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-05
Identities = 22/137 (16%), Positives = 32/137 (23%), Gaps = 7/137 (5%)
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTA-PPPASHPSNTAPPPASHPSNTAPPP 330
PP A P PP + + P NT PA++P T PA T
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
P + P AL + + ++ +
Sbjct: 116 PGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYG----APASGQLPSQQQSAQKN 171
Query: 391 NTAPPHASHPSNTALTP 407
N P
Sbjct: 172 --DESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 29/112 (25%), Positives = 38/112 (33%), Gaps = 7/112 (6%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
S P A+ A L AP PA A P + +P P++ P A A+
Sbjct: 345 SYGQLPLELAVIEALLVPVPAPQPA-----KPTAAAPSPVRPTPAPSTRP--KAAAAANI 397
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P + P P P + P P A + A P P T P P
Sbjct: 398 PPKEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 30/123 (24%), Positives = 35/123 (28%), Gaps = 16/123 (13%)
Query: 232 ASLPSK--TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
A L K A P P T P A PS A S ++A S
Sbjct: 360 AQLTQKGDDASGG------RGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS- 412
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAP-PPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
AP A+ P+ T P + P P P S P P S S
Sbjct: 413 ----APQSATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEK--KIPVSKVSSL 466
Query: 349 APP 351
P
Sbjct: 467 GPS 469
|
Length = 614 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-05
Identities = 104/482 (21%), Positives = 143/482 (29%), Gaps = 67/482 (13%)
Query: 80 PSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPI 139
PS PS P A P T + PP + APPPS +
Sbjct: 455 PSDQPSVPVEPA----HLTPVEHTTVILHQPPQSPPTVAIKPAPPPSRRRRGACV----V 506
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
++ V+ + TT ++ A P R + A PP PS
Sbjct: 507 YDDDIIEVID----VETTEEEESVTQPAKPHRKVQDGFQR--SGRRQKRATPPKVSPSDR 560
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
PP AS P P T P + PS P P T P + PPAS P++
Sbjct: 561 GPPKASPPV--MAPPSTGPRVMATPS--TGPRDMAPPSTGPRQQAKCK--DGPPASGPHE 614
Query: 260 TSPLPASHPSKTAPPPASH-------PSNTAPPPAS--------HPSKTAPPPASHPSNT 304
P P+S P AP +T P P S S P+S
Sbjct: 615 KQP-PSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSRRQPA 673
Query: 305 APPPASHPS---NTAPPPASHPSNTAPPPASHPSNTAPP-PASHSSKTAPPPASHPSNTA 360
PS + P+ P SH S+ +P P SH + P + +
Sbjct: 674 TQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDPLDLS 733
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA-------SHPSNTALTPASHPSN 413
L P P P S A +P P P + +S+P
Sbjct: 734 LHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQAQGVQVSSYPGY 793
Query: 414 IAPPPL------------FVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIH 461
P L + P + P + P LP + G+
Sbjct: 794 AGPWGLRAQHPRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSA-GHGQDQVSQFP 852
Query: 462 PSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPD 521
PP Q + P ++ + P +S Q RPI PT P P
Sbjct: 853 HLQSETGPPRLQLSQV--PQLPYSQTLVSSSAPSWSSPQPRAPIRPI-----PTRFPPPP 905
Query: 522 VP 523
+P
Sbjct: 906 MP 907
|
Length = 1000 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGRE---FLAEVEMLSRLHHR 956
+F+ +++G G FG V L + KV A+K+L + + E F E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARAL 1013
+ L +E LV + G + + L + E + A + IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
Y +HRD K NIL++ + +++DFG M++ + S V GT Y++
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 1074 PEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 1104
PE AM G + D +S GV + E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-05
Identities = 58/229 (25%), Positives = 80/229 (34%), Gaps = 22/229 (9%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVA-SPPSI 113
P ++G A E + PP P +AP A PP + +A +P ++
Sbjct: 258 PPVVGEGADRAPETARGATGPP--------PPPEAAAPNGAAAPPDGVWGAALAGAPLAL 309
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
APP PPP A +V+ LP P + P +P
Sbjct: 310 PAPPD----PPPPAPAGDAEEEDDEDGAMEVVSPLPRPR----QHYPLGFPKRRRPTWTP 361
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAP----PPASHPSNTALPSKTAPSPASHPSNTAL 229
PS+ A + R+A P A P AP PAS P+
Sbjct: 362 PSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPT 421
Query: 230 P-PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P PAS P A P S + PA P + P PA+ P+ P A+
Sbjct: 422 PVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 30/124 (24%), Positives = 44/124 (35%), Gaps = 1/124 (0%)
Query: 315 TAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
P P +N+ + A S P +++ S PS P P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPV 434
+ S+ P+S S+T PP P+N + P PP VP L +A P
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPP-PPPVQQVPPLSTAKPTPPSA 264
Query: 435 SQSP 438
S +P
Sbjct: 265 SATP 268
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 58/280 (20%), Positives = 89/280 (31%), Gaps = 24/280 (8%)
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARP-PASHPSRTAPPPASHPSNTA 211
L P L + + S+ PP S+AA P P+ P S P PP
Sbjct: 313 LTPMEELLAKIPSQRVPP--KESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRP 370
Query: 212 LPSKTA------PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPA 265
L TA P+ ++ P +S PA +P AS+ + P
Sbjct: 371 LSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQV 430
Query: 266 SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSN 325
+K P + + P + PS TAP S P S S+ P +
Sbjct: 431 --EAKKTRPLSPYARYEDLKPPTSPSPTAPTGVS-------PSVSSTSSVPAVPDT---- 477
Query: 326 TAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPP 385
P + APPPA+ + P + P P +++
Sbjct: 478 --APATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNS 535
Query: 386 ASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
A + H + P L+P + ++ PP P
Sbjct: 536 APPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-05
Identities = 21/82 (25%), Positives = 33/82 (40%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
P S + TA A+ + +AP A A P + + AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 368 SNPAIPPASHPSNTAIPPASHP 389
+ PA A+ P+ A+ P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-05
Identities = 24/120 (20%), Positives = 37/120 (30%), Gaps = 6/120 (5%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
S + APP A+ P+ PPPA+ P+ PA+ + AP H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 335 SNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP 394
+ A P A AP + + A P A+ ++
Sbjct: 103 ARAAAPAA--PEAQAPAAPAERAAAENAARRLARAAAAAPRPRVP---ADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (111), Expect = 3e-05
Identities = 53/170 (31%), Positives = 71/170 (41%), Gaps = 25/170 (14%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
A A+ AA A+ PS A+ P++ A PA + A + A+ P+
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 227 TALPPA---SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
A PPA + P+K A PPA A PPA A+ P+K A PPA
Sbjct: 253 AAAPPAKAAAPPAKAAAPPA----KAAAPPAK--------AAAPPAKAAAPPAK------ 294
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP--PASHPSNTAPPPA 331
A+ P+K A PA + A A APP A+ P+ A PPA
Sbjct: 295 --AAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-05
Identities = 26/127 (20%), Positives = 39/127 (30%), Gaps = 7/127 (5%)
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH--PSNTAPPPASHPSNTAPPPA 342
P + P + P+ AP P++ + + P S +AP A+ P+ T P +
Sbjct: 370 SGGRGPKQHIKPVFTQPAA-APQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 343 SHSSKTAP-PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPS 401
P P S P IP + S P P A+
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKK-IPVSKVSSLG--PSTLRPIQEKAEQATGNI 485
Query: 402 NTALTPA 408
A T
Sbjct: 486 KEAPTGT 492
|
Length = 614 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-05
Identities = 58/331 (17%), Positives = 90/331 (27%), Gaps = 15/331 (4%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
A P P + A+ + PA A A A A
Sbjct: 361 AVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAA 420
Query: 354 SHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSN 413
+ P + P+ PA + P +N S P + +
Sbjct: 421 TRAE----APPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGS 476
Query: 414 IAPPPLFVPVLPSALP-----GKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPL 468
+ P P + P + + + + APAA R + + P P
Sbjct: 477 ASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPT 536
Query: 469 PPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPP 528
P A + A + + + R A P P A+P P P
Sbjct: 537 PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAA-KPAAAPAAAPKPAAPRVAVQ 595
Query: 529 LSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGP---VVPPSFIPTSRKRHYGPPPLNSVS 585
+ R A P+ + P + P ++P S +G P V
Sbjct: 596 VPTPRARAATGDAPPNGAARAEQAAESRGAPPPWEDIPPDDYVPLSADEGFGGPDDGFV- 654
Query: 586 PSHSPLPTPVSRVPTSPSPSPTSASGQTELP 616
P P V RV P+ +P LP
Sbjct: 655 PVFDSGPDDV-RVAPKPADAPAPPVDTRPLP 684
|
Length = 830 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 31/133 (23%), Positives = 42/133 (31%), Gaps = 5/133 (3%)
Query: 304 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPP 363
P P +N+ ++ A S ++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 364 ASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV 423
+ S+ PPA + PP S S T P S P A P + P P
Sbjct: 206 SPSDSSL--PPAPSSFQSDTPPPSPESPTNP---SPPPGPAAPPPPPVQQVPPLSTAKPT 260
Query: 424 LPSALPGKAPVSQ 436
PSA AP+
Sbjct: 261 PPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 56/227 (24%), Positives = 76/227 (33%), Gaps = 26/227 (11%)
Query: 63 PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSIT-------- 114
P P PP P +P +A D+ PP S IPT P +SP S
Sbjct: 349 PEAPSPPIEEEPPQPKAVVPRPLSP-YTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKP 407
Query: 115 -APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
P V S +P A PL L P T + + P S
Sbjct: 408 AEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSS 467
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS-------HPSN 226
S+ P + P+ A A+ P P + + L T+PSPA+ +N
Sbjct: 468 TSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTN 527
Query: 227 TALPPASLPSKTAPPPASHLSNTAPPPASHPYK--------TSPLPA 265
+ + TA H + P P S PY TSP P+
Sbjct: 528 EVVKVGNSAPPTALADEQHHAQPKPRPLS-PYTMYEDLKPPTSPTPS 573
|
Length = 576 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-05
Identities = 34/223 (15%), Positives = 53/223 (23%), Gaps = 17/223 (7%)
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
PS APPP A P P P A A H++ T P A+ P+ A
Sbjct: 51 PSPQAPPP------VAQLPQPLP-QPPPTQALQAL-PAGDQQQHNTPTGSPAANPPATFA 102
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLF 420
LP +P N A P+ AP
Sbjct: 103 LPAGPAG-PTIQTEPGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQ 160
Query: 421 VPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNR 480
+P + P+ + + + ++R
Sbjct: 161 LPSQQQ--SAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLREADGTLEQRIKGAE 218
Query: 481 EAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP 523
+ + + KS R I + + D
Sbjct: 219 GGGAMKVLK-----QPKKQAKSSKRRTIAQIDGIDSDDEGDGS 256
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-05
Identities = 24/105 (22%), Positives = 36/105 (34%), Gaps = 7/105 (6%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
APP A+ + PPPA+ P PA+ ++ AP H ++ A P A
Sbjct: 52 APPAAAAPAAAQPPPAAAP-AAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAA 110
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
AP + + A A+ P P A+
Sbjct: 111 PEA--QAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-05
Identities = 22/116 (18%), Positives = 33/116 (28%), Gaps = 4/116 (3%)
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+APP + P A PPP AP V+ AP+ P L + AA
Sbjct: 50 ALAPPAAAAP--AAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
P A A + + A + + + A +
Sbjct: 108 PAAPEA--QAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARIE 161
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 187 NTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHL 246
+T PA+ P+ AP + ++ TAP+PA P A+ PS+ A
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA---PSQANVDTA--- 220
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHP 279
+ AP + P +PLP + P +
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-05
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 993 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052
ES L + + + A + +L +S +HRD + N+L+ K+ DFGLAR
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 1053 AMDEESRHISTRVMGTF---GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
M +S +IS TF ++APE SDV+S+G+++ E+ +
Sbjct: 289 IM-RDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-05
Identities = 46/151 (30%), Positives = 62/151 (41%), Gaps = 17/151 (11%)
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPP 202
L+N+ P L+P L + AS PS +A PAS + T P + + P
Sbjct: 356 LLNLAMLPRLMPVESL-----RPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAP 410
Query: 203 PASHPSNTALPSKTAPSPASHPSN--TALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
A ++A P+ APS A P PPA S P PA + +P P +
Sbjct: 411 AAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGA----- 465
Query: 261 SPLPASHPSKT-APPPASHPSNTAPPPASHP 290
P S S + APP PS+TA S P
Sbjct: 466 ---PDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+F+ +++G G FG +VAV +K ++ + L + EML R
Sbjct: 2 DFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAE------ 44
Query: 961 LIGICIEEQARCLVYELIPNGSV------------ESHLH-------GVDKESAPLGWDA 1001
C E+ LV NG E++L+ G D + ++
Sbjct: 45 --TACFREERNVLV-----NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED 97
Query: 1002 RLKIALG---AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058
RL + A + +H +HRD K N+LL+ + +++DFG + +
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 1059 RHISTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 1104
S V GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 158 VQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-05
Identities = 24/98 (24%), Positives = 30/98 (30%), Gaps = 9/98 (9%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
P PA P+ + + P PS A+ P TA PP
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRE----TATPP-----P 411
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P P + P P A + A P P T P P
Sbjct: 412 VPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-05
Identities = 21/95 (22%), Positives = 30/95 (31%), Gaps = 1/95 (1%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
P A A P + PT ++ P A + P T P P P
Sbjct: 359 LLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRP-V 417
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
APP+ + + + + K PPA P
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 62/270 (22%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 906 RILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL---AEVEMLSRLHHRNLVKL 961
+ LG G FG V + +D A+K L++ D + AE ++L+ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 962 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1019
++ V + IP G + S L V E + A L +A+ + + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---- 122
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------------- 1050
IHRD K NIL++ D K++DFGL
Sbjct: 123 -----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 1051 ----------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 1094
+ A + R ++ ++GT Y+APE + D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 1095 ILELLSGRKPVDMTQPP-GQENLVAWARPL 1123
+ E+L G+ P P Q ++ W L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-05
Identities = 25/91 (27%), Positives = 31/91 (34%), Gaps = 15/91 (16%)
Query: 157 TPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKT 216
+P SP K P P P + P PA P PAS P P +
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPA-----ELPSPASAP----TPEQQ 433
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLS 247
P S P LPP+ P +AP +
Sbjct: 434 PPVARSAP----LPPS--PQASAPRNVASGK 458
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-05
Identities = 33/156 (21%), Positives = 47/156 (30%), Gaps = 14/156 (8%)
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP-------SNTALPSKT 216
SS P +PPS A PPAS + P AS S + AL S +
Sbjct: 639 SSADRKPKTPPSRA--PPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGS 696
Query: 217 APSPASHPSNTALPPASLPSKTAP---PPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
AP+P P PP + A P + S L A +
Sbjct: 697 APAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESV-EDASNSELQAVEQ-QATH 754
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P +P + ++T+ N +
Sbjct: 755 QPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-05
Identities = 29/125 (23%), Positives = 37/125 (29%), Gaps = 7/125 (5%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
LP + A A + AP PA T+ P+ AP + A P
Sbjct: 345 SYGQLPLELAVIEALLVPVPAPQPAK---PTAAAPSPVRPTPAPSTRPKAAAAANIPPKE 401
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P + P P P P + P P A + A P P T P P K
Sbjct: 402 PVRETATP---PPVP-PRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKAL 457
Query: 350 PPPAS 354
Sbjct: 458 IADGD 462
|
Length = 585 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-05
Identities = 26/121 (21%), Positives = 35/121 (28%), Gaps = 13/121 (10%)
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
P P T P A PS A S ++A S AP A+ P+ T
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSATQPAGT 423
Query: 327 APPPASHPSNTAP-PPASHSSKTAPPPASHPSNTALPPASHPS------NPAIPPASHPS 379
P + P P P S + + P P + S P A +
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKI-PVSKVSSLGPSTLRPIQEKAEQAT 482
Query: 380 N 380
Sbjct: 483 G 483
|
Length = 614 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-05
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 15/175 (8%)
Query: 175 SNAARPPASHPSNT--ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPA 232
SNAA+ A SN + P S+P P ++ P N S T P S+P N+ P +
Sbjct: 400 SNAAQSNAGF-SNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNT---PYSNPPNSNPPYS 455
Query: 233 SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSK 292
+LP P + LSN PP+S S A++ + A PA++ P ++
Sbjct: 456 NLPYSNTPYSNAPLSNA--PPSSAKDHHSAYHAAYQHRAANQPAAN------LPTANQPA 507
Query: 293 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSK 347
+ ++ P AS P +A P + + TA P P ++ K
Sbjct: 508 ANNFHGAAGNSVGNPFASRPFGSA-PYGGNAATTADPNGIAKREDHPEGGTNRQK 561
|
Length = 1560 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 8e-05
Identities = 28/159 (17%), Positives = 42/159 (26%), Gaps = 5/159 (3%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVN 120
P P P +AP + +P+ PPP + P +P
Sbjct: 364 PLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPP--ASAPQQAPAVPLPETTSQ 421
Query: 121 -MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+A L P S + P + A A A R
Sbjct: 422 LLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRP-APSALEKAPAKKEAYR 480
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAP 218
A++P + P + P H L +K A
Sbjct: 481 WKATNPVEVKKEPVATPK-ALKKALEHEKTPELAAKLAA 518
|
Length = 647 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-05
Identities = 26/107 (24%), Positives = 31/107 (28%), Gaps = 7/107 (6%)
Query: 283 APPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPP 340
P PA P A P A+ PS P PA PS A+ P P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRETATPPPVPPR 415
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
P + P A + A+P P P I
Sbjct: 416 PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-05
Identities = 18/92 (19%), Positives = 27/92 (29%), Gaps = 6/92 (6%)
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPS 368
+ T P PA+ T + TAP PA + A S + +
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQAN------VDTAA 221
Query: 369 NPAIPPASHPSNTAIPPASHPSNTAPPHASHP 400
PA + P A P + P +
Sbjct: 222 TPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-05
Identities = 23/110 (20%), Positives = 35/110 (31%), Gaps = 3/110 (2%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
S + APP A+ P+ PPPA+ P+ PA+ +++ AP H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
+ A P A A + + A P A
Sbjct: 103 ARAAAPAAPEAQAPA--APAERAAAENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-05
Identities = 38/214 (17%), Positives = 56/214 (26%), Gaps = 22/214 (10%)
Query: 65 PIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPP 124
P+ P P V+ A ++ V + + P V P
Sbjct: 846 PVVRPQDVQVEEQREAEEVQVQPVVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQ 905
Query: 125 PSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASH 184
P + P I AP V P +A ++ A P P
Sbjct: 906 PEEVVVVETTHPEVIAAP--VTEQPQVITESDVAVAQEVAEHAEPVVEPQ---------- 953
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
A+ + + A P A A + TA+ P P++
Sbjct: 954 DETADIEEAAETAEVVVAEPEVVAQPAAPV-VAEVAAEVETVTAVEPEVAPAQVPEATVE 1012
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
H TA P +P P P P S
Sbjct: 1013 HNHATA------PMTRAPAPEYVPE---APRHSD 1037
|
Length = 1068 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 906 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 960
+++G+G FG V K AVKVL++ + ++ + ++E +L + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L V + I G + HL +E L AR A A AL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARF-YAAEIASALGYLH--- 113
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +++RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ 171
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-04
Identities = 41/180 (22%), Positives = 52/180 (28%), Gaps = 28/180 (15%)
Query: 353 ASHPSNT-ALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
A HP+ P S A + A + PP PAS P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPP----------PASAP 407
Query: 412 SNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPV 471
PL + + + L A AT + P+ PV
Sbjct: 408 QQAPAVPLPETT--------SQLLAARQQLQRAQGATK-------AKKSEPAAASRARPV 452
Query: 472 --AQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPL 529
A +R AS R AP A AP + +PV P TP A TP L
Sbjct: 453 NSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPEL 512
|
Length = 647 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-04
Identities = 20/73 (27%), Positives = 31/73 (42%), Gaps = 2/73 (2%)
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPPPASHSSKTAPPPASHPSNTALPP 363
P + P+ A A+ S A PA+ + PPA+ + P PA+ + A P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 364 ASHPSNPAIPPAS 376
A + A PA+
Sbjct: 98 APPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-04
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
S + APP A+ P+ PPPA+ P+ PA+ + AP H+ +
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 357 SNTALPPASHPSNPAIPPA-----SHPSNTAIPPASHPSNTAPPHAS 398
+ A P A PA P + A A+ P P A+
Sbjct: 103 ARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (107), Expect = 1e-04
Identities = 50/157 (31%), Positives = 69/157 (43%), Gaps = 32/157 (20%)
Query: 150 APSLIPTTPLASPLSSKAFPP--ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
APS + A+P + A P A+PP+ AA PA + A+ A P++ A PPA
Sbjct: 210 APSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAP-PAKAAAPPAKAA 268
Query: 208 SNTALPSKTAPSPASHPSNTALPPA---SLPSKTAPPPASHLSNTAPPPASHPYKTSPLP 264
+ A + A+ P+ A PPA + P+K A PA
Sbjct: 269 APPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAK-------------------A 309
Query: 265 ASHPSKTAPPPASHPSNTAPPP---ASHPSKTAPPPA 298
A+ P+K A PPA A PP A+ P+K A PPA
Sbjct: 310 AAAPAKAAAPPA----KAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (107), Expect = 1e-04
Identities = 49/151 (32%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA---SHPSKTAPPPASHPSNTAP 306
A A+ K + A+ PS A+ P+ A PA + P+K A PA + A
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 307 PPASHPSNTAPPP--ASHPSNTAPPP---ASHPSNTAPPPASHSS---KTAPPP---ASH 355
A APP A+ P+ A PP A+ P+ A PPA ++ K A P A+
Sbjct: 253 AAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAA 312
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
P+ A PPA + PA A+ P+ A PPA
Sbjct: 313 PAKAAAPPAKAAAPPA-KAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (106), Expect = 1e-04
Identities = 44/132 (33%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPA--- 171
AP AP + P A+ P A PA + P A+P + A PPA
Sbjct: 221 APAKAAAAPAKAAAPPAKAAAAPAKAAAA-----PAKAAAPPAKAAAPPAKAAAPPAKAA 275
Query: 172 SPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
+PP+ AA PPA + A+ A+ P++ A PA A P+K A PA + A
Sbjct: 276 APPAKAAAPPAKAAAPPAKA-AAAPAKAAAAPAK---AAAAPAKAAAPPAKAAAPPA-KA 330
Query: 232 ASLPSKTAPPPA 243
A+ P+K A PPA
Sbjct: 331 ATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (106), Expect = 1e-04
Identities = 53/158 (33%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 160 ASPLSSKAFPPASPPSNAARPP--ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTA 217
A+P K+ A+P AA P A+ P+ A PA + A A A P+K A
Sbjct: 209 AAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAA 268
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP-- 275
PA A+ P+K A PPA A PPA A+ P+K A P
Sbjct: 269 APPAK--------AAAPPAKAAAPPA----KAAAPPAK--------AAAAPAKAAAAPAK 308
Query: 276 -ASHPSNTAPPPASHPSKTAPPP---ASHPSNTAPPPA 309
A+ P+ A PPA K A PP A+ P+ A PPA
Sbjct: 309 AAAAPAKAAAPPA----KAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 20/89 (22%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA--SHPSNTA 228
+ PA+ T + TAP PA P A+ APS A + A
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAV---VAPSQANVDTAATPA 224
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHP 257
+ P AP P + P +
Sbjct: 225 PAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
+T PA T P PA+ T + TAP PA P A S +N
Sbjct: 167 STTTDPA-----TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS-QANVDTA 220
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
+ A P + P T + S PA P
Sbjct: 221 ATPAPAAPATPDGAAPLPTD---QAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-04
Identities = 23/99 (23%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNT 315
P P T P A PS A + PS+++ +AP A+ P+
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSA-AAAASPSPSQSSAAAQP----SAPQSATQPA-G 422
Query: 316 APPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
PP S A P + P +TAP +
Sbjct: 423 TPPTVSVDP-PAAVPVN-PPSTAPQAVRPAQFKEEKKIP 459
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-04
Identities = 21/97 (21%), Positives = 27/97 (27%), Gaps = 6/97 (6%)
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNT 359
P P T P A PS A S ++A S AP A+ P+ T
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSATQPAGT 423
Query: 360 ALPPASHPSNPA-IPPASHPSNTAIPPASHPSNTAPP 395
+ P + P S P P
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-04
Identities = 40/171 (23%), Positives = 55/171 (32%), Gaps = 31/171 (18%)
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
A P+ A A KT P + A P A+ + A PA P A+ +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEA-----AAPAAAPVAQAAAAPAPAA----APAAAASA 413
Query: 391 NTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT-P 449
APP A+ P+ +A P P+A P AP + + P A AA
Sbjct: 414 PAAPP-----------AAAPPAPVAAPA---AAAPAAAPAAAPAAVALAPAPPAQAAPET 459
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQ 500
R +P + P P A A P G +Q
Sbjct: 460 VAIPVRVAPEPAVASAAPAPAAAP-------AAARLTPTEEGDVWHATVQQ 503
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 23/102 (22%), Positives = 34/102 (33%), Gaps = 3/102 (2%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPS---ITAPP 117
+ A P S + PA + P +A P + P A+ P+ + P
Sbjct: 392 APVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAP 451
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPL 159
P AP IP P +A P PA + + T
Sbjct: 452 PAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-04
Identities = 41/226 (18%), Positives = 50/226 (22%), Gaps = 19/226 (8%)
Query: 307 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
+ P + AS P S P P PP +
Sbjct: 86 SVGPDSDLSQKTSTFSPCQS-GYEASTDPEYIPDLQPDPSLWGTAPKPEPQ----PPQAP 140
Query: 367 PSNPAIPPASHPSNTAIP-PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
S P + + A P P L P A P P P
Sbjct: 141 ESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQP 200
Query: 426 SA---LPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREA 482
P P P AP+ P P P P PL
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLPAPSQAPAQ---PPLPPQLPQQPPPLQQPQF-------PG 250
Query: 483 PIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPP 528
+ P P PP +Q P PT P + P
Sbjct: 251 LSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPL 296
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-04
Identities = 28/161 (17%), Positives = 36/161 (22%), Gaps = 6/161 (3%)
Query: 51 FTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP 110
+ P LP P P P P + P P
Sbjct: 163 LQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGP--PEQPPGYPQPPQGHPEQVQPQQFL 220
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
P+ + P P P +P P P + P P P P PP
Sbjct: 221 PAPSQAPA--QPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPP 278
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
+ P+ P N PP P
Sbjct: 279 QNQPTPHPGLPQG--QNAPLPPPQQPQLLPLVQQPQGQQRG 317
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 901 NFDASRILGEGGFGLVYS------GVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 953
N + LG G FG V G D+ +VAVK+LK RE L +E+++LS L
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 954 -HHRNLVKLIGIC 965
H+N+V L+G C
Sbjct: 99 GQHKNIVNLLGAC 111
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 26/133 (19%), Positives = 39/133 (29%), Gaps = 5/133 (3%)
Query: 337 TAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPH 396
P P + +N+ ++PA S P +++ S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 397 ASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLP-----DAPAATPRG 451
+ S+ P+S S+ PP P PS PG A P+ P
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 452 NFHRHSPAIHPSM 464
I
Sbjct: 266 ATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 23/133 (17%), Positives = 35/133 (26%), Gaps = 13/133 (9%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLP 149
+ S + + S + PP + P P +SP + PP
Sbjct: 161 ADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPP------ 214
Query: 150 APSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSN 209
APS + S P P A PP + P+ P S +
Sbjct: 215 APSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVP--PLSTAKPT-----PPSASAT 267
Query: 210 TALPSKTAPSPAS 222
A +
Sbjct: 268 PAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 28/138 (20%), Positives = 34/138 (24%), Gaps = 6/138 (4%)
Query: 102 IPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLAS 161
P P+ N P ++ P V PS S
Sbjct: 149 NPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPS 208
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
S PPA + PP S S S P A PP S P+P
Sbjct: 209 DSSL---PPAPSSFQSDTPPPSPESP---TNPSPPPGPAAPPPPPVQQVPPLSTAKPTPP 262
Query: 222 SHPSNTALPPASLPSKTA 239
S + A A
Sbjct: 263 SASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-04
Identities = 51/302 (16%), Positives = 78/302 (25%), Gaps = 19/302 (6%)
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS---NTAPPPASHPSK 292
T P + + TA + P P+ + P + P + P+ P P +
Sbjct: 315 PITEPVAVAAAATTATQSWAAP--VEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPV 372
Query: 293 TAPPPASHP--SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
AP P +P S A P + P AP PA P
Sbjct: 373 IAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQP 432
Query: 351 PPASHPSNTALPPASHPSNPAIP----PASHPSNTAIPP-ASHPSNTAPPHASHPSNTAL 405
A P A T P A P P
Sbjct: 433 YYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVVEP 492
Query: 406 TPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMP 465
P + A PPL+ + K + ++ P P + I S+
Sbjct: 493 EPVVEETKPARPPLY---YFEEVEEKRAREREQLAAWYQPIPEPV----KEPEPIKSSLK 545
Query: 466 GPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPS 525
P A+ +P+A + G + + + G P + P
Sbjct: 546 APSVAAVPPVEAAAAVSPLASGVKKATLATGAAATVAAPVFSLANSGGPRPQVKEGIGPQ 605
Query: 526 TP 527
P
Sbjct: 606 LP 607
|
Length = 1355 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 60/262 (22%), Positives = 89/262 (33%), Gaps = 19/262 (7%)
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
TAP + P L+ P PP + P P+ T SP + P P
Sbjct: 310 TAP----LTPMEELLAKIPSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEE--PPQP 363
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ RP + + + P + P T PP +S S+ ++ + P+ +
Sbjct: 364 KAVVPRPLSPYTAYEDLKPPTSPIPT-PPSSSPASSKSVDAVAKPAEPDVVPSPGSASNV 422
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
+ A A +P K P + PS TAP S PS ++ T
Sbjct: 423 PEVEPAQVEAKKTRPLSPYARYEDLK----PPTSPSPTAPTGVS-PSVSSTSSVPAVPDT 477
Query: 294 APPPASHPSNTAPPPASHPSNTAP-----PPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
AP A+ + PP P + P + PS AP PS+T +
Sbjct: 478 APATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSST--NEVVKVGNS 535
Query: 349 APPPASHPSNTALPPASHPSNP 370
APP A P P +P
Sbjct: 536 APPTALADEQHHAQPKPRPLSP 557
|
Length = 576 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-04
Identities = 38/208 (18%), Positives = 53/208 (25%), Gaps = 20/208 (9%)
Query: 102 IPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLAS 161
I +P A P+ PP P L P P + P P A
Sbjct: 86 ITVDPSAGEPA-PPPPHARRTSEPEL-PRPGRRPYEGYGGPRADDRPPGLPRQDQLPTAR 143
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTAR----PPASHPSRTAPPPASHPSNTALPSKTA 217
P + A+ P R + R P A + S + P P
Sbjct: 144 P-AYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAG 200
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNT--APPPASHPYKTSPLPASHPSKTAPPP 275
P P ++ PP A H ++ P P P
Sbjct: 201 RPEYDQRR----RDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPI 256
Query: 276 ASHPSNTAP-PPASHPSKTAPPPASHPS 302
+AP P A+ P+ P
Sbjct: 257 RP----SAPGPLAAQPAPAPGPGEPTAR 280
|
Length = 617 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 52/281 (18%), Positives = 74/281 (26%), Gaps = 8/281 (2%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
A + S AP + P P PA + S
Sbjct: 34 AQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAP 93
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS---HPSNT 337
+ P+ P + P+ P PS PPPA P P P
Sbjct: 94 PSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQY 153
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
PP + PPP + +P P S+P N +P + P
Sbjct: 154 QSPPQQPQYQQNPPPQ--AQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQ--PPYSG 209
Query: 398 SHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHS 457
+ PS P + P P + P SQ + +GN +
Sbjct: 210 APPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVA 269
Query: 458 PAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNS 498
P A + P A P++ P G S
Sbjct: 270 SY-APQGSSQSYSTAYPSLPAATVLPQALPMSSAPMSGGGS 309
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-04
Identities = 23/92 (25%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 172 SPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
P S AA A+ + A + P A P A P+ AP+ P+ A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAP---APPAAAAPAAPPKPAAAAAAA 93
Query: 232 ASLPSKTAPPPASHLSNTAPPPASHPYKTSPL 263
A+ + A A AP A+ + +PL
Sbjct: 94 AAPAAPPAAAAA-----AAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-04
Identities = 23/104 (22%), Positives = 33/104 (31%), Gaps = 8/104 (7%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P+ A A P AP S P+ A ++ AP H L ++ A P A
Sbjct: 54 PAAAAPAAAQPPPAAAPAAVSRPA--APAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
AP + + A A+ P P A+
Sbjct: 112 --EAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/99 (28%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
L AP PA P A+ PS P PA A A+ P K + P
Sbjct: 358 ALLVPVPAPQPAK-------PTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPP 410
Query: 270 KTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
P P + P P A ++ A P P T P P
Sbjct: 411 PVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (105), Expect = 2e-04
Identities = 47/142 (33%), Positives = 61/142 (42%), Gaps = 26/142 (18%)
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPA---SPPSNAARPPA---SHPSNTARPPAS 194
AP PA + P A+ + A PA +PP+ AA PPA + P+ A PPA
Sbjct: 221 APAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAK 280
Query: 195 HPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPA 254
+ A A A P+K A +PA A+ P+K A PPA A PPA
Sbjct: 281 AAAPPAKAAAPPAKAAAAPAKAAAAPAK--------AAAAPAKAAAPPA----KAAAPPA 328
Query: 255 SHPYKTSPLPASHPSKTAPPPA 276
A+ P+K A PPA
Sbjct: 329 K--------AATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 20/87 (22%), Positives = 26/87 (29%), Gaps = 6/87 (6%)
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
T P PA+ T + TAP PA P A S + AP
Sbjct: 173 ATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------QANVDTAATPAPA 226
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHP 334
+ P AP P + P +
Sbjct: 227 APATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/115 (24%), Positives = 34/115 (29%), Gaps = 6/115 (5%)
Query: 64 SPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAP 123
S P P P+ +P A +A +P S P A A P P
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAA-SPSPSQSSAAAQPSAPQS---ATQPAGTPP 425
Query: 124 PPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAA 178
S+ P V PP TAP V S +SS P A
Sbjct: 426 TVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV--SKVSSLGPSTLRPIQEKA 478
|
Length = 614 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 19/79 (24%), Positives = 25/79 (31%), Gaps = 4/79 (5%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP----A 232
A P S P P P + P PSPAS P+ PP A
Sbjct: 381 APSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARSA 440
Query: 233 SLPSKTAPPPASHLSNTAP 251
LP ++++ P
Sbjct: 441 PLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-04
Identities = 27/93 (29%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 225 SNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
S T +PP P + AP P L T H ++ +P P P+ P N A
Sbjct: 168 SGTYIPPN--PPREAPAPG--LPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQ 223
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
P P + PA P T PA P T
Sbjct: 224 QPQQQPQQQPVQPAQQP--TPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 911 GGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966
G FG VY G + +K+ AVKV+K+ +++ + AE + L+ +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 967 EEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
LV E + G V+S LH D+E A +K A AL YLH
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALALDYLHRHG--- 124
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057
+IHRD K N+L+ ++ K++DFGL++ ++ E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 966
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 1021
R + L+ + + H + A +++ G ++L Y +H +
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 1022 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 1075
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1076 YAMTGHLLVKS-DVYSYGVVILELLS 1100
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 44/292 (15%), Positives = 75/292 (25%), Gaps = 48/292 (16%)
Query: 340 PPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS---NTAP-P 395
P + + T P + + TA + P P + P + P+ P P
Sbjct: 309 PLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVA--SVDVPPAQPTVAWQPVPGP 366
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHR 455
P A P +P P + P + PV A + ++
Sbjct: 367 QTGEPV-IAPAPEGYPQQ---SQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYA 422
Query: 456 HSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPT 515
+P P P Q + +A ++ + P
Sbjct: 423 PAPEQPAQQPYYAPAPEQPVAGNAWQAE----------EQQSTFAPQSTYQTEQTYQQPA 472
Query: 516 ASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRH 575
A P +PV + P P P++ P+ + R R
Sbjct: 473 AQEPLYQQP-------------QPVEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRARE 519
Query: 576 -------YGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPP 620
Y P P P+ P + +PS + + P
Sbjct: 520 REQLAAWYQPIP--------EPVKEPEPIKSSLKAPSVAAVPPVEAAAAVSP 563
|
Length = 1355 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 53/254 (20%), Positives = 79/254 (31%), Gaps = 22/254 (8%)
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
PS+ PP S ++ P + P P S P PP P +
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKP--VTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLK 381
Query: 350 PPPASHP-SNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPA 408
PP + P ++ P +S + PA + AS+ P L+P
Sbjct: 382 PPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPY 441
Query: 409 SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPA--------- 459
+ ++ PP P P+ + + S ++PD AT + PA
Sbjct: 442 ARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYA 501
Query: 460 -----IHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIP---- 510
P+ P P PV + +S E AP P RP+ P
Sbjct: 502 VYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMY 561
Query: 511 -GGTPTASPDPDVP 523
P SP P
Sbjct: 562 EDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 57/270 (21%), Positives = 82/270 (30%), Gaps = 10/270 (3%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
AP + + P + + P PA +P S P P PS P V
Sbjct: 52 APEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAP--PSHQYPSQLPPQQVQS 109
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPP 181
P P PP PP A P P P + P P PP
Sbjct: 110 VPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQ--PQPPPQVPQQQQYQSPPQQPQYQQNPP 167
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S + +P + P S+P N LPS A P P + A P P
Sbjct: 168 PQAQS-APQVSGLYPEESPYQPQSYPPNEPLPSSMAMQP---PYSGAPPSQQFYGPPQPS 223
Query: 242 PASHLSNTAPPPASHPYKTSPLPA--SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPAS 299
P + P + P P P+ + PP S ++ + + + +
Sbjct: 224 PYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTA 283
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPP 329
+PS A + P S + +P
Sbjct: 284 YPSLPAATVLPQALPMSSAPMSGGGSGSPQ 313
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-04
Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 4/76 (5%)
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
S AP+ A+ + A + P A PPA+ P PA+ + A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAP----APAPPAAAAPAAPPKPAAAAAAAA 94
Query: 273 PPPASHPSNTAPPPAS 288
P A + A PA+
Sbjct: 95 APAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.8 bits (105), Expect = 3e-04
Identities = 58/344 (16%), Positives = 89/344 (25%), Gaps = 28/344 (8%)
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
S TA P + P ++P + +++ +
Sbjct: 423 HKAPDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTL 482
Query: 384 PPASHP-SNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLP 442
P + P S T + S T + ++ P S +PI +
Sbjct: 483 PEDTSPTSRTTSATPNATSPTPAVTTPNATS--------PTTQKTSDTPNATSPTPIVIG 534
Query: 443 DAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAP--IAEPIAPGPFPPGNSRQ 500
AT P PV AP + + G G+S
Sbjct: 535 VTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPT 594
Query: 501 KSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEP------SYDIPMPPPVN 554
P TP ++ P T G+ + + S P P P
Sbjct: 595 SQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGT 654
Query: 555 HSPSKGPVVPP-SFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQT 613
S GP S P G P N+ SPS P + P+ + T +
Sbjct: 655 TSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPS-----APSGQKTAVPTVTSTGGKANS 709
Query: 614 ELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSP 657
K + + A P N T T PP +
Sbjct: 710 TT-----KETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTS 748
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-04
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 7/105 (6%)
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPA 276
AP A+ P+ PPA+ P+ + P A + AP H +
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKR--LTAQREQLVARAAAP 108
Query: 277 SHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
+ P AP + + A A+ P P A+
Sbjct: 109 AAPEAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-04
Identities = 26/93 (27%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS--HPSNTALP 362
P PA P A P A+ PS P PA PS A+ + P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRETATPPPVPPR 415
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
P + P A + AIP P T P
Sbjct: 416 PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPA 448
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-04
Identities = 22/80 (27%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 263 LPASHPSKTAPPPASHPSN--TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
AS+ +KT PPP P PP + PP P TA +S+ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 321 SHPSNTAPPPASHPSNTAPP 340
S P P P+ + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-04
Identities = 20/83 (24%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
S +A A P P P PP + PP P TA +S+ P
Sbjct: 514 SGSASNTAKTPPPPQKSPP--PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 329 PPASHPSNTAPPPASHSSKTAPP 351
+S P P +K + P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-04
Identities = 16/81 (19%), Positives = 24/81 (29%), Gaps = 1/81 (1%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ T P PA+ T P + P+ P + A +N P+
Sbjct: 168 TTTDPATTPAPAAPVD-TTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPA 226
Query: 336 NTAPPPASHSSKTAPPPASHP 356
A P + T S P
Sbjct: 227 APATPDGAAPLPTDQAGVSTP 247
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-04
Identities = 24/104 (23%), Positives = 30/104 (28%), Gaps = 9/104 (8%)
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
P P T P A PS A S ++A S AP A+
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSAT-QPAG 422
Query: 349 APPPASH--PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
PP S P+ + P S P IP + S
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKK-IPVSKVSS 465
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 22/107 (20%), Positives = 35/107 (32%), Gaps = 8/107 (7%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
P + P + P+ PS A + + PS ++ +AP A+ + T
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPS-AAAAASPSPSQSSAAAQP----SAPQSATQPAGTP 424
Query: 251 PPPASHPYKTSPL-PASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
P + P P+ P S + P P S S P
Sbjct: 425 PTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEK--KIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 47/227 (20%), Positives = 72/227 (31%), Gaps = 24/227 (10%)
Query: 150 APSLIPTTPLASPLSSKAFPPAS-------PPSNAARPPASHPSNTARPPASHPSRTAPP 202
A ++I T L SP + A + P + A+ P S A P +TA P
Sbjct: 368 ANAVIENTELQSPSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMPSEG---KTAGP 424
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
++ +N P + AP A TA A +K+ S PP + K
Sbjct: 425 VSNQENNDVPPWEDAPDEAQ----TAAGTAQTSAKSI----QTASEAETPPENQVSKNKA 476
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
+ + P+ +P P + ++T A P N PP
Sbjct: 477 ADNETDAPLSEVPSENPIQATPNDEAVETETFAHEAPAE---PFYGYGFPDNDCPP---E 530
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
PPP + A + + A +NT P S
Sbjct: 531 DGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPPEFST 577
|
Length = 709 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 29/119 (24%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 130 TTPVASPPPITA-------PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPA 182
T PVA+ P +A P +P+P++IP++ ++ + S P
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 183 SHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
T PA+ P P P S + S A+ P+ T+LP A P+ P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPT-TSLPAA--PASNIPV 413
|
Length = 421 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.4 bits (104), Expect = 4e-04
Identities = 45/242 (18%), Positives = 76/242 (31%), Gaps = 18/242 (7%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
A SP S + SA PT+ PS + P +
Sbjct: 552 ATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRS- 610
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPP 181
S T + S P + P+ SP P S + P
Sbjct: 611 ---NSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPG-----PGPGTTSQVSGPG 662
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S S + P H + P P N PS + + P+ T+ + +
Sbjct: 663 NS--STSRYPGEVHVTEGMPNP-----NATSPSAPSGQKTAVPTVTSTGGKANSTTKETS 715
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHP--SNTAPPPASHPSKTAPPPAS 299
++ +++T+P ++T+P A+ + P + T+PP + + PP
Sbjct: 716 GSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVPPTQ 775
Query: 300 HP 301
HP
Sbjct: 776 HP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-04
Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 2/80 (2%)
Query: 285 PPASHPSKTAPPPASHPSN--TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
AS+ +KT PPP P PP + PP P TA +S+ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 343 SHSSKTAPPPASHPSNTALP 362
S P P+ + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 946 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------VDKESAPLGW 999
E+ L RL+H N++K IEE R + + L+ D + PL
Sbjct: 213 EILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 1000 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059
R I A+ Y+H ++IHRD K NI L D + DFG A ++E
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKERE 322
Query: 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100
+GT +PE +D++S G+++L++LS
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.4 bits (104), Expect = 5e-04
Identities = 67/356 (18%), Positives = 118/356 (33%), Gaps = 19/356 (5%)
Query: 196 PSRTAPPPASHPSNTALPSKTA--PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
P T + P KT P+ S P + P S T+ P S+T P
Sbjct: 426 PDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPED 485
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
S +T+ + S T + ++ S P T +
Sbjct: 486 TSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTG 545
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
T+ P A+ P T P ++ + A +A H T P S P IP
Sbjct: 546 TTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQH--GTGSSPTS--QQPGIP 601
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSN----TALTPAS----HPSNIAPPPLFVPVLP 425
+SH + P ++ S T ++HP+ T TP+ H S ++P P
Sbjct: 602 SSSHST----PRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQ 657
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIA 485
+ PG + S+ P + +P+ + + K N++ +E +
Sbjct: 658 VSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTKETSGS 717
Query: 486 EPIAPG-PFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPV 540
+A P + + +P + ++ P ++PP++ V P
Sbjct: 718 TLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVPP 773
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 20/104 (19%), Positives = 28/104 (26%), Gaps = 17/104 (16%)
Query: 209 NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHP 268
+T T P+PA+ T + TAP PA A S
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------------- 213
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ AP + P AP P + P +
Sbjct: 214 ----QANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 22/86 (25%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
T P PA+ + T + T+P PA P + A PS A+ P AP
Sbjct: 174 TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA---PSQANVDTAATP---APAA 227
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHP 323
+ P AP P + P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-04
Identities = 32/142 (22%), Positives = 60/142 (42%), Gaps = 13/142 (9%)
Query: 219 SPASHPSNTALPPASLPSKTAP---PPASHLSNTAPPPASHPYKTSPL---PASHPSKTA 272
+ S+P N+ + P+ P PP S+ + PP ++ PY P P S+ +
Sbjct: 412 AGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPLSN 471
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
PP+S + + A++ + A PA++ P ++ + ++ P AS
Sbjct: 472 APPSSAKDHHSAYHAAYQHRAANQPAANL------PTANQPAANNFHGAAGNSVGNPFAS 525
Query: 333 HPSNTAPPPASHSSKTAPPPAS 354
P +A P +++ TA P
Sbjct: 526 RPFGSA-PYGGNAATTADPNGI 546
|
Length = 1560 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-04
Identities = 41/169 (24%), Positives = 55/169 (32%), Gaps = 13/169 (7%)
Query: 240 PPPASHLSNTAPPPA--SHP-YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
P A S T P SHP Y + P S P+ A+ + T
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
P PP PS + P S S +T H+ + PPA
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTT--------SQDQSTTGDGQEHTQRRKTPPA--T 277
Query: 357 SNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTAL 405
SN P ++ P T P A+ S ++PPH+S P A
Sbjct: 278 SNRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGVQAN 326
|
Length = 408 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-04
Identities = 32/205 (15%), Positives = 49/205 (23%), Gaps = 34/205 (16%)
Query: 179 RPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKT 238
R + + PP S S + PS + N SL
Sbjct: 437 RQEKQRAKARKKLANKTSTVMEPPYGSTES----SVPSTPSTRRNDRNITSNTPSLKRT- 491
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKT---APPPASHPSNTAPPPASHPSK-TA 294
P S+ S + P + P AS SK
Sbjct: 492 ---PNLTKSSL---------SQEASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNL 539
Query: 295 PPPASHP--SNTAPPPAS----HPSNTAPP--PASHPSNTAPPPASHPSNTAPPPASHSS 346
++ S+ P S P ++ P AS P+++
Sbjct: 540 IRSGANGNASSDLSSPGSINSKSPEHSVPLVRVFDIHLR-----ASTTKGRHSTPSTNEK 594
Query: 347 KTAPPPASHPSNTALPPASHPSNPA 371
K S S A+ P +
Sbjct: 595 KKRLLKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 26/180 (14%)
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALA 1014
N+V L + E + LV + G + SH+ E W A + +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
LH + ++ RD +NILL+ +++ F D + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAW----ARPLLT 1125
E D +S G ++ ELL+G+ V+ P G N+ W AR LL
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-04
Identities = 39/191 (20%), Positives = 54/191 (28%), Gaps = 3/191 (1%)
Query: 142 PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAP 201
P LV A +L P + + PP + RP S A AS +
Sbjct: 761 PSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRK 820
Query: 202 PPASHPSNTALPS--KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH-PY 258
+ P + S P A+ P +S A + N P P
Sbjct: 821 SRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPR 880
Query: 259 KTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP 318
A + A PPA P+ P PP P +T P
Sbjct: 881 ARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPAP 940
Query: 319 PASHPSNTAPP 329
A+ + PP
Sbjct: 941 SAAALAAYCPP 951
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-04
Identities = 28/117 (23%), Positives = 39/117 (33%), Gaps = 4/117 (3%)
Query: 130 TTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTA 189
P A+ P A + P A ++ PA P+ A PP+ + A
Sbjct: 392 GAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAP-QPAPAPAPAPAPPSPAGNAPA 450
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTA---PSPASHPSNTALPPASLPSKTAPPPA 243
S P AP P+ A P TA P+P + P+ A P A
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 6e-04
Identities = 65/355 (18%), Positives = 96/355 (27%), Gaps = 21/355 (5%)
Query: 214 SKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK-TSPLPASHPSKTA 272
K + S L TA P L + P TS P S T
Sbjct: 423 HKAPDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTL 482
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
P S S T + S T P+ T+P + A+
Sbjct: 483 PEDTSPTSRTTSATPNATSPTPAVTT--PNATSPTTQKTSDTPNATSPTPIVIGVTTTAT 540
Query: 333 HPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNT 392
P + +S + + S PS + T P S
Sbjct: 541 SPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTS--QQP 598
Query: 393 APPHASHP-------SNTALTPASHPSNIAPPPLFVPVLPS------ALPGKAPVSQSPI 439
P +SH S T L ++HP+ P +PS PG P + S +
Sbjct: 599 GIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQV 658
Query: 440 SLPDAPAATPR-GNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNS 498
S P + + G H +P+ P P QK + + + G++
Sbjct: 659 SGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTKETSGST 718
Query: 499 RQKSPVARPIIPGGTPTASPDPDVPPSTPP--LSVDGKRVGKPVAEPSYDIPMPP 551
S T P + L PV +P+PP
Sbjct: 719 LMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVPP 773
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-04
Identities = 103/542 (19%), Positives = 149/542 (27%), Gaps = 42/542 (7%)
Query: 138 PITAPPLVNVLPAPSLIPTT-PLASPLSSKAFPPASPPSNAARPPASHPSNTARP-PASH 195
P+ P++ V P P T P +P + S + S RP P+
Sbjct: 399 PVQQRPVMFVSRVPWRKPRTLPWPTPKTHPVKRTLVKTSGRSDEAEQAQSTPERPGPSDQ 458
Query: 196 PSRTAPPPASHPS--NTALPSKTAPSPASHPSNTALPPASLPSKT-------------AP 240
PS P P T + + SP + A PP+
Sbjct: 459 PSVPVEPAHLTPVEHTTVILHQPPQSPPTVAIKPAPPPSRRRRGACVVYDDDIIEVIDVE 518
Query: 241 PPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH 300
S T P + + K A PP PS+ PP AS P PP++
Sbjct: 519 TTEEEESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRGPPKASPPV--MAPPSTG 576
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT---APPPASHSSKTAPPPASHPS 357
P A P PP++ P A P++ PP+S AP
Sbjct: 577 PRVMATPSTGPRD--MAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFL 634
Query: 358 NTALPPASHPSNP----AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSN 413
L S P + S P+S PS +
Sbjct: 635 RERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVD 694
Query: 414 IAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQ 473
S++ P+S + P + H P P +
Sbjct: 695 AGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDPLDLSLHPDQAP----PPSHQAPYSG 750
Query: 474 KRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDG 533
++AP P P + P A+ G ++ P P L
Sbjct: 751 HEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQAQ----GVQVSSYPGYAGP---WGLRAQH 803
Query: 534 KRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPT 593
R A S P + P +PP + ++ + P
Sbjct: 804 PRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSAGHGQDQVSQFPHLQSETGPPRL 863
Query: 594 PVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPI--RAFPPPPPNADCSTTICTEPYTN 651
+S+VP P +S P +P PI R PPP P D C T
Sbjct: 864 QLSQVPQLPYSQTLVSSSAPSW-SSPQPRAPIRPIPTRFPPPPMPLQDSMAVGCDSSGTA 922
Query: 652 TP 653
P
Sbjct: 923 CP 924
|
Length = 1000 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-04
Identities = 48/232 (20%), Positives = 64/232 (27%), Gaps = 18/232 (7%)
Query: 167 AFPPASPPS---NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
AF P + S NA S +A+ + P P P +TA + A
Sbjct: 357 AFAPLAAASCDANAVIENTELQSPSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMP 416
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
P S PP AP A T+ A TA + P N
Sbjct: 417 SEGKTAGPVSNQENNDVPPWE----DAPDEAQTAAGTAQTSAKSIQ-TASEAETPPENQV 471
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA----SHPSNTAP 339
+ ++T P + PS P N ++ AP P N P
Sbjct: 472 SKNKAADNETDAPLSEVPS---ENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCP 528
Query: 340 PPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
P PPP + A A +NT P S
Sbjct: 529 P---EDGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPPEFST 577
|
Length = 709 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-04
Identities = 64/308 (20%), Positives = 89/308 (28%), Gaps = 17/308 (5%)
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLV--NVLPAPSLIPTTPLASPLSSKAF 168
PS++ PV+ P PS P SP PL L + + L S +
Sbjct: 151 PSLSNSRPVHELPKPSTPVLQPRRSPRKQLHRPLSLPRSLHLHNSRQHSSLHPRRSPRRQ 210
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPP-ASHPSNTALPSKTAPSPASHPSNT 227
+P HP + +P P P P H + + P S P +
Sbjct: 211 LQPAPRRPLLAENQLHPLPSPQPVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSP 270
Query: 228 ALPPASLP-----SKTAPPPASHLSNTAPPPASHPYKTSPLPAS-HPSKTAPPP------ 275
P++ + HL P P H S+ P
Sbjct: 271 LPRPSTRRGLLPNPRLPRASRGHLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRI 330
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH--PSNTAPPPASHPSNTAPPPASH 333
+ H P S PP PP TA P
Sbjct: 331 RKNSLQQTRARLGHSKSLGQSPNLRSSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVR 390
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
S + P P S+ + AS + LPP+ P P+ PS P + P +
Sbjct: 391 HSPSIPLPHPPSALPSHVGASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPAS 450
Query: 394 PPHASHPS 401
PP S PS
Sbjct: 451 PPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 45/249 (18%), Positives = 78/249 (31%), Gaps = 13/249 (5%)
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
VN A PP+ P +P + P + P+ + P PP
Sbjct: 66 LQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPP 125
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL- 234
+ +PP A+ P + + P + P + P + P S
Sbjct: 126 SQPQPP------PAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGL 179
Query: 235 -PSKTAPPPASHLSNTAPPPA---SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P ++ P S+ N P + PY +P P P + P + P
Sbjct: 180 YPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFP 239
Query: 291 SKTAPPPA--SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
S PPP+ + PP S ++ + + ++ ++PS A +
Sbjct: 240 SGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPM 299
Query: 349 APPPASHPS 357
+ P S
Sbjct: 300 SSAPMSGGG 308
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-04
Identities = 27/121 (22%), Positives = 39/121 (32%), Gaps = 4/121 (3%)
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP 378
S + APP A+ P+ PPPA + PA+ + A H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPA-AAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 379 SNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSP 438
+ A P A A P + A + + AP P V A A ++
Sbjct: 103 ARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRP---RVPADAAAAVADAVKAR 159
Query: 439 I 439
I
Sbjct: 160 I 160
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-04
Identities = 27/104 (25%), Positives = 36/104 (34%), Gaps = 9/104 (8%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
P PA P A P A+ PS P PA PS A+ P + T PP
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRE--TATPPPVP 413
Query: 354 SHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
P +P S P + A+ P + P + P+
Sbjct: 414 PRPVAPPVPHTP-ESAPKLTRAAIPVDEK-PKYTPPAPPKEEEK 455
|
Length = 585 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-04
Identities = 39/140 (27%), Positives = 51/140 (36%), Gaps = 14/140 (10%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
P+ + PS S + A PAS + T P P + P A ++A P
Sbjct: 367 PVESLRPSGGGASAPS--GSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATP 424
Query: 322 HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNT 381
PS A P P + APP S P P + +P A P S S +
Sbjct: 425 APS--AAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGA---------PDSVASAS 473
Query: 382 AIPPA-SHPSNTAPPHASHP 400
PP PS+TA S P
Sbjct: 474 DAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 8e-04
Identities = 29/120 (24%), Positives = 43/120 (35%), Gaps = 5/120 (4%)
Query: 96 APPPSLIPTNPVASPPSITAPP----PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAP 151
A P+ + A+ P+ P P A P P +P P APP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPA 450
Query: 152 SLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
P+ P A+ S++ P + PA P P A+ P+ A P A ++ A
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAA-PAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 8e-04
Identities = 22/89 (24%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP 378
P S + TA A+ + +AP A + A P + PPA+ PA+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA-------PPAAAAPAAPPKPAAAA 90
Query: 379 SNTAIPPASHPSNTAPPHASHPSNTALTP 407
+ A P A + A A+ +TP
Sbjct: 91 AAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-04
Identities = 20/101 (19%), Positives = 31/101 (30%), Gaps = 11/101 (10%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
S P P + P+ P A+ ++ +P +S +AP A+
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAA----------AQPSAPQSATQ 419
Query: 279 PSNTAPPPASHPSKTAP-PPASHPSNTAPPPASHPSNTAPP 318
P+ T P + P P P S P P
Sbjct: 420 PAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-04
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
A PAS T P P + + P A ++A P PS A P P + APP
Sbjct: 386 AEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPS--AAPSPRVPWDDAPP-- 441
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
APP + P AP P + S+ APP PS+TA
Sbjct: 442 ------APPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTA 486
|
Length = 624 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-04
Identities = 37/139 (26%), Positives = 48/139 (34%), Gaps = 6/139 (4%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S ++A P +S PP S P NT+ + S NT A+
Sbjct: 274 YSFSRSSAYPNSSPRQAL-PPSISLPQNTSTSGSLHSAQTSRRPNTTFDKAASSGTKDSL 332
Query: 242 -PASHLSNTAPPPASHPYKTSPLPA--SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
S L A PP+S L SH S AP P S PS T+PPP
Sbjct: 333 WSPSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTG-SGKGEPASESTPS-TSPPPP 390
Query: 299 SHPSNTAPPPASHPSNTAP 317
+ + S +AP
Sbjct: 391 GLADDIVRAIFATSSRSAP 409
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-04
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY--AM-- 1078
+HRD K N+LL+ + +++DFG + + S +GT Y++PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 1079 -TGHLLVKSDVYSYGVVILELLSGRKP 1104
G + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-04
Identities = 45/214 (21%), Positives = 66/214 (30%), Gaps = 19/214 (8%)
Query: 128 IPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSN 187
P T A P P P P + + + A+ + A+ AA
Sbjct: 62 TPATAAA-PAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVASAAEDMIAAM-------- 112
Query: 188 TARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
R P S P PA+ P A + PSPA+ A + P + A
Sbjct: 113 ALRQPVSVP---RQAPAAAPVRAA----SIPSPAAQALAHAAAVRTAPRQEHALSAVPEQ 165
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
A + P +P+ A + AP PA + A + + A P
Sbjct: 166 LFADFLTTAPVPRAPVQAPVVAAPAPVPAIAAALAAHAAYAQDDDEQLDDDGFDLDDALP 225
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
P A P + AP + + AP P
Sbjct: 226 QILPP---AALPPIVVAPAAPAALAAVAAAAPAP 256
|
Length = 559 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 9e-04
Identities = 17/88 (19%), Positives = 25/88 (28%), Gaps = 5/88 (5%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
S + ++ + T P S P P A A+ + P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSA-----PKTKQAATTPSPPPAKASPPI 415
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPP 363
P S A+ P + L
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSLNLEE 443
|
Length = 620 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 0.001
Identities = 31/121 (25%), Positives = 42/121 (34%), Gaps = 5/121 (4%)
Query: 80 PSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPI 139
P+ + + A +AP P + P A P+ P P A P
Sbjct: 394 PAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQP---APAPAPAPAPPSPAGNAPA 450
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
P APS P A+ A P +PP AA PA+ P+ A P A +
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPP--AAPAPAAAPAAPAAPAAPAGADD 508
Query: 200 A 200
A
Sbjct: 509 A 509
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 26/125 (20%), Positives = 40/125 (32%), Gaps = 4/125 (3%)
Query: 63 PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMA 122
P E + N + P A A + PPS P P P P + +
Sbjct: 152 PPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSS 211
Query: 123 PPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPA 182
PP+ P++ + PP + N P P P P P+ + P+ +
Sbjct: 212 LPPA--PSSFQSDTPPPSPESPTNPSPPPG--PAAPPPPPVQQVPPLSTAKPTPPSASAT 267
Query: 183 SHPSN 187
P
Sbjct: 268 PAPIG 272
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 24/134 (17%), Positives = 35/134 (26%), Gaps = 5/134 (3%)
Query: 508 IIPGGTPTASP---DPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVP 564
+ G P P + D + D G+ S PP SP
Sbjct: 142 LKEGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPS--SSPGVPSFPS 199
Query: 565 PSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSP 624
P P+S PP +S P P+ P + + P
Sbjct: 200 PPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKP 259
Query: 625 SEPIRAFPPPPPNA 638
+ P + P P
Sbjct: 260 TPPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 38/201 (18%), Positives = 51/201 (25%), Gaps = 10/201 (4%)
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHP 400
S+ PP H T+ P P P PP + P + P
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLP--TARP 144
Query: 401 SNTALTPASHPSNIAPPPLFVPV------LPSALPGKAPVSQSPISLPDA-PAATPRGNF 453
+ A P P P +P S +P D P R +
Sbjct: 145 AYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEY 204
Query: 454 HRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGT 513
+ P P + + GP PP RP P G
Sbjct: 205 DQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP-GP 263
Query: 514 PTASPDPDVPPSTPPLSVDGK 534
A P P P P ++ K
Sbjct: 264 LAAQPAPAPGPGEPTARLNPK 284
|
Length = 617 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 0.001
Identities = 17/86 (19%), Positives = 31/86 (36%)
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
+ + TA + A+ + +A A A P + + AP P + A+ +
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 270 KTAPPPASHPSNTAPPPASHPSKTAP 295
A A+ P+ A P + A
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 11/93 (11%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
P S + TA A+ + +A + A + P PPA+ P PA+ + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAP--APAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P A P + + AP A+ P
Sbjct: 96 PAA---------PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 23/110 (20%), Positives = 33/110 (30%), Gaps = 6/110 (5%)
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPA--SHPYKT 260
S + A P+ AP+ A P A S P+ A PA L A
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVA 103
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
+ P AP + + + A A+ P P A+
Sbjct: 104 RAAAPAAPEAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 20/103 (19%), Positives = 31/103 (30%), Gaps = 6/103 (5%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
PPA+ A PP + PA+ + +P H + + A P A
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
AP + + A A+ P P A+
Sbjct: 113 A--QAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
AS+ + T PPP P AP P P A P+ PPP + +++ P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTP---PLPQPTATAPPPTPPPPPPTATQASSNAPAQI- 570
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNT 359
P++++PPP T P
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 21/82 (25%), Positives = 28/82 (34%), Gaps = 1/82 (1%)
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
L S ++ + T P S P P A A P+ P A PP
Sbjct: 359 LLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSP-PPAKASPPIPV 417
Query: 323 PSNTAPPPASHPSNTAPPPASH 344
P+ P + P+N A P S
Sbjct: 418 PAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 47/230 (20%), Positives = 64/230 (27%), Gaps = 15/230 (6%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
PV P I P P++ P + P PL L+P L
Sbjct: 233 PVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLLPNPRLPRASRG 292
Query: 166 KAFPPASPPSNAA-----RPPASHPSNTARPP------ASHPSRTAPPPASHPSNTALPS 214
PP S RP H S P + + H +
Sbjct: 293 HLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRIRKNSLQQTRARLGHSKSLGQSP 352
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
S P+ L +P TA P + PLP + +
Sbjct: 353 NLRSSQLPPPTKRRLRLLPVPPPKVQALPL----TALAPLVRHSPSIPLPHPPSALPSHV 408
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
AS + PP+ P P+ PS P + P +PP S PS
Sbjct: 409 GASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPASPPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 27/135 (20%), Positives = 44/135 (32%), Gaps = 9/135 (6%)
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP-----SKTA 294
PP S S Y P P P +T P S P++ PP P + A
Sbjct: 55 YPPRETGSGGGVAT-STIYTV-PRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGA 112
Query: 295 PPPASHPSNTAPPPASHPSNTA-PPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
P +T+P + P ++++ + ++ PPP+ S K
Sbjct: 113 SSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPSE-SLKVKNGGK 171
Query: 354 SHPSNTALPPASHPS 368
+P + S
Sbjct: 172 VYPKGFSKHKTHKRS 186
|
Length = 580 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 29/141 (20%), Positives = 39/141 (27%), Gaps = 11/141 (7%)
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
AS S + S A SP S L S AS PAS P +
Sbjct: 2 AASVSSGS--TSGDASSPRS------SSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPA 53
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
S S S ++ S+ P PS A S + + +S
Sbjct: 54 RNTSSSSSFGL---SKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSP 110
Query: 323 PSNTAPPPASHPSNTAPPPAS 343
+ + S P S
Sbjct: 111 SRSRRTTSSDLSSGNGPSVLS 131
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH---- 1060
I GA R L YLH++ IHR+ K+S+IL+ D +S S + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 1061 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
ST V+ + G+ VKSD+YS G+ EL +GR P
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 966
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 1021
R + L+ + + H + A +++ ++L Y +H +
Sbjct: 69 SHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 1022 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 1075
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1076 YAMTGHLLVKS-DVYSYGVVILELLS 1100
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 25/140 (17%), Positives = 37/140 (26%), Gaps = 11/140 (7%)
Query: 57 LLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAP 116
L G P+P + S + D A P + PS +P
Sbjct: 142 LKEGEDPNPGPPLDEEDEDADVATTNSDN-SFPGEDADPASASPSDPPSSSPGVPSFPSP 200
Query: 117 PPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSN 176
P +P S +P P + P + SP A PP P
Sbjct: 201 PEDPSSPSDSSLPPAPSSFQSD----------TPPPSPESPTNPSPPPGPAAPPPPPVQQ 250
Query: 177 AARPPASHPSNTARPPASHP 196
+ P+ + P
Sbjct: 251 VPPLSTAKPTPPSASATPAP 270
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 53/263 (20%), Positives = 71/263 (26%), Gaps = 17/263 (6%)
Query: 47 LPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNP 106
L P +P P + APP PS P S P P P
Sbjct: 66 LQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPP 125
Query: 107 VASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSK 166
P P PP +P PP N P P P S
Sbjct: 126 SQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESP 185
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
P + PP N P + PP + P + PSP +
Sbjct: 186 YQPQSYPP------------NEPLPSSMAMQ---PPYSGAPPSQQFYGPPQPSPYMYGGP 230
Query: 227 TALPPASLPSKTAPPPA--SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P + PS PPP+ + PP S S + + ++PS A
Sbjct: 231 GGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAA 290
Query: 285 PPASHPSKTAPPPASHPSNTAPP 307
+ P S + +P
Sbjct: 291 TVLPQALPMSSAPMSGGGSGSPQ 313
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 0.002
Identities = 20/86 (23%), Positives = 35/86 (40%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
+T + ++ A AS P+ A A A P A+ P+ P A+ + A +
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 215 KTAPSPASHPSNTALPPASLPSKTAP 240
A + A+ P+ A+ P + A
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.002
Identities = 15/83 (18%), Positives = 23/83 (27%), Gaps = 6/83 (7%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
+ P+ A A+ S A A P+ A + P K A A A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA------A 92
Query: 251 PPPASHPYKTSPLPASHPSKTAP 273
+ P + A +
Sbjct: 93 AAAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 22/104 (21%), Positives = 33/104 (31%), Gaps = 6/104 (5%)
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
APP A P + + PA+P + A H +R A
Sbjct: 52 APPAAAAPAAAQ-----PPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAA 106
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P A A P++ A + + A A+ P P A+
Sbjct: 107 APAAPEAQAPAAPAERAAAENA-ARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 22/88 (25%), Positives = 30/88 (34%), Gaps = 1/88 (1%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P + ++ A P P + P + + PP TA PP P A P
Sbjct: 363 VPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANI-PPKEPVRETATPPPVPPRPVAPPV 421
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPP 242
P A + A+P P T P P
Sbjct: 422 PHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 20/83 (24%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
S +A A P P + P PP + PP P TA +S+ P
Sbjct: 514 SGSASNTAKTP--PPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 307 PPASHPSNTAPPPASHPSNTAPP 329
+S P P P+ + P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 19/80 (23%), Positives = 27/80 (33%), Gaps = 1/80 (1%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
S ++ + T P S P P A A P+ P A PP +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSP-PPAKASPPIPVPA 419
Query: 347 KTAPPPASHPSNTALPPASH 366
+ P + P+N A P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 19/80 (23%), Positives = 26/80 (32%), Gaps = 2/80 (2%)
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
S +A A P P P PP + PP P TA +S++ P
Sbjct: 514 SGSASNTAKTPPPPQKSPP--PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 351 PPASHPSNTALPPASHPSNP 370
+S P P P+
Sbjct: 572 ADSSPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 25/82 (30%), Positives = 34/82 (41%), Gaps = 4/82 (4%)
Query: 307 PPASHPSNTAPPPASHPSN-TAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
AS+ + T PPP P PP P+ TAPPP PP A+ S+ A
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPP---PPPTATQASSNAPAQIP 571
Query: 366 HPSNPAIPPASHPSNTAIPPAS 387
S+P P P+ + +S
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 17/84 (20%), Positives = 24/84 (28%), Gaps = 5/84 (5%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
S + ++ + T P S P P A A P+ P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPS-----PPPAKASPPI 415
Query: 358 NTALPPASHPSNPAIPPASHPSNT 381
P P A+ P +
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.002
Identities = 42/233 (18%), Positives = 55/233 (23%), Gaps = 35/233 (15%)
Query: 320 ASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPS 379
S + ++ + T P S PP PS A+ +P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSP-----PPAPIQPSAPKTKQAATTPSPPPAKASPPI 415
Query: 380 NTAIPPASHPSNTAPPHASHPSNTALTPASHP--SNIAPPP---LF-------------- 420
P A+ P + L + + P L
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSLNLEELWQQILAKLELPSTRMLLSQQAELVSLDSNRA 475
Query: 421 VPVLPSALPGKAPVSQSPISLPDAPAATPRG-----NFHRHSPAIHPSMPGPLPPVAQKR 475
V + G QS L + A G N S + S PP QK
Sbjct: 476 VIAVSPNWLGMV---QSRKPLLEQAFAKVLGRSIKLNLESQSGSA--SNTAKTPPPPQKS 530
Query: 476 NASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPP 528
P PP P A D PP P
Sbjct: 531 PPPPAPTPPLPQPTATAPPPTPPPP-PPTATQASSNAPAQIPADSSPPPPIPE 582
|
Length = 620 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (96), Expect = 0.002
Identities = 44/148 (29%), Positives = 60/148 (40%), Gaps = 10/148 (6%)
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP---ASHPSNTAL 361
A A+ A A+ PS A+ P+ A PA K A PP A+ P+ A
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPA----KAAAPPAKAAAAPAKAAA 248
Query: 362 PPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFV 421
PA + PA A+ P+ A PPA + P A+ P A P + +
Sbjct: 249 APAKAAAPPA-KAAAPPAKAAAPPAK--AAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAA 305
Query: 422 PVLPSALPGKAPVSQSPISLPDAPAATP 449
P +A P KA + + P A AATP
Sbjct: 306 PAKAAAAPAKAAAPPAKAAAPPAKAATP 333
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.002
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
PV + P+ A P + A S P+ A+ P P PT + P
Sbjct: 378 HIKPVFTQPA--AAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTP---PTVSVDPP 432
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARP 191
+ PP++ P A RP
Sbjct: 433 AAVPVNPPSTAP-QAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 27/133 (20%), Positives = 46/133 (34%), Gaps = 13/133 (9%)
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
P +P + P+ AP P++ + + PS+++ + +A A+ P+
Sbjct: 370 SGGRGPKQHIKPVFTQPA-AAPQPSAAAAASPSPSQSSAAAQP----SAPQSATQPA-GT 423
Query: 240 PPPASHLSNTA---PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
PP S A PP++ P P K P + S P P +
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKK--IPVSKVSSLG--PSTLRPIQEKAE 479
Query: 297 PASHPSNTAPPPA 309
A+ AP
Sbjct: 480 QATGNIKEAPTGT 492
|
Length = 614 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 29/107 (27%), Positives = 32/107 (29%), Gaps = 6/107 (5%)
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
PA Y + S T PP +P AP P KT H AP P P
Sbjct: 152 PAGGTYIPAGGTYILASGTYIPP--NPPREAPAPGL--PKTFTSSHGHRHRHAPKPTQQP 207
Query: 313 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNT 359
T PA P+ P P T PA P T
Sbjct: 208 --TVQNPAQQPTVQNPAQQPQQQPQQQPVQPAQQPTPQNPAQQPPQT 252
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 28/119 (23%), Positives = 43/119 (36%), Gaps = 12/119 (10%)
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
A P+S ++++ S S P PA PS+ A+ T + S P
Sbjct: 302 AAVTPSSAVTQSSAITPS--SAAIPSPAVIPSSVTTQSAT---TTQASAVALSSAGVLPS 356
Query: 342 ASHSSKTAPPPASHPSNTALPPASHP-----SNPAIPPASHPSNTAIPPASHPSNTAPP 395
T PA+ P N P S S I ++ T++P A P++ P
Sbjct: 357 DVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAA--PASNIPV 413
|
Length = 421 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 29/131 (22%), Positives = 45/131 (34%), Gaps = 4/131 (3%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPS 219
AS S AS P +++R S+ AS R PAS PS++ + ++ S
Sbjct: 3 ASVSSGSTSGDASSPRSSSR--RRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSS 60
Query: 220 PA--SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
S ++L L S+ P S A S ++ +S +
Sbjct: 61 SFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSD 120
Query: 278 HPSNTAPPPAS 288
S P S
Sbjct: 121 LSSGNGPSVLS 131
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.002
Identities = 41/229 (17%), Positives = 62/229 (27%), Gaps = 25/229 (10%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP---PASHLSNTA 250
+ P R AP SP +H N P + + A
Sbjct: 486 AKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSFA 545
Query: 251 PPPASHPYKTSP------LPASHPSKT-------APPPASHP-SNTAPPPASHPSKTAPP 296
A+ Y + P P +T P H ++T P + A
Sbjct: 546 NVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILALR 605
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
A P+ HPS+ + HP P + P P+ H S+
Sbjct: 606 DAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEVFMGYPFQS 665
Query: 357 SNTALPPASHPSNP-AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTA 404
+ P S P P P + HP + HP ++
Sbjct: 666 PHLGAPSGSPPGKDRDSPDLPRP-----TTSLHPKLLS--AHHHPGSSP 707
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.002
Identities = 21/72 (29%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 280 SNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 339
PP++ P + APPPA+ P PA P+ P PA P A
Sbjct: 379 RGAPAPPSAAWGAPTPAAPA-----APPPAAAPPVPPAAPAR-PAAARPAPAPAPPAAAA 432
Query: 340 PPASHSSKTAPP 351
PPA + A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.002
Identities = 24/118 (20%), Positives = 36/118 (30%), Gaps = 2/118 (1%)
Query: 442 PDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQK 501
A H++ P + P PV Q A P P P P +
Sbjct: 78 AQEHEAARPSPQHQYQPPYASAQPRQ--PVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQ 135
Query: 502 SPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSK 559
+P+ +P +P P S P + + +PVA P + P K
Sbjct: 136 PQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 32/131 (24%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 241 PPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH 300
P + A P H Y+ P ++ P + P P A P++ AP P
Sbjct: 75 PANAQEHEAARPSPQHQYQ-PPYASAQPRQPVQQPPEAQ--VPPQHAPRPAQPAPQPV-- 129
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
PA P P AP P P ++AP PA + + A P A+
Sbjct: 130 -----QQPAYQPQPEQPLQQPVSPQVAPAPQ--PVHSAPQPAQQAFQPAEPVAAPQPEPV 182
Query: 361 LPPASHPSNPA 371
PA P
Sbjct: 183 AEPAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 39/140 (27%), Positives = 56/140 (40%), Gaps = 10/140 (7%)
Query: 219 SPASHPSNTALP---PASLPSKTAPPPASH-LSNTAPPPASHPYKTSPLPASHPSKTAPP 274
A+ +N +P ++ K P PA H ++ AP PA P TS AP
Sbjct: 18 IIANLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAP--TSAASRKPDLAQAPT 75
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHP-SNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
PA+ P + AP PA P AP P + + T+ A A A
Sbjct: 76 PAASEKFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSA-- 133
Query: 334 PSNTAPPPASHSSKTAPPPA 353
++ P PA+H+ + PP A
Sbjct: 134 -ASKKPDPAAHTQHSPPPFA 152
|
Length = 566 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 27/81 (33%), Positives = 31/81 (38%), Gaps = 6/81 (7%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
LPA+ + APPP + A P A PP P P P N APPP
Sbjct: 32 ALPATANADPAPPPPPPSTAAAAPAP------AAPPPPPPPAAPPAPQPDDPNAAPPPPP 85
Query: 322 HPSNTAPPPASHPSNTAPPPA 342
N PPP P+ PP
Sbjct: 86 ADPNAPPPPPVDPNAPPPPAP 106
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 23/160 (14%)
Query: 901 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRV-----DQQGGREFLAEVEMLSR 952
+F +++G+G FG LV D G A+K L + DQ AE ++L+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLA--HVKAERDVLAE 57
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAA 1010
+V L + Q L+ E +P G + + L D E + A +A+ A
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050
L + IHRD K NIL++ K+SDFGL+
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 32/148 (21%), Positives = 47/148 (31%), Gaps = 7/148 (4%)
Query: 179 RPPASHPSNTARP-PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSK 237
R P AR A+ + A A+ P+ + A A+H A
Sbjct: 261 RSPERKERAAAREARAAAAAPAATAAAAAPAEEPAVAPMAAIRAAHVETAADKGER---A 317
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P A ++ K + PA + A PA ++ A A P +A
Sbjct: 318 AKPAAADKAADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSADKPGASADAA 377
Query: 298 ASHPSNT---APPPASHPSNTAPPPASH 322
A P+ A P A P A A+
Sbjct: 378 ARTPARARDAAAPDADTPPGGASLAAAQ 405
|
Length = 413 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 33/109 (30%), Positives = 46/109 (42%), Gaps = 24/109 (22%)
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK-----VSDFGLARSAMDEES 1058
KI AL LH +IH D K N+L + + D+GL
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVL----YDRAKDRIYLCDYGL--------C 157
Query: 1059 RHISTRVM--GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
+ I T GT Y +PE + GH S D ++ GV+ ELL+G+ P
Sbjct: 158 KIIGTPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.003
Identities = 30/126 (23%), Positives = 43/126 (34%), Gaps = 4/126 (3%)
Query: 404 ALTPASHPSNIAPPPLFVPVLPSA-LPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
A PA+ AP P P A P APV+Q+ APAA P +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAA--AAPAPAAAPAAAASAPAAPPAA 420
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDV 522
+ P P+ A A+ A +A P PP + ++ + AS P
Sbjct: 421 APPAPVAAPAAAAPAA-APAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAP 479
Query: 523 PPSTPP 528
+
Sbjct: 480 AAAPAA 485
|
Length = 618 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 26/134 (19%), Positives = 39/134 (29%), Gaps = 10/134 (7%)
Query: 67 ELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPS 126
E + SF ++ PP S SPP + P + PP
Sbjct: 157 EDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPA- 215
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
P++ + PP + N P P P P P+ + P+ P S +
Sbjct: 216 --PSSFQSDTPPPSPESPTNPSPPPG--PAAPPPPPVQQVPPLSTAKPT-----PPSASA 266
Query: 187 NTARPPASHPSRTA 200
A A
Sbjct: 267 TPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.003
Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 3/77 (3%)
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P +TA P A + A A+ AP + ++ PPA+ PA+ +
Sbjct: 37 GPGSTAAPTA---AAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 371 AIPPASHPSNTAIPPAS 387
A P A + A PA+
Sbjct: 94 AAPAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.003
Identities = 27/100 (27%), Positives = 37/100 (37%), Gaps = 8/100 (8%)
Query: 481 EAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPV 540
EA + AP P P + P+ P P+ P + PP + P
Sbjct: 357 EALLVPVPAPQPAKP-----TAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPP 411
Query: 541 AEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPP 580
P P+ PPV H+P P + + IP K Y PP
Sbjct: 412 VPPR---PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPA 448
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.003
Identities = 20/103 (19%), Positives = 27/103 (26%), Gaps = 2/103 (1%)
Query: 176 NAARPPASHPSNTARPPASHPSRT-APPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
P A P P+ + P + + P + A P P +
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA-TPPPVPPRPVAP 419
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P P A L+ A P P T P P K
Sbjct: 420 PVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 23/92 (25%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
P PA P A P A+ S P PA A A+ P + + P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPV 417
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
+ P P A + A+ P P P
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 29/103 (28%), Positives = 35/103 (33%), Gaps = 14/103 (13%)
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPA 276
P PA P A P A+ PS P PA + P A+ P + T PP
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPAP----STRPKAAAAANIPPKEPVRETATPPPV- 412
Query: 277 SHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
P P + P P A + A P P T P P
Sbjct: 413 ------PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.003
Identities = 45/250 (18%), Positives = 54/250 (21%), Gaps = 16/250 (6%)
Query: 151 PSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNT 210
PS IPT P P RP + P S
Sbjct: 569 PSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPE 628
Query: 211 ALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSK 270
+ S P P PS+ P K+ PP S P P P +
Sbjct: 629 SPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS------PKPPFDPKFKEKFYDDYLDA 682
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
A + + K P T P P P
Sbjct: 683 AAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRDEEFPFEPIGDPDAE 742
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTAL----------PPASHPSNPAIPPASHPSN 380
PP + PA P L P P S +
Sbjct: 743 QPDDIEFFTPPEEERTFFHETPADTPLPDILAEEFKEEDIHAETGEPDEAMKRPDSPSEH 802
Query: 381 TAIPPASHPS 390
PP HPS
Sbjct: 803 EDKPPGDHPS 812
|
Length = 943 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (95), Expect = 0.003
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP- 352
A A+ A A+ PS A+ P+ A PA + A A+ + A P
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 353 -ASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTP---A 408
A+ P+ A PPA + PA A+ P+ A PPA + A A+ P+ A P A
Sbjct: 253 AAAPPAKAAAPPAKAAAPPA-KAAAPPAKAAAPPAKAAAPPAKA-AAAPAKAAAAPAKAA 310
Query: 409 SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
+ P+ A P P +A P KA + + P A AA
Sbjct: 311 AAPAKAAAP----PAKAAAPPAKAATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.003
Identities = 41/140 (29%), Positives = 54/140 (38%), Gaps = 19/140 (13%)
Query: 209 NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH-PYKTSPLPASH 267
N A+ + P + PS S A PAS + T P P + P T+P
Sbjct: 358 NLAMLPRLMPVESLRPSGGGASAPS--GSAAEGPASGGAATIPTPGTQGPQGTAPAAGMT 415
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAP----PPASHPSNTAPPPASHPSNTAP----PP 319
PS AP P P++ PS P PPA S P PA +P P
Sbjct: 416 PSSAAP--------ATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPD 467
Query: 320 ASHPSNTAPPPASHPSNTAP 339
+ ++ APP PS+TA
Sbjct: 468 SVASASDAPPTLGDPSDTAE 487
|
Length = 624 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.003
Identities = 28/146 (19%), Positives = 43/146 (29%), Gaps = 8/146 (5%)
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP--PPASHPSNTAPPPASHPSN 325
P PPAS + P AS S + T P A+ S +AP P P
Sbjct: 648 PPS-RAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDP 706
Query: 326 TAPPP---ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTA 382
PP A ++ P + + SN+ L + P +
Sbjct: 707 YDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATH--QPQVQAEAQS 764
Query: 383 IPPASHPSNTAPPHASHPSNTALTPA 408
+ + T+ N L +
Sbjct: 765 PASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.003
Identities = 30/174 (17%), Positives = 45/174 (25%), Gaps = 15/174 (8%)
Query: 62 APSPIELP-THSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP--- 117
A P P + + + + P + P T P
Sbjct: 861 AEEVQVQPVVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVVVETTHPEVI 920
Query: 118 --PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL-----SSKAFPP 170
PV P VA A P+V + I + + A P
Sbjct: 921 AAPVTEQPQVITESDVAVAQEVAEHAEPVVEPQDETADIEEAAETAEVVVAEPEVVAQPA 980
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP 224
A + A + + P P++ H TA P AP+P P
Sbjct: 981 APVVAEVAAEVETVTA---VEPEVAPAQVPEATVEHNHATA-PMTRAPAPEYVP 1030
|
Length = 1068 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.003
Identities = 29/180 (16%), Positives = 50/180 (27%), Gaps = 20/180 (11%)
Query: 392 TAPPHASHPSNTALTPA--SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
PP+ S S+ TP+ + NI +L +++S +S + +
Sbjct: 457 MEPPYGSTESSVPSTPSTRRNDRNITSNT-------PSLKRTPNLTKSSLSQEASLISKS 509
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPII 509
GN H+HS + P P A + + N A N+ I
Sbjct: 510 TGNTHKHSTPRRLTT-LPKLPAASRSSKGNLIRSGANG---------NASSDLSSPGSIN 559
Query: 510 PGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIP 569
+ P + K + + SP K V +
Sbjct: 560 SKSPEHSVP-LVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPPKESVATTPRLN 618
|
Length = 619 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 21/72 (29%), Positives = 26/72 (36%), Gaps = 6/72 (8%)
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
PP++ P + APPPA+ P PA P+ P PA P A
Sbjct: 379 RGAPAPPSAAWGAPTPAAPA-----APPPAAAPPVPPAAPAR-PAAARPAPAPAPPAAAA 432
Query: 329 PPASHPSNTAPP 340
PPA A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 28/123 (22%), Positives = 36/123 (29%), Gaps = 1/123 (0%)
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
P+NA A+ PS + + S P P +P + AP PA
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPA-SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
PA P P AP P H A P++ P P P
Sbjct: 130 QQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVM 189
Query: 288 SHP 290
P
Sbjct: 190 DKP 192
|
Length = 333 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.003
Identities = 54/320 (16%), Positives = 79/320 (24%), Gaps = 52/320 (16%)
Query: 145 VNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPA 204
+N L A + I T + S A AA + P++ RP + P
Sbjct: 338 INGLKAHNEILKTASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPAR 397
Query: 205 SHPSN----TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
S + +P + P PP ++ A+ Y
Sbjct: 398 SPMTAYPPVPQFCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPG 457
Query: 261 SPLPASHPSK-----------------------TAPPPASHPSNTAPPPASHPSKTAPPP 297
P H K A TA +
Sbjct: 458 HPQEHGHERKRKRGGELKEELIETLKLVKKLKEEQESLAKELEATAHKSEIKKIAESEFK 517
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPS------------------NTAPPPA---SHPSN 336
+ A + S A PA+ + PA S S
Sbjct: 518 NAGAKTAAANIEPNCSADAAAPATKRARPETKTELEAVVRFPYQIRNMESPAFVHSFTST 577
Query: 337 TAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI----PPASHPSNT 392
T A S TA A ++ P+ ++P + P N + PP P
Sbjct: 578 TLAAAAGQGSDTAEALAGAIETLLTQASAQPAGLSLPAPAVPVNASTPASTPPPLAPQEP 637
Query: 393 APPHASHPSNTALTPASHPS 412
P S PS P P
Sbjct: 638 PQPGTSAPSLETSLPQQKPV 657
|
Length = 663 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 38/196 (19%), Positives = 58/196 (29%), Gaps = 32/196 (16%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
P H S+ + A N L ++ S + S +A S +
Sbjct: 61 PTEHESQQSSNNAGAEKNIDLSGSSSLSSGNQSSPSAANNTSDGH----------DASGV 110
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPS---------------------NTAPPPASHP 290
+ P S P S A PP + N A A
Sbjct: 111 KNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDALSQQQGQVNAASQNAQGN 170
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
+ T P + + + + T P P P+ P H + T P + S K
Sbjct: 171 TSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKTATVAVPPATSGKPKS 230
Query: 351 PPASHPSNTALPPASH 366
AS + ++ PASH
Sbjct: 231 GAASARALSSA-PASH 245
|
Length = 327 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.004
Identities = 49/307 (15%), Positives = 82/307 (26%), Gaps = 33/307 (10%)
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
A P P + + A+ + PA + + A A
Sbjct: 361 AVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTA--VTGAAGAALAPKAAAAA 418
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPA 446
+ APP A P TA AP +P+ +A P
Sbjct: 419 AATRAEAPPAAPAPPATADRGDDAADGDAP-------VPAKANARASADSRCDERDAQPP 471
Query: 447 ATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVAR 506
A A P+ P + + + P P + ++ A
Sbjct: 472 ADSG-------SASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAA 524
Query: 507 PIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPS 566
A P P+ P TP + R G A + D+ + S +G +
Sbjct: 525 A--------APPAPEARPPTPAAAAPAARAGGAAA--ALDVLRNAGMRVSSDRGARAAAA 574
Query: 567 FIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSE 626
P + P + + P R + +P + + + E + P
Sbjct: 575 AKPAA-----APAAAPKPAAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRGAPP-- 627
Query: 627 PIRAFPP 633
P PP
Sbjct: 628 PWEDIPP 634
|
Length = 830 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.004
Identities = 54/273 (19%), Positives = 66/273 (24%), Gaps = 28/273 (10%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPS--NTAPPPASHPSNTAPPPAS 321
S + ++ + AS + P PS TAP P PP A
Sbjct: 86 SVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTAPKPEP-----QPPQAP 140
Query: 322 HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP---PASHP 378
PA + A + P P LP P A P P P
Sbjct: 141 ESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQP 200
Query: 379 SNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSP 438
PP HP P PS P P LP P Q P
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLP----------APSQAPAQPPLPPQLPQQ-PPPLQQPQFP 249
Query: 439 ISLPDAPAATPRGNFHRHSPAIHPSMPGPL-PPVAQKRNASNREAPIAEPIAPGPFPPGN 497
P P+ + P + P P P + AP+ P P P
Sbjct: 250 GLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLPPPQQPQLLPLVQ 309
Query: 498 SRQKSPVARPIIPGGTPTASPDPDVPPSTPPLS 530
Q G LS
Sbjct: 310 QPQGQQ------RGPQFREQLVQLSQQQREALS 336
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.004
Identities = 20/85 (23%), Positives = 28/85 (32%), Gaps = 1/85 (1%)
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
P + P+ AA P + P + + PP TA P P P + P
Sbjct: 366 PQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRE-TATPPPVPPRPVAPPVPHT 424
Query: 229 LPPASLPSKTAPPPASHLSNTAPPP 253
A ++ A P T P P
Sbjct: 425 PESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.004
Identities = 24/80 (30%), Positives = 32/80 (40%), Gaps = 2/80 (2%)
Query: 234 LPSKTAPPPA--SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPS 291
LPS A S +N P P P P++ +K A S P A PP P+
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 292 KTAPPPASHPSNTAPPPASH 311
+ P + P+N A P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.004
Identities = 20/80 (25%), Positives = 28/80 (35%), Gaps = 1/80 (1%)
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
S ++ + T P S P P A + A P+ P A PP P+
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSP-PPAKASPPIPVPA 419
Query: 314 NTAPPPASHPSNTAPPPASH 333
P + P+N A P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (94), Expect = 0.004
Identities = 38/119 (31%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPV--ASPPSITAPPPVNMAPPPS 126
P +A PP + + A +AP A PP+ P A+PP+ A PP A PP+
Sbjct: 229 PAKAAAPPAK--AAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPA 286
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP---ASPPSNAARPPA 182
P + AP PA + A+P + A PP A+PP+ AA PPA
Sbjct: 287 KAAAPPAKAA---AAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.004
Identities = 24/96 (25%), Positives = 32/96 (33%), Gaps = 1/96 (1%)
Query: 344 HSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNT 403
S P P T A PS A S ++A S P + P + P+ +
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 404 ALTPASHPSNIA-PPPLFVPVLPSALPGKAPVSQSP 438
PA+ P N P V K PVS+
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVS 464
|
Length = 614 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.004
Identities = 31/229 (13%), Positives = 56/229 (24%), Gaps = 31/229 (13%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS------------------- 222
+ A + A P + S + + A S A
Sbjct: 569 DDEQHSANVQSAQSAA-EAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSDLD 627
Query: 223 --HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
P +S K PP S P S P + + S P +
Sbjct: 628 ALSPKEGDGKKSSADRKPKTPP----SRAPPASLSKPASSPDASQTSASFDLDPDFELAT 683
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPP---ASHPSNTAPPPASHPSNTAPPPASHPSNT 337
+ + P A+ S +AP P P PP A ++ P + +
Sbjct: 684 HQSVPEAALASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESV--EDAS 741
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
+ + P + + + + N + +
Sbjct: 742 NSELQAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.004
Identities = 30/145 (20%), Positives = 48/145 (33%), Gaps = 10/145 (6%)
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP--PPASHPSNTAPPPASHSSK 347
P PPAS + P AS S + T P A+ S +AP P
Sbjct: 648 PPS-RAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDP 706
Query: 348 TAPPP---ASHPSNTALPPASHPSNP---AIPPASHPSNTAIPPASHPSNTAPPHASHPS 401
PP A ++ P + ++ AS+ A+ + A P+
Sbjct: 707 YDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATHQPQVQAEAQSPA 766
Query: 402 NTALTPASHPSNIAPPPLFVPVLPS 426
+T + S + L + +L S
Sbjct: 767 STTALTQT-SSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.004
Identities = 27/93 (29%), Positives = 31/93 (33%), Gaps = 6/93 (6%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
S T PP +P + +P P KT H AP P P+ P N A
Sbjct: 168 SGTYIPP--NPPREAPAPGL--PKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQ 223
Query: 307 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 339
P P PA P T PA P T
Sbjct: 224 QPQQQPQQQPVQPAQQP--TPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 26/162 (16%), Positives = 48/162 (29%), Gaps = 15/162 (9%)
Query: 257 PYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTA 316
PY ++ + P + N PS P + S +
Sbjct: 460 PYGSTESSV----PSTPSTRRNDRNITSN---TPSLKRTPNLTKSSL-------SQEASL 505
Query: 317 PPPASHPSNTAPPPASHPSNTAPPPASHSSK-TAPPPASHPSNTALPPASHPSNPAIPPA 375
++ ++ P + P AS SSK ++ + ++ + N P
Sbjct: 506 ISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEH 565
Query: 376 SHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
S P S T H++ +N S ++PP
Sbjct: 566 SVPLVRVFDIHLRASTTKGRHSTPSTNEKKKRLLKRSPLSPP 607
|
Length = 619 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 28/136 (20%), Positives = 42/136 (30%), Gaps = 5/136 (3%)
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
AS S + AS P +++ S AS PAS PS++ S
Sbjct: 1 RAASVSSGSTSGDASSPRSSSR--RRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSS 58
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTA 382
S+ S ++ SS+ P PS A S + +S +
Sbjct: 59 SSSFGL---SKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRR 115
Query: 383 IPPASHPSNTAPPHAS 398
+ S P S
Sbjct: 116 TTSSDLSSGNGPSVLS 131
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.004
Identities = 16/72 (22%), Positives = 22/72 (30%), Gaps = 6/72 (8%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
PP++ +P + P A PP PA+ AP P +
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPPPAAAPPVPPA--APARPAAARPAPAPAPPAAA----A 432
Query: 307 PPASHPSNTAPP 318
PPA A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.004
Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 3/135 (2%)
Query: 197 SRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH 256
+ P +A K P+PA H + + P ++ +A L+ P AS
Sbjct: 21 NLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPTPAASE 80
Query: 257 PYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTA 316
+ +P P S+ P + AP P + + T+ A A A ++
Sbjct: 81 KFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSA---ASKK 137
Query: 317 PPPASHPSNTAPPPA 331
P PA+H ++ PP A
Sbjct: 138 PDPAAHTQHSPPPFA 152
|
Length = 566 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK-VLKRVDQQG-GREFLAEVEMLSRLHHRN 957
++ +GEG +G VY + G VA+K +D++G L E+ +L L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 958 -LVKLIGICIEEQAR-----CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIALGAA 1010
+V+L+ + E+ LV+E + + ++ + + PL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-KVSDFGLARSAMDEESRHISTRVMGTF 1069
+ +A+ H V+HRD K N+L++ K++D GL R+ + T + T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTL 175
Query: 1070 GYVAPEYAMTG-HLLVKSDVYSYGVVILELLSG 1101
Y APE + H D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|225711 COG3170, FimV, Tfp pilus assembly protein FimV [Cell motility and secretion / Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.004
Identities = 57/356 (16%), Positives = 90/356 (25%), Gaps = 40/356 (11%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL-- 163
P SP S + P + P P+ P AP T L
Sbjct: 142 PGYSPKSALSAEPSHPVPAPAAASAPPPPPRAARPVRQPAPAPAAPGDTYTVRSGDTLWD 201
Query: 164 -SSKAFPPASPPSN-------AARPPASHPSNTAR---------PPASHPSRTAPPPA-- 204
+S+ P P A N R P A+ R +P A
Sbjct: 202 IASRLRPQDHVTVEQMLLALYQLNPQAFVNGNINRLRAGSVLRIPSAAQILRESPQEALA 261
Query: 205 ---SHPS------NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPAS 255
+ + + A + A A LP++ A A
Sbjct: 262 EVKAQTAAFAGEPSKADRVGKPVAKAPAKVAKERALAELPARVAELQA----QLNKAQHE 317
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN- 314
K +PL A+ + AP + + P S S A P + + P +
Sbjct: 318 LAQKAAPLAAAQAALDAPAETATAPSAPAPQVSAESSPAQPGSYLLAAPGDAPLGELAQA 377
Query: 315 -TAPPPASHPSNTAPPPASH--PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
+A + S A P S P P + + L
Sbjct: 378 QSARERLAEESVPAAEPRSRLAPVAAVEQPFAEVESPLSSLPAPLLALGLVALDGGWLVL 437
Query: 372 IPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSA 427
P T + A+ +N+ A + +P P+ +
Sbjct: 438 RRAQQPPVETQGFQNRLLNRADTLLAA--ANSLFGGAGLQWDTSPHPVPAADFRAG 491
|
Length = 755 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1299 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.75 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.31 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 97.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.99 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.6 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.98 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.72 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.14 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=504.81 Aligned_cols=290 Identities=57% Similarity=0.946 Sum_probs=256.8
Q ss_pred CcccCCHHHHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeee
Q 000757 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965 (1299)
Q Consensus 886 S~k~Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~ 965 (1299)
....|++.+|+.+|++|+..++||+|+||.||+|.+++|+.||||++.....+..++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999998754332156799999999999999999999999
Q ss_pred eecc-ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCccee
Q 000757 966 IEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044 (1299)
Q Consensus 966 ~e~~-~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKL 1044 (1299)
.+.+ ..+||||||.+|+|+++|+..... .|+|.+|++|+.++|+||+|||+.+.+.|||||||++|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 499999999999999999864433 7999999999999999999999998889999999999999999999999
Q ss_pred cCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc
Q 000757 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
+|||||+..... .....+...||.+|+||||+..+.++.|+|||||||+|+||+||+++++.....++.++++|++..+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999765431 1111111179999999999999999999999999999999999999998776666778999999888
Q ss_pred ccccccceeecCCCC-CCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1125 TSREGLERIIDPSLG-NDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~-~~~p~-ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
.+. .+.+++|+.+. +.+.. +++.++..++.+|++.++++||+|.||+++|+.+.
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 765 79999999987 55654 68999999999999999999999999999995543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=488.97 Aligned_cols=405 Identities=24% Similarity=0.370 Sum_probs=288.7
Q ss_pred ccChhhHHhhhhcccCccccccccCCCCeeEEEeeCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc--cCCcccc
Q 000757 725 KFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEGV--DVPKRRQ 802 (1299)
Q Consensus 725 sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LsGpIPs~ls~~~tf~assFaGN~GLCG~PL~v--d~~~~rs 802 (1299)
.+..++.+||++|.++|.||..+..+..|+.|+|++|+|+|.||..-+. .++...+|.||.++||..... ..|....
T Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~-~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~ 623 (968)
T PLN00113 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF-LAINASAVAGNIDLCGGDTTSGLPPCKRVR 623 (968)
T ss_pred CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchh-cccChhhhcCCccccCCccccCCCCCcccc
Confidence 4567889999999999999999999999999999999999999954332 237888999999999865432 1222111
Q ss_pred ccCCCCceeeeehhHHHHHHHHHHHHHHHHHHhhccccccccccccccccCCcCCCCCCCcccccCCCCCccccCccccc
Q 000757 803 KYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIAT 882 (1299)
Q Consensus 803 kkglS~giIa~IVVgavVavVLllaIa~l~l~krKrrr~k~ee~~~s~q~s~~~~s~as~l~vss~~~S~S~s~gSs~at 882 (1299)
+ .. .++++++++++++++++++++++++++++++.+.++... + .+.... ..+.
T Consensus 624 ~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~~~~~-------~~~~----- 676 (968)
T PLN00113 624 K---TP-SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN--E---------DGTWEL-------QFFD----- 676 (968)
T ss_pred c---cc-eeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccc--c---------cccccc-------cccc-----
Confidence 1 11 112222222222222222222222222222111111000 0 000000 0000
Q ss_pred ccCCcccCCHHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceee
Q 000757 883 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961 (1299)
Q Consensus 883 ~sgS~k~Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrL 961 (1299)
......++.+++. ..|+..++||+|+||.||+|+. .+|+.||||+++.... ...+|++++++++|+|||++
T Consensus 677 -~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~ 748 (968)
T PLN00113 677 -SKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKL 748 (968)
T ss_pred -cccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceE
Confidence 0011223444443 4577788999999999999996 5789999999874332 22356889999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc
Q 000757 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041 (1299)
Q Consensus 962 lG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~ 1041 (1299)
+|+|.+++..|+||||+++|+|.++++ .++|.++.+|+.|+++||+|||..+.++|+|||||++|||+|.++.
T Consensus 749 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~ 821 (968)
T PLN00113 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821 (968)
T ss_pred EEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence 999999999999999999999999994 3899999999999999999999776667999999999999999988
Q ss_pred ceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh
Q 000757 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1042 VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
.++. ||....... .....|+.+|||||++.+..++.|+|||||||++|||++|+.||+.... ....+++|++
T Consensus 822 ~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 893 (968)
T PLN00113 822 PHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR 893 (968)
T ss_pred eEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHH
Confidence 8875 665543321 1223588999999999999999999999999999999999999965332 3345777776
Q ss_pred cccccccccceeecCCCCCC--CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1122 PLLTSREGLERIIDPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~--~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
..... .....++|+.+... ...++..++.+++.+||+.+|++||+|.||+++|+.+...
T Consensus 894 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 894 YCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 55432 23455666666443 3346677899999999999999999999999999977653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=427.21 Aligned_cols=261 Identities=34% Similarity=0.568 Sum_probs=216.4
Q ss_pred cceeeEEeecCceEEEEEEecCCCEEEEEEeecccccc--hhHHHHHHHHhhhcccccceeeeeeeeecc-ceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~--~keFlrEIeILsrLrHPNIVrLlG~~~e~~-~~~LVyEYm 978 (1299)
+.+.+.||+|+||+||+|.++....||||++...+... .++|.+|+.+|++|+|+|||+|+|+|.+.. ..+||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33455699999999999999943349999997543222 568999999999999999999999999887 789999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCCCccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~~~~~~ 1057 (1299)
++|+|.++|+.. .+..+++..+++|+.|||+||.|||+++. |||||||++||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999754 35679999999999999999999998752 99999999999999997 99999999998654321
Q ss_pred cccccccccccccccCccccc--cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1058 SRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~--~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
...+...||..|||||+++ ...|+.|+|||||||+||||+||+.||..... . .....++.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~---------------~~~~~v~~ 260 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V---------------QVASAVVV 260 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H---------------HHHHHHHh
Confidence 2233467999999999999 56999999999999999999999999986543 1 11112222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhhh
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1184 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~e 1184 (1299)
...+..++.++...+..|+.+||+.||++||++.||+..|+.+......
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 3344455556778999999999999999999999999999988776553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=434.51 Aligned_cols=266 Identities=29% Similarity=0.488 Sum_probs=224.9
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeecc
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~ 969 (1299)
....+.+..+.||+|+||+||+|+.. +...||||.|++.... ...+|+||+++|..|+|+|||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33456677889999999999999943 3467999999876555 7889999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhccccccc------C----CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC
Q 000757 970 ARCLVYELIPNGSVESHLHGVDK------E----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1039 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~------~----~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed 1039 (1299)
-.|||+|||..|+|.+||+.... . ..+|+..+.+.|+.|||.||+||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999974221 1 234899999999999999999999776 9999999999999999
Q ss_pred CcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 000757 1040 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVA 1118 (1299)
Q Consensus 1040 g~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~ 1118 (1299)
..|||+||||+|.....++.....+-.-..+||+||.++.++||.+||||||||||||+++ |+.||.....
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------- 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------- 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence 9999999999998776666655545556789999999999999999999999999999999 9999875432
Q ss_pred hhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1119 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1119 wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.+.++.+-+..+ -..++.+..+++.||..||+.+|++||+++||-..|+...+..
T Consensus 712 --------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 --------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222222222223 3566788999999999999999999999999999999876643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=411.50 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=217.8
Q ss_pred cceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+.+.+.||+|-||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+|+|+|..++.+|||||||..|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456799999999999999997779999999864 455678999999999999999999999999988999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+||+. .....+...+.+.++.|||+||+||++++ +|||||..+||||+++..+||+|||||+...++ ....
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~ 360 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA 360 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence 99999975 33456889999999999999999999887 999999999999999999999999999954433 3333
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.||...... .+.+.++...+-
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----------------ev~~~le~GyRl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----------------EVLELLERGYRL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----------------HHHHHHhccCcC
Confidence 333344679999999999999999999999999999999 99998754321 122334455555
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
..+..|...+.+||..||+.+|++|||+..+...|+++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 6777899999999999999999999999988888877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=394.24 Aligned_cols=202 Identities=31% Similarity=0.538 Sum_probs=181.4
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.++|.+.+.||+|.||+||+|++ +++..||||.+.+. .....+.+..||++|+.|+|+|||+|+++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46789999999999999999994 46899999999654 4555667889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC------CcceecCCCc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD------FTPKVSDFGL 1049 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed------g~VKLsDFGL 1049 (1299)
|||+||+|.+||+. ...+++++...++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999964 336999999999999999999999988 9999999999999764 4589999999
Q ss_pred cccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~ 1110 (1299)
|+.... .....+.||++.|||||+++..+|+.|+|+||+|+|||||++|+.||+..+.
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 998753 3445678999999999999999999999999999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=404.13 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=213.5
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.+|...++||+|||++||+++. .+|+.||+|++.+. .....+.+.+||+|.++|+|+|||+|+++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999996 89999999999652 4455678899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|+|.+|+|.++++ +...+++.+++.++.||+.||.|||+.+ |||||||..|+||+++.+|||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999995 3457999999999999999999999887 99999999999999999999999999998754
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
+.. ...+.|||+.|+|||++.....+..+||||+|||||-||.|+.||+...-.+..+.+. ..+
T Consensus 171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------~~~-------- 234 (592)
T KOG0575|consen 171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------LNE-------- 234 (592)
T ss_pred ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------hcC--------
Confidence 333 3456899999999999999999999999999999999999999998653222111111 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..++.....+..+||..+|+.||.+||++++|+..-
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 122334556788999999999999999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=391.47 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=210.0
Q ss_pred ceeeEEeecCceEEEEEEec-CCCEEEEEEeec-ccccchhHHHHHHHHhhhcccccceeeeeeeeecc-ceEEEEeecC
Q 000757 903 DASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIP 979 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~-~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-~~~LVyEYm~ 979 (1299)
+..+.||+|..|+|||++++ +++.+|+|.+.. .+....+++.+|++++++.+|+|||.++|.|.... .++|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34579999999999999965 688999999943 34556788999999999999999999999999988 4999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|++++... +.+++...-+|+.++++||.|||+. ++||||||||+||||+.+|+|||||||.++.+...
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999543 4689999999999999999999962 24999999999999999999999999999876432
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
.....+||..|||||.+.+..|+.++||||||++|+||.+|+.||..... ....|+. .+..|++...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~~-------Ll~~Iv~~pp- 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIFE-------LLCAIVDEPP- 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHHH-------HHHHHhcCCC-
Confidence 45667899999999999999999999999999999999999999975411 1112221 1223333211
Q ss_pred CCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1140 NDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1140 ~~~p~-ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
...+. .+..+|..++..||++||.+|++..|+++.-..
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 12333 477899999999999999999999999887543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=382.50 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=207.3
Q ss_pred hCCcceeeEEeecCceEEEEEEe------cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeec-c
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-Q 969 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l------kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~-~ 969 (1299)
.++|++.++||+|+||.||+|.+ .+++.||||+++... ....+.+++|+++|.++ +|+||++++++|.+. .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 235679999997532 23346789999999999 899999999998764 4
Q ss_pred ceEEEEeecCCCChhhccccccc---------------------------------------------------------
Q 000757 970 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 992 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~--------------------------------------------------------- 992 (1299)
..++||||+++|+|.++|+....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred -CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccc
Q 000757 993 -ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071 (1299)
Q Consensus 993 -~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gY 1071 (1299)
....+++.++++++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235889999999999999999999887 999999999999999999999999999865432222222234467899
Q ss_pred cCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHH
Q 000757 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKV 1150 (1299)
Q Consensus 1072 mAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL 1150 (1299)
+|||++.+..++.++|||||||+||||++ |+.||....... .+... +.... .......+...+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~----~~~~~----------~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQR----LKDGT----------RMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHH----HhcCC----------CCCCCCCCCHHH
Confidence 99999999999999999999999999997 999997643221 11110 11010 001122345678
Q ss_pred HHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1151 AAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1151 ~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
.+|+.+||+.||++||++.||++.|+.++.+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=383.98 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=208.6
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccccc-------chhHHHHHHHHhhhcccccceeeeeeeeecc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ-------GGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~-------~~keFlrEIeILsrLrHPNIVrLlG~~~e~~ 969 (1299)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ...++.+|+++|++|+|||||++++++.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678889999999999999999 668999999999653211 2234679999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC---CcceecC
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSD 1046 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed---g~VKLsD 1046 (1299)
..|||||||+||+|.+++- .+..+.++.-..+++|++.||.|||++| |+||||||+||||..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999984 3456788888999999999999999998 9999999999999655 7899999
Q ss_pred CCccccccccccccccccccccccccCccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1047 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1047 FGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~---~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
||||+... ......+.|||+.|+|||++.+.. +..|.|+||+|||||-+|+|..||....... .+.+.+.
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~-- 395 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL-- 395 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh--
Confidence 99999774 334556789999999999998654 3458899999999999999999997543321 1111111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
..+ + . +......+..++.++||.+||..||++|++..|+++.-+..
T Consensus 396 -~G~--y--~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 396 -KGR--Y--A----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred -cCc--c--c----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 000 0 0 01122345668899999999999999999999999886644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=374.86 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=213.2
Q ss_pred CcceeeEEeecCceEEEEEE-ecCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeee-eeeeccc-eEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIG-ICIEEQA-RCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG-~~~e~~~-~~LVy 975 (1299)
+|++.+.||+|.||+|||+. +.+|..||.|.++- .+....+++..|+.+|++|+|+|||++++ -+.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47888999999999999999 67899999999863 35556678899999999999999999999 4555555 79999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCc--eeeecccccCeeeccCCcceecCCCccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR--VIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~--IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|||+.|+|.+.++.+++.++.+.+.++|+++.|+++||..||..- ++ |+||||||.||+||.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999888888889999999999999999999999842 33 999999999999999999999999999987
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
... .......+||+.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.+ +........
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI~--------- 241 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKIE--------- 241 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHHH---------
Confidence 542 334456789999999999999999999999999999999999999998652 221111110
Q ss_pred ecCCCCCCCC-hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1134 IDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1134 VDp~L~~~~p-~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
.... ...+ .-+...+.+||..|+..|++.||+...+++.+..
T Consensus 242 -qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 -QGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -cCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 0001 1122 4567889999999999999999997666666554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=378.94 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=207.9
Q ss_pred HHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc----cc-cchhHHHHHHHHhhhcc-cccceeeeeeeeecc
Q 000757 897 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV----DQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 969 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~----d~-~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~ 969 (1299)
...++|.+.+.||+|.||+||+|. ..+|+.||||++++. .. ...+.+.+|+.++++++ |+||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 445789999999999999999998 457899999977653 12 34556778999999999 999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCCC
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFG 1048 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDFG 1048 (1299)
.+|+||||+.||+|++++.. ..++.+.+..+++.|++.||+|||+++ |+|||||++|||||.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999953 456888999999999999999999888 9999999999999999 999999999
Q ss_pred ccccccccccccccccccccccccCccccccCC-CC-ccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~-~T-~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
++.... .........+||+.|+|||++.+.. |+ .++|||||||+||.|++|+.||+..+. ....+.....
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKIRKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHHhcC
Confidence 998763 2334456688999999999999866 75 899999999999999999999987332 1111111111
Q ss_pred ccccceeecCCCCCCCChhh-HHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDS-VAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee-~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.- .++... ..++..|+.+||..||.+|+++.||++.
T Consensus 239 ~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 239 EF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred Cc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11 122222 5678999999999999999999999843
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=360.96 Aligned_cols=264 Identities=26% Similarity=0.452 Sum_probs=205.5
Q ss_pred CCcceeeEEeecCceEEEEEEecC-----------------CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKL 961 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd-----------------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrL 961 (1299)
++|++.++||+|+||.||++.+++ +..||+|+++... .....+|.+|+++|.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999998542 3369999987532 3335679999999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhccccccc---------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceee
Q 000757 962 IGICIEEQARCLVYELIPNGSVESHLHGVDK---------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026 (1299)
Q Consensus 962 lG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~---------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVH 1026 (1299)
++++.+.+..++||||+.+|+|.+++..... ....++|.++++|+.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854211 1134788999999999999999999887 999
Q ss_pred ecccccCeeeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCC
Q 000757 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKP 1104 (1299)
Q Consensus 1027 RDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT--Gr~P 1104 (1299)
||||++||||++++.+||+|||+++...............++..|||||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543332223334456889999999998999999999999999999987 5566
Q ss_pred CCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1105 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1105 Fd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
|..... .....++...+...... +. ......+...+.+|+.+||+.+|++||++.||++.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQ--VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcccc--cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 654322 22222222222111100 00 0112234568999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=359.46 Aligned_cols=262 Identities=19% Similarity=0.346 Sum_probs=207.8
Q ss_pred CcccCCHHHHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccc---hhHHHHHHHHhhhcccccceeee
Q 000757 886 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---GREFLAEVEMLSRLHHRNLVKLI 962 (1299)
Q Consensus 886 S~k~Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~---~keFlrEIeILsrLrHPNIVrLl 962 (1299)
+.+.++.++++ +.....||+|++|.||+|.++ |+.||||+++...... .+.|.+|+++|++++|+|||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 45556666663 222368999999999999985 8899999997543322 46778999999999999999999
Q ss_pred eeeee----ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc
Q 000757 963 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH 1038 (1299)
Q Consensus 963 G~~~e----~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe 1038 (1299)
|++.+ ....++||||+.+|+|.++++. ...++|.++++++.|++.||.|||+.. +++|||||++|||+++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence 99876 3467899999999999999953 246899999999999999999999752 2889999999999999
Q ss_pred CCcceecCCCccccccccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhh
Q 000757 1039 DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1116 (1299)
Q Consensus 1039 dg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nL 1116 (1299)
++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+.. .+
T Consensus 159 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~ 230 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI 230 (283)
T ss_pred CCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH
Confidence 9999999999998653211 23458899999999876 68999999999999999999999999754321 11
Q ss_pred HHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1117 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1117 V~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
... ..... .....+..+...+.+|+.+||+.||++||++.||++.|+++..
T Consensus 231 ~~~---i~~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 231 YDL---IINKN----------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHH---HHhcC----------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111 11111 1111223456689999999999999999999999999987643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=411.69 Aligned_cols=264 Identities=31% Similarity=0.503 Sum_probs=219.5
Q ss_pred CCcceeeEEeecCceEEEEEEecC--CC----EEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD--GT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd--Gr----~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
.+.++.+.||+|.||.||+|.+.+ |. .||||.+++. +.+...+|++|..+|++++|+|||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456678999999999999999653 33 4999999764 5667789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhccccccc---CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 973 LVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~---~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
|++|||++|+|..||++.+. ....|...+++.|+.|||+|+.||++++ +|||||..+|+||++...|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976432 1346899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e 1128 (1299)
|+...+.++.......+-...|||||.++++.++.|+|||||||+||||+| |..||...... +-+..|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~~-------- 918 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDVL-------- 918 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHHH--------
Confidence 996655444433333344579999999999999999999999999999999 99999754321 1111121
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhh
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
... +-+.+..|...+.+||..||+.+|++||++..|++.+..+.+...
T Consensus 919 ------~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 919 ------EGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ------hCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 111 235566788999999999999999999999999998887776543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=375.57 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=206.1
Q ss_pred hCCcceeeEEeecCceEEEEEEe------cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccc
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l------kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~ 970 (1299)
.++|++.+.||+|+||.||+|++ +++..||||+++... ....+.+.+|+.+|+.+ +|+||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688999999999999999973 245689999997432 33456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000757 971 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 992 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~---------------------------------------------------------- 992 (1299)
.++|||||++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864211
Q ss_pred -------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 993 -------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 993 -------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
....++|.++++|+.||++||+|||+.+ |+|||||++|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125889999999999999999999887 999999999999999999999999999865433222
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+..+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~-------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKEGY-------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHhCc--------------
Confidence 22223345678999999999999999999999999999998 88888654221 12222211110
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
....+.....++.+|+.+||+.||++||+|.||++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011112345789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=353.21 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=208.1
Q ss_pred CCcceeeEEeecCceEEEEEEecC------CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
++|++.+.||+|+||.||+|.... ...|++|.++... ....++|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368889999999999999998542 2579999986432 233457899999999999999999999999989999
Q ss_pred EEEeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC
Q 000757 973 LVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg 1040 (1299)
++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ |+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 1145889999999999999999999887 99999999999999999
Q ss_pred cceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHh
Q 000757 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 1119 (1299)
Q Consensus 1041 ~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~w 1119 (1299)
.+||+|||+++...............++..|+|||++.++.++.++|||||||+||||++ |..||...... .+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543332223334457889999999998899999999999999999998 99998754321 22222
Q ss_pred hhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1120 a~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
+.. ......+..+..++.+|+.+||+.+|++||++.||++.|+.
T Consensus 239 i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 11112233556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=396.34 Aligned_cols=267 Identities=27% Similarity=0.450 Sum_probs=223.9
Q ss_pred CCcceeeEEeecCceEEEEEEecC----CCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
....++++||.|.||+||+|+++. ...||||.||.. .+....+|+.|+.||.+++||||++|.|+.....-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456688999999999999999762 456999999865 345567899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
.|||+||+|+.||+..+ ..+++.++.-++++||.||.||-+++ +|||||..+||||+.+..+||+||||+|...
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999997654 45999999999999999999999887 9999999999999999999999999999775
Q ss_pred ccccccccc-cccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1055 DEESRHIST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1055 ~~~~~~~st-~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
++.....++ ...-..+|.|||.+..+++|.++|||||||||||.|+ |.+||-.... .+ +.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------Qd-VIk 845 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QD-VIK 845 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HH-HHH
Confidence 543222221 1223479999999999999999999999999999998 9998843221 11 223
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhhhhhhcC
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 1189 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~e~~e~g 1189 (1299)
.++..++-.-+.+|...|.+||+.||++|-.+||.+.||+..|.++..+-..-+...
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~ 902 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA 902 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence 344455556778999999999999999999999999999999998887665444333
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=352.55 Aligned_cols=251 Identities=34% Similarity=0.582 Sum_probs=196.7
Q ss_pred ceeeEEeecCceEEEEEEec-----CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 903 DASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lk-----dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++++++++|+||++++|+|.+.+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999977 3567999999653 23346789999999999999999999999998888999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.++|+.. ....+++.++++|+.||++||.|||+.+ |+||||+++||||++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999754 2346899999999999999999999887 999999999999999999999999999876332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
..........+...|+|||++....++.++||||||+++|||++ |+.||.... ...+...+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~----~~------- 222 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQ----GQ------- 222 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHT----TE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc----cc-------
Confidence 22222333457789999999999999999999999999999999 678875432 1222221110 10
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.......+...+.+++.+||+.+|++||+|.||++.|
T Consensus 223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112233556799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=351.55 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=202.1
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.|++.+.||+|+||+||++.. .+|+.||||.+.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999985 578999999986432 2234467899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999887532 2335899999999999999999999887 999999999999999999999999999765322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.......... .... .+. +
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~-~~~---------~- 219 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDR-RVK---------E- 219 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHH-Hhh---------c-
Confidence 1 1234568999999999999999999999999999999999999997644321111 0000 000 0
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq~ 1174 (1299)
....+..+....+.+|+.+||+.||++|++ +.|+++.
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001122334567899999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=373.58 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=205.9
Q ss_pred hCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccc
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~ 970 (1299)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+++|+++++++ +|+|||+++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357899999999999999998832 33579999997532 23345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhcccccc-----------------------------------------------------------
Q 000757 971 RCLVYELIPNGSVESHLHGVD----------------------------------------------------------- 991 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~----------------------------------------------------------- 991 (1299)
.++||||+.+|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred -------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccccccc
Q 000757 992 -------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064 (1299)
Q Consensus 992 -------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~ 1064 (1299)
.....+++.++++|+.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235789999999999999999999887 99999999999999999999999999986543222222223
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1065 v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
..++..|||||++....++.++|||||||+||||++ |+.||....... .+... .. ........
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~----------~~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VK----------RGYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HH----------cccCccCC
Confidence 345678999999998999999999999999999997 999997543211 11110 00 00011111
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
.....++.+++.+||+.||++||++.||++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.41 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=204.5
Q ss_pred CCcceeeEEeecCceEEEEEEec----CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk----dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.++||+|+||.||+|.++ .+..||+|.++... ....+.|++|+.++++++|+||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46899999999999999999853 35689999997542 23345789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|.+++... ...++|.++++++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998532 246899999999999999999999887 9999999999999999999999999876532
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... .+..... +.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~------ 224 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVE----DG------ 224 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----CC------
Confidence 2111 11122345678999999999999999999999999999885 99999654321 1111111 00
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
........+...+.+++.+||+.+|++||++.||++.|..+
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00112234556799999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=376.17 Aligned_cols=266 Identities=25% Similarity=0.441 Sum_probs=221.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
..+...+.++||+|.||+|.++..+.+..||||.++..... ..++|.+||++|.+|+|||||+|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34556778999999999999999998899999999865444 45899999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||++|+|.+||...... .+.....++|+.||+.||+||.+.+ +|||||.++|||+|.++++||+|||++|.+..+
T Consensus 616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999643222 2466677889999999999999887 999999999999999999999999999988777
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT--Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
++.+...+.+-..+|||+|.+..++++.++|||+|||+|||+++ ...||..... +..++-...++....... .
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~-~- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQV-V- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcce-e-
Confidence 77777777778899999999999999999999999999999876 7788865432 233333333333222111 1
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
-..+.-+..++++++.+||..|-++||+++++...|.+.
T Consensus 766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123345678899999999999999999999998888753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.50 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=205.4
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCC----EEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr----~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
.+|++.+.||+|+||.||+|++. +|+ .||||+++... ....++|.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46999999999999999999853 344 38999986432 34456789999999999999999999999864 5689
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|+||+.+|+|.++++.. ...+++..+++++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999642 235889999999999999999999887 999999999999999999999999999876
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.............++..|++||++.+..++.++|||||||+||||++ |+.||+..... .+..+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~---- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGE---- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----CCC----
Confidence 43322222222335678999999999999999999999999999998 99998653211 1111111 000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.......+...+.+++.+||..+|++||++.|+++.|..+..+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111234457899999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.61 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=208.0
Q ss_pred CCcceeeEEeecCceEEEEEEecC------CCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd------Gr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..++|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999999754333 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccc----------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 973 LVYELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~----------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
+||||+.+|+|.++++... .....+.+.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 12345889999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhh
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
||+|||+++...............++..|+|||++.++.++.++|||||||+||||++ |+.||..... ....++..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 9999999976533222222233446789999999999999999999999999999998 9999865432 22222221
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
. .. ...........+.+++.+||+.||++||++.||++.|+
T Consensus 239 ~-----~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 Q-----GR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred c-----CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 00 01112234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.53 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=203.9
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||++.++++..+|+|.++.. ....++|.+|+++|++++|+||++++++|.+++..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 458889999999999999999988889999998643 3345689999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.++++.. ...++|..+++++.|++.||+|||+.+ |+|||||++||+|++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998642 235899999999999999999999887 999999999999999999999999998865332211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......++..|+|||++....++.++|||||||++|||++ |+.||..... .....+..... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~-------~~----- 220 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGF-------RL----- 220 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC-------CC-----
Confidence 1122235678999999988889999999999999999999 8999865432 22222221100 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..+......+.+++.+||+.+|++||++.|+++.|
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01112335789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=380.26 Aligned_cols=272 Identities=27% Similarity=0.461 Sum_probs=216.9
Q ss_pred CCHHHHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeee
Q 000757 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e 967 (1299)
.+.++++...+.+.+.+.||+|.||+||+|++. | .||||+|+..+ .+..+.|++|+.+|++-||.||+-|.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344666666677888999999999999999987 3 49999997543 3456789999999999999999999999998
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
... .||+.+|+|.+|+.+||..+ ..++..+.+.|++||++||.|||.++ |||||||..||||++++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 776 99999999999999998654 45889999999999999999999987 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~---~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
||+.....-........-.|...|||||+++. ..|+..+||||||||+|||++|..||...+. ++ +-|.
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq---Iifm---- 604 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ---IIFM---- 604 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh---eEEE----
Confidence 99975432211222223347889999999874 4689999999999999999999999973221 11 1110
Q ss_pred ccccc-cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhhh
Q 000757 1125 TSREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1184 (1299)
Q Consensus 1125 s~~e~-L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~e 1184 (1299)
..++. ..++ ......+.+++.+|+..||..++++||.+.+|+..|+.+.....+
T Consensus 605 VGrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 605 VGRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred ecccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 01110 1111 122346778999999999999999999999999998887765433
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.24 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=207.3
Q ss_pred hCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.++|++.+.||+|+||.||+|.+++++.||||.++.. ....++|.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4679999999999999999999888888999998753 334578999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.... ...++|.++++++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999996432 346899999999999999999999887 99999999999999999999999999986643211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+...... .
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~----~---------- 220 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVDQ----G---------- 220 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc----C----------
Confidence 1 1111223468999999998999999999999999999999 99998653211 11111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
............+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011222345679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.86 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=202.3
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||+||+++.+ +++.||||+++... ....+.+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999965 67889999987532 3335678899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.++.|..+.. ....+++..++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765542 2345889999999999999999999887 999999999999999999999999999865332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh-cc-------ccccc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR-PL-------LTSRE 1128 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~-pl-------ls~~e 1128 (1299)
.. .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+......... .+ +....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 12234568999999999998889999999999999999999999997643222111111100 00 00000
Q ss_pred ccceeecCCCC------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1129 GLERIIDPSLG------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1129 ~L~eIVDp~L~------~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
....+..+... ..........+.+|+.+||+.||++|+++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0011123457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=359.10 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=206.7
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.++|++.+.||+|+||.||+++.. +|..||+|+++.. .....++|.+|+++|++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999965 6888999998643 22335679999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++|+|.+++.. ...+++..+.+++.|++.||.|||+.+ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999853 235889999999999999999999753 4999999999999999999999999998765332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc-ccccccc------
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP-LLTSREG------ 1129 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p-lls~~e~------ 1129 (1299)
......|+..|+|||++.+..++.++|||||||+||||++|+.||....... +...... .....+.
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence 1234569999999999999999999999999999999999999996533211 1111100 0000000
Q ss_pred --------------------------cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1130 --------------------------LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1130 --------------------------L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
+..++..............++.+|+.+||+.||++||++.||++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000000000111244678999999999999999999999887553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.53 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=203.4
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.++|++.++||+|+||+||.++ .++++.+|+|++++. .....+..++|..||.+++||.||.|+-.|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999998 557899999999763 334456788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
+||+.||.|+.+|. +...++++...-++.+|+.||.|||+.+ ||||||||+|||||++|.++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999994 3456889989999999999999999998 9999999999999999999999999998654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
... ..+.+.|||..|||||++.+..|+..+|.|||||+||||++|..||...+. ..+....+...
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK------- 241 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc-------
Confidence 322 233457999999999999999999999999999999999999999976432 22322222211
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1167 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS 1167 (1299)
....+.-...+..+++.+.|..||++|..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01112223467889999999999999963
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=349.33 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=209.2
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeec
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~ 968 (1299)
...++|++.+.||+|+||.||++... +...||+|+++.. ......++.+|+++++++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467999999999999999999854 2357999998643 223345688999999999 799999999999999
Q ss_pred cceEEEEeecCCCChhhcccccc------------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 969 QARCLVYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~------------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
+..++||||+.+|+|.++++... .....+++..+++++.|++.||+|||+.+ |+|||||++|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999986421 23456899999999999999999999887 9999999999999
Q ss_pred ccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhh
Q 000757 1037 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~n 1115 (1299)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 9999999999999986544322222223345678999999988899999999999999999998 888886432211
Q ss_pred hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
+... +. ..........+...+.+|+.+||+.+|++||++.||++.|+.+.
T Consensus 243 ~~~~----~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKL----LK----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH----HH----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 00 11111222344568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=359.09 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=206.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 58899999997532 234457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+.+.+++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999953 345889999999999999999999887 99999999999999999999999999975533
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcccccccccceee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIV 1134 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+..+. ..+..|... +..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------~~~-- 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-------LQR-- 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-------ccC--
Confidence 22345699999999999999999999999999999999999999976543221 111222110 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
+ ...........++.+++.+||..++++|+++.|+++.-
T Consensus 220 -~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 220 -P-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -C-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0 00000123456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.72 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=212.6
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+...+|++.++||+|+||.||+|...+++.|++|+++........++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567899999999999999999988899999999986655556789999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++|+|.++++.. ....+++.++++++.||+.||+|||+.+ |+|||||++||||++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999643 2346899999999999999999999887 999999999999999999999999999765332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. ......++..|++||++..+.++.++|||||||++|||++ |+.||..... .....+...
T Consensus 158 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~------------- 219 (261)
T cd05148 158 VY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITA------------- 219 (261)
T ss_pred cc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHh-------------
Confidence 11 1123346778999999988899999999999999999998 8999965431 112222111
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
......+..+...+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 -GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11112233455778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=349.82 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=211.4
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
++|.+.+.||+|+||.||+|+.. ++..|++|.++.......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999842 345689999876555555789999999999999999999999999999999
Q ss_pred EEeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc
Q 000757 974 VYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~ 1041 (1299)
||||+.+++|.+++..... ....++|.++++++.||+.||+|||+++ |+|||||++|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999864321 1235899999999999999999999887 999999999999999999
Q ss_pred ceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhh
Q 000757 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1042 VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa 1120 (1299)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999976543332222334557889999999999999999999999999999999 99998654321 122211
Q ss_pred hcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
.. .... .....+...+.+++.+||+.+|++||++.+|+++|+.+...
T Consensus 239 ~~-----~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQ-----GRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hC-----CCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 0000 11122446789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=342.73 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=206.8
Q ss_pred CCcceeeEEeecCceEEEEEEecC----CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|.+.. ...|+||+++... ....++|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 579999999999999999999642 4579999986432 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+++|.+++... ...+++.++++++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 236899999999999999999999887 9999999999999999999999999998764
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
............++..|++||++.+..++.++||||||+++|||++ |+.||..... ..+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~--------- 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGY--------- 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC---------
Confidence 2222222222345678999999998999999999999999999998 9999854321 12222211100
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
......++...+.+|+.+||+.+|++||++.||++.|+.+
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011224456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=349.12 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=210.4
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
.+|.+.+.||+|+||+||++... ++..|++|.++.......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57899999999999999999842 345689999876555556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc---------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCccee
Q 000757 974 VYELIPNGSVESHLHGVD---------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~---------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKL 1044 (1299)
||||+.+++|.+++.... .....++|.++++++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 12235899999999999999999999887 999999999999999999999
Q ss_pred cCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcc
Q 000757 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i~~- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQ- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-
Confidence 99999986543222222233446788999999998999999999999999999998 89988654321 11111110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
.... .........+.+|+.+||+.+|.+||++.||++.|+.+...
T Consensus 238 ----~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 ----GRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----CCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 11112345799999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.60 Aligned_cols=259 Identities=28% Similarity=0.502 Sum_probs=205.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~ 970 (1299)
.+++|++.+.||+|+||.||+|.+. +++.||||+++... .....+|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24679999986432 2334578899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccC------CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCccee
Q 000757 971 RCLVYELIPNGSVESHLHGVDKE------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~------~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKL 1044 (1299)
.++||||+.+|+|.++++..... ...++|..++.++.|++.||+|||+.+ ++|||||++||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 234688999999999999999999887 999999999999999999999
Q ss_pred cCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcc
Q 000757 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... ....++...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~~- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVME- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc-
Confidence 99999875543222222223346788999999998899999999999999999999 7888865332 111111110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
. .. ......+...+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ---~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 ---G-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---C-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 00 0112234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=340.74 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=209.5
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+|+. .+++.||||.++.. +....++|.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999995 47899999988542 2333456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.........+++.++++++.|+++||+|||+.+ |+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444556889999999999999999999887 99999999999999999999999999886543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+...+. . .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~---~-~-------- 223 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE---Q-C-------- 223 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh---c-C--------
Confidence 211 1223468899999999998889999999999999999999999986432211 11111111 0 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.............+.+++.+||+.+|++||++.||++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 -DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000111123446799999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=346.46 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=205.6
Q ss_pred CCcceeeEEeecCceEEEEEEe-----cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-----kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
.+|++.+.||+|+||+||+|.+ .+++.|++|.++... .+..++|.+|++++++++|+||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688999999999999999984 246789999997432 3334678899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc-------------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC
Q 000757 974 VYELIPNGSVESHLHGVD-------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~-------------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg 1040 (1299)
||||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+.+ |+||||||+||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985221 11235889999999999999999999887 99999999999999999
Q ss_pred cceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHh
Q 000757 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 1119 (1299)
Q Consensus 1041 ~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~w 1119 (1299)
.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543332222333446778999999988889999999999999999998 9888864321 112222
Q ss_pred hhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1120 a~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
... .. .......+..++.+++.+||+.+|++||++.+|.+.|+.
T Consensus 239 ~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 00 001122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=361.60 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=194.6
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
+|+..+.||+|+||+||+|++. +|+.||||++.... ....++|.+|++++++++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999954 68999999986432 333567899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++|+|.+.. .+.+..+..|+.||++||+|||+.+ |+|||||++||||++++++||+|||+++......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999987543 3457788899999999999999887 9999999999999999999999999998653321
Q ss_pred ccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1059 RHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.......||..|+|||++.. ...+.++|||||||+||||++|+.||......+...+..... .
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~-------- 290 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---M-------- 290 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---c--------
Confidence 11234569999999998743 234568999999999999999999997433222111111100 0
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
............++.+|+.+||+.||++||++.||++.
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011222345679999999999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.86 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=207.0
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.++||+|+||.||+|.+.++..|++|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 579999999999999999999888889999998643 2345789999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.++++.. ....+++.+++.++.|++.||+|||+.+ ++|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999643 2345889999999999999999999887 99999999999999999999999999986543221
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|+|||++..+.++.++|||||||++|||++ |+.||..... .....+..... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~----~--------- 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGY----R--------- 222 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC----C---------
Confidence 11222346778999999988889999999999999999998 9999865322 12222211110 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
..........+.+++.+||..+|++||++.+|.+.|+.
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 -MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.29 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=203.5
Q ss_pred cceeeEEeecCceEEEEEEecC----CCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccc-----
Q 000757 902 FDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA----- 970 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~----- 970 (1299)
|++.+.||+|+||.||+|.+.. +..||||+++.. .....+++.+|++++++++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998642 367999998743 22334678999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhcccccc--cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 971 -RCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 971 -~~LVyEYm~GGSL~d~L~~~~--~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
.++||||+.+|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 22346899999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++...............++..|++||++....++.++|||||||++|||++ |..||..... ..+.++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99986644332222222335678999999988899999999999999999999 8888865332 112222111
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.. .......+..++.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234556899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=347.50 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=207.5
Q ss_pred CcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
+|++.++||+|+||.||+|+.. ....+++|.+.... ....+++.+|+.++++++|+||++++++|.+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5788999999999999999853 23568999886432 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc--------------------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccC
Q 000757 974 VYELIPNGSVESHLHGVD--------------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1033 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~--------------------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsN 1033 (1299)
||||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+.+ |+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 11235889999999999999999999887 9999999999
Q ss_pred eeeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCc
Q 000757 1034 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 1112 (1299)
Q Consensus 1034 ILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~ 1112 (1299)
|||++++.+||+|||+++...............++..|++||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543222222233456789999999988889999999999999999998 9999865332
Q ss_pred hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1113 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1113 ~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
..+..+... .........+...+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 -~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -ERLFNLLKT--------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHHhC--------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122222111 01111223445679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.91 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=206.4
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.+|++.+.||+|+||.||+|.++ +++.|++|+++. +....+++.+|++++++++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888999999999999999954 588899999874 3344568999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++... ....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998542 2345899999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...... .+... ... .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~---~~~-----------~ 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL---LEK-----------G 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---HHC-----------C
Confidence 1 1112234668999999998999999999999999999998 89998653211 11111 110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
............+.+++.+||+.+|++||++.|++++|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122233457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.91 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=211.0
Q ss_pred hCCcceeeEEeecCceEEEEEEecC-----CCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeee-ccce
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQAR 971 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkd-----Gr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e-~~~~ 971 (1299)
.++|++.++||+|+||.||+|.+.+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999765 688999998743 23345678899999999999999999999876 4678
Q ss_pred EEEEeecCCCChhhcccccccC----CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 972 CLVYELIPNGSVESHLHGVDKE----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~----~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
++++||+.+|+|.++|...... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998653222 146899999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...+. ..+..+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~-- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGY-- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCC--
Confidence 99986544333222233456788999999998889999999999999999999 9999965432 22233222110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
.+ .....+...+.+++.+||..+|++||++.|+++.|+.+..
T Consensus 237 --~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 --RL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --CC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 1112234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=376.98 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=206.9
Q ss_pred CcceeeEEeecCceEEEEEEec-C-CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-D-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-d-Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.|.+.++||+|+||.||+|... + ++.||+|++...+......+.+|+++|++++|+|||+++++|.+++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999844 3 5778888875544444567788999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
+||+|.++|+........+++.++..++.||+.||.|||+.+ |+|||||++||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654444557899999999999999999999887 99999999999999999999999999986644333
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......+||.+|+|||++.+..++.++|||||||++|||++|+.||..... ..+... .+... .+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~---~~~~~------~~--- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQ---VLYGK------YD--- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHhCC------CC---
Confidence 2334456799999999999999999999999999999999999999965321 111111 11100 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+......+.+|+.+||+.+|++||++.++++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122344678999999999999999999999754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.14 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=211.2
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+|... +|+.|++|.++.. +....+++.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999976 7899999988632 2333567899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.........+++.++++++.|+++||+|||+.+ |+|||||++||++++++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654444556899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+.++......
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~---------- 222 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK---------- 222 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc----------
Confidence 21 112234688999999999988899999999999999999999999864321 11111111110
Q ss_pred CCCCCCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1136 PSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1136 p~L~~~~p~-ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
........ .....+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 223 -~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00011111 34467899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=350.68 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=200.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999965 68899999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999853 346889999999999999999999887 99999999999999999999999999986532
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
. ....+|+..|+|||++.+..++.++|||||||+||||++|+.||...+... +... .....
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~---i~~~~-------- 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEK---ILAGK-------- 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC--------
Confidence 1 123569999999999998889999999999999999999999997543211 1111 11100
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq~ 1174 (1299)
..++......+.+|+.+||+.||.+|++ +.|+++.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112223457889999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.27 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=202.2
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCC----EEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr----~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
++|++.+.||+|+||+||+|++. +|+ .|++|.+.... ....+++..|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999953 454 36777775322 2234567888889999999999999999864 55789
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|+||+.+|+|.++++.. ...++|..++.|+.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999632 346899999999999999999999887 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.............++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+.++.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~----~~~~--- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLE----KGER--- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCc---
Confidence 44333223334557789999999998899999999999999999998 9999865432 11222211 1110
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
. .....+...+.+++.+||..+|++||++.|+++.|..+.+
T Consensus 230 ~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 0111233567889999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.98 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=209.8
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||++.. .+++.|+||.+... +....++|.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999994 57899999988643 2233457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.+++.........++|.++++++.||+.||+|||+.+ |+|+|||++|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998654444557899999999999999999999887 99999999999999999999999999876533
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. .......|+..|+|||++.+..++.++||||||+++|||++|..||....... ..+... +.+...
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-------~~~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-------IEQCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh-------hhcCCC
Confidence 22 11233568899999999998899999999999999999999999986432211 111110 000000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
. ..........+.+++.+||+.+|++||+|.+|++.++++
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 011123456799999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.15 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=200.8
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.++|++.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357999999999999999999965 68899999997532 23345788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|.+++.. ...+.+..+..++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999853 335788999999999999999999887 9999999999999999999999999998653
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.. ....+||..|+|||++.+..++.++|||||||+||||++|+.||...... ...+ ......
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~---~i~~~~------- 231 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYE---KILAGR------- 231 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHH---HHhcCC-------
Confidence 22 12356999999999999999999999999999999999999999643211 1111 111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq~ 1174 (1299)
+ .++.....++.+|+.+||+.||++|++ +.++++.
T Consensus 232 ---~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ---L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 111223456889999999999999996 5666544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=355.42 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=197.2
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
++||+|+||.||+++. .+|+.||||+++... .....++++|++++++++|+||+++++++.+.+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 478999999997532 233456789999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+++.. ...+++.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99999853 346899999999999999999999887 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1141 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~ 1141 (1299)
....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+..... ... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~---~~~------------~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELIL---MEE------------IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHH---cCC------------CC
Confidence 2345799999999999999999999999999999999999999965321 11111110 000 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1142 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1142 ~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
++.....++.+++.+||+.||++|+ +..|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2223456789999999999999999 78888654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.53 Aligned_cols=265 Identities=24% Similarity=0.363 Sum_probs=196.9
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec-----cceE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~-----~~~~ 972 (1299)
+|++.++||+|+||.||+|+. .+|+.||||+++.. ......++++|++++++++|+||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999995 46899999998642 223345788999999999999999999998643 2479
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+ +++|.+++.. ...+++.+++.++.||++||+|||+.+ |+|||||++|||+++++.+||+|||+++.
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 5789888842 335899999999999999999999887 99999999999999999999999999985
Q ss_pred cccccc-ccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH-Hhhhc------
Q 000757 1053 AMDEES-RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARP------ 1122 (1299)
Q Consensus 1053 ~~~~~~-~~~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV-~wa~p------ 1122 (1299)
...... .......+||..|+|||++.+ ..++.++|||||||++|||++|+.||...+........ +....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 112234569999999998875 67899999999999999999999999754322111100 00000
Q ss_pred -ccccccccceeec---CCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1123 -LLTSREGLERIID---PSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 -lls~~e~L~eIVD---p~L~~~~---p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+. .+...+.++ ....... -......+.+++.+||+.||++||++.|+++.
T Consensus 233 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000000 0000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.09 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=208.3
Q ss_pred hCCcceeeEEeecCceEEEEEEec--------CCCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeec
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk--------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~ 968 (1299)
.++|.+.+.||+|+||.||++... ++..||+|+++.. .....+++.+|+++++++ +|+||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999742 2346999999743 233445788999999999 799999999999999
Q ss_pred cceEEEEeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 969 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
+..|+||||+.+|+|.+++..... ....++|.++++|+.|++.||+|||+.+ |+|||||++|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 1235899999999999999999999887 9999999999999
Q ss_pred ccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhh
Q 000757 1037 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~n 1115 (1299)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H
Confidence 9999999999999876533221111222234578999999998889999999999999999998 88888643211 1
Q ss_pred hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
+.... . .............++.+|+.+||+.+|++||+|.||++.|+.+....
T Consensus 251 ~~~~~----~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLL----K----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHH----H----------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 0 01111222344568899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=375.70 Aligned_cols=240 Identities=28% Similarity=0.509 Sum_probs=205.3
Q ss_pred eeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 904 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 904 i~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
.++.||.|+.|.||+|+++ ++.||||+++..++ .+|+-|++|+|+||+.|.|+|.....+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3568999999999999999 78899999875332 478889999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
++.|+ ....++-.....|..+||.||.|||.+. |||||||.-||||..+..|||+|||-++...+. ....
T Consensus 200 ~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 99995 3456888899999999999999999886 999999999999999999999999998865432 2334
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
.++||..|||||++++...++|+|||||||||||||||..||...+. ..+.| .+-...|.-.++
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw------------GVGsNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW------------GVGSNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEE------------eccCCcccccCc
Confidence 57899999999999999999999999999999999999999965321 11122 112233444566
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
..+...|.-|++.||+..|..||+|.+|+..|..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 7888999999999999999999999999998863
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.55 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=205.6
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeee-ccc
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIE-EQA 970 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e-~~~ 970 (1299)
++|++.++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46999999999999999999732 34789999987432 23345678999999999 79999999998865 456
Q ss_pred eEEEEeecCCCChhhcccccccC---------------------------------------------------------
Q 000757 971 RCLVYELIPNGSVESHLHGVDKE--------------------------------------------------------- 993 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~--------------------------------------------------------- 993 (1299)
.+++|||+.+|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988532110
Q ss_pred CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccccC
Q 000757 994 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073 (1299)
Q Consensus 994 ~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmA 1073 (1299)
...++|..+++++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++...............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999887 99999999999999999999999999986543222222233456788999
Q ss_pred ccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHH
Q 000757 1074 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 1152 (1299)
Q Consensus 1074 PE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~ 1152 (1299)
||++.+..++.++|||||||+||||++ |+.||......+ .+... +... ...........++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~----------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR----LKEG----------TRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH----Hhcc----------CCCCCCccCCHHHHH
Confidence 999999999999999999999999998 999986533211 11111 1100 001112234467899
Q ss_pred HHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1153 IASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1153 LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
++.+||+.+|++||++.||+++|+.+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.25 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=207.2
Q ss_pred hCCcceeeEEeecCceEEEEEEecC------CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccce
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkd------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~ 971 (1299)
.++|++.+.||+|+||.||+|.+.+ +..|++|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4579999999999999999998642 3679999986432 23345788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhccccccc------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceec
Q 000757 972 CLVYELIPNGSVESHLHGVDK------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1045 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLs 1045 (1299)
++||||+.+|+|.+++..... ....++|..+++++.|++.||.|||+.+ |+|||||++|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864322 1234789999999999999999999887 9999999999999999999999
Q ss_pred CCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccc
Q 000757 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1046 DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh---
Confidence 9999986544332222333457889999999988889999999999999999998 8888864332 12222211
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
... ....+..+...+.+++.+||+.+|++||++.|+++.|+
T Consensus 236 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 01122334578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=368.82 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=207.6
Q ss_pred hCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccc
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA 970 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~ 970 (1299)
.++|++.++||+|+||.||+|++. .+..||||+++... ....+.|++|+++|++++ |+|||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567889999999999999999843 13469999996432 333467899999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000757 971 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 992 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~---------------------------------------------------------- 992 (1299)
.|||||||.+|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864211
Q ss_pred ----------------------------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc
Q 000757 993 ----------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH 1038 (1299)
Q Consensus 993 ----------------------------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe 1038 (1299)
....+++.++++++.|+++||+|||+.+ |+|||||++|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788999999999999999999887 999999999999999
Q ss_pred CCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhH
Q 000757 1039 DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLV 1117 (1299)
Q Consensus 1039 dg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV 1117 (1299)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |+.||....... .+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 99999999999986543222222233457788999999998899999999999999999997 999986532211 111
Q ss_pred HhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1118 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1118 ~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
... ... ............+.+++.+||+.+|++||++.+|+++|+.++.
T Consensus 351 ~~~----~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKI----KSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----hcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111 000 0011122345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.92 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=209.0
Q ss_pred hCCcceeeEEeecCceEEEEEEec--------CCCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeec
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk--------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~ 968 (1299)
.++|++.+.||+|+||.||+|+.. ++..|++|.++.. .....+++.+|+.+++++ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456889999999999999999741 2457999998643 234456789999999999 799999999999999
Q ss_pred cceEEEEeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 969 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
...|+||||+.+|+|.+++..... ....++|.++++++.||+.||+|||+.+ |+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999965321 1235889999999999999999999887 9999999999999
Q ss_pred ccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhh
Q 000757 1037 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~n 1115 (1299)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999986643322222233446778999999998889999999999999999998 7788754321
Q ss_pred hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
.++.... ... ........+...+.+|+.+||+.+|++||+|.||++.|+++...
T Consensus 246 -~~~~~~~-~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLL-KEG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHH-HcC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 111 01112234557899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=374.02 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=212.4
Q ss_pred HHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccce
Q 000757 897 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~ 971 (1299)
+-..||..+++||+|.|++||+|+ .++++.||||++.+. .+...+-+.+|-++|.+| .|+.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999999 557999999999653 334455678899999999 799999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+|+||++||+|.++|+.+ ..|++...+.++.+|+.||+|||.+| ||||||||+|||||+|+++||+|||-|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999654 46999999999999999999999888 9999999999999999999999999998
Q ss_pred cccccccc---------ccc--ccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhh
Q 000757 1052 SAMDEESR---------HIS--TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1052 ~~~~~~~~---------~~s--t~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa 1120 (1299)
.+...... ... ...+||..|++||++..+..+..+|+|+||||||+|+.|+.||...++.-
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------- 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------- 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence 76542221 111 44789999999999999999999999999999999999999998754311
Q ss_pred hcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+++|++ +.-.++......+.+|+.+.|..||.+|.+..||.+..
T Consensus 295 --------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 --------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0112221 11233444457889999999999999999999987764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=363.80 Aligned_cols=288 Identities=25% Similarity=0.332 Sum_probs=217.2
Q ss_pred cCCcccCCHHHHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhh--cccccceee
Q 000757 884 TGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVKL 961 (1299)
Q Consensus 884 sgS~k~Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsr--LrHPNIVrL 961 (1299)
+|++....+--.+...++..+.+.||+|+||+||+|+++ |+.||||++...+ ++.+.||.+|+.. |||+||+.|
T Consensus 195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhh
Confidence 455666677777888899999999999999999999999 8999999997433 4577788888775 599999999
Q ss_pred eeeeeec----cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhc-----CCCceeeeccccc
Q 000757 962 IGICIEE----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-----SSPRVIHRDFKSS 1032 (1299)
Q Consensus 962 lG~~~e~----~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~-----gsp~IVHRDIKPs 1032 (1299)
++.-..+ .++|||.+|.+.|||+|||.. ..++.+..++++..+|.||++||.. |++.|.|||||++
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 9986543 356999999999999999952 4699999999999999999999964 7888999999999
Q ss_pred CeeeccCCcceecCCCcccccccccc--ccccccccccccccCccccccC----CC--CccccchhhHHHHHHHHhCCCC
Q 000757 1033 NILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTG----HL--LVKSDVYSYGVVILELLSGRKP 1104 (1299)
Q Consensus 1033 NILLDedg~VKLsDFGLAr~~~~~~~--~~~st~v~GT~gYmAPE~l~~~----~~--T~KSDVWSLGVVLyELLTGr~P 1104 (1299)
||||..++.+.|+|+|||........ .--....+||.+|||||++... .+ ...+||||||+||||+.....-
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 99999999999999999976544321 1123456799999999988643 22 2568999999999999863210
Q ss_pred CCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1105 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1105 Fd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
.+...+.+--+.+|+...-..++..+-+....++..++ .+.+..+.+||+.||..+|..|-|+-.|.+.|.++.
T Consensus 426 -ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 426 -GGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred -CCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 00000001111122222222222222222333333333 577899999999999999999999999999998877
Q ss_pred hh
Q 000757 1180 NE 1181 (1299)
Q Consensus 1180 ~e 1181 (1299)
+.
T Consensus 505 ~~ 506 (513)
T KOG2052|consen 505 NS 506 (513)
T ss_pred cC
Confidence 54
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.39 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=204.4
Q ss_pred CcceeeEEeecCceEEEEEEec------CCCEEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
+|++.+.||+|+||.||+|.+. +++.||||+++.... ...++|.+|+.++++++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4777889999999999999853 246799999974332 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhccccc------------ccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc
Q 000757 974 VYELIPNGSVESHLHGV------------DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~------------~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~ 1041 (1299)
++||+.+++|.+++... ......+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 111235889999999999999999999887 999999999999999999
Q ss_pred ceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhh
Q 000757 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1042 VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa 1120 (1299)
+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||..... ..+.+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 99999999886543332222233456789999999988899999999999999999998 8888864322 1122211
Q ss_pred hcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
. . . . ...+..++...+.+|+..||+.+|++||++.||++.|+.
T Consensus 240 ~---~-~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R---N-R---------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---c-C---------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1 0 0 012233456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=379.34 Aligned_cols=267 Identities=28% Similarity=0.449 Sum_probs=218.0
Q ss_pred HHHHHHhCCcceeeEEeecCceEEEEEEecCC----CE-EEEEEeec---ccccchhHHHHHHHHhhhcccccceeeeee
Q 000757 893 SEIEKATGNFDASRILGEGGFGLVYSGVLDDG----TK-VAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964 (1299)
Q Consensus 893 ~ELe~at~nFsi~elLGeGgFGtVYKA~lkdG----r~-VAVK~Lk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~ 964 (1299)
..++...++..+.++||+|+||+||+|+++.+ .. ||||..+. ......++|++|.++|++++|+|||+|+|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34455566777789999999999999996532 23 89999874 345667789999999999999999999999
Q ss_pred eeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCccee
Q 000757 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044 (1299)
Q Consensus 965 ~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKL 1044 (1299)
+..+.-+|||||+|.||+|.++|.... ..++..+++++++++|+||+|||.++ +|||||..+|||++.++.+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999996432 25999999999999999999999887 999999999999999999999
Q ss_pred cCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcc
Q 000757 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
+||||++.... +........-...|+|||.+..+.|+.++|||||||++||+++ |..||...+.. .+..|
T Consensus 304 SDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~k---- 374 (474)
T KOG0194|consen 304 SDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAK---- 374 (474)
T ss_pred CccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHH----
Confidence 99999875431 1111112235679999999999999999999999999999999 88898765322 11122
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhh
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
++....+...+......+..++..||..+|++|++|.++.+.|+.+.....
T Consensus 375 ---------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 ---------IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---------HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 222233344555677889999999999999999999999999998876544
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.96 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=199.0
Q ss_pred cceeeEEeecCceEEEEEEecCC-C--EEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec------cc
Q 000757 902 FDASRILGEGGFGLVYSGVLDDG-T--KVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QA 970 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdG-r--~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~------~~ 970 (1299)
|.+.++||+|+||.||+|++.+. . .||+|.++.. .....++|.+|++++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45678999999999999996543 2 5899988643 233456788999999999999999999987532 24
Q ss_pred eEEEEeecCCCChhhcccccc--cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 971 RCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~--~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
.++||||+.+|+|.+++.... .....++|.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 589999999999999874221 22345899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+++...............++..|++||++....++.++|||||||++|||++ |+.||..... ..+.+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HcC
Confidence 9986543222111222346778999999999999999999999999999999 7888864321 1111111 111
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
+.. .........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11123446789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=353.20 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=197.2
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
++||+|+||.||++.. .+|+.||||+++.. .....+++.+|++++++++|+||+++++++.+++..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 46899999999753 2334567889999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99988843 346899999999999999999999887 999999999999999999999999998754221 112
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1141 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~ 1141 (1299)
....+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... ..... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~---~~~~~------------~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILMED------------IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHH---hccCC------------cc
Confidence 23457999999999999999999999999999999999999999653221 11111 11100 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1142 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1142 ~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
++.....++.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2223446788999999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.81 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=197.0
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
+.||+|+||.||+|++. +++.||+|.+... .......|.+|++++++++|+||++++++|......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 7889999987643 233456799999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++.. ....++|.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999853 2235889999999999999999999887 9999999999999999999999999987543211111111
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~ 1142 (1299)
...++..|+|||++.++.++.++|||||||++|||++ |..||...... ....... .......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~--------------~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIE--------------QGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHH--------------cCCCCCC
Confidence 1123467999999999899999999999999999998 88888643211 1111110 0111112
Q ss_pred ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1143 p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.......+.+++.+||+.+|++||++.||+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=350.68 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=199.0
Q ss_pred CcceeeEEeecCceEEEEEEe----cCCCEEEEEEeeccc----ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccce
Q 000757 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l----kdGr~VAVK~Lk~~d----~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~ 971 (1299)
+|++.+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|++++++++ |+||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999885 357899999996432 233456788999999995 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+.+|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 345889999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
....... ......+||..|||||++.+. .++.++||||||||||||++|+.||.......... ........
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 6533222 122345799999999998765 47889999999999999999999997543222111 11111111
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
.+. .+.......+.+++.+||+.||++|+ ++.|+++.
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011 12223446788999999999999999 66676554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.61 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=203.4
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||+|.++++..||||.++.. ....++|.+|+.++++++|+||++++++|.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 458889999999999999999887778999998743 3345679999999999999999999999998888999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++... ...++|.++++++.||+.||+|||+.+ |+|+|||++|||+++++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999998542 225899999999999999999999887 99999999999999999999999999876543221
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|++||++.+..++.++|||||||++|||++ |+.||...+.. ........ ..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~----~~---------- 218 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQ----GL---------- 218 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhc----CC----------
Confidence 11122335678999999988889999999999999999998 99998654321 11111110 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
...........+.+++.+||+.+|++||++.+|++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 0011112346889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.87 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=204.0
Q ss_pred hCCcceeeEEeecCceEEEEEEecC------CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccce
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkd------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~ 971 (1299)
+++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999653 5678999886432 33345799999999999999999999999998999
Q ss_pred EEEEeecCCCChhhccccccc---CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC---cceec
Q 000757 972 CLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVS 1045 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~---~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg---~VKLs 1045 (1299)
++||||+.+++|.++++.... ....++|.++++++.||+.||+|||+.+ |+|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 1235899999999999999999999887 99999999999998754 59999
Q ss_pred CCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccc
Q 000757 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1046 DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~--- 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVT--- 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---
Confidence 9999986532222111222234568999999999999999999999999999997 99998754321 1111110
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.......+......+.+++.+||+.+|++||++.||++.|+
T Consensus 236 -----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -----------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00111122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.63 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=204.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999965 78999999997532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++... ..+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999532 46899999999999999999999887 99999999999999999999999999986543
Q ss_pred cc---------------------------cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 000757 1056 EE---------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1108 (1299)
Q Consensus 1056 ~~---------------------------~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s 1108 (1299)
.. .........||..|+|||++.+..++.++||||||||||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 011223456999999999999999999999999999999999999999764
Q ss_pred CCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-HHHHHHH
Q 000757 1109 QPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQA 1174 (1299)
Q Consensus 1109 ~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-MsEVLq~ 1174 (1299)
..... ..+..|. ..+ ...........+.+++.+|+. +|++|++ +.|+++.
T Consensus 234 ~~~~~~~~i~~~~-------~~~--------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK-------ESL--------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC-------Ccc--------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 42111 1111110 000 000111135678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=339.95 Aligned_cols=268 Identities=29% Similarity=0.409 Sum_probs=206.1
Q ss_pred cceeeEEeecCceEEEEEEe-----cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceEE
Q 000757 902 FDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 973 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-----kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~L 973 (1299)
|++.+.||+|+||+||++.+ .+++.||+|+++... ....+.|.+|+++|++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 357789999987532 23456788999999999999999999998653 35789
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.+|+|.+++.. ..++|.++++|+.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999853 24899999999999999999999887 999999999999999999999999999865
Q ss_pred cccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~-~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
...... .......++..|++||++....++.++|||||||++|||++|+.||....... ..+..+...... ...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMT-VVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccc-hhhhhh
Confidence 432221 11122345678999999988899999999999999999999999986532211 111111111000 111122
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
+++.............++.+++.+||+.+|++||++++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222233455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=372.98 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=211.1
Q ss_pred CcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
.|..-..||+|..|.||.++ ..+++.||||++....+...+-+++|+.+|+.++|+|||++++.|..++++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46666789999999999998 56788999999987777777788999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
||+|.|.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+||||+.+|++||+|||++..+..+..
T Consensus 354 ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999843 35999999999999999999999888 99999999999999999999999999987765443
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
.....+||+.|||||+.....|+.|.||||||++++||+-|+.||-..+......+ +..++ ...
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~ng--------~P~ 488 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG--------TPK 488 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------HhhcC--------CCC
Confidence 33567899999999999999999999999999999999999999964332211111 11111 111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-.........|.+++.+||..|+++|+++.|+++.
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12334456789999999999999999999999976
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.57 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=203.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-----CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeee--ccceE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARC 972 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-----dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~~ 972 (1299)
++|++.+.||+|+||.||++.++ +++.|++|+++.......++|.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999743 578899999976655556789999999999999999999998754 34678
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+.+|+|.+++... ...++|..++.++.|+++||+|||+.+ |+|||||++||||++++++||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998532 235899999999999999999999887 99999999999999999999999999986
Q ss_pred cccccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc---c
Q 000757 1053 AMDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---E 1128 (1299)
Q Consensus 1053 ~~~~~~~~-~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~---e 1128 (1299)
........ ......++..|+|||++.+..++.++|||||||++|||++|..++...... +........... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 54322211 111222445699999999889999999999999999999987765322110 000000000000 0
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.+.++++..............+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111112234456799999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=336.88 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=202.2
Q ss_pred CcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+|++.+.||+|+||.||+|.+++++.+++|++... ....++|.+|++++++++|+||+++++++.+.+..|+||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 57888999999999999999887788999998643 23446788999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
++|.++++.. ...++|..+++|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++...+....
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999998632 236899999999999999999999887 999999999999999999999999999765432111
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
......++..|+|||++.+..++.++|||||||+||||++ |+.||+..... ........ ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~--------------~~~ 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVSA--------------GYR 219 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHHc--------------CCc
Confidence 1111224468999999998899999999999999999999 88998654321 11111110 001
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
......+..++.+|+.+||..+|++||+|.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112223556899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=342.09 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=200.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.++||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999954 68899999986432 23345678999999999999999999999998899999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. |+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 96 5898888532 235788999999999999999999887 9999999999999999999999999997543221
Q ss_pred cccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH-Hhh-------hccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWA-------RPLLTSRE 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV-~wa-------~plls~~e 1128 (1299)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+..... ... ++.+...+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 11233468999999998865 56899999999999999999999999765432211111 000 00111111
Q ss_pred ccceeecCCCCCC----CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1129 GLERIIDPSLGND----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~----~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
...+.+.+..... .......++.+|+.+||+.||++|+|+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111100 01123356889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.58 Aligned_cols=265 Identities=22% Similarity=0.281 Sum_probs=196.6
Q ss_pred CCcceeeEEeecCceEEEEEEe-c-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhc---ccccceeeeeeee-----e
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-D-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICI-----E 967 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-k-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~-----e 967 (1299)
++|++.+.||+|+||+||+|+. . +|+.||||+++... ......+.+|+++++++ +|+||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999985 3 46789999986432 22234667888887776 6999999999985 2
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
....++||||+. ++|.+++.... ...+++.+++.|+.|++.||+|||+.+ |+|||||++||||++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456799999995 68999885432 235899999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhhcccc-
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLT- 1125 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~plls- 1125 (1299)
|+++..... .......|+..|+|||++....++.++|||||||+||||++|+.+|......+.. .+.+.......
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999765332 2234456899999999998889999999999999999999999999765432211 11111100000
Q ss_pred ---ccc-ccceeecCCCCC---CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1126 ---SRE-GLERIIDPSLGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1126 ---~~e-~L~eIVDp~L~~---~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
... .....+...... ....+....+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000001000000 011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=354.39 Aligned_cols=268 Identities=21% Similarity=0.337 Sum_probs=203.9
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.++|++.++||+|+||.||++..+ +++.+|+|+++.. .....+++.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999965 6888999988643 23344678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++.. ...+++..+.+++.|++.||.|||+.+ +|+|||||++||||++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999853 335889999999999999999999742 3999999999999999999999999998755322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH------hhhcccccc---
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA------WARPLLTSR--- 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~------wa~plls~~--- 1127 (1299)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. +........
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1233468999999999998889999999999999999999999997543211111000 000000000
Q ss_pred ---------------cccceeecCCCC---CCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1128 ---------------EGLERIIDPSLG---NDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1128 ---------------e~L~eIVDp~L~---~~~-p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
..+.++.+.... ... ......++.+|+.+||+.||++||++.|+++.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000000000 000 0113456899999999999999999999976533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.21 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=204.8
Q ss_pred CCcceeeEEeecCceEEEEEEecC-CC--EEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD-GT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd-Gr--~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.++||+|+||.||+|++++ +. .+++|.++.. .....++|.+|++++.++ +|+||+++++++.+.+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998653 33 4788888743 233456789999999999 799999999999999999999
Q ss_pred EeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 975 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
|||+.+|+|.++++.... ....+++.++++|+.|++.||+|||+.+ |+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999964321 1135889999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhh
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
||+|||++....... .......+..|++||++....++.++|||||||++|||++ |+.||...... .+...
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEK-- 230 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence 999999986432110 1111223567999999988889999999999999999997 99999654321 11111
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
... .........+...+.+|+.+||+.+|.+||++.+|++.|+.+.+..
T Consensus 231 -~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 -LPQ-----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -Hhc-----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 110 0111122234467899999999999999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.61 Aligned_cols=251 Identities=31% Similarity=0.520 Sum_probs=204.8
Q ss_pred eEEeecCceEEEEEEecC----CCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+.||+|+||.||+|...+ +..|++|+++..... ..+++.+|++++++++|+||+++++++.++...++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999654 788999999754333 367889999999999999999999999999999999999999
Q ss_pred CChhhcccccccC-----CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 981 GSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 981 GSL~d~L~~~~~~-----~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
++|.+++...... ...+++.++++++.|+++||+|||+.+ |+|||||++|||+++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754222 357999999999999999999999887 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
...........++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+.... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK----G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----C-------
Confidence 332222334567889999999988899999999999999999999 6999976421 112121111 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
...........++.+++.+||+.+|++||++.|+++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011222334578999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=351.79 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=196.3
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
++||+|+||.||+++. .+|+.||+|+++.. ......++.+|++++++++|+||+++++++...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999995 46899999999753 2234456788999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988843 346899999999999999999999887 9999999999999999999999999987532211 11
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1141 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~ 1141 (1299)
....+||..|+|||++.++.++.++|||||||+||||++|+.||...+... +.... .... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~~---~~~~------------~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LMEE------------IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---hcCC------------CC
Confidence 234569999999999999999999999999999999999999996543211 11110 0000 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1142 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1142 ~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2223456789999999999999998 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.21 Aligned_cols=265 Identities=26% Similarity=0.442 Sum_probs=206.9
Q ss_pred hCCcceeeEEeecCceEEEEEEecC-----------------CCEEEEEEeeccc-ccchhHHHHHHHHhhhccccccee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVK 960 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkd-----------------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVr 960 (1299)
.++|++.+.||+|+||.||+++..+ +..||+|++.... ....++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999998542 2458999986432 334567899999999999999999
Q ss_pred eeeeeeeccceEEEEeecCCCChhhccccccc-------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccC
Q 000757 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1033 (1299)
Q Consensus 961 LlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~-------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsN 1033 (1299)
++++|..++..++||||+.+++|.++|..... ....+++..++.++.|++.||+|||+.+ |+|||||++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965331 1236899999999999999999999887 9999999999
Q ss_pred eeeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCCC
Q 000757 1034 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPP 1111 (1299)
Q Consensus 1034 ILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT--Gr~PFd~s~~~ 1111 (1299)
||+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543332233334556789999999998899999999999999999998 6677754321
Q ss_pred chhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1112 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1112 ~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.....+....+.... .... ......+..++.+++.+||+.+|++||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDG-RQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccc-cccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 122222221111110 0000 0111233468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.21 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=204.9
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CC---CEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dG---r~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
.++|+..++||+|+||.||+|++. ++ ..+++|+++.. .....+++.+|++++++++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999965 33 36999998643 23345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.+++|.+++.. ....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999853 2246899999999999999999999887 999999999999999999999999999765
Q ss_pred ccccccccc-ccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1054 MDEESRHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1054 ~~~~~~~~s-t~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
......... .....+..|++||++..+.++.++|||||||++|||++ |+.||..... ..+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~----~---- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIND----G---- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhc----C----
Confidence 432221111 11223467999999998899999999999999999998 9999964332 111111110 0
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.......++...+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=355.03 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=199.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999954 68999999997532 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 235899999999999999999999887 99999999999999999999999999875422
Q ss_pred cccc------------------------------------cccccccccccccCccccccCCCCccccchhhHHHHHHHH
Q 000757 1056 EESR------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1099 (1299)
Q Consensus 1056 ~~~~------------------------------------~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELL 1099 (1299)
.... ......+||..|+|||++....++.++|||||||+||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---HHHHHHH
Q 000757 1100 SGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF---MGEVVQA 1174 (1299)
Q Consensus 1100 TGr~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS---MsEVLq~ 1174 (1299)
+|+.||........ ..+..|. ..+. + .........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~-------~~~~------~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWK-------ETLQ------F--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC-------CccC------C--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975432111 1111111 0000 0 0011234567889999996 8999998 8888664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.51 Aligned_cols=262 Identities=27% Similarity=0.460 Sum_probs=205.4
Q ss_pred HhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~ 970 (1299)
..++|++.+.||+|+||.||+|..+ .+..||+|.++... .....++.+|++++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999754 24579999986432 2233468899999999999999999999999899
Q ss_pred eEEEEeecCCCChhhccccccc------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCccee
Q 000757 971 RCLVYELIPNGSVESHLHGVDK------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKL 1044 (1299)
.|+||||+.+|+|.++++.... ....+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 1234577889999999999999999887 999999999999999999999
Q ss_pred cCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcc
Q 000757 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
+|||+++...............++..|++||++.++.++.++|||||||++|||++ |+.||...... .+..+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~-- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFVM-- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH--
Confidence 99999986543222222223345778999999999999999999999999999998 78888643221 1111110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
. .+ . ......+...+.+++.+||+.+|++||++.|+++.|+...
T Consensus 236 -~-~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -D-GG---------Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -c-CC---------C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 00 0 0112233468999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=334.02 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=203.9
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||+|..+++..|++|.++... ...++|.+|++++++++|+||+++++++. +...++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4688899999999999999998888899999997533 34567999999999999999999999885 456799999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+++|.++++.. ....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999998642 2345899999999999999999999887 999999999999999999999999999765332211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...+. ....++... ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~--------------~~ 220 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVER--------------GY 220 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc--------------CC
Confidence 1122335678999999988899999999999999999999 8889865332 112222111 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
......+....+.+|+.+||..+|++||++.++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223445679999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=358.38 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=205.3
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeecc--ceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ--ARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~--~~~LVyE 976 (1299)
.++...+.||+|.||.||++... +|+..|||.+...+....+.+.+|+.+|++|+|+|||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999965 48999999987553333567899999999999999999999855544 5899999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr~~~~ 1055 (1299)
|+.+|+|.+++.+... .|++..+.++..||++||+|||+++ |||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999964332 5999999999999999999999887 999999999999999 79999999999986653
Q ss_pred -cccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1056 -EESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1056 -~~~~~~st~v~GT~gYmAPE~l~~~~-~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
...........||+.|||||++..+. ...++|||||||+++||+||+.||... . ....+......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~-------- 237 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGR-------- 237 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhc--------
Confidence 11112233467999999999998643 345999999999999999999999653 1 11111111111
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
......++.....+..+++.+|+..+|++|||+.|+++......
T Consensus 238 --~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 238 --EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred --cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 01111344456678899999999999999999999988766443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.40 Aligned_cols=237 Identities=23% Similarity=0.264 Sum_probs=192.7
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|++++++++|+||+++++++.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5889999999753 233456788999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999853 345899999999999999999999887 9999999999999999999999999997543221 2234
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
..+||..|+|||++.+..++.++|||||||++|||++|+.||...+. .......+... ..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~------------~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP------------LRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC------------CCCC
Confidence 46799999999999999999999999999999999999999965321 11111111110 0122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEV 1171 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEV 1171 (1299)
......+.+++.+||+.||++|+++..+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 2344678899999999999999865333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.09 Aligned_cols=264 Identities=23% Similarity=0.434 Sum_probs=202.9
Q ss_pred CCcceeeEEeecCceEEEEEEecC---------------CCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD---------------GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIG 963 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd---------------Gr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG 963 (1299)
++|++.+.||+|+||.||+++..+ ...||+|+++.. .....++|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987542 224899998643 2333457899999999999999999999
Q ss_pred eeeeccceEEEEeecCCCChhhccccccc--------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCee
Q 000757 964 ICIEEQARCLVYELIPNGSVESHLHGVDK--------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 1035 (1299)
Q Consensus 964 ~~~e~~~~~LVyEYm~GGSL~d~L~~~~~--------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNIL 1035 (1299)
++..++..++||||+.+++|.+++..... ....++|.++++++.|++.||+|||+.+ |+||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854221 1124789999999999999999999887 999999999999
Q ss_pred eccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCch
Q 000757 1036 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQ 1113 (1299)
Q Consensus 1036 LDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT--Gr~PFd~s~~~~~ 1113 (1299)
|++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999976543222222233446789999999998899999999999999999998 55676543321
Q ss_pred hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1114 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1114 ~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.........+...... . ...........+.+|+.+||+.+|++||+|.+|++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGRQ--I-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhcccc--c-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111110000 0 00111223468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.46 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=205.2
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 973 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~L 973 (1299)
.+.|+..++||+|+||.||||+ ..+|+.||+|++.... .....-..|||.||++|+|+||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888899999999999999 6789999999997533 33344557999999999999999999999876 68899
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|+|||+ -+|.-++.. ..-.|++.++..++.||+.||+|||.++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999995 477776642 2346899999999999999999999888 999999999999999999999999999987
Q ss_pred cccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH----------Hhhhc
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV----------AWARP 1122 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV----------~wa~p 1122 (1299)
....... .+..+-|++|.+||++.+ ..|+.+.|+||+||||.||++|+..|.+.++-++...+ .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6544443 344567999999998876 47999999999999999999999999887654443322 12211
Q ss_pred ccccccccceeecCCC------CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1123 LLTSREGLERIIDPSL------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 lls~~e~L~eIVDp~L------~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+. ...++.+.. ++. -.......++|+..+|..||++|.|+.++++.
T Consensus 348 kLP----~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLP----HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCC----cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 001111111 111 01223567889999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.89 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=205.2
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+.|+...++|+|+||.|||++. ++|+.||||++.+.. ....+-.+|||++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999995 469999999996532 2334456899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||+.--|. .|. .....++.+.+.++++|+++|+.|||+++ +|||||||+||||+.++.+||||||+|+.....
T Consensus 82 ~~dhTvL~-eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLH-ELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHH-HHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99654443 342 22345888999999999999999999887 999999999999999999999999999987632
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHh--------hhcccccc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW--------ARPLLTSR 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~w--------a~plls~~ 1127 (1299)
. ...+..+.|.+|+|||.+.+ -+|+..+|||++||++.||++|..-|-+...-++...+.- ....+..+
T Consensus 155 g--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 G--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred c--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 1 22244568999999998887 7899999999999999999999998877655444332221 11222222
Q ss_pred cccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+.-+......+ .....-+++++..||+.||++|.+-+|++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 2222222111111111 1234578999999999999999999999754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=329.87 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=205.4
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|+.+ +++.|++|.+... .....+++.+|++++++++|+||+++++++.+++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888999999999999999964 6889999998632 344567889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.++++... ...+++.++++++.|++.||.|||+.+ |+|||||++|||+++++++||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999996432 346899999999999999999999887 9999999999999999999999999988654322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...+. .....+... .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-----~--------- 216 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKIIR-----G--------- 216 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc-----C---------
Confidence 122345688999999999999999999999999999999999999975431 111111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
............+.+++.+||+.+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011222345679999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.06 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=203.9
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||+|+++++..|++|+++.. ....++|.+|++++++++|+||+++++++.+ +..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 569999999999999999999877778999999753 2345679999999999999999999998754 56799999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++... ....++|..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 99999999642 2235789999999999999999999887 99999999999999999999999999976543221
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|++||++.+..++.++|||||||++|||++ |+.||....... ..+- ... . .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~---~~~-~----------~ 220 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ---VER-G----------Y 220 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHH---Hhc-C----------C
Confidence 11122346778999999988899999999999999999999 888886543211 1110 000 0 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
......+....+.+|+.+||+.+|++||++.++++.|+..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011224456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.22 Aligned_cols=247 Identities=32% Similarity=0.461 Sum_probs=199.1
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 984 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~ 984 (1299)
++||+|+||.||+|..++++.||+|+++... ......|.+|++++++++|+||++++++|.+.+..++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3799999999999998888999999986543 233456889999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccccccc
Q 000757 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064 (1299)
Q Consensus 985 d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~ 1064 (1299)
+++... ...++|.++++++.|++.+|.|||+.+ ++|||||++||++++++.+||+|||+++....... .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 998532 235889999999999999999999887 99999999999999999999999999875432111 11122
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1065 v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
..++..|+|||++.++.++.++|||||||++|||++ |..||...... ........ .......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~--------------~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEK--------------GYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc--------------CCCCCCC
Confidence 234678999999998999999999999999999998 99999654321 11111110 0011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
......+.+++.+||..+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.19 Aligned_cols=266 Identities=22% Similarity=0.307 Sum_probs=198.7
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 68899999986432 2234467899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.....
T Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YV-HTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-CcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99 46888877532 345889999999999999999999887 999999999999999999999999998754321
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc-------ccccc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL-------LTSRE 1128 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl-------ls~~e 1128 (1299)
. .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ..+....... +....
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhCCCChhhccchh
Confidence 1 12233568999999998765 457899999999999999999999997543211 1111000000 00000
Q ss_pred ccceeecCCCCCCCC---------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVP---------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p---------~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+..+....+..... ......+.+|+.+||+.||++|+|+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000000 0123567899999999999999999999763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.45 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=205.5
Q ss_pred hCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.++|++.++||+|+||.||+|..++++.||+|.+... ....++|.+|++++++++|+||+++++++. ++..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 4679999999999999999999988999999998743 334568999999999999999999999874 46789999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+|||||++||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999998542 2346899999999999999999999887 99999999999999999999999999976542211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.......++..|++||++....++.++|||||||++|||++ |+.||...+.. .+...... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~----~---------- 219 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLER----G---------- 219 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHc----C----------
Confidence 11122345678999999998889999999999999999999 99999654321 11111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
...........++.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001112334679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.61 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=201.5
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+|++.++||+|+||+||++.. .+++.||||++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999995 468899999996432 2223567889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++... ....+++.+++.++.|++.||.|||+.+ |+|||||++|||+++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888532 2345899999999999999999999887 999999999999999999999999998765322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .... ...+. .
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~-~~~~~------~---- 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEV-ERRVK------E---- 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHH-HHHhh------h----
Confidence 1 12234689999999999988999999999999999999999999975432211 1011 00000 0
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
....+.......+.+|+.+||+.||++|+ +++++++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112223456789999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=373.97 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=209.9
Q ss_pred HHHHHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc
Q 000757 893 SEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 893 ~ELe~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~ 969 (1299)
.+++...++|++.++||+|+||+||+|+ ..+|+.||||+++.. .......+.+|+.++..++|+||+++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3444556799999999999999999998 457899999998643 3344557889999999999999999988775432
Q ss_pred --------ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc
Q 000757 970 --------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041 (1299)
Q Consensus 970 --------~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~ 1041 (1299)
.+++||||+.+|+|.++|+........+.+.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 357999999999999999755444567899999999999999999999887 999999999999999999
Q ss_pred ceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh
Q 000757 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1042 VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
+||+|||+++..............+||..|+|||++.+..++.++|||||||+||||++|+.||...+. .+++.
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence 999999999865433223333456799999999999999999999999999999999999999965321 11111
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+... . ...+.....++.+|+.+||+.+|++||++.|+++.
T Consensus 256 ~~~~~~------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGR------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCC------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111100 0 01222345679999999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.88 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=204.5
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCC----EEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr----~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
.++|++.++||+|+||+||+|++ .+|+ .||+|+++.. .....+++.+|+.++++++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788999999999999999984 3454 4799998643 33345678899999999999999999999975 4568
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
++|||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999998642 335899999999999999999999887 99999999999999999999999999986
Q ss_pred ccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
..............++..|++||.+.+..++.++|||||||+||||++ |..||+.... ..+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~------ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEKGER------ 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCc------
Confidence 643222111222235678999999988899999999999999999998 8999864322 222222221100
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
......+...+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011123446789999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.80 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=206.5
Q ss_pred CCcceeeEEeecCceEEEEEEec--------CCCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeecc
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk--------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~ 969 (1299)
++|.+.+.||+|+||.||++... .+..||+|+++.. .....+++.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56889999999999999999742 2456899998743 233456788999999999 6999999999999989
Q ss_pred ceEEEEeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec
Q 000757 970 ARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1037 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD 1037 (1299)
..|+||||+.+|+|.+++..... ....++|.++++++.|++.||+|||+.+ |+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999864321 1245899999999999999999999887 99999999999999
Q ss_pred cCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhh
Q 000757 1038 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 1116 (1299)
Q Consensus 1038 edg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nL 1116 (1299)
+++++||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||...... .+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 999999999999986543222211222234568999999998899999999999999999999 88888643221 11
Q ss_pred HHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1117 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1117 V~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
..... .. ........+..++.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 246 ~~~~~----~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 FKLLR----EG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111 00 00112233456788999999999999999999999999977653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=374.68 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=210.6
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
+-|++++.||+|+.|.|..|+ ..+|+.+|||++.+. .......+.+||.||+.|.|+||++|++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 458889999999999999999 678999999999654 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||++||.|+++|- .+++|.+.+..+++.||+.||.|||..+ |+|||||++|+|||.++++||+|||+|.+...
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999993 4567999999999999999999999887 99999999999999999999999999986533
Q ss_pred cccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~-T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
..+..+-||.+.|.|||++++..| +.++||||+|||||.||+|+.||++++. ........ .+..
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------r~LLlKV~---~G~f--- 229 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI------RVLLLKVQ---RGVF--- 229 (786)
T ss_pred ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH------HHHHHHHH---cCcc---
Confidence 344566799999999999999887 4899999999999999999999985432 11111111 1111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
+++.....+..+|+.+|+..||++|.|+.||++.-.
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 233455678899999999999999999999987754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=369.12 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=209.5
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHH--HHHHHHhhhcc-cccceeeeeeeeecc-ceE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH-HRNLVKLIGICIEEQ-ARC 972 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keF--lrEIeILsrLr-HPNIVrLlG~~~e~~-~~~ 972 (1299)
..++|.+.++||.|.||.||+|+ .++|+.||||++++.- ...++. +||++.|++|+ |+|||+|.+++.+.+ .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678999999999999999999 6679999999998632 223443 68999999999 999999999999887 899
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||| ..+|++++++. +..+++.+++.|++||++||+|+|++| ++||||||+||||..+..+||+||||||.
T Consensus 87 fVfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 999999 68999999643 568999999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccccccccccccccccCcccc-ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh--ccc---cc
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR--PLL---TS 1126 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l-~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~--pll---s~ 1126 (1299)
.... .-.+..+.|.+|+|||++ +.+.|+.+.|||++|||++||.+-+.-|-+.++-++...+-.+. +.. ..
T Consensus 160 v~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 7432 223456689999999965 46789999999999999999999999998766544332211100 000 00
Q ss_pred ccccceeec--------CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1127 REGLERIID--------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1127 ~e~L~eIVD--------p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
...+...+. ..+..-.+ .+..+..+|+.+|+..||++|||+.|.++.-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 001111111 11111122 2567899999999999999999999998763
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.96 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=207.6
Q ss_pred CCcceeeEEeecCceEEEEEEec--------CCCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeecc
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk--------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~ 969 (1299)
.+|++.+.||+|+||.||++... ++..||+|.++.. .....+++.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46899999999999999999742 1236899988743 233456789999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccc------------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec
Q 000757 970 ARCLVYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1037 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~------------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD 1037 (1299)
..++||||+.+|+|.++|.... .....+.|.++++++.|++.||+|||+.+ |+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 12345889999999999999999999887 99999999999999
Q ss_pred cCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhh
Q 000757 1038 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 1116 (1299)
Q Consensus 1038 edg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nL 1116 (1299)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999986543222222222334578999999999999999999999999999998 8888864321
Q ss_pred HHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1117 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1117 V~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.++...... . ........+..++.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 243 ~~~~~~~~~-~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLKE-G----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHc-C----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111111 0 011122344567999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=349.60 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=195.8
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
++||+|+||+||++.. .+|+.||+|+++... .....++.+|++++++++|+||+++++++.+.+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 578999999997532 233456788999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
+|.+++.. ...+++.+++.|+.||+.||+|||+ .+ |+||||||+||||++++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99988843 3468999999999999999999996 56 9999999999999999999999999987543211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+... +.... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~i---~~~~------------~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LMEE------------I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHHH---hcCC------------C
Confidence 1234569999999999999999999999999999999999999996543211 11110 0000 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
.++.....++.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12223446789999999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.91 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=205.5
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
.+|+..++||+|+||.||++... ++..+++|.++.......++|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999742 356799999876666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhccccccc-----------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 974 VYELIPNGSVESHLHGVDK-----------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~-----------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
||||+.+|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1135899999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhh
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHHHH
Confidence 9999999975533222122223345788999999999999999999999999999998 899986433211 111110
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
. .. .......+...+.+|+.+||+.||++||++.||++.|+
T Consensus 239 ---~-~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ---Q-GR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---c-Cc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 00 00111234467899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.35 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=205.2
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCC--EEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr--~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|.++ ++. .+++|.++.. .....++|.+|++++.++ +|+||+++++++.+++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57899999999999999999964 454 4577777643 233456788999999999 899999999999999999999
Q ss_pred EeecCCCChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 975 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
|||+.+|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+|||||++||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999964321 1235889999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhh
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~ 1121 (1299)
||+|||+++..... .......++..|+|||++....++.++|||||||+||||++ |..||......+ ..+...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~ 237 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 237 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHHh
Confidence 99999998632111 01111234678999999988889999999999999999998 999986543211 111110
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhhh
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1184 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~e 1184 (1299)
. .............+.+|+.+||+.+|++||++.++++.|+++......
T Consensus 238 ~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 238 Q--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred c--------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 0 000011122345789999999999999999999999999987765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=349.45 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=195.4
Q ss_pred eEEeecCceEEEEEEe----cCCCEEEEEEeeccc----ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l----kdGr~VAVK~Lk~~d----~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+.||+|+||.||+++. ++++.||||+++... ......+.+|+++|++++|+||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 357889999997532 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+|+|.+++.. ...+.+.++..++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999853 335788899999999999999999887 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.......||..|+|||++.+..++.++|||||||+||||++|+.||...+... .........
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~---------- 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGK---------- 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC----------
Confidence 12234579999999999998889999999999999999999999997543211 111111110
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
...+......+.+++.+||+.+|++|+ ++.++++.
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 012223346789999999999999999 77777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.35 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+|++.+.||+|+||+||+|+. ++++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999984 568899999996532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 235888999999999999999999887 999999999999999999999999997643110
Q ss_pred cc---------------------------------------------ccccccccccccccCccccccCCCCccccchhh
Q 000757 1057 ES---------------------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 1091 (1299)
Q Consensus 1057 ~~---------------------------------------------~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSL 1091 (1299)
.. .......+||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHH--hcCcCcCCCCCH
Q 000757 1092 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM--CVQPEVQHRPFM 1168 (1299)
Q Consensus 1092 GVVLyELLTGr~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~--CL~~dPskRPSM 1168 (1299)
||+||||++|+.||...+.... ..+..|... + ..........++.+++.+ |+..++.+|+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------~--------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT-------L--------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc-------c--------CCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976442211 111111100 0 000011233567777776 566677779999
Q ss_pred HHHHHH
Q 000757 1169 GEVVQA 1174 (1299)
Q Consensus 1169 sEVLq~ 1174 (1299)
.|+++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.08 Aligned_cols=250 Identities=30% Similarity=0.480 Sum_probs=206.0
Q ss_pred hCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.++|++.+.||+|+||.||+|... |+.|++|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999876 78899999975433 5678999999999999999999999999889999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.... ...++|.+++.++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999996432 235899999999999999999999887 9999999999999999999999999998653211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
....++..|+|||++..+.++.++||||||+++|||++ |+.||..... ..+.......
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~-------------- 215 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKG-------------- 215 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcC--------------
Confidence 12335678999999998899999999999999999997 9999865421 1121111110
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
............+.+++.+||..+|++||++.|++++|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.17 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=207.5
Q ss_pred HhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..++|++.+.||+|+||.||+|.+++++.|+||.++.. ....+++.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34689999999999999999999888889999998743 34457899999999999999999999999988899999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+|||||++||+|++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999996432 345899999999999999999999887 9999999999999999999999999987654321
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. .......++..|++||.+.+..++.++|||||||++|||++ |+.||...+.. .........
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~------------- 220 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG------------- 220 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-------------
Confidence 1 11122234578999999998899999999999999999999 99998643211 111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
.......+....+.+++.+||+.+|++||+++|+++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.90 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=203.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CC---CEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dG---r~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|.+. ++ ..|+||+++.. +....++|.+|+.++++++|+||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45889999999999999999965 33 35999998753 333456899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|||||++||||+.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998542 235899999999999999999999887 9999999999999999999999999987654
Q ss_pred cccccccccc-c--cccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1055 DEESRHISTR-V--MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1055 ~~~~~~~st~-v--~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
.......... . ..+..|++||++....++.++|||||||++|||++ |..||..... .....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~------ 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDY------ 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCC------
Confidence 3222111111 1 12457999999999999999999999999999987 9999865332 22233321110
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.-....++...+.+++.+||+.+|++||+|.+|++.|+.+
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223456788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.12 Aligned_cols=264 Identities=23% Similarity=0.433 Sum_probs=203.3
Q ss_pred CCcceeeEEeecCceEEEEEEec-----------------CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-----------------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKL 961 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-----------------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrL 961 (1299)
++|++.+.||+|+||.||++... ++..||+|+++.. .....++|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2346899998753 33345689999999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhccccccc-------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCe
Q 000757 962 IGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1034 (1299)
Q Consensus 962 lG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~-------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNI 1034 (1299)
++++.+++..++||||+.+|+|.+++..... ....+++.++++++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 1234788999999999999999999887 99999999999
Q ss_pred eeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCc
Q 000757 1035 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPG 1112 (1299)
Q Consensus 1035 LLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT--Gr~PFd~s~~~~ 1112 (1299)
||++++.+||+|||+++...............++..|++||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543222222233345678999999888899999999999999999998 667775432211
Q ss_pred hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1113 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1113 ~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
........+.... . .... .....+...+.+|+.+||+.||++||+|.||++.|+
T Consensus 242 ---~~~~~~~~~~~~~-~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQG-R-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhcc-c-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111000 0 0000 111234478999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.32 Aligned_cols=239 Identities=25% Similarity=0.362 Sum_probs=191.8
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHh---hhcccccceeeeeeeeeccceEEE
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEML---SRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeIL---srLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
|++.+.||+|+||.||+|..+ +|+.||||+++... ....+.+.+|++++ ++++|+||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999854 68999999997532 23345666776655 566899999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|..+++. ..+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988842 35899999999999999999999887 9999999999999999999999999987532
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.. .......+|+..|||||++.+..++.++|||||||+||||++|+.||...+... +. .......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~---~~i~~~~------- 217 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VF---DSIVNDE------- 217 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCC-------
Confidence 21 122234679999999999999999999999999999999999999997543211 11 1111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
..++......+.+++.+||+.||++|+++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 01222345678899999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=356.65 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=197.9
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+++. .+|+.||||++... .....+++.+|++++++++|+|||++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999984 47899999998643 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999853 245889999999999999999999887 99999999999999999999999999963321
Q ss_pred cccc---------------------------------------------cccccccccccccCccccccCCCCccccchh
Q 000757 1056 EESR---------------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 1090 (1299)
Q Consensus 1056 ~~~~---------------------------------------------~~st~v~GT~gYmAPE~l~~~~~T~KSDVWS 1090 (1299)
.... ......+||..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCC---C
Q 000757 1091 YGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR---P 1166 (1299)
Q Consensus 1091 LGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskR---P 1166 (1299)
|||+||||++|+.||........ ..+..|.. .+. +.. ......++.+++.+|+. ++.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------~~~------~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE-------TLY------FPD--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-------ccC------CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999975432111 11111110 000 000 01234578899999997 66665 5
Q ss_pred CHHHHHHHH
Q 000757 1167 FMGEVVQAL 1175 (1299)
Q Consensus 1167 SMsEVLq~L 1175 (1299)
++.|+++.-
T Consensus 298 ~~~~~l~hp 306 (377)
T cd05629 298 GAHEIKSHP 306 (377)
T ss_pred CHHHHhcCC
Confidence 898887753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=339.35 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=204.6
Q ss_pred hCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccce
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~ 971 (1299)
.++|++.+.||+|+||.||+|... ++..||+|+++... ....++|.+|+.++++++|+||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 46789999986432 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhccccccc------------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccC
Q 000757 972 CLVYELIPNGSVESHLHGVDK------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1033 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~------------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsN 1033 (1299)
++||||+.+|+|.+++..... ....+++.++++++.|++.||+|||+.+ |+|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999963211 1235788999999999999999999887 9999999999
Q ss_pred eeeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCc
Q 000757 1034 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 1112 (1299)
Q Consensus 1034 ILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~ 1112 (1299)
||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999875533222122222345678999999988899999999999999999998 8888854322
Q ss_pred hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1113 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1113 ~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
..+..+.. . .+ +. ........++.+|+.+||+.+|++||++.|+++.|+
T Consensus 239 -~~~~~~~~---~-~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -EEVIYYVR---D-GN-VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -HHHHHHHh---c-CC-CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111111 0 00 00 111234467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.95 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-----ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
++|++.+.||+|+||.||++.. ++++.|++|.+.... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999985 468999999986432 1223568899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.+++|.+++.. ...+++..+++++.|++.||.|||+.+ |+|||||++||||++++++||+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999853 235889999999999999999999887 999999999999999999999999998754
Q ss_pred ccccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~-~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ..+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~-~~~~~---~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--A-IFKIA---T------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--H-HHHHh---c-------
Confidence 3211111 1123457889999999999889999999999999999999999986432111 1 11100 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
......++......+.+++.+||..+|++||++.|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001112223345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=353.79 Aligned_cols=203 Identities=27% Similarity=0.389 Sum_probs=175.2
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||++... +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999854 68899999997532 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||++||+|.+++.. ...+++.++..++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999953 346899999999999999999999887 99999999999999999999999999875432
Q ss_pred ccc---------------------------------ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCC
Q 000757 1056 EES---------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1102 (1299)
Q Consensus 1056 ~~~---------------------------------~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr 1102 (1299)
... .......+||..|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 000757 1103 KPVDMTQ 1109 (1299)
Q Consensus 1103 ~PFd~s~ 1109 (1299)
.||...+
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=348.86 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=201.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+++.. +|+.||||+++... ....+.+.+|++++++++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999954 68899999997532 234556889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+|||||++||||+.++++||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999643 246899999999999999999999887 99999999999999999999999999986543
Q ss_pred cccccccccccccccccCccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~------~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~ 1129 (1299)
... .......||..|+|||++. ...++.++|||||||+||||++|+.||....... .....+....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~- 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR- 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC-
Confidence 222 1223356999999999886 4567899999999999999999999997543211 1111111100
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1130 L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.++ . .........+.+|+..||. +|++|+++.++++.
T Consensus 227 ---~~~--~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 ---FLK--F--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---ccC--C--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0 0011234678899999998 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.11 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=205.4
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccce
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~ 971 (1299)
++|++.+.||+|+||.||++... ++..||||+++... ....+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56999999999999999999742 34579999987543 23345789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+.+|+|.++++... ...+++.++++|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999996422 234899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+..+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~~~~-------- 259 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKLIKE-------- 259 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHHHHc--------
Confidence 6543222112223346788999999999999999999999999999998 999986543221 11111110
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
............++.+++.+||+.+|++||++.||++.|+++
T Consensus 260 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001111112345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.97 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=201.5
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.++++++|+||+++++++..++..|+||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5799999999999999999995 568899999997544445567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.++++. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999853 235889999999999999999999887 99999999999999999999999999986532211
Q ss_pred ccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1059 RHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+.. . .+..
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~~------~---~~~~ 228 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMSK------S---NFQP 228 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeeec------C---CCCC
Confidence 112346889999999874 34578899999999999999999999854321111 000000 0 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..+. ........+.+++.+||+.+|++||++++|++.|
T Consensus 229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 0112346789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=355.37 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=197.6
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 468899999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999953 235788999999999999999999887 99999999999999999999999999753210
Q ss_pred cc-----------------------------------------cccccccccccccccCccccccCCCCccccchhhHHH
Q 000757 1056 EE-----------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 1094 (1299)
Q Consensus 1056 ~~-----------------------------------------~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVV 1094 (1299)
.. ........+||..|||||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchh-hhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC---CHHH
Q 000757 1095 ILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP---FMGE 1170 (1299)
Q Consensus 1095 LyELLTGr~PFd~s~~~~~~-nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP---SMsE 1170 (1299)
||||++|+.||......+.. .+..|.. .+ ...........+.+++.+|+ .+|++|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~-------~~--------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET-------TL--------HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc-------cc--------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999765432111 1111110 00 00011123456777888876 4999999 8888
Q ss_pred HHHH
Q 000757 1171 VVQA 1174 (1299)
Q Consensus 1171 VLq~ 1174 (1299)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.43 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=203.6
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||+|.++++..|++|.+... ....+.+.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 568999999999999999999887778999998643 334567899999999999999999999875 456799999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.++++.. ....++|..++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999643 2335889999999999999999999887 999999999999999999999999999765332211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......++..|++||++..+.++.++|||||||++|||++ |+.||..... ....++.....
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-------------- 220 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGY-------------- 220 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC--------------
Confidence 1122346778999999988899999999999999999999 8999865332 11222211100
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
......+....+.+++.+||..+|++||++++|++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001122345679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.68 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=196.7
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+++.+ +++.||||+++... ....+.+.+|+.++.++ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999954 68899999997532 23345678999999998 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999988842 346899999999999999999999887 9999999999999999999999999987432211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc--hhhhHHhhhcccccccccceeecCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~--~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.....+||..|+|||++.+..++.++|||||||++|||++|+.||+...... .....+|....+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------KQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------CCC
Confidence 2234679999999999999999999999999999999999999997543221 11222222211111 111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCC------HHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPF------MGEVVQ 1173 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPS------MsEVLq 1173 (1299)
.++.....++.+++.+||+.||++|++ +.++++
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122334567899999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.71 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=200.0
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeeec------
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE------ 968 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~------ 968 (1299)
.+++.|++.+.||+|+||.||+|... +++.||+|++... .....++.+|+++++++ +|+||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999854 6788999998643 34456788999999999 699999999998753
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
...|+||||+.+|+|.+++... ....+.|..++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 4578999999999999998642 2346899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
+++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||......... ....
T Consensus 157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~~~-- 229 (272)
T cd06637 157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIP-- 229 (272)
T ss_pred Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HHHh--
Confidence 987653211 1223456899999999876 345788999999999999999999999643211111 0000
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
...... .........+.+|+.+||..+|++||++.|+++
T Consensus 230 ---~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 ---RNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---cCCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000000 111123457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.36 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=197.1
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||+||++... +|+.||||++.... ....+.+..|++++++++|+||+++++++.++...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 68899999986432 22335678899999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++.........+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654444557999999999999999999999887 99999999999999999999999999976543221 123
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
...||..|+|||++.+..++.++|||||||++|||++|+.||......... .......+ ... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~----------~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL----------NDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc----------ccC--CCCc
Confidence 356899999999999999999999999999999999999999754322110 01111011 100 0122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
......+.+++.+||+.||++|+ +++|+++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 33456789999999999999999 55666553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.49 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=196.2
Q ss_pred EEeecCceEEEEEEe---cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 907 ILGEGGFGLVYSGVL---DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 907 lLGeGgFGtVYKA~l---kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
.||+|+||.||+|.+ +++..||+|+++... ....++|.+|+.++++++|+||+++++++.. +..++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999974 357889999986432 2345678999999999999999999999864 5678999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc-
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH- 1060 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~- 1060 (1299)
+|.+++.. ...+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 235899999999999999999999887 9999999999999999999999999998654322211
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
......++..|+|||.+....++.++|||||||++|||++ |+.||...+.. .+..... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~--------------~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE--------------SGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH--------------CCCC
Confidence 1122334679999999988889999999999999999998 99999754321 1112111 0111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
...+..+..++.+++.+||+.||++||+|.+|++.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12223455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.50 Aligned_cols=251 Identities=28% Similarity=0.496 Sum_probs=202.8
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
.+|++.+.||+|+||.||++.+.+++.+++|.++.. .....+|.+|++++++++|+||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468889999999999999999877889999998643 3345679999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+++|.+++... ...+.++.++.++.|++.+|+|||+.+ |+|||||++||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999998532 235889999999999999999999887 99999999999999999999999999876533211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++.+|+|||++.++.++.++|||||||++|||++ |+.||..... ..+..... . . ....+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~-~---~~~~~--- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETIN---A-G---FRLYK--- 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHh---C-C---CCCCC---
Confidence 11112235678999999998899999999999999999998 9999864321 11111111 0 0 00111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
+......+.+|+.+||+.+|++||++.|+++.|
T Consensus 223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 112346799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.34 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=203.1
Q ss_pred CCcceeeEEeecCceEEEEEEe------cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeec-cc
Q 000757 900 GNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-QA 970 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l------kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~-~~ 970 (1299)
++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++|.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999973 356789999997532 23345688999999999 689999999988654 46
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000757 971 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 992 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~---------------------------------------------------------- 992 (1299)
.++||||+.+|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998864211
Q ss_pred -----CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccc
Q 000757 993 -----ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067 (1299)
Q Consensus 993 -----~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~G 1067 (1299)
....++|..+++++.||++||+|||+.+ |+|||||++|||+++++++||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0124788999999999999999999887 99999999999999999999999999986533222122223345
Q ss_pred cccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhh
Q 000757 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDS 1146 (1299)
Q Consensus 1068 T~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee 1146 (1299)
+..|+|||++.+..++.++|||||||++|||++ |..||....... .+..- +.... ....+...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~----~~~~~----------~~~~~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKEGT----------RMRAPDYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHH----HhccC----------CCCCCCCC
Confidence 678999999988899999999999999999997 999986532211 11110 11000 00111122
Q ss_pred HHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1147 VAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1147 ~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
..++.+++.+||+.+|++||++.||++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.50 Aligned_cols=269 Identities=26% Similarity=0.386 Sum_probs=205.6
Q ss_pred CCcceeeEEeecCceEEEEEEec-----CCCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeee--ccce
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIE--EQAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-----dGr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~ 971 (1299)
++|++.+.||+|+||.||+|+++ +++.||||+++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999854 3678999999754332 46789999999999999999999999877 5578
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+.+++|.+++... ...++|.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999643 225899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc--cccc
Q 000757 1052 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL--TSRE 1128 (1299)
Q Consensus 1052 ~~~~~~~~-~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll--s~~e 1128 (1299)
........ .......++..|++||++.+..++.++|||||||++|||++|+.|+......... ++.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHH
Confidence 76532221 1111233566799999998889999999999999999999999987543211100 000000 0000
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.+.+.+...........+..++.+|+.+||+.+|++||+|.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00111111111112223446899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.17 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=199.5
Q ss_pred CCcceeeEEeecCceEEEEEEecC--CCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd--Gr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|.+++ +..||+|++... .....+.+.+|++++++++|+||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 469999999999999999998543 368999998643 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||||++||||+.++++||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999853 345889999999999999999999887 9999999999999999999999999997643
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.. ....+||..|||||++.+..++.++|||||||+||||++|+.||...+... ... ......
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~---~i~~~~------- 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQ---KILEGI------- 244 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHH---HHhcCC-------
Confidence 21 234579999999999998889999999999999999999999997543211 000 011100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~ 1174 (1299)
. .++......+.+++.+||+.+|++|+ +++|+++.
T Consensus 245 ---~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 11222345678999999999999995 78877654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.21 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=196.9
Q ss_pred eEEeecCceEEEEEEecC-CC--EEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLDD-GT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-Gr--~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|++++ +. .+++|.++.. .....+.+.+|++++.++ +|+||++++++|..++..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999753 43 4688888743 234456788999999999 799999999999999999999999999
Q ss_pred CChhhccccccc------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 981 GSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 981 GSL~d~L~~~~~------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
|+|.++++.... ....+.+.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 1235889999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+++..... ........+..|+|||++....++.++|||||||++|||++ |+.||...... ....... . .
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~---~-~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP---Q-G 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHHh---C-C
Confidence 98632211 11111234568999999988899999999999999999997 99999653221 1111110 0 0
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
............+.+|+.+||+.+|.+||++.|+++.|+.+.
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.28 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=194.3
Q ss_pred eEEeecCceEEEEEEecC---CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd---Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+.||+|+||.||+|.+.+ +..+++|.++... .....+|.+|+.++++++|+||+++++++.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 3578999886533 233457889999999999999999999999989999999999999
Q ss_pred Chhhccccccc-CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 982 SVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 982 SL~d~L~~~~~-~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
+|.++++.... ....+++..+++++.|+++||+|||+.+ |+|||||++|||+++++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 2235678888999999999999999887 9999999999999999999999999997543322222
Q ss_pred ccccccccccccCccccccC-------CCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1061 ISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~-------~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
......|+..|+|||++... .++.++|||||||++|||++ |+.||......+. ..+.. .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~-----~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV-----REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh-----hcccCC
Confidence 22345578899999987632 35789999999999999996 9999965432211 11100 011111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
+.++.+ .......+.+|+.+|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 112221 1223456888999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.77 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=206.2
Q ss_pred CCHHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeee-
Q 000757 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICI- 966 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~- 966 (1299)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.+++|+++.. ....+++.+|+++++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566677889999999999999999999985 45789999998642 23346788999999999 6999999999885
Q ss_pred ----eccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 967 ----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 967 ----e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
.++..++||||+++++|.++++........+++..+..++.|+++||.|||+.+ |+|||||++||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345679999999999999988644334456899999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV 1117 (1299)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence 999999987653321 12233468999999998753 457889999999999999999999986542211 111
Q ss_pred HhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1118 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1118 ~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+ .. . ....+. .......++.+|+.+||+.+|++||++.||++.+
T Consensus 240 ~~----~~-~-~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KI----PR-N-PPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hc----cc-c-CCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 10 00 0 000011 1112235689999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=361.10 Aligned_cols=264 Identities=24% Similarity=0.401 Sum_probs=207.4
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcc-cccceeeeeeeeec
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE 968 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~ 968 (1299)
...++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+++|+++|.++. |+|||+++++|.+.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33456888899999999999999853 34679999997532 223457889999999997 99999999999999
Q ss_pred cceEEEEeecCCCChhhccccccc--------------------------------------------------------
Q 000757 969 QARCLVYELIPNGSVESHLHGVDK-------------------------------------------------------- 992 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~-------------------------------------------------------- 992 (1299)
+..++||||+.+|+|.++|+....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964321
Q ss_pred --------------------------------------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCe
Q 000757 993 --------------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1034 (1299)
Q Consensus 993 --------------------------------------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNI 1034 (1299)
....++|..+++|+.||+.||+|||+.+ |+|||||++||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124788889999999999999999876 99999999999
Q ss_pred eeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCch
Q 000757 1035 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQ 1113 (1299)
Q Consensus 1035 LLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~ 1113 (1299)
|+++++.+||+|||+++...............++..|||||++....++.++|||||||+||||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533222112223457789999999998889999999999999999998 8888865322111
Q ss_pred hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000757 1114 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1114 ~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~ 1179 (1299)
+... + ........+.....++.+|+.+||..+|++||+++||++.|+.++
T Consensus 351 --~~~~----~----------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 --FYNA----I----------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHH----H----------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1110 0 011111122234568999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.04 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=200.0
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccch--hHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~--keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
|++.+.||+|+||+||+++.. +++.||+|++........ ....+|+.++++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999965 466899999976433322 23456999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.++|. ....+++.+++.++.|+++||+|||+.+ |+|||||++|||++++++++|+|||++.... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cc
Confidence 9999999995 3346899999999999999999999987 9999999999999999999999999987541 12
Q ss_pred ccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~-~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
........++..|+|||++. +..++.++||||||+++|+|++|+.||......+........ .... +...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~------~~~~ 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKRP------LPSS 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHTH------HHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---cccc------cccc
Confidence 22334456899999999988 888999999999999999999999999764211111111110 0000 0000
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
. .........+.+++.+||+.||++||++.|+++
T Consensus 223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000112378999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.24 Aligned_cols=248 Identities=30% Similarity=0.476 Sum_probs=201.1
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeee-eccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI-EEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~-e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||++..+ |+.|++|.++.. ...+.|.+|+.++++++|+||+++++++. ++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46889999999999999999876 788999998642 33567899999999999999999999865 456789999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+|+|.++++... ...+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999986422 235889999999999999999999887 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..+....
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~-------------- 215 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKG-------------- 215 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcC--------------
Confidence 22335678999999998899999999999999999998 9998864321 2222222110
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
........+...+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111222345688999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.12 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=204.0
Q ss_pred CCcceeeEEeecCceEEEEEEec----CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk----dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|++. ++..||+|.++... ....+.|.+|++++++++|+||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56889999999999999999853 23369999986432 33356789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+++++|.+++... ...+++.++++|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999632 235899999999999999999999887 9999999999999999999999999998664
Q ss_pred ccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1055 DEESRHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1055 ~~~~~~~-st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
....... .....++..|++||++.++.++.++|||||||++|||++ |+.||...... ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~-------- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY-------- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC--------
Confidence 3221111 112234568999999998899999999999999999887 99998654321 1222211100
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
...........+.+++.+||+.+|++||+|.++++.|+.+
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=351.71 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=193.9
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+|++.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+|||++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999995 468899999997532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||.+|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999853 235788999999999999999999887 999999999999999999999999997532100
Q ss_pred c---------------------------------------------cccccccccccccccCccccccCCCCccccchhh
Q 000757 1057 E---------------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 1091 (1299)
Q Consensus 1057 ~---------------------------------------------~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSL 1091 (1299)
. ........+||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---
Q 000757 1092 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF--- 1167 (1299)
Q Consensus 1092 GVVLyELLTGr~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS--- 1167 (1299)
||+||||++|+.||...+.... ..+..|... +..........++.+++.+|+ .+|++|.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999999975432211 111111100 000001122345666676665 48999987
Q ss_pred HHHHHH
Q 000757 1168 MGEVVQ 1173 (1299)
Q Consensus 1168 MsEVLq 1173 (1299)
+.|+++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.05 Aligned_cols=248 Identities=30% Similarity=0.464 Sum_probs=199.7
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 984 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~ 984 (1299)
++||+|+||.||++.+.+++.|++|+++..... ..++|.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998754332 4568999999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccccccc
Q 000757 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064 (1299)
Q Consensus 985 d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~ 1064 (1299)
+++... ...+++..++.++.+++.+|+|||+.+ |+|||||++||||+.++.+||+|||+++.............
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998532 235789999999999999999999887 99999999999999999999999999975532211111122
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1065 v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
..++..|++||++.++.++.++|||||||++|||++ |..||....... ....... .......
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~--------------~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIES--------------GYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhc--------------CCCCCCC
Confidence 234677999999988899999999999999999999 888886543211 1111110 0011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.....++.+++.+||..+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=342.99 Aligned_cols=241 Identities=22% Similarity=0.288 Sum_probs=194.7
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhccc-ccceeeeeeeeeccceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrH-PNIVrLlG~~~e~~~~~LVy 975 (1299)
+|++.+.||+|+||.||+|+.+ +++.||||+++.. .....+.+..|++++..++| .+|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999955 5788999999753 23345678889999999975 56888999999889999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+.+.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998853 235889999999999999999999887 99999999999999999999999999874322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. ......+||..|+|||++.+..++.++|||||||+||||++|+.||...... .+..... ..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~---~~--------- 216 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIM---EH--------- 216 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---cC---------
Confidence 11 1223456999999999999999999999999999999999999999754321 1111111 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
...++.....++.+++.+||+.||++|++.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011222344678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.32 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=199.7
Q ss_pred eEEeecCceEEEEEEecC--CC--EEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLDD--GT--KVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd--Gr--~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+.||+|+||.||+|.+.+ ++ .||||+++.... ...++|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 33 589999976544 556789999999999999999999999988 888999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc-
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1059 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~- 1059 (1299)
|+|.+++..... ..++|.+++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965332 46899999999999999999999887 999999999999999999999999999876442211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|++||++.+..++.++|||||||++|||++ |+.||+..+.. .+...... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~~~~--------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK---EGER--------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh---cCCc---------
Confidence 11223457889999999999999999999999999999999 99998643221 11111110 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
..........+.+++.+||+.+|++||++.||++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111234467999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.67 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=195.0
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVy 975 (1299)
+|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+..|+.++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999855 57899999997532 22334567788888877 5899999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998853 235889999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. ......+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+..... .
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~---~---------- 215 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM---E---------- 215 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH---h----------
Confidence 11 1223467999999999999999999999999999999999999999754321 1111111 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
.. ..++.....++.+++.+||+.+|++|++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01223345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=365.69 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=226.0
Q ss_pred HHHHHHhCCcceeeEEeecCceEEEEEEecC-CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccce
Q 000757 893 SEIEKATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 893 ~ELe~at~nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~ 971 (1299)
++++.-..++.+.++||.|.||.||.|+|+. .-.||||.|+. +....++|+.|..+|+.|+|+|+|+|+|+|..+.-+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555556678889999999999999999874 45699999985 566788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|||+|||..|+|.+||++..+ ..+.--.++.++.||+.||+||..++ +|||||..+|+||.++..|||+||||++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999999976543 34666778999999999999999887 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
++..+.+.. .....-...|.|||.+..+.++.|+|||+|||+||||.| |..||-+.+ ...+
T Consensus 414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQV 475 (1157)
T ss_pred hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHH
Confidence 876543322 122223578999999999999999999999999999999 888886532 1123
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.++++..++.+.+..|..++++||+.||+.+|.+||++.|+-+.++.+..+.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 3455566777888899999999999999999999999999999998666543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.66 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=199.0
Q ss_pred eEEeecCceEEEEEEecC-------CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-------Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+.||+|+||.||+|+..+ ++.|+||.+.... .....+|.+|++++++++|+||++++++|.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886432 23456889999999999999999999999999999999999
Q ss_pred cCCCChhhccccccc---CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-----cceecCCCc
Q 000757 978 IPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-----TPKVSDFGL 1049 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~---~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-----~VKLsDFGL 1049 (1299)
+.+|+|.++++.... ....++|.+++.++.|++.||+|||+.+ |+|+|||++|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 2235889999999999999999999887 99999999999999877 899999999
Q ss_pred cccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e 1128 (1299)
++...............++..|++||++.++.++.++|||||||++|||++ |+.||...+. .....+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence 976543322222223346789999999999999999999999999999998 9999864321 11111111 000
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
...........+.+++.+||..+|++||++.+|++.|+
T Consensus 231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112234567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.94 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=192.6
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+++.. +++.||+|+++.. +....+.+.+|+.++.++ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999954 6789999999753 223345677899998877 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988842 346899999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc--hhhhHHhhhcccccccccceeecCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~--~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.....+||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......|........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------~- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------Q- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------C-
Confidence 2234579999999999999999999999999999999999999996432111 111122222111110 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
..++.....++.+++.+||+.||++|++.
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 12233445678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.99 Aligned_cols=256 Identities=20% Similarity=0.257 Sum_probs=202.0
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
...++|++.++||+|+||.||+++.+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567999999999999999999954 6889999999643 2233455788999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+.+|+|.++++. ..+++..+..++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999853 24778889999999999999999887 99999999999999999999999999976
Q ss_pred ccccccccccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccc
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~~----~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e 1128 (1299)
...... ......+||..|+|||++.+. .++.++|||||||+||||++|+.||....... .....+....
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~ 264 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN 264 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC
Confidence 533211 122345799999999988643 47899999999999999999999997543211 1111111100
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQAL 1175 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPsk--RPSMsEVLq~L 1175 (1299)
.+ .-.........+.+++.+||+.+|++ |+++.|+++.-
T Consensus 265 ~~--------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 SL--------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred cC--------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00 00011134567889999999999988 99999997763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=337.66 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||++... +++.|++|.++.. .....+++.+|++++++++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999854 6788999998643 223345688999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|.++++. ...+++..+..++.|++.||+|||+.. +|+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999953 245889999999999999999999742 3999999999999999999999999998754322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccc---c-----
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE---G----- 1129 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e---~----- 1129 (1299)
......|+..|++||++.+..++.++|||||||++|||++|+.||...+... +..+......... .
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence 1233568999999999888889999999999999999999999996543211 1111111100000 0
Q ss_pred ---------------cceeecCCCCCCCC-hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1130 ---------------LERIIDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1130 ---------------L~eIVDp~L~~~~p-~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
+..++... ....+ ......+.+++.+||..+|++||++.||++....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000 00000 1134568999999999999999999999887654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.80 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=196.1
Q ss_pred EEeecCceEEEEEEec---CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCC
Q 000757 907 ILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 982 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lk---dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGS 982 (1299)
.||+|+||.||+|++. ++..||+|+++... ....++|.+|++++++++|+||++++++|.. +..++||||+.+|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999854 45579999986543 2334678999999999999999999998854 57799999999999
Q ss_pred hhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc-c
Q 000757 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH-I 1061 (1299)
Q Consensus 983 L~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~-~ 1061 (1299)
|.+++... ...+++.++++++.|++.||+|||+++ |+|||||++|||++.++.+||+|||+++......... .
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998532 346899999999999999999999887 9999999999999999999999999997553322211 1
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+. .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~--------------~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIE--------------QGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHH--------------CCCCC
Confidence 112234578999999988889999999999999999996 99999654321 1111111 01111
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
..+..+..++.+++.+||..++++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22234557889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.44 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=206.1
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCC----EEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr----~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
++|++.+.||+|+||.||+|.++ +|+ .|++|+++... ....+++.+|++++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999954 343 58999886543 2345678899999999999999999999987 78899
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.+|+|.++++.. ...+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998642 235899999999999999999999877 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.............++..|++||.+....++.++|||||||++|||++ |+.||+.... ..+...+.. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~---- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEK----GE---- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhC----CC----
Confidence 43222222222234678999999988889999999999999999998 9999975432 112222111 00
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
....+..+...+.+++.+||..+|++||++.++++.|+.+.+..
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00111223457889999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=374.79 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=212.9
Q ss_pred hCCcceeeEEeecCceEEEEEEecCC-CEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeee-eee------cc
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDG-TKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGI-CIE------EQ 969 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkdG-r~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~-~~e------~~ 969 (1299)
..++++.++|.+|||+.||.|.+..+ ..||+|++-..++...+.+.+||++|++|+ |+|||.++|. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35688899999999999999997655 999999997778888889999999999997 9999999993 221 13
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
+++|.||||.||.|-|+|..... ..|++.++++|+.|+++||++||.. .++|||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 56899999999999999975433 3499999999999999999999988 58899999999999999999999999999
Q ss_pred cccccccccc-c------ccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHh
Q 000757 1050 ARSAMDEESR-H------ISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1119 (1299)
Q Consensus 1050 Ar~~~~~~~~-~------~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~w 1119 (1299)
|......... . ..-...-|+-|++||++. +...++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 8643221110 0 001234689999999764 6678999999999999999999999997542
Q ss_pred hhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1120 a~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
...|++..+.---...+..+|.+||..||+.||++||++.+|+.++.++...
T Consensus 263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 2234444433223346888999999999999999999999999998877653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=343.02 Aligned_cols=240 Identities=24% Similarity=0.346 Sum_probs=191.4
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|+.+ +++.||||+++.. .....+.+..|.+++..+ +|+||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999954 5788999999753 223344566777777754 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998853 235889999999999999999999887 9999999999999999999999999997543222 2
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+... +.. ..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD---SILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHcC------------CC
Confidence 2344679999999999999899999999999999999999999997543211 111 11100 01
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVV 1172 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMs-EVL 1172 (1299)
.++.....++.+++.+||+.+|++|+++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12223445788999999999999999985 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.59 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=205.9
Q ss_pred HhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..++|++.+.||+|+||.||++.+.++..+++|.++.. ....++|.+|++++++++|+||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34689999999999999999999887888999998743 3345678999999999999999999999887 778999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ ++|||||++||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999643 2345889999999999999999999887 9999999999999999999999999997653322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. .......++..|++||++..+.++.++|||||||++|||++ |+.||..... ..+..+... ..
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~----~~-------- 220 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER----GY-------- 220 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhC----CC--------
Confidence 1 11122345678999999998889999999999999999999 8999865322 122222111 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
..........++.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112344678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.99 Aligned_cols=273 Identities=28% Similarity=0.396 Sum_probs=202.9
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhh--cccccceeeeeeeeecc----ceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVKLIGICIEEQ----ARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsr--LrHPNIVrLlG~~~e~~----~~~L 973 (1299)
...++.++||+|+||.||||.++ ++.||||++.. +..+.|.+|-+|++. |+|+||++|+++-...+ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34555679999999999999999 58999999964 344678888888765 57999999999876554 7899
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC------CCceeeecccccCeeeccCCcceecCC
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS------SPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g------sp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
|+||.++|+|.+||.. ..++|.+..+|+..+++||+|||+.- ++.|+|||||++||||..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999953 36999999999999999999999863 567999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCC------CCccccchhhHHHHHHHHhCCCCCCC-CCCCchhhhHHhh
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSGRKPVDM-TQPPGQENLVAWA 1120 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~------~T~KSDVWSLGVVLyELLTGr~PFd~-s~~~~~~nLV~wa 1120 (1299)
|||..+..+.........+||.+|||||++.+.. .-.+.||||+|+|||||++...-++- .-.+.+.-+...+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998877655554455588999999999886532 22568999999999999997665531 1110000000000
Q ss_pred hcccccccccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
...-.-++.-.-++.+..+..++ ...+..+.+.+..||+.|++.|.|..=|.+.+.++...
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 00000000001111122222222 24567899999999999999999998888887766543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.67 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=203.0
Q ss_pred CCcceeeEEeecCceEEEEEEe-----cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeec--cce
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-----kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~ 971 (1299)
+.|++.+.||+|+||.||++.+ .+++.|++|.++... ....+++.+|++++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999984 357889999986432 33346789999999999999999999998775 567
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+++++|.+++... ...++|.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998532 235899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCC---------chhhhHHhhh
Q 000757 1052 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP---------GQENLVAWAR 1121 (1299)
Q Consensus 1052 ~~~~~~~~-~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~---------~~~nLV~wa~ 1121 (1299)
........ .......++..|+|||++.+..++.++|||||||++|||++++.+....... .+.....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432211 1122345677899999998888999999999999999999987654321100 0001111110
Q ss_pred cccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1122 plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.+ ...........+...+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 238 -~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VL----------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HH----------HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 01111112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=353.25 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=200.1
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccc
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~ 970 (1299)
+....++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+++++.++|+||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999965 5789999998642 22334567899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||+.+|+|.+++.. ..+++.++..++.||+.||+|||+.+ |+|||||++||||++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999853 24788999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1051 r~~~~~~~~~~st~v~GT~gYmAPE~l~~~----~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
+...... .......+||..|||||++.+. .++.++|||||||+||||++|+.||....... .+ ......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--~~----~~i~~~ 262 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--TY----SKIMDH 262 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--HH----HHHHhC
Confidence 8653221 1122346799999999988653 37899999999999999999999997543211 11 111110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 1174 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPsk--RPSMsEVLq~ 1174 (1299)
... +.-.........+.+++..|+..++.+ |+++.|+++.
T Consensus 263 ~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Ccc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 000011123566788999999865544 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=331.42 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=200.2
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.++||+|+||.||+|+. .+++.||+|++... .....++|.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688899999999999999984 57889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|..+. .+++..+.+++.|++.||+|||+.+ |+|+|||++|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999987553 3678889999999999999999887 999999999999999999999999999755322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhhcccccccccceeecC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~plls~~e~L~eIVDp 1136 (1299)
.....+|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.... .+.
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~ 215 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI----------VDE 215 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH----------hcc
Confidence 223456899999999999889999999999999999999999999653322111 001111100 000
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
............++.+++.+||+.+|++||++.|+++...
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 0000011123457899999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.95 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=194.5
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|+.. +++.||||+++.. .....+.+..|++++..+ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 5789999999753 233345677899999876 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999988853 335889999999999999999999887 9999999999999999999999999987543221 2
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||++|||++|+.||...+.. .+... ..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~---i~~~~-----~------- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFES---ILHDD-----V------- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHH---HHcCC-----C-------
Confidence 233457999999999999989999999999999999999999999754321 11111 11100 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCC-------CHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRP-------FMGEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRP-------SMsEVLq~ 1174 (1299)
..+.....++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11122346788999999999999999 66777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=326.38 Aligned_cols=248 Identities=30% Similarity=0.437 Sum_probs=197.6
Q ss_pred eEEeecCceEEEEEEecC----CCEEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|++.. +..|++|.++.... ...+++.+|++++++++|+|||++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998432 26899999875433 34567899999999999999999999876 4567999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++... ..+++.++++++.|++.+|+|||+.+ |+|||||++||||+.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999532 26899999999999999999999887 9999999999999999999999999998664322211
Q ss_pred c-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1061 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1061 ~-st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
. .....++..|+|||++....++.++|||||||++|||++ |+.||+..+. ..+..+..... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~----~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE----R--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC----c---------
Confidence 1 112224568999999998899999999999999999998 9999965432 22233322110 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
......+...+.+++.+||..+|++||++.+|++.|+.+
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 012223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.45 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=204.7
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeee--ccceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~~LVy 975 (1299)
+|++.+.||.|+||.||++.. .+++.|++|+++.. .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999984 56889999998642 23345678899999999999999999998764 34578999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC--CCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g--sp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||+.+++|.+++.........+++.+++.++.||+.||+|||..+ +.+|+|||||++|||+++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444567999999999999999999999332 334999999999999999999999999999866
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
..... ......|+..|++||++....++.++||||||+++|+|++|+.||.... ...+......
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~----------- 224 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKE----------- 224 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhc-----------
Confidence 43221 1233468999999999998889999999999999999999999997643 1222222111
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.............+.+++.+||+.+|++||++.||++.
T Consensus 225 ---~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ---GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00112233445689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=351.11 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=208.9
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.++|++.++||.|..+.||+|+ ...++.||||++.-. .....+.+.+|+..|+.++||||++.+..|+.+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999999 557899999999643 23335789999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||.+|++.+.++..... .+++..+..|++++++||.|||++| .||||||+.|||||++|.|||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999765433 4899999999999999999999998 999999999999999999999999988765543
Q ss_pred ccccc-c-ccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1057 ESRHI-S-TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1057 ~~~~~-s-t~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
..+.. . .+.+||+.|||||+++. ..|+.|+||||||++.+||.+|..||...-.-. .+..- +-. ....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~t---Lqn---~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLT---LQN---DPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHH---hcC---CCCC
Confidence 32221 1 45689999999999653 468999999999999999999999997543211 11111 000 0000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..-..+..+........|.+++..||+.||++|||..++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000011111222334589999999999999999999999854
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.57 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=193.2
Q ss_pred eEEeecCceEEEEEEe----cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l----kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
+.||+|+||.||+++. .+|+.||+|+++... .....++.+|+++|++++|+||+++++++.+.+..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++.. ...+++.+++.|+.||++||+|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999843 346899999999999999999999887 9999999999999999999999999987653321
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ....... ....
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i---~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMI---LKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHH---HcCC------------
Confidence 122345799999999999988899999999999999999999999975421 1111111 1100
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
..++......+.+|+.+||+.||++|+++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0122233467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=325.35 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=202.3
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
+|++.+.||+|+||.||++... +++.|++|.++.. .....+++.+|+.++++++|+||+++++++.+++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999954 6889999998642 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++|+|.+++... ....+++..+++++.|++.||.|||+.+ |+|+|||++|||++++++++|+|||+++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988532 2345789999999999999999999887 9999999999999999999999999987653321
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.. ... ..... ....
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~---~~~~~--~~~~------- 218 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLI---LKVCQ--GSYK------- 218 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHH---HHHhc--CCCC-------
Confidence 1223356889999999999888999999999999999999999999753211 111 11111 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.........+.+++.+||+.+|++||++.||++.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=334.98 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=204.3
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.+|++.+.||+|+||.||+|+. .+++.|++|.+........+.+.+|++++++++|+||+++++++.+....|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5799999999999999999984 568899999997655555678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.+ ..+++.+++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999842 34789999999999999999999887 99999999999999999999999999876533221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+..+. ... ...
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~----~~~--~~~------ 235 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA----TNG--TPE------ 235 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh----cCC--CCC------
Confidence 1233468899999999998889999999999999999999999997543211 111110 000 000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..........+.+++.+||..+|++||++.||++.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01112334568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=361.04 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=196.9
Q ss_pred HHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccc------cceeeeeee
Q 000757 893 SEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR------NLVKLIGIC 965 (1299)
Q Consensus 893 ~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHP------NIVrLlG~~ 965 (1299)
+++...+++|++.++||+|+||+||+|.+ .+++.||||+++... ...+++..|++++++++|. +|+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44555678999999999999999999985 457889999997432 2344567788888877654 588899988
Q ss_pred eec-cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeeeccCC---
Q 000757 966 IEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDF--- 1040 (1299)
Q Consensus 966 ~e~-~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg--- 1040 (1299)
..+ ...|+|||++ +++|.+++.. ...+++.+++.|+.||+.||+|||+ .+ ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 754 5678999988 7889888853 3468999999999999999999997 46 99999999999998765
Q ss_pred -------------cceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 000757 1041 -------------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107 (1299)
Q Consensus 1041 -------------~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~ 1107 (1299)
.+||+|||++.... ......+||..|||||++.+..++.++|||||||+||||++|+.||+.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876322 123456799999999999999999999999999999999999999976
Q ss_pred CCCCchhhhHH---------hhhc--------ccccccccceeecCC-----CCCC--CChhhHHHHHHHHHHhcCcCcC
Q 000757 1108 TQPPGQENLVA---------WARP--------LLTSREGLERIIDPS-----LGND--VPFDSVAKVAAIASMCVQPEVQ 1163 (1299)
Q Consensus 1108 s~~~~~~nLV~---------wa~p--------lls~~e~L~eIVDp~-----L~~~--~p~ee~~eL~~LI~~CL~~dPs 1163 (1299)
.+..+...++. |... ++.....+....++. .... ........+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 54322211111 1110 000000000000000 0000 0001134678999999999999
Q ss_pred CCCCHHHHHHH
Q 000757 1164 HRPFMGEVVQA 1174 (1299)
Q Consensus 1164 kRPSMsEVLq~ 1174 (1299)
+|+++.|+++.
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999875
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=327.45 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=203.9
Q ss_pred HHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 894 EIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 894 ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
|++.+++++.....||+|+||.||+|++ ++++.|++|.+........+.+.+|++++++++|+||+++++++.+++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456677888888999999999999995 467889999987655556678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCC--ChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGL 1049 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pL--dw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGL 1049 (1299)
+||||+.+++|.++++... ..+ ++..++.++.||+.||+|||+.+ |+|||||++||||+. ++.+||+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999986321 234 78889999999999999999887 999999999999986 67999999999
Q ss_pred cccccccccccccccccccccccCccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~--~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+....... .......|+..|+|||++.... ++.++|||||||++|||++|+.||...... ....|......
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~-- 228 (268)
T cd06624 156 SKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK-- 228 (268)
T ss_pred heecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc--
Confidence 87553221 1122345889999999886543 789999999999999999999998643211 11111111110
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
....++.....++.+++.+||+.+|++||++.||++.
T Consensus 229 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111223344678899999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=353.57 Aligned_cols=258 Identities=26% Similarity=0.354 Sum_probs=204.3
Q ss_pred HHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccc--------------ccchhHHHHHHHHhhhccccccee
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--------------QQGGREFLAEVEMLSRLHHRNLVK 960 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d--------------~~~~keFlrEIeILsrLrHPNIVr 960 (1299)
.+..++|++.+.||+|.||+|-+|+ ..+++.||||++.+.. ....+++.+||.||++|+|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4556889999999999999999999 4578999999995311 112357889999999999999999
Q ss_pred eeeeeee--ccceEEEEeecCCCChhhcccccccCCCC-CChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec
Q 000757 961 LIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1037 (1299)
Q Consensus 961 LlG~~~e--~~~~~LVyEYm~GGSL~d~L~~~~~~~~p-Ldw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD 1037 (1299)
|+++..+ .+.+|||+|||..|.+...= .... |++.+.++|+.+++.||+|||.++ ||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999875 57889999999998876543 2233 999999999999999999999998 99999999999999
Q ss_pred cCCcceecCCCcccccccc---ccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCC
Q 000757 1038 HDFTPKVSDFGLARSAMDE---ESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQP 1110 (1299)
Q Consensus 1038 edg~VKLsDFGLAr~~~~~---~~~~~st~v~GT~gYmAPE~l~~~~----~T~KSDVWSLGVVLyELLTGr~PFd~s~~ 1110 (1299)
++|++||+|||.+..+... +......+..||+.|||||...++. .+.+.||||+||+||+|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999998755221 1222233467999999999877632 35788999999999999999999965321
Q ss_pred CchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1111 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1111 ~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
.+. ..+|+...+.-....++...+.+||.++|.+||++|.++.+|....+.
T Consensus 325 ------~~l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 ------LEL----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ------HHH----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111 223333333222223456789999999999999999999999877663
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=358.80 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=209.6
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|.+.+.||+|.||+||||+.+ +.+.||+|++.+. .+.+.+.+.+|++|+++|+|+|||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999955 6788999999653 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.| +|+.+|. .+..|.++.+..|+++++.||.|||+.+ |+|||+||.||||+..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9966 9999995 3456999999999999999999999876 99999999999999999999999999997643
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
.....+.+.||+.|||||+..++.|+..+|+||+|||||||++|+.||... .+...++..+.+.
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~--------- 216 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP--------- 216 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC---------
Confidence 455667789999999999999999999999999999999999999999532 1222222222110
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-..+......|..+++-.|.+||.+|.+..+++..
T Consensus 217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12334667789999999999999999999998765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=325.65 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=200.8
Q ss_pred CcceeeEEeecCceEEEEEEecCCCEEEEEEeeccc------ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
+|++.+.||+|+||.||+|...+|+.+|||.++... ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999986321 12235688999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+++|.+++.. ...+.+..++.++.|++.||+|||+.+ |+|+|||++|||+++++.+||+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999853 235789999999999999999999887 9999999999999999999999999987542
Q ss_pred ccc----cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1055 DEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1055 ~~~----~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
... .........|+..|++||++.+..++.++|||||||++|||++|+.||....... ...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~----~~~~-- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYIG----AHRG-- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHhh----hccC--
Confidence 211 1111233568999999999998889999999999999999999999996532111 110000 0000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
............+.+++.+||+.+|++||++.|+++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001122234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.23 Aligned_cols=238 Identities=25% Similarity=0.333 Sum_probs=189.7
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHH-HhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+|+.. +|+.||||++.... ....+++++|.. +++.++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999964 68999999996432 223345566655 45789999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+.+..++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999998853 346889999999999999999999887 999999999999999999999999998754221 12
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~----------~~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNK----------PL-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcC----------CC--
Confidence 234457999999999999999999999999999999999999999753211 111111110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
.........+.+++.+||+.||++|+++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 111223567899999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.94 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=204.3
Q ss_pred CCcceeeEEeecCceEEEEEEecCC----CEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDG----TKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdG----r~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
++|.+.+.||+|+||.||+|.+.+. ..|+||...... ....+.|.+|+.++++++|+||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688999999999999999986432 468999886433 3445689999999999999999999999875 557899
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|||||++|||++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999542 235899999999999999999999887 9999999999999999999999999997654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.... .......++..|+|||++....++.++|||||||++|||++ |+.||...... ....+... ...+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~----~~~~--- 227 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIEN----GERL--- 227 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHc----CCcC---
Confidence 3321 11222334568999999988889999999999999999996 99999654322 11122110 0000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
....++...+.+++.+||..+|++||++.|+++.|+.+.++
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456799999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=342.06 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=193.8
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+|... +++.||+|+++.. +....+.+.+|+.++.++ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999954 6788999999753 223345678999999988 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988842 236899999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||+........+..++....... .. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~--~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP--I 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC--C
Confidence 223467999999999999999999999999999999999999999754332222222222211111 00 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMs 1169 (1299)
.++......+.+++.+||+.||++|+++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12223446788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.32 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=199.2
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.|+..+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++|++++|+||+.+++++.+++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999985 468899999986432 2233457889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++... ....+++..++.++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888532 2336999999999999999999999887 999999999999999999999999998754321
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+........
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~--------- 221 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE--------- 221 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc---------
Confidence 1 11234689999999999988999999999999999999999999975432111 111111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq~ 1174 (1299)
..+.......+.+|+.+||+.||++|++ +.|+++.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112233456889999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=333.43 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=195.2
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||.||+++.+ +|+.||+|++.... ....+.+..|++++++++|+||+++++++.++...|+||||+.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 68999999986422 12234566799999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++... ....+++..++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888532 2335889999999999999999999887 9999999999999999999999999987653321 123
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
...|+..|+|||++.+..++.++|||||||+||||++|+.||........ ........+. ..... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~----------~~~~~-~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE----------DEVKF-EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc----------ccccc-cc
Confidence 35689999999999988899999999999999999999999975432211 1111111111 00000 00
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.....++.+|+.+||+.||++|+++.|+++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 123457899999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=325.23 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=194.4
Q ss_pred eEEeecCceEEEEEEecC----CCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeee-ccceEEEEeecC
Q 000757 906 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYELIP 979 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e-~~~~~LVyEYm~ 979 (1299)
++||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.+++.++|+||++++++|.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 356999998543 23345688899999999999999999998764 556799999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.++++.. ...+.+..+++++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998632 234678888999999999999999887 999999999999999999999999999755332111
Q ss_pred c--ccccccccccccCccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1060 H--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1060 ~--~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTG-r~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......++..|+|||++....++.++|||||||++|||++| ..+|...+ ...+..+.. ... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~---~~~-~------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLL---QGR-R------- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh---cCC-C-------
Confidence 1 11233467789999999888999999999999999999995 55554322 122222211 100 0
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
..........+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01111234578999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.15 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=190.9
Q ss_pred eEEeecCceEEEEEEecC---CCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd---Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+.||+|+||.||+|...+ ...+++|.+.... ....++|++|+++++.++|+||++++++|.+....|+||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998543 3467888775432 233457889999999999999999999999999999999999999
Q ss_pred ChhhcccccccC-CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 982 SVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 982 SL~d~L~~~~~~-~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
+|.+++...... ....++...++++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++....+....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654322 234578889999999999999999887 9999999999999999999999999987543322222
Q ss_pred ccccccccccccCcccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1061 ISTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~-------~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .+ ... .. +...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~-~~~---~~--~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL-KQV---VR--EQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH-HHH---hh--ccCcc
Confidence 2233446778999998643 356789999999999999999 778886432211 11 110 00 00111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
+.++. ........+.+++..|| .||++||+++||++.|
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11121 22234466778899998 4999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=322.42 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=203.3
Q ss_pred CCcceeeEEeecCceEEEEEEecC-CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|+..+ ++.|++|.++.... .+++.+|++++++++|+||+++++++.++...|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999999764 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.. ....++|.+++.++.|++.||.|||+.+ |+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999853 2346899999999999999999999887 99999999999999999999999999886543221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......|+..|++||++.+..++.++|||||||++|||++|+.||........ .... . .. ....+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~-~-----~~-----~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMI-P-----NK-----PPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhh-c-----cC-----CCCCC
Confidence 22334588999999999988999999999999999999999999975432111 0000 0 00 00000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.........+.+++.+||+.+|++||++.||++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223457899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=348.21 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=199.5
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc-----ceE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-----~~~ 972 (1299)
+|++.+.||+|+||.||++.. .+|+.||||++... +....+++.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588899999999999999995 57899999998643 2234567889999999999999999999998766 789
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+. ++|.+++. ....+++.+++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 67877773 2346899999999999999999999887 99999999999999999999999999986
Q ss_pred ccccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHh------------
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW------------ 1119 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~w------------ 1119 (1299)
...... .......++..|+|||++.+. .++.++|||||||++|||++|+.||...+.......+..
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 533221 222334688999999988764 578999999999999999999999976543221111110
Q ss_pred ----hhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1120 ----ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1120 ----a~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
....+............ ......+...++.+|+.+||+.||++|+++.|+++.-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPV--LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHH--hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000000000000000 0011123356788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.29 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=202.2
Q ss_pred CcceeeEEeecCceEEEEEEecC--CCEEEEEEeecc----------cccchhHHHHHHHHhhh-cccccceeeeeeeee
Q 000757 901 NFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV----------DQQGGREFLAEVEMLSR-LHHRNLVKLIGICIE 967 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkd--Gr~VAVK~Lk~~----------d~~~~keFlrEIeILsr-LrHPNIVrLlG~~~e 967 (1299)
+|++.+.||+|+||.||+|.+++ ++.+|+|.+... .....+++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999987532 12223457789988875 799999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeeeccCCcceecC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSD 1046 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg~VKLsD 1046 (1299)
++..++||||+.+++|.+++.........+++..+++++.|++.+|.|||+ .+ |+|||||++|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544445578999999999999999999996 44 99999999999999999999999
Q ss_pred CCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1047 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1047 FGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
||++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||...... ...... ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~---~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKI---VE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHH---hh-
Confidence 99998654322 223456899999999999888999999999999999999999998643211 111110 00
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
..............+.+++.+||+.||++||++.||..+++
T Consensus 228 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 ---------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000011123467899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=340.89 Aligned_cols=238 Identities=26% Similarity=0.338 Sum_probs=192.3
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+|+.+ +++.||||+++.. .....+.+.+|++++.++ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 6889999999753 233455678899999877 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999998853 345899999999999999999999887 9999999999999999999999999987542211 2
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.... .... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i---~~~~-----~------- 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAI---LNDE-----V------- 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---hcCC-----C-------
Confidence 233457999999999999989999999999999999999999999754321 111111 1100 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
..+......+.+++.+||+.||++|++..+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 111223457889999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.95 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=195.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhc---ccccceeeeeeeee-----cc
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIE-----EQ 969 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~e-----~~ 969 (1299)
+|++.+.||+|+||+||+|... +|+.||+|.++... ......+.+|+++++++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999854 68899999986432 22234567788888776 69999999998864 24
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..++||||+. ++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999996 58888885432 235899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcc----c
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPL----L 1124 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~pl----l 1124 (1299)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|......+. ..+..+.... +
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98653221 12335689999999999988999999999999999999999999965432211 1111111000 0
Q ss_pred ccccc-cceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1125 TSREG-LERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1125 s~~e~-L~eIVDp~L~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..... ....+..... .....+....+.+++.+||+.||++|+++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000000 0011133456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.73 Aligned_cols=249 Identities=23% Similarity=0.409 Sum_probs=199.6
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccccc---------chhHHHHHHHHhhhcccccceeeeeeeeeccc
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQ---------GGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 970 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~---------~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~ 970 (1299)
+|.+.+.||+|+||.||+|.. .+++.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 46789999988643221 12468899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.++||||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||||++||||++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999953 245889999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccc----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1051 RSAMDEESR----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1051 r~~~~~~~~----~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
+........ .......|+..|++||++.+..++.++|||||||++|||++|+.||...+.. ..+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~-- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKI----G-- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHH----h--
Confidence 866421111 1112345889999999999888999999999999999999999999753211 111000 0
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
. ......+......+.+++.+||+.+|++||++.||++
T Consensus 226 -----~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -----E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0111222334567899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.13 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=203.7
Q ss_pred CCcceeeEEeecCceEEEEEEec------CCCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
++|++.+.||+|+||+||+|+.+ +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999954 3467999988654333 3567999999999999999999999999989999
Q ss_pred EEEeecCCCChhhcccccccC-----CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 973 LVYELIPNGSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~-----~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
+||||+++|+|.++++..... ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999644321 125899999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++....... .......++..|++||.+.+...+.++|||||||++|||++ |..||..... ..++.+...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~---- 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQA---- 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHc----
Confidence 99875432211 11223346788999999988888999999999999999999 7888854321 112221110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
..+ ...........+.+++.+||+.+|++||++.|+++.|.
T Consensus 234 -~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00111234467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=357.26 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=207.1
Q ss_pred HHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 897 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
.-.++|+++..||+|+||.||+++ .++|..+|+|+|++.. ....+.++.|-.+|...++++||+|+-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 345789999999999999999999 5579999999998743 344566789999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
|||||++||++..+|. ....|+++....++.+++.|++-||+.| +|||||||+|+|||.+|.+||+||||+.-
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999994 4567999999999999999999999998 99999999999999999999999999852
Q ss_pred ccc----------------------cccc-----------------------cccccccccccccCccccccCCCCcccc
Q 000757 1053 AMD----------------------EESR-----------------------HISTRVMGTFGYVAPEYAMTGHLLVKSD 1087 (1299)
Q Consensus 1053 ~~~----------------------~~~~-----------------------~~st~v~GT~gYmAPE~l~~~~~T~KSD 1087 (1299)
... .+.. ......+||+.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 0000 0011357999999999999999999999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCc-hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC
Q 000757 1088 VYSYGVVILELLSGRKPVDMTQPPG-QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166 (1299)
Q Consensus 1088 VWSLGVVLyELLTGr~PFd~s~~~~-~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP 1166 (1299)
.|||||||||||.|..||...+... ..+++.|-..+.... ..++..+..+||.+|+. |+++|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999999877654 456777754322211 11233678899999999 999998
Q ss_pred C
Q 000757 1167 F 1167 (1299)
Q Consensus 1167 S 1167 (1299)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 6
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.02 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=200.2
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56999999999999999999954 67889999987432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 96 4888887432 335889999999999999999999887 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhh--------hccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA--------RPLLTSRE 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa--------~plls~~e 1128 (1299)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+........ ++.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223457899999998764 56889999999999999999999999765433221111110 00000000
Q ss_pred ccceeecCCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1129 GLERIIDPSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1129 ~L~eIVDp~L~~----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.....-...... ........++.+++.+||+.||++|+|+.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000000000000 00012345678999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.28 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=200.7
Q ss_pred cceeeEEeecCceEEEEEEec----CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc------
Q 000757 902 FDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 969 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk----dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~------ 969 (1299)
|++.+.||+|+||.||+|.+. +++.||||+++.. +....+++.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 3678999998643 2334567889999999999999999999886532
Q ss_pred ceEEEEeecCCCChhhcccccc--cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 970 ARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~--~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
..++++||+.+|+|.+++.... .....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998874321 22335889999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++...............++..|++||.+..+.++.++|||||||++|||++ |+.||..... ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99986543222222223345678999999998889999999999999999999 8888864322 222222111
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
...+ .........+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11123456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.69 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=198.6
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc-----
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 969 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~----- 969 (1299)
..++|++.+.||+|+||.||++.. .+|+.||||+++.. .....+++.+|+.++++++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 46889999999642 2334567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 970 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 970 -~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
..|+||||+.+ +|.++++ ..+++.++..++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999964 5666653 23788999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh------------h
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN------------L 1116 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n------------L 1116 (1299)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+... +
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 99754321 12234568999999999999999999999999999999999999997543211100 0
Q ss_pred ----HHhhhccccccc-----ccceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1117 ----VAWARPLLTSRE-----GLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1117 ----V~wa~plls~~e-----~L~eIVDp~L~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
............ .+.+++..... ..........+.+|+.+||+.||++|+++.|+++.-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000000000000 00000000000 0011122356889999999999999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=352.45 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=196.8
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
.++|++.+.||+|+||.||++.. ++++.||+|.... +.+.+|+++|++|+|+|||++++++......++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999995 5688999997542 3578999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+ +++|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 165 ~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 Y-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9 5788888743 235889999999999999999999887 9999999999999999999999999997543211
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc-----hhhhHHhhhcc--------c
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAWARPL--------L 1124 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~-----~~nLV~wa~pl--------l 1124 (1299)
........||..|+|||++.+..++.++|||||||+||||++|+.+|-...... ...+....... .
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122234579999999999999899999999999999999999998764322110 00000000000 0
Q ss_pred ccccccceee---------cCCCCCCC--ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1125 TSREGLERII---------DPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 s~~e~L~eIV---------Dp~L~~~~--p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+.+++ ....+... ..+....+.+|+.+||+.||++|||+.|+++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00000000 01234578899999999999999999999864
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.95 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=207.8
Q ss_pred CCHHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeee
Q 000757 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 967 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e 967 (1299)
+...++..++++|++.+.||+|+||.||++.. ++++.+|+|++... ....+++.+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566777889999999999999999999996 56889999998643 22346788999999999 79999999999875
Q ss_pred c-----cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 968 E-----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 968 ~-----~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
. +..|+||||+.+|+|.++++........+.|..++.++.|++.||+|||+.+ |+|||||++|||+++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3579999999999999998654444456899999999999999999999887 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~-----~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV 1117 (1299)
||+|||+++....... ......|+..|++||++... .++.++|||||||++|||++|+.||..... ...+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHH
Confidence 9999999876543221 12234588999999987643 368999999999999999999999965322 11222
Q ss_pred HhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1118 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1118 ~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.+. ....+. ...+....+.+++.+||+.+|++||++.|+++.
T Consensus 244 ~~~~~------~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRN------PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcC------CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 21110 000111 112334578999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.28 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=200.6
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.|++.++||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++|+||+.+++.+.+++..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3788899999999999999954 68899999986432 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+|+|.+++... ....+++.+++.++.|++.||.|||+.+ |+|||||++|||+++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988532 2335899999999999999999999887 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ... .+
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~------~~--- 220 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVK------EV--- 220 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhh------hh---
Confidence 11 1234689999999999999999999999999999999999999975432211110000 000 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq~ 1174 (1299)
...+.......+.+|+.+||+.||++|++ +.|+++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00112234456899999999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.06 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=192.4
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|++++.++ +|+||+++++++.+++..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999965 68899999997532 23345677788888765 899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.++.|+++||+|||+.+ |+|||||++||||++++.+||+|||+++..... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999998853 345889999999999999999999887 999999999999999999999999998743221 12
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||..... ..+.+... .. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~---~~--------~----~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIR---VD--------T----P 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hC--------C----C
Confidence 23446799999999999999999999999999999999999999975432 11111110 00 0 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVV 1172 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMs-EVL 1172 (1299)
.++.....++.+++.+||+.||++|+++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11222346788999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=343.58 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=198.2
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec------
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 968 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~------ 968 (1299)
..++|++.+.||+|+||.||++.. .+++.||||+++.. .....+++.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 46889999999643 233346788999999999999999999988643
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
...|+||||++ ++|.+++. ..+++..++.++.|+++||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 34699999996 46766663 24788999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hH--------H-
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LV--------A- 1118 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV--------~- 1118 (1299)
+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||......+... .. +
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99854321 12234568999999999998899999999999999999999999997543211100 00 0
Q ss_pred ------hhhcccccccccceee-----cCCC---CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1119 ------WARPLLTSREGLERII-----DPSL---GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1119 ------wa~plls~~e~L~eIV-----Dp~L---~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..............+. ...+ ...........+.+|+.+||+.||++|||+.|+++.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000000000000000 0000 0011112345789999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.32 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=202.2
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCC----EEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr----~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
++|+..+.||+|+||.||+|.+ .+|+ .||+|++.... .....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5678889999999999999985 3454 47888876432 22334788999999999999999999998754 4679
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
++||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998532 335889999999999999999999887 999999999999999999999999999865
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.............++..|++||++.+..++.++|||||||++|||++ |+.||.... ...+..+... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEK----GERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHC----CCCC--
Confidence 43222222223345779999999998999999999999999999997 899986532 1222222211 1100
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
.....+...+.+++.+||..+|++||++.|+++.|+.+...
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01122345789999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.35 Aligned_cols=237 Identities=26% Similarity=0.476 Sum_probs=189.2
Q ss_pred eEEeecCceEEEEEEecCCC-----------EEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 906 RILGEGGFGLVYSGVLDDGT-----------KVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr-----------~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
+.||+|+||.||+|.+.+.. .|++|.++..... .+.|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 4788877643332 6789999999999999999999999988 778999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-------cceecCC
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-------TPKVSDF 1047 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-------~VKLsDF 1047 (1299)
|||+.+|+|.+++... ...+++..+++++.||+.||+|||+.+ |+|||||++|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999642 226899999999999999999999887 99999999999999887 7999999
Q ss_pred CccccccccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~--~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..||....... ...+..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ--- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---
Confidence 99986532 1223467789999998876 78999999999999999999 577775543211 111111
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
... .........+.+++.+||..+|++||++.||++.|
T Consensus 221 -~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -DQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -cCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 00111126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=326.26 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.0
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|+. .+++.|++|+++.........+.+|+.+++.++|+||+++++++.+++..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999985 468899999987554445567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999853 336899999999999999999999887 9999999999999999999999999987553221
Q ss_pred ccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1059 RHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||........ +....... ...
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~---------~~~ 228 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSN---------FQP 228 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhccC---------CCC
Confidence 1123346899999999874 45688999999999999999999999854332111 10000000 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..+.. .......+.+++.+||..+|++||++.+|++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00100 0123356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=356.89 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=196.6
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeec--------
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-------- 968 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~-------- 968 (1299)
..++|++.++||+|+||.||+|+. .+++.||||++.... ....+|+.+|++++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456899999999999999999996 468899999885422 2345799999999999999999986432
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 1047 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDF 1047 (1299)
...++||||+. ++|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 23578999996 5787777544444567999999999999999999999887 99999999999999664 7999999
Q ss_pred CccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++...... ......||..|+|||++.+ ..++.++|||||||+||||++|+.||......+ .+......+...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 9998653321 1223468999999998765 468999999999999999999999997643221 111111100000
Q ss_pred c--------cccce-----eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1127 R--------EGLER-----IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1127 ~--------e~L~e-----IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
. ....+ +....+...++.....++.+|+.+||..||++|+++.|+++.-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 00000 0001111112223446789999999999999999999998663
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=339.49 Aligned_cols=241 Identities=25% Similarity=0.342 Sum_probs=192.4
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 57899999997532 23345677788888765 899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999853 235889999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
......||..|+|||++.+..++.++|||||||++|||++|+.||...+.. .+...... . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~----~-------~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRM----D-------NP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----C-------CC----
Confidence 223456999999999999989999999999999999999999999754321 11111110 0 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQ 1173 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMs-EVLq 1173 (1299)
.++......+.+++.+||+.+|++|+++. ++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11112345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=339.10 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=195.1
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|++++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 5789999999753 233445678899999888 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999988853 236899999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... .... .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i---~~~~------------~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSI---LEDE------------V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHH---HcCC------------C
Confidence 22345699999999999999999999999999999999999999975431 1111111 1100 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCH-----HHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFM-----GEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSM-----sEVLq~ 1174 (1299)
.++......+.+|+.+||+.||++|+++ .++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122344678999999999999999999 776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.96 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=204.3
Q ss_pred CcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|+..++||+|+||.||.++ .++++.|++|.+... +....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999988 456889999998643 344456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+|+|.+++.... ...+++.+++.++.|++++|+|||+.+ |+|||||++||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996432 346899999999999999999999887 9999999999999999999999999998654322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.+|+...... .. ...... ...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~~~--~~~------ 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LV---VKIVQG--NYT------ 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHcC--CCC------
Confidence 1 2234568999999999988888999999999999999999999996533211 11 111110 000
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
........++.+++.+||+.+|++||++.|+++.+
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123456789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.34 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=191.0
Q ss_pred eEEeecCceEEEEEEecCCC---EEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 906 RILGEGGFGLVYSGVLDDGT---KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr---~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+.||+|+||+||+|.+.++. .+++|.++... ....++|.+|++++++++|+||++++++|.+....|+||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999855443 45566665332 234568999999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+++++.......+.+..+++++.||++||+|||+.+ |+|||||++|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999754333345677788999999999999999887 99999999999999999999999999864322222122
Q ss_pred cccccccccccCcccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1062 STRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~-------~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||...... .... ..+. +....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~--~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---HVIK--DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHh--hccccc
Confidence 234568899999998753 245789999999999999997 56677543211 1111 1111 111223
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.++.+.. ....++.+++..|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333322 23457788999999 57999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=346.83 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+++.+ +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+++..||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 68899999997432 333456788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999853 346899999999999999999999887 99999999999999999999999999875422
Q ss_pred ccc---------------------------------ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCC
Q 000757 1056 EES---------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1102 (1299)
Q Consensus 1056 ~~~---------------------------------~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr 1102 (1299)
... .......+||..|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---HHHHHH
Q 000757 1103 KPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF---MGEVVQ 1173 (1299)
Q Consensus 1103 ~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS---MsEVLq 1173 (1299)
.||........ ..+..|. ..+ .+.. . .....++.+++.+|+. +|++|++ +.|+++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~-------~~~--~~p~----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKVMNWK-------ETL--VFPP----E--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHHHcCC-------Cce--ecCC----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99976443211 1111110 000 0000 0 1133567778877764 9999985 455543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.84 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=199.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|+.. +++.||||+++.. +....+.+.+|+.++++++|+||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999964 6889999998643 223346788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 96 688888864332 346899999999999999999999887 999999999999999999999999998754321
Q ss_pred cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhh-------ccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWAR-------PLLTSRE 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~-------plls~~e 1128 (1299)
........++..|+|||++.+. .++.++|||||||++|||++|+.+|......... ....... .......
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1122334578999999987654 5789999999999999999999999754321110 0000000 0000000
Q ss_pred ccceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1129 GLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1129 ~L~eIVDp~L~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.....++.... .........++.+++.+||+.||++||++.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0011123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.70 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=200.6
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-----ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
+|+..+.||+|+||+||+|..+ +++.|++|.+.... .+..+++.+|++++++++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999986432 22456788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||+++||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999853 235889999999999999999999887 9999999999999999999999999987653
Q ss_pred ccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~-~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
... ......|+..|++||.+.... ++.++|||||||++|||++|+.||..... ......+.. ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~-----~~~~--- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGR-----SKEL--- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHh-----cccC---
Confidence 322 223456889999999887766 89999999999999999999999965431 111111110 0000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..+.......+.+++.+||+.+|++||++.|+++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122233467889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=341.70 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=191.9
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHH-HhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||+||+|+. .+|+.||||++... .....+++.+|.. +++.++|+||+++++++.+++..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46899999999643 2233445666665 46778999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988842 346899999999999999999999887 999999999999999999999999998753221 12
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||....... + ....+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~~~~~----------~~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M---YDNILHK----------PL-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H---HHHHHcC----------Cc--
Confidence 2344679999999999999999999999999999999999999997543211 1 1111110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.........+.+++.+|++.+|.+|+++.+.++++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 11112345788999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.56 Aligned_cols=251 Identities=31% Similarity=0.524 Sum_probs=201.2
Q ss_pred cceeeEEeecCceEEEEEEecC-----CCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 902 FDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkd-----Gr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
|++.+.||+|+||.||+++..+ +..||+|+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999653 378999999754333 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.+++..... ..+++.+++.++.|++.||+|||+.+ |+|||||++||++++++.+||+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999964321 12899999999999999999999887 99999999999999999999999999986654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
..... .....++..|++||.+.+..++.++|||||||++|||++ |+.||+.... ..+...... ..
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~----~~------ 221 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKK----GY------ 221 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----CC------
Confidence 32211 112337789999999988889999999999999999998 7888865321 222222111 00
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..........++.+++.+||..+|++||++.|+++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011122456799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.14 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=200.7
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999965 58899999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++++|..++.. ...++|.++++++.|++.+|+|||+.+ |+|||||++||||++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887642 235899999999999999999999887 999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhhcccc-------cc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLT-------SR 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~plls-------~~ 1127 (1299)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .+......... ..
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1123457889999998875 56789999999999999999999999754322111 11111111100 00
Q ss_pred cccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.....+..+....... ......+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000011000000 122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.62 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=204.4
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++|+||+++++++.+.+..|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67999999999999999999954 57889999997655556678999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988532 246899999999999999999999887 9999999999999999999999999987653321
Q ss_pred ccccccccccccccCccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~---~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.......++..|++||++... .++.++|||||||++|||++|+.||....... ....... ..+. .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~~------~~~~---~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLISK------SNFP---P 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh------ccCC---C
Confidence 112335688899999998776 88999999999999999999999996533211 1111100 0000 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..+ .........+.+++.+||..+|.+||++.+|+.
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 112234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.00 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=202.4
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||.||+|..+ +++.|+||+++.. +....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999965 5889999998643 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.++.|..++. ....+++.+++.++.||+.||+|||+.+ |+||||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766553 2335899999999999999999999887 999999999999999999999999999866443
Q ss_pred ccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhhc-------ccccc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARP-------LLTSR 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~p-------lls~~ 1127 (1299)
.. .......++..|+|||++.+. .++.++||||||++||||++|+.+|......+... +..+... .+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122335688999999999888 88999999999999999999999997543221110 0010000 00000
Q ss_pred cccc--eeecCC----CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1128 EGLE--RIIDPS----LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1128 e~L~--eIVDp~----L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.... ++.+.. +...+......++.+++++||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 000112223578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=338.62 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=188.5
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHH-HhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
++||+|+||.||+|+.. +|+.||+|++.... ....+++++|+. +++.++|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 68899999996432 223345566654 57889999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+.+.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988842 345788899999999999999999887 999999999999999999999999998753221 12
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.+. .+.. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~---i~~~----------~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDN---ILHK----------P--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHH---HhcC----------C--C
Confidence 23345799999999999988999999999999999999999999965421 111111 1110 0 1
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMs 1169 (1299)
.++......+.+++.+||+.+|++|++..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12233456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.71 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=196.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+++.. +++.||||++++. .....+.|.+|+.++.+++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999954 6889999999642 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++... ...+++.++..++.||+.||+|||+++ |+|||||++||||+.++++||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999532 335889999999999999999999887 99999999999999999999999999875533
Q ss_pred cccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
... ......+||..|||||++.. +.++.++|||||||+||||++|+.||...... +.....+......
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHF 227 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcc
Confidence 221 12233469999999998863 45788999999999999999999999653221 1111111111100
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCc--CcCCCCCHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQP--EVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~--dPskRPSMsEVLq~ 1174 (1299)
.+. .........+.+++.+|+.. ++..|+++.++++.
T Consensus 228 -~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -QFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 01112345677788887654 33447899888776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.39 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=202.1
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeeecc-----
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ----- 969 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~----- 969 (1299)
..+++|++.+.||+|+||.||+|..+ +++.|++|++.... ...++|.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999964 67889999987533 3456799999999999 6999999999997644
Q ss_pred -ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 970 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 970 -~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
..++||||+++++|.++++........+++..++.++.|++.||.|||+.+ |+||||+++||+|++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999998654433567899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
++....... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||...... ..+....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~--- 231 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIP--- 231 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhh---
Confidence 987543221 11223458899999998753 34678999999999999999999999643211 1111110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
. .... .+ .........+.+++.+||..||++||++.||++
T Consensus 232 -~--~~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -R--NPPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -c--cCCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000 00 111234567899999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.14 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=200.6
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeee-ccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e-~~~~~LVyE 976 (1299)
+|++.+.||+|++|.||++..+ +++.|++|++... .....+.+.+|++++++++|+||+++++.+.. +...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999954 5788999998643 23345578899999999999999999998764 446789999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+++|.+++... ....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999642 2345899999999999999999999887 999999999999999999999999999765322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||+..+.. .+....... .+
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~--~~------ 219 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG--KL------ 219 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc--CC------
Confidence 1 1223456889999999999999999999999999999999999998643211 111111110 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..........+.+++.+||+.+|++||++.|+++.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01122344679999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.91 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=201.4
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|... +++.|++|++...+....+++.+|++++++++|+||+++++++..+...|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999965 58899999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.+. ...+++.+++.++.|++.+|+|||+.+ |+|||||++|||++.++++||+|||++......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999998887432 235899999999999999999999887 999999999999999999999999998754221
Q ss_pred ccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1059 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
........++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+..+... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~----~------ 231 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS----E------ 231 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHhcC----C------
Confidence 11123345889999999874 345688999999999999999999998653311 111111100 0
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.... ........++.+++.+||+.+|++||++.|+++.
T Consensus 232 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 1112344578999999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.49 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=199.9
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++.++...++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677789999999999999965 5778899998755555567889999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
++|.+++.. ....++|.+++.++.|++.||+|||+.+ |+|||||++|||++.++++||+|||++....... .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999988753 2346899999999999999999999887 9999999999999999999999999987543211 1
Q ss_pred ccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1061 ISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
......|+..|+|||++. +..++.++|||||||++|||++|+.||...... .......... ...+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~------~~~~-- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSE------PPTL-- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcC------CCCC--
Confidence 223356899999999874 345778999999999999999999998654321 1111111100 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..+......+.+++.+||+.+|++||++.++++.-
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 11122346789999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.27 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.+|++.+.||.|+||.||+|+. .+|+.|++|.+........+.+.+|++++++++|+||+++++++.+.+..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999984 578999999997655555678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.. ..+++.++++++.|++.||+|||+.+ |+|||||++||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 35899999999999999999999887 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......|+..|++||.+.+..++.++|||||||++|||++|+.||...+.... +. +.. ... ...
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~-~~~---~~~--~~~------ 234 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY-LIA---TNG--TPE------ 234 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHH---hcC--Ccc------
Confidence 12334688999999999988899999999999999999999999976432111 11 110 000 000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..........+.+++.+||..+|++||++.+|++.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01112334578899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.29 Aligned_cols=247 Identities=31% Similarity=0.486 Sum_probs=198.8
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
++|++.+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|+.++++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 4788999998642 2346789999999999999999999998764 5799999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++.... ...+++.++++++.|++.||+|||+.+ ++|||||++|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999996432 235889999999999999999999887 999999999999999999999999998754321
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......+..|++||++.++.++.++|||||||++|||++ |+.||......+ +..... . ..
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~-----------~~ 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECVE---K-----------GY 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHh---C-----------CC
Confidence 112234578999999998899999999999999999998 999986543211 111111 0 01
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
...........+.+++.+||+.+|++||++++|++.|+.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122345678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.34 Aligned_cols=242 Identities=22% Similarity=0.311 Sum_probs=194.7
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVy 975 (1299)
+|+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+..|++++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999985 46889999999753 2233456788999998886 577888999999989999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998843 345899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.. .......||..|+|||++.+..++.++|||||||+||||++|+.||..... ..+..... ..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~~--------- 216 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM---EH--------- 216 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hC---------
Confidence 11 122345699999999999988999999999999999999999999975432 11111111 10
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMs 1169 (1299)
. ..++......+.+++.+||+.+|++|++..
T Consensus 217 -~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 -N--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -C--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 012223346788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.15 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=204.2
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.++++++|+||+++++++..++..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6799999999999999999995 578999999997655555677889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++++|.+++.. ..+++.++++++.|++.+|.|||+.+ |+|||||++||||+.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999842 35789999999999999999999887 99999999999999999999999999876533221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......++..|++||++.+..++.++|||||||++|||++|+.||...+...... .... .. ..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~--~~-------~~ 233 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--NG-------TP 233 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eecc--CC-------CC
Confidence 1233468899999999998889999999999999999999999996543211100 0000 00 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122334568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.40 Aligned_cols=261 Identities=27% Similarity=0.396 Sum_probs=204.7
Q ss_pred cCCHHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeee
Q 000757 889 TFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICI 966 (1299)
Q Consensus 889 ~Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~ 966 (1299)
..++.++....+.|++.+.||+|+||.||+|.. ++++.||+|++... .....++..|+.+++++ +|+||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 346677777889999999999999999999995 56889999998643 23446788999999999 6999999999986
Q ss_pred e------ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC
Q 000757 967 E------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040 (1299)
Q Consensus 967 e------~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg 1040 (1299)
. ....|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+|||||++||+|++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCC
Confidence 3 456799999999999999985432 345788899999999999999999887 99999999999999999
Q ss_pred cceecCCCccccccccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh
Q 000757 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1041 ~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n 1115 (1299)
.+||+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 159 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 99999999987543211 1123356899999999875 3467889999999999999999999996432211100
Q ss_pred hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.. .+..... ....++...+.+++.+||+.||++||++.||++
T Consensus 237 ~~-------------~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI-------------PRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH-------------hhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000000 111234467999999999999999999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.00 Aligned_cols=192 Identities=24% Similarity=0.359 Sum_probs=164.7
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
...+|++.+.||+|+||.||+|+.. +++.||+|+... ..+..|+.++++++|+||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999965 567899997542 234579999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+ .++|.+++.. ....++|.++++|+.||+.||.|||+.+ |+|||||++||||+.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred cc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99 5788888853 2346899999999999999999999887 999999999999999999999999999753221
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1105 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PF 1105 (1299)
.......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1123456999999999999999999999999999999999865544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.58 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=202.6
Q ss_pred HHHHHHHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeee
Q 000757 892 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 892 l~ELe~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e 967 (1299)
..+++...++|++.+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+++++.++|+||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999965 6788999998642 22334567899999999999999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
++..|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+|||||++||||+.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999853 24788889999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~----~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
|+++...... .......+||..|||||++... .++.++|||||||+||||++|+.||...+... .....
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 9998654322 1122346799999999988653 37899999999999999999999997543211 11111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQAL 1175 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPsk--RPSMsEVLq~L 1175 (1299)
+.....+ .+ ....+....+.+++.+|+..++.+ |+++.||++..
T Consensus 260 ~~~~~~~-~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNSL-TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCcc-cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111000 00 011234567889999999854443 77888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.47 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=191.0
Q ss_pred eEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHH-HhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+.||+|+||+||+|+.. +++.||+|++.... .....++.+|.. +++.++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999965 57789999996432 222344555544 56788999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+.+.+...++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999853 335778888899999999999999887 999999999999999999999999999754321 12
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+..+. ... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~~----------~~-- 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI---LNK----------PL-- 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH---HhC----------Cc--
Confidence 234467999999999999999999999999999999999999999753321 111111 110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.........+.+++.+||+.+|++|++..+.++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11123446789999999999999999987654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=346.59 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=200.4
Q ss_pred hCCcceeeEEeecCceEEEEEEec---CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk---dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
..+|++.+.||+|+||.||++... .++.|+||.+... +.+.+|+++|++|+|+|||++++++......|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3577999988642 34568999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+ +++|.+++. ....++|.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 166 e~~-~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKY-KCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999 478888883 2346899999999999999999999887 99999999999999999999999999976544
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhccc------cccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLL------TSRE 1128 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~pll------s~~e 1128 (1299)
...........||..|+|||++....++.++|||||||+||||++|+.||........ ..+..-...+. ....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3333333456799999999999999999999999999999999999999965443221 11111000000 0000
Q ss_pred --cccee---ecCCCCCCCC-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1129 --GLERI---IDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1129 --~L~eI---VDp~L~~~~p-------~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+.+. +....+..+. ......+.+++.+||..||++||++.|+++.-
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000 0000000000 12234678899999999999999999998763
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.55 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=205.6
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||.|+||+||+|.. .++..|++|++.... ....+++.+|++++++++|+||+++++.+.+++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999995 467889999986432 23557889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.++++.... ...+++...+.++.|++.||+|||+.+ |+|||||++||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999964322 245899999999999999999999887 9999999999999999999999999997665432
Q ss_pred cc--cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1058 SR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1058 ~~--~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.. .......|+..|++||++... .++.++|||||||++|||++|+.||...... ..+..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~---~------- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQND---P------- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCC---C-------
Confidence 22 123445689999999998877 7899999999999999999999999754322 1111211110 0
Q ss_pred cCCCCCCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1135 DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1135 Dp~L~~~~-p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..+.... .......+.+++.+||+.||++||++.||++
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 -PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0010000 1134567899999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.30 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=196.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.++||+|+||.||+++++ +++.||+|++.+. .....+.|.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999965 5778999998642 2223345788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.++|+.. ...+++..++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999632 235889999999999999999999887 99999999999999999999999999875533
Q ss_pred cccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
.. .......+||..|+|||++. ...++.++|||||||+||||++|+.||...... +............
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccc
Confidence 22 12223457999999999886 346889999999999999999999999753211 1111111111000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 1174 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPsk--RPSMsEVLq~ 1174 (1299)
. + ..........+.+|+.+|+..++++ |+++.|+++.
T Consensus 228 ~------~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q------F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c------C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0111234567888899888654444 6888888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.29 Aligned_cols=239 Identities=23% Similarity=0.439 Sum_probs=188.8
Q ss_pred eEEeecCceEEEEEEecC-------------CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 906 RILGEGGFGLVYSGVLDD-------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-------------Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++++++|+||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998542 2258889886544445567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc-------ceec
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT-------PKVS 1045 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~-------VKLs 1045 (1299)
+||||+.+|+|..+++. ....+++.++++|+.||+.||+|||+.+ |+||||||+||||+.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988853 2345899999999999999999999887 999999999999987664 8999
Q ss_pred CCCccccccccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHH-hCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1046 DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~-~~~~T~KSDVWSLGVVLyELL-TGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
|||++...... ....++..|+|||++. ...++.++|||||||+||||+ +|+.||........ ...
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~--- 221 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERF--- 221 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHH---
Confidence 99998654221 2235788999999886 567899999999999999998 48888754321111 010
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.... . .........+.+|+.+||+.||++||++.+|++.|
T Consensus 222 ~~~~----------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQ----------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcC----------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 0 01112245788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.15 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=188.0
Q ss_pred EEeecCceEEEEEEecC-------------------------CCEEEEEEeecccccchhHHHHHHHHhhhcccccceee
Q 000757 907 ILGEGGFGLVYSGVLDD-------------------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkd-------------------------Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrL 961 (1299)
.||+|+||.||+|.+.. ...|++|+++.......++|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13588999875544455678899999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-
Q 000757 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF- 1040 (1299)
Q Consensus 962 lG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg- 1040 (1299)
+++|.+....++||||+++|+|.+++.. ....+++.++++|+.||++||+|||+.+ |+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999853 2346889999999999999999999887 99999999999997644
Q ss_pred ------cceecCCCccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHH-hCCCCCCCCCCCc
Q 000757 1041 ------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPG 1112 (1299)
Q Consensus 1041 ------~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELL-TGr~PFd~s~~~~ 1112 (1299)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999988643221 12347788999998865 56899999999999999995 6899886543221
Q ss_pred hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1113 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1113 ~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
. ..+... .. ..+......+.+++.+||+.+|++||+|.||++.|
T Consensus 230 ~---~~~~~~----~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 K---ERFYEK----KH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HHHHHh----cc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 111110 00 01111224688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.30 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=196.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||+||+++.. +++.||+|++.+. .....+.+.+|+.++.+++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 6788999999642 2223445788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.||+|.++++.. ...+++..+..++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999632 235889999999999999999999887 99999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
... ......+||..|+|||++.+ +.++.++|||||||+||||++|+.||...+... ...........+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCcc
Confidence 221 12233569999999998875 567899999999999999999999997543211 111111110000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 1174 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPsk--RPSMsEVLq~ 1174 (1299)
. +. ....+...++.+++.+|+..++++ |.++.++++.
T Consensus 228 -~-~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -Q-FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c-CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 00 011123467888999988865544 4577777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.78 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=201.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.|+..+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|++++++++|+||+++++++..++..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999854 57889999986432 334567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+++|.+++.. ..+.+..++.++.|+++||.|||+.+ |+|+||+++||++++++.+||+|||+++......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998842 35889999999999999999999887 9999999999999999999999999987654321
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......|+..|++||++.+..++.++|||||||++|||++|+.||....... ...+ + ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~----------~~~~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----I----------PKNS 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----h----------hcCC
Confidence 11223458899999999998889999999999999999999999986432211 1111 0 0001
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
...........+.+++.+||+.+|++||+|.||++.-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 1112223456789999999999999999999999854
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.36 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=210.6
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
..+|++.+.||+|.||+|-+|. ...|+.||||.+++... ++.-.+.+||+||+.|+|+||+.++++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4579999999999999999998 47899999999976433 3344578999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||..+|.|+||+. +.+.|++.+...|+.||..|+.|||.++ |+|||||.+|||||+|+++||+||||+..+.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999994 4457999999999999999999999886 9999999999999999999999999998774
Q ss_pred ccccccccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T-~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
+ ..+..++||++.|.+||+.++..|. ...|.|||||+||-|+.|..||++.+ ..+++..+.. +...+
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~-----GaYrE- 272 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISR-----GAYRE- 272 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhc-----ccccC-
Confidence 3 3455678999999999999988875 78999999999999999999998753 3344443221 11110
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.+......-||++||..||++|.|+.+|....+
T Consensus 273 ----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 ----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 122334667999999999999999999988765
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.04 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=196.7
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHH-hhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEM-LSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeI-LsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+++ ++.++|+||+++++++.+++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999965 68999999986532 2334566777776 556689999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhc-CCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~-gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|++ |+|.+++.........+++.++++++.|++.||+|||++ + ++|||||++|||+++++++||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788888765433445799999999999999999999986 5 99999999999999999999999999886532
Q ss_pred cccccccccccccccccCcccccc----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
. .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.... . ...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~----~--~~~- 225 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVV----E--EPS- 225 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHH----h--cCC-
Confidence 1 11233468899999998754 45688999999999999999999999643211 11111110 0 000
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+ ........+.+++.+||..+|++||++.+|++.
T Consensus 226 ----~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 ----PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011234678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.17 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=202.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||.|+||.||+|+.. +++.|++|++.... ......+.+|++++++++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999954 68899999986432 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.++++. ..+++.+++.++.|++.||.|||+.+ |+||||+++||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999853 26899999999999999999999887 9999999999999999999999999998664321
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.......|+..|++||++.+..++.++|||||||++|||++|+.||...+.... .. .... . ....
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~---~~~~--~-----~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF---LIPK--N-----NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH---Hhhh--c-----CCCC
Confidence 112334688899999999988899999999999999999999999975432110 00 0000 0 0001
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+... .....+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 134568899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.24 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=208.3
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|++|.||+|+.+ +++.|+||++..... ...+++.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999966 589999999875433 4467899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
+++++|.+++... ..+++..+++++.|++++|+|||+ .+ ++||||+++||+|+.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999532 468999999999999999999998 76 999999999999999999999999998865432
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
... .....++..|++||++.+..++.++||||||+++|||++|+.||...+......+..+.... ..
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~------ 220 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-----PP------ 220 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----CC------
Confidence 221 12456889999999999999999999999999999999999999765432223333332210 00
Q ss_pred CCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~e-e~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...... ....+.+++.+||..+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 45689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=356.40 Aligned_cols=263 Identities=21% Similarity=0.230 Sum_probs=196.9
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..+|.+.+.||+|+||.||+++.. +++.||||... ...+.+|+++|++|+|+|||++++++..++..+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 57889999643 23467899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+ .++|.+++... ...++|.++++|+.||++||+|||+.+ |||||||++||||+.++.+||+|||+++......
T Consensus 242 ~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 57888888532 236999999999999999999999887 9999999999999999999999999998654332
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC-CCc----hhh---hHHhhhccccccc-
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ-PPG----QEN---LVAWARPLLTSRE- 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~-~~~----~~n---LV~wa~plls~~e- 1128 (1299)
.........||..|+|||++.+..++.++||||||||||||++|..++-... ... ... ++.+.........
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2223334679999999999999999999999999999999999876543221 111 111 1111111000000
Q ss_pred ----ccce-eec---CCCCCCCCh-------hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 ----GLER-IID---PSLGNDVPF-------DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ----~L~e-IVD---p~L~~~~p~-------ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.. +.+ ......... .....+.+|+.+||+.||++||++.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000 000000000 112368889999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.52 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=207.6
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.+|...++||+|.||.||+|+ .++|+.||||+++..+. ......+|||+.|+.++|+||+.|+++|-..+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788999999999999999 66899999999975432 224467899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|| .-+|+..++ .+...+.-.++..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||||+.+...
T Consensus 82 fm-~tdLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FM-PTDLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ec-cccHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99 568988885 34567889999999999999999999988 999999999999999999999999999987653
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH--------hhhcccccc
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA--------WARPLLTSR 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~--------wa~plls~~ 1127 (1299)
... .+..+-|.+|+|||.+.+ +.|+...|+||.|||+.||+-|..-|.+.+.-++...+- ..|+.+...
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 322 233468999999998775 579999999999999999999988777655444322221 112222211
Q ss_pred ccccee---ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERI---IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eI---VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+..++ -.+.+.. .-..+....++|+..+|..||.+|.+..|++++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 0111111 223455677999999999999999999998765
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.15 Aligned_cols=266 Identities=22% Similarity=0.338 Sum_probs=200.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999975 588999999864322 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++++|.++... ...++|.+++.++.|++.||+|||+.+ |+||||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998887642 234899999999999999999999887 999999999999999999999999998765332
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhccccc-------c
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTS-------R 1127 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~plls~-------~ 1127 (1299)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.+|........ ..+..+...+... .
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22233458899999998875 4578899999999999999999999865432111 1111111111100 0
Q ss_pred cccceeecCCCCC-----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERIIDPSLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIVDp~L~~-----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+....... .........+.+++.+||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011234679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.74 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||+||++... +|+.||+|++.... ....++|.+|+++++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999954 68899999886432 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.+++.. ...+++..+++++.+++.+|.|||+.. +|+|||||++|||+++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999998853 235899999999999999999999742 3999999999999999999999999998654221
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc-----hhhhHHhhhcccccccccce
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~-----~~nLV~wa~plls~~e~L~e 1132 (1299)
......|+..|++||++.+..++.++|||||||++|||++|+.||......+ ...+.++.......
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1223568999999999988899999999999999999999999998654321 11122222221111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
........+....+.+|+.+||+.||++||++.||+++..
T Consensus 229 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 229 ----PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ----cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000001124467899999999999999999999988644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.04 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=193.9
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-----ccchhHHHHHHHHhhhcccccceeeeeeeee--ccce
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~ 971 (1299)
.+|+..+.||+|+||.||+|.. .+++.|++|++.... ....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999985 468899999986321 1223568899999999999999999998875 3567
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
+++|||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 235889999999999999999999887 9999999999999999999999999987
Q ss_pred ccccccc-ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~-~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||....... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~----~~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AI----FKIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HH----HHHhc-----
Confidence 5432111 111123458899999999998889999999999999999999999996432111 00 00000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
......++......+.+++ +||..+|++||+|+||++
T Consensus 224 -----~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 -----QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0001112222334556666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.92 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=196.4
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-----ccchhHHHHHHHHhhhcccccceeeeeeeeec--cce
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~ 971 (1299)
.+|++.++||+|+||.||+|.. ++|+.|+||++.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999995 468999999985321 12235678899999999999999999988763 457
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+.+++|.+++.. ...+++...++++.|++.+|+|||+.+ |+|||||++|||++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999853 234788999999999999999999887 9999999999999999999999999987
Q ss_pred cccccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~-~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFK----IAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHH----Hhc-----
Confidence 54321111 1122346899999999998888999999999999999999999999643211 11100 000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.......+......+.+++.+|+. +|++||+++||++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 001112233445678889999985 89999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.03 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=199.5
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccc----------cchhHHHHHHHHhhhcccccceeeeeeeeecc
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ----------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~----------~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~ 969 (1299)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 4688999998853111 11245788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..++||||+.+|+|.++++.. ..+++..+..++.||+.||.|||+.+ ++|||||++||++++++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999543 46899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~~--~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
++...............|+..|++||++.... ++.++||||||+++|||++|+.||...... ..+.+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLG----N-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhh----c--
Confidence 97653322222223456889999999887654 789999999999999999999998643211 1111110 0
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
......++. ....+....+.+++.+||..+|++||++.||++.
T Consensus 227 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111111 1112345689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.69 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=205.9
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeec--cceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~LVy 975 (1299)
+|++.+.||+|++|.||+|... +++.|++|+++.... ...+.+.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788999999999999999966 788999999865432 4567889999999999999999999999988 8899999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.+++... ..++|.+++.++.|++++|+|||+.+ ++|+||+++||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998532 26899999999999999999999887 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
...........++..|++||++.+...+.++||||||+++|||++|+.||...... ....| ... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~--~~~----------~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALY--KIG----------S 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHH--hcc----------c
Confidence 33211133456889999999998888999999999999999999999999764411 00111 000 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
......++......+.+++.+||..+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011112233345789999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=330.13 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=161.2
Q ss_pred eeEEeecCceEEEEEEec---CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeee--ccceEEEEeecC
Q 000757 905 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 979 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lk---dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~~LVyEYm~ 979 (1299)
.++||+|+||+||+|+.. +++.||+|.++.. .....+.+|+++|++++|+||+++++++.. +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 4678999998643 233567899999999999999999998864 456789999994
Q ss_pred CCChhhcccccc-----cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee----ccCCcceecCCCcc
Q 000757 980 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 1050 (1299)
Q Consensus 980 GGSL~d~L~~~~-----~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL----Dedg~VKLsDFGLA 1050 (1299)
++|.+++.... .....+++.+++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877764221 12235889999999999999999999887 9999999999999 45679999999999
Q ss_pred ccccccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 000757 1051 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1109 (1299)
Q Consensus 1051 r~~~~~~~~-~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~ 1109 (1299)
+........ .......||..|+|||++.+ ..++.++|||||||++|||++|+.+|...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 865432111 12234578999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=359.23 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=206.1
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccce
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~ 971 (1299)
...++|.+.++||+|.||+|+++.++ +++.+|||++++.. .++.+..+.|..|+.... ||.|++|+..+...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999965 67899999998753 445667788999988885 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+.||++..+.+ ...+++....-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999555543 346888999999999999999999998 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
.... ....+.+.|||+.|||||++.+..|+..+|.|+|||+|||||.|+.||...++++.. +
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F----------------d 578 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF----------------D 578 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------H
Confidence 6543 233567789999999999999999999999999999999999999999865432211 1
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
.|+.. .-.++.....+..+|++++|..+|++|.-+
T Consensus 579 sI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11110 124566778899999999999999999877
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=339.79 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=197.6
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec------
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 968 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~------ 968 (1299)
..++|++.+.||+|+||.||++.. .+++.||||++... +....+++.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999985 46889999999643 233456788999999999999999999987543
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
...|+||||+. ++|.+++. ..+++.+++.++.|+++||+|||+.+ |+|||||++||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35699999995 56777663 24788999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH-H--------h
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-A--------W 1119 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV-~--------w 1119 (1299)
+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+..+....+ . +
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99865321 1223456899999999999999999999999999999999999999754322111100 0 0
Q ss_pred h-------hccccccccc-----ceeecCCC---CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1120 A-------RPLLTSREGL-----ERIIDPSL---GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1120 a-------~plls~~e~L-----~eIVDp~L---~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
. .......... .+++...+ ...........+.+|+.+||+.||++|+|+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000000000 00000000 001111223578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.12 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=202.7
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||++.. .+|+.|++|++... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999985 46889999998642 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.+++... ....+++.++++++.|++.||+|||+.+ ++|+||+++||||+.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988532 2235789999999999999999999887 9999999999999999999999999997653321
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
. ......|+..|+|||++.++..+.++|||||||++|||++|+.+|...+. . +.+...+...
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~---~~~~~~~~~~---------- 217 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K---NLVLKIIRGS---------- 217 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---H---HHHHHHhcCC----------
Confidence 1 12234588899999999988999999999999999999999999864321 1 1111111100
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...........+.+++.+||+.+|++||+|.||++.
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001223345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.56 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=203.4
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
.++|++.+.||+|+||.||+|... +++.|++|+++.......++|.+|++++++++|+||+++++++.++...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356889999999999999999964 6889999999765555567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.+++... ...+++.++++++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998532 236899999999999999999999887 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1058 SRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
. ......|+..|++||++. ...++.++|||||||++|||++|+.||...... ..+..+... . .
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~----~--~-- 225 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKILKS----E--P-- 225 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHHhcC----C--C--
Confidence 1 123356899999999875 344678999999999999999999999654221 111111110 0 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+ .........+.+++.+||+.+|++||++.+|++.
T Consensus 226 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1112334578899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.86 Aligned_cols=249 Identities=23% Similarity=0.371 Sum_probs=201.3
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||++.. .+++.++||++... .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999985 46888999998643 233456789999999999999999999999989999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDFGLAr~~~~~ 1056 (1299)
+.+++|.+++.... ...+++..+++++.|++++|+|||+.+ |+|||||++||+++++ +.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999996432 345899999999999999999999887 9999999999999865 46899999999865432
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......|+..|+|||.+....++.++||||||+++|||++|+.+|+..+.. ....+. ... ..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~~--~~------ 218 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MSG--TF------ 218 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hhc--CC------
Confidence 2 122356889999999998888999999999999999999999999654321 111111 110 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..........+.+++.+||+.+|++||++.|+++.
T Consensus 219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01122345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.56 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.8
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|.. .+|+.|+||++.... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999996 468999999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+ +++|.+++.... ..+++.++++++.||+++|+|||+.+ |+|+|||++||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999985432 46899999999999999999999887 9999999999999999999999999998664322
Q ss_pred cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHh-------hhccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAW-------ARPLLTSRE 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~w-------a~plls~~e 1128 (1299)
. .......|+..|+|||++.+. .++.++|||||||++|||++|+.+|.......... .... .++.+.+..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 122335689999999988654 46899999999999999999988776543211100 0000 000000000
Q ss_pred ccceeecCCCC----CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERIIDPSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIVDp~L~----~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
....+...... .....+....+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111334789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.80 Aligned_cols=267 Identities=23% Similarity=0.292 Sum_probs=199.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++|+|+||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999864 67889999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++... ...+++..++.++.|+++||+|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 6898888532 335889999999999999999999887 9999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhh-HHhh-------hccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-VAWA-------RPLLTSRE 1128 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nL-V~wa-------~plls~~e 1128 (1299)
.......++..|++||++.+ ..++.++|||||||++|||++|+.+|...+..+.... .... +..+...+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11223457889999998765 4578899999999999999999999976543221110 0000 00000000
Q ss_pred ccceeecCCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1129 GLERIIDPSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1129 ~L~eIVDp~L~~----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.....-.+.... .........+.+|+.+||+.||.+|+|+.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000000000000 01112345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=317.97 Aligned_cols=253 Identities=23% Similarity=0.406 Sum_probs=201.4
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc------ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
+|+..++||+|+||.||+|.. .+++.||+|++.... ....+++++|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 578999999986422 1134678899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCCCcccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1052 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~ 1052 (1299)
||||+.+++|.+++.. ...+++..+++++.|++.||.|||+.+ |+|||||++||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 236889999999999999999999887 99999999999998775 699999999876
Q ss_pred cccccc--ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1053 AMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1053 ~~~~~~--~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
...... ........|+..|++||++.+..++.++|||||||++|||++|+.||.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---IAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH---Hhc-----
Confidence 543211 1112335688999999999888899999999999999999999999965432211111100 000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.......+......+.+++.+||+.+|++||++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111223334567899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=336.29 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=196.6
Q ss_pred HHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec-----
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE----- 968 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~----- 968 (1299)
...++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+++|++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 56889999998643 223345678999999999999999999987543
Q ss_pred -cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 969 -QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 969 -~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
...|+++|++ +++|.+++. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468999998 889988874 235899999999999999999999887 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
|+++..... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..+.......
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTP 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 999865321 233468999999998876 568899999999999999999999996543211 111111000000
Q ss_pred -c--------cccceeecCCCCCCCC--------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 -R--------EGLERIIDPSLGNDVP--------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 -~--------e~L~eIVDp~L~~~~p--------~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
. +...+.+. .+. ... ......+.+|+.+||+.||++|+++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000 000 000 1122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.92 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=203.7
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.|+..+.||+|+||.||+|..+ +++.||+|+++... ....+++.+|++++++++|+||+++++++.++...|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4777889999999999999965 58899999987432 344567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+++||+++.+++++|+|||++.......
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999842 35889999999999999999999887 9999999999999999999999999997654322
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.......++..|+|||++.+..++.++|||||||++|||++|+.||......... . .+....
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~--------------~~~~~~ 217 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---F--------------LIPKNN 217 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---h--------------hhhcCC
Confidence 1123345888999999998888999999999999999999999998653321110 0 000111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
...........+.+++.+||+.+|++||++.++++.-.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 11233345678999999999999999999999987744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=316.23 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=201.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|... +++.|++|.++.... ...+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999854 688999999875433 2567889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.+++.. ...+++..+++|+.|+++||+|||+.+ |+||||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 235789999999999999999999887 9999999999999999999999999988654322
Q ss_pred cccc--cccccccccccCccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1058 SRHI--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1058 ~~~~--st~v~GT~gYmAPE~l~~~~---~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.... .....++..|++||++.... ++.++||||||+++|||++|+.||...... ........ . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~---~--~~--- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVG---A--GH--- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHh---c--CC---
Confidence 2111 11345788999999988766 889999999999999999999999643211 11111100 0 00
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
...+. ........+.+++.+||+.+|++||++.|+++
T Consensus 224 --~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 01123466789999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.43 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=205.7
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~LVy 975 (1299)
++|+..+.||.|++|.||++.+. +++.||+|.+.... ....+++.+|++++++++|+||++++++|.+. +..|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47899999999999999999964 67889999987432 23456789999999999999999999998653 4679999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++++|.+++.........+++..+++|+.|++.||+|||+.+ ++|+||+++||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988654444556899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC--CchhhhHHhhhccccccccccee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP--PGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~--~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.. .....++..|++||.+.+..++.++|||||||++|||++|+.||+.... .....+..|..... ...+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPEL--- 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhh---
Confidence 11 1234578899999999999999999999999999999999999976532 11222233322110 0000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.... .........+.+++.+||+.+|++||++.||++.-
T Consensus 229 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 229 -KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0000 11122456789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.81 Aligned_cols=252 Identities=26% Similarity=0.335 Sum_probs=210.5
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.++|++++.||+|.||.||.|+. +++-.||+|++.+. ..+..+++.+|++|-+.|+|+||+++++||.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35689999999999999999994 56788999998642 334457899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
+||..+|+|+..|... ....+++.....++.|+|.||.|||..+ ||||||||+|+|++.++.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999643 3446888899999999999999999876 9999999999999999999999999997653
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.....+.|||+.|++||+..+...+.+.|+|++||+.||++.|..||+.....+ .+.+-.. .++
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tYkrI~k---------~~~- 239 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TYKRIRK---------VDL- 239 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HHHHHHH---------ccc-
Confidence 223356889999999999999999999999999999999999999998654211 1111000 011
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
.++........++|.+|+..+|.+|....|+++.-..
T Consensus 240 ------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 240 ------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 2223445678999999999999999999999887553
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=326.48 Aligned_cols=199 Identities=24% Similarity=0.334 Sum_probs=160.7
Q ss_pred eeEEeecCceEEEEEEec---CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeee--ccceEEEEeecC
Q 000757 905 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 979 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lk---dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~~LVyEYm~ 979 (1299)
..+||+|+||+||+|+.+ +++.||+|.++... ....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999965 35789999986432 23567899999999999999999999854 456789999985
Q ss_pred CCChhhcccccc-----cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee----ccCCcceecCCCcc
Q 000757 980 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 1050 (1299)
Q Consensus 980 GGSL~d~L~~~~-----~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL----Dedg~VKLsDFGLA 1050 (1299)
++|.+++.... .....+++..+++|+.||+.||.|||+.+ |+|||||++|||+ ++++++||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 12235889999999999999999999887 9999999999999 56679999999999
Q ss_pred ccccccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 000757 1051 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1109 (1299)
Q Consensus 1051 r~~~~~~~~-~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~ 1109 (1299)
+........ .......||..|+|||++.+ ..++.++|||||||+||||++|+.+|....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865432211 11234568999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.71 Aligned_cols=239 Identities=24% Similarity=0.454 Sum_probs=189.7
Q ss_pred eEEeecCceEEEEEEecC--------CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd--------Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+.||+|+||.||+|..+. ...|++|.+........++|.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998542 234888888655455566889999999999999999999999998999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc--------ceecCCCc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--------PKVSDFGL 1049 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~--------VKLsDFGL 1049 (1299)
+.+|+|.++++.. ...+++..+++++.||+.||+|||+.+ |+|||||++|||++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999643 235899999999999999999999887 999999999999987765 59999998
Q ss_pred cccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCC-CCCCCCCCCchhhhHHhhhcccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr-~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .+|........ .... ...
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~----~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFY----EDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHH----Hcc
Confidence 864422 123457889999999876 45899999999999999999985 55543221111 1110 000
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
..++.....++.+|+.+||+.+|++||++++|++.|
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112223346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=350.35 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=208.3
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..|+..++||+|.||.||||. .++++.||+|++.-. .....+++.+|+.+|.+++++||.+.||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 347777899999999999999 457899999999643 445567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
|.||++.+.|. ....+++.+..-|+.++..||.|||.++ .+|||||..||||..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999994 2334588888889999999999999887 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.. ..+.+||+.|||||++....|+.|+||||||++.+||++|..|+....+. ..+. ++-+.
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlf-lIpk~ 226 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLF-LIPKS 226 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEE-eccCC
Confidence 32 25678999999999999889999999999999999999999999754331 1111 12222
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
........+...|.+++..||+.||+.||++.++++.
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222333556779999999999999999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=322.84 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=201.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||++..+ +|+.||+|.++.. +....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999965 7899999998643 233346789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|.++++... ....+++..+++++.|++.||.|||+.. +|+|||||++|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999886431 1336899999999999999999999641 3999999999999999999999999998754321
Q ss_pred cccccccccccccccCccccccC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~------~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
......|+..|++||++.+. .++.++|||||||+||||++|+.||....... ......
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~---------- 220 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS---------- 220 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH----------
Confidence 22334588899999988544 35889999999999999999999996532211 111000
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+.+.. ......+....+.+++.+||+.+|++||++.++++.-
T Consensus 221 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 221 AIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 011100 0112223556788999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=325.29 Aligned_cols=269 Identities=20% Similarity=0.262 Sum_probs=199.1
Q ss_pred CcceeeEEeecCceEEEEEEec---CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk---dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~ 972 (1299)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4889999999999999999964 47899999997532 34456788999999999999999999999887 7889
Q ss_pred EEEeecCCCChhhcccccccC-CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc----CCcceecCC
Q 000757 973 LVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSDF 1047 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~-~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe----dg~VKLsDF 1047 (1299)
+||||+. ++|.+++...... ...+++..++.|+.|++.||+|||+.+ |+|||||++|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 4677766433222 236889999999999999999999887 999999999999999 999999999
Q ss_pred Ccccccccccc-ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-------hhhHH
Q 000757 1048 GLARSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-------ENLVA 1118 (1299)
Q Consensus 1048 GLAr~~~~~~~-~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-------~nLV~ 1118 (1299)
|+++....... ........++..|+|||++.+ ..++.++|||||||+||||++|+.+|........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 111233568899999998766 4578999999999999999999999976543320 01111
Q ss_pred hhhcc----------cccccccceeecCCCCCCCC-----------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1119 WARPL----------LTSREGLERIIDPSLGNDVP-----------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1119 wa~pl----------ls~~e~L~eIVDp~L~~~~p-----------~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.+..+ +.......++.+......+. .....++.+++.+||+.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10000 00000000000000000111 033457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.45 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=196.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999965 688999999864322 2234677899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++... ...+++...+.++.|++.||.|||+.+ |+|||||++|||+++++++||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 5899988533 236889999999999999999999887 9999999999999999999999999987542211
Q ss_pred cccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHh-h--------hcccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-A--------RPLLTSR 1127 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~w-a--------~plls~~ 1127 (1299)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|.............| . +......
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122346889999998865 4588999999999999999999999965432111100000 0 0000000
Q ss_pred cccce----ee-cCCCCCCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1128 EGLER----II-DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1128 e~L~e----IV-Dp~L~~~~-p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..... .. ...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00 00000000 0112367789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.05 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=204.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
+|++.+.||+|++|.||++... +++.|++|++........+++.+|++++++++|+||+++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5888999999999999999975 688999999976554466789999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+++|.+++... ...+++.+++.++.|++.+|+|||+.+ ++||||+++||++++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998542 246899999999999999999999877 99999999999999999999999999876644321
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
.....|+..|++||++....++.++||||||+++|||++|+.||....... . ...... .....+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~~~~~-----~~~~~~~----- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--A-LFKIAT-----NGPPGLR----- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--H-HHHHHh-----cCCCCcC-----
Confidence 234568899999999988889999999999999999999999986542111 1 111000 0011110
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
........+.+++.+||+.+|++||++.|+++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112467999999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.37 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=203.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
++|++.+.||+|+||.||++..+ +++.|++|++.... ....+++.+|++++++++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888899999999999999965 68899999987542 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
+.+++|.+++.... ..+++..+++++.|++.+|+|||+ .+ ++|||||++||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999986432 568899999999999999999998 66 999999999999999999999999998765332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
.. ....++..|++||++.+..++.++|||||||++|||++|+.||....... ....+........
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---------- 219 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE---------- 219 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC----------
Confidence 11 12568899999999998899999999999999999999999996543211 1112221111110
Q ss_pred CCCCCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~-ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.. ..... .....+.+++.+||..+|++||++.|+++.
T Consensus 220 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 01111 145678999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.55 Aligned_cols=236 Identities=28% Similarity=0.367 Sum_probs=197.7
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|+..+.||.|+||+|.+++.+ +|..+|+|+|++.+ ....+...+|..+|+.+.||++++|++.|.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888899999999999999954 68889999997643 334456778999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||++||.|+.+|+. .+++++...+-++.||+.||+|||..+ |++|||||+|||||++|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999963 456999999999999999999999887 99999999999999999999999999986533
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
.+.+.|||+.|+|||++....+...+|.|+|||++|||+.|+.||...+... ..++|+.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~ 255 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILE 255 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHh
Confidence 2567899999999999999999999999999999999999999997765411 1112222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCC
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1165 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskR 1165 (1299)
..+ .++.-....+.+|+...|+.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 111 2333344567778888888777776
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.02 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=199.4
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccccc-----chhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ-----GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~-----~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
+|++.+.||+|+||.||+|... +|+.|+||+++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888999999999999999954 6899999999754322 244577899999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+ +|+|.+++.... ..+++.++++++.||++||+|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999995322 36999999999999999999999887 9999999999999999999999999998664
Q ss_pred ccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcc----ccccc
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPL----LTSRE 1128 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~pl----ls~~e 1128 (1299)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|..+|......+. .......... +....
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 3221 1123346788999998764 4678999999999999999999877765432111 0111110000 00000
Q ss_pred ccceeecCCCCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERIIDPSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~-----p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+............ .......+.+++.+||+.+|++||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00011110000111 12234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.12 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=199.3
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999965 589999999865322 24457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.+ |+|||||++||||+.+++++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998632 2346899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccc---------------------------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 000757 1056 EESR---------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1108 (1299)
Q Consensus 1056 ~~~~---------------------------~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s 1108 (1299)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0112346889999999999888999999999999999999999999654
Q ss_pred CCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHH
Q 000757 1109 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1171 (1299)
Q Consensus 1109 ~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEV 1171 (1299)
+... .+.. +.+....-.........+.+++.+||..+|++|+++.+.
T Consensus 236 ~~~~--~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 236 NRDE--TFSN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred chHH--HHHH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 3211 1111 011111001111245789999999999999999994444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=321.00 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=196.0
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|+.. +|+.|++|+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999964 6899999998642 222345688999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++... ...+++.+++.++.||++||.|||+.+ |+|||||++|||++.++++||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 5788877432 245899999999999999999999887 9999999999999999999999999997553221
Q ss_pred cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH----------hhhccccc
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA----------WARPLLTS 1126 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~----------wa~plls~ 1126 (1299)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+....... ..+.. +.+..+..
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhh
Confidence 112234578999999988764 46899999999999999999998864322211 11100 00000000
Q ss_pred ccccceeecCCCCC-----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1127 REGLERIIDPSLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~-----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..... .+ ..... ........++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYK-PY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccc-cc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00 00000 111123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.25 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=194.6
Q ss_pred eeeEEeec--CceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 904 ASRILGEG--GFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 904 i~elLGeG--gFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
+.++||+| +|++||+++. .+|+.||||+++... ....+.+.+|+++++.++|+||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6899999985 578999999996432 233456778999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++|+|.+++.... ...+++.++++|+.|++.||+|||+.+ |+|||||++||||+.+++++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985322 235899999999999999999999887 99999999999999999999999987643322111
Q ss_pred -----ccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc-----
Q 000757 1059 -----RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS----- 1126 (1299)
Q Consensus 1059 -----~~~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~----- 1126 (1299)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence 011122357788999999876 458899999999999999999999997532211 111110000000
Q ss_pred ----------------ccccceee---------cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 ----------------REGLERII---------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ----------------~e~L~eIV---------Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...+.+.. ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000001112234578999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.90 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=200.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999954 57889999987532 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||++|++|.+++.. ...+.+..+..++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999953 235899999999999999999999887 99999999999999999999999999874211
Q ss_pred cc-------------cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc
Q 000757 1056 EE-------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122 (1299)
Q Consensus 1056 ~~-------------~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p 1122 (1299)
.. .........|+..|+|||++....++.++|||||||++|||++|+.||...... +.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~~--- 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQV--- 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---
Confidence 00 001112345788999999998888999999999999999999999999643221 111111
Q ss_pred ccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1123 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1123 lls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
... .+..+.. .......+.+++.+||+.+|++||++.++.+.|+
T Consensus 229 -~~~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 -ISD-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -Hhc-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 000 0000000 0123456899999999999999999766666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=350.26 Aligned_cols=258 Identities=31% Similarity=0.461 Sum_probs=217.0
Q ss_pred CCcceeeEEeecCceEEEEEEecC---CC--EEEEEEeec-ccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD---GT--KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd---Gr--~VAVK~Lk~-~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
....+.++||+|.||.||+|++.+ |+ .||||..+. .+.+..+.|+.|..+|++++|+|||+|+|+|.+ .-.||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 345556789999999999999543 33 488998876 345567889999999999999999999999987 46699
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|||.+.-|.|.+||.. ++..|+..+...+++||+.+|+|||+.. +|||||..+||||....-|||+||||+|..
T Consensus 468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999964 3456889999999999999999999776 999999999999999999999999999988
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.++.+.+.+ +..-...|||||.++-++++.++|||-|||++||+++ |.+||.+... .+ +..
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sD-VI~ 603 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SD-VIG 603 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cc-eEE
Confidence 765554433 4556789999999999999999999999999999998 9999976432 22 222
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.++..-+-..+..|...+..|+.+||..+|.+||.+.|+...|..++++.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 23334444566788899999999999999999999999999999888743
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.14 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=197.6
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++++|.+.+.||+|+||.||+|.. .+|+.|++|+++... ......+.+|++++++++|+||+++++++.+++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 468899999986433 233346789999999999999999999999989999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+. ++|.+++... ...+.+.++..++.|++.||+|||+.+ |+|||||++||||+.++++||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 7777776422 235788889999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc------c
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR------E 1128 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~------e 1128 (1299)
.. .......++..|+|||++.+. .++.++|||||||+||||++|+.||+......+.....|........ .
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 11 112234578999999988754 57889999999999999999999997543321111111110000000 0
Q ss_pred ccceeecCCCCC----C-----CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1129 GLERIIDPSLGN----D-----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1129 ~L~eIVDp~L~~----~-----~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.+.+..+..... . ........+.+++.+|+..||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0 00112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.74 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=206.5
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||++... +++.|++|++.... ....+++.+|++++++++|+|++++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999965 68899999987532 24566788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|.+++.........+++.+++.++.+++.||+|||+.+ ++|+||+++|||+++++++||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754333467999999999999999999999887 9999999999999999999999999997654322
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.......|+..|++||++....++.++||||||+++|+|++|+.||+..... .+.. ..... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~~~--~-------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELAL---KILKG--Q-------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHH---HHhcC--C--------
Confidence 1223356889999999998888999999999999999999999998654311 1111 11110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
....+......+.+++.+||..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011222345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.79 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=199.8
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc-cccchhHHHHHHHHhhhcc---cccceeeeeeeeeccceEEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~e~~~~~LVy 975 (1299)
.|++.+.||+|+||.||+|.. .+++.|++|.++.. .....+++.+|++++++++ |+||+++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577889999999999999995 57899999998643 3344567889999999997 999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.++++. ..+++..++.++.|++.||.|||+.+ |+||||+++||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998843 26899999999999999999999887 99999999999999999999999999986644
Q ss_pred cccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||....... ...+. . ...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~----~------~~~ 218 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLI----P------KSK 218 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcc----c------cCC
Confidence 321 12334688999999988754 46899999999999999999999997543211 11110 0 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...+.. ......+.+++.+||+.+|++||++.|+++.
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 011111 1144678999999999999999999999774
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=314.39 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=205.1
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+++. .+++.+++|++... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999984 46889999998643 233455788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++++|.+++.........+++.+++.++.|++.||+|||+.+ ++||||+++||++++++++||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998654444457899999999999999999999887 999999999999999999999999999866443
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
......|+..|++||++.+..++.++|+||||+++|||++|+.||...+.. .+..... . .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~-----~---------~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQ-----R---------G 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh-----c---------C
Confidence 222345889999999999888999999999999999999999999654321 1111110 0 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...........++.+++.+||..+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111222445679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.08 Aligned_cols=235 Identities=23% Similarity=0.290 Sum_probs=183.3
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeecccc---cchhHHHHHHHHhhhc---ccccceeeeeeeeeccceEEEEeecCC
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~---~~~keFlrEIeILsrL---rHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
||+|+||+||+|+.. +|+.||||++..... ....++.+|.+++.++ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 689999999964321 2233455677777765 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.+++.. ...+++.+++.|+.||++||+|||+.+ |+|||||++||||+.++++||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998852 346899999999999999999999887 9999999999999999999999999987543221 2
Q ss_pred ccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
.....+||..|+|||++.+. .++.++|||||||+||||++|+.||...+... + ......... + +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~---~~~i~~~~~---~-----~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---M---YRNIAFGKV---R-----FP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---H---HHHHHcCCC---C-----CC
Confidence 22346799999999988754 47899999999999999999999996533211 1 111110000 0 00
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
.......+.+++.+||+.||++|++.
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 01134567899999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=327.71 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=198.9
Q ss_pred ceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 903 DASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
.....||+|+||.||++... +++.||||+++.......+.+.+|+.++++++|+||+++++++...+..|+||||+.++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999854 68899999987655555677899999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
+|.+++.. ..+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||++........ .
T Consensus 105 ~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 105 ALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 99998842 34889999999999999999999887 99999999999999999999999999875432211 1
Q ss_pred cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCC
Q 000757 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1141 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~ 1141 (1299)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+... . ..+...+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~-~----------~~~~~~~~~- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRI-R----------DNLPPRVKD- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-H----------hcCCCcccc-
Confidence 233568999999999988889999999999999999999999996532211 11110 0 001111111
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1142 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1142 ~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.......+.+++.+||..+|++||++.|+++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234568899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.48 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=215.9
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeecc-----ceE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 972 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-----~~~ 972 (1299)
.++|++.++||+|||+.||.++ +.+++.+|+|++.....++.+..++|++..++++|+||+++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999999 7789999999998777777889999999999999999999999986544 489
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
|++.|...|+|.+.+.....+...+++.+.++|+.+|++||++||+.. +.++||||||.|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999877777778999999999999999999999884 5799999999999999999999999999876
Q ss_pred cccccc---c----cccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc
Q 000757 1053 AMDEES---R----HISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122 (1299)
Q Consensus 1053 ~~~~~~---~----~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p 1122 (1299)
..-.-. . ........|.-|+|||.+. +...++++|||||||+||+||.|..||+...+.+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------- 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------- 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC----------
Confidence 532111 0 0112245789999999886 4467899999999999999999999998643322
Q ss_pred ccccccccceee-cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1123 LLTSREGLERII-DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1123 lls~~e~L~eIV-Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
+.+.-.+ ...+.-.......+.+.+++.+|++.||.+||++.|++..+..+
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111 11111111123678899999999999999999999999888765
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.51 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=200.3
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
|++.+.||+|+||.||+|.. .+++.||||++.... ....++|.+|++++++++|+||+++++++.+++..|+||||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 67788999999999999985 468899999986432 2334678899999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+++|.+++.. ..+++..++.++.|++.+|.|||+.+ |+|+|||++||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999842 35889999999999999999999887 99999999999999999999999999876533211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
......|+..|++||++.+..++.++|||||||++|||++|..||...... ...... .. . ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~---~~-~----------~~ 218 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFLI---PK-N----------NP 218 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHHH---hc-C----------CC
Confidence 122346888999999998888999999999999999999999998643211 111110 00 0 00
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222345678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.95 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=203.7
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
++|++.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++|+||++++++|...+..|+||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6789999999999999999985 467889999987555555677899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+|||||++||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999842 24789999999999999999999887 99999999999999999999999999875543221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
......|+..|++||++....++.++|||||||++|||++|+.||...+.... +.. ... ....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~----~~~---------~~~~ 233 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IAT---------NGTP 233 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee----hhc---------CCCC
Confidence 12334688999999999888899999999999999999999999975432111 000 000 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
...........+.+++.+||+.+|++||++.+++++-
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0011122345688999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.87 Aligned_cols=244 Identities=26% Similarity=0.369 Sum_probs=199.6
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999954 68999999986532 233567889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+++|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||+++||||++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999853 246899999999999999999999887 99999999999999999999999999986543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
. .....|+..|++||++.+...+.++||||||+++|||++|+.||..... ....... ...
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~~~--------- 213 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKI---LEG--------- 213 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---hcC---------
Confidence 2 2345689999999999888889999999999999999999999965431 1111110 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 1173 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq 1173 (1299)
. ..++......+.+++.+||..+|++|+ +++|+++
T Consensus 214 -~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 -K--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -C--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 011222346788999999999999998 5666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.67 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=201.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|..+ +|..||+|.+... .....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999965 5888999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~~~~~ 1056 (1299)
+.+++|.+++... ....++|..+++++.|++.||+|||+.+ |+|+|||++|||+++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998542 2335899999999999999999999887 99999999999999885 4699999999765432
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+. .++....... .. .
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~--~~----~- 220 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG--YF----A- 220 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc--cC----C-
Confidence 1 112234588999999999888899999999999999999999999864321 1222111110 01 0
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.........+.+++.+||..+|++||++.||++.
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234579999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=355.71 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=210.7
Q ss_pred cceeeEEeecCceEEEEEEec--CCC--EEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 902 FDASRILGEGGFGLVYSGVLD--DGT--KVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk--dGr--~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+.+.++||+|.||.|++|.|+ .|+ .||||+|+..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 334679999999999999976 344 5899999864433 56799999999999999999999999987 67789999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
++..|+|.++|++ .....|-...+..++.|||.||.||..++ +|||||..+||||-....|||+||||.+.+..+
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999986 34456888899999999999999999876 999999999999999999999999999987654
Q ss_pred cccccc-ccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1057 ESRHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1057 ~~~~~s-t~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
+..... ....-.+.|.|||.++.+.++.++|||+|||+||||++ |+.||-+.... . +-+.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------q-IL~~i 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------Q-ILKNI 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------H-HHHhc
Confidence 443322 22335689999999999999999999999999999999 88898654321 1 11223
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
|..-+-..+..|.+.+++|+..||..+|++||+|..|.+.+-....
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 3333334567899999999999999999999999999876554433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=349.55 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=212.4
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeeeccc-eEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA-RCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~-~~LV 974 (1299)
.++|+.+++||+|+||.++..+.+ ++..|++|.+.- ......+...+|+.++++++|||||.+++.+++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999998844 577899999853 233444567899999999999999999999999888 8999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|+||+||+|.+.+...+ ..-+.++.+++|+.|++.||.|||+.. |+|||||+.|||++.+..|||+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999996543 456889999999999999999999776 9999999999999999999999999999876
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.+. .....++||+.||.||++.+..|..|+|||||||++|||++-+.+|...+-. .++.- ++
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~k-------------i~ 219 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILK-------------IN 219 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHH-------------Hh
Confidence 543 2445678999999999999999999999999999999999999999764321 11111 11
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
. ....-.+..+..++..|+..|++.+|+.||+..+++..-
T Consensus 220 ~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 220 R-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred h-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1 112234556778899999999999999999999999873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.97 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=199.6
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
|+....||+|+||.||++... +++.|++|+++.......+.+.+|+.++++++|+||+++++++..++..|+||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333457999999999999854 6889999999765555567789999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 999987732 35889999999999999999999887 99999999999999999999999999875433211
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ........... ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~----------~~~-- 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSPP----------PKL-- 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccCC----------CCc--
Confidence 123356899999999999888999999999999999999999999643221 11111110000 000
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.........+.+++.+||+.+|++||++.||++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0111234568899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.71 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=197.3
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|+||.||+|+.. +|+.|+||+++... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999864 68899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. ++|.+++... ....+++.++++++.|++.||+|||+.+ ++||||+++|||+++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6898888543 2346899999999999999999999887 9999999999999999999999999987553221
Q ss_pred cccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhccc-------ccc-
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLL-------TSR- 1127 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~-~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~pll-------s~~- 1127 (1299)
.......++..|+|||++.+.. ++.++|||||||++|||++|+.||........ ..+.++..... ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1123345788999999877644 68899999999999999999999965432110 11111111000 000
Q ss_pred ---cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1128 ---EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1128 ---e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..........+. .........+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=367.43 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=206.7
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.++||+|+||.||+|+.. +|+.||||+++... ....++|.+|++++++++|+||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999954 68999999996432 223457899999999999999999999999999999999
Q ss_pred eecCCCChhhccccccc-------CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 976 ELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~-------~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
||++||+|.+++..... ....+++.++++|+.||++||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234677889999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccc----------------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc
Q 000757 1049 LARSAMDEESR----------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 1112 (1299)
Q Consensus 1049 LAr~~~~~~~~----------------~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~ 1112 (1299)
+++........ ......+||..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99865211100 11123569999999999999999999999999999999999999996532211
Q ss_pred hhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-CHHHHHHHHHHHHhh
Q 000757 1113 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1113 ~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-SMsEVLq~Lk~I~~e 1181 (1299)
+. +. ... .++... ....+....+.+++.+||+.||++|+ +++++.+.|+...+.
T Consensus 239 ---i~-~~-~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ---IS-YR-DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ---hh-hh-hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00 000 000000 00113345688999999999999995 677888888877654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.00 Aligned_cols=269 Identities=21% Similarity=0.284 Sum_probs=195.8
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeecc------
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 969 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~------ 969 (1299)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999954 68899999986432 222345678999999999999999999987643
Q ss_pred --ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 970 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 970 --~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
..++||||+. ++|.+++.. ....+++.++++++.||+.||+|||+.+ |+|||||++||||+.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999995 578887743 2235899999999999999999999887 999999999999999999999999
Q ss_pred Cccccccccccc--cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc
Q 000757 1048 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1048 GLAr~~~~~~~~--~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.+|...+..............+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999765432211 112234578899999987654 47889999999999999999999997654322222211111000
Q ss_pred c--------cccccceeec-CCCCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1125 T--------SREGLERIID-PSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 s--------~~e~L~eIVD-p~L~~~~-----p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
. ......++.. ....... .......+.+|+.+||..||++||+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 0000000000 0000000 00123467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.48 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=202.4
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+|++.+.||+|+||.||+|..+ +++.|++|++.... ....+++.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999965 68999999996432 2345688999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+++|.+++.. ...+++.+++.|+.|+++||.|||+.+ |+|+|||++|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 246899999999999999999999887 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
. ......|+..|++||++.+..++.++||||||+++|+|++|+.||........ ++.......
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------
Confidence 2 12335588899999999988899999999999999999999999976543211 111111110
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH--HHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM--GEVV 1172 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM--sEVL 1172 (1299)
.....+......+.+++.+||+.+|++|+++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0112222344788999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.97 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=199.1
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceEEEEe
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYE 976 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~LVyE 976 (1299)
|++.+.||+|+||.||+|+.. +|+.|++|++.... ....+++.+|++++++++|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 58899999997542 33345788999999999999999999999887 78999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+. ++|.+++... ...+++.+++.++.||++||+|||+.+ ++|+|||++|||+++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 5888887532 246899999999999999999999887 999999999999999999999999999866443
Q ss_pred ccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhh-HHhhhccc-ccccccce-
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-VAWARPLL-TSREGLER- 1132 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nL-V~wa~pll-s~~e~L~e- 1132 (1299)
.. .......++..|++||.+.+ ..++.++|||||||++|||++|+.||+..+....... ........ .....+.+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11233457889999997764 4578999999999999999999999976543221111 11000000 00000000
Q ss_pred ----------eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 ----------IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 ----------IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+...+...+...+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011111135678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.42 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=205.0
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.+++|+..+.||+|+||.||+|.++ +++.|++|+++.... ..+.+.+|++++++++|+||+++++++...+..|+|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999976 688999999975433 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+|+|||++||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996422 36999999999999999999999877 999999999999999999999999998654332
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecC
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp 1136 (1299)
.. ......++..|++||++.+..++.++|||||||++|||++|+.||...... .....+.. .....+
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~------~~~~~~--- 236 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITT------KGIPPL--- 236 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------cCCCCC---
Confidence 11 123345788999999998888999999999999999999999998643221 11111110 000000
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1137 ~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.........+.+++.+||+.+|.+||++.+|++..
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 01112346788999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.36 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=198.9
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeec--cceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~LV 974 (1299)
++|++.+.||+|+||.||+|... +++.|++|.++... ......+.+|++++++++|+||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999965 58889999996432 22234577899999999999999999999877 889999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+. ++|.+++... ...+++.++++|+.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5898888532 236899999999999999999999887 9999999999999999999999999998654
Q ss_pred ccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhh-------hcccc
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWA-------RPLLT 1125 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa-------~plls 1125 (1299)
.... ......++..|+|||++.+. .++.++|||||||++|||++|+.+|......... .+.... +..+.
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 3221 12234578899999988654 4689999999999999999999999754322111 011000 00000
Q ss_pred c----c-cccceeecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1126 S----R-EGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1126 ~----~-e~L~eIVDp~L~~~~p~e-e~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
. . ....+.....+...+... ....+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 000011111111122222 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.98 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=199.9
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
|+..+.||+|++|.||++.. .+++.|++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999985 46889999998755555566789999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+|||||++||++++++.+||+|||++........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999999853 35889999999999999999999887 99999999999999999999999998875433211
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
......|+..|++||++.+..++.++|||||||++|||++|+.||...+... +....... ....+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~~-------~~~~~~- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRDN-------LPPKLK- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHhc-------CCCCCc-
Confidence 1223458999999999988889999999999999999999999986533211 11111100 000010
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
........+.+++.+||+.+|++||++.|+++.
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111234679999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=313.00 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=199.0
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc-cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
+|++.+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999965 688999999875432 23467789999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
. ++|.+++..... ...+++.++++++.|++.||+|||+.+ |+|||||++||++++++.+||+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 7 488888754322 346899999999999999999999887 9999999999999999999999999997543211
Q ss_pred ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhh-ccccccc---ccce
Q 000757 1059 RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWAR-PLLTSRE---GLER 1132 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~-plls~~e---~L~e 1132 (1299)
.......++..|++||++.+ ..++.++|||+|||++|||++|+.+|......+... ..+... +.....+ .+..
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11223457889999998765 457899999999999999999999997654322111 111100 0000000 0000
Q ss_pred eecCCCC------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1133 IIDPSLG------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1133 IVDp~L~------~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+...... ..+.......+.+++.+||+.+|++|+++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0001122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=316.86 Aligned_cols=269 Identities=19% Similarity=0.235 Sum_probs=196.8
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccc-----
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA----- 970 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~----- 970 (1299)
++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999954 68999999986432 223457889999999995 6999999999887665
Q ss_pred eEEEEeecCCCChhhcccccccC-CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCC
Q 000757 971 RCLVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFG 1048 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~-~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFG 1048 (1299)
.|+||||+.+ +|.+++...... ...+++.+++.++.||+.||+|||+.+ |+|||||++|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 898888643332 346899999999999999999999887 999999999999998 8899999999
Q ss_pred ccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhc-c--
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARP-L-- 1123 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~p-l-- 1123 (1299)
+++....... ......++..|+|||++.+ ..++.++|||||||++|||++|..||........ ..+...... .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432111 1122356889999998765 4578999999999999999999999975432111 011110000 0
Q ss_pred -cccccccceeec-CCC----CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1124 -LTSREGLERIID-PSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1124 -ls~~e~L~eIVD-p~L----~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+.....+..... ... ..........++.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 000 000011244678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.11 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=194.1
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc-cccchhHHHHHHHHhhhcc-cccceeeeeeeeec--cceEEEEe
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLVYE 976 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~--~~~~LVyE 976 (1299)
|++.+.||+|+||.||+|.. .+++.||+|+++.. .........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999995 46889999998653 2223334568999999995 99999999999887 88999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+. |+|.+++... ...++|.+++.++.|++.||+|||+.+ |+|||||++||+|++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 6888887532 246899999999999999999999887 999999999999999 99999999999865332
Q ss_pred ccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc-cc------
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-RE------ 1128 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~-~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~-~e------ 1128 (1299)
.. .....++..|+|||++. .+.++.++|||||||++|||++|+.||...+..+ .+.+....+.. .+
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 11 12345789999999765 4567899999999999999999999997644221 11111111100 00
Q ss_pred ---ccceeecCC-CCC---CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 ---GLERIIDPS-LGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ---~L~eIVDp~-L~~---~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.......+. ... .........+.+|+.+||+.+|++||++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 000 0011345789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.83 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=195.9
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||.||+++.. +|+.|++|++..... ...+.+.+|++++++++|+||+++++.+.+++..|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999864322 3456788999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc-----
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES----- 1058 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~----- 1058 (1299)
.++++.. ..+++.++++++.|++.||+|||+.+ |+||||+++|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999532 26899999999999999999999887 99999999999999999999999999875433211
Q ss_pred -ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1059 -RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1059 -~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
........++..|++||++.....+.++||||||+++|||++|+.||...... ...... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~~~--~~------ 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNI---LNGK--IE------ 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---hcCC--cC------
Confidence 11223456888999999998888999999999999999999999999754321 111111 1100 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
. .........+.+++.+||+.+|++||++.++.+.|+
T Consensus 220 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 W--PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C--CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 000012467899999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.24 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=195.4
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|+..+.||+|+||.||++.. .+++.||+|.+.... .....++.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455677899999999999995 468999999986432 234567889999999996 99999999999998999999999
Q ss_pred cCCCChhhccccc-ccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~-~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
+. ++|.++.... ......+++..+.+++.|++.||+|||+.. +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4555543211 112356899999999999999999999751 3999999999999999999999999999755332
Q ss_pred ccccccccccccccccCccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~---~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ...........
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------- 226 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------- 226 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC-------
Confidence 1 11234588999999998766 689999999999999999999999964321 11111111100
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
....+..........++.+|+.+||+.+|++||++.||++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111112223456689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=355.39 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=212.6
Q ss_pred ceeeEEeecCceEEEEEEe-cCCC----EEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 903 DASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~l-kdGr----~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+.+++||.|+||+||||.+ .+|+ .||||++... ..+..++|++|+.+|.+|+|+||++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999994 3454 4788888643 3445678999999999999999999999998765 789999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||+.|+|.||++. .+..+.-+..+.|.+|||+||.|||++. +|||||..+||||.+-..+||.|||+++....+
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999975 3456888999999999999999999876 999999999999999999999999999987665
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
..........-.+.|||-|.++...|+.++|||||||++||||| |..|++....+ .+.+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence 55444444445689999999999999999999999999999999 99999764322 1223333
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
...+-..+.-+...+..++.+||..|.+.||+++|+..++.+...+.
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 33333445567788999999999999999999999999988766543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.17 Aligned_cols=248 Identities=29% Similarity=0.371 Sum_probs=196.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
..|++.+.||+|+||+||+|+.. +|+.|++|++.... ....+++.+|++++++++|+||++++++|.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999954 68899999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+. |+|.+++.. ....+++.++..++.|++.||.|||+.+ |+||||+++||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 677776642 2235899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
. ....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+.... .... .. .+ .
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~---~~-~~-~-- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI---AQ-ND-S-- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHH---hc-CC-C--
Confidence 1 2345788999999874 46688999999999999999999999864321111 1110 00 00 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.. .....+...+.+++.+||+.+|++||++.+|++...
T Consensus 232 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 ---PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 011234567999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.15 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
|++.+.||+|++|.||+|.. .+|+.|++|++.... ....+.+.+|++++++++|+||+++++++.+.+..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999985 479999999986432 223457889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
+++|.+++.... ...+++.++++++.|+++||+|||+.+ ++||||+++|||+++++.+||+|||+++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 -DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred -CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 578999885432 135899999999999999999999887 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHHhhhcc-------cccccc
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPL-------LTSREG 1129 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~wa~pl-------ls~~e~ 1129 (1299)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ....++.... ......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999987654 578999999999999999999999975432111 1111111000 000000
Q ss_pred ----cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1130 ----LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1130 ----L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+...... ..........+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 01112234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=336.57 Aligned_cols=252 Identities=26% Similarity=0.302 Sum_probs=210.7
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccccc---chhHHHHHHHHhhhcc-cccceeeeeeeeeccceE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ---GGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~---~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~ 972 (1299)
....|++.+.||+|.||.||+++.+ +|+.+|+|++.+.... ..+.+.+|+.+|++|. |+|||.+++++++.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567999999999999999999965 5999999999754332 3468999999999998 999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC----CcceecCCC
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKVSDFG 1048 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed----g~VKLsDFG 1048 (1299)
+|||++.||.|++.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999543 2899999999999999999999887 9999999999999543 579999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e 1128 (1299)
++..... .......+||+.|+|||++....|+...||||+||++|.|++|..||...+.......+ ...+
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~~~- 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LRGD- 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------HcCC-
Confidence 9987654 33456788999999999999999999999999999999999999999876543322111 0000
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+...........+.+++..|+..||.+|.++.++++.
T Consensus 255 -------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 011222334456789999999999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.74 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=199.0
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec------
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 968 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~------ 968 (1299)
..++|++.+.||+|+||.||+|+. .+|+.||||++... +....+++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999995 47899999998642 233445778999999999999999999988643
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
...|+||||+. ++|.+++.. .+++.++..++.|++.||+|||+.+ |+|||||++|||++.++++||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999995 588887732 2888999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHH--------h
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVA--------W 1119 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~--------w 1119 (1299)
+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.+|...+..... .+.. |
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998653321 123345889999999999999999999999999999999999999754321110 0000 0
Q ss_pred h-------hcccccc-----cccceeecCCC----CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1120 A-------RPLLTSR-----EGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1120 a-------~plls~~-----e~L~eIVDp~L----~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
. ....... ..+.+++...+ ...........+.+++.+||+.||++||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 00111111110 011112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.50 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=197.4
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeec--cceEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 973 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~~L 973 (1299)
.++|++.++||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 689999999864322 2233567899999999999999999998764 46799
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+. ++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999995 5888887532 246899999999999999999999887 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhh-------ccc
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWAR-------PLL 1124 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~-------pll 1124 (1299)
..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|...+...... +..+.. +.+
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 43221 1222346788999998865 567899999999999999999999997544322111 111110 000
Q ss_pred ccccccceee-cCCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1125 TSREGLERII-DPSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 s~~e~L~eIV-Dp~L~~~~---p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
........+. ........ .......+.+++.+||+.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00000000 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.34 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=202.1
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+++.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999854 678899999975433 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.+++|.+++... ..+++.+++.++.|++.+|.|||+.+ |+|||||++||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998532 46899999999999999999999887 9999999999999999999999999998664422
Q ss_pred cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCC
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~ 1137 (1299)
.. .....++..|++||++.+..++.++|||+||+++|||++|+.||..... . ...|... . .
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~--~~~~~~~--~--~--------- 214 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--M--AALFRIV--Q--D--------- 214 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--H--HHHHHHh--c--c---------
Confidence 21 2335688999999998888889999999999999999999999864321 1 1111100 0 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1138 L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.....+......+.+++.+||..+|++||++.|++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001122233467889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=325.75 Aligned_cols=265 Identities=27% Similarity=0.367 Sum_probs=197.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeecc-----c
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----A 970 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-----~ 970 (1299)
.+++|++.++||+|+||.||+|+. .+|+.||||+++.. ......++.+|+.++++++|+||+++++++...+ .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999984 57899999998643 2334567889999999999999999999876543 4
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||+. ++|.+++. ...+++..++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 799999995 58877773 235899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc--
Q 000757 1051 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-- 1126 (1299)
Q Consensus 1051 r~~~~~~~~-~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~-- 1126 (1299)
+........ .......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+.... ..+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 765332211 11233568999999998654 5688999999999999999999999965332111 1111000000
Q ss_pred ccccceeecCC-------C--CCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 REGLERIIDPS-------L--GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ~e~L~eIVDp~-------L--~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.+..+.+.. . ..... .....++.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011001000 0 00000 1124568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.20 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=197.2
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc-----cccchhHHHHHHHHhhhcccccceeeeeeeeec--cce
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 971 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~-----d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--~~~ 971 (1299)
.+|++.+.||+|+||.||+|.. .+++.|++|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999995 46899999987421 123345788999999999999999999998764 457
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+.+++|.+++.. ...+++...++++.|++.||.|||+.+ |+|||||++||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999853 234789999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccc
Q 000757 1052 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~-~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L 1130 (1299)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----------- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----------- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH-----------
Confidence 65321111 1112346889999999999888999999999999999999999999643211 111111
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1131 ~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.........+......+.+++.+||+ ++.+||+..++++
T Consensus 222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00011112333455779999999999 4699999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=326.35 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=202.7
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccccc--chhHHHHHHHHhhhccccc-ceeeeeeeeecc------
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRN-LVKLIGICIEEQ------ 969 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~--~~keFlrEIeILsrLrHPN-IVrLlG~~~e~~------ 969 (1299)
.+|+..++||+|+||+||+|+ ..+|+.||+|+++-...+ .-....+|+.+|++|+|.| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667789999999999999 557899999999753332 2345689999999999999 999999998877
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..+|||||+ .-+|..++.........++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 67999999765433245777889999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh--ccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR--PLLTS 1126 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~--plls~ 1126 (1299)
|+...-.. ...+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+....++...+-... +....
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99554221 224557799999999998876 78999999999999999999999998765433211110000 00011
Q ss_pred ccccceeecCC--CCCCC-Ch-------hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 REGLERIIDPS--LGNDV-PF-------DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ~e~L~eIVDp~--L~~~~-p~-------ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...+..+.+-. ..... .. .......+++.+||+.+|.+|.+.+..+++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111111111 00000 00 111468899999999999999999999775
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=365.49 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=201.2
Q ss_pred HHHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeee--ccc
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQA 970 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--~~~ 970 (1299)
+...++|++.+.||+|+||+||++... +++.||+|++... .......|.+|+.+|++|+|+|||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999954 5778999998642 33345678999999999999999999998864 356
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCC----CceeeecccccCeeeccC-------
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS----PRVIHRDFKSSNILLEHD------- 1039 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gs----p~IVHRDIKPsNILLDed------- 1039 (1299)
+||||||+.+|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997544444579999999999999999999998531 349999999999999642
Q ss_pred ----------CcceecCCCccccccccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCC
Q 000757 1040 ----------FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDM 1107 (1299)
Q Consensus 1040 ----------g~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~ 1107 (1299)
+.+||+|||+++..... ......+||..|+|||++.. ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34899999999865322 12234569999999998854 4588999999999999999999999964
Q ss_pred CCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1108 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1108 s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.... . .++.. +.... + + ........+.+||..||+.+|++||++.|+++.
T Consensus 246 ~~~~--~---qli~~-lk~~p------~--l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNF--S---QLISE-LKRGP------D--L---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcH--H---HHHHH-HhcCC------C--C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3211 1 11111 11000 0 0 001234678999999999999999999999854
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.13 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=195.0
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||.||+++.. +++.|++|++.... ....+.+.+|++++++++|+||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999965 58899999986432 23456789999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++.. ...+++.+++.++.||+.||+|||+.+ ++|+|||++||+|++++.+||+|||+++...... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999953 234889999999999999999999887 9999999999999999999999999998664322 122
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
...|+..|++||++....++.++||||||+++|||++|+.||.....+. .++..... +......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~----------~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL----------KGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh----------ccCCCCCCC
Confidence 3468899999999988889999999999999999999999997654211 11111111 001111222
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQ 1173 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPS-----MsEVLq 1173 (1299)
......+.+++.+||+.+|++|++ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233568999999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.15 Aligned_cols=261 Identities=24% Similarity=0.284 Sum_probs=195.8
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhc---ccccceeeeeeeeeccc-----
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQA----- 970 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~e~~~----- 970 (1299)
|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+++++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 48999999996422 22234567888888776 59999999999988776
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ |+|+|||++|||+++++++||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58988885422 235899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccc--
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE-- 1128 (1299)
Q Consensus 1051 r~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e-- 1128 (1299)
....... ......++..|++||++.+..++.++|||||||++|||++|+.+|......+ .+..+.........
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 7653321 1123457889999999998899999999999999999999999987644221 11111111000000
Q ss_pred -cc-----ceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1129 -GL-----ERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1129 -~L-----~eIVDp~L~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
.. ...+..... .....+....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000000 0111123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.87 Aligned_cols=247 Identities=29% Similarity=0.385 Sum_probs=196.5
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
|+..+.||+|+||.||+|+. .+++.|++|++.... ....+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999995 468899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. |+|.+++.. ....++|.+++.++.|++.||.|||+.+ |+||||+++||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 96 577777642 2345899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1058 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+..+....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~----------- 240 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNE----------- 240 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhcc-----------
Confidence 12345888999999874 467889999999999999999999998643211 1111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
............+.+++.+||+.+|++||++.+|++.+..
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0001112344578999999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.65 Aligned_cols=268 Identities=25% Similarity=0.299 Sum_probs=197.8
Q ss_pred HHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeecc----
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ---- 969 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~---- 969 (1299)
...++|++.+.||+|+||.||+|..+ +|+.|+||+++... ......+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999965 58899999996432 223356788999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcce
Q 000757 970 ------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1043 (1299)
Q Consensus 970 ------~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VK 1043 (1299)
..++|+||+.+ +|.+++... ...+++.+++.|+.||+.||+|||+.+ |+|||||++||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 677766432 346899999999999999999999887 99999999999999999999
Q ss_pred ecCCCccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhh
Q 000757 1044 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWAR 1121 (1299)
Q Consensus 1044 LsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~ 1121 (1299)
|+|||++........ .......++..|++||++.+ ..++.++|||||||++|||++|+.+|......... .+.....
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999986543222 11222346788999998764 45789999999999999999999999754321111 0111000
Q ss_pred -------cccccccccc-----eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1122 -------PLLTSREGLE-----RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1122 -------plls~~e~L~-----eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+.+....... .......+... ......+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 00000000000 123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.78 Aligned_cols=267 Identities=19% Similarity=0.256 Sum_probs=196.6
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|++|.||+|..+ +|+.|++|+++... ....+.+.+|++++++++|+||+++++++.+....|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999965 68899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr~~~~ 1055 (1299)
|+. ++|.+++... ....+++...+.++.||+.||+|||+.+ |+|||||++|||+++ ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5788877432 2234678888999999999999999887 999999999999985 56799999999975432
Q ss_pred cccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhhccccc----ccc
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLLTS----REG 1129 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~plls~----~e~ 1129 (1299)
.. .......++..|++||++.+ ..++.++|||||||++|||++|+.||......+... ...+....... ...
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 11 11223457889999998865 457899999999999999999999997543222111 11110000000 000
Q ss_pred ccee---ecCCCCC---CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1130 LERI---IDPSLGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1130 L~eI---VDp~L~~---~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+... ....... ........++.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000 0111234568899999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.15 Aligned_cols=268 Identities=25% Similarity=0.325 Sum_probs=206.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeee-----cc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-----EQ 969 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e-----~~ 969 (1299)
....|...+.||+|+||.|+.+.. .+|+.||||++.+ .+....++..||+++|++++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678999999999999994 5789999999973 455567788999999999999999999999865 34
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
.+|+|+|+| +-+|.+.++ ....|+.+....+++||++||.|+|+.+ |+||||||+|+|++.+..+||+||||
T Consensus 100 DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 679999999 778888884 3345999999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccc
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~-~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e 1128 (1299)
|+...........+..+-|.+|.|||++. ...|+...||||.||||.|||+|+.-|.+.+.-.+..+.-....--. .+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~-~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS-EE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC-HH
Confidence 99775432233345567899999999765 56799999999999999999999999987664443333221111110 01
Q ss_pred cccee--------ecCC-CCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERI--------IDPS-LGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eI--------VDp~-L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+..+ +... .....+ ........+|+.+||..||++|.|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 1000 000111 1233568899999999999999999999876
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.29 Aligned_cols=268 Identities=23% Similarity=0.273 Sum_probs=195.2
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeecc------
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 969 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~------ 969 (1299)
.++|++.+.||+|+||.||+|..+ +++.|+||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999954 688999999864322 22346789999999999999999999875533
Q ss_pred --ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 970 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 970 --~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
..++||||+. ++|.+++.. ....+++.+++.++.|+++||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4599999995 467776643 2346899999999999999999999887 999999999999999999999999
Q ss_pred Cccccccccccc---------cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH
Q 000757 1048 GLARSAMDEESR---------HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117 (1299)
Q Consensus 1048 GLAr~~~~~~~~---------~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV 1117 (1299)
|+++........ ...+...|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 11123467889999998765 45789999999999999999999999754432211111
Q ss_pred Hhhhcc-----cccccccceeecCCCCCCCC-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1118 AWARPL-----LTSREGLERIIDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1118 ~wa~pl-----ls~~e~L~eIVDp~L~~~~p-------~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
...... +.....+....+........ ......+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100000 00000001100000000000 112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.89 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=197.3
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc-cchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
|++.+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999975 578899999865322 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
+|+|.+++.... ...+++.+++.++.|++.+|.|||+.+ |+|+||+++||+|++++.+||+|||+++......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 889999886432 246899999999999999999999887 9999999999999999999999999997653321
Q ss_pred ccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhhccc----ccccccce
Q 000757 1059 RHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLL----TSREGLER 1132 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~-~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~pll----s~~e~L~e 1132 (1299)
......++..|+|||++. ...++.++||||||+++|||++|+.+|......+... ...+..... .+...+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122345888999999775 4567899999999999999999999996554322110 111100000 00000000
Q ss_pred eecCCCC-------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 IIDPSLG-------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IVDp~L~-------~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.++..+. ..........+.+++++||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00011124678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.06 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=199.7
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeecccc--cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
|++.+.||+|++|.||++... +|+.+++|+++.... ...+++.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999854 688999999865332 24567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
. ++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 6 4888887532 246899999999999999999999887 9999999999999999999999999997664432
Q ss_pred ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhh-HHh-------hhccccc--c
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-VAW-------ARPLLTS--R 1127 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nL-V~w-------a~plls~--~ 1127 (1299)
.......++..|++||.+.+. .++.++|||||||++|||++|+.+|...+..+.... .+. .+..+.. .
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999988776 789999999999999999999999965443221110 000 0000000 0
Q ss_pred cccceeecCCC--CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1128 EGLERIIDPSL--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIVDp~L--~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+.+... ......+...++.+++.+||+.||++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 001112345689999999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.35 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=187.9
Q ss_pred EEeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhh---cccccceeeeeeeeeccceEEEEeecC
Q 000757 907 ILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSR---LHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 907 lLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsr---LrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
+||+|+||.||++.. .+++.||+|++.... ....+.+++|..+++. .+|+||+.+++++.+++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 468899999986432 1222334555554444 369999999999999899999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++.. ...++|.++..|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998852 345899999999999999999999887 9999999999999999999999999987543211
Q ss_pred cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.... .. .+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~--------~~--- 215 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT--------VN--- 215 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hc--------CC---
Confidence 123468999999998864 55789999999999999999999999754332221111110 00 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq~L 1175 (1299)
...+.....++.+++.+||+.||++|+ +++|+++..
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 112223456789999999999999999 588887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.56 Aligned_cols=268 Identities=24% Similarity=0.313 Sum_probs=198.9
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhc-ccccceeeeeeeeec--cce
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE--QAR 971 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~--~~~ 971 (1299)
..++|++.+.||+|+||.||+|.+. +|+.|+||++... +......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999965 6888999988542 233445678899999999 999999999998653 357
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+. ++|.+++.. ..++|..++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 689888842 26889999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc---cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc-
Q 000757 1052 SAMDEESR---HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 1126 (1299)
Q Consensus 1052 ~~~~~~~~---~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~- 1126 (1299)
........ .......|+..|++||++.. ..++.++|||||||++|||++|+.+|.............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433221 12234568999999998754 56789999999999999999999999654322111111000000000
Q ss_pred ------ccccceeecCCC------CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 ------REGLERIIDPSL------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ------~e~L~eIVDp~L------~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....++++... ..........++.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000111000 000111235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.36 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=197.9
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-----cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-----d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
+|.+.+.||+|+||.||+++.. .+..+++|+++.. ......++.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999854 3455666666532 222334577899999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+++|.+++.........+++.+++.++.|++.||.|||+.+ |+|+|||++||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754444567999999999999999999999887 999999999999975 569999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.... ......|+..|++||++.+..++.++||||||+++|+|++|+.+|..... ..........
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~-------- 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVEG-------- 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHcC--------
Confidence 3221 22335588899999999888889999999999999999999999864321 1111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
........+...+.+++.+||+.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0011223445688999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.90 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=190.5
Q ss_pred EeecCceEEEEEEe-cCCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||+||++.. .+|+.|++|.+.... ....+.+.+|+++|++++|+||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468899999986422 23345678899999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++.... ...+++.+++.++.|++.||.|||+.+ |+||||+++|||+++++.+||+|||++...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99986432 236899999999999999999999887 999999999999999999999999998765331 1122
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
...++..|++||++.++.++.++|||||||++|||++|+.||.......... ........ ......
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~------------~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLE------------MAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcccc------------ccccCC
Confidence 3457889999999988889999999999999999999999997544311111 00000000 011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
......+.+++.+||+.+|++|+++.|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 234567899999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.27 Aligned_cols=266 Identities=22% Similarity=0.267 Sum_probs=203.5
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccch--hHHHHHHHHhhhcccccceeeeeeeee--ccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~--keFlrEIeILsrLrHPNIVrLlG~~~e--~~~~~LV 974 (1299)
++|+.++.|++|.||.||+|+++ +++.||+|+++-...... -.-+|||.+|.+++|+|||.+.++.+. -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34777899999999999999954 789999999974332211 134799999999999999999998764 4578999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
||||+ -+|..+|+.. .+++...++..+..|+++||+|||.+. |+|||||++|+|+...|.+||+||||||.+.
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99995 5888888643 357899999999999999999999988 9999999999999999999999999999875
Q ss_pred ccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH--------hhhcccc
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA--------WARPLLT 1125 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~--------wa~plls 1125 (1299)
.. ....+..+-|.+|+|||++.+ ..|+...|+||+|||+.||++++.-|.+..+.++.+.+- -.|+-+.
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 43 223456778999999998875 568999999999999999999999998766555433221 1111111
Q ss_pred ccccc-----ceeecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1126 SREGL-----ERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1126 ~~e~L-----~eIVDp~L~~~~p~e-e~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.-... .+-.-..++..+... ....-.+|+...|..||.+|-|+.|.++.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11100 000011122222222 33667889999999999999999998654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.24 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=202.0
Q ss_pred CCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LV 974 (1299)
++|.+.+.||+|+||.||+|+.. +|+.|++|++... .....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999964 7899999998642 2233467889999999998 99999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+.+++|.+++.. ...+++.+++.|+.|++.||+|||+.+ ++|+|||++||+|+.+++++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999953 236999999999999999999999887 9999999999999999999999999988654
Q ss_pred ccccc------------------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhh
Q 000757 1055 DEESR------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1116 (1299)
Q Consensus 1055 ~~~~~------------------~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nL 1116 (1299)
..... .......|+..|++||++....++.++||||||+++|||++|+.||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 32211 112234578999999999888899999999999999999999999975431 111
Q ss_pred HHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH----HHHHH
Q 000757 1117 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM----GEVVQ 1173 (1299)
Q Consensus 1117 V~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSM----sEVLq 1173 (1299)
..... . ....++......+.+++.+||+.+|++||++ .|+++
T Consensus 231 ~~~~~---~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKIL---K------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH---h------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 0011222335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=309.27 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=196.7
Q ss_pred CcceeeEEeecCceEEEEEEe----cCCCEEEEEEeeccc----ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccce
Q 000757 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l----kdGr~VAVK~Lk~~d----~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~ 971 (1299)
+|++.+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.+++++ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 588999999999999999985 368899999997532 22346688999999999 599999999999988899
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+++++|.+++.. ...+.+.++..++.|+++||.|||+.+ |+|||||++||||++++++||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 235888999999999999999999887 9999999999999999999999999997
Q ss_pred cccccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~--~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~ 1129 (1299)
....... .......|+..|++||++... .++.++|||||||++|||++|+.||....... ...++........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-- 228 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC--
Confidence 6533221 112235689999999988753 46789999999999999999999996533211 1112211111110
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHH
Q 000757 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 1173 (1299)
Q Consensus 1130 L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq 1173 (1299)
..++......+.+++.+||+.+|++|+ +..+++.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 012223456788999999999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.97 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=198.3
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec-----cc
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QA 970 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~-----~~ 970 (1299)
.++|.+.+.||+|+||+||+|+. .+++.||||+++.. ......++.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999994 46899999998642 233455678899999999999999999988654 34
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||+. ++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 788888842 346899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhhcccc---
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLLT--- 1125 (1299)
Q Consensus 1051 r~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~plls--- 1125 (1299)
+...... .......++..|+|||++.. ..++.++|||||||++|||++|+.+|...+...... +.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8654321 12233457889999998764 568899999999999999999999996543211100 0000000000
Q ss_pred ---cccccceeec-------CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1126 ---SREGLERIID-------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1126 ---~~e~L~eIVD-------p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
......+.++ ..+. ....+...++.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0000 0112345678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=345.02 Aligned_cols=272 Identities=22% Similarity=0.252 Sum_probs=191.0
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecC--CCEEEEE------------------EeecccccchhHHHHHHHHhhhcccc
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDD--GTKVAVK------------------VLKRVDQQGGREFLAEVEMLSRLHHR 956 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkd--Gr~VAVK------------------~Lk~~d~~~~keFlrEIeILsrLrHP 956 (1299)
...++|++.+.||+|+||+||++.++. ++.+++| .++ ......+++.+|+++|++|+|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987542 2222222 111 1222345688999999999999
Q ss_pred cceeeeeeeeeccceEEEEeecCCCChhhccccccc-CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCee
Q 000757 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 1035 (1299)
Q Consensus 957 NIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~-~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNIL 1035 (1299)
|||++++++.+.+..|+|+|++ +++|.+++..... ......+.+.++|+.||+.||+|||+.+ |||||||++|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999999 5677777643221 1222345667889999999999999887 999999999999
Q ss_pred eccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC-CCCCCCCCchh
Q 000757 1036 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK-PVDMTQPPGQE 1114 (1299)
Q Consensus 1036 LDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~-PFd~s~~~~~~ 1114 (1299)
|+.++.+||+|||+++...... .......+||..|+|||++.+..++.++|||||||+||||++|.. |+.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999998654322 222334679999999999999999999999999999999999875 44433222212
Q ss_pred hhHHhhhccccccc-------ccceeecCC-C---CCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1115 NLVAWARPLLTSRE-------GLERIIDPS-L---GNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1115 nLV~wa~plls~~e-------~L~eIVDp~-L---~~~~-----p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.+....+....+ .+.+.++.. + .... .......+.+++.+||+.||++||++.|+++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22211110000000 000000000 0 0000 00122457888999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=313.51 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=195.5
Q ss_pred CCcceeeEEeecCceEEEEEEecC-CCEEEEEEeeccc-ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyE 976 (1299)
++|++.+.||+|+||.||+|+.++ ++.||||+++... .....++.+|++++.++. |+||++++++|.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999764 8899999997532 233456778888777775 9999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+ +++|.+++... ...+++.++.+++.|+++||+|||+.. +|+||||+++|||+++++.+||+|||++......
T Consensus 95 ~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred cc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 98 45777666432 236899999999999999999999741 3999999999999999999999999998765332
Q ss_pred ccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~----~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.. .....++..|+|||++.+.. ++.++|||||||++|||++|+.||...... .+.+..+.. .. ...
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----~~--~~~ 238 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQ----EE--PPS 238 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhc----CC--CCC
Confidence 11 12335788999999887553 789999999999999999999999643211 111111111 00 000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
+ ........++.+++.+||+.+|++||++.++++...
T Consensus 239 ~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 L-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0 001124467899999999999999999999987754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=340.87 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=204.1
Q ss_pred CcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-c-----ccceeeeeeeeeccceEE
Q 000757 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-H-----RNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-H-----PNIVrLlG~~~e~~~~~L 973 (1299)
+|+++++||+|.||.|.||. .++++.||||++++. ....++-..|+.+|.+|+ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 79999999999999999999 567999999999853 344556678999999997 4 389999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc--CCcceecCCCccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH--DFTPKVSDFGLAR 1051 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe--dg~VKLsDFGLAr 1051 (1299)
|+|.+ .-+|+++|+... ...|+...++.|+.||+.||.+||+.+ |||+||||+||||.+ ..+|||+|||.+.
T Consensus 266 VfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999 789999997543 345889999999999999999999887 999999999999965 3489999999998
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH-------------
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA------------- 1118 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~------------- 1118 (1299)
.....-. ..+-+..|+|||++.+..|+.+.||||||||++||++|..-|.+.++.++..++.
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6533222 3345779999999999999999999999999999999988887766544332221
Q ss_pred ------------hhhccccccccc--------ce----eecCCC--------CCCCChhhHHHHHHHHHHhcCcCcCCCC
Q 000757 1119 ------------WARPLLTSREGL--------ER----IIDPSL--------GNDVPFDSVAKVAAIASMCVQPEVQHRP 1166 (1299)
Q Consensus 1119 ------------wa~plls~~e~L--------~e----IVDp~L--------~~~~p~ee~~eL~~LI~~CL~~dPskRP 1166 (1299)
|........+.. .+ ..+... ........-..|.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 111100000000 00 000000 0001113446799999999999999999
Q ss_pred CHHHHHHHHH
Q 000757 1167 FMGEVVQALK 1176 (1299)
Q Consensus 1167 SMsEVLq~Lk 1176 (1299)
|..|.++.-.
T Consensus 495 tp~qal~Hpf 504 (586)
T KOG0667|consen 495 TPAQALNHPF 504 (586)
T ss_pred CHHHHhcCcc
Confidence 9999987643
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.38 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=200.2
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeee----ccce
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQAR 971 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e----~~~~ 971 (1299)
.++|++.+.||+|+||.||+|+. .+|+.|++|++.... ....+.+.+|+.+|++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999995 468999999986532 2345677889999999999999999998763 3467
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+. |+|.+++.. ...+++.++++++.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999994 689888853 235899999999999999999999887 9999999999999999999999999997
Q ss_pred cccccccc--cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc-----c
Q 000757 1052 SAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP-----L 1123 (1299)
Q Consensus 1052 ~~~~~~~~--~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p-----l 1123 (1299)
........ .......|+..|++||++.. ..++.++|||||||++|||++|+.||................. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65332211 12234568999999998765 5688999999999999999999999965432111100000000 0
Q ss_pred cc--cccccceeecCC-CCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1124 LT--SREGLERIIDPS-LGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1124 ls--~~e~L~eIVDp~-L~~~~-----p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
+. ..+.+.+.++.. ..... ..+...++.+++.+||+.+|++||++.++++.-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00 000011111100 00001 1123567999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=349.48 Aligned_cols=268 Identities=25% Similarity=0.428 Sum_probs=214.7
Q ss_pred HHHHHhCCcceeeEEeecCceEEEEEEec----C----CCEEEEEEeecc-cccchhHHHHHHHHhhhc-ccccceeeee
Q 000757 894 EIEKATGNFDASRILGEGGFGLVYSGVLD----D----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIG 963 (1299)
Q Consensus 894 ELe~at~nFsi~elLGeGgFGtVYKA~lk----d----Gr~VAVK~Lk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG 963 (1299)
.++...+++.+.+.||+|.||.||+|.+. . ...||||.++.. +..+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444555667779999999999999844 1 356999999753 345567899999999999 5999999999
Q ss_pred eeeeccceEEEEeecCCCChhhcccccc---c-------CC--CCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccc
Q 000757 964 ICIEEQARCLVYELIPNGSVESHLHGVD---K-------ES--APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKS 1031 (1299)
Q Consensus 964 ~~~e~~~~~LVyEYm~GGSL~d~L~~~~---~-------~~--~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKP 1031 (1299)
+|.+++..++|+||+..|+|.++|+..+ . .. ..|...+++.++.|||+||+||++.. +|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997654 0 01 23889999999999999999999876 99999999
Q ss_pred cCeeeccCCcceecCCCcccccccccccccccccc--ccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 000757 1032 SNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMT 1108 (1299)
Q Consensus 1032 sNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~--GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s 1108 (1299)
+||||+++..+||+||||++........... ... -...|||||.+....|+.|+|||||||+||||++ |..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999965443332211 111 2457999999999999999999999999999999 88898642
Q ss_pred CCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhh
Q 000757 1109 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1109 ~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e 1181 (1299)
. ....+.++ +....+...+..+..++.++|+.||+.+|++||++.|+++.+...+.+
T Consensus 526 ~--~~~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 526 P--PTEELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred C--cHHHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 11222222 222233345566788999999999999999999999999999986544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=311.66 Aligned_cols=256 Identities=15% Similarity=0.196 Sum_probs=183.9
Q ss_pred hCCcceeeEEeecCceEEEEEEecC----CCEEEEEEeecccccch-----------hHHHHHHHHhhhcccccceeeee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGG-----------REFLAEVEMLSRLHHRNLVKLIG 963 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~d~~~~-----------keFlrEIeILsrLrHPNIVrLlG 963 (1299)
.++|++.++||+|+||+||+|...+ +..+++|+......... .....++..+..++|.||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999654 34566665432111110 11223334456678999999999
Q ss_pred eeeecc----ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC
Q 000757 964 ICIEEQ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1039 (1299)
Q Consensus 964 ~~~e~~----~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed 1039 (1299)
++.... ..++++|++ ..++.+.+... ....+..++.|+.|+++||+|||+.+ |+||||||+||||+.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 776543 336777876 34565555321 23567889999999999999999887 9999999999999999
Q ss_pred CcceecCCCccccccccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh
Q 000757 1040 FTPKVSDFGLARSAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 1114 (1299)
Q Consensus 1040 g~VKLsDFGLAr~~~~~~~~-----~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~ 1114 (1299)
+++||+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999865432111 1112346999999999999999999999999999999999999999765322211
Q ss_pred h---hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1115 N---LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1115 n---LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
. ..++...... ..+ ....+...+.+++..|+..++++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHE----------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhh----------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 1112111111 000 0112346799999999999999999999998876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.26 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=188.8
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeecccc---cchhHHHHHHHHh-hhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---QGGREFLAEVEML-SRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~---~~~keFlrEIeIL-srLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
+.||+|+||.||+|.. .+|+.||||++..... .....+..|..++ ..++|+||+++++++.+++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 4688999999864322 2223445555544 455899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
++|.+++.. ...+++..+.+++.|++.||.|||+.+ |+||||+++||||++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999853 235889999999999999999999887 99999999999999999999999999875432
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.....|+..|++||++.+..++.++||||||+++|||++|..||...+... .+.... ... . ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~~~--~------~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFDNIL----SRR--I------NWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH----hcc--c------CCCC
Confidence 223458889999999988889999999999999999999999996543211 111110 000 0 0001
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.....+...+.+++.+||+.+|++|+++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111234567899999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.37 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=199.8
Q ss_pred CcceeeEEeecCceEEEEEEe----cCCCEEEEEEeeccc----ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccce
Q 000757 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l----kdGr~VAVK~Lk~~d----~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~ 971 (1299)
+|++.+.||+|+||.||+++. .+++.||||+++... ....+++.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999884 357889999987432 22345688999999999 599999999999988999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++||||+.+|+|.+++.. ...+.+.+++.++.|++++|+|||+.+ ++|||||++|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999853 235889999999999999999999887 9999999999999999999999999987
Q ss_pred cccccccccccccccccccccCccccccCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~--~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~ 1129 (1299)
....... .......|+..|++||++.+.. .+.++||||||+++|||++|+.||....... ...++........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~-- 228 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK-- 228 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC--
Confidence 6543221 1223356899999999887655 7889999999999999999999996432211 1111111111100
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000757 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1130 L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~ 1177 (1299)
...+......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01122233568899999999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=311.69 Aligned_cols=266 Identities=21% Similarity=0.232 Sum_probs=195.4
Q ss_pred ceeeEEeecCceEEEEEEecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
.+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+++..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666655 5899999998643 344556899999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc--
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES-- 1058 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~-- 1058 (1299)
|+|.++++... ...+++.....++.|+++||+|||+.+ |+|||||++|||++.++.+||+|||++........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999996432 235889999999999999999999887 99999999999999999999999998875432211
Q ss_pred ---ccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc----cccc---
Q 000757 1059 ---RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP----LLTS--- 1126 (1299)
Q Consensus 1059 ---~~~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p----lls~--- 1126 (1299)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+.... .+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCch
Confidence 111233457789999998875 35789999999999999999999999754321 111111100 0000
Q ss_pred ---ccccce----eecCCC----CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1127 ---REGLER----IIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1127 ---~e~L~e----IVDp~L----~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
...+.. ..+... ..........++.+++.+||+.||++||++.|+++.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 000000 01111233467889999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=318.36 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=192.8
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc------
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 969 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~------ 969 (1299)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 46899999998642 2223456889999999999999999999987542
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..|+|+||+. .+|.+++. ..+.+.++..++.|+++||+|||+.+ |+|||||++|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999995 46766541 25889999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhh-------
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR------- 1121 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~------- 1121 (1299)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.+|.............+..
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8754221 123457889999998876 468899999999999999999999997543211111000000
Q ss_pred -cccccccccceeec---CCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1122 -PLLTSREGLERIID---PSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1122 -plls~~e~L~eIVD---p~L~~~~---p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+.. ......++ ....... .......+.+++.+||+.||++||++.|+++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000 0000000 01233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.85 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=196.5
Q ss_pred eEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000757 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 984 (1299)
Q Consensus 906 elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~ 984 (1299)
.+||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+.+++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478899999986545555667899999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccccccc
Q 000757 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064 (1299)
Q Consensus 985 d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~ 1064 (1299)
+++.. ..+++..++.++.|++.+|+|||+.+ |+|||||++||+|++++.++|+|||++........ ....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 98742 24789999999999999999999887 99999999999999999999999999875543221 1233
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCCh
Q 000757 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1144 (1299)
Q Consensus 1065 v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ 1144 (1299)
..|+..|++||++.+..++.++|||||||++|||++|+.||...... .........+. ..+. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~----------~~~~--~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP----------PKLK--NLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC----------cccC--Ccc
Confidence 46889999999998888899999999999999999999998643221 11111111110 0000 001
Q ss_pred hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1145 DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1145 ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.....+.+++.+||+.+|.+|+++.++++.
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 233567889999999999999999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=314.61 Aligned_cols=266 Identities=25% Similarity=0.342 Sum_probs=201.7
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeecc-----ceE
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-----~~~ 972 (1299)
+|++.+.||+|+||.||+|+.. +++.|+||++.... ....+.+.+|++++++++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999965 58899999987533 344567899999999999999999999998765 789
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+. ++|.++++. ...+++..++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 588888853 237999999999999999999999887 99999999999999999999999999986
Q ss_pred ccccccc-cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHHhhhccc-----
Q 000757 1053 AMDEESR-HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLL----- 1124 (1299)
Q Consensus 1053 ~~~~~~~-~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~wa~pll----- 1124 (1299)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|+.+|...+...... +..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6443210 112334578899999999887 78999999999999999999999997654321111 111000000
Q ss_pred -ccccccceeecC-CCCC-----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1125 -TSREGLERIIDP-SLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 -s~~e~L~eIVDp-~L~~-----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.......+.+.. .... ....+....+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000001100 0000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.93 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=194.5
Q ss_pred eEEeec--CceEEEEEEe-cCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 906 RILGEG--GFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 elLGeG--gFGtVYKA~l-kdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
..||+| +||+||++.. .+|+.||||++.... ....+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8999999995 478999999986432 23346788999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc-
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1059 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~- 1059 (1299)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986532 235889999999999999999999887 999999999999999999999999865433221110
Q ss_pred c----ccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc---------c
Q 000757 1060 H----ISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL---------L 1124 (1299)
Q Consensus 1060 ~----~st~v~GT~gYmAPE~l~~~--~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl---------l 1124 (1299)
. ......++..|++||++.+. .++.++|||||||++|||++|+.||...... ..+....... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence 0 01112356679999998763 4789999999999999999999999754321 1111110000 0
Q ss_pred cc------------c----------cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1125 TS------------R----------EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1125 s~------------~----------e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.. . .....+.+..+.......+...+.+|+.+||..||++|||+.|+++.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 0 0000111111122222345678999999999999999999999987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.25 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=186.5
Q ss_pred EEeecCceEEEEEEe-cCCCEEEEEEeecccc---cchhHHHHHHHH---hhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 907 ILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---QGGREFLAEVEM---LSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 907 lLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~---~~~keFlrEIeI---LsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
+||+|+||.||++.. .+++.||+|++..... .....+..|..+ ++..+|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4688999999864321 222234445444 344579999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
||+|.+++.. ...++|.+++.|+.|+++||+|||+.+ |+|||||++|||+++++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998842 346999999999999999999999887 9999999999999999999999999987543211
Q ss_pred cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... .... . ..+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~--~--------~~~--- 215 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMT--L--------TMA--- 215 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHh--h--------ccC---
Confidence 1234689999999998754 688999999999999999999999975432221111 0000 0 000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQ 1173 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRP-----SMsEVLq 1173 (1299)
...+.....++.+++.+||..+|++|+ ++.|+++
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 112222356899999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.57 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=198.8
Q ss_pred cceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
|++.+.||+|+||.||+|+.. +++.|++|+++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999965 58999999987542 333467889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
. ++|.+++.... ..+++.++++++.|+++||+|||+.+ |+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 68999986422 46899999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhh-------hccccc---
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWA-------RPLLTS--- 1126 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa-------~plls~--- 1126 (1299)
......++..|+|||++.+. .++.++|||||||++|||++|+.+|......+.. .+.... +..+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234467889999988766 7899999999999999999999999664322110 011100 000000
Q ss_pred -ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1127 -REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1127 -~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
................ ......+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000000 112457999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.28 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=211.8
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.+-|++.+.||+|-|+.|-+|+ .-+|+.||||++.+. +......+.+|++.|+.++|+|||+||++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3557888999999999999998 567999999999754 4444567899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCcccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr~~~ 1054 (1299)
|+-++|+|++|+-+. ...+.++...+++.||+.|+.|||+.. ||||||||+||.+-+ -|-|||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999533 345899999999999999999999887 999999999998855 5789999999998775
Q ss_pred ccccccccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T-~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.+.. .++.||.+.|-|||++.+..|+ .+.||||||||||-|++|+.||+..+. .+.+..|
T Consensus 171 PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmI 231 (864)
T KOG4717|consen 171 PGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMI 231 (864)
T ss_pred Ccch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhh
Confidence 5432 3567899999999999988886 678999999999999999999976543 3445556
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+|... .++.....+..+||..||..||++|.+.+||+.
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 66443 445566788999999999999999999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=335.93 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=208.5
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEee--cccccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEE
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk--~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~L 973 (1299)
.....|+++++||+||.++||++...+.+.||+|++. ..+.+...-|.+||++|.+|+ |.+||+|+||-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3345688899999999999999998888889999874 346666778999999999996 9999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||= +.+|..+|.+.. ....+| .++.+..|++.++.++|++| |||.||||.|+|+- +|.+||+|||+|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99986 789999996533 233456 78889999999999999998 99999999999996 578999999999988
Q ss_pred cccccccccccccccccccCccccccC-----------CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~-----------~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p 1122 (1299)
..+...-.....+||+.||+||.+... +.+.++||||||||||+|+.|+.||.... + .|
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~--- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QI--- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HH---
Confidence 776666667778999999999977532 25689999999999999999999996321 1 12
Q ss_pred ccccccccceeecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1123 LLTSREGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 lls~~e~L~eIVDp~L~~~~p~e-e~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+..|.|+...-.++.- .-.++.++|..||..||++||++.|+++.
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 224455666543344321 22339999999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.22 Aligned_cols=266 Identities=21% Similarity=0.259 Sum_probs=195.2
Q ss_pred CCcc-eeeEEeecCceEEEEEEec-CCCEEEEEEeecccccc--------------hhHHHHHHHHhhhcccccceeeee
Q 000757 900 GNFD-ASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQG--------------GREFLAEVEMLSRLHHRNLVKLIG 963 (1299)
Q Consensus 900 ~nFs-i~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~--------------~keFlrEIeILsrLrHPNIVrLlG 963 (1299)
++|. +.+.||+|+||+||+|+.. +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3578999999999999954 68999999986432211 125789999999999999999999
Q ss_pred eeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcce
Q 000757 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1043 (1299)
Q Consensus 964 ~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VK 1043 (1299)
++..++..++||||+. |+|.+++.. ...+++...+.++.|++.||+|||+.+ |+|||||++||||+.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 689888842 345889999999999999999999887 99999999999999999999
Q ss_pred ecCCCccccccccc------------cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 000757 1044 VSDFGLARSAMDEE------------SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110 (1299)
Q Consensus 1044 LsDFGLAr~~~~~~------------~~~~st~v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~ 1110 (1299)
|+|||+++...... .........++..|++||++.+. .++.++|||||||++|||++|+.+|...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654110 01111223468899999988764 468999999999999999999999976543
Q ss_pred Cchh-hhHHhhhcc----cccccccc------eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1111 PGQE-NLVAWARPL----LTSREGLE------RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1111 ~~~~-nLV~wa~pl----ls~~e~L~------eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.. .+..+.... +.....+. ......+. ........++.+++.+||+.+|++|+++.|++..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2211 111111000 00000000 00000000 0011234678899999999999999999999763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.54 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=192.8
Q ss_pred HHHHHHhCCcceeeEE--eecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeeec
Q 000757 893 SEIEKATGNFDASRIL--GEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 893 ~ELe~at~nFsi~elL--GeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~ 968 (1299)
.++....++|++.+.+ |+|+||.||+++. .+++.+++|.+...... . .|+.....+ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444555677777776 9999999999995 46888999998643211 1 133333323 699999999999999
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 1047 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDF 1047 (1299)
+..|+||||+++|+|.+++.. ...++|++++.++.|+++||.|||+.+ |+|||||++||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999953 237899999999999999999999887 99999999999999988 9999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
|+++..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....|.... ...
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~ 226 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QKK 226 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-ccc
Confidence 998754321 22358899999999998889999999999999999999999997443221 1222222211 000
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-HHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQ 1173 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS-MsEVLq 1173 (1299)
. .........+.+++.+||+.+|++|++ ++|+++
T Consensus 227 --~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 --L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 111134567899999999999999995 688864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.94 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=193.3
Q ss_pred CcceeeEEeecCceEEEEEEec-C--CCEEEEEEeecc--cccchhHHHHHHHHhhhc-ccccceeeeeeeeec----cc
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-D--GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE----QA 970 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-d--Gr~VAVK~Lk~~--d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~----~~ 970 (1299)
+|++.+.||+|+||.||+++.. + +..||+|++... .....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999955 3 678999998642 222356788999999999 499999999976432 45
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+++||+. ++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++|||+++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889884 789888842 346899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccc--cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hH--------H
Q 000757 1051 RSAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LV--------A 1118 (1299)
Q Consensus 1051 r~~~~~~~~--~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV--------~ 1118 (1299)
+........ .......|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+...... .. +
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 11233568999999998765 468899999999999999999999997543211000 00 0
Q ss_pred hhhccccccc-ccceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1119 WARPLLTSRE-GLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1119 wa~plls~~e-~L~eIVDp~L~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+......... .....++.... ..........+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000000000 00111234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=322.46 Aligned_cols=261 Identities=25% Similarity=0.321 Sum_probs=197.8
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeecc-----ceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-----~~~LV 974 (1299)
.|+..++||.|.||.||+|++ .+++.||||++-.... .-.+|+++|++++|+|||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 477789999999999999995 4578999999843221 2237999999999999999999886422 23589
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCCCccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSA 1053 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDFGLAr~~ 1053 (1299)
||||+ .+|.++++.+...+..++...+.-+..||.+||+|||+.+ |+||||||.|||||.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99994 6999999876666677888899999999999999999887 9999999999999976 99999999999977
Q ss_pred cccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc-cc---
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-RE--- 1128 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~-~e--- 1128 (1299)
..+... .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+....+ .+++.++-+-.. ++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence 554332 22346889999998775 579999999999999999999999997754332 233222211111 00
Q ss_pred ---------ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 ---------GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ---------~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...++....+..-+......+.++|+.++|..+|.+|-+..|+++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111111223455789999999999999999999998754
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=338.43 Aligned_cols=244 Identities=31% Similarity=0.426 Sum_probs=198.3
Q ss_pred cceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
|..++.||.|.||.||-|+ ..+.+.||||++.-... ....+++.|+.+|++|+|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6667899999999999999 45678899999964333 3456899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
| -|+-.|.|. ..+.+|-+.++..|+.|.+.||+|||+.+ .||||||..||||++.|.|||+|||.|......
T Consensus 108 C-lGSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 567677663 23457999999999999999999999887 999999999999999999999999998765432
Q ss_pred cccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1058 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
..++||+.|||||++. .+.|+-|+|||||||+..||.-.+.|+-..+.- ..+...+ .++
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIA-----QNe------ 241 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA-----QNE------ 241 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHH-----hcC------
Confidence 3467999999999875 689999999999999999999999887433211 1111111 010
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.+ -..+....|++++..||+.-|.+|||..++++.
T Consensus 242 sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 134667889999999999999999999988753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=316.50 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred CCHHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeee
Q 000757 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICI 966 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~ 966 (1299)
....++..+.++|++.+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999984 57889999998643 2233467889999999999999999999886
Q ss_pred ec------cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC
Q 000757 967 EE------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040 (1299)
Q Consensus 967 e~------~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg 1040 (1299)
.. ...|+++|++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+|||||++||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 43 3467888887 8899887742 25899999999999999999999887 99999999999999999
Q ss_pred cceecCCCccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh-hHH
Q 000757 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVA 1118 (1299)
Q Consensus 1041 ~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n-LV~ 1118 (1299)
.+||+|||+++.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +..
T Consensus 158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999875422 1223468899999998765 568899999999999999999999996543221111 111
Q ss_pred hhh-------cccccc---c---ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1119 WAR-------PLLTSR---E---GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1119 wa~-------plls~~---e---~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+.. ..+... . .+..+.+..+. +........+.+++.+||+.+|++|+++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100 000000 0 00000000000 0001234568899999999999999999999776
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.74 Aligned_cols=247 Identities=28% Similarity=0.367 Sum_probs=194.9
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.|+..+.||+|+||.||+|+.. +++.|++|.+... .....+++.+|++++++++|+|++++++++.+....++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667789999999999999954 6788999998632 22334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+. |+|.+++.. ....+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 995 688777642 2345889999999999999999999887 999999999999999999999999998754321
Q ss_pred ccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+... ....+.. . ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~-----~-~~--- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ-----N-ES--- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHhh-----c-CC---
Confidence 2345888999999874 3567889999999999999999999985432111 1111111 0 00
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.. .........+.+|+.+||+.+|++||++.++++...
T Consensus 232 --~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 011234467889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.67 Aligned_cols=244 Identities=28% Similarity=0.392 Sum_probs=192.7
Q ss_pred cceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
|...+.||+|+||+||+|+. .+|+.|++|++..... ...+++.+|++++++++|+||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999995 4688999999864322 2335688999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+. |+|.+++.. ....++|.+++.++.|++.+|.|||+.+ |+|||||++||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 677777742 2346899999999999999999999887 99999999999999999999999999864321
Q ss_pred cccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1058 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1058 ~~~~st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+.... ..+.. . . ....
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~~~---~-~-~~~~-- 239 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA---Q-N-DSPT-- 239 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH---h-c-CCCC--
Confidence 12356889999999874 46688999999999999999999999865432111 11110 0 0 0000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.........+.+++.+||+.+|++||++.++++.
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=313.87 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=197.6
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeecc--
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-- 969 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-- 969 (1299)
+....++|++.+.||+|+||.||++. ..+|+.||||+++.. .....+.+.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34467889999999999999999998 457899999998542 2223456889999999999999999999987543
Q ss_pred ----ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceec
Q 000757 970 ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1045 (1299)
Q Consensus 970 ----~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLs 1045 (1299)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+|||||++|||+++++.+||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 7899888742 35899999999999999999999887 9999999999999999999999
Q ss_pred CCCccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhH------
Q 000757 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLV------ 1117 (1299)
Q Consensus 1046 DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV------ 1117 (1299)
|||+++..... .....++..|++||++.+ ..++.++|||||||++|+|++|+.||......... ...
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999754321 123457889999998875 45889999999999999999999999754321110 000
Q ss_pred --HhhhcccccccccceeecC--CC-C---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1118 --AWARPLLTSREGLERIIDP--SL-G---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1118 --~wa~plls~~e~L~eIVDp--~L-~---~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+|...+.. . .....+.. .. . ..........+.+++.+|++.||++|+++.++++.
T Consensus 236 ~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQS-E-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcc-h-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0 00000000 00 0 00111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=311.92 Aligned_cols=265 Identities=25% Similarity=0.337 Sum_probs=199.0
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeee-ccc
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQA 970 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e-~~~ 970 (1299)
+..++++|++.+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457889999999999999999999844 7899999988532 23345678899999999999999999999865 567
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||+ +++|.++++. ..+.+.....++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 6789888742 35788889999999999999999887 999999999999999999999999998
Q ss_pred ccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCch-hhhHH--------hh
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVA--------WA 1120 (1299)
Q Consensus 1051 r~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~-~nLV~--------wa 1120 (1299)
+..... .....++..|++||++.+ ..++.++|||||||++|||++|+.+|........ ..+.+ |.
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 754221 123457889999998765 5689999999999999999999999965432111 01111 11
Q ss_pred hcccccccccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~L~~~~p-----~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
...... ..+..+.+-......+ ......+.+++.+||+.+|++||++.|++..
T Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred Hhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111100 0000000000001111 1234678999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=314.90 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=196.0
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeec---------
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--------- 968 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~--------- 968 (1299)
.++|++.+.||+|+||.||+|.. .+|+.|++|++...+....+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999995 46889999999765556667889999999999999999999876543
Q ss_pred -----cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcc
Q 000757 969 -----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTP 1042 (1299)
Q Consensus 969 -----~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~V 1042 (1299)
...|+||||+. ++|.+++.. ..+.+..++.++.||+.||.|||+.+ |+|||||++||||+. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35689999996 688888742 35889999999999999999999887 999999999999974 5678
Q ss_pred eecCCCcccccccccc-ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhh
Q 000757 1043 KVSDFGLARSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~-~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa 1120 (1299)
||+|||+++....... ........|+..|+|||++.. ..++.++|||||||++|||++|+.||...+...........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999975532111 111123457889999997654 56789999999999999999999999755432211111100
Q ss_pred hccccc--ccccc----eeec-CCCCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1121 RPLLTS--REGLE----RIID-PSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1121 ~plls~--~e~L~----eIVD-p~L~~~~-----p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+.... ...+. ..+. ....... ......++.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 00000 0000 0000000 01233578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=319.07 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=201.9
Q ss_pred CCcceeeEEeecCceEEEEEEecC-CCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
++|++.+.||+|.-|+||++.+++ +..+|+|++.+.. .+...+...|-+||+.++||.+..||..+..++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346778899999999999999764 5789999997643 333446677999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|||.||+|...++.. ....+++..+.-++.+++.||+|||..| ||.|||||+||||.++|.+.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999998653 3456899999999999999999999998 99999999999999999999999998742210
Q ss_pred ---------------------------------ccc---------------------ccccccccccccccCccccccCC
Q 000757 1056 ---------------------------------EES---------------------RHISTRVMGTFGYVAPEYAMTGH 1081 (1299)
Q Consensus 1056 ---------------------------------~~~---------------------~~~st~v~GT~gYmAPE~l~~~~ 1081 (1299)
... ...+...+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01122357999999999999999
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcC
Q 000757 1082 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 1161 (1299)
Q Consensus 1082 ~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~d 1161 (1299)
.+.++|.|.|||+|||||.|.-||.+.+.+.. +..++-..+.-...........+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999987654321 22222222211111245678999999999999
Q ss_pred cCCCCCHHHHHH
Q 000757 1162 VQHRPFMGEVVQ 1173 (1299)
Q Consensus 1162 PskRPSMsEVLq 1173 (1299)
|++|.....-..
T Consensus 376 P~kRlg~~rGA~ 387 (459)
T KOG0610|consen 376 PSKRLGSKRGAA 387 (459)
T ss_pred hhhhhccccchH
Confidence 999998433333
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=332.41 Aligned_cols=245 Identities=26% Similarity=0.447 Sum_probs=203.5
Q ss_pred EEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChhh
Q 000757 907 ILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 985 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d 985 (1299)
+||+|.||+||-|++. +..++|||.+...+....+-+..||.+.++|+|+|||+.+|.|.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999954 566799999987777777788999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC--ChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec-cCCcceecCCCcccccccccccccc
Q 000757 986 HLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHIS 1062 (1299)
Q Consensus 986 ~L~~~~~~~~pL--dw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD-edg~VKLsDFGLAr~~~~~~~~~~s 1062 (1299)
+|+. +..+| .+.+.-.+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.... ....+
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 9963 33456 67788889999999999999887 99999999999996 578999999999886543 33344
Q ss_pred ccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1063 TRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1063 t~v~GT~gYmAPE~l~~~--~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
.+..||..|||||++..+ .|+.++|||||||++.||.||+.||...+...... ++ -++.+ ...
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------Fk--VGmyK-----vHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FK--VGMYK-----VHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hh--hccee-----cCC
Confidence 567799999999999865 58899999999999999999999996543322110 00 01111 123
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.++.+...+...+|.+|+.++|.+||++.++++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 5677888999999999999999999999999764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=291.38 Aligned_cols=236 Identities=30% Similarity=0.349 Sum_probs=192.3
Q ss_pred EeecCceEEEEEEec-CCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 908 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 908 LGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
||+|+||.||++... +++.|++|+++.... ...+.+.+|++++++++|+||+++++.+..++..|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 588999999865322 2455788999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
.+++... ..+++.+++.++.|++.||.|||+.+ ++|+|||++||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 9999532 35899999999999999999999877 9999999999999999999999999997654321 1223
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
...++..|++||.+.+...+.++|||+||+++|||++|+.||..... ..+..... ... ..++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~~~------------~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---KDP------------LRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---cCC------------CCCC
Confidence 45688999999999888899999999999999999999999965432 11111111 000 1122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 223467889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=331.12 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=202.1
Q ss_pred CcceeeEEeecCceEEEEEEecC-CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 901 NFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
.|++...||.|+||+||+|+.++ +-..|.|++........++|+-||+||..++||+||+|++.|+-++.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 36677889999999999999664 44567888876677778899999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
||-++..+-.. ...|.++++.-+++|++.||.|||+.. |||||||..|||++.+|.++|+|||.+..... ..
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99998887433 346999999999999999999999887 99999999999999999999999999864322 12
Q ss_pred cccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1060 HISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.....+.||++|||||+.+ ...|+.++||||||++|.||..+..|....+.- +-+....+ ..-..++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaK--SePPTLl 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK--SEPPTLL 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhh--cCCCccc
Confidence 2234577999999999876 457899999999999999999999987643321 11110000 0001111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-+......|.+++.+||..||..||+..++++.
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 123456789999999999999999999999853
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.87 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=203.3
Q ss_pred HHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccc-----cc---chhHHHHHHHHhhhcc-cccceeeeeeee
Q 000757 897 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD-----QQ---GGREFLAEVEMLSRLH-HRNLVKLIGICI 966 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d-----~~---~~keFlrEIeILsrLr-HPNIVrLlG~~~ 966 (1299)
..-++|+..++||+|..+.|.++. ..+|...|+|++.... .. ..+.-.+|+.||+++. ||+|+.|.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344668888999999999999887 4578889999985321 11 1223457999999985 999999999999
Q ss_pred eccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecC
Q 000757 967 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1046 (1299)
Q Consensus 967 e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsD 1046 (1299)
.+...++|+|.|+.|.|+|+|. ..-.+++++..+|+.|+..|++|||.++ |||||||++|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 9999999999999999999994 3456899999999999999999999887 99999999999999999999999
Q ss_pred CCccccccccccccccccccccccccCccccccC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhh
Q 000757 1047 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1047 FGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~------~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa 1120 (1299)
||+++....+.. ....|||++|+|||.+... .|+...|+|++|||||-||.|..||-... +..+.+
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR-- 238 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLR-- 238 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHH--
Confidence 999998755432 3568999999999988643 47788999999999999999999994321 111111
Q ss_pred hcccccccccceeecCC--CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1121 RPLLTSREGLERIIDPS--LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1121 ~plls~~e~L~eIVDp~--L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.++... +......+......+||.+||+.||.+|-|.+|+++.-.
T Consensus 239 -----------~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 239 -----------MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred -----------HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 111111 112222455678999999999999999999999987643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=313.47 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=197.8
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccc----
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA---- 970 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~---- 970 (1299)
..++|++.+.||+|+||.||+|+.. +++.||||++... +....+++.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999965 5788999998642 23334667889999999999999999998876554
Q ss_pred --eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 971 --RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 971 --~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
.++|+||+ +++|.+++.. ..+++.++++++.|+++||+|||+.+ |+|||||++|||+++++++||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 7799998842 35899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHhhhc----
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARP---- 1122 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~wa~p---- 1122 (1299)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+......
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865332 223457889999998765 46789999999999999999999999754322110 00010000
Q ss_pred ---ccccccccceeecCCC---CCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1123 ---LLTSREGLERIIDPSL---GNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 ---lls~~e~L~eIVDp~L---~~~~---p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.+. .+....+++... ...+ .......+.+++.+||+.+|++||++.||++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 000000100000 0000 01235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=312.99 Aligned_cols=271 Identities=23% Similarity=0.353 Sum_probs=223.9
Q ss_pred HHHHHHHhCCcceeeEEeecCceEEEEEEec------CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeee
Q 000757 892 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGI 964 (1299)
Q Consensus 892 l~ELe~at~nFsi~elLGeGgFGtVYKA~lk------dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~ 964 (1299)
..++.....++++..++.+|.||+||+|.+. +.+.|.||.+++. .+.....++.|--+|..+.|+|+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455555677888889999999999999654 3456788888653 34445678899999999999999999999
Q ss_pred eeec-cceEEEEeecCCCChhhccccccc----CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC
Q 000757 965 CIEE-QARCLVYELIPNGSVESHLHGVDK----ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1039 (1299)
Q Consensus 965 ~~e~-~~~~LVyEYm~GGSL~d~L~~~~~----~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed 1039 (1299)
+.++ +..+++|.++.-|+|..||...+. ..+.++..+...++.|++.||+|||+++ |||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 566889999999999999973221 2345778889999999999999999887 9999999999999999
Q ss_pred CcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHH
Q 000757 1040 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVA 1118 (1299)
Q Consensus 1040 g~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~ 1118 (1299)
.++||+|-.|+|.....++....+.......||++|.+.+..|+.++|||||||+||||+| |+.|+...++.+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---- 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---- 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence 9999999999999998888888888888999999999999999999999999999999999 99998654332211
Q ss_pred hhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1119 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1119 wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
..+....+-..+..|..++..+|.-||...|++||++.|+++-|.+...+.
T Consensus 509 -------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 509 -------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 111222233455678899999999999999999999999999888765543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.59 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=203.3
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.++.|++.++||+|.|+.||+.. ..+|+.+|+|++.. ....+.+++.+|+.|.+.|+|||||+|.+.+.++...|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34668888999999999999988 45789999998742 3445678899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc---CCcceecCCCccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLAR 1051 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe---dg~VKLsDFGLAr 1051 (1299)
+|+|.|++|..-+-. +.-+++...-.+++||+++|.|+|.++ |||||+||+|+||-. .--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876622 234677778889999999999999887 999999999999943 3469999999998
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
...++ .......||++|||||+++...|+..+|||++|||||-||.|+.||.+.. +..+.+.+..-
T Consensus 162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g-------- 227 (355)
T KOG0033|consen 162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAG-------- 227 (355)
T ss_pred EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhcc--------
Confidence 77632 23345679999999999999999999999999999999999999997532 22222221110
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+| +.............+|+++||..||.+|.|..|.++.-
T Consensus 228 -~yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 228 -AYD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred -ccC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 001 11112223446788999999999999999999988653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=356.88 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=204.1
Q ss_pred HHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
...+-++....+||.|.||.||-|. +++|+..|||.++- .+....+.+.+|+.+|..|+|+|||+.+|+-.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3445566677899999999999999 77899999998753 33445667889999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
|.||||++|+|.+.+.. .+.+++.....+..|++.||+|||+.| |||||||+.|||||.+|-+|++|||.|+.
T Consensus 1311 IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999942 334666677778899999999999998 99999999999999999999999999987
Q ss_pred ccccc--cccccccccccccccCccccccCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1053 AMDEE--SRHISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1053 ~~~~~--~~~~st~v~GT~gYmAPE~l~~~~---~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
..... ........+||+.|||||++.+.. -..+.||||||||++||+||+.||...+. +|+--+.
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~--- 1453 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH--- 1453 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH---
Confidence 65431 111223467999999999987543 45788999999999999999999964432 2221111
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+-......++.....+-.+++..||..||++|+++.|+++
T Consensus 1454 ------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 ------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1112223455567778899999999999999988777644
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=327.06 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=208.3
Q ss_pred HHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceE
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~ 972 (1299)
....+.|.+.+.||+|.|++|.+|+ ..++..||||.+++. +......+.+|+++|+.|+|||||+|+.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3456789999999999999999999 456999999999763 2333345889999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+.+|.+++||... ..+.+.+...++.|+.++++|||.++ |||||||.+|||||.+.++||+|||++..
T Consensus 132 lV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 999999999999999643 34556888899999999999999988 99999999999999999999999999987
Q ss_pred ccccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccc
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~~~~-T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~ 1131 (1299)
+. ........||++-|.|||++.+..| +.+.|+||+|++||-|++|..||++.+..+. . .
T Consensus 205 ~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r-----~ 265 (596)
T KOG0586|consen 205 FD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------R-----P 265 (596)
T ss_pred ec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------c-----c
Confidence 74 3344566899999999999998776 5899999999999999999999987543221 1 0
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1132 eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
+.+-..+ .++.-...+..++++++|..+|.+|.++++|.+.-
T Consensus 266 rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 266 RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1111111 23334455678899999999999999999997653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=333.13 Aligned_cols=146 Identities=31% Similarity=0.411 Sum_probs=130.7
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.++|++.++||+|+||+||+|.+. +++.||||+++... ....+++.+|+++++.++|+||+++++++...+..|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999965 68999999997532 22346788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|||+.+++|.++++.. ..+++..+++|+.||+.||+|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998532 35888999999999999999999887 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=279.30 Aligned_cols=238 Identities=29% Similarity=0.383 Sum_probs=193.0
Q ss_pred CceEEEEEEec-CCCEEEEEEeecccccc-hhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccc
Q 000757 912 GFGLVYSGVLD-DGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 989 (1299)
Q Consensus 912 gFGtVYKA~lk-dGr~VAVK~Lk~~d~~~-~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~ 989 (1299)
+||.||+|+.. +|+.|++|++....... .+.+.+|++++++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997654444 67899999999999999999999999999999999999999999999853
Q ss_pred cccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccc
Q 000757 990 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069 (1299)
Q Consensus 990 ~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~ 1069 (1299)
.. .+++.+++.++.+++++|.|||+.+ |+|+||+++||++++++.++|+|||++....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 22 2889999999999999999999887 9999999999999999999999999998664422 223455888
Q ss_pred cccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHH
Q 000757 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1149 (1299)
Q Consensus 1070 gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~e 1149 (1299)
.|++||.+....++.++|||+||+++|||++|..||.... ....+.++........ .........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~------------~~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPPF------------PPPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCC------------ccccccCCHH
Confidence 9999999988889999999999999999999999986531 1222222221110000 0000014467
Q ss_pred HHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1150 VAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1150 L~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=308.89 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=207.5
Q ss_pred cceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCC
Q 000757 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~G 980 (1299)
|+++++||+|.||.|||+. .+.|..||||.+-. +.+.+++.+||.|+.+++.++||++||.|.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 7788999999999999999 45799999999863 33457899999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|++.+.++. ++.+|.++++..|+...++||+|||... -||||||..||||+.+|.+||+|||.|..+.+.. .
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 999999853 4568999999999999999999999875 7999999999999999999999999998765421 2
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee-cCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII-DPSLG 1139 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV-Dp~L~ 1139 (1299)
...++.||+.|||||++..-.|..++||||||++..||..|+.||.+... ...+.-+- .+-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCCC
Confidence 23457899999999999999999999999999999999999999965321 11111111 11111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-..++....+|-++++.||...|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12345677899999999999999999999999865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=325.81 Aligned_cols=272 Identities=25% Similarity=0.373 Sum_probs=208.4
Q ss_pred CcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeeecc------ceE
Q 000757 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~------~~~ 972 (1299)
.+...+.||+|+||.||+|+ .++|+.||||.++.. .....+...+|+++|++|+|+|||+++|+-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35567899999999999999 668999999999763 3344567889999999999999999999866543 458
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec--cCC--cceecCCC
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDF--TPKVSDFG 1048 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD--edg--~VKLsDFG 1048 (1299)
+|||||.||+|+.+|+.... ...|.+.+.+.++.+++.||.|||+++ ||||||||.||++- ++| -.||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999976543 346999999999999999999999887 99999999999993 233 47999999
Q ss_pred ccccccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc-
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 1126 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~- 1126 (1299)
+|+...++. ....++||..|++||+... +.|+..+|.|||||++||++||..||..........-+.|. ...+
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKK 244 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccC
Confidence 999775432 5567889999999998884 88999999999999999999999999765544322112222 1221
Q ss_pred ccccceeecCCCCCC------------CChhhHHHHHHHHHHhcCcCcCCCC--CHHHHHHHHHHHHhh
Q 000757 1127 REGLERIIDPSLGND------------VPFDSVAKVAAIASMCVQPEVQHRP--FMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~------------~p~ee~~eL~~LI~~CL~~dPskRP--SMsEVLq~Lk~I~~e 1181 (1299)
...+.-.++....+. .......++...+..+|..++++|. .+.++...+..+++.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111122221111 1123345677788888888999999 778888777777653
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=328.85 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=191.5
Q ss_pred eeeEEeecCceEEEEEEec-CCCEEEEEEee--cc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccc--eEEEEe
Q 000757 904 ASRILGEGGFGLVYSGVLD-DGTKVAVKVLK--RV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYE 976 (1299)
Q Consensus 904 i~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk--~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~--~~LVyE 976 (1299)
...+||+|+|-+||||.+. +|..||--.++ +. +....++|..|+.+|+.|+|+|||++++++.+... +-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999964 57777654443 22 23344789999999999999999999999987665 678999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCCCccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDFGLAr~~~~ 1055 (1299)
.+..|+|+.|+++. +.++...+.+|+.||++||.|||++ .++|||||||.+||+|+.+ |.|||+|+|||+....
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999644 3578889999999999999999998 5899999999999999864 8999999999987643
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc--cccccee
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REGLERI 1133 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~--~e~L~eI 1133 (1299)
. ....+.||+.|||||+.. ..|.+..||||||++|+||+|+..||..-.. -..-++..... -..+.++
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCCCHHHhhcc
Confidence 2 223478999999999766 7899999999999999999999999853321 11111111111 0111111
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
- .-++.+||.+|+.. .++|+++.|+++.
T Consensus 269 ~------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 K------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 24688999999999 9999999999754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=338.96 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=190.3
Q ss_pred HHHhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcccccceeeeeeeee------
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE------ 967 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e------ 967 (1299)
.+...+|+..++||+||||.|||++.+ ||+.||||++.-. .......+++|++.|.+|+|+|||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 466778999999999999999999965 7999999998532 45556788999999999999999998821100
Q ss_pred --------------------------------------------------------------------------------
Q 000757 968 -------------------------------------------------------------------------------- 967 (1299)
Q Consensus 968 -------------------------------------------------------------------------------- 967 (1299)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHH
Q 000757 968 -------------------------E--------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014 (1299)
Q Consensus 968 -------------------------~--------~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALa 1014 (1299)
+ ..+||-||||+..+|.++++...-. -.-+..|+++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 0 1246778999888888887532211 146788999999999999
Q ss_pred HhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc------c----------cccccccccccccccccCccccc
Q 000757 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM------D----------EESRHISTRVMGTFGYVAPEYAM 1078 (1299)
Q Consensus 1015 YLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~------~----------~~~~~~st~v~GT~gYmAPE~l~ 1078 (1299)
|+|+.| ||||||||.||+||+++.|||+|||+|+... + +......+..+||..|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999998 9999999999999999999999999998621 0 01111235578999999999887
Q ss_pred cC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHH
Q 000757 1079 TG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIAS 1155 (1299)
Q Consensus 1079 ~~---~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~ 1155 (1299)
+. .|+.|.|+|||||||+||+. ||...- +..... ..+. ...+.. ..++.......=..+|+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL----~~LR-~g~iP~------~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASIL----TNLR-KGSIPE------PADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHH----Hhcc-cCCCCC------CcccccccchHHHHHHH
Confidence 54 59999999999999999985 354211 111111 1111 111110 01233344556678999
Q ss_pred HhcCcCcCCCCCHHHHHH
Q 000757 1156 MCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1156 ~CL~~dPskRPSMsEVLq 1173 (1299)
++++.||.+|||+.|+++
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.83 Aligned_cols=222 Identities=20% Similarity=0.197 Sum_probs=176.5
Q ss_pred cCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccc
Q 000757 911 GGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 989 (1299)
Q Consensus 911 GgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~ 989 (1299)
|.||.||+++. .+++.||+|+++... .+.+|...+....|+||+++++++.+.+..++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468899999997532 234455555566799999999999999999999999999999999853
Q ss_pred cccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccc
Q 000757 990 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069 (1299)
Q Consensus 990 ~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~ 1069 (1299)
...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 235899999999999999999999887 999999999999999999999999987654321 12334677
Q ss_pred cccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHH
Q 000757 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1149 (1299)
Q Consensus 1070 gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~e 1149 (1299)
.|+|||++....++.++|||||||++|||++|+.+++..... .... . ....+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~---~-------~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH---T-------TLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc---c-------ccCCcccCCHH
Confidence 899999998888999999999999999999999876432110 0000 0 00112223467
Q ss_pred HHHHHHHhcCcCcCCCCCHHHH
Q 000757 1150 VAAIASMCVQPEVQHRPFMGEV 1171 (1299)
Q Consensus 1150 L~~LI~~CL~~dPskRPSMsEV 1171 (1299)
+.+++.+||+.||++|+++.+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCcc
Confidence 8999999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=308.90 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=202.4
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LV 974 (1299)
.+.|+.-++||+||||.||-++ ..+|+-+|+|++.+. ..+.+...++|-.||.+++.+.||.|--.|...+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3678889999999999999988 457999999998542 344455678999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
+..|+||+|.-+|.+. .+..+++...+-++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999888643 3356899999999999999999999887 9999999999999999999999999999775
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
++.. ....+||.||||||++.++.|+...|.|+|||+||||+.|+.||....... .| +.+++.+
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~--------eEvdrr~ 402 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KR--------EEVDRRT 402 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hH--------HHHHHHH
Confidence 5332 223479999999999999999999999999999999999999997543322 11 0011110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMs 1169 (1299)
.. ....++.....+..+|....|..||++|..-.
T Consensus 403 ~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00 01134445566788889999999999997544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=300.30 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=197.6
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
..++|+.+++||+|.||+|.+++ ..+|+.+|+|+|++.-. +....-+.|-++|+..+||.+..|.-.|...+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34789999999999999999998 45799999999986432 333445679999999999999999988999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.||.|+-+|.. ...++++....+-..|+.||.|||+++ ||.||||.+|+|||.||.+||+||||++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999843 345777777778889999999999887 999999999999999999999999999854
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.. +.....+.|||+.|+|||++....|+...|.|.+|||+|||++|+.||...+.+.. .+.+. . +
T Consensus 319 I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---FeLIl---~-----e-- 383 (516)
T KOG0690|consen 319 IK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FELIL---M-----E-- 383 (516)
T ss_pred cc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HHHHH---h-----h--
Confidence 32 22334568999999999999999999999999999999999999999975433221 11110 0 0
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP 1166 (1299)
| -.++.....+...|+.-.|..||++|.
T Consensus 384 -d----~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -D----LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -h----ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0 134444556778889999999999996
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=294.45 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=195.4
Q ss_pred eeEEeecCceEEEEEEec-CCCEEEEEEeecc-cccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEeecCCC
Q 000757 905 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~-d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+..||.|..|.||+++.+ +|...|||.+.+. +.++.++++..+.++.+-+ .++||+.+|||..+...++.||.| .-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 457999999999999954 6889999999654 4556678888888877765 899999999999999999999999 44
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~ 1061 (1299)
.++.+|+. ...++.+..+-++...+++||.||.++. +|||||+||+|||+|+.|++||||||++..+.+.. .
T Consensus 176 C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 176 CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 45555542 2346888889999999999999999875 79999999999999999999999999998765422 2
Q ss_pred cccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec---
Q 000757 1062 STRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID--- 1135 (1299)
Q Consensus 1062 st~v~GT~gYmAPE~l~---~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD--- 1135 (1299)
.++..|-..|||||.+. ...|+.++||||||+.|+||.||+.||...+.+ .+. +.++++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~--------------ltkvln~eP 312 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEV--------------LTKVLNEEP 312 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHH--------------HHHHHhcCC
Confidence 34556889999999876 347899999999999999999999999764321 111 111221
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
+.+.+ .......|.+++..||..|+.+||...++++.-.
T Consensus 313 P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 313 PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 22221 1225678999999999999999999999987643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=316.64 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=213.5
Q ss_pred CCHHHHHHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeee
Q 000757 890 FSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 967 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e 967 (1299)
..++.+..-++.|++.++||+|.+|.||+++ .++|+.+|+|++.- +.+..+++..|.+||+.+ +|+|++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444555567889999999999999999999 67789999999863 455567888999999988 59999999999864
Q ss_pred -----ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcc
Q 000757 968 -----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 968 -----~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
++++|||||||.+|+..|++++.. ...+.|..+..|+.++++||.+||+.. ++|||||-.||||+.++.|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 578899999999999999998765 567999999999999999999999776 9999999999999999999
Q ss_pred eecCCCccccccccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhH
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~-----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV 1117 (1299)
||+|||++..... ......+..||+.|||||++.. ..|+.++|+||||++..||--|..|+.+.-.-
T Consensus 163 KLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------ 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------ 234 (953)
T ss_pred EEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------
Confidence 9999999986643 2233445679999999998864 35778999999999999999999998653221
Q ss_pred Hhhhcccccccccceee-cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1118 AWARPLLTSREGLERII-DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1118 ~wa~plls~~e~L~eIV-Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+..+. .+-..-.-+....++|.++|..||..|-++||++.++++.
T Consensus 235 ----------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ----------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 1222223345678899999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=310.92 Aligned_cols=262 Identities=18% Similarity=0.251 Sum_probs=183.9
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-----------------cCCCEEEEEEeecccccchhH--------------HHHH
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-----------------DDGTKVAVKVLKRVDQQGGRE--------------FLAE 946 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-----------------kdGr~VAVK~Lk~~d~~~~ke--------------FlrE 946 (1299)
..++|++.++||+|+||+||+|.+ .+++.||||+++.......++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 245689999986433222223 3457
Q ss_pred HHHhhhcccccc-----eeeeeeeee--------ccceEEEEeecCCCChhhccccccc--------------------C
Q 000757 947 VEMLSRLHHRNL-----VKLIGICIE--------EQARCLVYELIPNGSVESHLHGVDK--------------------E 993 (1299)
Q Consensus 947 IeILsrLrHPNI-----VrLlG~~~e--------~~~~~LVyEYm~GGSL~d~L~~~~~--------------------~ 993 (1299)
+.++.+++|.++ +++++||.. ++..||||||+.+|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 678888753 3567999999999999999874211 1
Q ss_pred CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccccC
Q 000757 994 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073 (1299)
Q Consensus 994 ~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmA 1073 (1299)
...++|..++.|+.|++.+|.|||+.+ |+|||||++|||++.++.+||+|||+++....... .......+++.|++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123578889999999999999999887 99999999999999999999999999975533211 11122345789999
Q ss_pred ccccccCC--------------------C--CccccchhhHHHHHHHHhCCC-CCCCCCCCc------hhhhHHhhhccc
Q 000757 1074 PEYAMTGH--------------------L--LVKSDVYSYGVVILELLSGRK-PVDMTQPPG------QENLVAWARPLL 1124 (1299)
Q Consensus 1074 PE~l~~~~--------------------~--T~KSDVWSLGVVLyELLTGr~-PFd~s~~~~------~~nLV~wa~pll 1124 (1299)
||.+.... + ..+.||||+|||||||++|.. +|....... ...+..|.. .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence 99875322 1 235799999999999999875 664321110 111222211 0
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCc---CCCCCHHHHHHH
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEV---QHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dP---skRPSMsEVLq~ 1174 (1299)
... .++- ...........+|+.+||..++ .+|+|+.|++++
T Consensus 457 ~~~-----~~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQ-----KYDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccc-----CCCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 0010 1112234667889999998765 689999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=305.30 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=198.8
Q ss_pred HHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEee--c-cccc----chhHHHHHHHHhhhcccccceeeeeeee-e
Q 000757 897 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--R-VDQQ----GGREFLAEVEMLSRLHHRNLVKLIGICI-E 967 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk--~-~d~~----~~keFlrEIeILsrLrHPNIVrLlG~~~-e 967 (1299)
...++|-++++||+|||+.||||. +...+.||||+-. + +.++ -.+...+|..|.+.|+|+.||++|+|+. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 344678888999999999999998 5667889999853 1 2111 1234578999999999999999999985 5
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc---CCccee
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKV 1044 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe---dg~VKL 1044 (1299)
.+.+|-|+|||+|.+|+-||+. ...+++.+...|+.||+.||.||.+. +++|||-||||.||||-. .|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6788999999999999999953 44689999999999999999999998 688999999999999943 588999
Q ss_pred cCCCcccccccccccc-----ccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh
Q 000757 1045 SDFGLARSAMDEESRH-----ISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~~-----~st~v~GT~gYmAPE~l~~~----~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n 1115 (1299)
+||||++.+.++.+.+ ++....||++|++||++.-+ +.+.|+||||+|||+|.++.|++||..... ++.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHH
Confidence 9999999876544432 34456799999999988755 578999999999999999999999976432 222
Q ss_pred hHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHH
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1171 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEV 1171 (1299)
+..+- ..+...+. .+ ........+..++|++||...-++|-...++
T Consensus 693 ILqeN-TIlkAtEV-------qF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 ILQEN-TILKATEV-------QF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HHhhh-chhcceec-------cC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 22211 11111110 01 0111234567889999999999999776665
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=294.68 Aligned_cols=207 Identities=24% Similarity=0.321 Sum_probs=169.5
Q ss_pred HhCCcceeeEEeecCceEEEEEEecC-----CCEEEEEEeeccccc--chhHHHHHHHHhhhcccccceeeeeeeee-cc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGICIE-EQ 969 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lkd-----Gr~VAVK~Lk~~d~~--~~keFlrEIeILsrLrHPNIVrLlG~~~e-~~ 969 (1299)
....|+....||+|.||.||||+.++ .+.+|||+++...+. ......|||.+++.|+|+||+.|..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34569999999999999999997332 236899999754322 22356799999999999999999999987 78
Q ss_pred ceEEEEeecCCCChhhccccccc-CCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC----Cccee
Q 000757 970 ARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKV 1044 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~-~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed----g~VKL 1044 (1299)
.++|++||.+ -+|.+.++..+. +...+.-..+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 8899999995 577777754322 2346888999999999999999999998 9999999999999877 99999
Q ss_pred cCCCccccccccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 000757 1045 SDFGLARSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMT 1108 (1299)
Q Consensus 1045 sDFGLAr~~~~~~~~-~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s 1108 (1299)
+|||++|.+...-.. .....++-|++|.|||++.+ ..||.+.|||+.|||+.||++-+.-|...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999987653222 23456788999999998876 56899999999999999999987777543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=315.06 Aligned_cols=262 Identities=20% Similarity=0.218 Sum_probs=171.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-C----CCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeee------ee
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-D----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI------CI 966 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-d----Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~------~~ 966 (1299)
..++|++.++||+|+||.||+|++. + +..||||+++.... .+.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 4 68999999864221 1111111 1222222233322221 24
Q ss_pred eccceEEEEeecCCCChhhcccccccC----------------CCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeeccc
Q 000757 967 EEQARCLVYELIPNGSVESHLHGVDKE----------------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1030 (1299)
Q Consensus 967 e~~~~~LVyEYm~GGSL~d~L~~~~~~----------------~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIK 1030 (1299)
++...+|||||+.+++|.++++..... .....+..+..|+.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988642100 011223446689999999999999887 9999999
Q ss_pred ccCeeecc-CCcceecCCCccccccccccccccccccccccccCccccccC----------------------CCCcccc
Q 000757 1031 SSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----------------------HLLVKSD 1087 (1299)
Q Consensus 1031 PsNILLDe-dg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~----------------------~~T~KSD 1087 (1299)
|+||||++ ++++||+|||+++...... .......+|+..|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998653322 2233456789999999965321 2445779
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCC-------chhhhHHhhhcccccccccceeecCCCCC--CCChhhHHHHHHHHHHhc
Q 000757 1088 VYSYGVVILELLSGRKPVDMTQPP-------GQENLVAWARPLLTSREGLERIIDPSLGN--DVPFDSVAKVAAIASMCV 1158 (1299)
Q Consensus 1088 VWSLGVVLyELLTGr~PFd~s~~~-------~~~nLV~wa~plls~~e~L~eIVDp~L~~--~~p~ee~~eL~~LI~~CL 1158 (1299)
|||||||||||+++..+++..... ....+..|....... ....+.. ...........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987665421100 001122232111100 0000000 000111234568999999
Q ss_pred CcCcCCCCCHHHHHHH
Q 000757 1159 QPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1159 ~~dPskRPSMsEVLq~ 1174 (1299)
+.||++|||+.|+++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=322.36 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=209.8
Q ss_pred HHHHHHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeee
Q 000757 892 ASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 892 l~ELe~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e 967 (1299)
..+++...++|+++++||+|+||.|..++. .+++.||+|++.++ ......-|..|-++|..-+.+=||+|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 445666778999999999999999999995 46889999999873 33445678889999999899999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
+.++|||||||.||+|..+|..++ .++++....++..|+.||.-||+.| +|||||||+|||||.+|.+||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999995443 5889999999999999999999888 999999999999999999999999
Q ss_pred CccccccccccccccccccccccccCccccc----c-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAM----T-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~----~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p 1122 (1299)
|.+-.+.. +....+...+||+.|++||++. + +.|+..+|.||+||++|||+.|..||.. +.+++-+..
T Consensus 220 GsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~K 292 (1317)
T KOG0612|consen 220 GSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGK 292 (1317)
T ss_pred hhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHH
Confidence 98866543 2333455668999999999886 2 6789999999999999999999999964 455555544
Q ss_pred ccccccccceeecCCCCCCCC--hhhHHHHHHHHHHhcCcCcCCCCC---HHHHHHHH
Q 000757 1123 LLTSREGLERIIDPSLGNDVP--FDSVAKVAAIASMCVQPEVQHRPF---MGEVVQAL 1175 (1299)
Q Consensus 1123 lls~~e~L~eIVDp~L~~~~p--~ee~~eL~~LI~~CL~~dPskRPS---MsEVLq~L 1175 (1299)
.+.-.+.+ .++ .+...+..+||++.+. +++.|.. +.++....
T Consensus 293 Im~hk~~l----------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 293 IMNHKESL----------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred Hhchhhhc----------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 44332211 222 3356678888887654 5677777 77776553
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-31 Score=288.96 Aligned_cols=267 Identities=23% Similarity=0.358 Sum_probs=202.4
Q ss_pred CHHHHHHHhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeeec
Q 000757 891 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE 968 (1299)
Q Consensus 891 sl~ELe~at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~ 968 (1299)
.++++-+.| .++||+|+|+.|--++ +.+|.++|||++.+.......++.||++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666655 4689999999999888 7889999999998776677889999999999996 99999999999999
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC---cceec
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVS 1045 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg---~VKLs 1045 (1299)
+..|||||.|.||.|..++++ ..-+++.+..+++.+|+.||.|||.+| |.||||||+|||...-. -+|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999963 345889999999999999999999988 99999999999996543 58999
Q ss_pred CCCccccccccc-c----ccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhh
Q 000757 1046 DFGLARSAMDEE-S----RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1046 DFGLAr~~~~~~-~----~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~n 1115 (1299)
||.|........ . .....+-+|+..|||||+.. ...|+.+.|.||||||||-||+|+.||.+.-..+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-- 299 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-- 299 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--
Confidence 999875332111 1 11123457999999999653 23578899999999999999999999976533221
Q ss_pred hHHhhhcccccccccceeecCCCCC--CCChh----hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGN--DVPFD----SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1116 LV~wa~plls~~e~L~eIVDp~L~~--~~p~e----e~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-|-+-...+ ....+++.....+ .++++ ...+..+++...+..++.+|.+..++++.
T Consensus 300 --GWdrGe~Cr-~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 300 --GWDRGEVCR-VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred --CccCCCccH-HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 121110000 0000111111111 23333 34567789999999999999999998874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=286.26 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=197.3
Q ss_pred HhCCccee-eEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeee----ccc
Q 000757 898 ATGNFDAS-RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIE----EQA 970 (1299)
Q Consensus 898 at~nFsi~-elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e----~~~ 970 (1299)
++++|++. ++||-|-.|+|..+. ..+|+.+|+|+|.+. ...++|+++.-+.. |+|||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677764 579999999999988 457899999999642 35678999877774 9999999999864 445
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc---CCcceecCC
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 1047 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe---dg~VKLsDF 1047 (1299)
+++|||.|+||.|+..+.. .....+++.+.-.|+.||..|+.|||..+ |.||||||+|+|... |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 6789999999999999954 34557999999999999999999999887 999999999999964 567999999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
|+|+.... .....+-|-|+.|+|||++...+|+...|+||+||++|-||+|..||......- +. +-++
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is----pgMk-- 276 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS----PGMK-- 276 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC----hhHH--
Confidence 99986532 223345678999999999999999999999999999999999999997543210 00 0000
Q ss_pred cccceeecCCCCCCCCh----hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPF----DSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~----ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.+|... .-.++. ...+...++|+.+|.-+|.+|.|+.|++..-+
T Consensus 277 ---~rI~~g--qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 277 ---RRIRTG--QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ---hHhhcc--CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 011100 012232 33467788999999999999999999976543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=249.28 Aligned_cols=210 Identities=37% Similarity=0.592 Sum_probs=182.3
Q ss_pred EeecCceEEEEEEecC-CCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChhh
Q 000757 908 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 985 (1299)
Q Consensus 908 LGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d 985 (1299)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++++++++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999999754322 35689999999999999999999999999899999999999999999
Q ss_pred cccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCcccccccccccccccc
Q 000757 986 HLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTR 1064 (1299)
Q Consensus 986 ~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr~~~~~~~~~~st~ 1064 (1299)
++.... ..+++..++.++.+++++|+|||+.+ ++|+||++.||+++. +++++|+|||++........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 985321 35889999999999999999999887 999999999999999 89999999999986543221 1233
Q ss_pred ccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCC
Q 000757 1065 VMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143 (1299)
Q Consensus 1065 v~GT~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p 1143 (1299)
..+...|++||.+... ..+.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999998877 888999999999999999
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1144 ~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..+.+++..|++.+|++|+++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=300.05 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=195.8
Q ss_pred eeEEeecCceEEEEEE-ecCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000757 905 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+++||.|.||+||-|+ .++|+.||||++.+. ....+.++++|+.||.+++||.||.|...|+..+.+++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 5789999999999999 668999999999754 3445578899999999999999999999999999999999999 45
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC---CcceecCCCcccccccccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed---g~VKLsDFGLAr~~~~~~~ 1058 (1299)
++.+.+- ..++.+|.+..-..++.||+.||.|||.++ |+|+||||+||||... -++||||||+||...+.
T Consensus 648 DMLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 5555542 345567888888889999999999999988 9999999999999654 47999999999988553
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
.....++||+.|+|||+++++.|...-|+||.|||+|.-|+|.-||..... +.+.+.. ..=++-+
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQN-------AaFMyPp-- 785 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQN-------AAFMYPP-- 785 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhc-------cccccCC--
Confidence 334568899999999999999999999999999999999999999964321 1111110 0001111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.-..+......+||...|+..-.+|-+.++.+...
T Consensus 786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 11234445677888888888888998888776553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-32 Score=291.86 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=193.7
Q ss_pred eeEEeecCceEEEEEEe-cCCCEEEEEEeeccc-ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecCCC
Q 000757 905 SRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+..||.|.||+|+|-.. ..|+..|||+++... ..+.++++.|.+...+- +.+|||+++|.+..++.+|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 45899999999999884 479999999997543 35567888998887665 6999999999999999999999999 45
Q ss_pred Chhhcccc-cccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 982 SVESHLHG-VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 982 SL~d~L~~-~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
+|+.+... +...+..+.+..+-+|...+++||.||.+.- +||||||||+|||||..|.+||||||++..+.+ ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 66544321 2234456888989999999999999998764 699999999999999999999999999876533 12
Q ss_pred ccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~--~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L 1138 (1299)
..+...|-.-|||||.+.. ..|+.++||||||++|||+.||+.||...+ ++.+.+...... .-..+ ..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~g--dpp~l-~~-- 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIG--DPPIL-LF-- 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcC--CCCee-cC--
Confidence 2344567889999998763 348999999999999999999999997542 222222211111 11111 10
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
..-..+....+..++..|+.+|-.+||.+.++.+.
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11113456789999999999999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=302.46 Aligned_cols=243 Identities=23% Similarity=0.249 Sum_probs=196.5
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.++.|++...||.|.|+.|-++. ..+++..+||++.+. ..+-.+|+.++.+. +|+||+++.+.|.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888899999999999888 456888999999754 22344678777776 5999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee-ccCCcceecCCCcccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL-Dedg~VKLsDFGLAr~~~ 1054 (1299)
|++.|+-|.+.+... .....++..|+.+|+.+|.|||++| ||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999988877421 2233778889999999999999987 9999999999999 588999999999998764
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.. ..+-+-|..|.|||++....|+.++|+||||++|||||+|+.||...-.. ..+ .
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-----------------~ 523 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-----------------H 523 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-----------------H
Confidence 43 23345688999999999999999999999999999999999999754221 111 1
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.....+.+.........+|+..||+.||.+|++|+|+...-.
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 111112233455678899999999999999999999976533
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=294.82 Aligned_cols=213 Identities=27% Similarity=0.374 Sum_probs=178.5
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccc---cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.-|..++.||-|+||+|.++. .++...+|+|.|++.+. .....++.|-+||...+.+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458889999999999999998 56667799999976443 33445778999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||++||++-.+|.+ ...+.++....++.++..|+++.|..| +|||||||+|||||.+|.+||+||||+.-+..
T Consensus 709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999853 346888888889999999999999887 99999999999999999999999999853211
Q ss_pred --------ccc--------------------------------ccccccccccccccCccccccCCCCccccchhhHHHH
Q 000757 1056 --------EES--------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVI 1095 (1299)
Q Consensus 1056 --------~~~--------------------------------~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVL 1095 (1299)
+.. ..+....+||..|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 000 0011236799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCc-hhhhHHh
Q 000757 1096 LELLSGRKPVDMTQPPG-QENLVAW 1119 (1299)
Q Consensus 1096 yELLTGr~PFd~s~~~~-~~nLV~w 1119 (1299)
|||+.|+.||......+ +..+..|
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh
Confidence 99999999998776654 3344555
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=259.69 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=196.4
Q ss_pred CCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeeccc--ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.+|+..++||+|.||+||||+ .++++.||+|+++-.+ +..-...++||.+|+.|+|+|||+++++...+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356777899999999999999 5678999999986432 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|| .-+|..|... -+..++.+....++.|+++||.|+|+++ +.|||+||.|+||+.+|++||+|||+++-+.-
T Consensus 82 ~c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi- 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI- 153 (292)
T ss_pred Hh-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC-
Confidence 99 4567766643 3456899999999999999999999887 99999999999999999999999999986542
Q ss_pred ccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhccccc--ccccce
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS--REGLER 1132 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l~~~~-~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~--~e~L~e 1132 (1299)
.... ....+-|.+|..|+++.+.+ |+...|+||-|||+.||.. |+.-|.+.+..++...+-|......+ ...+.+
T Consensus 154 pvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred ceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 1222 23355799999999887654 6788899999999999997 77777665544433333333222211 112223
Q ss_pred eecCCCCCCCCh---------hhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1133 IIDPSLGNDVPF---------DSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1133 IVDp~L~~~~p~---------ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+-|-....-++. .....=.+++++.+.-+|.+|.++++.+|
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 323222111211 11123356777777778999988887765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=284.91 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=194.4
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc---ccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~ 972 (1299)
...+|..+.+||+|.||+|.+|..+ +.+.+|||+|++.- .++.+--+.|-++|... +-+.+++|+.++..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457999999999999999999855 56789999997632 22223335677777665 5789999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+.||+|--++.+.. .+.+...+-++.+||-||-|||+++ ||.||||.+|||||.+|.+||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999988886543 4667788899999999999999888 99999999999999999999999999985
Q ss_pred ccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
..-+ ...+.+.|||+.|+|||++....|+..+|.|||||+|||||.|+.||+..++++. ...
T Consensus 500 ni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----------------F~a 561 (683)
T KOG0696|consen 500 NIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------------FQA 561 (683)
T ss_pred cccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHH
Confidence 4332 2334568999999999999999999999999999999999999999987543221 111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1167 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS 1167 (1299)
|.+... .++.....+...+....|...|.+|..
T Consensus 562 I~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 222211 344455677888888889999999954
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=295.62 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=201.1
Q ss_pred CCcceeeEEeecCceEEEEEEecCCC-EEEEEEeec---ccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGT-KVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr-~VAVK~Lk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.+++....||-|+||.|=++..+..+ .+|+|++++ ++....+.+..|-.||...+.+.||+||..|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45556678999999999998877444 388998865 35555677889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|-|-||.|...|+ ++..++..+...++..+.+|++|||+++ ||.|||||+|+|||.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999995 3456888899999999999999999998 99999999999999999999999999998855
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeec
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVD 1135 (1299)
+.. +.+.|||+.|+|||++.+...+..+|.|+||+++||||+|..||...++-...+++ ++.. +.+
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGi---d~i-- 638 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGI---DKI-- 638 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhh---hhh--
Confidence 433 45689999999999999999999999999999999999999999876544333221 1111 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1167 (1299)
Q Consensus 1136 p~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS 1167 (1299)
.++........+|+++....+|.+|..
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 233445566788888888999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=249.72 Aligned_cols=199 Identities=36% Similarity=0.484 Sum_probs=172.0
Q ss_pred cceeeEEeecCceEEEEEEecC-CCEEEEEEeeccccc-chhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecC
Q 000757 902 FDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678999999999999999764 889999999764443 56789999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+++|.+++..... .+++..++.++.+++++|.|||+.+ ++|+||+++||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 9999999854221 1789999999999999999999887 99999999999999999999999999987644321
Q ss_pred cccccccccccccCcccc-ccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l-~~~~~T~KSDVWSLGVVLyELLTGr~PFd~ 1107 (1299)
.......++..|++||.+ ....++.++|||+||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335678899999988 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=283.68 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=200.7
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhccc--c----cceeeeeeeeeccc
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH--R----NLVKLIGICIEEQA 970 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrH--P----NIVrLlG~~~e~~~ 970 (1299)
.+++|.+..+||+|.||.|.++.+. .++.||||+++..+.. .+..+-||++|.+|.+ | -+|.+.+||.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999844 4788999999876543 3455679999999942 2 27888899999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc------------
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH------------ 1038 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe------------ 1038 (1299)
.|||+|.+ |-+++++|... .-.++..+++..|+.|++++|+|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 77999999643 2346888999999999999999999887 999999999999931
Q ss_pred --------CCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 000757 1039 --------DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1110 (1299)
Q Consensus 1039 --------dg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~ 1110 (1299)
+..|||+|||.|+...+.. ..++.|..|.|||++.+..++..+||||+||||+||++|..-|+....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3468999999998643322 456789999999999999999999999999999999999998876542
Q ss_pred CchhhhHHhhh--------------cccccc----------cccceeecCCC----CCCCChhhHHHHHHHHHHhcCcCc
Q 000757 1111 PGQENLVAWAR--------------PLLTSR----------EGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEV 1162 (1299)
Q Consensus 1111 ~~~~nLV~wa~--------------plls~~----------e~L~eIVDp~L----~~~~p~ee~~eL~~LI~~CL~~dP 1162 (1299)
.+...+.+.+. ..+... ..+..+.+... .......+..+|.+|+++||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 22111111110 000000 00011111110 011224556789999999999999
Q ss_pred CCCCCHHHHHHH
Q 000757 1163 QHRPFMGEVVQA 1174 (1299)
Q Consensus 1163 skRPSMsEVLq~ 1174 (1299)
.+|.|+.|+++.
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=271.28 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=198.4
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~L 973 (1299)
.++|+++++||+|.|++|..+++ ++.+.+|+|++++. ++++.+=+..|-.+..+. +||.+|.|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 47899999999999999999995 46788999999763 223333345677777766 69999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|.||++||+|--++.+ ...|.++....+..+|..||.|||++| ||.||||.+|||||.+|.+||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999777743 335889999999999999999999998 999999999999999999999999999854
Q ss_pred cccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCc-hhhhHHhhhcccccccccce
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-QENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~-~~nLV~wa~plls~~e~L~e 1132 (1299)
.. ....+.+.|||+.|+|||++++..|....|.|+|||+++||+.|+.||+...-+. .+|-.++.-..+
T Consensus 402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-------- 471 (593)
T KOG0695|consen 402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-------- 471 (593)
T ss_pred CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------
Confidence 33 2234567899999999999999999999999999999999999999998654222 223333322211
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRP 1166 (1299)
++..+ .++.....+...+++.-|+.||++|.
T Consensus 472 -lekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 -LEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -hhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11111 23444455677788899999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=297.08 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=189.1
Q ss_pred cceeeEEeecCce-EEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEEeecC
Q 000757 902 FDASRILGEGGFG-LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 902 Fsi~elLGeGgFG-tVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
|.-.+++|.|..| .||+|.++ |+.||||++-. ...+...+||..|+.- +|+|||++++.-.+++..||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3345678999988 57999999 88999999853 2334567999999888 4999999999888899999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-----CCcceecCCCcccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-----dg~VKLsDFGLAr~~~ 1054 (1299)
..+|.+++.....+.....-...+.+..|++.||++||..+ ||||||||.||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 78999999753111111121455778899999999999877 999999999999975 3589999999999876
Q ss_pred cccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1055 DEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1055 ~~~~~~-~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.+.... .....-||-||+|||++....-+...||||||||+|+.++ |..||...... +.|+ +..+..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI-------l~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI-------LTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh-------hcCccceee
Confidence 543321 2345679999999999998888889999999999999999 48999764322 1221 111222221
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+-. ..++ +..+||.+|++.+|..||++.+|+..
T Consensus 735 L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 LEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 110 1122 78899999999999999999999854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-30 Score=274.40 Aligned_cols=269 Identities=21% Similarity=0.309 Sum_probs=196.1
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeee--------c
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--------E 968 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e--------~ 968 (1299)
+.|+...+||+|.||+||+|+. ++|+.||+|++-- .....-...++|+++|..|+|+|++.|++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466677999999999999994 4678889887532 222233456899999999999999999999864 2
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
..+||||++|+ -+|.-.|.. ....++..++.+++.++..||.|+|+.. |+|||+|+.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 34799999995 467777632 3356889999999999999999999887 9999999999999999999999999
Q ss_pred cccccccccc--ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH-------
Q 000757 1049 LARSAMDEES--RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA------- 1118 (1299)
Q Consensus 1049 LAr~~~~~~~--~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~------- 1118 (1299)
+++.+...+. ....+..+-|.+|+.||.+.+ +.|+.+.|||+-||||.||++|..-+.......+..++.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9976543221 222344557999999997764 678999999999999999999998887665444333222
Q ss_pred -hhhcccccccccceee-cCCCCCCCC--hhh------HHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1119 -WARPLLTSREGLERII-DPSLGNDVP--FDS------VAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1119 -wa~plls~~e~L~eIV-Dp~L~~~~p--~ee------~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
.+|+........+.+- .+...+.+. .+. -.+.++|+..++..||.+|+..++++...
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2233222222111110 101111110 111 13678899999999999999999987653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=256.40 Aligned_cols=205 Identities=30% Similarity=0.423 Sum_probs=170.3
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeec-ccccchhHHHHHHHHhhhc-ccccceeeeeeeeeccceEEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~-~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~e~~~~~LVy 975 (1299)
.++......||+|++|.|-+-+ ..+|...|+|++.. ...+..++.++|+++..+. .++.+|.|+|.+.+....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3444556789999999998877 45799999999964 3556677888999987765 6999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|.| .-+|+.+-++.-+....+.+..+-+|+..+..||.|||++- .|||||+||+||||+.+|++||||||++..+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 56887776655566778999999999999999999999875 699999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccc----CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1109 (1299)
Q Consensus 1056 ~~~~~~st~v~GT~gYmAPE~l~~----~~~T~KSDVWSLGVVLyELLTGr~PFd~s~ 1109 (1299)
.-- .+-..|-.-|||||.+.. ..|+.|+||||||+.++||.+++.||+...
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 211 122346778999998753 478999999999999999999999997543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=266.55 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred CcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc--cccchhHHHHHHHHhhhcccccceeeeeeeeec-----cceE
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARC 972 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~-----~~~~ 972 (1299)
+.+-++-||-|+||.||.+++ ++|+.|++|++-.. +-...+++.+|+++|..++|.|++..+++..-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345578999999999999884 57999999998543 334467899999999999999999999876432 3567
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+|+|.| ..+|...+ ...+.|+-+.+.-+++||++||+|||+.+ |.||||||.|+||+.|..+|||||||++.
T Consensus 134 V~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 888888 45555554 45667899999999999999999999887 99999999999999999999999999996
Q ss_pred ccccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhc--cccc---
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP--LLTS--- 1126 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~p--lls~--- 1126 (1299)
...++..+ .+..+-|..|.|||++++ +.|+.+.||||.|||+.||+..+.-|+..+...+..++.-... -+..
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 55433333 445667999999999886 5689999999999999999999988876665443332211100 0000
Q ss_pred --ccccceeec-----CCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1127 --REGLERIID-----PSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1127 --~e~L~eIVD-----p~L~~----~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
++.-..++. +.+.. ....+.-.+.+.+.+.+++.||++|.+..+.++.+-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000111 00000 011123345677888999999999999988876643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=251.07 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=194.0
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeeec--cceEEE
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLV 974 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~--~~~~LV 974 (1299)
.++|++.+.+|+|.+++||.|. ..+++.++||+|+... .+.+.||++||..|+ |+||+.|+++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3678999999999999999999 5678899999998543 468999999999998 99999999998764 456799
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCCccccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSA 1053 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr~~ 1053 (1299)
+||+++.+...+. ..|+.-.+..++.+++.||.|||++| |+|||+||.|++||. +..++|+|+|||...
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998876655 24666778889999999999999888 999999999999986 457999999999876
Q ss_pred cccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc------
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS------ 1126 (1299)
Q Consensus 1054 ~~~~~~~~st~v~GT~gYmAPE~l~~-~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~------ 1126 (1299)
..+.... ..+.+..|--||++.. ..|+..-|+|||||+|.+|+..+.||-... .....++.-++-+-.+
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHH
Confidence 5443322 1235667888998875 457788999999999999999999985332 2233344333322211
Q ss_pred -------ccccceeecCCCCCC-------CCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1127 -------REGLERIIDPSLGND-------VPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 -------~e~L~eIVDp~L~~~-------~p~-ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
......++....+.. .+. -...+..+++.+.|..|-.+|+|++|.+..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000111111110000 000 112578899999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=262.83 Aligned_cols=132 Identities=27% Similarity=0.421 Sum_probs=112.8
Q ss_pred hCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcc-----c---ccceeeeeeeee--
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----H---RNLVKLIGICIE-- 967 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-----H---PNIVrLlG~~~e-- 967 (1299)
.++|.+.++||.|-|++||++.+ .+.+.||+|+.+. .+.-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37899999999999999999984 4678899999984 3444566789999999985 2 469999999975
Q ss_pred --ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 968 --EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 968 --~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
+.++|||+|++ |.+|..++....- +.+....+.+|++||+.||.|||+.+ +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 8899999865433 35788999999999999999999987 79999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=268.34 Aligned_cols=269 Identities=22% Similarity=0.260 Sum_probs=203.7
Q ss_pred HHHhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcc------cccceeeeeeeeec
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH------HRNLVKLIGICIEE 968 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr------HPNIVrLlG~~~e~ 968 (1299)
+..-++|.+....|+|-|++|.+|.. ..|..||||++... ....+.=++|++||++|+ --|+++|+..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 45568899999999999999999994 45789999999753 344456678999999996 24789999999999
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 1047 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDF 1047 (1299)
+++|||+|-+ ..+|.+.|+.+.. +..|....+..+++|+..||..|...+ |+|.||||+||||++. ..+|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 9999999988 6799999987654 446888999999999999999999887 9999999999999875 56899999
Q ss_pred CccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH---------
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA--------- 1118 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~--------- 1118 (1299)
|.|..+.+..... ..-+..|.|||++.+..|+...|+||.||+||||+||+.-|.+........+.-
T Consensus 582 GSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 9998775533221 224568999999999999999999999999999999999887654322111100
Q ss_pred ------hhhcccc--------------cccccc--eeecC------CCCC--CCC---hhhHHHHHHHHHHhcCcCcCCC
Q 000757 1119 ------WARPLLT--------------SREGLE--RIIDP------SLGN--DVP---FDSVAKVAAIASMCVQPEVQHR 1165 (1299)
Q Consensus 1119 ------wa~plls--------------~~e~L~--eIVDp------~L~~--~~p---~ee~~eL~~LI~~CL~~dPskR 1165 (1299)
+....+. +.+... ..+.+ .+.. .++ ...+.+|.+|+..||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0000000 000000 00111 0111 122 2346789999999999999999
Q ss_pred CCHHHHHHH
Q 000757 1166 PFMGEVVQA 1174 (1299)
Q Consensus 1166 PSMsEVLq~ 1174 (1299)
.+..+.++.
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999988754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=269.88 Aligned_cols=197 Identities=20% Similarity=0.322 Sum_probs=166.6
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeeccc--------ccchhHHHHHHHHhhhcc---cccceeeeeeee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRLH---HRNLVKLIGICI 966 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d--------~~~~keFlrEIeILsrLr---HPNIVrLlG~~~ 966 (1299)
..+|...+.||+|+||.|+.+.++ +...|+||.+.+.. +...-.+-.||.||.+|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356899999999999999999966 45679999986421 111223557999999998 999999999999
Q ss_pred eccceEEEEeecC-CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceec
Q 000757 967 EEQARCLVYELIP-NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1045 (1299)
Q Consensus 967 e~~~~~LVyEYm~-GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLs 1045 (1299)
+++.+||+||-.. |-+|++++. .+..+++.+...|++|++.|+++||..+ |||||||-+||.||.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 9999999999764 458888884 3457999999999999999999999988 9999999999999999999999
Q ss_pred CCCccccccccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCC
Q 000757 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVD 1106 (1299)
Q Consensus 1046 DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~-T~KSDVWSLGVVLyELLTGr~PFd 1106 (1299)
|||.+.....+. ....+||.+|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999987653332 345679999999999998877 466899999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=247.48 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=188.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeee-eeeccceEEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI-CIEEQARCLV 974 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~-~~e~~~~~LV 974 (1299)
..+.|.+.+.||+|.||.+.++..+ ..+.+++|.+.+ .....++|.+|...--.| .|.||+.-+++ |...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999955 567899999864 344567899998876667 49999998876 5566778899
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec--cCCcceecCCCcccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDFTPKVSDFGLARS 1052 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD--edg~VKLsDFGLAr~ 1052 (1299)
+||++.|+|.+-+.. ..+.+....+++.|++.|+.|||+++ +||||||.+||||- +..++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999988732 34778888999999999999999887 99999999999993 345899999999875
Q ss_pred ccccccccccccccccccccCcccccc---C--CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMT---G--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1053 ~~~~~~~~~st~v~GT~gYmAPE~l~~---~--~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
... ...+..-+..|.+||.... + .....+|||.||+|+|.+|||..||+... .....+.+|..-+....
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC
Confidence 422 1223335678999996653 2 23567899999999999999999998432 23334444433221111
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
-.+.+.+. ....+++.+.++-+..++++|=-..++.++.+
T Consensus 247 ~~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 PALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11111111 22356778888899999999955555555444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=271.67 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=202.1
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEe
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyE 976 (1299)
-.++|++.+.+|.|.||.|||+++ ..++..|||+++-.-.+..+-+.+||-+++..+|+|||.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457899999999999999999994 4688999999987666666778899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||.||+|.+.-+. ..++++.++..++....+||+|||..+ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999987753 457999999999999999999999887 79999999999999999999999999875532
Q ss_pred ccccccccccccccccCcccc---ccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccccccccee
Q 000757 1057 ESRHISTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1057 ~~~~~st~v~GT~gYmAPE~l---~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eI 1133 (1299)
.-.......||+.|||||+. +.+.|..++|||++|+.-.||---+.|.-..-+ .+++ .+++ . ..
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l-----~LmT-k----S~ 231 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRAL-----FLMT-K----SG 231 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHH-----HHhh-c----cC
Confidence 11112335699999999975 467789999999999999999776665432111 1111 1111 1 11
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1134 VDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
+++-... -.......|-++++.|+-.+|++||+.+.+++
T Consensus 232 ~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2221111 12345567889999999999999999988875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=282.80 Aligned_cols=199 Identities=18% Similarity=0.241 Sum_probs=142.8
Q ss_pred hhhccc-ccceeeeeee-------eeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCC
Q 000757 950 LSRLHH-RNLVKLIGIC-------IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021 (1299)
Q Consensus 950 LsrLrH-PNIVrLlG~~-------~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gs 1021 (1299)
.++++| .||++++|+| .+.+..++++||+ +++|.++|+.. ...+++.+++.|+.||++||+|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 345666 6888899987 3334567888988 77999999632 345999999999999999999999887
Q ss_pred CceeeecccccCeeecc-------------------CCcceecCCCcccccccccc--------------cccccccccc
Q 000757 1022 PRVIHRDFKSSNILLEH-------------------DFTPKVSDFGLARSAMDEES--------------RHISTRVMGT 1068 (1299)
Q Consensus 1022 p~IVHRDIKPsNILLDe-------------------dg~VKLsDFGLAr~~~~~~~--------------~~~st~v~GT 1068 (1299)
|+||||||+||||+. ++.+||+|||+++....... .......+||
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999954 45677777777764211000 0001124688
Q ss_pred ccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHH
Q 000757 1069 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVA 1148 (1299)
Q Consensus 1069 ~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~ 1148 (1299)
..|||||++.+..++.++|||||||+||||++|..++.... ..+..+... .+.... .....
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~----------~~~~~~-----~~~~~ 239 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR----------VLPPQI-----LLNWP 239 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh----------hcChhh-----hhcCH
Confidence 99999999999999999999999999999999988764211 111111000 011100 11223
Q ss_pred HHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1149 KVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1149 eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
+..+++.+||+.+|.+||+|.||++.
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 45688899999999999999999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=217.72 Aligned_cols=261 Identities=31% Similarity=0.433 Sum_probs=199.0
Q ss_pred cceeeEEeecCceEEEEEEecCCCEEEEEEeeccccc---chhHHHHHHHHhhhcccc-cceeeeeeeeeccceEEEEee
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ---GGREFLAEVEMLSRLHHR-NLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~---~~keFlrEIeILsrLrHP-NIVrLlG~~~e~~~~~LVyEY 977 (1299)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|. +|+++++++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999977 78999998654332 367899999999999988 799999999777778999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC-cceecCCCcccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~~~~~ 1056 (1299)
+.+++|.+++...... ..+.......++.|++.+++|+|+.+ ++|||||++|||++..+ .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776432211 36888999999999999999999988 99999999999999988 7999999999855443
Q ss_pred cccc----ccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCC-chhhhHHhhhccccccc
Q 000757 1057 ESRH----ISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1057 ~~~~----~st~v~GT~gYmAPE~l~~---~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~-~~~nLV~wa~plls~~e 1128 (1299)
.... ......|+..|++||.+.. ..+....|+|++|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3221 2356779999999999887 57889999999999999999999997654421 011111211111110
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.................+.+++..|+..++..|.++.+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002234578899999999999999999887765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=245.22 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=193.1
Q ss_pred CCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeec--ccccchhHHHHHHHHhhhcccccceeeeeeeeec------cc
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QA 970 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~------~~ 970 (1299)
.+|.-.+.+|.|.- .|..+.+ -.++.||+|++.. .+....++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34666677888887 5555552 2578899999843 3445567788999999999999999999998643 45
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||| .++|.+.++ ..++-++..+|++|++.|+.|||+.+ |+||||||+||+|..++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 69999999 678888875 23677888999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHH------------
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA------------ 1118 (1299)
Q Consensus 1051 r~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~------------ 1118 (1299)
+.... ....+-.+.|..|.|||++.+-.+.+.+||||+||++.||++|+.-|.+....++.+.+.
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 86533 234455678999999999998889999999999999999999998887544332221110
Q ss_pred ----hhhccccccc-----ccceee-cCCCCCC--CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1119 ----WARPLLTSRE-----GLERII-DPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1119 ----wa~plls~~e-----~L~eIV-Dp~L~~~--~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
-++....... ...+++ |..+... .+.-......+++.+||..+|++|-+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0110000000 011111 1111111 111234568889999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=216.48 Aligned_cols=169 Identities=22% Similarity=0.212 Sum_probs=127.2
Q ss_pred CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccccccccc
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~ 1060 (1299)
|+|.++++.. ...++|.++++|+.||++||+|||+.+ |++|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 7899998532 346999999999999999999999874 999999999999999 9998765331
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1061 ~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
...||..|||||++.+..++.++|||||||+||||++|+.||....... ..+..+...... . +.. ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-~-------~~~-~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-D-------DPR-DR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-C-------Ccc-cc
Confidence 1258999999999999999999999999999999999999996532211 111122111110 0 000 00
Q ss_pred CCChhhH--HHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1141 DVPFDSV--AKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1141 ~~p~ee~--~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
....... .++.+++.+||+.+|++||++.|+++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0111222 269999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-22 Score=227.79 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=199.0
Q ss_pred CcceeeEEeecCceEEEEEEecCC--CEEEEEEeecccccchhHHHHHHHHhhhccc----ccceeeeeee-eeccceEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDG--TKVAVKVLKRVDQQGGREFLAEVEMLSRLHH----RNLVKLIGIC-IEEQARCL 973 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdG--r~VAVK~Lk~~d~~~~keFlrEIeILsrLrH----PNIVrLlG~~-~e~~~~~L 973 (1299)
+|.+.+.||+|+||.||++...+. +.+|+|............+..|+.++..+.. .++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996643 4788888765433333378889999999873 6899999998 47778899
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-----CcceecCCC
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-----FTPKVSDFG 1048 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-----g~VKLsDFG 1048 (1299)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..++|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 999999775433 457999999999999999999999988 9999999999999754 469999999
Q ss_pred ccc--cccccccc---cc---cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchh-hhHHh
Q 000757 1049 LAR--SAMDEESR---HI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAW 1119 (1299)
Q Consensus 1049 LAr--~~~~~~~~---~~---st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~-nLV~w 1119 (1299)
+++ ........ .. .....||..|.+++...+...+.+.|+||++.++.||+.|..||......... .+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 43222211 11 22355999999999999999999999999999999999999999654322211 11111
Q ss_pred hhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhh
Q 000757 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1120 a~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.... .... ........+.++...+-..+...+|....+.+.|+......
T Consensus 253 ~~~~---------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKL---------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhh---------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1000 0000 11223355666666666689999999999999988776543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=240.47 Aligned_cols=202 Identities=28% Similarity=0.371 Sum_probs=166.8
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEEec----CCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeeecc
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 969 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~lk----dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~ 969 (1299)
+....+.|.++++||+|.|+.||++.+. .++.||+|.+.... .-.++.+|+++|.++. +.||+.+.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455678999999999999999999954 46789999997543 3357899999999996 999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-CCcceecCCC
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFG 1048 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-dg~VKLsDFG 1048 (1299)
..++|+||++.....+++. .++..++..++..+..||+++|..| ||||||||+|+|.+. .++-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 9999999999999888874 3667889999999999999999888 999999999999975 4678999999
Q ss_pred cccccccc-------c------------c-----------------------ccccccccccccccCccccc-cCCCCcc
Q 000757 1049 LARSAMDE-------E------------S-----------------------RHISTRVMGTFGYVAPEYAM-TGHLLVK 1085 (1299)
Q Consensus 1049 LAr~~~~~-------~------------~-----------------------~~~st~v~GT~gYmAPE~l~-~~~~T~K 1085 (1299)
||...... . . ........||.||.|||++. ...-+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99721000 0 0 00001235999999999765 5677899
Q ss_pred ccchhhHHHHHHHHhCCCCCCCC
Q 000757 1086 SDVYSYGVVILELLSGRKPVDMT 1108 (1299)
Q Consensus 1086 SDVWSLGVVLyELLTGr~PFd~s 1108 (1299)
.||||.|||++.+++++.||-..
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeeccceeehhhccccccccC
Confidence 99999999999999999998543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-23 Score=235.27 Aligned_cols=167 Identities=21% Similarity=0.176 Sum_probs=130.3
Q ss_pred HHHhCCcceeeEEeecCceEEEEEEec--CCCEEEEEEeecc-----cccchhHHHHHHHHhhhccccccee-eeeeeee
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVK-LIGICIE 967 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~lk--dGr~VAVK~Lk~~-----d~~~~keFlrEIeILsrLrHPNIVr-LlG~~~e 967 (1299)
....++|++.+.||+|+||+||+|+++ +++.||||++... .....+.|.+|+++|++|+|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 445678999999999999999999864 5777899987532 1223456899999999999999985 4432
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecc-cccCeeeccCCcceecC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSD 1046 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDI-KPsNILLDedg~VKLsD 1046 (1299)
+..||||||++|++|.... .. . ...++.+++++|+|||+.+ |+|||| ||+||||+.++++||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~~----~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR----PH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC----cc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 4579999999999996321 10 0 1467889999999999887 999999 99999999999999999
Q ss_pred CCccccccccccccc------cccccccccccCccccccC
Q 000757 1047 FGLARSAMDEESRHI------STRVMGTFGYVAPEYAMTG 1080 (1299)
Q Consensus 1047 FGLAr~~~~~~~~~~------st~v~GT~gYmAPE~l~~~ 1080 (1299)
||+++.......... .+..++++.|++||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999986644221111 1356789999999988643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=245.36 Aligned_cols=257 Identities=20% Similarity=0.198 Sum_probs=191.7
Q ss_pred ceeeEEeecCceEEEEEE-ecCCCEEEEEEee----cc-c-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 903 DASRILGEGGFGLVYSGV-LDDGTKVAVKVLK----RV-D-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk----~~-d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
...+++|.|.+|.|+... ....+..+.|.+. .. . .+....+..|+.+-..|+|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 346789999999777766 3334444444432 11 1 111122667888889999999999998888877777779
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|||++ +|+.++.. ...+...++..++.|+.+||+|||..| |.|||||++|+|++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999842 236888899999999999999999998 99999999999999999999999999987665
Q ss_pred cccc--cccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccce
Q 000757 1056 EESR--HISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1056 ~~~~--~~st~v~GT~gYmAPE~l~~~~~T-~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~e 1132 (1299)
.... .....++|.-.|+|||.+....|. ...||||.|+++..|++|+.+|......+.+... ......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---------~~~~~~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---------NNYSDQ 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---------hccccc
Confidence 4444 566778899999999999988887 5679999999999999999999765544332100 000000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1133 IVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.-+..-...+..+...+...++.++|+.+|.+|-+|.+|++.=+
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 00000001122344567788999999999999999999987543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-22 Score=217.50 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=193.7
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEee--cccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk--~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
-+|.+.-.|+.|+|+++ |..+++|+++ +......++|..|.-.|+-+.||||+.++|.|.......++..||+-|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46788889999999998 5667888874 33445567899999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st 1063 (1299)
+..||+.. +--++-.+.++++.++|+|++|||+.. +-|----|....|+||++.+.+|+- +-++.... ..
T Consensus 275 ynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsfq------e~ 344 (448)
T KOG0195|consen 275 YNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ------EV 344 (448)
T ss_pred HHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeeee------cc
Confidence 99998643 345778899999999999999999985 3344457889999999999888741 11111111 01
Q ss_pred cccccccccCccccccCCCC---ccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCC
Q 000757 1064 RVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140 (1299)
Q Consensus 1064 ~v~GT~gYmAPE~l~~~~~T---~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~ 1140 (1299)
...-.+.||+||.+.....+ ...|+|||.++||||.|...||.....- +.-.++.-+.++-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----------------ecgmkialeglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----------------ECGMKIALEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch----------------hhhhhhhhccccc
Confidence 12235799999988766543 5789999999999999999999754322 2222333445666
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1141 ~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
.++......+.+|+.-|++.||.+||.++.|+-.|+..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 77778888999999999999999999999999988864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=201.95 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=204.2
Q ss_pred HhCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhccc-ccceeeeeeeeeccceEEEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrH-PNIVrLlG~~~e~~~~~LVy 975 (1299)
..++|.+++.||.|.||.+|.|. ..+|+.||||+-... ...-++..|.++.+.|++ ..|..++.|..++..-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999999 778999999997532 233577889999999974 56777888888888889999
Q ss_pred eecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc---CCcceecCCCcccc
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARS 1052 (1299)
Q Consensus 976 EYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe---dg~VKLsDFGLAr~ 1052 (1299)
|.+ |-+|++++.- ....++..+.+.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||||+.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 999 8999998753 2346888999999999999999999998 999999999999954 35789999999997
Q ss_pred ccccccc-cc----cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1053 AMDEESR-HI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1053 ~~~~~~~-~~----st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+.+.... ++ .....||.+|.+-....+..-+.+.|+-|+|.||..+.-|..||++..........+-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk-------- 235 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK-------- 235 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--------
Confidence 7653322 22 2346799999887776677778899999999999999999999987654432222111
Q ss_pred cccceeecCCCCC---CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhh
Q 000757 1128 EGLERIIDPSLGN---DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1128 e~L~eIVDp~L~~---~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
|.+..+.. ........+|...+..|-...-++-|...-+-+.++.+.....
T Consensus 236 -----I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 236 -----ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred -----HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 11111110 1112345678889999998888999998888777776665443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-20 Score=204.97 Aligned_cols=263 Identities=20% Similarity=0.269 Sum_probs=199.0
Q ss_pred hCCcceeeEEeecCceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEe
Q 000757 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyE 976 (1299)
.-+|+++++||+|.||.++.|+ +-+++.||||.--.. ...-++..|....+.|. .++|...+-|..++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4579999999999999999999 667999999986432 22346778888888885 7889998888888888899999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-----CCcceecCCCccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 1051 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-----dg~VKLsDFGLAr 1051 (1299)
.+ |-+|+|++. -....++.+++..|+.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99 889999874 23456899999999999999999999988 999999999999954 3468999999999
Q ss_pred ccccccc-cccc----ccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccccc
Q 000757 1052 SAMDEES-RHIS----TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1052 ~~~~~~~-~~~s----t~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~ 1126 (1299)
.+.+... .++. ....||.+||+-....++.-+.+.|+-|||-|++..|-|..||++.......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK------------ 245 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK------------ 245 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH------------
Confidence 8766433 2222 2356999999999999999999999999999999999999999875433211
Q ss_pred ccccceeecCCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhh
Q 000757 1127 REGLERIIDPSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1127 ~e~L~eIVDp~L~~~~---p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
+..++|-|......+ ......+|...+...-..+-++-|..+-+...+..++....
T Consensus 246 -~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 246 -EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred -HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 111222221111111 11223455555555555677888888877776666665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=203.32 Aligned_cols=172 Identities=13% Similarity=0.143 Sum_probs=134.4
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchh---------HHHHHHHHhhhcccccceeeeeeeee
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR---------EFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~k---------eFlrEIeILsrLrHPNIVrLlG~~~e 967 (1299)
-..++|+..++||.|+||.||+... ++..+|||+++.......+ .+.+|+..+.+|+|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568999999999999999999666 5778999999643322222 26799999999999999999998664
Q ss_pred c--------cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC
Q 000757 968 E--------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1039 (1299)
Q Consensus 968 ~--------~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed 1039 (1299)
. ...+|||||++|.+|.++.. ++. .+..+++.+|..||+.+ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999988741 222 24558999999999988 9999999999999998
Q ss_pred CcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHH
Q 000757 1040 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1099 (1299)
Q Consensus 1040 g~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELL 1099 (1299)
+ ++|+|||..+......... .+.....+..+.|+|+||+.|.-+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 8 9999999887542211110 0344556668999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-20 Score=195.27 Aligned_cols=139 Identities=20% Similarity=0.232 Sum_probs=108.1
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeeccccc--c-------hhHH-----------------HHHHHHhhhcccccc
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--G-------GREF-----------------LAEVEMLSRLHHRNL 958 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~--~-------~keF-----------------lrEIeILsrLrHPNI 958 (1299)
.+.||+|+||.||+|...+|+.||||+++..... . ..+| .+|+++|.+|.+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999643211 1 1122 349999999988877
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHh-hhcCCCceeeecccccCeeec
Q 000757 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRDFKSSNILLE 1037 (1299)
Q Consensus 959 VrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYL-Hs~gsp~IVHRDIKPsNILLD 1037 (1299)
.....+.. ...+|||||+.|++|...+. ....+++.+..+++.|++.+|.|| |+.+ |+||||||+||||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333222 23489999998887765431 123688999999999999999999 6777 99999999999998
Q ss_pred cCCcceecCCCccccc
Q 000757 1038 HDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1038 edg~VKLsDFGLAr~~ 1053 (1299)
+++++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=232.74 Aligned_cols=248 Identities=23% Similarity=0.249 Sum_probs=183.6
Q ss_pred CcceeeEEeecCceEEEEEEecCCCEEEEEEeecc-cccchhHHHHHHHH--hhhcccccceeeeeeeeeccceEEEEee
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV-DQQGGREFLAEVEM--LSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~-d~~~~keFlrEIeI--LsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+|...+.||.++|=+|.+|+.+.|. |+||++-+. .....+.|.++++- ...++++|.+.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 889987443 34455556554444 4455899999998887777777899899
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc--c
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM--D 1055 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~--~ 1055 (1299)
+ .-+|+|+|. .+.-|...+.+.|++|++.||.-+|+.| |+|||||.+||||+.-.-+.|+||.--+... +
T Consensus 103 v-khnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 V-KHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred H-hhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 8 568999883 3345778889999999999999999998 9999999999999998889999997655321 1
Q ss_pred c---ccccccccccccccccCccccccC-----------CCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhh
Q 000757 1056 E---ESRHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1056 ~---~~~~~st~v~GT~gYmAPE~l~~~-----------~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa 1120 (1299)
+ +.....++-.....|+|||.+... .++.+-||||+|||++||++ |+.+|+.. .+..+-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 1 111222223344689999977542 26678899999999999999 78888643 222221
Q ss_pred hc-ccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000757 1121 RP-LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1121 ~p-lls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~L 1175 (1299)
+. ....+..+++|-|. .+.+|+..|++.||++|.+++++++.-
T Consensus 249 ~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11 01111112222221 477899999999999999999999873
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=188.31 Aligned_cols=139 Identities=22% Similarity=0.217 Sum_probs=110.3
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeecccccc--------------------------hhHHHHHHHHhhhcccccc
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG--------------------------GREFLAEVEMLSRLHHRNL 958 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~--------------------------~keFlrEIeILsrLrHPNI 958 (1299)
.+.||+|+||.||+|++.+|+.||||+++...... ...+.+|++.+.+++|.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987432110 1123578999999999987
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhc-ccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeee
Q 000757 959 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 959 VrLlG~~~e~~~~~LVyEYm~GGSL~d~-L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILL 1036 (1299)
.....+... ..||||||+.|+++... +. ...++..+..+|+.|++.+|.|||+ .+ |+||||||+||||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554444333 34899999988865443 32 2347788899999999999999998 77 9999999999999
Q ss_pred ccCCcceecCCCcccccc
Q 000757 1037 EHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~~ 1054 (1299)
+ +++++|+|||+++...
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=210.49 Aligned_cols=218 Identities=23% Similarity=0.380 Sum_probs=164.2
Q ss_pred hhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecc
Q 000757 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1029 (1299)
Q Consensus 950 LsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDI 1029 (1299)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.|.+.. ....++|.....++.+|+.||+|||... -.+|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4678999999999999999999999999999999999964 4567999999999999999999999753 2399999
Q ss_pred cccCeeeccCCcceecCCCccccccccccccccccccccccccCccccccC-------CCCccccchhhHHHHHHHHhCC
Q 000757 1030 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLSGR 1102 (1299)
Q Consensus 1030 KPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~-------~~T~KSDVWSLGVVLyELLTGr 1102 (1299)
+..|+++|..+.+||+|||+.................-...|.|||.++.. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765321111111122245689999988763 2567899999999999999999
Q ss_pred CCCCCCCCCch-hhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHh
Q 000757 1103 KPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1103 ~PFd~s~~~~~-~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~ 1180 (1299)
.||+....... ..++.++.. .-...+-+.+.... +....+..++..||..+|++||++.+|-..++.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99987543322 223333222 01111112111111 233478999999999999999999999887775554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-19 Score=197.15 Aligned_cols=234 Identities=21% Similarity=0.346 Sum_probs=150.9
Q ss_pred CcceeeEEeecCceEEEEEEec-CCCEEEEEEeecc---cccchhHHHHHHHHhhhcc----------cccceeeeeeee
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH----------HRNLVKLIGICI 966 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLr----------HPNIVrLlG~~~ 966 (1299)
.+...+.||.|+|+.||++++. +|+.+|||++... .....+++++|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567889999999999999965 5899999997432 2334556777765554432 222222222221
Q ss_pred ---------ecc--------ceEEEEeecCCCChhhcccccc---cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceee
Q 000757 967 ---------EEQ--------ARCLVYELIPNGSVESHLHGVD---KESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026 (1299)
Q Consensus 967 ---------e~~--------~~~LVyEYm~GGSL~d~L~~~~---~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVH 1026 (1299)
... ..+++|+-+ .++|.+++.... .....+....++.+..|+++.+++||..| |||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 236778877 678887764221 11223556677888899999999999998 999
Q ss_pred ecccccCeeeccCCcceecCCCccccccccccccccccccccccccCcccccc--------CCCCccccchhhHHHHHHH
Q 000757 1027 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVILEL 1098 (1299)
Q Consensus 1027 RDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~--------~~~T~KSDVWSLGVVLyEL 1098 (1299)
+|||++|+||+++|.++|+||+......... .. ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999998776543211 11 235578999997643 2478899999999999999
Q ss_pred HhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCC
Q 000757 1099 LSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1165 (1299)
Q Consensus 1099 LTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskR 1165 (1299)
+||+.||+........ +| .+. .+. +..+.+..||..+|+.++.+|
T Consensus 244 WC~~lPf~~~~~~~~~---~~-----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP---EW-----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTS---GG-----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccc---cc-----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999865322111 11 111 222 667889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=187.54 Aligned_cols=187 Identities=19% Similarity=0.143 Sum_probs=139.8
Q ss_pred cceeeEEeecCceEEEEEEecCCCEEEEEEeecccc----cchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEe
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ----QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~----~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyE 976 (1299)
+.+...|++|+||+||.+.. +++.++.+.+..... .....|.+|+++|++|. |++|.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34578999999999997766 578888887764322 11225789999999995 5889999886 45699999
Q ss_pred ecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecc-cccCeeeccCCcceecCCCccccccc
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 977 Ym~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDI-KPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
|+.|.+|.+.+.. ....++.|++++|++||+.| |+|||| |++|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998765410 12357789999999999998 999999 79999999999999999999985432
Q ss_pred ccc----------cc-ccccccccccccCccccccC-CC-CccccchhhHHHHHHHHhCCCCCCC
Q 000757 1056 EES----------RH-ISTRVMGTFGYVAPEYAMTG-HL-LVKSDVYSYGVVILELLSGRKPVDM 1107 (1299)
Q Consensus 1056 ~~~----------~~-~st~v~GT~gYmAPE~l~~~-~~-T~KSDVWSLGVVLyELLTGr~PFd~ 1107 (1299)
... .+ .......+..|+.|+...-. .. -...+.++.|+.+|.++|++.+.-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 211 00 11223467788888854322 22 2566899999999999999887643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=216.63 Aligned_cols=258 Identities=21% Similarity=0.222 Sum_probs=183.6
Q ss_pred HHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcc---cccceeeeeeeeeccc
Q 000757 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQA 970 (1299)
Q Consensus 894 ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~e~~~ 970 (1299)
+++.-...|.|.+.||+|+||.||+|...+|+.||+|+=+.... -+|.-=..++.||+ -+.|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34555678999999999999999999988899999999753211 12222222344444 2334455555555677
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-------CCcce
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-------DFTPK 1043 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-------dg~VK 1043 (1299)
.+||+||.+-|+|.+++. ....++|...+.|+.|+++.|+.||..+ ||||||||+|+||.. ..-++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999996 4557999999999999999999999988 999999999999942 34689
Q ss_pred ecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcc
Q 000757 1044 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1044 LsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
|+|||.+-.+.--.........++|-++-+.|+..++..+...|.|.|.-+++.||.|+.-= .|
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~---- 905 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VK---- 905 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hc----
Confidence 99999986554322233445577899999999999999999999999999999999986310 01
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHhhhhh
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1184 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk~I~~e~~e 1184 (1299)
.+-...++..+..-...+.+.+|.+++.. .|=..=|...++...++.+..+..+
T Consensus 906 ----~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 906 ----NGSSWMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ----CCcceeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHHHHHH
Confidence 11112222223323334555555555544 4444446666666666666655543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-19 Score=215.01 Aligned_cols=225 Identities=27% Similarity=0.347 Sum_probs=178.3
Q ss_pred EEeecCceEEEEEE----ecCCCEEEEEEeecccccc--hhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEeecC
Q 000757 907 ILGEGGFGLVYSGV----LDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 907 lLGeGgFGtVYKA~----lkdGr~VAVK~Lk~~d~~~--~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyEYm~ 979 (1299)
.+|+|.||.|++++ .+.|..+|+|++++..... ......|..++..++ |+.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 3346778999986532111 114456888888887 9999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
||.|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||++|.+|.+|+.|||+++...+....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999998853 334667777788889999999999988 999999999999999999999999999876553332
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCC
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139 (1299)
Q Consensus 1060 ~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~ 1139 (1299)
|||..|||||+++ ......|.||||++++||++|..||.. +- +..|+...
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~----------~~~Il~~~-- 203 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DT----------MKRILKAE-- 203 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HH----------HHHHhhhc--
Confidence 8999999999988 556789999999999999999999964 01 11111111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000757 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1140 ~~~p~ee~~eL~~LI~~CL~~dPskRPSM 1168 (1299)
-.++.+.......++..++..+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 13445666778888888889999998755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=179.29 Aligned_cols=137 Identities=17% Similarity=0.266 Sum_probs=106.1
Q ss_pred ceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhc-----ccccceeeeeeeeecc---c-eEE
Q 000757 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-----HHRNLVKLIGICIEEQ---A-RCL 973 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-----rHPNIVrLlG~~~e~~---~-~~L 973 (1299)
.-.++||+|+||.||. .-+++.. +||++........+++.+|++++++| +|+||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 3344444 68888654444567899999999999 5799999999998763 3 337
Q ss_pred EEee--cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHH-HHhhhcCCCceeeecccccCeeecc----CCcceecC
Q 000757 974 VYEL--IPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL-AYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSD 1046 (1299)
Q Consensus 974 VyEY--m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~AL-aYLHs~gsp~IVHRDIKPsNILLDe----dg~VKLsD 1046 (1299)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +++++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999531 24444 35677888777 9999887 999999999999974 34899999
Q ss_pred CCccc
Q 000757 1047 FGLAR 1051 (1299)
Q Consensus 1047 FGLAr 1051 (1299)
|+.++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=173.65 Aligned_cols=134 Identities=21% Similarity=0.287 Sum_probs=113.0
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccc--------cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ--------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~--------~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
+.||+|++|.||+|.. +|..|+||+...... ...+++.+|++++.+++|.+|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899998643211 1124578899999999999998888887777888999999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
++|++|.+++... .+ ++..++.+++.+|.+||+.+ |+|||++++|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988421 12 88999999999999999887 99999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=170.46 Aligned_cols=144 Identities=19% Similarity=0.113 Sum_probs=112.2
Q ss_pred HHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccc----------------------cchhHHHHHHHHhh
Q 000757 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ----------------------QGGREFLAEVEMLS 951 (1299)
Q Consensus 894 ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~----------------------~~~keFlrEIeILs 951 (1299)
++......|.+.+.||+|+||.||++..++|+.||||++..... .....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999988899999998753210 01123567899999
Q ss_pred hccccc--ceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecc
Q 000757 952 RLHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1029 (1299)
Q Consensus 952 rLrHPN--IVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDI 1029 (1299)
++.|.+ +...++ ....++||||++|++|.+.... ....+++.+++.++.+||+.+ |+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 998874 444443 2455899999999998765420 335678899999999999887 999999
Q ss_pred cccCeeeccCCcceecCCCcccccc
Q 000757 1030 KSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 1030 KPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
||+||||+++++++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=176.87 Aligned_cols=148 Identities=17% Similarity=0.132 Sum_probs=113.0
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEE--ecCCCEEEEEEeeccccc------------------------chhHHHHHHH
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGV--LDDGTKVAVKVLKRVDQQ------------------------GGREFLAEVE 948 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~--lkdGr~VAVK~Lk~~d~~------------------------~~keFlrEIe 948 (1299)
+.+....|++.+.||+|+||.||+|+ ..+|+.||||+++..... ....+.+|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444458899999999999999998 568999999998643210 0123568999
Q ss_pred Hhhhccccc--ceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceee
Q 000757 949 MLSRLHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1026 (1299)
Q Consensus 949 ILsrLrHPN--IVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVH 1026 (1299)
++.+|.+.+ +.+++++ ...+|||||+.|++|..++.. ...+...+...++.|++.+|.|||+.+ .|+|
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 999997633 3334432 245899999999888776521 223556667899999999999999775 4999
Q ss_pred ecccccCeeeccCCcceecCCCccccc
Q 000757 1027 RDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1027 RDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|||||+|||++ +++++|+|||++...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998744
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-17 Score=169.15 Aligned_cols=130 Identities=20% Similarity=0.312 Sum_probs=106.5
Q ss_pred EEeecCceEEEEEEecCCCEEEEEEeecccc--------cchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeec
Q 000757 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ--------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~--------~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
+||+|+||.||+|.+. |..|++|+...... ...+++.+|++++.+++|.++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 78899998643211 11256778999999999887766666666677789999999
Q ss_pred CCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 979 ~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+|++|.+++.... ..++.+++.+|++||+.+ |+|||++++|||++ +++++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874210 178999999999999887 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-17 Score=186.16 Aligned_cols=200 Identities=22% Similarity=0.236 Sum_probs=137.5
Q ss_pred ccccceeeeeeeeec---------------------------cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHH
Q 000757 954 HHRNLVKLIGICIEE---------------------------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1006 (1299)
Q Consensus 954 rHPNIVrLlG~~~e~---------------------------~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa 1006 (1299)
+|||||++.++|.++ ...|+||..+ ..+|.+||.. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 599999999877632 2357888877 5688888842 235666777889
Q ss_pred HHHHHHHHHhhhcCCCceeeecccccCeee--ccCC--cceecCCCcccccccc----ccccccccccccccccCccccc
Q 000757 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILL--EHDF--TPKVSDFGLARSAMDE----ESRHISTRVMGTFGYVAPEYAM 1078 (1299)
Q Consensus 1007 ~QIA~ALaYLHs~gsp~IVHRDIKPsNILL--Dedg--~VKLsDFGLAr~~~~~----~~~~~st~v~GT~gYmAPE~l~ 1078 (1299)
.|+++|+.|||++| |.|||+|++|||| |+|. .+.|+|||++--.... .+..-.-..-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999998 9999999999999 3333 5789999987421110 0000011123677899999876
Q ss_pred cCC------CCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHH
Q 000757 1079 TGH------LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 1152 (1299)
Q Consensus 1079 ~~~------~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~ 1152 (1299)
... -..|+|.|+.|-+-||+++...||....+-. +..+ ..++ ......+..+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----------L~~r-~Yqe----~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----------LDTR-TYQE----SQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-----------echh-hhhh----hhCCCCcccCChHHHH
Confidence 431 2478999999999999999999997532110 0000 0000 0111233344557889
Q ss_pred HHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000757 1153 IASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1153 LI~~CL~~dPskRPSMsEVLq~Lk~I 1178 (1299)
|+...|+.||++|++..-..+.|...
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHH
Confidence 99999999999999987666665533
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-17 Score=197.04 Aligned_cols=140 Identities=18% Similarity=0.266 Sum_probs=113.9
Q ss_pred HHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEE-eecc-c------ccchhHHHHHHHHhhhcccccceeeeeeeee
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKV-LKRV-D------QQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 896 e~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~-Lk~~-d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~e 967 (1299)
+.....|...++||+|+||+||+|.+.+. .+++|+ +.+. . ....+++.+|++++++++|.+|+..+.++.+
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445566789999999999999987644 344443 2211 1 1123568899999999999999998888887
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCC
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
....++||||++|++|.+++. .+.+++.+++++|.|||+.+ |+||||||+|||| +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999883 45789999999999999887 9999999999999 5789999999
Q ss_pred Ccccc
Q 000757 1048 GLARS 1052 (1299)
Q Consensus 1048 GLAr~ 1052 (1299)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=150.68 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=115.5
Q ss_pred eeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccc--ccceeeeeeeeeccceEEEEeecCCC
Q 000757 904 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 904 i~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrH--PNIVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
+.+.||+|.++.||++..++ ..+++|+...... ..++.+|+.++++++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999874 7899999865332 5678999999999987 58999999988888899999999887
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
.+..+ ++.....++.+++++|++||.....+++||||+++|||+++++.++|.|||+++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4567788899999999999986445699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-17 Score=193.35 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=155.4
Q ss_pred eeEEeecCceEEEEEEecCC----CEEEEEEeecccccchhHHHHHHHHhhhcccccceeeee-----e--ee-----ec
Q 000757 905 SRILGEGGFGLVYSGVLDDG----TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG-----I--CI-----EE 968 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdG----r~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG-----~--~~-----e~ 968 (1299)
.+.+++..++.+.......+ +.+..|..+..+........+++..+....|-+..-+.+ + .. ..
T Consensus 249 ~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~ 328 (516)
T KOG1033|consen 249 SKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKK 328 (516)
T ss_pred cccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccc
Confidence 34455555666555542222 233444443222123333445555555554444333333 1 11 12
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCC
Q 000757 969 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 969 ~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
...|+.|++|...+|.+||.+.+. ....+|...+.++.|++.+++| ++ .+|||+|+.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 346899999999999999964432 3457889999999999999999 55 8999999999999999999999999
Q ss_pred ccccccccc----cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCchhhhHHhhhcc
Q 000757 1049 LARSAMDEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPL 1123 (1299)
Q Consensus 1049 LAr~~~~~~----~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTG-r~PFd~s~~~~~~nLV~wa~pl 1123 (1299)
|........ .....+...||..||+||.+.+..|+.|+|||+||+||+||+.- ...++.. .-
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~t---- 468 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------AT---- 468 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------Hh----
Confidence 998665433 12234567899999999999999999999999999999999972 2111100 00
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000757 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1170 (1299)
Q Consensus 1124 ls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsE 1170 (1299)
+ .+.-..++++....+++ +-..|+.+++..+|.+||++.+
T Consensus 469 ~--~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 469 L--TDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h--hhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 0 01111122222222232 2346899999999999994433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.4e-16 Score=190.35 Aligned_cols=210 Identities=22% Similarity=0.341 Sum_probs=142.2
Q ss_pred hCCcceeeEEeecCceEEEEEEec-CCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 t~nFsi~elLGeGgFGtVYKA~lk-dGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..+|+.+++|..|+||.||..+.+ +.+.+|+|+=++ + .++|- ++.....+.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----hhhhc--cccccCCccee------------------
Confidence 468999999999999999999865 355677743221 1 11111 22222233222
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
|+-...++.. ..+..+ .+.+++|||+.+ |+|||+|++|.||+.-|.+|++||||.+......
T Consensus 136 ---gDc~tllk~~----g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4444444321 122222 277899999887 9999999999999999999999999987432211
Q ss_pred ------------c-ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc
Q 000757 1058 ------------S-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1058 ------------~-~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
. .....++|||+.|+|||++....|...+|.|++|+|+||.+.|..||..+..++.... .+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------VI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------hh
Confidence 1 1122356999999999999999999999999999999999999999988765432111 11
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1167 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPS 1167 (1299)
.+. .++. +.......+..+++...|+.+|.+|--
T Consensus 272 sd~---i~wp------E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 272 SDD---IEWP------EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhh---cccc------ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 100 0000 112233457888999999999999953
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=154.08 Aligned_cols=135 Identities=24% Similarity=0.258 Sum_probs=98.1
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeeccccc--chhH----------------------HHHHHHHhhhccccc--c
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--GGRE----------------------FLAEVEMLSRLHHRN--L 958 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~--~~ke----------------------FlrEIeILsrLrHPN--I 958 (1299)
.+.||+|+||+||+|...+|+.||||+++..... .... ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998642211 1111 135666666665443 3
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhc-ccccccCCCCCChhHHHHHHHHHHHHHHHhhh-cCCCceeeecccccCeee
Q 000757 959 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 959 VrLlG~~~e~~~~~LVyEYm~GGSL~d~-L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs-~gsp~IVHRDIKPsNILL 1036 (1299)
.+.+++ ...++||||+.++.+... |... ... .+..+++.+++.++.+||. .+ |+|||||++||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 334332 245899999999654322 2110 011 6678899999999999998 66 9999999999999
Q ss_pred ccCCcceecCCCccccc
Q 000757 1037 EHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~ 1053 (1299)
+ ++.++|+|||++...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.1e-16 Score=189.17 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=192.7
Q ss_pred CCcceeeEEeecCceEEEEEEec--CCCEEEEEEeeccc--ccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEE
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lk--dGr~VAVK~Lk~~d--~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LV 974 (1299)
..|++.+.||+|.|+.|-..... ....+++|.+.... ....+.+..|..+-+.+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45677788999999999887753 34456777765432 233344556888888887 99999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhh-hcCCCceeeecccccCeeeccCC-cceecCCCcccc
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH-EDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1052 (1299)
Q Consensus 975 yEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLH-s~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~ 1052 (1299)
+||..|+++.+.+.. ......+....-.++.|+..+|.|+| +.+ +.||||||+|.+++..+ ++|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998831 12224566777888999999999999 777 99999999999999999 999999999998
Q ss_pred ccc-cccccccccccc-cccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccc
Q 000757 1053 AMD-EESRHISTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1053 ~~~-~~~~~~st~v~G-T~gYmAPE~l~~~-~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~ 1129 (1299)
+.. ..........+| +..|+|||...+. ......|+||+|+++.-+++|..|++...... .....|.... ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~----~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK----GR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc----cc
Confidence 776 444444555678 9999999988774 55678899999999999999999997654332 1222222110 00
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1130 L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
..............+++.+++..+++.|.+..++..
T Consensus 250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 001111233456778888999899999999888744
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=158.21 Aligned_cols=136 Identities=22% Similarity=0.282 Sum_probs=105.5
Q ss_pred eeEEe-ecCceEEEEEEecCCCEEEEEEeeccc-------------ccchhHHHHHHHHhhhcccccc--eeeeeeeeec
Q 000757 905 SRILG-EGGFGLVYSGVLDDGTKVAVKVLKRVD-------------QQGGREFLAEVEMLSRLHHRNL--VKLIGICIEE 968 (1299)
Q Consensus 905 ~elLG-eGgFGtVYKA~lkdGr~VAVK~Lk~~d-------------~~~~keFlrEIeILsrLrHPNI--VrLlG~~~e~ 968 (1299)
..+|| .|+.|+||++... +..++||+++... .....++.+|++++.+|+|.+| ++.++++..+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35787 8999999998876 6789999885311 1223467889999999998875 6777775443
Q ss_pred cc----eEEEEeecCC-CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcce
Q 000757 969 QA----RCLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1043 (1299)
Q Consensus 969 ~~----~~LVyEYm~G-GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VK 1043 (1299)
.. .++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|||||++||||+.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 689888742 124333 3568999999999988 99999999999999989999
Q ss_pred ecCCCccccc
Q 000757 1044 VSDFGLARSA 1053 (1299)
Q Consensus 1044 LsDFGLAr~~ 1053 (1299)
|+|||.++..
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.2e-13 Score=158.29 Aligned_cols=146 Identities=25% Similarity=0.257 Sum_probs=102.9
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccc----------------------------------------
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---------------------------------------- 939 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~---------------------------------------- 939 (1299)
..|+ .+.||.|++|.||+|++++|+.||||+.+..-...
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 36799999999999999999999999975321000
Q ss_pred hhHHHHHHHHhhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHH-HH
Q 000757 940 GREFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR-AL 1013 (1299)
Q Consensus 940 ~keFlrEIeILsrLr----HPNIVrLlG~~~e-~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~-AL 1013 (1299)
+-+|.+|...+.+++ |.+-+.+-.++.+ ....+|||||++|++|.+++.... ..+ .+.+++..+++ .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHH
Confidence 013455666666553 3333444444432 345789999999999998764211 111 34566666666 46
Q ss_pred HHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 1014 aYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
..+|..| ++|+|+||.||+++++++++|+|||++.....
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7889877 99999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-12 Score=151.40 Aligned_cols=267 Identities=14% Similarity=0.145 Sum_probs=176.6
Q ss_pred CceEEEEEE-ecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeee----eccceEEEEeecCC-CChhh
Q 000757 912 GFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI----EEQARCLVYELIPN-GSVES 985 (1299)
Q Consensus 912 gFGtVYKA~-lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~----e~~~~~LVyEYm~G-GSL~d 985 (1299)
.-.+.||+. ..||..|++|+++....+.......-+++++++.|.|||.|.+++. .+..++|||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 345789998 5689999999995443343434556788999999999999999886 34567999999987 57777
Q ss_pred cccccc-----------cCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccccc
Q 000757 986 HLHGVD-----------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 986 ~L~~~~-----------~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
+-.... ..+..+.+..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+.+|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 554221 12345778999999999999999999988 8889999999999999999999999877654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceee
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIV 1134 (1299)
.+.... +.. -.+-|.-.||.+|+.|.||..--...+. .+..-.+.
T Consensus 445 ~d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~~s~~~~--------------- 489 (655)
T KOG3741|consen 445 EDPTEP----------------LES---QQQNDLRDLGLLLLALATGTENSNRTDS-TQSSHLTR--------------- 489 (655)
T ss_pred CCCCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccccccccc-hHHHHHHH---------------
Confidence 432111 111 1367999999999999999653110000 00000000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHH----------------------HHHHHHHhhhhhhhhcCCCC
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV----------------------QALKLVCNECDEAKEVGSAS 1192 (1299)
Q Consensus 1135 Dp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVL----------------------q~Lk~I~~e~~e~~e~gs~s 1192 (1299)
+...+..++.+++......+.++ -++.+++ .+|.+.++..+.++......
T Consensus 490 -------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~Ls~emENGRLfRll~Kln 561 (655)
T KOG3741|consen 490 -------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETELSREMENGRLFRLLLKLN 561 (655)
T ss_pred -------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHhcchHHHHHHHHh
Confidence 01111222223333332233222 2222222 22444444555555555566
Q ss_pred CCcCccccccCCCCcCCCCCCCCCCCCCCCCC
Q 000757 1193 SSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVP 1224 (1299)
Q Consensus 1193 ss~eD~SidldssvSsgsgqlp~sk~R~~Sln 1224 (1299)
...+..+...|..|++.+.+....+.|+|-.-
T Consensus 562 ~I~dR~e~~~D~~WSesG~~fmi~LFRDYlFH 593 (655)
T KOG3741|consen 562 FIDDRPEYVDDPDWSESGDRFMIKLFRDYLFH 593 (655)
T ss_pred hhccCcccccCCcchhccceehHHHHHHhhhe
Confidence 67777777788889999998888888888654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=129.66 Aligned_cols=130 Identities=18% Similarity=0.071 Sum_probs=98.2
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccce-eeeeeeeeccceEEEEeecCCCCh
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
.+.|+.|.++.||++... ++.|++|+...... ....+.+|+++++.+.+.+++ +++++. .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999876 77899999764321 234578899999999765554 444443 3345899999999887
Q ss_pred hhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC--CCceeeecccccCeeeccCCcceecCCCccc
Q 000757 984 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 984 ~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g--sp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
.+.. .....++.+++++|+.||..+ ...++|||+++.||+++ ++.++|+|||.+.
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6431 111345678999999999876 22369999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.5e-13 Score=148.45 Aligned_cols=207 Identities=22% Similarity=0.294 Sum_probs=142.9
Q ss_pred HHHhhhcccccceeeeeeeeecc-----ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCC
Q 000757 947 VEMLSRLHHRNLVKLIGICIEEQ-----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021 (1299)
Q Consensus 947 IeILsrLrHPNIVrLlG~~~e~~-----~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gs 1021 (1299)
...|-++-|-|||+++.|+.+.+ ...++.|||..|+|.++|++..+....+......+|+.||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999987543 46899999999999999987766666777888899999999999999988 6
Q ss_pred CceeeecccccCeeeccCCcceecCCCccc--cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHH
Q 000757 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1099 (1299)
Q Consensus 1022 p~IVHRDIKPsNILLDedg~VKLsDFGLAr--~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELL 1099 (1299)
+.|+|+++..+-|++..++-+||.----.. ...............+-.+|.+||+-..-..+..+|||+||++.+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999888874211110 000000011112234678999999887778888999999999999998
Q ss_pred hCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000757 1100 SGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1100 TGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~ 1174 (1299)
.|..--... .. ...+ ++.+...+- .+... .=+.++..|++.+|..||+|.+++..
T Consensus 277 ilEiq~tns--eS-~~~~---------ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNS--ES-KVEV---------EENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCC--cc-eeeh---------hhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 876421110 00 0000 000110000 00000 11346889999999999999998644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.4e-12 Score=154.58 Aligned_cols=148 Identities=20% Similarity=0.216 Sum_probs=95.0
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecC-CCEEEEEEeecccc----------------------------------cchh
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQ----------------------------------QGGR 941 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~~d~----------------------------------~~~k 941 (1299)
....+|+. +-||.|++|.||+|++++ |+.||||+++..-. +..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 789999999999999887 99999999863210 0011
Q ss_pred ------HHHHHHHHhhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhcc--cccccCCCCCChhHHHHHHHH
Q 000757 942 ------EFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALG 1008 (1299)
Q Consensus 942 ------eFlrEIeILsrLr----HPNIVrLlG~~~e-~~~~~LVyEYm~GGSL~d~L--~~~~~~~~pLdw~erlkIa~Q 1008 (1299)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++. .........+.......++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2344444444443 3333444344433 34568999999999998742 111100011222222333333
Q ss_pred HHHHHHHhhhcCCCceeeecccccCeeeccCC----cceecCCCccccccc
Q 000757 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSDFGLARSAMD 1055 (1299)
Q Consensus 1009 IA~ALaYLHs~gsp~IVHRDIKPsNILLDedg----~VKLsDFGLAr~~~~ 1055 (1299)
+...| ++|+|+||.||+|+.++ ++++.|||++.....
T Consensus 276 -------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33455 99999999999999888 999999999976644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-12 Score=153.19 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=179.6
Q ss_pred CcceeeEEee--cCceEEEEEEe---cCCCEEEEEEeec--ccccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceE
Q 000757 901 NFDASRILGE--GGFGLVYSGVL---DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 901 nFsi~elLGe--GgFGtVYKA~l---kdGr~VAVK~Lk~--~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~ 972 (1299)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........=++|+...++++ |.|.++.+..+.+.+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667788999 99999999986 3677889988432 22233334457888888885 999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHH----HHHHhhhcCCCceeeecccccCeeeccC-CcceecCC
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR----ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 1047 (1299)
Q Consensus 973 LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~----ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDF 1047 (1299)
+-+|++ +.+|.++.+.... .+.....+.++.+..+ ||.++|... |+|-|+|+.||++..+ ..++++||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 999999 5788888764332 2555666667777777 999999776 9999999999999999 89999999
Q ss_pred Cccccccccccccc---cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhccc
Q 000757 1048 GLARSAMDEESRHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~---st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~pll 1124 (1299)
|+...+........ ..+..|...|++||.+ .+.++.++|+|+||.+++|-.+|.......... .|.. +
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc--c
Confidence 99988766443221 2233688899999954 567789999999999999999987755332111 1211 1
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000757 1125 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173 (1299)
Q Consensus 1125 s~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq 1173 (1299)
. .+. +..++......++..++..+++.++..|++..++..
T Consensus 339 r------~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 R------QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c------ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 111 111122222344555889999999999998877654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.5e-11 Score=124.98 Aligned_cols=142 Identities=22% Similarity=0.300 Sum_probs=111.7
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccc-cchhHHHHHHHHhhhcccc--cceeeeeeeeecc---ceEEEEeecC
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHR--NLVKLIGICIEEQ---ARCLVYELIP 979 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~-~~~keFlrEIeILsrLrHP--NIVrLlG~~~e~~---~~~LVyEYm~ 979 (1299)
+.|+.|.++.||++...+|+.+++|+...... ....++.+|+++++.+++. ++.+++.++.+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778899999764322 2456789999999999764 4577787776543 5689999999
Q ss_pred CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--------------------------------------- 1020 (1299)
Q Consensus 980 GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g--------------------------------------- 1020 (1299)
|++|.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876631 24677788888888888888888531
Q ss_pred --------------CCceeeecccccCeeecc--CCcceecCCCcccc
Q 000757 1021 --------------SPRVIHRDFKSSNILLEH--DFTPKVSDFGLARS 1052 (1299)
Q Consensus 1021 --------------sp~IVHRDIKPsNILLDe--dg~VKLsDFGLAr~ 1052 (1299)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-11 Score=147.87 Aligned_cols=250 Identities=21% Similarity=0.193 Sum_probs=179.8
Q ss_pred HHHHhCCcceeeEEeecCceEEEEEEe--cCCCEEEEEEeecccccchhHH--HHHHHHhhhcc-cccceeeeeeeeecc
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGVL--DDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH-HRNLVKLIGICIEEQ 969 (1299)
Q Consensus 895 Le~at~nFsi~elLGeGgFGtVYKA~l--kdGr~VAVK~Lk~~d~~~~keF--lrEIeILsrLr-HPNIVrLlG~~~e~~ 969 (1299)
....+.+|.++..||.|.|+.||+... .++..|++|.+.+.......++ +.|+-+...+. |.++++.+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 345567899999999999999999873 4678899999876433333333 46777777774 889999888888778
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC-CcceecCCC
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFG 1048 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDFG 1048 (1299)
..|+=.|||+++++...+ ....-++.+.++++..|++.++.++|+.. ++|+|+|++||++..+ +..+++|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence 888999999999987766 22345788899999999999999999776 9999999999999876 889999999
Q ss_pred ccccccccccccccccccccccc-cCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccc
Q 000757 1049 LARSAMDEESRHISTRVMGTFGY-VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~v~GT~gY-mAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~ 1127 (1299)
+...+.- .. ....-++..| .+++......+..+.|+|+||+-+.|.++|..--. +.+.|..-
T Consensus 413 ~~t~~~~---~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~i----- 475 (524)
T KOG0601|consen 413 CWTRLAF---SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLTI----- 475 (524)
T ss_pred cccccce---ec-ccccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccceee-----
Confidence 9864211 10 1111133344 35555566778899999999999999999865221 11222110
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1128 e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVLq~Lk 1176 (1299)
.. ..-...+... .++..+...++..++..|+.+.++.....
T Consensus 476 ------~~-~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 ------RS-GDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ------ec-ccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00 0001111222 66778888889999999999888766544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.1e-10 Score=141.20 Aligned_cols=166 Identities=22% Similarity=0.265 Sum_probs=127.1
Q ss_pred ecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChh
Q 000757 921 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1000 (1299)
Q Consensus 921 lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~ 1000 (1299)
..++..|.|+..+.......+...+-++.|+.||||||+++++.+++++..|||+|.+. -|..+|.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45688899998876555445667888999999999999999999999999999999883 45666642 3356
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccccCccccccC
Q 000757 1001 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080 (1299)
Q Consensus 1001 erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~ 1080 (1299)
.....+.||+.||.|||+.+ .++|++|.-..|+|++.|+.||++|.++.....-.. ......--..|..||.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 67778899999999999776 699999999999999999999999998865432111 00111112345566644322
Q ss_pred CCCccccchhhHHHHHHHHhC
Q 000757 1081 HLLVKSDVYSYGVVILELLSG 1101 (1299)
Q Consensus 1081 ~~T~KSDVWSLGVVLyELLTG 1101 (1299)
. ...|.|.|||++||++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=123.60 Aligned_cols=135 Identities=19% Similarity=0.212 Sum_probs=97.9
Q ss_pred eEEeecCceEEEEEEecC-------CCEEEEEEeecc-------------c---------ccchhHHH----HHHHHhhh
Q 000757 906 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRV-------------D---------QQGGREFL----AEVEMLSR 952 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-------Gr~VAVK~Lk~~-------------d---------~~~~keFl----rEIeILsr 952 (1299)
..||.|..+.||.|...+ +..+|||+.+.. + ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998553 478999997420 0 00112233 79999999
Q ss_pred ccc--ccceeeeeeeeeccceEEEEeecCCCChhh-cccccccCCCCCChhHHHHHHHHHHHHHHHh-hhcCCCceeeec
Q 000757 953 LHH--RNLVKLIGICIEEQARCLVYELIPNGSVES-HLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRD 1028 (1299)
Q Consensus 953 LrH--PNIVrLlG~~~e~~~~~LVyEYm~GGSL~d-~L~~~~~~~~pLdw~erlkIa~QIA~ALaYL-Hs~gsp~IVHRD 1028 (1299)
|.. -++-+.+++ ...+|||||+.++.+.. .|+ ...++..+...+..+++.+|.+| |+.+ |||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 864 355566654 45689999997654422 221 11344556677889999999999 7776 99999
Q ss_pred ccccCeeeccCCcceecCCCccccc
Q 000757 1029 FKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1029 IKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|++.|||++ ++.++|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5e-10 Score=140.19 Aligned_cols=250 Identities=20% Similarity=0.217 Sum_probs=172.5
Q ss_pred HhCCcceeeEEeecCceEEEEEEe-cCCCEEEEEEeecc---cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEE
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 898 at~nFsi~elLGeGgFGtVYKA~l-kdGr~VAVK~Lk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~L 973 (1299)
..++|.+.+-+-+|.++.++.+.- ..|-..++|+.+.. .....+.++++-.++-..+++-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 345677778888999999998772 23433455544322 22223344445555545566777766655555677899
Q ss_pred EEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|++|+.+++|...||... ..+.+.....+..+...++|||... ++|||+++.|+|+..++..+++|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999997533 3455555666777888999999775 899999999999999999999999843321
Q ss_pred ccc-----------------------------ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCC
Q 000757 1054 MDE-----------------------------ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104 (1299)
Q Consensus 1054 ~~~-----------------------------~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~P 1104 (1299)
... +.........||..|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 000112345689999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000757 1105 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169 (1299)
Q Consensus 1105 Fd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMs 1169 (1299)
|+........ ...+. . .-+ ......+...+..+++.+.+..++.+|-.+.
T Consensus 1035 ~na~tpq~~f------~ni~~------~-~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF------ENILN------R-DIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh------hcccc------C-CCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9765543211 00000 0 000 1122334455677888888889999998776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.1e-09 Score=111.05 Aligned_cols=143 Identities=21% Similarity=0.300 Sum_probs=106.4
Q ss_pred eeeEEeecCceEEEEEEecCCCEEEEEE-eecc-------cccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEE
Q 000757 904 ASRILGEGGFGLVYSGVLDDGTKVAVKV-LKRV-------DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 904 i~elLGeGgFGtVYKA~lkdGr~VAVK~-Lk~~-------d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVy 975 (1299)
...+|-+|+.+.|+++.+. |+.+.||. +.+. ..-..++.++|+++|.+++--.|..-.-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999988 77777775 3211 1223456788999999998666665555667777778999
Q ss_pred eecCC-CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCC---cceecCCCccc
Q 000757 976 ELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLAR 1051 (1299)
Q Consensus 976 EYm~G-GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg---~VKLsDFGLAr 1051 (1299)
||++| .++.+++..... ..........++..|-+.+.-||..+ |||+||..+||+|..++ .+.|+||||+.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 478888754322 12222333678888899999999888 99999999999996543 45899999986
Q ss_pred c
Q 000757 1052 S 1052 (1299)
Q Consensus 1052 ~ 1052 (1299)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.7e-09 Score=112.04 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=99.7
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEE-eecc------c-ccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKV-LKRV------D-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~-Lk~~------d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEY 977 (1299)
..|++|+-+.+|.+.+. |..+++|. +.+. + .-..++-.+|+.+|.+++--.|..-+-|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999876 44566665 3221 1 11123456899999999866665555566677778899999
Q ss_pred cCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCcccc
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 978 m~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
++|-.|.++|... +..++..+-+-+.-||..+ |||+||..+||+|..++ +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888421 3567777888889999988 99999999999998664 99999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=111.53 Aligned_cols=140 Identities=16% Similarity=0.092 Sum_probs=101.0
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccc-----------cchhHHHHHHHHhhhccccc--ceeeeeeeee-----
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-----------QGGREFLAEVEMLSRLHHRN--LVKLIGICIE----- 967 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~-----------~~~keFlrEIeILsrLrHPN--IVrLlG~~~e----- 967 (1299)
+.+-+.....|++..++ |+.|.||+...... .....+.+|...+.+|...+ +..++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44444444557777665 78899997643221 01114789999999986444 3445556543
Q ss_pred ccceEEEEeecCCC-ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeecc-------C
Q 000757 968 EQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-------D 1039 (1299)
Q Consensus 968 ~~~~~LVyEYm~GG-SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-------d 1039 (1299)
....+||+|++++. +|.+++.... ....+...+..++.+++..+.-||+.| |+|+|++++||||+. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 7988874221 223556778899999999999999998 999999999999985 4
Q ss_pred CcceecCCCccc
Q 000757 1040 FTPKVSDFGLAR 1051 (1299)
Q Consensus 1040 g~VKLsDFGLAr 1051 (1299)
+.+.|+||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.5e-08 Score=105.63 Aligned_cols=125 Identities=25% Similarity=0.301 Sum_probs=81.8
Q ss_pred EEEEEEecCCCEEEEEEeecc-------------ccc--------c-----hhHHHHHHHHhhhcccc--cceeeeeeee
Q 000757 915 LVYSGVLDDGTKVAVKVLKRV-------------DQQ--------G-----GREFLAEVEMLSRLHHR--NLVKLIGICI 966 (1299)
Q Consensus 915 tVYKA~lkdGr~VAVK~Lk~~-------------d~~--------~-----~keFlrEIeILsrLrHP--NIVrLlG~~~ 966 (1299)
.||.|...+|..||||+.+.. +.. . .....+|.+.|.++..- ++-+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999996420 000 0 11346799999999765 455665442
Q ss_pred eccceEEEEeecC--CCChhhcccccccCCCCCChhHHHHHHHHHHHHHHH-hhhcCCCceeeecccccCeeeccCCcce
Q 000757 967 EEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-LHEDSSPRVIHRDFKSSNILLEHDFTPK 1043 (1299)
Q Consensus 967 e~~~~~LVyEYm~--GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaY-LHs~gsp~IVHRDIKPsNILLDedg~VK 1043 (1299)
..+|||||++ |..+.. |... .++.++...++.+++..+.. +|..| |+|+||...|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 4579999998 444433 3211 12245667788888886665 56776 9999999999999987 999
Q ss_pred ecCCCccccc
Q 000757 1044 VSDFGLARSA 1053 (1299)
Q Consensus 1044 LsDFGLAr~~ 1053 (1299)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.9e-07 Score=107.43 Aligned_cols=272 Identities=18% Similarity=0.198 Sum_probs=160.2
Q ss_pred ceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhc-ccccceeeeee------eee-ccceEEE
Q 000757 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI------CIE-EQARCLV 974 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~------~~e-~~~~~LV 974 (1299)
...+.||+|+.+.+|-.- .-+..+-|+...-......+ .++.|... .|+-+-.-+.+ .-+ ....-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 446789999999999532 22234556665322221112 22223333 45543331111 011 2225677
Q ss_pred EeecCCCC-hhhcccc--cccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 975 YELIPNGS-VESHLHG--VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 975 yEYm~GGS-L~d~L~~--~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|..+.+.. +.+++.- .+..-...+|+..++++..+|.+.+.||+.| .+-+|+..+|+||.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776642 2222211 1112234799999999999999999999998 7889999999999999999998865433
Q ss_pred cccccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCchh-h-hH-Hhhhc
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQE-N-LV-AWARP 1122 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~-----~~~~T~KSDVWSLGVVLyELLTG-r~PFd~s~~~~~~-n-LV-~wa~p 1122 (1299)
.. ........-+|...|..||..+ +-..+...|.|.|||++++||.| +.||.+....... + +. +.+.-
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 22 1222223456889999999765 23446788999999999999986 9999765322110 0 00 00110
Q ss_pred ccccccccceeecCCCCCCCChhh-HHHHHHHHHHhcCcC--cCCCCCHHHHHHHHHHHHhhhhhhh
Q 000757 1123 LLTSREGLERIIDPSLGNDVPFDS-VAKVAAIASMCVQPE--VQHRPFMGEVVQALKLVCNECDEAK 1186 (1299)
Q Consensus 1123 lls~~e~L~eIVDp~L~~~~p~ee-~~eL~~LI~~CL~~d--PskRPSMsEVLq~Lk~I~~e~~e~~ 1186 (1299)
.+........-..+. ....+... ...+..|..+|+... +.-||+.+-++..|..+.++..+..
T Consensus 243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 111000000000000 01122221 245667788887654 5689999999999988877766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.7e-09 Score=127.86 Aligned_cols=153 Identities=17% Similarity=0.242 Sum_probs=106.1
Q ss_pred HHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccc-------cccccccccccccCccccc
Q 000757 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR-------HISTRVMGTFGYVAPEYAM 1078 (1299)
Q Consensus 1006 a~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~-------~~st~v~GT~gYmAPE~l~ 1078 (1299)
+.+++.||.|+|+.. ++||++|.|++|.++.++..||+.|+++......... ...-...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999764 7999999999999999999999999998755431111 1111233457899999999
Q ss_pred cCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHh
Q 000757 1079 TGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMC 1157 (1299)
Q Consensus 1079 ~~~~T~KSDVWSLGVVLyELLT-Gr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~C 1157 (1299)
....+.++|+|||||++|.+.. |+.-+...+........ ...+..-...+......++.+=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHH
Confidence 9889999999999999999995 55544433221111110 01111111122234556788888899
Q ss_pred cCcCcCCCCCHHHHHHH
Q 000757 1158 VQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1158 L~~dPskRPSMsEVLq~ 1174 (1299)
+..+...||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-07 Score=99.49 Aligned_cols=106 Identities=23% Similarity=0.257 Sum_probs=84.2
Q ss_pred hhHHHHHHHHhhhcccc--cceeeeeeeeecc----ceEEEEeecCCC-ChhhcccccccCCCCCChhHHHHHHHHHHHH
Q 000757 940 GREFLAEVEMLSRLHHR--NLVKLIGICIEEQ----ARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARA 1012 (1299)
Q Consensus 940 ~keFlrEIeILsrLrHP--NIVrLlG~~~e~~----~~~LVyEYm~GG-SL~d~L~~~~~~~~pLdw~erlkIa~QIA~A 1012 (1299)
.....+|...+.+|+.. .+.+.+++.+... ..+||+|++++. +|.+++.... .++...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 44678899999888643 3556666665532 348999999884 7998885322 15667788999999999
Q ss_pred HHHhhhcCCCceeeecccccCeeeccCC---cceecCCCcccc
Q 000757 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLARS 1052 (1299)
Q Consensus 1013 LaYLHs~gsp~IVHRDIKPsNILLDedg---~VKLsDFGLAr~ 1052 (1299)
++-||+.| |+|+|+++.||||+.+. ++.|+||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999998 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.4e-07 Score=102.79 Aligned_cols=136 Identities=23% Similarity=0.164 Sum_probs=95.1
Q ss_pred CcceeeEEeecCceEEEEEEecCCCEEEEEEeec----------ccc------------cchhHHHHHHHHhhhcccc--
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR----------VDQ------------QGGREFLAEVEMLSRLHHR-- 956 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~----------~d~------------~~~keFlrEIeILsrLrHP-- 956 (1299)
-..+++.||.|.-+.||.|...+|+.+|||.-+. ... ......++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3556789999999999999999999999997421 000 0112356899999998754
Q ss_pred cceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 957 NIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
.|-+-+++ +...+||||++|--|...- ++-+..-.|+..|++-+.-+-+.| |||+|+..-||||
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 55555543 4568999999886554322 122233334444444444444555 9999999999999
Q ss_pred ccCCcceecCCCcccc
Q 000757 1037 EHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~ 1052 (1299)
++||.+.|+||=.+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.5e-08 Score=118.93 Aligned_cols=98 Identities=12% Similarity=0.025 Sum_probs=70.9
Q ss_pred ccccChhhHHhhhhcccCccccccccCCCCeeEEEeeCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCcccCCccc
Q 000757 723 GEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIG-IIDDGPYSGNNGRATKPEGVDVPKRR 801 (1299)
Q Consensus 723 ~~sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LsGpIPs~ls~~~-tf~assFaGN~GLCG~PL~vd~~~~r 801 (1299)
--.+..++.|||++|.|+|.||..++.|.+|+.|+|++|+|+|.+|..+.... ......+.||.++|+.|....|...
T Consensus 462 ~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~- 540 (623)
T PLN03150 462 LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH- 540 (623)
T ss_pred HhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCccc-
Confidence 44567889999999999999999999999999999999999999997765421 1224467999999998754445321
Q ss_pred cccCCCCceeeeehhHHHHHHHHH
Q 000757 802 QKYGLSGGMIAIVVLSAFVAVVLC 825 (1299)
Q Consensus 802 skkglS~giIa~IVVgavVavVLl 825 (1299)
.+.+.+++++++++++++++
T Consensus 541 ----~~~~~~i~~~~~~~~~~l~~ 560 (623)
T PLN03150 541 ----LSVGAKIGIAFGVSVAFLFL 560 (623)
T ss_pred ----CCCceEEEEEhHHHHHHHHH
Confidence 22344555555555444333
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=90.52 Aligned_cols=144 Identities=22% Similarity=0.254 Sum_probs=87.1
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeeeeeeee---ccceEEEEeecC
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIE---EQARCLVYELIP 979 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~~~e---~~~~~LVyEYm~ 979 (1299)
.+.|+.|..+.||+...++ ..+++|+.... ...+++.+|+++++.|.... +.+++.++.. ....+++|+|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999887 68999997643 45567889999999986443 4567765433 234689999999
Q ss_pred CCChhh----------------cc---cccccCCCCCChhHH---------HHH------------HHHHHH-HHHHhhh
Q 000757 980 NGSVES----------------HL---HGVDKESAPLGWDAR---------LKI------------ALGAAR-ALAYLHE 1018 (1299)
Q Consensus 980 GGSL~d----------------~L---~~~~~~~~pLdw~er---------lkI------------a~QIA~-ALaYLHs 1018 (1299)
|..+.+ .| |........+.+... ... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111111111111110 000 111222 3333432
Q ss_pred c----CCCceeeecccccCeeec-cCCcceecCCCccc
Q 000757 1019 D----SSPRVIHRDFKSSNILLE-HDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1019 ~----gsp~IVHRDIKPsNILLD-edg~VKLsDFGLAr 1051 (1299)
. ....++|+|+.+.|||++ +++++.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 234599999999999999 66677899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.7e-06 Score=94.77 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=86.1
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeeeeeeeeccceEEEEeecCCCC-
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIEEQARCLVYELIPNGS- 982 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~~~e~~~~~LVyEYm~GGS- 982 (1299)
..||+|..+.||+.. |..+++|...... ....+.+|.++++.+..-. +.+.++++.+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 478999999999842 4567888876422 3356789999999997544 4677788777777889999998863
Q ss_pred hhhc---------------------ccccccCCCCCCh-hHHH-HHHH-------HHHH-HHHHhhhc-CCCceeeeccc
Q 000757 983 VESH---------------------LHGVDKESAPLGW-DARL-KIAL-------GAAR-ALAYLHED-SSPRVIHRDFK 1030 (1299)
Q Consensus 983 L~d~---------------------L~~~~~~~~pLdw-~erl-kIa~-------QIA~-ALaYLHs~-gsp~IVHRDIK 1030 (1299)
+.+. ||........+.. ..++ ..+. .+.. ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2211 1211111111100 0000 0000 0001 12222211 13357899999
Q ss_pred ccCeeeccCCcceecCCCccc
Q 000757 1031 SSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1031 PsNILLDedg~VKLsDFGLAr 1051 (1299)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.9e-06 Score=94.22 Aligned_cols=137 Identities=18% Similarity=0.158 Sum_probs=102.1
Q ss_pred eecCceEEEEEEecCCCEEEEEEeecc-----c-ccchhHHHHHHHHhhhccccc--ceeeeeeee-ec----cceEEEE
Q 000757 909 GEGGFGLVYSGVLDDGTKVAVKVLKRV-----D-QQGGREFLAEVEMLSRLHHRN--LVKLIGICI-EE----QARCLVY 975 (1299)
Q Consensus 909 GeGgFGtVYKA~lkdGr~VAVK~Lk~~-----d-~~~~keFlrEIeILsrLrHPN--IVrLlG~~~-e~----~~~~LVy 975 (1299)
|+||.+-|++-.++ |..+-+|+-... . ......|.+|+..|.+|..-+ +.+.+ ++. .. -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 56899999998777 456888886421 1 345678999999999996433 44444 332 21 2347999
Q ss_pred eecCC-CChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCc--ceecCCCcccc
Q 000757 976 ELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--PKVSDFGLARS 1052 (1299)
Q Consensus 976 EYm~G-GSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~--VKLsDFGLAr~ 1052 (1299)
|-+.| -+|.+++.+. ...+.+..++..++.+++..++-||..+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 5788887432 1235677888999999999999999988 999999999999986666 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-06 Score=106.02 Aligned_cols=146 Identities=24% Similarity=0.241 Sum_probs=94.0
Q ss_pred CCcceeeEEeecCceEEEEEEecCCCEEEEEEeecc----------------------ccc----c--------------
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV----------------------DQQ----G-------------- 939 (1299)
Q Consensus 900 ~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~----------------------d~~----~-------------- 939 (1299)
..|+. +-|+.++-|.||+|++++|+.||||+.+.. ... .
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34442 568899999999999999999999996410 000 0
Q ss_pred hhHHHHHHHHhhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHH-H
Q 000757 940 GREFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA-L 1013 (1299)
Q Consensus 940 ~keFlrEIeILsrLr----HPNIVrLlG~~~e-~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~A-L 1013 (1299)
+-++.+|...+.+++ ...-+++=.+|++ .....|+|||++|-.+.+...-. ...++.+. |+..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHHHHHHH
Confidence 012445555555553 2223333344443 45668999999999988874211 12344333 33333332 2
Q ss_pred HHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccc
Q 000757 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 1014 aYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
..+=..| ++|.|.+|.||+|+.++++.+.|||+......
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222344 99999999999999999999999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.1e-06 Score=90.35 Aligned_cols=140 Identities=21% Similarity=0.193 Sum_probs=86.5
Q ss_pred EeecCc-eEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-cccceeeeeeeeeccceEEEEeecCCCChhh
Q 000757 908 LGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVES 985 (1299)
Q Consensus 908 LGeGgF-GtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~e~~~~~LVyEYm~GGSL~d 985 (1299)
|-.|.. ..||+...+ +..++||+..... ..++.+|+++++.|. +--+.++++++...+..++||||++|.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998765 4678888876432 346778999998885 4345577777766667799999999987764
Q ss_pred cc-------------------cccccCCCCCCh--hHHHHHHH--------------------HHHHHHHHhhh----cC
Q 000757 986 HL-------------------HGVDKESAPLGW--DARLKIAL--------------------GAARALAYLHE----DS 1020 (1299)
Q Consensus 986 ~L-------------------~~~~~~~~pLdw--~erlkIa~--------------------QIA~ALaYLHs----~g 1020 (1299)
.. |........+.. ..++.... .+...+.+|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 111111111110 01110000 01111222211 12
Q ss_pred CCceeeecccccCeeeccCCcceecCCCccc
Q 000757 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1021 sp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
.+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3458999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=8e-06 Score=90.01 Aligned_cols=138 Identities=15% Similarity=0.183 Sum_probs=96.2
Q ss_pred HHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHH---------HHHHHHhhhcccccceee---eee
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF---------LAEVEMLSRLHHRNLVKL---IGI 964 (1299)
Q Consensus 897 ~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keF---------lrEIeILsrLrHPNIVrL---lG~ 964 (1299)
...++|...+++-......|.+-..+ |+.+++|..+......++.| .+++..+.+++...+..+ +.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45688999999988888888876666 78899999865443333333 345555666654333332 222
Q ss_pred eee-----ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccC
Q 000757 965 CIE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1039 (1299)
Q Consensus 965 ~~e-----~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDed 1039 (1299)
... ....+|||||++|..|.++.. ++. .+...+..+|.-||+.| ++|+|..+.|++|+++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 221 234468999999998877652 222 24456777899999998 9999999999999865
Q ss_pred CcceecCCCccc
Q 000757 1040 FTPKVSDFGLAR 1051 (1299)
Q Consensus 1040 g~VKLsDFGLAr 1051 (1299)
.+++.||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=9.7e-06 Score=90.53 Aligned_cols=152 Identities=21% Similarity=0.262 Sum_probs=96.8
Q ss_pred CCHHHHHHHhCCcceeeEEe---ecCceEEEEEEecCCCEEEEEEeecccccc---------hhHH--------------
Q 000757 890 FSASEIEKATGNFDASRILG---EGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---------GREF-------------- 943 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi~elLG---eGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~---------~keF-------------- 943 (1299)
.+++.|.....+..+.++.| .|..+.||+|...+++.||||+++...... ..+|
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 35666777777777766655 677889999998889999999985321111 1111
Q ss_pred -HHHHHHhhhccc--ccceeeeeeeeeccceEEEEeecCCCC-hhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhc
Q 000757 944 -LAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNGS-VESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019 (1299)
Q Consensus 944 -lrEIeILsrLrH--PNIVrLlG~~~e~~~~~LVyEYm~GGS-L~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~ 1019 (1299)
.+|+..|+++.. =.+-+-+++. .-.|||||+.... -.-.|. .-.+..++...+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 235555555432 1222222222 3369999995441 111221 11233335666777777777777663
Q ss_pred CCCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1020 gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
+ ++||+||.--|||+. ++.+.|+|||-|...
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 2 499999999999999 889999999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.3e-07 Score=110.23 Aligned_cols=192 Identities=18% Similarity=0.137 Sum_probs=136.3
Q ss_pred HHHHHhCCcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc-ceeeeeeeeeccceE
Q 000757 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN-LVKLIGICIEEQARC 972 (1299)
Q Consensus 894 ELe~at~nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN-IVrLlG~~~e~~~~~ 972 (1299)
.++..+..+..-+-+++|+++++||.+---.+....|++... ....-++++|.+++|+| .++.++-+..++..+
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 334444445555678899999999987433344446665432 34556899999999999 777777777788889
Q ss_pred EEEeecCCC-ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 973 LVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 973 LVyEYm~GG-SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
++++|+.++ +...... .....+..-+...+...-+++|+|||+.. =+||| |||..+ ...|..||+...
T Consensus 311 i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred hhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence 999999887 3222221 11122333444556667788999999763 48999 888765 678999999887
Q ss_pred cccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCC
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104 (1299)
Q Consensus 1052 ~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLTGr~P 1104 (1299)
.+.... ......++..|++||+...+.+..+.|+|++|+--.++--|..|
T Consensus 380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 380 QLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 664432 23445689999999999999999999999999876666666554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-05 Score=98.80 Aligned_cols=142 Identities=18% Similarity=0.181 Sum_probs=92.7
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccc-------------------------------c------chhHHHHHHH
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-------------------------------Q------GGREFLAEVE 948 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~-------------------------------~------~~keFlrEIe 948 (1299)
+-||.-..|.||+|++++|+.||||+-+..-. + .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57999999999999999999999999531100 0 0113555655
Q ss_pred Hhhhc----cccc---ceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC
Q 000757 949 MLSRL----HHRN---LVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020 (1299)
Q Consensus 949 ILsrL----rHPN---IVrLlG~~~e-~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g 1020 (1299)
...++ +|-+ -|.+=.++++ .....|+||||+|..+.|... . ++..++-..+..-+.++..-+-+.| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i--~~~gi~~~~i~~~l~~~~~~qIf~~--G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-I--DKRGISPHDILNKLVEAYLEQIFKT--G 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-H--HHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence 55444 3444 1222233333 356789999999998887642 1 1223555555444444433333333 3
Q ss_pred CCceeeecccccCeeecc----CCcceecCCCccccccc
Q 000757 1021 SPRVIHRDFKSSNILLEH----DFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 1021 sp~IVHRDIKPsNILLDe----dg~VKLsDFGLAr~~~~ 1055 (1299)
++|+|=+|.||||+. ++++.+.|||+......
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.06 E-value=3e-05 Score=99.46 Aligned_cols=148 Identities=16% Similarity=0.253 Sum_probs=93.2
Q ss_pred eeEEeecCceEEEEEEecCC---CEEEEEEeeccc-ccchhHHHHHHHHhhhcc-cccc--eeeeeeeeec---cceEEE
Q 000757 905 SRILGEGGFGLVYSGVLDDG---TKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNL--VKLIGICIEE---QARCLV 974 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdG---r~VAVK~Lk~~d-~~~~keFlrEIeILsrLr-HPNI--VrLlG~~~e~---~~~~LV 974 (1299)
.+.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 367777753322 123457889999999996 6665 7888888764 457899
Q ss_pred EeecCCCChhhc-----------------------ccccccCC-------CCCChh--HHHHHH---------------H
Q 000757 975 YELIPNGSVESH-----------------------LHGVDKES-------APLGWD--ARLKIA---------------L 1007 (1299)
Q Consensus 975 yEYm~GGSL~d~-----------------------L~~~~~~~-------~pLdw~--erlkIa---------------~ 1007 (1299)
|||++|..+.+. ||..+... .+.++. ++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988754321 22211110 011111 111111 1
Q ss_pred HHHHHHHHhhhcC--------CCceeeecccccCeeecc-CCc-ceecCCCcccc
Q 000757 1008 GAARALAYLHEDS--------SPRVIHRDFKSSNILLEH-DFT-PKVSDFGLARS 1052 (1299)
Q Consensus 1008 QIA~ALaYLHs~g--------sp~IVHRDIKPsNILLDe-dg~-VKLsDFGLAr~ 1052 (1299)
.+.+.++||..+- ...+||+|+++.|||++. +.+ +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2334466774432 134999999999999985 334 57899998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.3e-05 Score=85.68 Aligned_cols=80 Identities=14% Similarity=0.109 Sum_probs=59.7
Q ss_pred CcceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccc---ccceeeeeeeee---ccceEEE
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH---RNLVKLIGICIE---EQARCLV 974 (1299)
Q Consensus 901 nFsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrH---PNIVrLlG~~~e---~~~~~LV 974 (1299)
.....+.||+|..+.||+....+++ +++|..+. ......|.+|.+.|+.|.- -.+.+++++|.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3445678999999999998776664 67777543 1133588999999999853 357788888754 3568999
Q ss_pred EeecCCCCh
Q 000757 975 YELIPNGSV 983 (1299)
Q Consensus 975 yEYm~GGSL 983 (1299)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00023 Score=84.79 Aligned_cols=76 Identities=21% Similarity=0.179 Sum_probs=55.2
Q ss_pred eeEEeecCceEEEEEEecCC-CEEEEEEeecc-----c--ccchhHHHHHHHHhhhcc---cccceeeeeeeeeccceEE
Q 000757 905 SRILGEGGFGLVYSGVLDDG-TKVAVKVLKRV-----D--QQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdG-r~VAVK~Lk~~-----d--~~~~keFlrEIeILsrLr---HPNIVrLlG~~~e~~~~~L 973 (1299)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|+.+. -.++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 36799999999999998877 48999984311 1 124456788888888873 24567777663 355789
Q ss_pred EEeecCCCC
Q 000757 974 VYELIPNGS 982 (1299)
Q Consensus 974 VyEYm~GGS 982 (1299)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.4e-05 Score=83.16 Aligned_cols=74 Identities=15% Similarity=0.177 Sum_probs=47.7
Q ss_pred eEEeecCce-EEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccc---cceeeeeeeeec---cceEEEEeec
Q 000757 906 RILGEGGFG-LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR---NLVKLIGICIEE---QARCLVYELI 978 (1299)
Q Consensus 906 elLGeGgFG-tVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHP---NIVrLlG~~~e~---~~~~LVyEYm 978 (1299)
+.|+.|+.. .||+. +..+++|..+. .....++.+|+++|..|... -+.++++.+... ...++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467767766 59975 23577887653 22345788999999888632 234444444332 2348899999
Q ss_pred CCCChhh
Q 000757 979 PNGSVES 985 (1299)
Q Consensus 979 ~GGSL~d 985 (1299)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=2.8e-05 Score=83.42 Aligned_cols=103 Identities=24% Similarity=0.255 Sum_probs=81.2
Q ss_pred HHHHHhhhccc-ccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCc
Q 000757 945 AEVEMLSRLHH-RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023 (1299)
Q Consensus 945 rEIeILsrLrH-PNIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~ 1023 (1299)
.|.-+|+.+.+ +++.+++|+| ..++|.||+..+++...-... ..-...+|..|.+|+.++++.+.+|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888888875 6999999999 347899999877664221000 01124689999999999999999999864445
Q ss_pred eeeecccccCeeeccCCcceecCCCcccc
Q 000757 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1024 IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
++-.|++++|+-|++++++|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.5e-05 Score=80.57 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=83.6
Q ss_pred eeEEeecCceEEEEEEecC--CCEEEEEEeecccccchhHHHHHHHHhhhccccc-ceeeeeeeeeccceEEEEeecCCC
Q 000757 905 SRILGEGGFGLVYSGVLDD--GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN-LVKLIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkd--Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN-IVrLlG~~~e~~~~~LVyEYm~GG 981 (1299)
.+.|..|-...+|+....+ ++.|++|+...... ..-+..+|+.+++.+...+ ..++++.+. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888899999998764 67899998754322 2224457999999986433 344444332 24899999997
Q ss_pred Chhhc-----------------ccccccCC-------CCC-ChhHHHHHHH----------------------HHHHHHH
Q 000757 982 SVESH-----------------LHGVDKES-------APL-GWDARLKIAL----------------------GAARALA 1014 (1299)
Q Consensus 982 SL~d~-----------------L~~~~~~~-------~pL-dw~erlkIa~----------------------QIA~ALa 1014 (1299)
++... ||...... ... -|+.+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 11111110 011 1222111111 1111112
Q ss_pred Hh----hhc-CCCceeeecccccCeeecc-CCcceecCCCccc
Q 000757 1015 YL----HED-SSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1051 (1299)
Q Consensus 1015 YL----Hs~-gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr 1051 (1299)
.| -.. ....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 1235899999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=8.5e-05 Score=80.69 Aligned_cols=128 Identities=20% Similarity=0.274 Sum_probs=91.4
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeeccc----------------ccchhHHHHHHHHhhhcc------cccceeee
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD----------------QQGGREFLAEVEMLSRLH------HRNLVKLI 962 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d----------------~~~~keFlrEIeILsrLr------HPNIVrLl 962 (1299)
...||+|+.-.||. ..++....||+++... ....+++++|+....++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999994 5556678999986543 223467788888877776 78899999
Q ss_pred eeeeeccceEEEEeecCCC------ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeee
Q 000757 963 GICIEEQARCLVYELIPNG------SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 963 G~~~e~~~~~LVyEYm~GG------SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
|+..++...-+|+|.+.+. +|.+++. ...++. +..+.+. +-..||-+.+ |+.+||++.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999988653 3666662 223444 3333333 4445666555 9999999999999
Q ss_pred ccCC----cceecC
Q 000757 1037 EHDF----TPKVSD 1046 (1299)
Q Consensus 1037 Dedg----~VKLsD 1046 (1299)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 6432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.83 E-value=7.1e-05 Score=83.61 Aligned_cols=143 Identities=20% Similarity=0.169 Sum_probs=87.9
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeeeee------eeeccceEEEEe
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGI------CIEEQARCLVYE 976 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~------~~e~~~~~LVyE 976 (1299)
.+.|..|....+|+...++ ..+++|+... ...+++..|++++..|.+.+ +.+++.. ....+..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987664 4688898764 23456778999998886433 4444432 122445689999
Q ss_pred ecCCCChhh--------------cccccc----c---CCCCCChhHHHH----------HHHHHHHHHHHhhhc----CC
Q 000757 977 LIPNGSVES--------------HLHGVD----K---ESAPLGWDARLK----------IALGAARALAYLHED----SS 1021 (1299)
Q Consensus 977 Ym~GGSL~d--------------~L~~~~----~---~~~pLdw~erlk----------Ia~QIA~ALaYLHs~----gs 1021 (1299)
|++|..+.. .||... . ......|..... ....+...+.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999887643 011110 0 001123322211 111233445555431 12
Q ss_pred CceeeecccccCeeeccCCcceecCCCccc
Q 000757 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1022 p~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
..++|+|+.+.|||+++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999988777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00012 Score=80.56 Aligned_cols=139 Identities=19% Similarity=0.156 Sum_probs=81.5
Q ss_pred EEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccc-eeeeeeeeeccceEEEEeecCCCChhh
Q 000757 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNGSVES 985 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNI-VrLlG~~~e~~~~~LVyEYm~GGSL~d 985 (1299)
.+..|-.+.+|+... +++.+++|+.........-+..+|.++++.+....+ .+++.++. .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355688889998874 467788988654322221245789999999864434 34444332 369999999877653
Q ss_pred c-----------------ccccccCCCCCChhHHH-HHHHH---------HHHHHHHhhhc-----CCCceeeecccccC
Q 000757 986 H-----------------LHGVDKESAPLGWDARL-KIALG---------AARALAYLHED-----SSPRVIHRDFKSSN 1033 (1299)
Q Consensus 986 ~-----------------L~~~~~~~~pLdw~erl-kIa~Q---------IA~ALaYLHs~-----gsp~IVHRDIKPsN 1033 (1299)
. ||........++...++ .+..+ +.+.+..+-.. ....++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 22222112222222211 11111 11112222111 12348999999999
Q ss_pred eeeccCCcceecCCCccc
Q 000757 1034 ILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1034 ILLDedg~VKLsDFGLAr 1051 (1299)
||+++++ ++|+||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999876 8999999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0002 Score=78.27 Aligned_cols=125 Identities=25% Similarity=0.389 Sum_probs=90.1
Q ss_pred CCcceeeEEeecCc-eEEEEEEecCCCEEEEEEeecc------------cc---------cchhHHHHHHHHhhhcc---
Q 000757 900 GNFDASRILGEGGF-GLVYSGVLDDGTKVAVKVLKRV------------DQ---------QGGREFLAEVEMLSRLH--- 954 (1299)
Q Consensus 900 ~nFsi~elLGeGgF-GtVYKA~lkdGr~VAVK~Lk~~------------d~---------~~~keFlrEIeILsrLr--- 954 (1299)
.+|+..+.||.|.. |.|||++.. |+.+|+|+++.. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 999999988 789999994321 00 11234778988888885
Q ss_pred cccc--eeeeeeeeec------------------cceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHH
Q 000757 955 HRNL--VKLIGICIEE------------------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014 (1299)
Q Consensus 955 HPNI--VrLlG~~~e~------------------~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALa 1014 (1299)
+.++ |+++||..-. ..+.||.||+.... ....+-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4466 9999987321 01246777664432 112334556777888
Q ss_pred HhhhcCCCceeeecccccCeeeccCCcceecCCCcc
Q 000757 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 1015 YLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.||..+ |+-+|+|..|.. +-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 899888 999999999985 3489999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=7.2e-05 Score=80.24 Aligned_cols=127 Identities=21% Similarity=0.243 Sum_probs=86.8
Q ss_pred ceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccccee-eeeeeeeccceEEEEeecCCC
Q 000757 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK-LIGICIEEQARCLVYELIPNG 981 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVr-LlG~~~e~~~~~LVyEYm~GG 981 (1299)
+..+.|++|++|.||+|.+. |..+|+|+-+. +.....+..|+++|..+.-.++-. ++.|.. .++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34578999999999999998 56788988653 344568899999999998766643 444332 24569999998
Q ss_pred ChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccc--cCeeeccCCcceecCCCccc
Q 000757 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKS--SNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 982 SL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKP--sNILLDedg~VKLsDFGLAr 1051 (1299)
.|.++.... +-+++++ ++..---|-..| |-|+.|.- .||++. ++++.|+||.-|+
T Consensus 98 ~L~~~~~~~-------~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~-~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG-------DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVN-DRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc-------cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEec-CCcEEEEEccchh
Confidence 887765321 2223333 333322244444 88888873 555555 4499999999887
|
|
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.7 Score=64.77 Aligned_cols=20 Identities=30% Similarity=0.469 Sum_probs=10.7
Q ss_pred CCCCCCCCCCcccCCCCCCC
Q 000757 618 LPPKSSPSEPIRAFPPPPPN 637 (1299)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~ 637 (1299)
+++.+-++.+.++++.|+.+
T Consensus 2978 ~~pp~~pp~p~p~~~~~~~~ 2997 (3151)
T PHA03247 2978 RVPQPAPSREAPASSTPPLT 2997 (3151)
T ss_pred CCCCCCCCCCCCCCCCCCCC
Confidence 34444455556666665544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00059 Score=77.37 Aligned_cols=159 Identities=20% Similarity=0.234 Sum_probs=92.2
Q ss_pred CCHHHHHHHhCCcce-----eeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeee
Q 000757 890 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 962 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi-----~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLl 962 (1299)
.+.++|......|.+ .+.|+.|....+|+...++| .+++|+.+... ..+++..|++++..|.... +.+++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344566555555655 34566777789999876655 57788765421 2345667888888885322 34444
Q ss_pred eee------eeccceEEEEeecCCCChhhc--------------cccccc----C--C--CCCChhHHHH----------
Q 000757 963 GIC------IEEQARCLVYELIPNGSVESH--------------LHGVDK----E--S--APLGWDARLK---------- 1004 (1299)
Q Consensus 963 G~~------~e~~~~~LVyEYm~GGSL~d~--------------L~~~~~----~--~--~pLdw~erlk---------- 1004 (1299)
... ...+..+++|||++|..+... ||.... . . ..-.|.....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 321 123556899999998664311 121110 0 0 0112221110
Q ss_pred --HHHHHHHHHHHhhh----cCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 1005 --IALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1005 --Ia~QIA~ALaYLHs----~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
....+.+.+++|.. .....++|+|++..||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01123344555542 123469999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00074 Score=76.61 Aligned_cols=158 Identities=17% Similarity=0.201 Sum_probs=87.9
Q ss_pred CCHHHHHHHhCCcce-----eeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeee
Q 000757 890 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 962 (1299)
Q Consensus 890 Fsl~ELe~at~nFsi-----~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLl 962 (1299)
++.+++......|.+ .+.|+.|....+|+...++| .+++|++.. ...+++..|++++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 455566555556655 24566777789999887766 588888752 22344555677777764322 22333
Q ss_pred e------eeeeccceEEEEeecCCCChhh--------------ccccccc-------CCCCCCh-hHHHHH---------
Q 000757 963 G------ICIEEQARCLVYELIPNGSVES--------------HLHGVDK-------ESAPLGW-DARLKI--------- 1005 (1299)
Q Consensus 963 G------~~~e~~~~~LVyEYm~GGSL~d--------------~L~~~~~-------~~~pLdw-~erlkI--------- 1005 (1299)
. +....+..++++||++|..+.. .||.... ....+.| .+.+.-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1122455789999999875421 1111110 0011222 211111
Q ss_pred ---HHH-HHHHHHHhhhc----CCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 1006 ---ALG-AARALAYLHED----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1006 ---a~Q-IA~ALaYLHs~----gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
+.+ +...++.+.+. -...+||+|+++.|||++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 111 11122333211 13359999999999999976556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00095 Score=75.15 Aligned_cols=141 Identities=28% Similarity=0.318 Sum_probs=85.7
Q ss_pred eEEeecCceEEEEEEecC-------CCEEEEEEeecccccchhHHHHHHHHhhhcccccce-eeeeeeeeccceEEEEee
Q 000757 906 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-------Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~e~~~~~LVyEY 977 (1299)
+.|..|-...||+....+ ++.+++|+..... ....+..+|++++..|....+. ++++++. + .+||||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~--~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N--GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C--Cchhhe
Confidence 456677788999988765 4789999976432 2334567899999988644443 4555443 2 368999
Q ss_pred cCCCChhhc-----------------ccccccCC-------CCCChhHHHH--------------------------HHH
Q 000757 978 IPNGSVESH-----------------LHGVDKES-------APLGWDARLK--------------------------IAL 1007 (1299)
Q Consensus 978 m~GGSL~d~-----------------L~~~~~~~-------~pLdw~erlk--------------------------Ia~ 1007 (1299)
++|..+... ||...... ...-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876531 12111110 0111111111 111
Q ss_pred HHHHHHHHhhh------cCCCceeeecccccCeeeccC----CcceecCCCccc
Q 000757 1008 GAARALAYLHE------DSSPRVIHRDFKSSNILLEHD----FTPKVSDFGLAR 1051 (1299)
Q Consensus 1008 QIA~ALaYLHs------~gsp~IVHRDIKPsNILLDed----g~VKLsDFGLAr 1051 (1299)
.+.+.+.+|-. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 123468999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00046 Score=89.26 Aligned_cols=196 Identities=18% Similarity=0.178 Sum_probs=134.4
Q ss_pred HHHHHHhhhcccccceeeeeeeeeccceE----EEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhc
Q 000757 944 LAEVEMLSRLHHRNLVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019 (1299)
Q Consensus 944 lrEIeILsrLrHPNIVrLlG~~~e~~~~~----LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~ 1019 (1299)
..|++.+.++.|.|++.+++|..++...- +..||+...++...+. ....+..++.+.+..++..||+|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 45677788889999999999987654332 3457888888887774 334678888999999999999999987
Q ss_pred CCCceeeeccccc---CeeeccCCcceec--CCCccccccccccccccccccccccccCccccccCCCC--ccccchhhH
Q 000757 1020 SSPRVIHRDFKSS---NILLEHDFTPKVS--DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--VKSDVYSYG 1092 (1299)
Q Consensus 1020 gsp~IVHRDIKPs---NILLDedg~VKLs--DFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T--~KSDVWSLG 1092 (1299)
. +.|.-+..+ +..++.++.+.++ ||+..+...+.... ....-...|.++|......+. .+.|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 4 555555555 5555667777777 99888765432221 122245567888877666554 447999999
Q ss_pred HHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHH
Q 000757 1093 VVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 1172 (1299)
Q Consensus 1093 VVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI~~CL~~dPskRPSMsEVL 1172 (1299)
..+..+..|...-... .....+++. .. ...+.+....|+..+.++|....+++
T Consensus 380 ll~~~~~~~~~i~~~~-------------------~~~~~~l~~----~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-------------------AVPVSLLDV----LS----TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccc-------------------cchhhhhcc----cc----chhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999876532211 001111111 11 11567788999999999999999998
Q ss_pred HHHH
Q 000757 1173 QALK 1176 (1299)
Q Consensus 1173 q~Lk 1176 (1299)
....
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=3.4e-05 Score=100.54 Aligned_cols=159 Identities=11% Similarity=-0.029 Sum_probs=117.4
Q ss_pred HHHHHhhhcccccceeeeeeee--eccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcC--
Q 000757 945 AEVEMLSRLHHRNLVKLIGICI--EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS-- 1020 (1299)
Q Consensus 945 rEIeILsrLrHPNIVrLlG~~~--e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~g-- 1020 (1299)
.|.+-++...|.+++....-.. +..+.|.+++|+.+|.+++.+-+..++...++..-+.....+......-+|...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444455567888776555443 345668999999999999998766666666666666555555455555555442
Q ss_pred CCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh
Q 000757 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1100 (1299)
Q Consensus 1021 sp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAPE~l~~~~~T~KSDVWSLGVVLyELLT 1100 (1299)
..-.+|+++|..|.+|+.+.++|++++|+.+.... .........+++.|+.+++...-.++.++|+|..|+.+|++.-
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 33479999999999999999999999999983221 2222344567889999999998899999999999999999987
Q ss_pred CCCCC
Q 000757 1101 GRKPV 1105 (1299)
Q Consensus 1101 Gr~PF 1105 (1299)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 76654
|
|
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=2.2 Score=60.35 Aligned_cols=13 Identities=31% Similarity=0.350 Sum_probs=6.6
Q ss_pred CccCCCCCCCCCC
Q 000757 87 PAVSAPFDMAPPP 99 (1299)
Q Consensus 87 ~~~~~~~~~~~~~ 99 (1299)
.-+.+.++-|||+
T Consensus 2499 ~~~~~~~~~a~p~ 2511 (3151)
T PHA03247 2499 GGGGPPDPDAPPA 2511 (3151)
T ss_pred CCCCCCCcccCCC
Confidence 3445555555543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0024 Score=73.15 Aligned_cols=76 Identities=24% Similarity=0.250 Sum_probs=49.7
Q ss_pred cceeeEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcc---cccceeeeeeeeeccceEEEEeec
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~e~~~~~LVyEYm 978 (1299)
.+..+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++...++..||||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4446678999999999977 567889999876 233457889999999884 345778888887777779999999
Q ss_pred CCC
Q 000757 979 PNG 981 (1299)
Q Consensus 979 ~GG 981 (1299)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 887
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.002 Score=72.90 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=42.3
Q ss_pred EEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000757 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~~~~LVyEYm~GGSL 983 (1299)
.+++|....||.....+|+.+++|+-... .....+.+|.++|+.|...-=+..-.+... +.-+++|+++.|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~-~~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRVH-TPELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceeee-cCceEEEeccCCCcc
Confidence 34555556677665556888999987532 223567899999998863210111111111 123567777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00023 Score=88.91 Aligned_cols=62 Identities=15% Similarity=0.111 Sum_probs=50.4
Q ss_pred ccChhhHHhhhhcccCccccccccCCCCeeEEEeeCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 000757 725 KFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNN 786 (1299)
Q Consensus 725 sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LsGpIPs~ls~~~tf~assFaGN~ 786 (1299)
.+.+++.|+|+.|.|+|.||..++.|.+|+.|++++|+|+|.+|..+............+|.
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 46788899999999999999999999999999999999999999877653333333334553
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00069 Score=78.41 Aligned_cols=149 Identities=18% Similarity=0.213 Sum_probs=99.2
Q ss_pred CcccCCHHHHHHHhCC---cceeeEEeecCceEEEEEEecCCCEEEEEEee--c-----c----------cccc-----h
Q 000757 886 SAKTFSASEIEKATGN---FDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--R-----V----------DQQG-----G 940 (1299)
Q Consensus 886 S~k~Fsl~ELe~at~n---Fsi~elLGeGgFGtVYKA~lkdGr~VAVK~Lk--~-----~----------d~~~-----~ 940 (1299)
+...+++..|....++ +.+++.||-|.-+.||.+...+|+..++|.-+ + . .... .
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 3344566666555443 67789999999999999999999999999631 1 0 0000 0
Q ss_pred hHHHHHHHHhhhccc-c-cceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhh
Q 000757 941 REFLAEVEMLSRLHH-R-NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018 (1299)
Q Consensus 941 keFlrEIeILsrLrH-P-NIVrLlG~~~e~~~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs 1018 (1299)
-...+|...|+.|.. - -|.+.++ .+..++|||++.|..|.+.-+- .+- -.+...+..-+.-|-+
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~---~~ly~~lm~~Iv~la~ 220 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDP---PTLYDDLMGLIVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-------CCh---HHHHHHHHHHHHHHHH
Confidence 123468888887753 2 2333333 3456899999998888765431 111 2233333444445555
Q ss_pred cCCCceeeecccccCeeeccCCcceecCCCccc
Q 000757 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1019 ~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
+| +||+|+.-=||+|++++.++++||--..
T Consensus 221 ~G---lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 221 HG---LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cC---ceecccchheeEEecCCCEEEeechHhh
Confidence 66 9999999999999999999999996554
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0046 Score=71.94 Aligned_cols=149 Identities=19% Similarity=0.256 Sum_probs=85.8
Q ss_pred ceeeEEeecCceEEEEEEecCCCEEEEEEee--cccccchhHHHHHHHHhhhccc--ccceeeeeeeeecc--ceEEEEe
Q 000757 903 DASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQ--ARCLVYE 976 (1299)
Q Consensus 903 si~elLGeGgFGtVYKA~lkdGr~VAVK~Lk--~~d~~~~keFlrEIeILsrLrH--PNIVrLlG~~~e~~--~~~LVyE 976 (1299)
.+.+.+..|..-.+|+.... ++.++++ .- ........+..+|.++|+.+.- --+-+.+++|.++. ..|+||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34445544444455554444 6777777 32 1223334556678888887753 22345567777665 6699999
Q ss_pred ecCCCChhhccc---------------------ccccC-------------CCCCChhHHHHHHH--------HHHHHHH
Q 000757 977 LIPNGSVESHLH---------------------GVDKE-------------SAPLGWDARLKIAL--------GAARALA 1014 (1299)
Q Consensus 977 Ym~GGSL~d~L~---------------------~~~~~-------------~~pLdw~erlkIa~--------QIA~ALa 1014 (1299)
|++|..+.+.+. +.+.. .+...|...++.+. ...+-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 999854433332 11100 01112222221111 1223345
Q ss_pred HhhhcC-----CCceeeecccccCeeeccCCcceecCCCccccc
Q 000757 1015 YLHEDS-----SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 1015 YLHs~g-----sp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||+.+. ...++|+|+++.||+|+.++-+=|.||+++..-
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 555442 346999999999999999888999999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0039 Score=73.45 Aligned_cols=137 Identities=22% Similarity=0.291 Sum_probs=93.2
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeecc-------cc--cchhH-----------------HHHHHHHhhhcccccc
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRV-------DQ--QGGRE-----------------FLAEVEMLSRLHHRNL 958 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~-------d~--~~~ke-----------------FlrEIeILsrLrHPNI 958 (1299)
-..|..|.-+.||.+.-.+|+.+|||+++.. +. .++.+ ...|+.-|.+|+.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3467789999999999999999999997521 10 00111 1246666777654332
Q ss_pred eeeeeeeeeccceEEEEeecCCCChh-hcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeec
Q 000757 959 VKLIGICIEEQARCLVYELIPNGSVE-SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1037 (1299)
Q Consensus 959 VrLlG~~~e~~~~~LVyEYm~GGSL~-d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLD 1037 (1299)
..---+.. ....|||+|+.....- -.| +...++...+..+..|+++-|.-|-+.| ++||.||.--|+|+.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 21111111 2346999999532221 122 2345777788888889999999998877 799999999999996
Q ss_pred cCCcceecCCCccc
Q 000757 1038 HDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1038 edg~VKLsDFGLAr 1051 (1299)
+|.++|+|-+.+.
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 5689999998765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0076 Score=70.37 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=83.1
Q ss_pred eEEeecCceEEEEEEecC-----CCEEEEEEeecccccchhHHHHHHHHhhhcccccce-eeeeeeeeccceEEEEeecC
Q 000757 906 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkd-----Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~e~~~~~LVyEYm~ 979 (1299)
+.|-.|-...+|+..+.+ ++.|++|+......... +..+|+.+++.+..-++. ++++++.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557788999987542 36789998865432222 336799999998654443 55555532 2 5899998
Q ss_pred CCChhhc-----------------ccccccC--CCCCChhHHHHHHHH-----------------HHHHHHHhh----h-
Q 000757 980 NGSVESH-----------------LHGVDKE--SAPLGWDARLKIALG-----------------AARALAYLH----E- 1018 (1299)
Q Consensus 980 GGSL~d~-----------------L~~~~~~--~~pLdw~erlkIa~Q-----------------IA~ALaYLH----s- 1018 (1299)
+.+|... ||..... ....-|++..++..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 2222111 111223333333221 111222222 1
Q ss_pred cCCCceeeecccccCeeecc-CCcceecCCCccc
Q 000757 1019 DSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1051 (1299)
Q Consensus 1019 ~gsp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr 1051 (1299)
.....++|+|+++.|||+++ ++.++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11235899999999999986 4689999998875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.028 Score=66.61 Aligned_cols=73 Identities=16% Similarity=0.123 Sum_probs=49.0
Q ss_pred EEeecCceEEEEEEecCC-CEEEEEEeec-------ccccchhHHHHHHHHhhhcc--cc-cceeeeeeeeeccceEEEE
Q 000757 907 ILGEGGFGLVYSGVLDDG-TKVAVKVLKR-------VDQQGGREFLAEVEMLSRLH--HR-NLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkdG-r~VAVK~Lk~-------~d~~~~keFlrEIeILsrLr--HP-NIVrLlG~~~e~~~~~LVy 975 (1299)
.||.|....||++...+| +.|+||.-.. .-....++...|.+.|+... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999997755 6899998521 11333456667888887664 33 3444443 3445667999
Q ss_pred eecCCC
Q 000757 976 ELIPNG 981 (1299)
Q Consensus 976 EYm~GG 981 (1299)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.011 Score=66.57 Aligned_cols=65 Identities=15% Similarity=0.171 Sum_probs=40.7
Q ss_pred EEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeeeee------eeeccceEEEEeecCCCChh
Q 000757 915 LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGI------CIEEQARCLVYELIPNGSVE 984 (1299)
Q Consensus 915 tVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~------~~e~~~~~LVyEYm~GGSL~ 984 (1299)
.||+...++| .+++|++.. ..+++..|+.++..|.... +.+++.. ...++..++||||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4898876655 578888752 1244566777777775433 3333322 12245678999999986653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.019 Score=68.83 Aligned_cols=75 Identities=16% Similarity=0.205 Sum_probs=51.1
Q ss_pred eeEEeecCceEEEEEEecC-CCEEEEEEeec---c---cccchhHHHHHHHHhhhcc--cc-cceeeeeeeeeccceEEE
Q 000757 905 SRILGEGGFGLVYSGVLDD-GTKVAVKVLKR---V---DQQGGREFLAEVEMLSRLH--HR-NLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkd-Gr~VAVK~Lk~---~---d~~~~keFlrEIeILsrLr--HP-NIVrLlG~~~e~~~~~LV 974 (1299)
.+.||.|.-..||++.+.+ ++.|+||.-.. . -.-..++...|.++|+.+. -| .+.+++.| +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4688999999999999753 56899998521 1 1233556777888888764 34 34455543 34556789
Q ss_pred EeecCCC
Q 000757 975 YELIPNG 981 (1299)
Q Consensus 975 yEYm~GG 981 (1299)
||++...
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.023 Score=66.53 Aligned_cols=141 Identities=23% Similarity=0.318 Sum_probs=85.6
Q ss_pred EEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccce------eeeeee--eecc--ceEEEEe
Q 000757 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV------KLIGIC--IEEQ--ARCLVYE 976 (1299)
Q Consensus 907 lLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIV------rLlG~~--~e~~--~~~LVyE 976 (1299)
.|.+ .-..||+...++|+. ++|+.... ....++..|++.|..|.-..|. .+=|-. .-.. ..+-|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 567899999887776 88887653 4556778888888888533322 111211 1123 6678999
Q ss_pred ecCCCChhh-c--------------cc----ccc----cCCCCCChhH---H----------HHHHHHHHHHHHHhhhc-
Q 000757 977 LIPNGSVES-H--------------LH----GVD----KESAPLGWDA---R----------LKIALGAARALAYLHED- 1019 (1299)
Q Consensus 977 Ym~GGSL~d-~--------------L~----~~~----~~~~pLdw~e---r----------lkIa~QIA~ALaYLHs~- 1019 (1299)
|++|..+.. . || +.. .......|+. + .....++...++.+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 1 11 111 1112345541 1 11223333444444432
Q ss_pred ---CC---CceeeecccccCeeeccCCc-ceecCCCccc
Q 000757 1020 ---SS---PRVIHRDFKSSNILLEHDFT-PKVSDFGLAR 1051 (1299)
Q Consensus 1020 ---gs---p~IVHRDIKPsNILLDedg~-VKLsDFGLAr 1051 (1299)
-. ..|||+|+.+.|||+|.+.. +.+.|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22999999999999998875 8899999765
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.055 Score=62.64 Aligned_cols=73 Identities=16% Similarity=0.180 Sum_probs=47.9
Q ss_pred ecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhccccc--ceeee---e--eeeeccceEEEEeecCCCC
Q 000757 910 EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI---G--ICIEEQARCLVYELIPNGS 982 (1299)
Q Consensus 910 eGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPN--IVrLl---G--~~~e~~~~~LVyEYm~GGS 982 (1299)
.+....||+...++|+.+++|+.+. ......++..|++.+..|.... ++..+ | +...++..+.|+++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4566789999888888899998753 2234567778888888774221 22211 1 1222456788999998875
Q ss_pred h
Q 000757 983 V 983 (1299)
Q Consensus 983 L 983 (1299)
+
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 4
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.034 Score=64.55 Aligned_cols=144 Identities=17% Similarity=0.247 Sum_probs=82.7
Q ss_pred cceeeEEeecCceEEEEEEecC----CCEEEEEEeecccccchhHHHHHHHHhhhcccccc-eeeeeeeeeccceEEEEe
Q 000757 902 FDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 902 Fsi~elLGeGgFGtVYKA~lkd----Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNI-VrLlG~~~e~~~~~LVyE 976 (1299)
+++ +.|..|-...+|+....+ +..|++|+....... .-+..+|+.+++.+..-++ .++++++. +. +|.+
T Consensus 17 i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~ 90 (330)
T PLN02421 17 FSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS 90 (330)
T ss_pred eEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence 444 345557788999987543 237899988653322 2234679999999975555 35665552 22 5899
Q ss_pred ecCCCChhh-----------------cccccccC--CCCCChhHHHHHHHHH----------------------HHHHHH
Q 000757 977 LIPNGSVES-----------------HLHGVDKE--SAPLGWDARLKIALGA----------------------ARALAY 1015 (1299)
Q Consensus 977 Ym~GGSL~d-----------------~L~~~~~~--~~pLdw~erlkIa~QI----------------------A~ALaY 1015 (1299)
|+++..|.. .||..... ...--|....++..++ .+-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998776532 11222111 1111233332222221 111222
Q ss_pred ----hhhcC-CCceeeecccccCeeecc-CCcceecCCCccc
Q 000757 1016 ----LHEDS-SPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1051 (1299)
Q Consensus 1016 ----LHs~g-sp~IVHRDIKPsNILLDe-dg~VKLsDFGLAr 1051 (1299)
+...+ ...++|+|+.+.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21111 124789999999999975 5789999999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.066 Score=64.53 Aligned_cols=80 Identities=11% Similarity=0.112 Sum_probs=54.3
Q ss_pred eeEEeecCceEEEEEEecCCCEEEEEEeec----ccc---cchhHHHHHHHHhhhcc---cccceeeeeeeeeccceEEE
Q 000757 905 SRILGEGGFGLVYSGVLDDGTKVAVKVLKR----VDQ---QGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 905 ~elLGeGgFGtVYKA~lkdGr~VAVK~Lk~----~d~---~~~keFlrEIeILsrLr---HPNIVrLlG~~~e~~~~~LV 974 (1299)
.+.||.|....||+.... +..|+||+-.. ... ...++-..|.+.|+.+. --++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 568899999999998765 55699998531 111 13344455677776664 247888888887 446789
Q ss_pred EeecCCC--Chhhcc
Q 000757 975 YELIPNG--SVESHL 987 (1299)
Q Consensus 975 yEYm~GG--SL~d~L 987 (1299)
|||++++ .|.+.|
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 9999773 454433
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.019 Score=61.78 Aligned_cols=123 Identities=24% Similarity=0.233 Sum_probs=61.4
Q ss_pred CCEEEEEEeecccccchhHHHHHHHHhhhcccccc-eeeeeeeeeccceEEEEeecCCCChhhc-c--------------
Q 000757 924 GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNGSVESH-L-------------- 987 (1299)
Q Consensus 924 Gr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNI-VrLlG~~~e~~~~~LVyEYm~GGSL~d~-L-------------- 987 (1299)
++.|+||+..... ...-+..+|.++++.+..-++ .++++++.+ .+|+||+++..|... +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678899887543 333455689999998865444 455555432 267799977665331 1
Q ss_pred --ccccc---CCCCCChhHHHHH----------------------HHHHHHHHHHhh----hcCC-CceeeecccccCee
Q 000757 988 --HGVDK---ESAPLGWDARLKI----------------------ALGAARALAYLH----EDSS-PRVIHRDFKSSNIL 1035 (1299)
Q Consensus 988 --~~~~~---~~~pLdw~erlkI----------------------a~QIA~ALaYLH----s~gs-p~IVHRDIKPsNIL 1035 (1299)
|.... .....-|+...++ +..+..-+..+. ..+. ..++|+|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 11111 1111112222222 111122222222 1111 24789999999999
Q ss_pred e-ccCCcceecCCCccc
Q 000757 1036 L-EHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1036 L-Dedg~VKLsDFGLAr 1051 (1299)
+ +.++.++|+||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.037 Score=63.25 Aligned_cols=31 Identities=16% Similarity=0.174 Sum_probs=27.7
Q ss_pred CceeeecccccCeeeccCCcceecCCCcccc
Q 000757 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1022 p~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
..++|+|+...|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.11 Score=69.12 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=81.1
Q ss_pred eEEeecCceEEEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcc-------cccceeee-ee----eee-cc--c
Q 000757 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-------HRNLVKLI-GI----CIE-EQ--A 970 (1299)
Q Consensus 906 elLGeGgFGtVYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLr-------HPNIVrLl-G~----~~e-~~--~ 970 (1299)
+.|+ |..-.+|+....+|+.+++|+.+... ....+..|..+|..|. -+.+++.. |- ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4554 56788999988888899999997532 2234445666666553 22333322 11 111 22 3
Q ss_pred eEEEEeecCCCChhhcc-----------------c----ccc--cCCCCCChhHH-----------------HHHHHHHH
Q 000757 971 RCLVYELIPNGSVESHL-----------------H----GVD--KESAPLGWDAR-----------------LKIALGAA 1010 (1299)
Q Consensus 971 ~~LVyEYm~GGSL~d~L-----------------~----~~~--~~~~pLdw~er-----------------lkIa~QIA 1010 (1299)
.+.+|+|++|..|.+.. | +.. .....+.|+.+ ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999998776511 1 010 11123445421 12222222
Q ss_pred HHHH-----HhhhcCCCceeeecccccCeeeccCC--cce-ecCCCcccc
Q 000757 1011 RALA-----YLHEDSSPRVIHRDFKSSNILLEHDF--TPK-VSDFGLARS 1052 (1299)
Q Consensus 1011 ~ALa-----YLHs~gsp~IVHRDIKPsNILLDedg--~VK-LsDFGLAr~ 1052 (1299)
+.++ .|.+. ...|||+|+...|||++.+. ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 12221 33599999999999999875 565 999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.0077 Score=73.30 Aligned_cols=187 Identities=21% Similarity=0.204 Sum_probs=99.8
Q ss_pred EEEEEecCCCEEEEEEeecccccchhHHHHHHHHhhhcccccceeeeeeeeecc-ceEEEEeecCCCChhhcccccccCC
Q 000757 916 VYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKES 994 (1299)
Q Consensus 916 VYKA~lkdGr~VAVK~Lk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~e~~-~~~LVyEYm~GGSL~d~L~~~~~~~ 994 (1299)
.+.|...+|+.+ .--+- -.....+++-...+++.+.|+|+...+++..... ...+|+|++ +.+|++.+....
T Consensus 5 ~~~a~~~~~~~c-~nglp--lt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--- 77 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLP--LTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--- 77 (725)
T ss_pred EEehhcCCCccc-cCCCc--CCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---
Confidence 455665555533 22111 1122346677788899999999999999876543 357889998 889999884321
Q ss_pred CCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCccccccccccccccccccccccccCc
Q 000757 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074 (1299)
Q Consensus 995 ~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~v~GT~gYmAP 1074 (1299)
+ ++...+ -| ++.|. | ..+++| -++. +. ....|
T Consensus 78 --l------~~~s~~------~~-----~~~~~-----~-------~~~~td-~~~t------~~---~~~~~------- 109 (725)
T KOG1093|consen 78 --L------KDESLL------AH-----GVLHL-----N-------IIYITD-HFLT------KY---PSPIG------- 109 (725)
T ss_pred --c------chhhhc------cc-----cccee-----h-------hhhccc-cccc------cC---CCCCC-------
Confidence 1 111111 11 12221 1 233334 1110 00 00111
Q ss_pred cccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCCchhhhHHhhhcccccccccceeecCCCCCCCChhhHHHHHHHH
Q 000757 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIA 1154 (1299)
Q Consensus 1075 E~l~~~~~T~KSDVWSLGVVLyELLTGr~PFd~s~~~~~~nLV~wa~plls~~e~L~eIVDp~L~~~~p~ee~~eL~~LI 1154 (1299)
.|+|||++|.++.|+.-|..-+.... ..+..+....+......+..+.... .+-.++...++++.
T Consensus 110 ---------pKsdVwsl~~i~~el~L~~~l~~~~~---~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~ 174 (725)
T KOG1093|consen 110 ---------PKSDVWSLGFIILELYLGISLEAELT---ESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLL 174 (725)
T ss_pred ---------cchhhhhHHHHHHHHHHhhHHHHHHH---HHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHh
Confidence 39999999999999999876543221 1111122222222111111111000 12234556788999
Q ss_pred HHhcCcCcCCCCCHHHHH
Q 000757 1155 SMCVQPEVQHRPFMGEVV 1172 (1299)
Q Consensus 1155 ~~CL~~dPskRPSMsEVL 1172 (1299)
..|+-..|..||...++.
T Consensus 175 ~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 175 KKCLWLEPIIRPLPMELS 192 (725)
T ss_pred ccCCccccccccchhHHh
Confidence 999999999988655543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.038 Score=65.44 Aligned_cols=73 Identities=18% Similarity=0.185 Sum_probs=56.7
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChhHHHHHHHHHHHHHHHhhhcCCCceeeecccccCeeeccCCcceecCCCc
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVyEYm~GGSL~d~L~~~~~~~~pLdw~erlkIa~QIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..|++|++. |+.|... ....|++.+.|+.+.+..+.-|... ...-|||+.-.||||| +|+|-|+||-|
T Consensus 300 y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 446677765 5554322 1357899999999998888777754 3688999999999999 99999999999
Q ss_pred ccccc
Q 000757 1050 ARSAM 1054 (1299)
Q Consensus 1050 Ar~~~ 1054 (1299)
+|...
T Consensus 368 sRl~~ 372 (488)
T COG5072 368 SRLSY 372 (488)
T ss_pred eeccc
Confidence 99543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1299 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-43 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1299 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-178 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-178 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-170 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-88 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-66 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 9e-63 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-62 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-61 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-61 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-59 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-56 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-53 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-53 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-52 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-50 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-47 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-44 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-44 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-43 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-43 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-42 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-42 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-42 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-42 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-42 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-42 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-42 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-42 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-40 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-40 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-40 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-40 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-40 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-40 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-39 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-39 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-39 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-39 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-39 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-39 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-39 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-39 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-39 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-38 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-38 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-37 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-36 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-36 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-35 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-35 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-35 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-35 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-35 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 8e-35 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-35 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-34 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-34 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-34 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-33 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-32 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-32 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 8e-32 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-31 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-31 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-30 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-30 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-30 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-30 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-30 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-30 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-30 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 9e-29 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-28 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-27 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-27 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-26 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-24 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-24 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 8e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-23 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-23 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-23 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-23 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-22 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-22 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-21 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-21 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-21 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 7e-21 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-21 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-20 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-20 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-20 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-20 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-20 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-20 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-20 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-20 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-20 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-20 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-19 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-19 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-19 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-19 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-18 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-18 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-17 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-17 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-16 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-16 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-16 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-15 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-15 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 8e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-13 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-13 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 5e-07 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-16 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-16 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 7e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-15 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 5e-15 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 9e-15 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 1e-14 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 4e-13 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 6e-13 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 3e-12 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 3e-12 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 7e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-14 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-14 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-14 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-13 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-13 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-12 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-12 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-12 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-12 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-11 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-11 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-11 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-10 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-10 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 9e-09 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-08 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-07 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-07 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-06 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-06 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-05 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 5e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-07 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 5e-07 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 5e-07 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-06 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 4e-06 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 6e-06 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 9e-06 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-05 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-05 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-04 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-04 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-04 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-07 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 6e-05 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-04 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 6e-04 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 8e-04 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-06 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 4e-06 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 8e-06 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-05 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 4e-05 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 9e-05 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-04 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 3e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-06 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 5e-06 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 1e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 6e-04 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 5e-06 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 8e-06 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 1e-05 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-05 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-05 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-05 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-05 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 1e-04 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-04 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 4e-04 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 4e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 7e-05 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-04 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-04 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 2e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 4e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 6e-04 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 8e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 6e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 8e-04 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 5e-05 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 2e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = e-178
Identities = 125/315 (39%), Positives = 181/315 (57%), Gaps = 7/315 (2%)
Query: 865 VGSGLDSASLSFG---SSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 921
+GS A+ S SS + ++E+AT NFD ++G G FG VY GVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 922 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 981
DG KVA+K QG EF E+E LS H +LV LIG C E L+Y+ + NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 982 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041
+++ HL+G D + + W+ RL+I +GAAR L YLH + +IHRD KS NILL+ +F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1101
PK++DFG+++ + + H+ST V GT GY+ PEY + G L KSDVYS+GVV+ E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 1102 RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 1161
R + + P NL WA + + LE+I+DP+L + + +S+ K A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 1162 VQHRPFMGEVVQALK 1176
+ RP MG+V+ L+
Sbjct: 297 SEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 527 bits (1359), Expect = e-178
Identities = 130/297 (43%), Positives = 181/297 (60%), Gaps = 5/297 (1%)
Query: 883 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG-R 941
+ G K FS E++ A+ NF ILG GGFG VY G L DGT VAVK LK QGG
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 942 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 1001
+F EVEM+S HRNL++L G C+ R LVY + NGSV S L + PL W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 1002 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061
R +IALG+AR LAYLH+ P++IHRD K++NILL+ +F V DFGLA+ MD + H+
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHV 191
Query: 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE--NLVAW 1119
+T V GT G++APEY TG K+DV+ YGV++LEL++G++ D+ + + L+ W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ LL ++ LE ++D L + + V ++ +A +C Q RP M EVV+ L+
Sbjct: 252 VKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 505 bits (1304), Expect = e-170
Identities = 110/310 (35%), Positives = 174/310 (56%), Gaps = 19/310 (6%)
Query: 877 GSSIATYTGSAKTFSASEIEKATGNFD------ASRILGEGGFGLVYSGVLDDGTKVAVK 930
S+ +FS E++ T NFD +GEGGFG+VY G ++ T VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 931 VLKRVD----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESH 986
L + ++ ++F E++++++ H NLV+L+G + CLVY +PNGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 987 LHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1046
L +D + PL W R KIA GAA + +LHE+ IHRD KS+NILL+ FT K+SD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 1047 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
FGLAR++ +++R++GT Y+APE + G + KSD+YS+GVV+LE+++G VD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 1107 MTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
+ P + L+ + + +E ID + + SV + ++AS C+ + RP
Sbjct: 236 EHREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 1167 FMGEVVQALK 1176
+ +V Q L+
Sbjct: 293 DIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-88
Identities = 71/308 (23%), Positives = 115/308 (37%), Gaps = 28/308 (9%)
Query: 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 949
+ + + G FG V+ L VAVK+ D+Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 950 LSRLHHRNLVKLIGICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1005
L + H N+++ IG + L+ GS+ L + W+ I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 1006 ALGAARALAYLHED-------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058
A AR LAYLHED P + HRD KS N+LL+++ T ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 1059 RHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
+ +GT Y+APE ++ D+Y+ G+V+ EL S D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 1114 ENLVAWARPLLTSRE----GLERIIDPSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFM 1168
+ + + + P L + + A + C + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 1169 GEVVQALK 1176
G V + +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 2e-66
Identities = 73/339 (21%), Positives = 127/339 (37%), Gaps = 43/339 (12%)
Query: 890 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 949
+ASE N ++G G +G VY G LD VAVKV ++Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58
Query: 950 --LSRLHHRNLVKLIGICIE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
+ + H N+ + I LV E PNGS+ +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 1003 LKIALGAARALAYLHED------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----- 1051
++A R LAYLH + P + HRD S N+L+++D T +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 1052 -SAMDEESRHISTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVILELLSGRK 1103
E + + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 1104 PVDMTQPPGQENLV-AWARPLLTSREGLERIID-----PSLGNDVPFDSVA--KVAAIAS 1155
+ + + + + E ++ ++ P +S+A +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 1156 MCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSS 1194
C + + R + + + + K V +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-64
Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 42/287 (14%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG-------REFLAEVEMLSRLHHRN 957
+ +G+GGFGLV+ G + D + VA+K L D +G +EF EV ++S L+H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+VKL G+ +V E +P G + L ++ P+ W +L++ L A + Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 1018 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ +P ++HRD +S NI L KV+DFGL++ +S H + ++G F ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 1073 APEYAMTGHLLV--KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREG 1129
APE K+D YS+ +++ +L+G P + + + + + EG
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFI--NMIREEG 246
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
L R P++ D P ++ + +C + + RP +V+ L
Sbjct: 247 L-R---PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-63
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
++G G FG+V VA+K ++ ++ + F+ E+ LSR++H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+ CLV E GS+ + LHG + + L ++ +AYLH +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 1026 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1084
HRD K N+LL K+ DFG A + + T G+ ++APE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 1085 KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1143
K DV+S+G+++ E+++ RKP ++ P + + WA G R P L ++P
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWA-----VHNGT-R---PPLIKNLP 230
Query: 1144 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ ++ + C + RP M E+V+ +
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-62
Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 963
+G G FG V+ G+ VAVK+L D EFL EV ++ RL H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+ +V E + GS+ LH L RL +A A+ + YLH +P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
++HR+ KS N+L++ +T KV DFGL+R + + S GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 1084 VKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
KSDVYS+GV++ EL + ++P ++ P Q V A R + ++
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLN--PAQ---VVAAVGFKCKR--------LEIPRNL 264
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+VAAI C E RP ++ L+
Sbjct: 265 N----PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-61
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKL 961
I+G GGFG VY G +VAVK + + E ++ + L H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
G+C++E CLV E G + L G + D + A+ AR + YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 1022 PRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
+IHRD KSSNIL+ K++DFGLAR E R G + ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMA 182
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLER 1132
PE SDV+SYGV++ ELL+G P + VA+ +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLA---VAYGVAMNKLA----- 232
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ + P A + C P+ RP ++ L
Sbjct: 233 ---LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-61
Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 42/287 (14%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
L E G ++ G G + VKVLK + R+F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 964 ICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
C A L+ +P GS+ + LH + + + +K AL AR +A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1075
P + S +++++ D T ++S + S S M +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKP 184
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERII 1134
+D++S+ V++ EL++ P D++ + + + EGL R
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVTREVPFADLS--NME---IGMK----VALEGL-R-- 229
Query: 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181
P++ + V+ + +C+ + RP +V L+ + ++
Sbjct: 230 -PTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-60
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+LG+G FG + G + +K L R D++ R FL EV+++ L H N++K IG+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+++ + E I G++ + + W R+ A A +AYLH S +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES------------RHISTRVMGTFGYV 1072
IHRD S N L+ + V+DFGLAR +DE++ R V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPLLTSREG 1129
APE K DV+S+G+V+ E++ N+ +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR------- 242
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 1189
P + I C + + RP ++ L+ + +G
Sbjct: 243 -----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 1190 SASSSQD 1196
D
Sbjct: 292 PQLEQLD 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-59
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+ +G G FG VY G VAVK+L Q + F EV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
Q +V + S+ HLH + IA AR + YLH +
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE---YAMTG 1080
+IHRD KS+NI L D T K+ DFGLA H ++ G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140
+SDVY++G+V+ EL++G+ P Q + G + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM-----VGRGSLSPDLSKVRS 252
Query: 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ P ++ + + C++ + RP ++ ++
Sbjct: 253 NCP----KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-56
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 49/310 (15%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
++G+G FG VY G +VA++++ R ++ + F EV + H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
C+ ++ L ++ S + L + +IA + + YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---GTFGYVAPEYAMTG 1080
++H+D KS N+ ++ ++DFGL + ++ ++ G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 1081 HLLV---------KSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA-----RPLLTS 1126
SDV++ G + EL + P TQP + W +P L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNL-- 263
Query: 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 1186
+++ I C E + RP +++ L+ +
Sbjct: 264 ---------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
Query: 1187 EVGSASSSQD 1196
G S +
Sbjct: 309 HPGHFWKSAE 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-53
Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 963
+G+G +G V+ G G VAVK+ D++ + E E+ L H N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 964 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+ + L+ GS+ +L L + L+I L A LA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 1020 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYV 1072
P + HRD KS NIL++ + ++D GLA S + + +GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 1073 APE------YAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPL 1123
APE + D++++G+V+ E+ V+ +PP + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD--------V 236
Query: 1124 LTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQA 1174
+ + E + P++ N D +A + C R + +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 1175 LK 1176
L
Sbjct: 297 LT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-52
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 50/310 (16%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 963
+ +G+G +G V+ G G KVAVKV ++ + E E+ + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 964 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
I+ L+ + NGS+ +L S L + LK+A + L +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 1020 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH--ISTRVMGTFGYV 1072
P + HRD KS NIL++ + T ++D GLA + + + +GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 1073 APEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARP 1122
PE + L +D+YS+G+++ E+ V+ Q P +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD-------- 264
Query: 1123 LLTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQ 1173
L+ S E + + PS N D ++ + + C R V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 1174 ALKLVCNECD 1183
L + D
Sbjct: 325 TLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-50
Identities = 65/306 (21%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 907 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIGI 964
+G+G FG V+ G G +VAVK+ +++ + E E+ L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA 104
Query: 965 CIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED- 1019
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 1020 ----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYVA 1073
P + HRD KS NIL++ + T ++D GLA + + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 1074 PEYAMTGHLLV-------KSDVYSYGVVILELLSGRKPVDMT---QPPGQENLVAWARPL 1123
PE + + + ++D+Y+ G+V E+ + Q P + + + P
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--LVPSDPS 276
Query: 1124 LTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177
+ + L I + +++ +A I C R + + L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSC---EALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 1178 VCNECD 1183
+ +
Sbjct: 334 LSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-47
Identities = 79/281 (28%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+C ++Q +V EL+ G + L E A L L++ AA + YL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV-----APEYAM 1078
IHRD + N L+ K+SDFG++R D G V APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGL-RQVPVKWTAPEALN 288
Query: 1079 TGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137
G +SDV+S+G+++ E S G P P N ++ E +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPY-----PNLSN-----------QQTREFVEK-- 330
Query: 1138 LGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
G P V + C E RP + Q L+
Sbjct: 331 -GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ LG G FG+V G VAVK++K EF E + + +L H LVK G+C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E +V E I NG + ++L K L L++ +A+L S + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1080
HRD + N L++ D KVSDFG+ R +D++ + T+ APE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYF 180
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+++G+++ E+ S G+ P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+L G+C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E+ CLV E + +G + +L + L + L +AYL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1080
HRD + N L+ + KVSDFG+ R +D++ + T+ +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFS 180
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+GV++ E+ S G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 906 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 957
LG+G F ++ GV T+V +KVL + + F M+S+L H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
LV G+C+ LV E + GS++++L K + +L++A A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTF 1069
+IH + + NILL + K+SD G++ + + ++ +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 1070 GYVAPEYAMTGHLL-VKSDVYSYGVVILELLS-GRKP 1104
PE L + +D +S+G + E+ S G KP
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 906 RILGEGGFGLVYSGVL---DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 960
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+IGIC E LV E+ G + +L +++ + +++ + + YL
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAM 1078
+HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 1079 TGHLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+GV++ E S G+KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 966 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 1080
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 189
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ E+ S GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 906 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 16/237 (6%)
Query: 906 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 961 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1076
+ R IHRD + NIL+E++ K+ DFGL + + ++ + G + APE
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ LG G FG+V G VA+K++K EF+ E +++ L H LV+L G+C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+++ ++ E + NG + ++L + L++ A+ YL S + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1080
HRD + N L+ KVSDFGL+R +D+E + + ++ PE M
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYS 196
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
KSD++++GV++ E+ S G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
C E ++ E + G++ +L +++ + L +A + A+ YL
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMT 1079
IHRD + N L+ + KV+DFGL+R + + H + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAY 186
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
+KSDV+++GV++ E+ + G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
LG G FG V+ G + TKVAVK LK FLAE ++ +L H+ LV+L +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E ++ E + NGS+ L L + L +A A +A++ I
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1084
HRD +++NIL+ + K++DFGLAR D E + + + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189
Query: 1085 KSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ E+++ GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 20/239 (8%)
Query: 906 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
R LGEG FG V D G +VAVK LK + E+E+L L+H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 960 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
K GIC E+ L+ E +P+GS++ +L K + +LK A+ + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 1075
S + +HRD + N+L+E + K+ DFGL + A++ + + + + + APE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
M + SDV+S+GV + ELL+ + ++ +T + +
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTL 256
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 908 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGH 1081
+HRD + N+LL + K+SDFGL++ A+ + + + R G + + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 1082 LLVKSDVYSYGVVILELLS-GRKP 1104
+SDV+SYGV + E LS G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-42
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 966 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 1080
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 361
Query: 1081 HLLVKSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ E+ S GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 19/238 (7%)
Query: 906 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
LG+G FG V D G VAVK L+ R+F E+++L LH +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 961 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
G+ + LV E +P+G + L + A L L + + + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1076
S R +HRD + NIL+E + K++DFGLA+ + + + R G + APE
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 1077 AMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
+SDV+S+GVV+ EL + K + ++ R + LE +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELL 257
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 16/237 (6%)
Query: 906 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 961 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1076
+ R IHRD + NIL+E++ K+ DFGL + + ++ + + G + APE
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 960
RILGEG FG VY GV + VAVK K+ +F++E ++ L H ++VK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
LIGI EE ++ EL P G + +L L + +L +A+AYL
Sbjct: 78 LIGIIEEEPT-WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL---E 130
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 1075
S +HRD NIL+ K+ DFGL+R DE+ + TR+ M +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPE 184
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
SDV+ + V + E+LS G++P
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 958
LG+G FG+V G VAVK LK + +F+ EV + L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
++L G+ + +V EL P GS+ L K + A+ A + YL
Sbjct: 84 IRLYGVVLTPPM-KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPE 1075
S R IHRD + N+LL K+ DFGL R+ + ++ F + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
T SD + +GV + E+ + G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 960
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 961 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L+GIC+ + + +V + +G + + + E+ + L A+ + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1077
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 1078 MTGHLLVKSDVYSYGVVILELLS-GRKP 1104
T KSDV+S+GV++ EL++ G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+ LG G FG V+ + TKVAVK +K FLAE ++ L H LVKL +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
+E ++ E + GS+ L E + + + A +A++ I
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV---APEYAMTGHL 1082
HRD +++NIL+ K++DFGLAR D E T G + APE G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFGSF 362
Query: 1083 LVKSDVYSYGVVILELLS-GRKP 1104
+KSDV+S+G++++E+++ GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 960
R +GEG FG V+ G+ VA+K K +FL E + + H ++VK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
LIG+ E ++ EL G + S L L + + A + ALAYL
Sbjct: 81 LIGVITENPV-WIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL---E 133
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 1075
S R +HRD + N+L+ + K+ DFGL+R D + ++ M APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------APE 187
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
SDV+ +GV + E+L G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 959
R+LG+G FG V L KVAVK+LK + EFL E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 960 KLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAAR 1011
KL+G+ + +A+ ++ + +G + + L + + L ++ + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV---- 1065
+ YL SS IHRD + N +L D T V+DFGL+R + + ++++
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ A E V SDV+++GV + E+++ G+ P
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 960
R++G+G FG+VY G D + A+K L R+ + Q FL E ++ L+H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 961 LIGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
LIGI + + + + +G + + + L AR + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1077
+ + +HRD + N +L+ FT KV+DFGLAR +D E + + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 1078 MTGHLLVKSDVYSYGVVILELLS-GRKP 1104
T KSDV+S+GV++ ELL+ G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1084
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 360
Query: 1085 KSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ EL + GR P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-40
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 960
+I+G G G V G L VA+K LK ++ R+FL+E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+ + +V E + NGS+++ L + + G + YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYVA 1073
+HRD + N+L++ + KVSDFGL+R D+ +T A
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT------A 222
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
PE SDV+S+GVV+ E+L+ G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 959
+ILGEG FG V G L KVAVK +K Q+ EFL+E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 960 KLIGICIEEQARC-----LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1012
+L+G+CIE ++ ++ + G + ++L ++ + LK + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 1066
+ YL S+ +HRD + N +L D T V+DFGL++ + + ++ +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
A E KSDV+++GV + E+ + G P
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-39
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 962
LG G +G VY GV VAVK LK ++ + EFL E ++ + H NLV+L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1022
G+C E ++ E + G++ +L + + L +A + A+ YL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKK 337
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGH 1081
IHR+ + N L+ + KV+DFGL+R + + H + + APE
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNK 395
Query: 1082 LLVKSDVYSYGVVILELLS-GRKP 1104
+KSDV+++GV++ E+ + G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 906 RILGEGGFGLVYSGVL-----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
+++G G FG VY G+L VA+K LK ++ +FL E ++ + H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L G+ + + ++ E + NG+++ L D E + + G A + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--- 163
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYV 1072
++ +HRD + NIL+ + KVSDFGL+R D+ +T
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
APE SDV+S+G+V+ E+++ G +P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 906 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG V+ GV V +KV++ +Q + + + L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+G+C LV + +P GS+ H+ + LG L + A+ + YL
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
++HR+ + N+LL+ +V+DFG+A ++ + + + ++A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
G +SDV+SYGV + EL++ G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 906 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 960
+++G G FG V SG L VA+K LK ++ R+FL E ++ + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+ + + +V E + NGS++S L K A + + G A + YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAM 1078
+HRD + NIL+ + KVSDFGL R ++++ T G +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 1079 TGHLLVKSDVYSYGVVILELLS-GRKP 1104
SDV+SYG+V+ E++S G +P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 4e-39
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIAL 1007
K G+C + +V+E + +G + L HG D G + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1065
A + YL +S +HRD + N L+ + K+ DFG++R + T +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 1066 ----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
M PE M +SDV+S+GV++ E+ + G++P
Sbjct: 198 PIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 906 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 958
R LG+G FG+VY GV T+VA+K + + EFL E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL------HGVDKESAPLGWDARLKIALGAARA 1012
V+L+G+ + Q ++ EL+ G ++S+L + AP +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 1066
+AYL ++ + +HRD + N ++ DFT K+ DFG+ R + + + + M
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+PE G SDV+S+GVV+ E+ + +P
Sbjct: 208 ------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 906 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 1080 GHLLVKSDVYSYGVVILELLS-GRKP 1104
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 74/239 (30%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 906 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
R LGEG FG V D G VAVK LK Q + E+++L L+H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 960 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
K G C + A LV E +P GS+ +L +G L A +AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 1075
+ IHRD + N+LL++D K+ DFGLA+ A+ E + R G + APE
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
SDV+S+GV + ELL+ + P L+ A+ +T E +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-38
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 30/293 (10%)
Query: 823 VLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIAT 882
L + A + + + +A L + + + + V D A I
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE------IID 372
Query: 883 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQ 937
+ S + E + R +GEG FG V+ G+ VA+K K
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 938 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPL 997
+FL E + + H ++VKLIG+ E ++ EL G + S L L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ---VRKFSL 488
Query: 998 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057
+ + A + ALAYL S R +HRD + N+L+ + K+ DFGL+R D
Sbjct: 489 DLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 1058 -----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ + M APE SDV+ +GV + E+L G KP
Sbjct: 546 YYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 906 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 960
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 961 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L+GIC+ + + +V + +G + + + E+ + L A+ + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1077
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 1078 MTGHLLVKSDVYSYGVVILELLS-GRKP 1104
T KSDV+S+GV++ EL++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 906 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 958
LGE FG VY G L VA+K LK + EF E + +RL H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIA 1006
V L+G+ ++Q +++ +G + L + D + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--- 1063
A + YL SS V+H+D + N+L+ K+SD GL R + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 1064 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
R M APE M G + SD++SYGVV+ E+ S G +P
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 906 RILGEGGFGLVYSGVLDDG------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
LGEG FG V+ + VAVK LK + ++F E E+L+ L H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHL-----------HGVDKESAPLGWDARLKIALG 1008
+ G+C E + +V+E + +G + L G D PLG L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 1065
A + YL + +HRD + N L+ K+ DFG++R + + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 1066 ---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
M PE + +SDV+S+GVV+ E+ + G++P
Sbjct: 224 IRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-37
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 908 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAMTGH 1081
+HR+ + N+LL + K+SDFGL++ A+ + + + R G + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 1082 LLVKSDVYSYGVVILELLS-GRKP 1104
+SDV+SYGV + E LS G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 906 RILGEGGFGLVYSGVLDDG---TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVK 960
++GEG FG V + A+K +K + R+F E+E+L +L HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 961 LIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIALG 1008
L+G C L E P+G++ L + ++ L L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 1065
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + + R+
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVR 206
Query: 1066 -MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
M A E SDV+SYGV++ E++S G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
++ + LGEGGF V L DG A+K + +QQ E E +M +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 960 KLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+L+ C+ E+ L+ G++ + + + + L D L + LG R L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------GT 1068
+H + HRD K +NILL + P + D G A + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 1069 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
Y APE + + ++DV+S G V+ ++ G P DM G
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 957
+ LG G FG V D KVAVK+LK ++E++++S L H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHL----------HGVDKESAPLGWDARLKIAL 1007
+V L+G C ++ E G + + L ++ L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1065
A+ +A+L +S IHRD + N+LL + K+ DFGLAR M++ + R+
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 1066 ----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
M APE V+SDV+SYG+++ E+ S G P
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 958
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 1015
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 1016 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L IHRD + N LL K+ DFG+AR G +
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207
Query: 1073 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
PE M G K+D +S+GV++ E+ S G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 966 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1025
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 1026 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1084
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 443
Query: 1085 KSDVYSYGVVILELLS-GRKP 1104
KSDV+S+G+++ EL + GR P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 906 RILGEGGFGLVYSGVLDDG------TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 958
+ LGEG FG V T VAVK+LK R+ L+E +L +++H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 998
+KL G C ++ L+ E GS+ L + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 999 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1057
+ A ++ + YL + +++HRD + NIL+ K+SDFGL+R +E+
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 1058 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ R+ M A E +SDV+S+GV++ E+++ G P
Sbjct: 206 YVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 906 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 955
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1003
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1061
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 1062 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 906 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 955
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+ + H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1003
+N++ L+G C ++ ++ E G++ +L + L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1061
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 1062 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 906 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 955
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1003
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1061
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 1062 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-35
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 958
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 1015
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 1016 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L IHRD + N LL K+ DFG+AR G +
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 1073 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
PE M G K+D +S+GV++ E+ S G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 957
+ LG G FG V D VAVK+LK ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHL--------------HGVDKESAPLGWDARL 1003
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+ A+ +A+L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 1064 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ M APE +SDV+SYG+ + EL S G P
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 957
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 958 LVKLIGIC-IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------------LK 1004
+V L+G C ++ E G++ ++L E P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHIS 1062
+ A+ + +L +S + IHRD + NILL K+ DFGLAR + R
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 1063 TRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
R+ M APE ++SDV+S+GV++ E+ S G P
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
+F+ +LG+G FG V D A+K ++ +++ L+EV +L+ L+H+ +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVV 65
Query: 960 KLIGICIEEQAR-------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1006
+ +E + + E NG++ +H E+ D ++
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLF 122
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-------------A 1053
AL+Y+H S +IHRD K NI ++ K+ DFGLA++
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 1054 MDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVILELLSG 1101
+ S ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 906 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 958
R +GEG FG V+ T VAVK+LK +F E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 998
VKL+G+C + CL++E + G + L PL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 999 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1057
+L IA A +AYL S + +HRD + N L+ + K++DFGL+R+ +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 1058 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ + M PE +SDV++YGVV+ E+ S G +P
Sbjct: 230 YKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 957
++LG G FG V + +VAVK+LK D ++E++M+++L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR------------- 1002
+V L+G C L++E G + ++L + ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 1003 ----LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1057
L A A+ + +L +HRD + N+L+ H K+ DFGLAR M +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 1058 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1104
+ R+ M APE G +KSDV+SYG+++ E+ S G P
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
+G G F VY G+ + +VA +++ + + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 964 ICIEEQAR----CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 1017
LV EL+ +G+++++L V K W R +I G L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW-CR-QILKG----LQFLH 146
Query: 1018 EDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM 201
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
+ DVY++G+ +LE+ + P Q Q + +++ P
Sbjct: 202 YEEKYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---VKPASFDKVAIP 257
Query: 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
+V I C++ R
Sbjct: 258 ------------EVKEIIEGCIRQNKDERY 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 906 RILGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLV 959
LG GG VY +L+ KVA+K + R ++ + F EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+I + E+ LV E I ++ ++ PL D + + + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
R++HRD K NIL++ + T K+ DFG+A+ A+ E S + V+GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKP 1104
+D+YS G+V+ E+L G P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/241 (24%), Positives = 110/241 (45%), Gaps = 19/241 (7%)
Query: 879 SIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 937
S+ + E + +LG+G +G+VY+G L + ++A+K + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 938 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES---HLHGVDKES 994
+ + E+ + L H+N+V+ +G E + E +P GS+ + G K++
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSA 1053
+I G L YLH++ +++HRD K N+L+ + K+SDFG ++
Sbjct: 121 EQTIGFYTKQILEG----LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 1054 MDEESRHISTRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQ 1109
+ GT Y+APE G+ +D++S G I+E+ +G+ P ++ +
Sbjct: 174 AGINPCTET--FTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGE 230
Query: 1110 P 1110
P
Sbjct: 231 P 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 957
+++ +G G +G DG + K + + + ++EV +L L H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 958 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 1016 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
H D V+HRD K +N+ L+ K+ DFGLAR ++ ++ T V GT Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFV-GTPYYMS 184
Query: 1074 PE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
PE Y KSD++S G ++ EL + P
Sbjct: 185 PEQMNRMSYNE------KSDIWSLGCLLYELCALMPP 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 43/228 (18%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
+F ++G GGFG V+ DG +K +K ++ + EV+ L++L H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIV 67
Query: 960 KLIGICIEEQAR-----------------CLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
G C + + E G++E + + L
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
L++ + + Y+H S ++I+RD K SNI L K+ DFGL S ++ R
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 1063 TRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
TR GT Y++PE Y G + D+Y+ G+++ ELL
Sbjct: 179 TRSKGTLRYMSPEQISSQDY---GK---EVDLYALGLILAELLHVCDT 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 21/246 (8%)
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 927
+D S K NF + +G G F VY L DG V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 928 AVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 984
A+K ++ D + + E+++L +L+H N++K IE+ +V EL G +
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1044
+ K+ + K + AL ++H RV+HRD K +N+ + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILEL 1098
D GL R ++ + V GT Y++PE Y KSD++S G ++ E+
Sbjct: 178 GDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEM 229
Query: 1099 LSGRKP 1104
+ + P
Sbjct: 230 AALQSP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRL--HHRNLVKL 961
+ +G GG V+ + + A+K L+ D Q + E+ L++L H +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1075
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 1076 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1104
+ KSDV+S G ++ + G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 892 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEV 947
A+ I + +F +LG+G F VY + G +VA+K++ K + + G + EV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 948 EMLSRLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLG-WDARLKI 1005
++ +L H ++++L E+ LV E+ NG + +L K P +AR +
Sbjct: 63 KIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFM 118
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1065
+ YLH S ++HRD SN+LL + K++DFGLA +H T +
Sbjct: 119 H-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 1066 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 1104
GT Y++PE A + H L +SDV+S G + LL GR P
Sbjct: 173 CGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 961
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
I +Q +V E N + S L K+S W+ + A+ +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDP-WERK-SYWKNMLEAVHTIHQH-- 146
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1075
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 1076 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1104
+ KSDV+S G ++ + G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 70/213 (32%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 955
+F+ R LG+G FG VY +A+KVL ++++ G EVE+ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 956 RNLVKLIGICIEEQARC-LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1012
N+++L G + R L+ E P G+V L E I A A
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITE-LANA 121
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L+Y H S RVIHRD K N+LL K++DFG S SR GT Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDL--CGTLDYL 174
Query: 1073 APEYAMT-GHLLVKSDVYSYGVVILELLSGRKP 1104
PE H K D++S GV+ E L G+ P
Sbjct: 175 PPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 958
+F+ + LG GGFG+V+ D A+K ++ +++ RE + EV+ L++L H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 959 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1006
V+ +E+ + +L ++ L I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIF 124
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ 1060
L A A+ +LH S ++HRD K SNI D KV DFGL + +E
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 1061 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1099
T +GT Y++PE K D++S G+++ ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-32
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 25/240 (10%)
Query: 877 GSSIATYTGSAKTFSASEIEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKV 931
G + G + I G+ + LG G +G V + A+K+
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 932 L--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-- 987
+ V + L EV +L L H N++KL +++ LV E G + +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 988 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKV 1044
E DA I + YLH ++HRD K N+LL E D K+
Sbjct: 130 RMKFNEV-----DAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 1045 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
DFGL SA+ E + + R+ GT Y+APE + K DV+S GV++ LL+G P
Sbjct: 181 VDFGL--SAVFENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 45/308 (14%)
Query: 885 GSAKTFSASEIEKATG-------NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ 937
GS+ + + ++ T +F +LG G G + + D VAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 938 QGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP 996
EV++L H N+++ + Q + + EL +++ ++ K+ A
Sbjct: 62 SFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 997 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 1051
LG + + LA+LH S ++HRD K NIL+ +SDFGL +
Sbjct: 116 LGLEPI-TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 1052 SAMDEE-SRHISTRVMGTFGYVAPEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1107
S + V GT G++APE + D++S G V ++S
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--- 228
Query: 1108 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA--IASMCVQPEVQHR 1165
P G+ R+ + SL P +A I M + + Q R
Sbjct: 229 --PFGKSL----------QRQANILLGACSLDCLHPEKHEDVIARELIEKM-IAMDPQKR 275
Query: 1166 PFMGEVVQ 1173
P V++
Sbjct: 276 PSAKHVLK 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRL 953
+ G ++ LG GGFG V + D G +VA+K ++ RE E++++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 954 HHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKI 1005
+H N+V + + + L E G + +L E+ L +
Sbjct: 70 NHPNVVSAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTL 126
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHIS 1062
+ AL YLHE+ R+IHRD K NI+L K+ D G A+ E +
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCT 181
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
V GT Y+APE V D +S+G + E ++G +P P
Sbjct: 182 EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 957
+ + +GEG FG +DG + +K + R+ + E EV +L+ + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V+ E + +V + G + ++ ++ D L + AL ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-- 1075
+++HRD KS NI L D T ++ DFG+AR ++ + GT Y++PE
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEIC 197
Query: 1076 ----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y KSD+++ G V+ EL + +
Sbjct: 198 ENKPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 896 EKATGN--FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLS 951
++T N + S ILG+G V+ G G A+KV + + E E+L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 952 RLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIAL 1007
+L+H+N+VKL I EE L+ E P GS+ + L + +A L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHIST 1063
+ +L E+ ++HR+ K NI+ + K++DFG AR D+E +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVS 174
Query: 1064 RVMGTFGYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQE 1114
GT Y+ P+ L D++S GV +G P P +
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1115 NL 1116
+
Sbjct: 234 EV 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-31
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 895 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAE 946
++ +T F R+LG+G FG V G + AVKV+ ++V Q+ +E L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 947 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK 1004
V++L +L H N++KL ++ LV E+ G + + E DA +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAA-R 130
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHI 1061
I + Y+H +++HRD K N+LL D ++ DFGL S E S+ +
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--STHFEASKKM 185
Query: 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
++ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 186 KDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 955
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1012
+++V G E+ +V EL S+ E +AR
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1071
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 128 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 181
Query: 1072 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+APE GH + DV+S G ++ LL G+ P +
Sbjct: 182 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 45/231 (19%), Positives = 90/231 (38%), Gaps = 36/231 (15%)
Query: 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA-------------- 945
++ R L +G F + D A+K ++ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 946 ---EVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLG- 998
E+++++ + + + GI I ++YE + N S+ V ++
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 999 --WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056
+ I + +Y+H + + HRD K SNIL++ + K+SDFG + +D+
Sbjct: 149 PIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 1057 ESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILELLSGRKP 1104
I GT+ ++ PE + K D++S G+ + + P
Sbjct: 206 ---KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 29/233 (12%)
Query: 883 YTGSAKTFSASE-IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQ 938
++ + + ++ +LG+G FG V + AVKV+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 939 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKES 994
L EVE+L +L H N++KL I + + +V EL G + + ++
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLAR 1051
A + +K + Y+H ++HRD K NILL E D K+ DFGL
Sbjct: 124 ARI-----IKQVFS---GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL-- 170
Query: 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
S +++ + R+ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 171 STCFQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 906 RILGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLV 959
ILG GG V+ VAVKVL+ D F E + + L+H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 960 KL--IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+ G +V E + ++ +H P+ +++ A +AL +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 131
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-RVMGTFGYVAP 1074
H++ +IHRD K +NI++ KV DFG+AR+ D + T V+GT Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 1075 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
E A + +SDVYS G V+ E+L+G P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-30
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 896 EKATGN--FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLS 951
++T N + S ILG+G V+ G G A+KV + + E E+L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 952 RLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIAL 1007
+L+H+N+VKL I EE L+ E P GS+ + L + +A L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHIST 1063
+ +L E+ ++HR+ K NI+ + K++DFG AR D+E +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVS 174
Query: 1064 RVMGTFGYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQE 1114
GT Y+ P+ L D++S GV +G P P +
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1115 NL 1116
+
Sbjct: 234 EV 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 961
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1075
++H D K +N L+ D K+ DFG+A + + + +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 1076 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1104
+ KSDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 32/279 (11%), Positives = 63/279 (22%), Gaps = 43/279 (15%)
Query: 870 DSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVA 928
+A + ++ + T S + + L G +V+ ++ A
Sbjct: 33 PAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 929 VKVL---KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC-------------------- 965
+KV + +RL + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 966 ------IEEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
L+ + S L V G A + R A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
S ++H F N+ + D + D Y E+
Sbjct: 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFL 263
Query: 1078 MTGHLLV--KSDVYSYGVVILELLSGRKPVDMTQPPGQE 1114
+ + G+ I + P + P +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 7e-30
Identities = 48/285 (16%), Positives = 87/285 (30%), Gaps = 31/285 (10%)
Query: 842 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFS-ASEIEKATG 900
+ P + + L+ SGL +S + + +E + +
Sbjct: 9 GTVDAPNFIVGNPWDDKLIFKLL--SGLSK-PVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 901 NFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGREFLAEVEMLSRL- 953
+LGEG F VY D K +KV K + EF +++ RL
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122
Query: 954 --HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAA 1010
+K + + LV EL G++ + + + + + A+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-----------KVSDFGLARSAMDEESR 1059
+ +H +IH D K N +L + F + D G +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
I T T G+ E + D + + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 895 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------------VD 936
+ K G R LG G +G V + ++ A+KV+K+
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 937 QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDK 992
++ E E+ +L L H N++KL + +++ LV E G + + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 993 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGL 1049
++A I + YLH ++HRD K NILLE+ K+ DFGL
Sbjct: 147 DAA--------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ + + R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 196 SS--FFSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 891 SASEIEKAT---GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFL 944
+ +E+ K +FD R LG+G FG VY + +A+KVL + ++++G L
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 945 A-EVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWD 1000
E+E+ S L H N++++ ++ R L+ E P G + L HG E
Sbjct: 62 RREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QR 115
Query: 1001 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060
+ + A AL Y H +VIHRD K N+L+ + K++DFG S R
Sbjct: 116 SATFMEE-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRR 169
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ GT Y+ PE K D++ GV+ E L G P
Sbjct: 170 RTM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 906 RILGEGGFGLVYSG---VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLV 959
R++G GG G VY V + VA+K++ D E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
+ + + LI + + L + PL + I AL H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
HRD K NIL+ D + DFG+A A +E +GT Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKP 1104
H ++D+Y+ V+ E L+G P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+G G FG V+ G + AVK L+ + E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E + EL+ GS+ + K+ L D L A L YLH R+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 1025 IHRDFKSSNILLEHDFTP-KVSDFGLA-RSAMDEESRHISTR--VMGTFGYVAPEYAM-T 1079
+H D K+ N+LL D + + DFG A D + + T + GT ++APE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKP 1104
K D++S ++L +L+G P
Sbjct: 232 PCDA-KVDIWSSCCMMLHMLNGCHP 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 955
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1012
+++V G E+ +V EL S+ E +AR
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEAR-YYLRQIVLG 153
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1071
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 154 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 207
Query: 1072 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 1104
+APE GH + DV+S G ++ LL G+ P
Sbjct: 208 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPP 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 15/208 (7%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRL-HHR 956
+F LG G +G V+ +DG AVK + + LAEV ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
V+L E L EL S++ H A L ALA+L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S ++H D K +NI L K+ DFGL + + G Y+APE
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPEL 227
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ +DV+S G+ ILE+ +
Sbjct: 228 LQGSYGT-AADVFSLGLTILEVACNMEL 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 67/272 (24%), Positives = 107/272 (39%), Gaps = 46/272 (16%)
Query: 862 GLMVGSGLDSASLSFGSSIATYTGSAKTF-----SASEIEKATGNF----DASRILGEGG 912
+VG G L+ S IA K F + + S+ LG G
Sbjct: 89 TELVGKG-KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 913 FGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
G V KVA++++ + + E+E+L +L+H ++K+
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 964 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
+ + +V EL+ G V + KE+ + A+ YLHE
Sbjct: 208 F-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYFYQMLLAVQYLHE 257
Query: 1019 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
+ +IHRD K N+LL E D K++DFG ++ + E+ + T GT Y+APE
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLC-GTPTYLAPE 311
Query: 1076 ---YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
T D +S GV++ LSG P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 37/231 (16%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVK 960
+ +ILG G G V G VAVK + L E+++L+ H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIR 73
Query: 961 LIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
++ + EL N + VES + ++ + A +A+L
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHL 131
Query: 1017 HEDSSPRVIHRDFKSSNILL-------------EHDFTPKVSDFGLARSAMDEES---RH 1060
H S ++IHRD K NIL+ + +SDFGL + +S +
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP 1104
++ GT G+ APE + L D++S G V +LS K
Sbjct: 189 LNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 31/238 (13%)
Query: 906 RILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKL 961
+ GG G +Y + D +G V +K L + +AE + L+ + H ++V++
Sbjct: 86 GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 962 --IGICIEEQARCLVY---ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ + Y E + S++ L + L AL+YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL 198
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +++ D K NI+L + K+ D G ++ + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEI 248
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134
V +D+Y+ G + L + G + P+L + + R++
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRLL 301
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 44/229 (19%), Positives = 75/229 (32%), Gaps = 35/229 (15%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRL-HHR 956
F +G G FG V+ V DG A+K K+ + L EV + L H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
++V+ E+ + E GS+ + + + + L R L Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 1017 HEDSSPRVIHRDFKSSNILLEHD-------------------FTPKVSDFGLARSAMDEE 1057
H S ++H D K SNI + K+ D G +
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 1058 SRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKP 1104
G ++A E HL K+D+++ + ++
Sbjct: 189 V------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 39/280 (13%), Positives = 80/280 (28%), Gaps = 54/280 (19%)
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 927
+ SA+ S S+ TG SE+ + +LG+ + G
Sbjct: 43 MQSAADSLVSTSLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 928 AVKVLKRVDQQGGRE----------------------------FLAEVEMLSRLHHRNLV 959
V V ++ F+ +++ + ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 960 KLIGIC--IEEQARCLVYELI--PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
++ + +R +Y + + L L ARL++ L R LA
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH ++H + +I+L+ ++ F + G+ PE
Sbjct: 222 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVSRGFEPPE 272
Query: 1076 YAMTGHLLV-----------KSDVYSYGVVILELLSGRKP 1104
+ D ++ G+VI + P
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 885 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGR 941
G++ S ++ + GN+ + +G+G F V + G +VA+K++ +++ +
Sbjct: 1 GNSIA-SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 942 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGW 999
+ EV ++ L+H N+VKL + E+ L+ E G V +L HG KE
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----- 114
Query: 1000 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059
+AR A+ Y H R++HRD K+ N+LL+ D K++DFG S
Sbjct: 115 EAR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF--SNEFTVGG 168
Query: 1060 HISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+ G Y APE Y G + DV+S GV++ L+SG P D
Sbjct: 169 KLDAFC-GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 39/228 (17%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEML 950
G + +LGEG +G V + + + AVK+LK+ + +E +++L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLL 60
Query: 951 SRLHHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1008
RL H+N+++L+ + E+ + +V E G E +K R +
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC-- 109
Query: 1009 AAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060
A L YLH S ++H+D K N+LL T K+S G+A + +
Sbjct: 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 1106
G+ + PE A K D++S GV + + +G P +
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 884 TGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE 942
+G + I+ F R LG G FG V+ G + +K + + Q E
Sbjct: 9 SGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 943 -FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESA 995
AE+E+L L H N++K+ + + +V E G E
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG- 124
Query: 996 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARS 1052
++ ALAY H V+H+D K NIL K+ DFGLA
Sbjct: 125 ----YVA-ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE- 175
Query: 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ + H + GT Y+APE + K D++S GVV+ LL+G P
Sbjct: 176 -LFKSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 24/221 (10%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 963
R+L EGGF VY + G + A+K L +++ R + EV + +L H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 964 ICI-------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
QA L+ + G + L + + PL D LKI RA+ ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---------- 1066
H P +IHRD K N+LL + T K+ DFG A + S +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 1067 GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVILELLSGRKP 1104
T Y PE + + + K D+++ G ++ L + P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-26
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 889 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEV 947
+ + I K F +LG G F V+ G A+K +K+ E+
Sbjct: 1 SMQTTNIRK---TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI 57
Query: 948 EMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDAR 1002
+L ++ H N+V L I LV +L+ G +E GV E DA
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE---RGVYTEK-----DAS 109
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESR 1059
+ A+ YLH ++HRD K N+L + ++DFGL++ M++
Sbjct: 110 -LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGI 163
Query: 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ST GT GYVAPE D +S GV+ LL G P
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 39/238 (16%)
Query: 883 YTGSAKTFS-ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQ 938
++ + + ++ +LG+G FG V + AVKV+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 939 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKES 994
L EVE+L +L H N++KL I + + +V EL G + + ++
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLAR 1051
A + +K + Y+H+ + ++HRD K NILLE D K+ DFGL+
Sbjct: 124 ARI-----IKQVFS---GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 1052 SAMDEESRHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+++ + R+ GT Y+APE Y K DV+S GV++ LLSG P
Sbjct: 173 CF--QQNTKMKDRI-GTAYYIAPEVLRGTYDE------KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+G G +G V V + A K + + + F E+E++ L H N+++L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 965 CIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+ LV EL G V + ++A + +K L A+AY H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL- 125
Query: 1021 SPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
V HRD K N L D K+ DFGLA + + + T+V GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQ-V 179
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ G + D +S GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 44/235 (18%)
Query: 889 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 942
T + + + + LG+G F +V V + G + A + L D Q +
Sbjct: 3 TITCTRFTE---EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---K 56
Query: 943 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLG 998
E + L H N+V+L EE L+++L+ G + + + + +++
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC- 115
Query: 999 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMD 1055
++ L A + + H+ V+HR+ K N+LL K++DFGLA ++
Sbjct: 116 ----IQQILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VE 164
Query: 1056 EESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
E + GT GY++PE Y D+++ GV++ LL G P
Sbjct: 165 GEQQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWACGVILYILLVGYPP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 38/239 (15%)
Query: 887 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQ 937
+ S + N++ ILG G +V + + AVK++ +
Sbjct: 7 PGSHSTHGFYE---NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 938 QGGREFLA-EVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVD 991
Q RE EV++L ++ H N+++L LV++L+ G + + +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 992 KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051
KE+ + ++ L + LH+ ++HRD K NILL+ D K++DFG +
Sbjct: 124 KETRKI-----MRALLEV---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 1052 SAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ + GT Y+APE + D++S GV++ LL+G P
Sbjct: 173 --QLDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE------FLAEVEMLS 951
+ S+ LG G G V KVA+K++ ++ RE E+E+L
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 1006
+L+H ++K+ + + +V EL+ G V + KE+ +
Sbjct: 71 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYF 120
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHIST 1063
A+ YLHE+ +IHRD K N+LL D K++DFG ++ + E+ + T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 1064 RVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT Y+APE G+ D +S GV++ LSG P
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 65/270 (24%)
Query: 890 FSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREF 943
F + + + +G+G +G+V + A+K+ +++++ +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 944 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGW 999
EV ++ +LHH N+ +L + +EQ CLV EL G + + + A
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 1000 DARLKIALG-------------------------AAR-------ALAYLHEDSSPRVIHR 1027
++ + AL YLH + + HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHR 192
Query: 1028 DFKSSNILLEHD--FTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE------- 1075
D K N L + F K+ DFGL++ + E ++T+ GT +VAPE
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 1076 -YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y K D +S GV++ LL G P
Sbjct: 252 SYGP------KCDAWSAGVLLHLLLMGAVP 275
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 2e-24
Identities = 29/237 (12%), Positives = 64/237 (27%), Gaps = 42/237 (17%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---------------------- 942
+LG+ + G V V ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 943 ------FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYELI--PNGSVESHLHGVDK 992
F+ +++ + ++++ + +R +Y + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 993 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052
L ARL++ L R LA LH ++H + +I+L+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 1053 AMDEESRHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ R A + D ++ G+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 957
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 958 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 1010
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 1071 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
++ LG+G FG VY + G A KV++ ++ +++ E+E+L+ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L+G + ++ E P G+V++ + +D+ L + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
R+IHRD K+ N+L+ + +++DFG++ + + S +GT ++APE M
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 1081 HLL-----VKSDVYSYGVVILELLSGRKP 1104
+ K+D++S G+ ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 26/234 (11%)
Query: 883 YTGSAKTFSASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 937
Y K + +E G+ D LG G FG+V+ V G K +
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89
Query: 938 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDK 992
E+ ++++LHH L+ L ++ L+ E + G +
Sbjct: 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149
Query: 993 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 1050
E ++ A L ++HE ++H D K NI+ E K+ DFGLA
Sbjct: 150 EVINY-----MRQACEG---LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+E I T + APE + +D+++ GV+ LLSG P
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 964
+LGEG V + + L + AVK++++ EVEML + HRN+++LI
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHEDSSP 1022
EE LV+E + GS+ SH+H E +A + A AL +LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLH---NK 130
Query: 1023 RVIHRDFKSSNILLEH---DFTPKVSDFGLAR------SAMDEESRHISTRVMGTFGYVA 1073
+ HRD K NIL EH K+ DF L + + T G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMA 189
Query: 1074 PEYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1104
PE D++S GV++ LLSG P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 27/219 (12%)
Query: 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSR 952
++ + + LG G FG+V+ V K + K DQ E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIAL 1007
HRN++ L + +++E I S ++E +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVC 112
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRV 1065
A L +LH + + H D + NI+ + + K+ +FG AR + +
Sbjct: 113 EA---LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLF 164
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
Y APE + +D++S G ++ LLSG P
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEM-LSRLHHRNLVKLIGI 964
LG G +G+V + G +AVK ++ V+ Q + L ++++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E + EL+ + S++ V + + D KIA+ +AL +LH V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE----YAMTG 1080
IHRD K SN+L+ K+ DFG++ +D+ ++ G Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQK 188
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
VKSD++S G+ ++EL R P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-24
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 26/280 (9%)
Query: 837 KSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIE 896
+S C+ + G G + + K + +E
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 897 KATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 951
+ D LG G FG+V+ G A K + + E++ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 1006
L H LV L ++ ++YE + G + H + E+ ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTR 1064
L ++HE++ +H D K NI+ + K+ DFGL + + +
Sbjct: 265 CK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVT 316
Query: 1065 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT + APE A + +D++S GV+ LLSG P
Sbjct: 317 T-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 51/233 (21%), Positives = 102/233 (43%), Gaps = 43/233 (18%)
Query: 892 ASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAE 946
++ + + F + +G G + + + + AVK++ + ++ E E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---E 65
Query: 947 VEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK----ESAPLGWDA 1001
+E+L R H N++ L + + + +V EL+ G + + + + E +A
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSER-----EA 118
Query: 1002 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEE 1057
+ + + YLH + V+HRD K SNIL + + ++ DFG A+ + E
Sbjct: 119 S-AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAE 173
Query: 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1104
+ + T T +VAPE +L + D++S GV++ +L+G P
Sbjct: 174 NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLA-EVEMLSRLH 954
+D LG G F +V G + A K K + RE + EV +L +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAA 1010
H N++ L + + L+ EL+ G + ++E+ LK L
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG- 126
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVM 1066
+ YLH + H D K NI+L P K+ DFGLA +D + +
Sbjct: 127 --VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEF--KNIF 178
Query: 1067 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 57/258 (22%), Positives = 107/258 (41%), Gaps = 12/258 (4%)
Query: 902 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 959
F+ LG G G+V+ G +A K++ + + + E+++L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
G + + E + GS++ L K++ + K+++ + L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
+++HRD K SNIL+ K+ DFG++ +D + + V GT Y++PE
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQG 204
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139
H V+SD++S G+ ++E+ GR P+ E + +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 1140 NDVPFDSVAKVAAIASMC 1157
N DS +A +
Sbjct: 265 NKFGMDSRPPMAIFELLD 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 47/214 (21%), Positives = 75/214 (35%), Gaps = 31/214 (14%)
Query: 909 GEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
G V G V V+ L+ + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 966 IEEQARCLVYELIPNGSV----ESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 1018
I + +V + GS +H E A IA G +AL Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKALDYIHH 146
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH-----ISTRVMGTFGYVA 1073
+HR K+S+IL+ D +S S + R + +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 1074 PEYAMTGHLL---VKSDVYSYGVVILELLSGRKP 1104
PE + +L KSD+YS G+ EL +G P
Sbjct: 204 PE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 892 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVE 948
+++ N+D LG+G F +V V G + A K++ K++ + ++ E
Sbjct: 1 STKFSD---NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 949 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 1004
+ +L H N+V+L EE LV++L+ G + + + +++ ++
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQ 112
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHI 1061
L + +AY H S ++HR+ K N+LL K++DFGLA D E+
Sbjct: 113 QILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--W 164
Query: 1062 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT GY++PE Y+ D+++ GV++ LL G P
Sbjct: 165 HGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRL 953
+++ LG G F +V G + A K +K+ R E EV +L +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGA 1009
H N++ L I + L+ EL+ G + + E+ LK L
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILDG 120
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRV 1065
+ YLH R+ H D K NI+L P K+ DFG+A E
Sbjct: 121 ---VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 172
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 905 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 962
+ LGEG F + V AVK++ + + ++ E+ L H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 963 GICIEEQARCLVYELIPNGSVESHLHGVDK----ESAPLGWDARLKIALGAARALAYLHE 1018
+ ++ LV EL+ G + + K E+ +A I A++++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERI--KKKKHFSET-----EAS-YIMRKLVSAVSHMH- 123
Query: 1019 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
V+HRD K N+L + K+ DFG AR +++ + T T Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPC-FTLHYAAPE 179
Query: 1076 YAMTGHLLVKS------DVYSYGVVILELLSGRKP 1104
LL ++ D++S GV++ +LSG+ P
Sbjct: 180 ------LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 891 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGR 941
A+ + + + LG G FG V++ V + +V VK +K+ ++
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 942 EFLAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGS------VESHLHGVDKES 994
+ E+ +LSR+ H N++K++ I E Q LV E +G H E
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEP 130
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054
A I A+ YL +IHRD K NI++ DFT K+ DFG +A
Sbjct: 131 -----LAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS--AAY 179
Query: 1055 DEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
E + T GT Y APE Y G + +++S GV + L+ P
Sbjct: 180 LERGKLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 957
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 958 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 1010
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1070
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 1071 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 41/249 (16%)
Query: 877 GSSIATYTGSAKTFSASE-IEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVK 930
G +A+ TG + SE + A+ F + LG+G F +V V G + A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 931 VL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVE 984
++ K++ + ++ E + +L H N+V+L EE LV++L+ G +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 985 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFT 1041
+ + +++ ++ L + +AY H + ++HR+ K N+LL
Sbjct: 121 AREFYSEADASHC-----IQQILES---IAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVI 1095
K++DFGLA +S GT GY++PE +L K D+++ GV++
Sbjct: 170 VKLADFGLAI--EVNDSEAWHGFA-GTPGYLSPE------VLKKDPYSKPVDIWACGVIL 220
Query: 1096 LELLSGRKP 1104
LL G P
Sbjct: 221 YILLVGYPP 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 32/232 (13%)
Query: 888 KTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGR 941
+ F ++E +D LG G F +V G + A K + + R
Sbjct: 3 EPFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 942 EFLA-EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAP 996
E + EV +L ++ H N++ L + L+ EL+ G + ++E+
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 997 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARS 1052
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 120 F-----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+++ + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 169 -IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 21/233 (9%)
Query: 885 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF 943
S S + G F+ ++G G +G VY G + G A+KV+ V E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEI 67
Query: 944 LAEVEMLSRL-HHRNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAP 996
E+ ML + HHRN+ G I++ LV E GSV + +
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 997 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056
W A I R L++LH +VIHRD K N+LL + K+ DFG++
Sbjct: 128 EEWIA--YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 1057 ESRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKP 1104
R + +GT ++APE KSD++S G+ +E+ G P
Sbjct: 183 VGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ +G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+ + +V E + GS+ + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
S +VIHRD KS NILL D + K++DFG E+S+ + ++GT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 36/233 (15%)
Query: 889 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 942
TF ++E +D LG G F +V G + A K + + RE
Sbjct: 4 TFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 943 FL-AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV------ESHLHGVDKESA 995
+ EV +L ++ H N++ L + L+ EL+ G + + L ++E+
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--EEEAT 118
Query: 996 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLAR 1051
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 119 SF-----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
E + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 168 E---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 956
F R+LG GGFG V++ + K+ A K L R+ ++ G + + E ++L+++H R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 957 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWD-ARL---KIALGAAR 1011
+V L E + CLV ++ G + H++ VD+++ A +I
Sbjct: 246 FIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---- 300
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L +LH+ +I+RD K N+LL+ D ++SD GLA +++ GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGF 355
Query: 1072 VAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
+APE + S D ++ GV + E+++ R P
Sbjct: 356 MAPELLLGEEY--DFSVDYFALGVTLYEMIAARGP 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 36/294 (12%)
Query: 836 YKSHACQAEEVPQSLQTSHVKPSGA--------------AGLMVGSGLDSASLSFGSSIA 881
+ H+ + ++L +K SG + + + S +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 882 TYTGSAKTFSASEIEKATGNF------DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR 934
F + G + ILG G FG V+ G K+A K++K
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 935 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 994
+ E E+ ++++L H NL++L + LV E + G E +D+
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESY 182
Query: 995 APLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 1050
D +K + ++H ++H D K NIL + K+ DFGLA
Sbjct: 183 NLTELDTILFMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
R E + GT ++APE + +D++S GV+ LLSG P
Sbjct: 237 RRYKPREK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 955
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1008
+++KL + I +V E + G + ++ HG +E +AR ++
Sbjct: 71 PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILS-- 122
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
A+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 123 ---AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 173
Query: 1069 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
Y APE YA G + D++S GV++ LL G P D
Sbjct: 174 PNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
D+ +GEG G+V G +VAVK++ QQ EV ++ H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+ + + ++ E + G++ + L + + +ALAYLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
+ VIHRD KS +ILL D K+SDFG + + S ++GT ++APE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 1081 HLLVKSDVYSYGVVILELLSGRKP 1104
+ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLAEVEMLSRLHH 955
++ ++G+G F +V + + G + AVK+ + E + L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 956 RNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESAPLGWDAR--LKIAL 1007
++V+L+ + +V+E + + V E+ A ++ L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYMRQIL 140
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTR 1064
AL Y H++ +IHRD K +LL E+ K+ FG+A + E R
Sbjct: 141 E---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGLVAGGR 193
Query: 1065 VMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
V GT ++APE G DV+ GV++ LLSG P
Sbjct: 194 V-GTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
LG G +VY A+KVL K VD++ R E+ +L RL H N++KL
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKE 115
Query: 964 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
I LV EL+ G VE G E DA A+AYLHE
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVE---KGYYSER-----DAA-DAVKQILEAVAYLHE 166
Query: 1019 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
+ ++HRD K N+L D K++DFGL++ + E + T GT GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVC-GTPGYCAPE 220
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ D++S G++ LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 957
FD LGEG +G VY + + G VA+K + +E + E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH 85
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+VK G + +V E GSV + +K L D I + L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
R IHRD K+ NILL + K++DFG+A D ++ + V+GT ++APE
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 32/237 (13%)
Query: 886 SAKTFSASEIEKATGNFD-----ASRILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQ 938
+ + ++ NF+ S+ LG G F +V + G + A K L KR Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 939 GGRE-FLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDK 992
R L E+ +L ++ L + L+ E G L +
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 993 ESAPLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 1047
E+ D +K L + YLH++ ++H D K NILL K+ DF
Sbjct: 130 EN-----DVIRLIKQILEG---VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
G++R + + + GT Y+APE + +D+++ G++ LL+ P
Sbjct: 179 GMSR--KIGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR--EFLAEVEMLSRLHHRNL 958
F +G+G FG V+ G+ VA+K++ +++ + E+ +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARAL 1013
K G +++ ++ E + GS L G E+ +IA + L
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET---------QIATILREILKGL 132
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
YLH + + IHRD K++N+LL K++DFG+A D + + + +GT ++A
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMA 187
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
PE K+D++S G+ +EL G P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEM 949
I + +D + +G G FG+ VAVK ++R +D+ RE +
Sbjct: 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IIN 69
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK--- 1004
L H N+V+ + + ++ E G + + G E +AR
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQ 124
Query: 1005 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHI 1061
++ ++Y H S ++ HRD K N LL+ P K+ DFG ++S++
Sbjct: 125 LLS-----GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 175
Query: 1062 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+ V GT Y+APE Y G +DV+S GV + +L G P +
Sbjct: 176 -STV-GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 60/248 (24%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA----------- 945
+ +G+G +G+V +D T A+KVL K++ +Q G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 946 -------------EVEMLSRLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHG 989
E+ +L +L H N+VKL+ + +++ +V+EL+ G V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV------ 125
Query: 990 VDKESAPLGWDARLKIALGAAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041
++ + L AR + YLH ++IHRD K SN+L+ D
Sbjct: 126 MEVPTLK-----PLSEDQ--ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGH 175
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILEL 1098
K++DFG+ S + S + + +GT ++APE + DV++ GV +
Sbjct: 176 IKIADFGV--SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 1099 LSGRKPVD 1106
+ G+ P
Sbjct: 234 VFGQCPFM 241
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 901 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 954
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 955 -HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIAL 1007
+V + + + +L+ G + HL HGV E+ D R +I L
Sbjct: 250 DCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIIL 303
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067
L ++H V++RD K +NILL+ ++SD GLA ++ V G
Sbjct: 304 ----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-G 352
Query: 1068 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
T GY+APE G S D +S G ++ +LL G P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 955
G + LGEG FG V KVA+K + R + + + E+ L L H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1008
+++KL + I +V E G + ++ E + R I
Sbjct: 69 PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC-- 119
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
A+ Y H +++HRD K N+LL+ + K++DFGL S + + + T G+
Sbjct: 120 ---AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGL--SNIMTDGNFLKTSC-GS 170
Query: 1069 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
Y APE YA G + DV+S G+V+ +L GR P D
Sbjct: 171 PNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 964
+G G +G V V G +AVK ++ VD++ ++ L +++++ R +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E + EL+ + + + + + KI L +AL +L E+ ++
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1083
IHRD K SNILL+ K+ DFG++ +D ++ TR G Y+APE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQ 204
Query: 1084 ---VKSDVYSYGVVILELLSGRKPVDMTQPP 1111
V+SDV+S G+ + EL +GR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REF---------LAEVEMLSRLH 954
R + G +G V +GV +G VA+K + G L E+ +L+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 955 HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALG 1008
H N++ L I + + LV EL+ + L V + + ++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVM 1066
L LH V+HRD NILL + + DF LAR + + +++ R
Sbjct: 143 ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198
Query: 1067 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
Y APE M K D++S G V+ E+ + +
Sbjct: 199 ----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 955
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1008
+++KL + I + +V E + G + ++ +G E ++R ++
Sbjct: 76 PHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS-- 127
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 128 ---GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 178
Query: 1069 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
Y APE YA G + D++S GV++ LL G P D
Sbjct: 179 PNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 37/286 (12%)
Query: 842 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 900
E+ +++ PS +A L+ + + + G+ + + A
Sbjct: 33 NREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF 92
Query: 901 --NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-------LKRVDQQGGREFLA-EVEM 949
+D ++G G +V V G + AVK+ L + RE E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 950 LSRLH-HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 1004
L ++ H +++ LI LV++L+ G + + +KE+ + ++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MR 207
Query: 1005 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1064
L A +++LH + ++HRD K NILL+ + ++SDFG + E +
Sbjct: 208 SLLEA---VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC--HLEPGEKLREL 259
Query: 1065 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
GT GY+APE + D+++ GV++ LL+G P
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 38/255 (14%)
Query: 864 MVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-D 922
M G+ + + A + +F +ILGEG F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELA 53
Query: 923 DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977
+ A+K+L+ + ++ E +++SRL H VKL +++
Sbjct: 54 TSREYAIKILEKRHIIKENKV--PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 978 IPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNI 1034
NG + ++ + R +I AL YLH +IHRD K NI
Sbjct: 112 AKNGELLKYIRKIGSFDET---CTRFYTAEIVS----ALEYLHGKG---IIHRDLKPENI 161
Query: 1035 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK-----SDVY 1089
LL D +++DFG A+ E + + +GT YV+PE L K SD++
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-----LTEKSACKSSDLW 216
Query: 1090 SYGVVILELLSGRKP 1104
+ G +I +L++G P
Sbjct: 217 ALGCIIYQLVAGLPP 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 7e-21
Identities = 49/271 (18%), Positives = 91/271 (33%), Gaps = 79/271 (29%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVA-------------------VKVLKRVDQQG- 939
+F+ + +G GGFG+V+ D A VK L +++ G
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 940 --------------------------------------GREFLAEVEMLSRLHHRNLVKL 961
++ + +N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 962 IGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHE 1018
+ + + +L +++ ++ ++ + ++IA + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH- 181
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH----------ISTRVMGT 1068
S ++HRD K SNI D KV DFGL + +E T +GT
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 1069 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1099
Y++PE + K D++S G+++ ELL
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
+GEG +G+V+ D G VA+K + + +A E+ ML +L H NLV L+ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 965 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
++ LV+E + + D+ + I +A+ + H
Sbjct: 71 FRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
IHRD K NIL+ K+ DFG AR + S + V T Y +PE LL
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVA-TRWYRSPE------LL 174
Query: 1084 VKSDVYSYGV-------VILELLSGR 1102
V Y V V ELLSG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 57/272 (20%), Positives = 97/272 (35%), Gaps = 51/272 (18%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
++G G +G VY + VA+K + R+ D + L E+ +L+RL +++L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 963 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYL 1016
+ I + +V E+ +S L + K L + +K I ++
Sbjct: 92 DLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFI 145
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +IHRD K +N LL D + KV DFGLAR+ E+ +I +
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 1077 A----MTGH----------LLVKSDVYSYGV----V--IL-ELLSGRKPVDMTQP----- 1110
+T H L++ + Y+ + I ELL+ +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 1111 -PGQENLVAWARPLLTSREG------LERIID 1135
PG L I +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-21
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 58/256 (22%)
Query: 877 GSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVK--VLK 933
S+ + +A S K F R+ G+G FG V G G VA+K +
Sbjct: 2 PGSMMSLNAAAAADERSR--KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD 59
Query: 934 RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESH 986
+ RE L ++ L+ LHH N+V+L R +V E +P
Sbjct: 60 PRFRN--RE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DT 111
Query: 987 LHGVDKESAPLGWDARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL 1036
LH + R ++A R++ LH S V HRD K N+L+
Sbjct: 112 LHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLV 164
Query: 1037 -EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS------- 1086
E D T K+ DFG A+ E +I +R Y APE L+ +
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTAV 213
Query: 1087 DVYSYGVVILELLSGR 1102
D++S G + E++ G
Sbjct: 214 DIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-21
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
+GEG +G+V D G VA+K D + +A E+++L +L H NLV L+ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 965 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
C +++ LV+E V+ + + L + K + + H S
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1083
+IHRD K NIL+ K+ DFG AR + V T Y APE LL
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA-TRWYRAPE------LL 196
Query: 1084 VKSDVYSYGV-------VILELLSGR 1102
V Y V ++ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-20
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 956
F R+LG+GGFG V + + K+ A K L+ R+ ++ G L E ++L +++ R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 957 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+V L E + CLV L+ G ++ H++ + + P A A L
Sbjct: 245 FVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA-EICCGLED 301
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH + R+++RD K NILL+ ++SD GLA + ++ I RV GT GY+APE
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 355
Query: 1076 -YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
+ S D ++ G ++ E+++G+ P
Sbjct: 356 VVKNERY--TFSPDWWALGCLLYEMIAGQSP 384
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
+G G +G V S + G KVA+K L R + + E+ +L + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 963 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAY 1015
+ + LV + ++ L + + +++ + + L Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG--LKFS-EEKIQYLVYQMLKGLKY 141
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
+H S V+HRD K N+ + D K+ DFGLAR A E + ++ TR Y APE
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 1076 YAMTGHLLVKS-DVYSYGVVILELLSGR 1102
++ ++ D++S G ++ E+L+G+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 963 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAY 1015
+ +++ +V EL+ +++L V + L R+ L + +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ--MEL-DHERMSYLLYQMLCGIKH 142
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH S +IHRD K SNI+++ D T K+ DFGLAR+A + T + T Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGR 1102
+ D++S G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 957
++ +GEG +G V+ + VA+K ++ D G A E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 1016
+V+L + ++ LV+E + L D + L + + L +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S V+HRD K N+L+ + K+++FGLAR A R S V+ T Y P+
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRPPD- 171
Query: 1077 AMTGHLLVKSDVYSYGV-------VILELLSGRKP 1104
+L + +YS + + EL + +P
Sbjct: 172 -----VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHH 955
+ + +G G +G V S V G KVA+K L R + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 956 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
N++ L+ + ++ LV + + L + K LG D +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK-HEKLGEDRIQFLVYQM 137
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
+ L Y+H + +IHRD K N+ + D K+ DFGLAR A E + ++ TR
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 1070 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 29/255 (11%)
Query: 867 SGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGT 925
+ + K E E + +LG GGFG VYSG+ + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 926 KVAVKVL--KRVDQQGGREFLA----EVEMLSRLHHR--NLVKLIGICIEEQARCLVYEL 977
VA+K + R+ G EV +L ++ +++L+ + L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 978 I-PNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1034
P + + G +E AR A+ + H + V+HRD K NI
Sbjct: 130 PEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENI 180
Query: 1035 LL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSY 1091
L+ + K+ DFG A+ +++ + GT Y PE+ + H + V+S
Sbjct: 181 LIDLNRGELKLIDFGS--GALLKDT-VYTDFD-GTRVYSPPEW-IRYHRYHGRSAAVWSL 235
Query: 1092 GVVILELLSGRKPVD 1106
G+++ +++ G P +
Sbjct: 236 GILLYDMVCGDIPFE 250
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 958
+ +GEG +G+VY + G A+K ++ + G E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 1017
VKL + ++ LV+E ++ L + D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
RV+HRD K N+L+ + K++DFGLAR A R + ++ T Y AP+
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRAPD-- 170
Query: 1078 MTGHLLVKSDVYSYGV-------VILELLSGR 1102
+L+ S YS + + E+++G
Sbjct: 171 ----VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 907 ILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 963
+LG G G V G K A+K+L + EV+ + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILD 89
Query: 964 ICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLG-WDARLKIALGAARALAYLH 1017
+ E ++ E + G + S + ++ +A +I A+ +LH
Sbjct: 90 VY-ENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 1018 EDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1074
S + HRD K N+L D K++DFG A+ + T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 1075 EYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1104
E +L D++S GV++ LL G P
Sbjct: 199 E------VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 60/224 (26%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 963
R LG G + V+ + + + KV VK+LK V ++ + E+++L L N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 98
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA------------- 1010
I + +R V H++ D K
Sbjct: 99 IVKDPVSRTPAL-------VFEHVNNTD-----------FKQLYQTLTDYDIRFYMYEIL 140
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESR--HISTRVMG 1067
+AL Y H S ++HRD K N++++H+ ++ D+GLA + +++R
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 1068 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGRKP 1104
+ PE LLV D++S G ++ ++ ++P
Sbjct: 196 ---FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 37/270 (13%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLH-HRNLVKLIGI 964
+G G G V+ G +AVK ++R +++ + L +++++ + H +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
I + EL+ E + P+ K+ + +AL YL E V
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GV 146
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1083
IHRD K SNILL+ K+ DFG++ +D++++ R G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTK 203
Query: 1084 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---P 1136
+++DV+S G+ ++EL +G+ P + E L +++ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTD---------------FEVLTKVLQEEPP 248
Query: 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1166
L + F + + C+ + + RP
Sbjct: 249 LLPGHMGFSGDFQ--SFVKDCLTKDHRKRP 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+G G +V + KVA+K + Q E L E++ +S+ HH N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 966 IEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 1020
+ + LV +L+ GSV + H V K G IA L YLH++
Sbjct: 83 VVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFG----LARSAMDEESRHISTRVMGTFGYVAPEY 1076
IHRD K+ NILL D + +++DFG LA ++ T V GT ++APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 1077 AMTGHLL-VKSDVYSYGVVILELLSGRKP 1104
K+D++S+G+ +EL +G P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 958
+ +GEG +G+VY G VA+K ++ + G A E+ +L LHH N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 1017
V LI + E+ LV+E +E L V D+ L R +A+ H
Sbjct: 82 VSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
R++HRD K N+L+ D K++DFGLAR A R + V+ T Y AP+
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAPD-- 189
Query: 1078 MTGHLLVKSDVYSYGV-------VILELLSGR 1102
+L+ S YS V + E+++G+
Sbjct: 190 ----VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-20
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 955
+LGEG +G+V S G VA+K + R L E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT--------LREIKILKHFKH 68
Query: 956 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKI----A 1006
N++ + I + ++ EL+ ++ LH V + L D ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVIS-TQMLS-DDHIQYFIYQT 121
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
L RA+ LH VIHRD K SN+L+ + KV DFGLAR + + +
Sbjct: 122 L---RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 1067 GTF--GYV------APEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
+ +V APE +T ++ DV+S G ++ EL R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
+G G +G V + G +VAVK L R + E+ +L + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 963 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ ++ LV L+ + L+ + K L D + R L Y+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI 148
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEI 200
Query: 1077 AMTGHLLVKS-DVYSYGVVILELLSGR 1102
+ ++ D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 961
+ +++G G FG+V+ L + +VA +K+V Q + E++++ + H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVA---IKKVLQDKRFK-NRELQIMRIVKHPNVVDL 97
Query: 962 IGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALA 1014
+ LV E +P +V K + +K+ + R+LA
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155
Query: 1015 YLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM-DEESRH-ISTRVMGTFGY 1071
Y+H S + HRD K N+LL K+ DFG A+ + E + I +R Y
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----Y 207
Query: 1072 VAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1102
APE L+ + D++S G V+ EL+ G+
Sbjct: 208 RAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 891 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------VDQQGGRE 942
+ E + +LG+GGFG V++G L D +VA+KV+ R
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 943 FLAEVEMLSRLH----HRNLVKLIGICIEEQARCLVYEL-IPNGSVESHL--HGVDKESA 995
L EV +L ++ H +++L+ ++ LV E +P + ++ G E
Sbjct: 82 PL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG- 139
Query: 996 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 1054
+R A+ + H S V+HRD K NIL+ K+ DFG
Sbjct: 140 ----PSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 1106
DE + GT Y PE+ ++ H + V+S G+++ +++ G P +
Sbjct: 192 DE---PYTDFD-GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
+ LG GG GLV+S V D +VA+K + D Q + L E++++ RL H N+VK+ I
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 965 CIEEQARC--------------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1010
++ +V E + E+ L V + PL +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE-QGPLLEEHARLFMYQLL 130
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESR------HIST 1063
R L Y+H S V+HRD K +N+ + D K+ DFGLAR S + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
+ Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 964
LG G + VY G+ G VA+K + ++D + G A E+ ++ L H N+V+L +
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 1022
E LV+E + N ++ ++ + P G + L + LA+ HE+
Sbjct: 72 IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--- 127
Query: 1023 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
+++HRD K N+L+ K+ DFGLAR A S+ V+ T Y AP+ +
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV-TLWYRAPD------V 179
Query: 1083 LVKSDVYSYGV-------VILELLSGR 1102
L+ S YS + ++ E+++G+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 955
+GEG +G+V S + +VA+K + +R L E+++L R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--------LREIKILLRFRH 84
Query: 956 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1010
N++ + I +V +L+ E+ L+ + K + L D
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLK-TQHLSNDHICYFLYQIL 138
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------HISTR 1064
R L Y+H S V+HRD K SN+LL K+ DFGLAR A + +++TR
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 1065 VMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1102
Y APE + KS D++S G ++ E+LS R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-19
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 42/247 (17%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRN 957
++ ++G G +G V + VA+K + RV D + L E+ +L+RL+H +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 958 LVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+VK++ I I + +V E+ +S + + L +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ Y+H S ++HRD K +N L+ D + KV DFGLAR+ E+ + + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 1073 APEYA---------MTGH----------LLVKSDVYSYGV------VIL-ELLSGRKPVD 1106
+TGH L++ + Y+ + I ELL+ K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 1107 MTQPPGQ 1113
Sbjct: 286 AYHADRG 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-19
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 953
+F+ R +G+G FG V + D A+K + + V++ R E++++ L
Sbjct: 16 HFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIALG 1008
H LV L +E+ +V +L+ G + HL + KE +L ++ +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-----VKLFICELVM- 126
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
AL YL + R+IHRD K NILL+ ++DF +A E T + GT
Sbjct: 127 ---ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 1069 FGYVAPE----YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
Y+APE G+ + D +S GV ELL GR+P
Sbjct: 178 KPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-19
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 901 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 957
+ LGEG + VY G VA+K + R++ + G A EV +L L H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 1016
+V L I E++ LV+E ++ L D + R LAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +V+HRD K N+L+ K++DFGLAR A ++ V+ T Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVV-TLWYRPPD- 170
Query: 1077 AMTGHLLVKSDVYSYGV-------VILELLSGR 1102
+L+ S YS + + E+ +GR
Sbjct: 171 -----ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 56/229 (24%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
++ ++++G G FG+VY L D G VA +K+V Q + E++++ +L H N+V
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQDKRFK-NRELQIMRKLDHCNIV 110
Query: 960 KLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA--- 1010
+L + LV + +P ++ V + + R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYS------RAKQTLPVIYVK 159
Query: 1011 -------RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARS-AMDEESRH- 1060
R+LAY+H S + HRD K N+LL K+ DFG A+ E +
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1102
I +R Y APE L+ + DV+S G V+ ELL G+
Sbjct: 217 ICSRY-----YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 962
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 963 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ ++ LV EL+ +++L V + L + + + +L
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 234
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGR 1102
+ D++S G ++ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRN 957
F R +G G FG VY + + VA+K + +Q ++ + EV L +L H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
++ G + E LV E GS L K PL + GA + LAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH 171
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPE 1075
S +IHRD K+ NILL K+ DFG + ++ +GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGS--------ASIMAPANSFVGTPYWMAPE 220
Query: 1076 YAMTGHLL---VKSDVYSYGVVILELLSGRKP 1104
+ K DV+S G+ +EL + P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-18
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---FLA--EVEMLSRLHHRNLVKL 961
LGEG F VY + VA+K +K + ++ A E+++L L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAYLHED 1019
+ + LV++ +E+ L + S L + +K L + L YLH+
Sbjct: 78 LDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEYLHQH 131
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
++HRD K +N+LL+ + K++DFGLA+ + +R + +V+ T Y APE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV-TRWYRAPE---- 182
Query: 1080 GHLLVKSDVYSYGV-------VILELLSGR 1102
LL + +Y GV ++ ELL
Sbjct: 183 --LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLH-HRNLVKL 961
+ LG+G +G+V+ + G VAVK + + + E+ +L+ L H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 962 IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHE 1018
+ + + R LV++ + E+ LH V + + L + + + + YLH
Sbjct: 75 LNVLRADNDRDVYLVFDYM-----ETDLHAVIR-ANILE-PVHKQYVVYQLIKVIKYLH- 126
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 1076
S ++HRD K SNILL + KV+DFGL+RS ++ + + +
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 1077 -AMTGH----------LLVKSDVYSYGV------VIL-ELLSGR 1102
+T + +L+ S Y+ G+ IL E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 951
FD + LG G FG V L + G A+K+L ++ Q L E +L
Sbjct: 42 QFDRIKTLGTGSFGRVM---LVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQ 96
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
++ LVKL + +V E + G + SHL + + S P AR +I L
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQIVL- 152
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1067
YLH +I+RD K N+L++ +V+DFG A+ T + G
Sbjct: 153 ---TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 200
Query: 1068 TFGYVAPEYAMT-GHLLVKS-DVYSYGVVILELLSGRKP 1104
T +APE ++ G+ K+ D ++ GV+I E+ +G P
Sbjct: 201 TPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 957
+ LGEG +G VY + VA+K ++ ++ G A EV +L L HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+++L + L++E E+ L ++ + + + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTP-----KVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
S R +HRD K N+LL K+ DFGLAR A R + ++ T Y
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEII-TLWYR 204
Query: 1073 APEYAMTGHLLVKSDVYSYGV-------VILELLSGR 1102
PE +L+ S YS V + E+L
Sbjct: 205 PPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 42/219 (19%)
Query: 905 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 962
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 121
Query: 963 GICIEEQARC----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
+ A +V E + G ++ E +A +I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 175
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
YLH S + HRD K N+L + K++DFG A+ S ++T T Y
Sbjct: 176 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYY 229
Query: 1072 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1104
VAPE +L D++S GV++ LL G P
Sbjct: 230 VAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 3e-16
Identities = 56/296 (18%), Positives = 98/296 (33%), Gaps = 21/296 (7%)
Query: 117 PPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSN 176
+ TP ++ + L + +PL S+ A
Sbjct: 1457 QKITEIEDGQDGGVTPYSNESGLVNADL----DVKDELMFSPLVDSGSNDAMAGGFTAYG 1512
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A S P S + P + SP P+ P S S
Sbjct: 1513 GADYG---------EATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPT---SPAYSPTS 1560
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
+ P + S T+P + SP + PS + P+ P++ + P S PS +
Sbjct: 1561 PSYSPTSPSYSPTSPSYSPTSPSYSP---TSPSYSPTSPSYSPTSPSYSPTS-PSYSPTS 1616
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPP-PASH 355
P+ P++ + P S + P S S + P + S T+P + S +P P+
Sbjct: 1617 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYS 1676
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
P++ + P S +P P S S + P + S +P ++ +
Sbjct: 1677 PTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 4e-16
Identities = 60/304 (19%), Positives = 102/304 (33%), Gaps = 13/304 (4%)
Query: 93 FDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPS 152
FD+ + + P S A ++ + S
Sbjct: 1441 FDVMIDEESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGS 1500
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTAL 212
+ + A+ P A + P P P+ P S S
Sbjct: 1501 NDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPT---SPTYSPTSPAYS 1557
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
P+ + SP S PS + P+ P+ + P S S + P+ P S P S PS +
Sbjct: 1558 PTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTS-PSYSP 1614
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP-PASHPSNTAPPPA 331
P+ P++ + P S P S S + P + S T+P + PS + P+
Sbjct: 1615 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPS 1674
Query: 332 SHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
P+ P S +S + P + + S T+ P+ P++P P S P+ + +
Sbjct: 1675 YSPT---SPSYSPTSPSYSPTSPNYSPTS--PSYSPTSPGYSPGS-PAYSPKQDEQKHNE 1728
Query: 392 TAPP 395
Sbjct: 1729 NENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 4e-16
Identities = 59/264 (22%), Positives = 95/264 (35%), Gaps = 13/264 (4%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
+S + V+A D+ P S ++ + A T
Sbjct: 1472 PYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPT 1531
Query: 141 APPLVNVLPAPSLIPTTPLASPLS------SKAFPPASPPSNAARPPASHPSNTARPPAS 194
+P P S PT+P SP S S ++ P SP + P S S + P +
Sbjct: 1532 SPGFGVSSPGFS--PTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1589
Query: 195 HPSRTAPP--PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
S T+P P S + PS + SP+ P++ + P S P S S + P
Sbjct: 1590 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1649
Query: 253 PASHPYKTSP-LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
+ TSP + PS + P+ P++ + P S S + P P++ + P S
Sbjct: 1650 TSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSP-SYSPTSPNYSPTSPSYSPTS- 1707
Query: 312 PSNTAPPPASHPSNTAPPPASHPS 335
P + PA P + +
Sbjct: 1708 PGYSPGSPAYSPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 1e-15
Identities = 55/304 (18%), Positives = 88/304 (28%), Gaps = 30/304 (9%)
Query: 73 APPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTP 132
P I P+ + + +P
Sbjct: 1453 YMPEQKITEIEDGQDGGVTPYSNESGLV---------NADLDVKDELMFSPLVDSGSNDA 1503
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
+A A SP + P SP + P S P++ P
Sbjct: 1504 MAGG-----------FTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFS-PTSPTYSP 1551
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
S P S S + P+ + SP S + P S S + P + S T+P
Sbjct: 1552 TSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1611
Query: 253 PASHPYKTSPL-----PASHPSKTAPPPASHPSNTAPPPASHPSKTAPP-PASHPSNTAP 306
+ SP P S P S S + P + S T+P + PS +
Sbjct: 1612 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPT 1671
Query: 307 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
P+ P+ P S S + P + + S T+P + S +P ++ +
Sbjct: 1672 SPSYSPT---SPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNE 1728
Query: 367 PSNP 370
N
Sbjct: 1729 NENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 1e-15
Identities = 61/288 (21%), Positives = 105/288 (36%), Gaps = 17/288 (5%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
+ + P + + + L K SP ++ A TA
Sbjct: 1454 MPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGG 1513
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
A + T+P A + T+ P SP P++ P S P S S + P
Sbjct: 1514 ADYGEATSPFGAYGEAPTS-PGFGVSSPGFSPTSPTYSPTS-------PAYSPTSPSYSP 1565
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ TSP + +P + PS + P+ P+ + P S PS + P+ P
Sbjct: 1566 TSPSYSPTSPSYSPTSPSYSP---TSPSYSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSP 1621
Query: 313 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPP-PASHPSNTALPPASHPSNPA 371
++ + P S + P S S + P + S T+P + PS + P+ P++P+
Sbjct: 1622 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPS 1681
Query: 372 IPPASHPSNTAIPPASHPSNTAP-PHASHPSNTALTPASHPSNIAPPP 418
P S + P + + S T+P + P + +PA P
Sbjct: 1682 YSPTSP---SYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKH 1726
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 8e-14
Identities = 59/231 (25%), Positives = 87/231 (37%), Gaps = 15/231 (6%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPS 126
A F A ++P P PT+P SP P+ + P PS
Sbjct: 1510 AYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPS 1569
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
PT+P SP + P +PS PT+P SP +S ++ P SP + P S P+
Sbjct: 1570 YSPTSPSYSPTSPSYSP-----TSPSYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYS-PT 1622
Query: 187 NTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH---PSNTALPPASLPSKTAPPPA 243
+ + P S P S S + P+ + SP S P++ + P S P
Sbjct: 1623 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSY 1682
Query: 244 SHLSNTAPPPASHPYKTSPL--PASHPSKTAPPPASHPSNTAPPPASHPSK 292
S S + P + + TSP P S P + PA P + +
Sbjct: 1683 SPTSPSYSPTSPNYSPTSPSYSPTS-PGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 1e-13
Identities = 73/322 (22%), Positives = 98/322 (30%), Gaps = 45/322 (13%)
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
P + P + + + P + +
Sbjct: 1452 KYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAY 1511
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPR-GNFH 454
+ A+ P P + PG +P S P P +PA +P ++
Sbjct: 1512 GGADYG-----EATSPFGAYGEAPTSPGFGVSSPGFSPTS--PTYSPTSPAYSPTSPSYS 1564
Query: 455 RHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTP 514
SP+ P+ P P +P P +P P SP P P +P
Sbjct: 1565 PTSPSYSPTSPSYSP-----------TSPSYSPTSPSYSPT------SPSYSPTSPSYSP 1607
Query: 515 TASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKR 574
T+ PS P S PSY P SPS P PS+ PTS
Sbjct: 1608 TSPSYSPTSPSYSPTS------------PSYSPTSPSYSPTSPSYSPT-SPSYSPTSPSY 1654
Query: 575 HYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKS---SPSEPIRAF 631
P + SPS+SP T S PTSPS SPTS S P P S SP+ P +
Sbjct: 1655 SPTSPAYSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSP--GY 1710
Query: 632 PPPPPNADCSTTICTEPYTNTP 653
P P
Sbjct: 1711 SPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 2e-13
Identities = 70/262 (26%), Positives = 101/262 (38%), Gaps = 30/262 (11%)
Query: 26 SAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAP-SPIELPTHSAPPPVNIPSFSP 84
S + A+ GG P G AP SP + P P++SP
Sbjct: 1493 SPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSP-TSPTYSP 1551
Query: 85 STPAVSA--PFDMAPPPSLIPTNPVASPPSITAPP--PVNMAPPPSLIPTTPVASPPPIT 140
++PA S P PS PT+P SP S + P P PS PT+P SP
Sbjct: 1552 TSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP---- 1607
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
+PS PT+P SP +S ++ P SP + P S S P+ P+ +
Sbjct: 1608 --------TSPSYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYSPTS-----PSYSPTSPS 1653
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP--PASHPY 258
P S + PS + SP+ P++ P S S + P + + S T+P P S Y
Sbjct: 1654 YSPTSPAYSPTSPSYSPTSPSYSPTS---PSYSPTSPSYSPTSPNYSPTSPSYSPTSPGY 1710
Query: 259 K-TSPLPASHPSKTAPPPASHP 279
SP + + +
Sbjct: 1711 SPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 5e-07
Identities = 53/221 (23%), Positives = 66/221 (29%), Gaps = 31/221 (14%)
Query: 445 PAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPV 504
TP + S ++ + S + G F
Sbjct: 1468 GGVTP---YSNESGLVNADLDVKDEL-----MFSPLVDSGSNDAMAGGFTAYGGADYGEA 1519
Query: 505 ARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVP 564
P G SP S+P S P+Y P SPS P P
Sbjct: 1520 TSPFGAYGEAPTSPGF--GVSSPGFSP---------TSPTYSPTSPAYSPTSPSYSPTSP 1568
Query: 565 ------PSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLL 618
PS+ PTS P + SPS+SP S PTSPS SPTS S P
Sbjct: 1569 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS--PTSPSYSPTSPSYSPTSPSY 1626
Query: 619 PPKSSPSEPIRAFPPPPPNADCSTTICTEP----YTNTPPG 655
P S P P + T+ P Y+ T P
Sbjct: 1627 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPS 1667
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 1e-06
Identities = 39/171 (22%), Positives = 53/171 (30%), Gaps = 6/171 (3%)
Query: 487 PIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYD 546
+ + SP+ S G+ P +
Sbjct: 1478 GLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATS-PFGAYGEAPTSPGFG 1536
Query: 547 IPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSP 606
+ P SP+ P P++ PTS P + SPS+SP S PTSPS SP
Sbjct: 1537 VSSPGFSPTSPTYSPT-SPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS--PTSPSYSP 1593
Query: 607 TSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPPGSP 657
TS S P P S P P P + + +P SP
Sbjct: 1594 TSPSYSPTSPSYSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSPTSPSYSP 1642
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-16
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLH 954
++ +G+G FG V+ G KVA LK+V + +E F L E+++L L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQLLK 74
Query: 955 HRNLVKLIGICIEEQARC--------LVYELIPNGSVESHLHGV-DKESAPLGWDARLKI 1005
H N+V LI IC + + LV++ E L G+ ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS---AMDEESRHIS 1062
L Y+H + +++HRD K++N+L+ D K++DFGLAR+ A + + +
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 1063 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VILELLSGR 1102
RV+ T Y PE LL+ Y + ++ E+ +
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 51/222 (22%)
Query: 906 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 956
++G+G FG V D + VA+K++K Q EV +L ++
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114
Query: 957 --NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1011
+V L + CLV+E++ N L+ + + + G L K A
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVM 1066
AL +L +IH D K NILL + K+ DFG S+ R I +R
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSR-- 222
Query: 1067 GTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1102
F Y +PE Y + D++S G +++E+ +G
Sbjct: 223 --F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 66/255 (25%)
Query: 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 954
E ++ + + LG G FG+V ++ G + A+K +V Q + E++++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYK-NRELDIMKVLD 58
Query: 955 HRNLVKLIGI----CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD---------- 1000
H N++KL+ EE + +++ +S +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 1001 -------------ARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL- 1036
R ++ RA+ ++H S + HRD K N+L+
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 1037 EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS-------D 1087
D T K+ DFG A+ + E +I +R Y APE L++ + D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSID 224
Query: 1088 VYSYGVVILELLSGR 1102
++S G V EL+ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
F+ ++LG+G FG V G A+K+LK+ V + L E +L H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 957 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARA 1012
L L + R C V E G + HL S AR +I A
Sbjct: 209 FLTALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVS----A 260
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1071
L YLH + + V++RD K N++L+ D K++DFGL + + + + + GT Y
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEY 315
Query: 1072 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
+APE + + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 7e-16
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 901 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH 954
F+ ++LG+G FG V+ D A+KVLK + + E ++L ++
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 955 HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAA 1010
H +VKL + + + L+ + + G + + L + D + ++AL
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELAL--- 137
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTF 1069
AL +LH +I+RD K NILL+ + K++DFGL++ ++D E + GT
Sbjct: 138 -ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 1070 GYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
Y+APE GH +S D +S+GV++ E+L+G P
Sbjct: 191 EYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 951
+F R LG G FG V+ L +G A+KVLK R+ Q E MLS
Sbjct: 7 DFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLS 61
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
+ H ++++ G + Q ++ + I G + S L + P A+ ++ L
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCL- 117
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1067
AL YLH +I+RD K NILL+ + K++DFG A+ D T + G
Sbjct: 118 ---ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCG 165
Query: 1068 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
T Y+APE + + KS D +S+G++I E+L+G P
Sbjct: 166 TPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 20/248 (8%)
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 926
+++ L +I Y AK F++ + +F+ +++G G FG V L + K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 927 V-AVKVLKRVD--QQGGRE-FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 982
V A+K+L + + ++ F E ++L + + L ++ LV + G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 983 VESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041
+ + L K L + AR +A A+ +H +HRD K NIL++ +
Sbjct: 161 LLTLL---SKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGH 213
Query: 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVIL 1096
+++DFG M++ + S V GT Y++PE D +S GV +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 1097 ELLSGRKP 1104
E+L G P
Sbjct: 273 EMLYGETP 280
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 908 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLSRLH---HRNL 958
+G G +G VY G VA+K ++ + GG + EV +L RL H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 959 VKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1011
V+L+ +C + LV+E V+ L ++ P G A + R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L +LH + ++HRD K NIL+ T K++DFGLAR + ++ V+ T Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA-LTPVVV-TLWY 185
Query: 1072 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 1102
APE +L++S D++S G + E+ +
Sbjct: 186 RAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 908 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 966
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 967 EEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAA--------RALAY 1015
R L+++ E L + A +++ G + Y
Sbjct: 89 SHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLAR--SAMDEESRHISTRVMGTF 1069
LH + V+HRD K +NIL+ + K++D G AR ++ + + V+ TF
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 1070 GYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1102
Y APE LL+ + D+++ G + ELL+
Sbjct: 200 WYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 836 YKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEI 895
+ H + E G G ++ A TG A+
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGG------DGGEQLLTVKHELRTANLTGHAEKVGIE-- 54
Query: 896 EKATGNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEV 947
NF+ ++LG G +G V+ D G A+KVLK+ V + E E
Sbjct: 55 -----NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 948 EMLSRL-HHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL-- 1003
++L + LV L + + + L+ + I G + +HL ++ + + ++
Sbjct: 110 QVLEHIRQSPFLVTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYV 165
Query: 1004 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+I L AL +LH+ +I+RD K NILL+ + ++DFGL++ + +E+
Sbjct: 166 GEIVL----ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 1063 TRVMGTFGYVAPE---YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT Y+AP+ +GH K+ D +S GV++ ELL+G P
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 5e-15
Identities = 70/326 (21%), Positives = 115/326 (35%), Gaps = 54/326 (16%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPS----LIPTNPVASP 110
L A +P E V P + +P V + L +P
Sbjct: 1475 TSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGV 1534
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
S P + A P T+P SP +P+ +P++P SP S P
Sbjct: 1535 QSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYST------SPAYMPSSPSYSPTS----PS 1584
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
SP S + P + S T+ P+ + + P S + PS + SP+ P++ +
Sbjct: 1585 YSPTSPSYSPTSPSYSPTS--PSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1642
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P S P S S P+ P+ + P S P+ P
Sbjct: 1643 PTS-------PSYSPTS----------------PSYSPTSPSYSPTS--------PSYSP 1671
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
+ P+ P++ + P S + P S S + P + S T+P + S +P
Sbjct: 1672 TS----PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1727
Query: 351 PPASHPSNTALPPASHPSNPAIPPAS 376
+ PS + P+ P++P+ P S
Sbjct: 1728 ---TSPSYSPTSPSYSPTSPSYSPTS 1750
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 9e-15
Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 20/304 (6%)
Query: 94 DMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSL 153
D + V + + +P+ + +P P
Sbjct: 1452 DQDMLMNYSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQG 1511
Query: 154 IPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALP 213
ASP P + P ++A P + + P+S P + P
Sbjct: 1512 GSEGREGFGDYG-LLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSS-PGYSTSP 1569
Query: 214 SKTAPSPASHPSNTALPPAS-LPSKTAPPPASHLSNTAPPPASHPYKTSPL-PASHPSKT 271
+ SP+ P++ + P S S T+P S T+P ++ SP P+ P+
Sbjct: 1570 AYMPSSPSYSPTSPSYSPTSPSYSPTSPSY----SPTSPSYSATSPSYSPTSPSYSPT-- 1623
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP-----PASHPSNT 326
P+ P++ + P S P S S + P + S T+P P+ P++
Sbjct: 1624 --SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1681
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
+ P S + P S +S + P + S T+ P+ P++P+ P S PS + P+
Sbjct: 1682 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSPTS-PSYSPTSPS 1738
Query: 387 SHPS 390
P+
Sbjct: 1739 YSPT 1742
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 1e-14
Identities = 74/314 (23%), Positives = 110/314 (35%), Gaps = 33/314 (10%)
Query: 333 HPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNT 392
T +S+ + + + + +P S +
Sbjct: 1463 TAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDY 1522
Query: 393 APPHASHPSNTALTPA-SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG 451
A+ P +P + P + A P + PS P S SP +P +P+ +P
Sbjct: 1523 GLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTS 1582
Query: 452 -NFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPG--PFPPGNSRQKSPVARPI 508
++ SP+ P+ P P S P P +P P P S SP P
Sbjct: 1583 PSYSPTSPSYSPTSPSYSPTSPSYSATS----PSYSPTSPSYSPTSPSYSPT-SPSYSPT 1637
Query: 509 IPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFI 568
P +PT P P++P S P+ P ++SP+ P S
Sbjct: 1638 SPSYSPT---SPSYSPTSPSYS------------PTSPSYSPTSPSYSPTSPSYSPTSPS 1682
Query: 569 PTSRKRHYGP--PPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKS---S 623
+ Y P P + SPS+SP S PTSPS SPTS S P P S S
Sbjct: 1683 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYS--PTSPSYSPTSPSYSPTSPSYSPTSPSYS 1740
Query: 624 PSEPIRAFPPPPPN 637
P+ P ++ P P+
Sbjct: 1741 PTSP--SYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 4e-13
Identities = 92/376 (24%), Positives = 132/376 (35%), Gaps = 88/376 (23%)
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP 295
+ + ++ P A PY+ SP+ S + A P
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEG-----REG 1518
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
A P S P + P ++A P + P S SS P ++
Sbjct: 1519 FGDYGLLGAASPYKGVQS----PGYTSPFSSAMSPGYGLT---SPSYSPSS---PGYSTS 1568
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP-PHASHPSNTALTPASHPSNI 414
P+ P+ P++P+ P S PS + P + S T+P A+ PS + +P+ P+
Sbjct: 1569 PAYMPSSPSYSPTSPSYSPTS-PSYS--PTSPSYSPTSPSYSATSPSYSPTSPSYSPT-- 1623
Query: 415 APPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQK 474
P + P PS P SP P +P+ +P SP+ P+ P P
Sbjct: 1624 --SPSYSPTSPSYSP------TSPSYSPTSPSYSPT------SPSYSPTSPSYSPT---- 1665
Query: 475 RNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGK 534
+P P +P P SP P P +PT+ PS P S
Sbjct: 1666 -------SPSYSPTSPSYSPT------SPSYSPTSPSYSPTSPSYSPTSPSYSPTS---- 1708
Query: 535 RVGKPVAEPSYDIPMPPPVNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTP 594
PSY SP+ PS+ PTS P + SPS+S
Sbjct: 1709 --------PSY----------SPTS-----PSYSPTSPSYSPTSPSYSPTSPSYS----- 1740
Query: 595 VSRVPTSPSPSPTSAS 610
PTSPS SPTS S
Sbjct: 1741 ----PTSPSYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 6e-13
Identities = 68/338 (20%), Positives = 114/338 (33%), Gaps = 52/338 (15%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
+ + + P P SP P A+ S P +
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPY--ERSPMVDSGFVGSPDAAAFS-----PLVQGGSEGR 1516
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP--PA 309
++ P + P ++A P + + P+S +T+P P+
Sbjct: 1517 EGFGDYGLLGAASPYKGVQS--PGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPS 1574
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
S + P S S + P + S T+P ++ S + P S PS + P+ P++
Sbjct: 1575 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATS--PSYSPTS-PSYSPTSPSYSPTS 1631
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALP 429
P+ P S + P S S + P + S T+ P+ P++ + P
Sbjct: 1632 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSP----------- 1678
Query: 430 GKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIA 489
SP P +P+ +P SP+ P+ P P S P P +
Sbjct: 1679 ------TSPSYSPTSPSYSPT------SPSYSPTSPSYSPTSPSYSPTS----PSYSPTS 1722
Query: 490 PGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP 527
P P SP P P +PT+ P P++P
Sbjct: 1723 PSYSP------TSPSYSPTSPSYSPTS---PSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 3e-12
Identities = 64/248 (25%), Positives = 93/248 (37%), Gaps = 14/248 (5%)
Query: 34 SPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPF 93
SP + GG L SP S+ SPS S +
Sbjct: 1506 SPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGY 1565
Query: 94 DMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAP 151
+P P++P SP PS + P PS PT+P S + P +P
Sbjct: 1566 STSPAYM--PSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPT-----SP 1618
Query: 152 SLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
S PT+P SP +S ++ P SP + P S P++ + P S P S S +
Sbjct: 1619 SYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPTSPSYSPTSPSY 1676
Query: 212 LPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP--PPASHPYKTSPLPASHPS 269
P+ + SP S + P S S + P + S T+P P S Y + P+ P+
Sbjct: 1677 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS-PSYSPT 1735
Query: 270 KTAPPPAS 277
+ P S
Sbjct: 1736 SPSYSPTS 1743
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 3e-12
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 16/300 (5%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
+ + + P P P + S + P S
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYG 1523
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP--PA 287
+ + S + + P P+ PS + ++P P
Sbjct: 1524 LLGAASPYKGVQSPGYTSPFSSAMS--PGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPT 1581
Query: 288 SHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSK 347
S PS + P+ P++ + P S + P S S + P + S T+P + S
Sbjct: 1582 S-PSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1640
Query: 348 TAP-PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
+P P+ P++ + P S +P P S S + P + S T+P + P++ + +
Sbjct: 1641 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP--SYSPTSPSYS 1698
Query: 407 PASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG-NFHRHSPAIHPSMP 465
P S PS P + P PS P SP P +P+ +P ++ SP+ P+ P
Sbjct: 1699 PTS-PSYSPTSPSYSPTSPSYSP------TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 7e-10
Identities = 63/231 (27%), Positives = 81/231 (35%), Gaps = 33/231 (14%)
Query: 433 PVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGP 492
P +SP+ + F SP + G +P +PG
Sbjct: 1485 PYERSPMVDSGFVGSPDAAAF---SPLVQGGSEGREGFGDY--GLLGAASPYKGVQSPGY 1539
Query: 493 FPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPP 552
P +S SP P +P+ SP P+ P S PSY P
Sbjct: 1540 TSPFSSAM-SPGYGLTSPSYSPS-SPGYSTSPAYMPSS------------PSYSPTSPSY 1585
Query: 553 VNHSPSKGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPL-----PTPVSRVPTSPSPSPT 607
SPS P PS+ PTS P ++ SPS+SP PT S PTSPS SPT
Sbjct: 1586 SPTSPSYSPT-SPSYSPTS-------PSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1637
Query: 608 SASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTP-PGSP 657
S S P P S P P + T+ P + + P SP
Sbjct: 1638 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1688
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 6e-15
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 885 GSAKTFSASEIEKAT-GNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVL-KRVDQQ 938
GS++T EK F+ R+LG+GG+G V+ + G A+KVL K + +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 939 GGREF---LAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKES 994
++ AE +L + H +V LI + + L+ E + G + L
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 995 APLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051
A +I++ AL +LH+ +I+RD K NI+L H K++DFGL +
Sbjct: 120 ED---TACFYLAEISM----ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 1052 SAMDEESRHISTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
++ + + T GT Y+APE +GH ++ D +S G ++ ++L+G P
Sbjct: 170 ESIHDGTV---THTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 19/246 (7%)
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 926
LD +L +I + K + +++ +++G G FG V K
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 927 V-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 982
V A+K+L + + + F E ++++ + +V+L +++ +V E +P G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042
+ + + P W AR A AL +H S IHRD K N+LL+
Sbjct: 156 LVNLM---SNYDVPEKW-ARFYTAEVVL-ALDAIH---SMGFIHRDVKPDNMLLDKSGHL 207
Query: 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVILEL 1098
K++DFG E T V GT Y++PE + D +S GV + E+
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 1099 LSGRKP 1104
L G P
Sbjct: 267 LVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRL 953
+FD ++LG+G FG V L G A+K+L++ E + E +L
Sbjct: 6 DFDYLKLLGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 954 HHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGA 1009
H L L + R C V E G + HL + AR +I
Sbjct: 63 RHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVS-- 116
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GT 1068
AL YLH V++RD K N++L+ D K++DFGL + + + + + GT
Sbjct: 117 --ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGT 168
Query: 1069 FGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
Y+APE + ++ D + GVV+ E++ GR P
Sbjct: 169 PEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---------- 954
R LG G F V+ + + T VA+K+++ D+ E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 955 -HRNLVKLIG----ICIEEQARCLVYELIPNGSVESHLHGVDKES--APLGWDARLKIAL 1007
+++KL+ +V+E++ +L + K+ + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-----GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEH------DFTPKVSDFGLARSAMDEESRHI 1061
L Y+H +IH D K N+L+E K++D G A + + I
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 1062 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1102
TR Y +PE + +D++S +I EL++G
Sbjct: 197 QTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 35/123 (28%), Positives = 55/123 (44%), Gaps = 4/123 (3%)
Query: 983 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042
VE D L + + + A+ + +L +S + IHRD + NILL
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 232
Query: 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-G 1101
K+ DFGLAR + ++APE ++SDV+S+GV++ E+ S G
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292
Query: 1102 RKP 1104
P
Sbjct: 293 ASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 20/163 (12%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRN 957
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 958 LVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+V L+G C + ++ E G++ ++L R + + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059
I D K + + S F +S D E
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 46/213 (21%), Positives = 76/213 (35%), Gaps = 53/213 (24%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 963
++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD 78
Query: 964 ICIEEQARC-----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
+ E +V E + G ++ E +A +I A+
Sbjct: 79 VY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 131
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
YLH S + HRD K N+L + K++DFG
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
A E + D++S GV++ LL G P
Sbjct: 167 -AKETTGEKYDK-SCDMWSLGVIMYILLCGYPP 197
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-14
Identities = 52/251 (20%), Positives = 98/251 (39%), Gaps = 24/251 (9%)
Query: 869 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 926
L ++ L+ +A + A+ E +F+ +++G G F V + +
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ 87
Query: 927 V-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNG 981
V A+K++ + + + F E ++L R + +L +++ LV E G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF-AFQDENYLYLVMEYYVGG 146
Query: 982 SVESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1040
+ + L K + + AR +A A+ +H +HRD K NILL+
Sbjct: 147 DLLTLL---SKFGERIPAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCG 199
Query: 1041 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY-------SYGV 1093
+++DFG + + V GT Y++PE + Y + GV
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 1094 VILELLSGRKP 1104
E+ G+ P
Sbjct: 259 FAYEMFYGQTP 269
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 4e-14
Identities = 39/254 (15%), Positives = 70/254 (27%), Gaps = 68/254 (26%)
Query: 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--------QQGGREFLAEVEM 949
T +GEG FG V+ + D T VA+K++ Q+ E L E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 950 LSRLH---------HRNLVKLIGICI------------------------------EEQA 970
L + L + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1030
+V E G + + I +LA S R HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 1031 SSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP--EYAMTGHLLVKSDV 1088
N+LL+ K+ +S+ + + G +Y ++ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 1089 YSYGVVILELLSGR 1102
+ + +L +G
Sbjct: 239 FCDVSMDEDLFTGD 252
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 906 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 956
+++G+G FG V D VA+K+++ +Q E+ +L L +
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 957 --NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARA 1012
N++ ++ C+ +EL+ +L+ + K++ G+ L K A +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVMG 1067
L LH R+IH D K NILL+ KV DFG S+ E R I +R
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSR--- 263
Query: 1068 TFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1102
F Y APE Y M D++S G ++ ELL+G
Sbjct: 264 -F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 901 NFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG------RE--FLAEVEML 950
++ +GEG +G V+ + + G VA+K ++ + G RE L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---L 68
Query: 951 SRLHHRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGV-DKESAPLGWDARLK 1004
H N+V+L +C + LV+E V+ L DK P +K
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIK 123
Query: 1005 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+ R L +LH S RV+HRD K NIL+ K++DFGLAR + +++
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA-LTS 178
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 1102
V+ T Y APE +L++S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 952
+F ++LG+G FG V+ L A+K LK+ + + E +LS
Sbjct: 18 DFILHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 953 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
H L + + + V E + G + H+ K A +I L
Sbjct: 75 WEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIIL- 129
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1067
L +LH +++RD K NILL+ D K++DFG+ + M +++ T G
Sbjct: 130 ---GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 1068 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
T Y+APE + G S D +S+GV++ E+L G+ P
Sbjct: 181 TPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 57/250 (22%), Positives = 92/250 (36%), Gaps = 89/250 (35%)
Query: 906 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRL-----HH 955
R +G+G FG V K AVKV++ + + E ++L ++ ++
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINN 95
Query: 956 RNLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARLKI 1005
N+VK G +C+ E L YE+I N H+ + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSL-YEIITRNNYNGFHIEDI-----------K-LY 142
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----------------------- 1042
+ +AL YL + + H D K NILL+ +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 1043 --KVSDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 1091
K+ DFG A + H I+TR Y APE + + SD++S+
Sbjct: 200 GIKLIDFG---CATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWSF 245
Query: 1092 GVVILELLSG 1101
G V+ EL +G
Sbjct: 246 GCVLAELYTG 255
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-13
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR- 952
+F+ +LG+G FG V L AVK+LK+ + + E +L+
Sbjct: 21 DFNFLMVLGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 953 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
L +L C + R V E + G + H+ V + P A +IA+
Sbjct: 78 GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAI- 132
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1067
L +L +I+RD K N++L+ + K++DFG+ + + + T+ G
Sbjct: 133 ---GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 183
Query: 1068 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
T Y+APE A + KS D +++GV++ E+L+G+ P
Sbjct: 184 TPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 1e-12
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 955
+F+ +LG+G FG V AVK+LK+ + + E +L+
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 956 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
L +L C + R V E + G + H+ V + P A A A L
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAA-EIAIGLF 456
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVA 1073
+L +I+RD K N++L+ + K++DFG+ + + + T+ GT Y+A
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIA 510
Query: 1074 PEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
PE + KS D +++GV++ E+L+G+ P
Sbjct: 511 PE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 38/266 (14%), Positives = 75/266 (28%), Gaps = 59/266 (22%)
Query: 908 LGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLVKL 961
G + LD +VA+ + + +E L+ LSR+ + ++
Sbjct: 39 HGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 962 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1021
+ + +V E I GS++ ++ A A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1081
V S + + D + +
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDANP---- 181
Query: 1082 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS-LGN 1140
+ D+ G + LL R P+ R+ + I+P+ +
Sbjct: 182 ---QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDR 230
Query: 1141 DVPFDSVAKVAAIASMCVQPEVQHRP 1166
D+PF ++A+A+ VQ + R
Sbjct: 231 DIPFQ----ISAVAARSVQGDGGIRS 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK--------RVDQ-QGGREFLAEV 947
+FD R++G G + V L A+KV+K +D Q + +
Sbjct: 10 DFDLLRVIGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 948 EMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL--- 1003
+H LV L C + ++R V E + G + H+ K AR
Sbjct: 67 -----SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSA 117
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+I+L AL YLHE +I+RD K N+LL+ + K++D+G+ + + T
Sbjct: 118 EISL----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---T 167
Query: 1064 RVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 168 STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 41/227 (18%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 957
NF + +G G FG + G L VA+K+ + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 958 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 1012
+ ++ + +V EL+ G S+E D+ ++ L IA+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-------LMIAIQLISR 117
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS-----DFGLARSAMDEES-RHISTR-- 1064
+ Y+H + +I+RD K N L+ DF LA+ +D E+ +HI R
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 1065 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
+ GT Y + HL + D+ + G + + L G P
Sbjct: 175 KSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 51/238 (21%), Positives = 84/238 (35%), Gaps = 69/238 (28%)
Query: 906 RILGEGGFGLVYSGV--LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 956
LGEG FG V + ++VA+K+++ V + E+ +L ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 957 --NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1011
V + C+ +EL+ N KE+ + +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKN------TFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KVSDFGLARS 1052
AL +LHE ++ H D K NIL + +V+DFG S
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---S 188
Query: 1053 AMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSG 1101
A + H ++TR Y PE +A DV+S G ++ E G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLK--------RVDQ-QGGREFLAEVEML 950
+FD R++G G + V L A++V+K +D Q + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA--- 109
Query: 951 SRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 1006
+H LV L C + ++R V E + G + H+ K AR +I+
Sbjct: 110 --SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
L AL YLHE +I+RD K N+LL+ + K++D+G+ + + T
Sbjct: 164 L----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTF 213
Query: 1067 -GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 214 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-12
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 952
NF+ R+LG+G FG V L + G AVKVLK+ + + E +LS
Sbjct: 24 NFEFIRVLGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 953 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1008
+H L +L C + R V E + G + H+ + AR +I
Sbjct: 81 RNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIIS- 135
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1067
AL +LH+ +I+RD K N+LL+H+ K++DFG+ + + T G
Sbjct: 136 ---ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186
Query: 1068 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
T Y+APE + + D ++ GV++ E+L G P
Sbjct: 187 TPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 85/246 (34%)
Query: 906 RILGEGGFGLVYSGVLDDGTK---VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR--- 956
LGEG FG V +D VAVK++K VD + +E+++L L+
Sbjct: 20 DTLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPN 74
Query: 957 ---NLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL 1003
V+++ ICI E Y+ I NG + L + R
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLST-YDFIKENGFLPFRLDHI-----------R- 121
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KV 1044
K+A +++ +LH ++ H D K NIL KV
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 1045 SDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVI 1095
DFG SA ++ H +STR Y APE ++ DV+S G ++
Sbjct: 179 VDFG---SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCIL 224
Query: 1096 LELLSG 1101
+E G
Sbjct: 225 IEYYLG 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 957
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 958 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ + E +V EL+ G S+E + ++ L +A + Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYI 121
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEESR-HISTR----VMGT 1068
H S IHRD K N L+ + DFGLA+ D + HI R + GT
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 1069 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
YA + HL + + D+ S G V++ G P
Sbjct: 179 -----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 951
+F +++G+G FG V L + AVKVL+ + ++ + ++E +L
Sbjct: 39 DFHFLKVIGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILKKKEE--KHIMSERNVLL 93
Query: 952 R-LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 1006
+ + H LV L + + V + I G + HL P AR +IA
Sbjct: 94 KNVKHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIA 149
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1066
AL YLH + +++RD K NILL+ ++DFGL + ++ S T
Sbjct: 150 S----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTF 199
Query: 1067 -GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1104
GT Y+APE + ++ D + G V+ E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 957
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 958 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 1012
+ + E LV +L+ G S+E L + ++ A
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV-------AMAAKQMLAR 118
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPK-----VSDFGLARSAMDEES-RHISTR-- 1064
+ +HE S +++RD K N L+ + V DFG+ + D + +HI R
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 1065 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
+ GT Y + HL + D+ + G V + L G P
Sbjct: 176 KNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 9e-12
Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 47/233 (20%)
Query: 906 RILGEGGFGLVYSGVLDDGT------KVAVKVLKRVDQQGGREF-----LAEVEMLSRLH 954
+G+GGFG +Y ++ VKV + E A+ E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 955 HRNLVKLIGIC----------IEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 1003
+K +G+ + R ++ + G ++ + + L
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFSRKTVL 155
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RH 1060
+++L L Y+HE +H D K+SN+LL + +V D+GLA E +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 1061 ISTR----VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
+ GT E+ + H V + D+ G +++ L+G P
Sbjct: 213 YAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 1e-11
Identities = 38/232 (16%), Positives = 54/232 (23%), Gaps = 12/232 (5%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
SH + P A P+ P + A S PP + P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGA-----VPSM 56
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
+ T H + + + P P+ A P P
Sbjct: 57 GQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPN--AYMQPQVPVQMGTPLQQQQQ 114
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
A P PS + P T PP PP P +
Sbjct: 115 PMAAPAYGQPSAAMGQNMRPMNQLYPIDLL----TELPPPITDLTLPPPPLVIPPERMLV 170
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P S SN + N P ++S + L + P
Sbjct: 171 P-SELSNASPDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPP 221
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 2e-11
Identities = 31/209 (14%), Positives = 49/209 (23%), Gaps = 3/209 (1%)
Query: 266 SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP-PASHPSNTAPPPASHPS 324
SH K P A P P++ PP + + P P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 325 NTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIP 384
T H + + P P+ A P P A P
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPN--AYMQPQVPVQMGTPLQQQQQPMAAP 119
Query: 385 PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDA 444
PS + + L +P P +P + + S +S
Sbjct: 120 AYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASP 179
Query: 445 PAATPRGNFHRHSPAIHPSMPGPLPPVAQ 473
N + ++ P V +
Sbjct: 180 DYIRSTLNAVPKNSSLLKKSKLPFGLVIR 208
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-11
Identities = 32/196 (16%), Positives = 53/196 (27%), Gaps = 1/196 (0%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
+P A P P+ P + + P A+PS + P+
Sbjct: 8 VYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLT-PAQ 66
Query: 227 TALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPP 286
L + T+ + P ++ P+ P + P + P+ P
Sbjct: 67 EQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
A + P T PPP S SN +P +
Sbjct: 127 AMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTL 186
Query: 347 KTAPPPASHPSNTALP 362
P +S + LP
Sbjct: 187 NAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 1e-10
Identities = 31/218 (14%), Positives = 46/218 (21%), Gaps = 6/218 (2%)
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
SH P A L P + PP S P + A P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 282 TAPPPASHPSKTAPPPAS------HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P + S H P A + P A+
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
+ + T LPP PP P + P+ + +
Sbjct: 122 GQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDY 181
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAP 433
S + + + P L + P
Sbjct: 182 IRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDP 219
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 33/217 (15%), Positives = 54/217 (24%), Gaps = 1/217 (0%)
Query: 158 PLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTA 217
P A + P P+ P + + P + A P P++
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLT-PAQEQ 68
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
+ T++ L + P +++ P P + P + P+ P A
Sbjct: 69 LHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 337
+ P T PPP S SN +P N
Sbjct: 129 GQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
P +S K+ P P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPPLNED 225
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 9e-09
Identities = 24/185 (12%), Positives = 43/185 (23%), Gaps = 8/185 (4%)
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
SH P A P P+ PP + + PP +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQ------MGMPPQGAVPS 55
Query: 359 TALPPASHPSNPAIPPASHPSNTAIPPASHPSN--TAPPHASHPSNTALTPASHPSNIAP 416
P+ + + T++ + P P P
Sbjct: 56 MGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQP 115
Query: 417 PPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRN 476
PSA G+ + + D P P +P V + +
Sbjct: 116 MAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELS 175
Query: 477 ASNRE 481
++ +
Sbjct: 176 NASPD 180
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 2e-08
Identities = 30/165 (18%), Positives = 42/165 (25%), Gaps = 2/165 (1%)
Query: 343 SHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
SH K P A P P+ P + + P A P S
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVP--SMGQQ 59
Query: 403 TALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
LTPA + + L V + P P + P P
Sbjct: 60 QFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAP 119
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARP 507
+ P + Q N+ PI P + P+ P
Sbjct: 120 AYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIP 164
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 27/206 (13%), Positives = 40/206 (19%), Gaps = 2/206 (0%)
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
A P P + P A + P +
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ + + P P+ P T L + P A +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
L PPP + T P P S SN +P
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDL--TLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 294 APPPASHPSNTAPPPASHPSNTAPPP 319
P +S + P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 2e-07
Identities = 33/206 (16%), Positives = 46/206 (22%), Gaps = 2/206 (0%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
+ P PP P S + PP V TP
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQD--PAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQ 68
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS 222
L + + ++ A P + P A P+ PS A
Sbjct: 69 LHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 223 HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNT 282
+ + P T PPP L S S +P N
Sbjct: 129 GQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 283 APPPASHPSKTAPPPASHPSNTAPPP 308
P +S K+ P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 30/193 (15%), Positives = 45/193 (23%), Gaps = 7/193 (3%)
Query: 60 GHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPV 119
G +P++ P PP + P P A
Sbjct: 17 GQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQA 76
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+ + P+ P P + + P P+A+P +
Sbjct: 77 TTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMN 136
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
T PP PPP P L S SN +
Sbjct: 137 QLYPIDLLTELPPPITDLTLPPPPLVIPPERML-------VPSELSNASPDYIRSTLNAV 189
Query: 240 PPPASHLSNTAPP 252
P +S L + P
Sbjct: 190 PKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 29/204 (14%), Positives = 45/204 (22%), Gaps = 1/204 (0%)
Query: 83 SPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAP 142
+ +A P + P +P A+ S PS+ +P
Sbjct: 12 AQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSM-GQQQFLTPAQEQLH 70
Query: 143 PLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPP 202
++ + A+ P P A P PS
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
+ P T PP + S LSN +P P
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVP 190
Query: 263 LPASHPSKTAPPPASHPSNTAPPP 286
+S K+ P
Sbjct: 191 KNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 3e-05
Identities = 31/193 (16%), Positives = 49/193 (25%), Gaps = 4/193 (2%)
Query: 24 QGSAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGG---HAPSPIELPTHSAPPPVNIP 80
Q YG +P F+ P+ P + +G A + P +
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
+ P + P + + P+ P P S
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
+N L L+ P + PP P P S SN +
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVP-SELSNASPDYIRSTLNAV 189
Query: 201 PPPASHPSNTALP 213
P +S + LP
Sbjct: 190 PKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 5e-05
Identities = 31/209 (14%), Positives = 51/209 (24%), Gaps = 16/209 (7%)
Query: 365 SHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVL 424
SH P A P P+ PP + S+ PP VP +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAA-----GMSYGQMGMPPQGAVPSM 56
Query: 425 PSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPI 484
Q + A + + H + P PV
Sbjct: 57 GQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQM----------- 105
Query: 485 AEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPS 544
P+ P P A D+ PP D P+ P
Sbjct: 106 GTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPP 165
Query: 545 YDIPMPPPVNHSPSKGPVVPPSFIPTSRK 573
+ +P ++++ + +P +
Sbjct: 166 ERMLVPSELSNASPDYIRSTLNAVPKNSS 194
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 46/231 (19%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRLHHR 956
+ +G GGFGL+Y + K A V+K Q+ G F +A+ + + + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 957 NLVKLIGI----------CIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKI 1005
+ +GI R +V E + G ++ L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTV----LQL 156
Query: 1006 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RHIS 1062
+ L Y+HE+ +H D K++N+LL + +V +D+GL+ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 1063 TRV----MGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
GT E+ + H V +SDV G +L L G+ P
Sbjct: 214 ENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 43/234 (18%), Positives = 83/234 (35%), Gaps = 49/234 (20%)
Query: 906 RILGEGGFGLVYSGV---------LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLS 951
G++Y K ++K+ + D + E A+ ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-DGRLFNEQNFFQRAAKPLQVN 106
Query: 952 RLHHRNLVKLIGI-------CIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 1003
+ L+ I +++ R LV + G S++S L K + L
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER--SVL 162
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEESRHI 1061
++A AL +LHE+ +H + + NI ++ + +V + +G A +H+
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHV 218
Query: 1062 STR------VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
+ G E+ M H +SD+ S G +L+ L G P
Sbjct: 219 AYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 54/269 (20%), Positives = 82/269 (30%), Gaps = 79/269 (29%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH--- 954
G + R LG G F V+ + VA+KV+K + L E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSD 94
Query: 955 -----HRNLVKLIGICIEEQA-----RCLVYELIPNGSVESHLHGVDKESAPLGWDARL- 1003
+V+L+ + C+V+E G HL +S G
Sbjct: 95 PNDPNREMVVQLLD-DFKISGVNGTHICMVFE--VLGH---HLLKWIIKSNYQGLPLPCV 148
Query: 1004 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLE------------------------- 1037
KI + L YLH R+IH D K NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 1038 ------------------------HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
K++D G A + I TR Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRS 261
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGR 1102
E + +D++S + EL +G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 958
F R +G G FG +Y G + +VA+K+ + + L E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 959 V-KLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ + +E LV +L+ G S+E + S L L +A + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEES-RHISTR----VMGT 1068
H S +HRD K N L+ + DFGLA+ D + +HI R + GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 1069 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1104
YA + HL + + D+ S G V++ L G P
Sbjct: 177 -----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 8e-08
Identities = 63/448 (14%), Positives = 123/448 (27%), Gaps = 143/448 (31%)
Query: 909 GEGGFG---LVYSGVLDDGTKVAVKVLKRVDQQG-----GREFLAE--VEMLSRLHHRNL 958
G G G + L KV ++D + E +EML +L ++
Sbjct: 157 GVLGSGKTWVALDVCLSY------KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-- 208
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
+ PN + S D S +L+I A L
Sbjct: 209 ------------------IDPNWTSRS-----DHSSNI-----KLRIHSIQAELRRLLKS 240
Query: 1019 DSSPR--VIHRDFKSSNILLEHDFTPKV----SDFGLARSAMDEESRHIS---------- 1062
++ + +++ + + K+ + + HIS
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 1063 TRVMGTFGYVA-------PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1115
V P +T + S +I E + ++
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-------IIAESI-------------RDG 340
Query: 1116 LVAWARPLLTSREGLERIIDPSLGNDVP------------F-DSV---AKVAAIASMCV- 1158
L W + + L II+ SL P F S + + +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-----LSLI 395
Query: 1159 --QPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDP 1216
+V+ + + K+ ++ S + ++L K+ L
Sbjct: 396 WFDVIKS------DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE-NEYALHRS 448
Query: 1217 LQRHYSVP-NYDLGLDTGRRLSLSYLFS------SSARSGKEESELFRR-YSSSGPLRTG 1268
+ HY++P +D D Y +S + E LFR + R
Sbjct: 449 IVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFRMVFLD---FR-- 501
Query: 1269 RGRQFW--QRIRRLVGGSDSEHGAVFSL 1294
+ Q+IR + + G++ +
Sbjct: 502 -----FLEQKIRH-DSTAWNASGSILNT 523
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 54.7 bits (130), Expect = 1e-07
Identities = 29/173 (16%), Positives = 44/173 (25%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
P + PSPA S K A PPA+ + A PPA +
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
S S PS P + PP + + S
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 321 SHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
A ++ + + P + P P+ + P P +
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 53.2 bits (126), Expect = 5e-07
Identities = 30/173 (17%), Positives = 41/173 (23%)
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
P + P T A P S ARPPA+ + ARPPA R
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
+ S PS P A + P A P + +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ + S P + AP + P
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 53.2 bits (126), Expect = 5e-07
Identities = 29/169 (17%), Positives = 44/169 (26%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P L+ + PA P A S ARPPA+ A PPA ++
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
++PS P A P K + P A + +
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
+ ++ S + P AP + P
Sbjct: 137 VRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 1e-06
Identities = 30/172 (17%), Positives = 48/172 (27%), Gaps = 3/172 (1%)
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P + APP + P PA + S K A PPA+ + A PPA + +
Sbjct: 17 PPRIAPPKLACR---TPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
S PS P + PP + + +S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 355 HPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
AL ++ + + P + P+ + P L
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 50.1 bits (118), Expect = 4e-06
Identities = 28/180 (15%), Positives = 43/180 (23%), Gaps = 5/180 (2%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A R P + PS P + S T+ K A PA+ + A PPA
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
+ + S +P P + K + P A P +
Sbjct: 71 RLSVDEVS-----SPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELAS 125
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
+ ++ S P AP + P
Sbjct: 126 CLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 6e-06
Identities = 26/173 (15%), Positives = 37/173 (21%)
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
P P+L S +A PPA+P + ARPPA
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSN 248
+ S PS P + K + A P +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
+ S + P AP + P
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.0 bits (115), Expect = 9e-06
Identities = 22/162 (13%), Positives = 37/162 (22%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
+ P PA S K + PA+ A PPA + S
Sbjct: 20 IAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSS 79
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
PS P + PP + + S + A
Sbjct: 80 PSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRA 139
Query: 350 PPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
++ + + P + P+ + P
Sbjct: 140 LKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGL 181
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.0 bits (115), Expect = 1e-05
Identities = 27/170 (15%), Positives = 38/170 (22%), Gaps = 2/170 (1%)
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 327
PP P PA + S A PPA+ + A PPA +
Sbjct: 16 GPPRIAPPKLAC--RTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 328 PPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
S PS P PP + + S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 388 HPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
A ++ + + TP + P P P
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 47.8 bits (112), Expect = 2e-05
Identities = 26/163 (15%), Positives = 41/163 (25%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
+ P PA S K A PPA+ + A PPA + S P
Sbjct: 21 APPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSP 80
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
S P + + PP + + S A+
Sbjct: 81 STPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRAL 140
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPS 426
++ + + + P+ L P LP
Sbjct: 141 KASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 44.0 bits (102), Expect = 3e-04
Identities = 24/163 (14%), Positives = 35/163 (21%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
P APP + + SP+ PA+ AP P A PP
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
++P P P L+S + A
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
R + +PA + P
Sbjct: 137 VRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQP 179
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 44.0 bits (102), Expect = 3e-04
Identities = 27/161 (16%), Positives = 40/161 (24%), Gaps = 2/161 (1%)
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHS 345
P P + P PA S A PPA+ + A PPA
Sbjct: 11 ARRRPGPPRIAPPK-LACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRR 69
Query: 346 SKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTAL 405
+ + S PS P +P + A P S S ++
Sbjct: 70 LRLSVDEVSSPSTPEAPDIPACPSPG-QKIKKSTPAAGQPPHLTSAQDQDTISELASCLQ 128
Query: 406 TPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPA 446
+ + + +A APA
Sbjct: 129 RARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPA 169
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 44.0 bits (102), Expect = 3e-04
Identities = 27/168 (16%), Positives = 45/168 (26%), Gaps = 4/168 (2%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP-PPASHPSNTA 305
PP SP + P+ AP A+ S P + P + PPA +
Sbjct: 17 PPRIAPPKLACRTPSP---ARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
S PS P + PP S++ + S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSN 413
A+ ++ + + P + P P+ + P
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGL 181
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 26/138 (18%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 241 PPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH 300
H+ + ++ + P S AP P S S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHS--PISTLSS 61
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P N PP S S+ P + T S S P + S + N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 361 LPPASHPSNPAIPPASHP 378
L +HPS H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 2e-06
Identities = 23/139 (16%), Positives = 35/139 (25%), Gaps = 6/139 (4%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
H ++ +++ P S AP P S S P
Sbjct: 5 HHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPI--STLSSP 62
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
N PP S S P S + P + +T P S P NP +
Sbjct: 63 INGMGPPFSVIS----SPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 384 PPASHPSNTAPPHASHPSN 402
+ + +
Sbjct: 119 NGVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 26/138 (18%), Positives = 37/138 (26%), Gaps = 2/138 (1%)
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP--PASH 311
A H + S + P+ A + P P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
P N PP S S+ P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 372 IPPASHPSNTAIPPASHP 389
+ +HPS H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 26/138 (18%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP--PASH 333
A H + S + P+ A + P P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
P N PP S S P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 394 PPHASHPSNTALTPASHP 411
+HPS + H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 26/138 (18%), Positives = 39/138 (28%), Gaps = 5/138 (3%)
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
H + ++ +++ P S AP P S S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHS--PISTLSS 61
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIA 415
P N PP S S+ P H + P S +P +S + + + P
Sbjct: 62 PINGMGPPFSVISS---PMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 416 PPPLFVPVLPSALPGKAP 433
L VP PS
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 22/135 (16%), Positives = 36/135 (26%), Gaps = 3/135 (2%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
A H S + P+ A + P P P ++ SS
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 347 ---KTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNT 403
PP + S S P+ P + ++ + P S+ +
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 404 ALTPASHPSNIAPPP 418
PA N+A
Sbjct: 122 LKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 23/138 (16%), Positives = 36/138 (26%), Gaps = 3/138 (2%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
A H + S + P+ + APS P L S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMA--APSLHPSLGPGIGSPGQLHS-PIST 58
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
+S ++ PP + P S P+ ++ + P S P
Sbjct: 59 LSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 302 SNTAPPPASHPSNTAPPP 319
+ PA N A
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 23/138 (16%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPP--PASHPYKTSPLPASHPSKTAPPPASH 278
A H + + S + + P+ HP + + + S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
P N PP S S P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 339 PPPASHSSKTAPPPASHP 356
+H S H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 26/132 (19%), Positives = 38/132 (28%), Gaps = 3/132 (2%)
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
H + ++ +++ P S AP P S I S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSP--ISTLSS 61
Query: 378 PSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
P N PP S S+ PH+ T S S P+ PV S
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPM-NPVSSSEDIKPPLGLNG 120
Query: 438 PISLPDAPAATP 449
+ +P P+
Sbjct: 121 VLKVPAHPSGNM 132
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 25/142 (17%), Positives = 37/142 (26%), Gaps = 4/142 (2%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
A + S + P+ A + P SP S +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPG--IGSPGQLHSP--IS 57
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
S P PP S +S+ P + T L S S P + S++
Sbjct: 58 TLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLG 117
Query: 291 SKTAPPPASHPSNTAPPPASHP 312
+HPS H
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 5/142 (3%)
Query: 58 LGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP 117
+ H ++ VN SP+ A + P + SP + +P
Sbjct: 1 MAHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGP----GIGSPGQLHSPI 56
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTP-LASPLSSKAFPPASPPSN 176
+P + P V S P V P +P L+SP++ + P
Sbjct: 57 STLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPL 116
Query: 177 AARPPASHPSNTARPPASHPSR 198
P++ + AS
Sbjct: 117 GLNGVLKVPAHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 19/131 (14%), Positives = 34/131 (25%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSIT 114
H + S P S + + S + P L S P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING 65
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPP 174
PP ++ P + V + P + L +P ++ P
Sbjct: 66 MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVP 125
Query: 175 SNAARPPASHP 185
++ + AS
Sbjct: 126 AHPSGNMASFT 136
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 16/150 (10%), Positives = 31/150 (20%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
+ P+ ++A+ + + S ++ ALPP ++
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
P+ P P + + + S PAS P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 20/152 (13%), Positives = 30/152 (19%), Gaps = 2/152 (1%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTA--PPPASHPSKTAPPPASHPSNTAPP 307
A + +S P N A PP S P S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
+ + P + S P S P + S +T+ P + L
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASH 399
S +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGLMC 157
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 15/150 (10%), Positives = 32/150 (21%), Gaps = 1/150 (0%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
+ + PS+ +++ + + L++ A PP + +
Sbjct: 7 MSQVIQAMPSDLT-ISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P+ P P + + + S PAS P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPAS 365
+
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 24/159 (15%), Positives = 39/159 (24%), Gaps = 6/159 (3%)
Query: 84 PSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPP 143
+ V P I + + P + A PP+ +P + P P
Sbjct: 5 EAMSQVIQA---MPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMP 61
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAP-- 201
L P + S P S P + T+ P +
Sbjct: 62 PHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLK 121
Query: 202 -PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
P + + A+ + L L K A
Sbjct: 122 CEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMA 160
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 26/169 (15%), Positives = 42/169 (24%), Gaps = 6/169 (3%)
Query: 255 SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN 314
+ +P+ +A S P PP S P S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLN----HAALPPTDYDRSPFVTSPISMTMP 61
Query: 315 TAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
+ + P + S P P + S ++ + S PAS P
Sbjct: 62 PHGSLQGYQTYGHFPSRAIKS-EYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV 423
P + A+ + L+ +A LF V
Sbjct: 121 KCEPDEPQVQAKIMAY-LQQEQANRSKHEKLSTFGLMCKMADQTLFSIV 168
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 5e-06
Identities = 24/133 (18%), Positives = 39/133 (29%), Gaps = 8/133 (6%)
Query: 253 PASHPYKTSPLP----ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
H + + +P PS + AS PP + P APPP P+ PP
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD-PAPPPPPAPAAGNPPD 63
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTAL--PPASH 366
++ + P+ + + PPA+ + L P
Sbjct: 64 TV-TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 367 PSNPAIPPASHPS 379
P + S
Sbjct: 123 PDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 8e-06
Identities = 26/147 (17%), Positives = 40/147 (27%), Gaps = 14/147 (9%)
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
+S H S P P + + + A HP T P P APPP
Sbjct: 3 SSHHHHHHSSGLVPRG---SHMVIPSASVTSAASDFLAALHPPVTVPDP-------APPP 52
Query: 320 ASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPS 379
P+ PP ++ + P+ + + PPA+
Sbjct: 53 PPAPAAGNPPDTV-TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGR- 110
Query: 380 NTAIPPASHPSNTAPPHASHPSNTALT 406
A+P H P +
Sbjct: 111 --AVPGLYHHPVPEPDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 21/137 (15%), Positives = 29/137 (21%), Gaps = 10/137 (7%)
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
S+ S PS + AS P T P PA PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAP-------PPPPA 55
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P+ PP + P + + + +
Sbjct: 56 PAAGNPPDTVTGDSVLQRILRGP---TGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAV 112
Query: 295 PPPASHPSNTAPPPASH 311
P HP P
Sbjct: 113 PGLYHHPVPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 21/143 (14%), Positives = 30/143 (20%), Gaps = 13/143 (9%)
Query: 205 SHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLP 264
S + S P +PS + AS PP + P P P
Sbjct: 3 SSHHHHHHSSGLVPRG---------SHMVIPSASVTSAASDFLAALHPPVTVPDPAPP-P 52
Query: 265 ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
P+ PP + P+ P + +
Sbjct: 53 PPAPAAGNPPDTVTGDSVLQRILRGPTG---PGTTSLAPAVRYGRQPGPEAPASAPPAAG 109
Query: 325 NTAPPPASHPSNTAPPPASHSSK 347
P HP P
Sbjct: 110 RAVPGLYHHPVPEPDPVRVEEVS 132
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 19/134 (14%), Positives = 31/134 (23%), Gaps = 4/134 (2%)
Query: 304 TAPPPASHPSNTAPP-PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
++ H S P + + A+ A P APPP P+ P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVP 422
+ ++ T S + + P P
Sbjct: 63 DT--VTGDSVLQRILRGPTGPGTTS-LAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
Query: 423 VLPSALPGKAPVSQ 436
V VS+
Sbjct: 120 VPEPDPVRVEEVSR 133
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 23/119 (19%), Positives = 33/119 (27%), Gaps = 3/119 (2%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSL-IPTTPVASPPPITAPPLVNVL 148
S+ L+P PS + + T P +PPP AP N
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN-- 60
Query: 149 PAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
P ++ + L L P + + A R R P HP
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 24/131 (18%), Positives = 32/131 (24%), Gaps = 6/131 (4%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
H + P PS + S AS PP ++P PPP + + P
Sbjct: 5 HHHHHHSSGLVPRGSHMVI--PSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
+ + T P S P A P P H
Sbjct: 63 DTVTGDSVLQRIL---RGPTGPGTTSLAPAVRYGRQPGPEAPASAP-PAAGRAVPGLYHH 118
Query: 312 PSNTAPPPASH 322
P P
Sbjct: 119 PVPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 15/143 (10%), Positives = 28/143 (19%), Gaps = 15/143 (10%)
Query: 130 TTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTA 189
++ P ++ + + +S PP P A
Sbjct: 3 SSHHHHHHSSGLVP-----RGSHMVIPSASVTSAASDFLAALHPPVTVPDP--------A 49
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPS--PASHPSNTALPPASLPSKTAPPPASHLS 247
PP P+ PP + P+ + + +
Sbjct: 50 PPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAG 109
Query: 248 NTAPPPASHPYKTSPLPASHPSK 270
P HP
Sbjct: 110 RAVPGLYHHPVPEPDPVRVEEVS 132
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 19/126 (15%), Positives = 32/126 (25%), Gaps = 4/126 (3%)
Query: 315 TAPPPASHPSNTAP--PPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
++ H S P PS + AS PP + P PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD--PAPPPPPAPAAGN 60
Query: 373 PPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKA 432
PP + ++ + + P+ + + PP +P
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
Query: 433 PVSQSP 438
P
Sbjct: 121 PEPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 21/128 (16%), Positives = 30/128 (23%), Gaps = 3/128 (2%)
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNA 177
+ L+P P + + A L P + P PA+
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAA-LHPPVTVPDPAPPPPPAPAAGNPPD 63
Query: 178 ARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSK 237
S R P + P T+ PA P A +P P
Sbjct: 64 TVTGDSVLQRILRGP-TGPGTTSLAPAVRYGRQPGPEAPASAP-PAAGRAVPGLYHHPVP 121
Query: 238 TAPPPASH 245
P
Sbjct: 122 EPDPVRVE 129
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 28/117 (23%), Positives = 37/117 (31%), Gaps = 8/117 (6%)
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
+T P + PA S+ AP ++ + + A
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP--SADAAQMKEMMAMMQKMQQQQ 385
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 331
A P APPP +P + PP PP P PPP P APP A
Sbjct: 386 AAYPPQGYAPPPQGYPPQGYPPQG------YPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 24/109 (22%), Positives = 30/109 (27%), Gaps = 3/109 (2%)
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA---PPPASHPSKT 293
+T P + + +PA S AP +
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAA 387
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
PP P PP +P PP P PPP P APP A
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 23/112 (20%), Positives = 31/112 (27%), Gaps = 6/112 (5%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P + K + + P++ + A A P
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP 390
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
APPP PP +P PP P PPP + APP A
Sbjct: 391 QGYAPPP------QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 27/117 (23%), Positives = 35/117 (29%), Gaps = 5/117 (4%)
Query: 258 YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+T P + PA S AP ++ + A
Sbjct: 327 SQTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP--SADAAQMKEMMAMMQKMQQQ 384
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
A P APPP +P PP + + PP P PP P PA PP
Sbjct: 385 QAAYPPQGYAPPPQGYPPQG-YPPQGYPPQGYPPQGYPPPPQGAPPQGAP--PAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 18/98 (18%), Positives = 27/98 (27%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
+ ++ +S + +A PP P
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P +P + PP P PPP P + APP A
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 22/111 (19%), Positives = 29/111 (26%), Gaps = 3/111 (2%)
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
P PA S AP S + + K A+
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP---SADAAQMKEMMAMMQKMQQQQAA 387
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+P + PP PP +P + PP P PP P P
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 22/109 (20%), Positives = 27/109 (24%), Gaps = 3/109 (2%)
Query: 292 KTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA---PPPASHSSKT 348
+T P + PA S+ AP +
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAA 387
Query: 349 APPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
PP P PP +P P P PP P APP A
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 3/97 (3%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
PA+ S P A+ PA+ P + P+ P + PP
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATP---APPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
N + A P A
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 1e-04
Identities = 15/85 (17%), Positives = 22/85 (25%)
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
P+ P + P+ APP P P + P P + A
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 339 PPPASHSSKTAPPPASHPSNTALPP 363
A H++ NT
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 13/91 (14%), Positives = 22/91 (24%), Gaps = 4/91 (4%)
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
TSP + T + P + P+ P + PP N
Sbjct: 6 TSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAA 65
Query: 320 ASHPSNTAPPPASHPSNTAP----PPASHSS 346
+ A PP + ++
Sbjct: 66 GHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 17/93 (18%), Positives = 23/93 (24%)
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P+ P + P+ APP P P + P P + A
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
A H + NT P T
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 15/91 (16%), Positives = 22/91 (24%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P S + PA AP P P P + A A+
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
+ A A ++ PP +
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 12/92 (13%), Positives = 21/92 (22%), Gaps = 2/92 (2%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
P S + + PA AP P P +P+ P +
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKP--KNPTPPRPAGDNAT 62
Query: 335 SNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
+ + + PP +
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 11/97 (11%), Positives = 20/97 (20%), Gaps = 6/97 (6%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
P S + + P P + + P + PP
Sbjct: 5 PTSPGTPGVAAATQAANGGPATP------APPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTA 404
N + + + A + P A
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 13/91 (14%), Positives = 21/91 (23%)
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
P S + + PA AP P P + A A+
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 357 SNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
+ A A ++ P +
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 17/108 (15%), Positives = 24/108 (22%), Gaps = 14/108 (12%)
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
PA+ S P A+ PA+ P + P+ P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATP--------------APPALGAAPTGDPKPKKNKK 47
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
K PP N + A P A
Sbjct: 48 PKNPTPPRPAGDNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 19/96 (19%), Positives = 29/96 (30%)
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
N P PPP++ P A+ + A A S AP P S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPAS 376
S++ K A+ + + S + A
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 17/93 (18%), Positives = 26/93 (27%)
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
P PPP++ P A+ + A A S AP P S S
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 355 HPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
+ A+ + + S + A
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 17/93 (18%), Positives = 27/93 (29%)
Query: 303 NTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
N P PPP++ P A+ + A A +S AP P S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
S+ A+ + + S +
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 5e-05
Identities = 25/217 (11%), Positives = 47/217 (21%), Gaps = 3/217 (1%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVL- 148
+ F + S + N A + +
Sbjct: 16 NLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETA 75
Query: 149 -PAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
PA + TT A S+ + A P A + + + P T S P
Sbjct: 76 SPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKP 135
Query: 208 SNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASH 267
+ A ++ P + + A + + L +
Sbjct: 136 AAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRR 195
Query: 268 PSKTAPPPASHPSNT-APPPASHPSKTAPPPASHPSN 303
AS + A + +K
Sbjct: 196 TGHLVNEKASKEAKVQALSNTNSKAKDHASVGGEEFK 232
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 45.0 bits (105), Expect = 2e-04
Identities = 32/226 (14%), Positives = 52/226 (23%), Gaps = 13/226 (5%)
Query: 56 HLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITA 115
H GH L V S +T VS + + + + +
Sbjct: 5 HHHHGHHHQLENLYFQGEETAVPENS-GANTELVSGESEHSTNEADKQNEGEHARENKLE 63
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
+P ++ T A S AS + ++ P A
Sbjct: 64 KAEGVATASE---TASPASNEAATTETA-----EAASAAKPEEKASEVVAET-PSAEAKP 114
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
+ + + P T + S P+ A P
Sbjct: 115 KSDKETEAKPEATNQGDESKPAAEANKT---EKEVQPDVPKNTEKTLKPKEIKFNSWEEL 171
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
K P + +T L SK A A +N
Sbjct: 172 LKWEPGAREDDAINRGSVVLASRRTGHLVNEKASKEAKVQALSNTN 217
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1299 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-29 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 3e-73
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 26/288 (9%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLS 951
+ E G + +G G FG VY G VAVK+L Q + F EV +L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
+ H N++ +G Q +V + S+ HLH + IA A+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQ 115
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
+ YLH +IHRD KS+NI L D T K+ DFGLA H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 1072 VAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128
+APE +SDVY++G+V+ EL++G+ P Q +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------- 223
Query: 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ P L + V + + + + C++ + RP +++ +++
Sbjct: 224 --RGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-69
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 28/278 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
LG G FG V+ G + TKVAVK LK+ FLAE ++ +L H+ LV+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L + +E ++ E + NGS+ L L + L +A A +A++
Sbjct: 73 LYAVVTQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
IHRD +++NIL+ + K++DFGLAR +++ + APE G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ--ENLVAWARPLLTSREGLERIIDPSL 1138
+KSDV+S+G+++ E+++ + + +NL R +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------- 231
Query: 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P + ++ + +C + + RP + L+
Sbjct: 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-68
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 24/276 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+C+E+ CLV+E + +G + +L + + L + L +AYL E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
VIHRD + N L+ + KVSDFG+ R +D++ ST + +PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140
KSDV+S+GV++ E+ S K + + ++ R+ P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
V I + C + + RP +++ L
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (571), Expect = 2e-66
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 889 TFSASEIEKATGNFDAS---------RILGEGGFGLVYSGVL----DDGTKVAVKVLKR- 934
F+ + +A F +++G G FG V SG L VA+K LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 935 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 994
++ R+FL+E ++ + H N++ L G+ + ++ E + NGS++S L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 995 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054
+ + G A + YL + +HRD + NIL+ + KVSDFGL+R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 1055 DEESRHISTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1111
D+ S T + APE SDV+SYG+V+ E++S + P
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------RP 233
Query: 1112 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1171
+ + + + I+ P D + + + C Q + HRP G++
Sbjct: 234 YWDM----------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 1172 VQALK 1176
V L
Sbjct: 284 VNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-66
Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 30/277 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 961 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L+G+ +EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
+HRD + N+L+ D KVSDFGL + A + + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 174
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139
KSDV+S+G+++ E+ S + P + L +E+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV-------PRVEKGYKMDAP 222
Query: 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ P V + C + RP ++ + L+
Sbjct: 223 DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-66
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 965
+G+G FG V+ G G +VAVK+ +++ AE+ L H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 966 IEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-- 1019
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 1020 ---SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAP 1074
P + HRD KS NIL++ + T ++D GLA +GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 1075 EYAMTGHLL------VKSDVYSYGVVILELLSGRKP----VDMTQPPGQENLVAWARPLL 1124
E + ++D+Y+ G+V E+ D P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 1125 TSREGLERIIDPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ E+ + P++ N +++ +A I C R + + L
Sbjct: 242 R-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 5e-66
Identities = 72/293 (24%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 906 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL-HHRN 957
+ LG G FG V D VAVK+LK RE ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHG--------------VDKESAPLGWDARL 1003
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
+ A+ +A+L S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
++APE +SDV+SYG+ + EL S P +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
++I P + A++ I C + RP ++VQ ++
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 1e-65
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 895 IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSR 952
+E +F+ LG G G+V+ G +A K++ + R + E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+ +V G + + E + GS++ L ++ + K+++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
L YL +++HRD K SNIL+ K+ DFG++ +D ++ +GT Y+
Sbjct: 117 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1106
+PE H V+SD++S G+ ++E+ GR P+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-65
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 24/276 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ + LG G FG+V G VA+K++K EF+ E +++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L G+C +++ ++ E + NG + ++L + L++ A+ YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
+ +HRD + N L+ KVSDFGL+R +D+E S + PE M
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS 176
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140
KSD++++GV++ E+ S K + I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRL 220
Query: 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P + KV I C + RP ++ +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 8e-65
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 26/296 (8%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 952
E+E+ + LG G +G VY GV VAVK LK D EFL E ++
Sbjct: 13 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 953 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1012
+ H NLV+L+G+C E ++ E + G++ +L +++ + L +A + A
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSA 127
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
+ YL IHRD + N L+ + KV+DFGL+R M ++ +
Sbjct: 128 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWT 183
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132
APE +KSDV+++GV++ E+ + Q +
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYE 227
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEV 1188
+++ + P KV + C Q RP E+ QA + + E + EV
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (559), Expect = 1e-64
Identities = 68/314 (21%), Positives = 121/314 (38%), Gaps = 46/314 (14%)
Query: 893 SEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLA 945
+E N + R +GEG FG V+ + T VAVK+LK +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 946 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES----------- 994
E +++ + N+VKL+G+C + CL++E + G + L + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 995 ---------APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1045
PL +L IA A +AYL + +HRD + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 1046 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1105
DFGL+R+ + ++ PE +SDV++YGVV+ E+ S
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 1106 DMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1165
E + + D ++ P + ++ + +C R
Sbjct: 243 YYGMAH---------------EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286
Query: 1166 PFMGEVVQALKLVC 1179
P + + L+ +C
Sbjct: 287 PSFCSIHRILQRMC 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-64
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 45/303 (14%)
Query: 901 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL 953
N + ++LG G FG V + +VAVK+LK RE ++E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 954 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-------------------VDKE 993
H N+V L+G C L++E G + ++L +++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 994 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053
L ++ L A A+ + +L +HRD + N+L+ H K+ DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1113
M + + + ++APE G +KSDV+SYG+++ E+ S P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 1114 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
++I D PF + ++ I C + + RP +
Sbjct: 275 N---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 1174 ALK 1176
L
Sbjct: 320 FLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-64
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 32/291 (10%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGG-REFLAEVE 948
+F+ ++G G FG VY G L D AVK L R+ G +FL E
Sbjct: 23 GPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 949 MLSRLHHRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL 1007
++ H N++ L+GIC+ E + +V + +G + + + E+ + L
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1065
A+ + +L + +HRD + N +L+ FT KV+DFGLAR D+E S H T
Sbjct: 138 QVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1125
++A E T KSDV+S+GV++ EL++ P P N LL
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQ 249
Query: 1126 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
R R++ P + + C P+ + RP E+V +
Sbjct: 250 GR----RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 7e-64
Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 31/291 (10%)
Query: 893 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGR-EFLAE 946
+EI +++G G FG VY G+L + VA+K LK + R +FL E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 947 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1006
++ + H N+++L G+ + + ++ E + NG+++ L ++ + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGML 116
Query: 1007 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM-DEESRHISTRV 1065
G A + YL + +HRD + NIL+ + KVSDFGL+R D E+ + ++
Sbjct: 117 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 1066 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1125
+ APE SDV+S+G+V+ E+++ + +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221
Query: 1126 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ + I+ P D + + + C Q E RP ++V L
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 26/280 (9%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 957
+++ +G G +G DG + K L + + + ++EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 958 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 1016 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
H D V+HRD K +N+ L+ K+ DFGLAR + S + +GT Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 1074 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133
PE KSD++S G ++ EL + P +E +I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------KELAGKI 226
Query: 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ +P+ ++ I + + + HRP + E+++
Sbjct: 227 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-62
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 30/275 (10%)
Query: 908 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 963
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1023
+C + +A LV E+ G + L G + + ++ + + YL E
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 1024 VIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
+HRD + N+LL + K+SDFGL+++ D+ + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 1083 LVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1141
+SDV+SYGV + E LS G+KP + P + + + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----------------E 232
Query: 1142 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P + ++ A+ S C + + RP V Q ++
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-61
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 906 RILGEGGFGLVYSGVLDD---GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 960
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
+IGIC E LV E+ G + +L ++ + +++ + + YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMT 1079
+HRD + N+LL K+SDFGL+++ DE T + APE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 1080 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139
KSDV+S+GV++ E S + + + +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P ++ + ++C +V++RP V L+
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-60
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 960
+ LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 961 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1020
L + EE +V E + GS+ L G + L + +A A +AY+
Sbjct: 77 LYAVVSEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1080
+HRD +++NIL+ + KV+DFGLAR +++ + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 1081 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1140
+KSDV+S+G+++ EL + + + + ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRM 233
Query: 1141 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P + + + C + E + RP + L+
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 9e-60
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 34/299 (11%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVE 948
EI++ + R +GEG FG V+ G+ + VA+K K RE FL E
Sbjct: 3 EIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 949 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1008
+ + H ++VKLIG+ E ++ EL G + S L L + + A
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQ 116
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1068
+ ALAYL R +HRD + N+L+ + K+ DFGL+R M++ + + +++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLP 172
Query: 1069 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPLLTSR 1127
++APE SDV+ +GV + E+L G KP + + L
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 228
Query: 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 1186
+P + + ++ + C + RP E+ L + E ++A+
Sbjct: 229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE-EKAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 68/277 (24%), Positives = 105/277 (37%), Gaps = 33/277 (11%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHR 956
+F+ R LG+G FG VY +A+KVL + + EVE+ S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N+++L G + L+ E P G+V L + + A AL+Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 122
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S RVIHRD K N+LL K++DFG + A + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEM 175
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
K D++S GV+ E L G+ P + ++ +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTE 229
Query: 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ S ++ RP + EV++
Sbjct: 230 GA------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-59
Identities = 72/284 (25%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 901 NFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 953
+ LG+G FG+V G D VAVK LK + +F+ EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 954 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
HRNL++L G+ + +V EL P GS+ L K + A+ A +
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGM 124
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI-STRVMGTFGYV 1072
YL S R IHRD + N+LL K+ DFGL R+ + ++ F +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132
APE T SD + +GV + E+ + + P N + E L R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPR 236
Query: 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
P D + + C + + RP + L
Sbjct: 237 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-59
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRL-HH 955
+ ++GEG FG V + DG + A+K +K + R+F E+E+L +L HH
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARL 1003
N++ L+G C L E P+G++ L + ++ L L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 1004 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1063
A AR + YL + IHRD + NIL+ ++ K++DFGL+R + T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 1064 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
++A E SDV+SYGV++ E++S P
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY--- 236
Query: 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ + P + +V + C + + RP +++ +L
Sbjct: 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-58
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 906 RILGEGGFGLVYSGVL-DDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+G G F VY G+ + +VA L+ ++ + + F E EML L H N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 963 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
++ LV EL+ +G+++++L + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 1019 DSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM- 184
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137
DVY++G+ +LE+ + P Q Q R+
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGV 229
Query: 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
++ +V I C++ R + +++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-58
Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG+G FG VY + A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
E ++ E G+V++ + +++ PL + AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1083
IHRD K+ NIL D K++DFG++ R +GT ++APE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKD 189
Query: 1084 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1139
K+DV+S G+ ++E+ P P +A + P P+L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------------PTLA 236
Query: 1140 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ S K C++ V R +++Q
Sbjct: 237 QPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-58
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 27/278 (9%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRN 957
++D + LGEG +G V V VAVK++ E E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+VK G E + L E G + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+ HRD K N+LL+ K+SDFGLA + ++ GT YVAPE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 1078 MTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136
DV+S G+V+ +L+G P D QE + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---------- 227
Query: 1137 SLGNDVPFDSVAKVA-AIASMCVQPEVQHRPFMGEVVQ 1173
P+ + A+ + R + ++ +
Sbjct: 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-58
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 30/289 (10%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGT----KVAVKVLKR-VDQQGGREFLAEV 947
I K T F ++LG G FG VY G+ + +G VA+K L+ + +E L E
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 948 EMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL 1007
+++ + + ++ +L+GIC+ L+ +L+P G L V + +G L +
Sbjct: 63 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGC---LLDYVREHKDNIGSQYLLNWCV 118
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067
A+ + YL + R++HRD + N+L++ K++DFGLA+ EE + +
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127
++A E + +SDV+SYGV + EL++ P +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------- 221
Query: 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
+ I++ P V I C + RP E++
Sbjct: 222 --ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (508), Expect = 1e-57
Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 887 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 942
A+ F + EK F R +G G FG VY + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 943 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1002
+ EV L +L H N ++ G + E LV E + + PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEI 117
Query: 1003 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1062
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A +
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168
Query: 1063 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVA 1118
+GT ++APE + G K DV+S G+ +EL + P +M ++
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 1119 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
P L S E + C+Q Q RP +++
Sbjct: 229 NESPALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-57
Identities = 76/307 (24%), Positives = 140/307 (45%), Gaps = 32/307 (10%)
Query: 883 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD 936
Y +A + E E A SR LG+G FG+VY GV + T+VA+K +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 937 QQGGR-EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------G 989
R EFL E ++ + ++V+L+G+ + Q ++ EL+ G ++S+L
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 990 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049
+ AP +++A A +AYL+ + + +HRD + N ++ DFT K+ DFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1109
R + + + + +++PE G SDV+S+GVV+ E+ + +
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----- 234
Query: 1110 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1169
L++ + L +++ L D P + + + MC Q + RP
Sbjct: 235 ----------PYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 1170 EVVQALK 1176
E++ ++K
Sbjct: 284 EIISSIK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-55
Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 901 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSR- 952
+ LG G FG V VAVK+LK R ++E+++L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 953 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAP------------LGW 999
HH N+V L+G C + ++ E G++ ++L E P L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 1000 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059
+ + + A+ + +L S + IHRD + NILL K+ DFGLAR +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1119
++APE ++SDV+S+GV++ E+ S P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE 245
Query: 1120 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
R + P + ++ C E RP E+V+ L
Sbjct: 246 ----------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-54
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 901 NFDASRILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 951
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 952 RL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLG 998
+ H+N++ L+G C ++ ++ E G++ +L L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 999 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058
+ A AR + YL S + IHRD + N+L+ D K++DFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1118
+T ++APE +SDV+S+GV++ E+ + P +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 1119 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
L +++ D P + ++ + C RP ++V+ L
Sbjct: 246 -----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-53
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 26/284 (9%)
Query: 891 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEM 949
S + + +G+G G VY+ + + G +VA++ + Q + E+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 950 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
+ + N+V + + +V E + GS+ + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCREC 125
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
+AL +LH S +VIHRD KS NILL D + K++DFG E+S+ + ++GT
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTP 180
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129
++APE K D++S G++ +E++ G P P L+A G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNG 232
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ +P ++ + + C+ +V+ R E++Q
Sbjct: 233 TPELQNPE-----KLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-49
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 896 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLS 951
+K +F +ILGEG F V L + A+K+L++ + + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
RL H VKL +++ NG + ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
AL YLH +IHRD K NILL D +++DFG A+ E + + +GT Y
Sbjct: 120 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
V+PE SD+++ G +I +L++G P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (443), Expect = 2e-49
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 31/292 (10%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH 954
+ ++ ILG GG V+ L VAVKVL+ D F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 955 HRNLVKLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1010
H +V + E +V E + ++ +H P+ +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-RVMGTF 1069
+AL + H +IHRD K +NI++ KV DFG+AR+ D + T V+GT
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129
Y++PE A + +SDVYS G V+ E+L+G P P P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 231
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCN 1180
I + + A + A+ + ++R E+ L V N
Sbjct: 232 ---IPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (440), Expect = 5e-49
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 41/290 (14%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---------RVDQQGGREFLAEVEML 950
N++ ILG G +V + + AVK++ Q+ L EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 951 SRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1009
++ H N+++L LV++L+ G + +L E L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 1010 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
+ LH ++HRD K NILL+ D K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173
Query: 1070 GYVAPEYAMTGHLL------VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1123
Y+APE + D++S GV++ LL+G P + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 1124 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
S E +D V + S + + Q R E +
Sbjct: 234 FGSPE----------WDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 6e-49
Identities = 53/287 (18%), Positives = 92/287 (32%), Gaps = 29/287 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 958
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 959 VKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+ I C E +V EL+ + S L +A + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 1018 EDSSPRVIHRDFKSSNIL---LEHDFTPKVSDFGLARSAMDEES-----RHISTRVMGTF 1069
S IHRD K N L + + DFGLA+ D + + + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 1070 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129
Y + + + D+ S G V++ G P + + E
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEK 231
Query: 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
L P ++ A + C +P + Q +
Sbjct: 232 KMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 2e-48
Identities = 55/271 (20%), Positives = 93/271 (34%), Gaps = 26/271 (9%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG G FG+V+ V G K + E+ ++++LHH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
++ L+ E + G + + E + + A L ++H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 1025 IHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
+H D K NI+ E K+ DFGLA +E T + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPV 205
Query: 1083 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
+D+++ GV+ LLSG P E L R E + P
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSVSPEA---- 259
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+Q E + R + + ++
Sbjct: 260 --------KDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 2e-48
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
++D LG G FG+V+ G A K + + E++ +S L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L ++ ++YE + G + + E + D ++ + L ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 1020 SSPRVIHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
+H D K NI+ + K+ DFGL ++S GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVA 197
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137
+ +D++S GV+ LLSG P V +D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------NMDDS 247
Query: 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ + D + + R + + ++
Sbjct: 248 AFSGISED----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (434), Expect = 4e-48
Identities = 45/289 (15%), Positives = 86/289 (29%), Gaps = 31/289 (10%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 957
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+ + E LV +L+ S +D A + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 1018 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESR-----HISTRVMG 1067
+++RD K N L+ ++ V DFG+ + D ++ + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127
T Y++ + + D+ + G V + L G P + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------G 229
Query: 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176
E + L P + P +
Sbjct: 230 EKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (436), Expect = 1e-47
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 19/227 (8%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 954
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 955 -HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
+V + + +L+ G + HL + A L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1073
++H + V++RD K +NILL+ ++SD GLA ++ +GT GY+A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173
Query: 1074 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1119
PE G +D +S G ++ +LL G P + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 5e-47
Identities = 55/282 (19%), Positives = 95/282 (33%), Gaps = 23/282 (8%)
Query: 894 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLS 951
+ E +D +LG G F V VA+K + + +G E+ +L
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 952 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
++ H N+V L I L+ +L+ G + + E ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLD 118
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
A+ YLH+ + L+ D +SDFGL++ E+ + + GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 175
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131
VAPE D +S GV+ LL G P + A
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--------- 226
Query: 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
D +D+ ++ + + R + +Q
Sbjct: 227 -EFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (420), Expect = 3e-46
Identities = 54/286 (18%), Positives = 107/286 (37%), Gaps = 21/286 (7%)
Query: 901 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNL 958
+ +GEG +G+VY + G A+K ++ + D+ + E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 959 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
VKL + ++ LV+E + +D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 1019 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1078
RV+HRD K N+L+ + K++DFGLAR+ R + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 1079 TGHLLVKSDVYSYGVVILELLSGRKPVD----------MTQPPGQENLVAWARPLLTSRE 1128
+ D++S G + E+++G + + G N W +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1129 GLERIIDPSLGNDVPFDSVAKVAA-IASMCVQPEVQHRPFMGEVVQ 1173
+ L + + + + S ++ + R + ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-45
Identities = 72/324 (22%), Positives = 125/324 (38%), Gaps = 25/324 (7%)
Query: 899 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHR 956
+ +GEG +G+V S + +VA+K + + Q + L E+++L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
N++ + I + + + + L+ + K L D R L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPE 1075
H S V+HRD K SN+LL K+ DFGLAR A D + T + T Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 1076 YAMTGHLLVKS-DVYSYGVVILELLSGRKP-------------VDMTQPPGQENLVAWAR 1121
+ KS D++S G ++ E+LS R + + P QE+L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA--LKLVC 1179
+ + N + ++ +K + + R + + + L+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 1180 NECDE--AKEVGSASSSQDDMSID 1201
+ DE A+ DD+ +
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-45
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 14/227 (6%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 955
+F ++LG+G FG V+ A+K LK+ + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
L + ++ V E + G + H+ A L +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
LH +++RD K NILL+ D K++DFG+ + M +++ GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122
+ D +S+GV++ E+L G+ P + + P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 28/297 (9%)
Query: 897 KATGNFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSR 952
+A ++ +GEG +G V+ + + G VA+K ++ + G + EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 953 L---HHRNLVKLIGICIEEQARCLVYELIPNGSV--ESHLHGVDKESAPLGWDARLKIAL 1007
L H N+V+L +C + + V + + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 1008 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1067
R L +LH S RV+HRD K NIL+ K++DFGLAR + T V+
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 177
Query: 1068 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------- 1117
T Y APE + D++S G + E+ + + Q +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 1118 AWARPLLTSREGLERIIDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
W R + R+ + V D + K + C+ R +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSALS 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-45
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 27/271 (9%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
LG G FG+V+ V K +K V E+ +L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 965 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024
+ +++E I + ++ + L + AL +LH S +
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 1025 IHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1082
H D + NI+ T K+ +FG AR ++ + + Y APE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180
Query: 1083 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1142
+D++S G ++ LLSG P + A D ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------TFDEEAFKEI 230
Query: 1143 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ + E + R E +Q
Sbjct: 231 S----IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (399), Expect = 4e-43
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
+F R LG G FG V+ +G A+KVLK+ V + E MLS + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
++++ G + Q ++ + I L + ++S A AL YL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H +I+RD K NILL+ + K++DFG A+ D + GT Y+APE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
T D +S+G++I E+L+G P
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-42
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 10/207 (4%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 957
NF +GEG +G+VY G VA+K ++ + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+VKL+ + E LV+E + + + + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCH 119
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
S RV+HRD K N+L+ + K++DFGLAR+ R + V+ +
Sbjct: 120 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILL 175
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ D++S G + E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-42
Identities = 62/283 (21%), Positives = 100/283 (35%), Gaps = 35/283 (12%)
Query: 902 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLH 954
+D LG G F +V G + A K +K+ + R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 955 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1014
H N++ L + + L+ EL+ G L E L + + +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 1015 YLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVMGTFG 1070
YLH S ++ H D K NI+L P K+ DFGLA + GT
Sbjct: 128 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 1071 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130
+VAPE L +++D++S GV+ LLSG P QE L + +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEY 239
Query: 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
+ + + R + + +Q
Sbjct: 240 FSNTSALA------------KDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-41
Identities = 60/278 (21%), Positives = 97/278 (34%), Gaps = 32/278 (11%)
Query: 905 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 962
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 963 GIC----IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1018
+ + +V E + G + S + D+ +I A+ YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 1019 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
S + HRD K N+L + K++DFG A+ S T YVAPE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183
Query: 1076 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135
D++S GV++ LL G P L R G +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
P K + ++ E R + E +
Sbjct: 239 PEWSE---VSEEVK--MLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-40
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 959
++ ++++G G FG+VY L D G VA+K + Q R E++++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 960 KLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1013
+L + LV + +P H + L R+L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 1014 AYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1072
AY+H S + HRD K N+LL+ D K+ DFG A+ + E + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 1073 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
DV+S G V+ ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 959
LGEG F VY + VA+K +K + ++ L E+++L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 960 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1019
L+ + LV++ + + S L L + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 1020 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1079
++HRD K +N+LL+ + K++DFGLA+S + T + T Y APE
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFG 174
Query: 1080 GHLL-VKSDVYSYGVVILELLSGRKP 1104
+ V D+++ G ++ ELL
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-39
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 45/285 (15%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSR 952
+ +LG GGFG VYSG+ + D VA+K +++ + G EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 953 LH--HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1010
+ +++L+ + L+ E E L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120
Query: 1011 RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1069
A+ + H V+HRD K NIL+ + K+ DFG D + T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTR 173
Query: 1070 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128
Y PE+ +S V+S G+++ +++ G P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------------FE 211
Query: 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1173
E II + S + + C+ RP E+
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-39
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
+FD ++LG+G FG V G A+K+L++ + + + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
L L C V E G + HL + AL YL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEV 176
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKP 1104
D + GVV+ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 900 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHR 956
++ +G+G FG V+ G KVA+K + +++ G L E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 957 NLVKLIGICIEEQAR--------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1008
N+V LI IC + + LV++ + + + K ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 1009 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVM 1066
L Y+H +++HRD K++N+L+ D K++DFGLAR S + T +
Sbjct: 126 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 1067 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117
T Y PE + D++ G ++ E+ + + Q L+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-38
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 14/237 (5%)
Query: 888 KTFSASEIEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGG 940
F E+ K A + +G G +G V S V G KVA+K L R +
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 941 REFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1000
+ E+ +L + H N++ L+ + ++ + G + LG D
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 1001 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1060
+ + L Y+H + +IHRD K N+ + D K+ DFGLAR +
Sbjct: 122 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSE 174
Query: 1061 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1117
++ V+ + D++S G ++ E+++G+ + Q +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 8e-38
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 11/207 (5%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 957
++ +GEG +G V+ + VA+K ++ D+ L E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 958 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1017
+V+L + ++ LV+E D + L + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 1018 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1077
V+HRD K N+L+ + K+++FGLAR+ R S V+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 1078 MTGHLLVKSDVYSYGVVILELLSGRKP 1104
D++S G + EL + +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 8e-37
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 16/226 (7%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 956
FD + LG G FG V + G A+K+L + V + L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 957 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
LVKL + +V E + G + SHL A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S +I+RD K N+L++ +V+DFG A+ + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEI 209
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1122
++ D ++ GV+I E+ +G P QP + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-34
Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 962
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 963 GICI------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ E Q LV EL+ + +D + + + +L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1076
H S +IHRD K SNI+++ D T K+ DFGLAR+A T + T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV 189
Query: 1077 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ----------------ENLVAWA 1120
+ D++S G ++ E++ + Q + L
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 1121 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM--------CVQPEVQHRPFMGEVV 1172
R + +R + P L D F + ++ + + + + R + + +
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 1173 Q 1173
Q
Sbjct: 310 Q 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 2e-34
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 901 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNL 958
++ R LG G + V+ + + + KV VK+LK V ++ + E+++L L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 959 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1016
+ L I + +R LV+E + N + L +AL Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC 145
Query: 1017 HEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1075
H S ++HRD K N++++H+ ++ D+GLA + + + + PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 1076 YAMTGHLL-VKSDVYSYGVVILELLSGRKP 1104
+ + D++S G ++ ++ ++P
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-33
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 901 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSR 952
NF+ ++LG G +G V+ D G A+KVLK+ + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 953 L-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1011
+ LV L E L+ + I G + +HL ++ + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ-------IYVGE 137
Query: 1012 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
+ L +I+RD K NILL+ + ++DFGL++ + +E+ + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 196
Query: 1072 VAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKP 1104
+AP+ G D +S GV++ ELL+G P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 117 bits (294), Expect = 1e-30
Identities = 35/203 (17%), Positives = 65/203 (32%), Gaps = 28/203 (13%)
Query: 906 RILGEGGFGLVYSGVLDDGTKVAVKVLK----------RVDQQGGREFLAEVEMLSRLHH 955
+++GEG V++ + + VK K G F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 956 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1015
R L KL G+ + + Y N + + + + + +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 1016 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVAP 1074
+ ++H D N+L+ + + DF + +E R I R V Y +
Sbjct: 119 FY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 1075 EYAMTGHLLVKSDVYSYGVVILE 1097
Y + D+ S IL+
Sbjct: 175 TYRT------EKDINSAIDRILQ 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-30
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 14/223 (6%)
Query: 889 TFSASEIEKA----TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--R 941
TF E+ K + +G G +G V + G +VAVK L R Q +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 942 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 1001
E+ +L + H N++ L+ + ++ ++ + + L D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 1002 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1061
+ R L Y+H S +IHRD K SN+ + D K+ DFGLAR +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEM 175
Query: 1062 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1104
+ V + H D++S G ++ ELL+GR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 7e-29
Identities = 54/297 (18%), Positives = 106/297 (35%), Gaps = 24/297 (8%)
Query: 906 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 964
R LG G F V+ + + T VA+K+++ D+ E+++L R++ + K +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 965 CIEEQARCLVY--ELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARA 1012
+ L + PNG + V E + +I+
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 1013 LAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1071
L Y+H +IH D K N+L+E D + +A T + T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 1072 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD-MTQPPGQENLVAWARPLLTSREGL 1130
+PE + +D++S +I EL++G + ++ A+ + E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKE 1187
++ F+S + I +++ P + + K +E E +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNI------SKLKFWPLEDVLTEKYKFSKDEAKEISD 306
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1299 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.07 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 94.19 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 93.25 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 92.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 88.63 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 87.87 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 84.12 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 82.64 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.87 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=213.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99215467710473689999953897899999211343322578998887551244661135414430363589996348
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi~ 979 (1299)
++|++.+.||+|+||+||+|.+.+++.||||+++. +....++|.+|++++++++|+|||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 99588889820888299999988999999999878-86768999999999996689975653524315993379998369
Q ss_pred CCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCCC
Q ss_conf 99810002356567888875689999999999998765249995353013456724316875035277752112333354
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++.. ....++|..+++|+.|++.||.|||+.+ |+|||||++|||||+++++||+|||+++.......
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-
T ss_conf 9918997520---1347889999999999999877653164---31044315326666887768655321002368873-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCC
Q ss_conf 421221365566675200149787211004169999999719-9999999997503468843100244345521104888
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTG-k~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L 1138 (1299)
.......|+..|+|||++.+..++.++|||||||+||||+|+ +.+|.... ...+...... ..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~--------------~~ 219 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIST--------------GF 219 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHH--------------TC
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHH--------------CC
T ss_conf 350430017666785786079998403321059999999878988877899---9999999980--------------68
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999913599999999971696968999989999999999965
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1139 ~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
+...+..+..++.+|+.+||+.+|++||+|.||++.|+.+.+.
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 8899543679999999997657976891999999999999857
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.44 Aligned_cols=264 Identities=27% Similarity=0.453 Sum_probs=212.0
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 80992154677104736899999538978999992113--4332257899888755124466113541443036358999
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
..++|++.+.||+|+||+||+|++++ .||||+++.. +....+.|++|++++++++|+|||+++|++.+ ...++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 54518998898307885899999999--89999997346998999999999999984799878645679715-5899999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687503527775211233
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.++++.. +..+++.+++.|+.|+++||+|||+.+ |+|||||++||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 658998889998523---578999999999999999988875099---95161478997981899788750022133355
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCE
Q ss_conf 335442122136556667520014---97872110041699999997199999999997503468843100244345521
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~---~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~e 1132 (1299)
...........||+.|||||++.+ ..|+.++|||||||+||||+||+.||......... ......... ...+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~-~p~~-- 231 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYL-SPDL-- 231 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSC-CCCG--
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHCCCC-CCCC--
T ss_conf 67763125665574317999995056899995315163599999999788998998969999--999965888-9860--
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 10488899999135999999999716969689999899999999999651
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1133 IiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.....++...+.+|+.+||+.+|++||+|.||++.|+.+.+..
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 -------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -------0036555499999999975889768929999999999999709
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=388.59 Aligned_cols=259 Identities=28% Similarity=0.461 Sum_probs=212.5
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CC---CEEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710473689999953-89---78999992113-433225789988875512446611354144303635899
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~-dG---~~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LV 974 (1299)
++|++.++||+|+||+||+|.+. ++ ..||||++... .....++|++|+++|++++|+|||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 96348998100023565678888756899999999999987652499953530134567243168750352777521123
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
||||++|+|.+++.. ....++|.++++|+.|+++||.|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCEEEECC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 972279853002104---5679999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 3335442---122136556667520014978721100416999999971-999999999975034688431002443455
Q 000757 1055 DEESRHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1055 ~~~~~~~---st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L 1130 (1299)
....... .....|+..|||||++.++.++.++|||||||+||||+| |+.||..... ..+.....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~--------- 247 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE--------- 247 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---------
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---------
T ss_conf 777765365025666883003878883699786121445357899998679999999999---99999997---------
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 211048889999913599999999971696968999989999999999965
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1131 ~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
...+...+.++...+.+|+.+||+.+|++||+|.||++.|+.+.++
T Consensus 248 -----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 -----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -----3788999742269999999997587976892999999999998418
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.14 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=214.2
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECC-C-----CEEEEEEEECC-CCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEECC
Q ss_conf 80992154677104736899999538-9-----78999992113-433225789988875512-4466113541443036
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDD-G-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 969 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l~d-G-----~~VAVK~Lk~~-~~~~~keflrEIeILsrL-rHPNIVrLlGv~~e~~ 969 (1299)
-.++|++.+.||+|+||+||+|++.. + ..||+|.+... +....+.+.+|+.++.++ +|+|||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CEEEEEEECCCCCHHHCCCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf 35899963489981000235656-------------------78888756899999999999987652499953530134
Q 000757 970 ARCLVYELIPNGSVESHLHGVDK-------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1030 (1299)
Q Consensus 970 ~~~LVmEYi~gGSL~d~L~~~~~-------------------~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIK 1030 (1299)
..++|||||++|+|.++|+.... ....++|.+++.|+.|++.||+|||+.+ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf 5899997279995999998625777510221000012220012577899999999999999999997399---0505270
Q ss_pred CCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 5672431687503527775211233335442122136556667520014978721100416999999971-999999999
Q 000757 1031 SSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQ 1109 (1299)
Q Consensus 1031 PsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~ 1109 (1299)
++|||++.++.+||+|||+|+...............||..|||||++.++.++.++|||||||+||||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 97503468843100244345521104888999991359999999997169696899998999999999
Q 000757 1110 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1110 ~~~~~nLv~wa~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~ 1177 (1299)
... .+.. ++....+...+..+...+.+|+.+||+.+|++||||.||++.|.-
T Consensus 272 ~~~--~~~~--------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDA--NFYK--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSH--HHHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHHH--------------HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 899--9999--------------985699899887678999999999758896689399999999748
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=390.61 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=215.8
Q ss_pred HHHHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 988099215467710473689999953-8978999992113433225789988875512446611354144303635899
Q 000757 896 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 896 e~aT~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LV 974 (1299)
|...++|++.+.||+|+||+||+|.+. +++.||||+++. +....++|++|+++|++++|+|||+++|+|.+.+..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf 7457993986598208880899999999996999999777-610399999999999867999882677527457854787
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 96348998100023565678888756899999999999987652499953530134567243168750352777521123
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+++|+|.++|... ....++|..++.|+.|++.||.|||+.+ |+|||||++||||++++.+||+|||+++...
T Consensus 92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 6314676067775303--5541579999999999999788898789---3057604576899899928983244546537
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEE
Q ss_conf 33354421221365566675200149787211004169999999719999999999750346884310024434552110
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIi 1134 (1299)
... ........|+..|+|||++.++.++.++|||||||+||||++|..|+..... ...+... +
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~--------------i 229 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYEL--------------L 229 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHH--------------H
T ss_pred CCC-CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH--------------H
T ss_conf 887-2210355665466692787279998104302178999999867998877425--9999999--------------8
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 488899999135999999999716969689999899999999999651
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1135 Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
....+...+......+.+|+.+||+.||++||+|.||++.|+.+.++.
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 558888887433099999999975779768939999999999998757
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.78 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=210.4
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 80992154677104736899999538978999992113433225789988875512446611354144303635899963
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEY 977 (1299)
..++|++.+.||+|+||.||+|.+++++.||||+++. +....++|.+|++++++++|+|||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEE
T ss_conf 8899388679810798289999999999999999864-76888999999999986799988578731045-976999995
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 48998100023565678888756899999999999987652499953530134567243168750352777521123333
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++|+|.+++.... ...++|.++++|+.|+++||.|||+.+ |+|||||++||||++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf 78982888875147--898878899999999999999997489---5467564225156202440423410147735886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCC
Q ss_conf 54421221365566675200149787211004169999999719999999999750346884310024434552110488
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1137 (1299)
Q Consensus 1058 ~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~ 1137 (1299)
........|+..|+|||++.++.++.++|||||||+||||+||..++..... ...+..... ..
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~--------------~~ 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE--------------RG 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------------TT
T ss_pred -CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH--------------HC
T ss_conf -4420356774444582898379998245645257999999968988888889--999999997--------------06
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8999991359999999997169696899998999999999996
Q 000757 1138 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1138 L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~ 1180 (1299)
.+...+......+.+|+.+||+.+|++||+|.||++.|+.+..
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8888965571999999999758897689399999998611321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.53 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=209.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 09921546771047368999995-389789999921134-3322578998887551244661135414430363589996
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmE 976 (1299)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++|+|||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 34899810002356567888875689999999999998765249995353013456724316875035277752112333
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+++|+|.+++.. ...+++.+++.|+.|++.||.|||+.+ |+|||||++|||+++++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 4589808999753----799999999999999999999999759---835754689978878998798323142240468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 35442122136556667520014978-72110041699999997199999999997503468843100244345521104
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1057 ~~~~~st~vvGT~gYmAPEvl~~~~~-T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
.........+||+.|||||++.+..+ +.++|||||||+||||++|+.||+........ ...+...
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~------------- 222 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK------------- 222 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTT-------------
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHCC-------------
T ss_conf 86531113255747428728618999997101617379999998299788889859999-9998638-------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999997169696899998999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.............+.+|+.+||+.||++||++.|+++.
T Consensus 223 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -88788644699999999999767996689099999619
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.75 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=213.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCC-----CEEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 09921546771047368999995389-----78999992113-4332257899888755124466113541443036358
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDG-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~dG-----~~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~ 972 (1299)
...|++.++||+|+||.||+|.+++. ..||||+++.. .....++|++|++++++++|+|||+++|+|.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf 99963489981000235656788887568999999999999876524999535301345672431687503527775211
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+.+|++.+++.. ....++|.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 99972135740222102---3454208999999999998541212123---42576564427888998499845510300
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 2333354-421221365566675200149787211004169999999719999999999750346884310024434552
Q 000757 1053 AMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1053 ~~~~~~~-~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~ 1131 (1299)
....... .......||..|+|||++.++.++.++|||||||+||||++|..++..... ...+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i----------- 226 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI----------- 226 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH-----------
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHH-----------
T ss_conf 35787652674267777343488887049999735563448989999967988655689--99999998-----------
Q ss_pred EEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 1104888999991359999999997169696899998999999999996512
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1132 eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
....+...+.++...+.+|+.+||+.+|++||+|.||++.|+.+.+..+
T Consensus 227 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 227 ---NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ---HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---HCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ---6357899850457999999999776797689399999999999866956
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.85 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=211.3
Q ss_pred HCCCCEEEE-EEECCCEEEEEEEEC---CCCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 099215467-710473689999953---89789999921134-3322578998887551244661135414430363589
Q 000757 899 TGNFDASRI-LGEGGFGLVYSGVLD---DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 899 T~~Fsi~ei-LGkGaFGtVYkA~l~---dG~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~L 973 (1299)
.++|.+.++ ||+|+||.||+|.+. ++..||||+++... ....++|++|+++|++++|+|||+++|+|.+ +..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 99634899810002356567888875689999999999998765249995353013456724316875035277752112
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+++|+|.+++.. .+..+++.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 9980789968997521---2569999999999999999878998688---105767646604546885420331342115
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 333354-42122136556667520014978721100416999999971-9999999999750346884310024434552
Q 000757 1054 MDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1054 ~~~~~~-~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~ 1131 (1299)
...... .......|+..|+|||++.++.++.++|||||||+||||+| |+.||....... +.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~---------- 226 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE---------- 226 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHH----------
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----------
T ss_conf 5434321135621137433586887279999541232201789999938999999979999---999998----------
Q ss_pred EEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 1104888999991359999999997169696899998999999999996512
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1132 eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
...+...+..+..++.+|+.+||+.+|++||+|.+|++.|+....+..
T Consensus 227 ----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 227 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf ----189999997678999999999757797689099999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.68 Aligned_cols=269 Identities=21% Similarity=0.312 Sum_probs=209.7
Q ss_pred HHHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 8809921546771047368999995-38978999992113-433225789988875512446611354144303635899
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 897 ~aT~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LV 974 (1299)
...++|++.+.||+|+||+||+|+. .+|+.||+|+++.. +....+++.+|+.+|++++|+|||++++++.+....|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 87568889789712778099999998999699999987540978999999999999867999999499999989999999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEEECCCCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 963489981000235656788887568999999999999876524-9995353013456724316875035277752112
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~-gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
|||+++|+|.+++.. ...+++.++..++.|++.||.|||+. + |+||||||+||||+.++++||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 976799868998742----4999999999999999999999998599---971445779946878998999548776256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH-HHCCCCC------
Q ss_conf 333354421221365566675200149787211004169999999719999999999750346884-3100244------
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLLTS------ 1126 (1299)
Q Consensus 1054 ~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~w-a~plls~------ 1126 (1299)
... .....+||..|+|||++.+..|+.++|||||||+||||++|+.||...+....+..... .......
T Consensus 156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CCC----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 788----6211137714119468758998948889989999999998889989988789999998875177545774212
Q ss_pred -------------------CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf -------------------34552110488899999135999999999716969689999899999999
Q 000757 1127 -------------------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1127 -------------------~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk 1176 (1299)
.+.+..+...............++.+|+.+||..||++|||+.|+++.-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHH
T ss_conf 333221111222354134778876650268766764448999999999986899467908999960986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.75 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=213.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCC----EEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 99215467710473689999953-897----8999992113-43322578998887551244661135414430363589
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~-dG~----~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~L 973 (1299)
.+|++.++||+|+||+||+|.+. +|+ .||+|+++.. +....++|++|++++++++|+|||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 99634899810002356567888875689999999999998765249995353013456724316875035277752112
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
++||+.+|+|.+++.. ....+++..+++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 9984268740101113---3457999999999999999999998769---504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCE
Q ss_conf 33335442122136556667520014978721100416999999971-99999999997503468843100244345521
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~e 1132 (1299)
.............||..|+|||++.++.++.++|||||||+||||+| |+.||+..........+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------------- 227 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------------- 227 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH--------------
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--------------
T ss_conf 544453223651058644670887469998356544079999999977999999999899999997--------------
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 104888999991359999999997169696899998999999999996512
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1183 (1299)
Q Consensus 1133 IiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~~ 1183 (1299)
...+...+..+...+.+|+.+||+.+|++||++.||++.|..+.++..
T Consensus 228 ---~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 228 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp ---HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCHH
T ss_conf ---599899985568999999998478993469199999999999875868
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.52 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=208.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 9921546771047368999995-389789999921134332257899888755124466113541443036358999634
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi 978 (1299)
++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|+|||++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89981000235656788887568999999999999876524999535301345672431687503527775211233335
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++|+|.+++.. ..+++.++..|+.|++.||.|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf 79808988641-----59999999999999999999999879---7226776888688789968642515641321366-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCC
Q ss_conf 44212213655666752001497872110041699999997199999999997503468843100244345521104888
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L 1138 (1299)
......+||..|+|||++.+..++.++|||||||+||||++|+.||...+... .+...... . ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~-----~--------~~ 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATN-----G--------TP 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHH-----C--------SC
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHC-----C--------CC
T ss_conf -64444444777368266447998801203137299999804889989979999--99999857-----9--------99
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 999991359999999997169696899998999999
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1139 ~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
....+......+.+|+.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 888855379999999999866996689099999649
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.68 Aligned_cols=268 Identities=26% Similarity=0.439 Sum_probs=218.2
Q ss_pred HHHHHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 7899988099215467710473689999953------89789999921134-3322578998887551244661135414
Q 000757 892 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGI 964 (1299)
Q Consensus 892 ~~ELe~aT~~Fsi~eiLGkGaFGtVYkA~l~------dG~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv 964 (1299)
+.++|...++|++.+.||+|+||.||+|++. +++.||||+++... ....++|.+|++++++++|+||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCCEEEEEEECCCCCHHHCCCCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 430363589996348998100023565--------------------678888756899999999999987652499953
Q 000757 965 CIEEQARCLVYELIPNGSVESHLHGVD--------------------KESAPLGWDARLKIALGAARALAYLHEDSSPRV 1024 (1299)
Q Consensus 965 ~~e~~~~~LVmEYi~gGSL~d~L~~~~--------------------~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~I 1024 (1299)
|.+....++||||+.+|+|.++|+... .....+++.++++|+.|++.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred EEECCCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-C
Q ss_conf 530134567243168750352777521123333544212213655666752001497872110041699999997199-9
Q 000757 1025 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-K 1103 (1299)
Q Consensus 1025 VHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk-~ 1103 (1299)
+|||||++|||||.++.+||+|||+++...............|+..|+|||++.+..++.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999750346884310024434552110488899999135999999999716969689999899999999999
Q 000757 1104 PVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1179 (1299)
Q Consensus 1104 PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~ 1179 (1299)
||...... .+...+.. . .....+..+..++.+|+.+||+.+|++||+|.||++.|++++
T Consensus 242 p~~~~~~~---e~~~~v~~----~----------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE---EVIYYVRD----G----------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH---HHHHHHHC----C----------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 99998999---99999973----9----------978887325299999999974889657939999999999842
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.20 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=212.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99215467710473689999953897899999211343322578998887551244661135414430363589996348
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 979 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi~ 979 (1299)
++|++.+.||+|+||+||+|++++++.||||+++.. ....++|++|++++++++|+||++++|+|.++...++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 997996898207883999999889989999998747-5778999999999996689860158899850781699997048
Q ss_pred CCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCCC
Q ss_conf 99810002356567888875689999999999998765249995353013456724316875035277752112333354
Q 000757 980 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1059 (1299)
Q Consensus 980 gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~ 1059 (1299)
+|+|.+++.. ....+.+..+++|+.|+++||.|||+.+ |+|||||++||||+.++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-
T ss_conf 9938886410---2467768999999999999999875468---43466541358876998479886144202357872-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCC
Q ss_conf 42122136556667520014978721100416999999971-99999999997503468843100244345521104888
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L 1138 (1299)
.......|+..|+|||++.+..++.++|||||||++|||+| |+.||+...... +..... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~--------------~~~ 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA--------------QGL 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH--------------TTC
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH---HHHHHH--------------HCC
T ss_conf 252465788775780786379988521033643246739755999988999999---999998--------------079
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999991359999999997169696899998999999999
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1177 (1299)
Q Consensus 1139 ~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~ 1177 (1299)
+...+......+.+|+.+||+.+|++||+|.||++.|..
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 789965465999999999766897689399999987418
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=373.94 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=207.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 09921546771047368999995-38978999992113433225789988875512446611354144303635899963
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEY 977 (1299)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|+|||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCCEECCCCCCCCCCC
Q ss_conf 4899810002356567888875689999999999998765249995353013456724316--87503527775211233
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH--DFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDe--dg~VKLsDFGLAr~~~~ 1055 (1299)
|++|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+|||||++||||+. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 799889999976---2378999999999999999999997569---7600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
. .......||..|||||++.+..++.++|||||||++|||++|+.||...+... +..... .....
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~---~~~~~------ 243 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVK---SCDWN------ 243 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HTCCC------
T ss_pred C---CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---HCCCC------
T ss_conf 5---43200068624218899758998726765546599999985989989979999---999998---47889------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999997169696899998999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
+...........+.+|+.+||..||++|||+.|+++.
T Consensus 244 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --8942235899999999999756896679089998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.02 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=208.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE--CCCEEE
Q ss_conf 09921546771047368999995-389789999921134--3322578998887551244661135414430--363589
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCL 973 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~--~~~~keflrEIeILsrLrHPNIVrLlGv~~e--~~~~~L 973 (1299)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++++++|+|||++++++.+ ....|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCEEECCCCCCEECCCCCCC
Q ss_conf 99634899810002356567888875689999999999998765249--9953530134567243168750352777521
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 974 VmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~g--sp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|||||++|+|.+++.........+++.+++.|+.|++.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 12333354421221365566675200149787211004169999999719999999999750346884310024434552
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1131 (1299)
Q Consensus 1052 ~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~ 1131 (1299)
...... ......+||+.|||||++.+..++.++|||||||+||||++|+.||...+.. .+.....
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~---------- 227 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR---------- 227 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH----------
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH---HHHHHHH----------
T ss_conf 224577--7556677882327999983999993898875278999980188998998999---9999997----------
Q ss_pred EEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 1104888999991359999999997169696899998999999
Q 000757 1132 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1132 eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
+..+ ...+.....++.+|+.+||+.||++||++.|+++.
T Consensus 228 ---~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 ---EGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---HTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ---1899-88974359999999999767995579189999729
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=371.84 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=208.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 09921546771047368999995-38978999992113433225789988875512446611354144303635899963
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEY 977 (1299)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++|+|||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC--CCCCCEECCCCCCCCCCC
Q ss_conf 489981000235656788887568999999999999876524999535301345672431--687503527775211233
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLD--edg~VKLsDFGLAr~~~~ 1055 (1299)
|++|+|.+++.. ....+++.+++.|+.|++.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 899808888986---3899899999999999999999999779---2651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
. .......|+..|+|||++.+..++.++|||||||+||||++|+.||...+... +...... ..
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~---~~-------- 244 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR---CD-------- 244 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH---CC--------
T ss_pred C---CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHH---CC--------
T ss_conf 8---72010047645348999747998976333898999999996889989979999---9999984---78--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999997169696899998999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
..+..........++.+|+.+||..||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 898930024799999999999756996689189999609
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.48 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=204.5
Q ss_pred EEEEECCCEEEEEEEECC---CCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECCC
Q ss_conf 677104736899999538---978999992113--433225789988875512446611354144303635899963489
Q 000757 906 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 980 (1299)
Q Consensus 906 eiLGkGaFGtVYkA~l~d---G~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi~g 980 (1299)
+.||+|+||+||+|.+.+ ++.||||+++.. +....++|.+|+++|++++|+|||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCCC-
Q ss_conf 9810002356567888875689999999999998765249995353013456724316875035277752112333354-
Q 000757 981 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1059 (1299)
Q Consensus 981 GSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~~- 1059 (1299)
|+|.++++. ...++|.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 968999752----257899999999999999976687479---5567776113102356751234134533134323443
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCC
Q ss_conf 42122136556667520014978721100416999999971-99999999997503468843100244345521104888
Q 000757 1060 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1060 ~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L 1138 (1299)
.......||..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..... ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~--------------~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE--------------KGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH--------------TTC
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH--------------CCC
T ss_conf 2244567784203916653799984344303403132896589999999899---99999998--------------289
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99999135999999999716969689999899999999999651
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1139 ~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
+...+..+..++.+|+.+||+.+|++||+|.+|++.|+....+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 99998656799999999975889768909899999852887504
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.38 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=207.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 9921546771047368999995-389789999921134332257899888755124466113541443036358999634
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi 978 (1299)
+.|++.+.||+|+||.||+|.. .+++.||+|+++.......+.+.+|++++++++|+|||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89981000235656788887568999999999999876524999535301345672431687503527775211233335
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
++|+|.+++... ...+++.++..|+.|++.||.|||+++ |+||||||+||||+.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-
T ss_conf 998188999862---899999999999999999999999889---8871407003148789998997161230357786-
Q ss_pred CCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 44212213655666752001-----4978721100416999999971999999999975034688431002443455211
Q 000757 1059 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1059 ~~~st~vvGT~gYmAPEvl~-----~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eI 1133 (1299)
......+||..|+|||++. ...|+.++|||||||+||||++|+.||...+.... +...... . ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~~~----~--~~-- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAKS----E--PP-- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHHS----C--CC--
T ss_pred -CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHCC----C--CC--
T ss_conf -41001025626479999832025788888066578789999998208899999899999--9999707----9--98--
Q ss_pred ECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04888999991359999999997169696899998999999
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 iDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
...........+.+|+.+||+.||++||++.|+++.
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----777656699999999999766996689199999629
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.28 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=210.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 09921546771047368999995389789999921134332257899888755124466113541443036358999634
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 978 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEYi 978 (1299)
.++|++.+.||+|+||.||+|++++++.||||+++. +....+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 799798469930798099999999999999999880-44888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCCC
Q ss_conf 89981000235656788887568999999999999876524999535301345672431687503527775211233335
Q 000757 979 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1058 (1299)
Q Consensus 979 ~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~~ 1058 (1299)
.+|+|.+++... ....++|.+++.|+.|++.||+|||+.+ |+|||||++|||||.++++||+|||+++......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC-
T ss_conf 799435420000--3553059999999999999999875411---4335312307999899929984425554256887-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECCCC
Q ss_conf 44212213655666752001497872110041699999997199999999997503468843100244345521104888
Q 000757 1059 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1138 (1299)
Q Consensus 1059 ~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp~L 1138 (1299)
........|+..|+|||++..+.++.++|||||||+||||++|..++..... ...+..+... ..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~--------------~~ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER--------------GY 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT--------------TC
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHHH--------------CC
T ss_conf 3352454556654580898379989177413235899999868999998888--9999999982--------------68
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 999991359999999997169696899998999999999996
Q 000757 1139 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1139 ~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~ 1180 (1299)
+......+..++.+++.+||+.+|++||+|.+|++.|+....
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 999983237999999999756697589199999998766623
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.02 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=210.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771047368999995-38978999992113---4332257899888755124466113541443036358999
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|++++++++|+||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687503527775211233
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 70489877776531----599999999999999999997621650---88476774123668885388603210242256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
..........+||..|+|||++.+..++.++|||||||+||||++|+.||...+... +.... ....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i---~~~~-------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKI---IKLE-------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HTTC--------
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HCCC--------
T ss_conf 776433355567755258440026898966623045699999803889989959999---99999---7189--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 88899999135999999999716969689999899999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk 1176 (1299)
..++.....++.+|+.+||+.||++|+|+.|+++...
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf ----9998547999999999985579768919789737789
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.63 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=207.0
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99215467710473689999953-8978999992113---4332257899888755124466113541443036358999
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
++|++.+.||+|+||+||+|+.. +++.||+|++... +....+.+.+|++++++++|+|||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687503527775211233
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+++|+|.+++.. ...+++.++..|+.|++.||+|||+.+ |+||||||+||||+.++++||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 50479858988750----489999999999999999999999889---46522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
. .....+||..|||||++.+..++.++|||||||+||||++|+.||...+... +.... ....
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~~~~-------- 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI---SRVE-------- 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HTTC--------
T ss_pred C----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH---HCCC--------
T ss_conf 8----5235578876349999758998931440467599999832999988899999---99999---7189--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 88899999135999999999716969689999899999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk 1176 (1299)
..++.....++.+|+.+||+.||++||++.|+++.-.
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf ----9998668999999999976479768909999971907
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.97 Aligned_cols=271 Identities=24% Similarity=0.358 Sum_probs=214.2
Q ss_pred HHHHHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECC-CCCCHHHHHHHHHHHHHC-CCCCCEEEEE
Q ss_conf 7899988099215467710473689999953------8978999992113-433225789988875512-4466113541
Q 000757 892 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIG 963 (1299)
Q Consensus 892 ~~ELe~aT~~Fsi~eiLGkGaFGtVYkA~l~------dG~~VAVK~Lk~~-~~~~~keflrEIeILsrL-rHPNIVrLlG 963 (1299)
..+++...++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 82526167997984498416783999999867775557839999998600171789999999999886149984997411
Q ss_pred EEEEC-CCEEEEEEECCCCCHHHCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf 44303-635899963489981000235656------------78888756899999999999987652499953530134
Q 000757 964 ICIEE-QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1030 (1299)
Q Consensus 964 v~~e~-~~~~LVmEYi~gGSL~d~L~~~~~------------~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIK 1030 (1299)
++.+. ...++|||||++|+|.++|+.... ....+++.+++.|+.|+++||.|||+.+ |+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCC
T ss_conf 5404797579999845899299999853666665322202332146899999999999999999887379---7178677
Q ss_pred CCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 567243168750352777521123333544212213655666752001497872110041699999997199-9999999
Q 000757 1031 SSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQ 1109 (1299)
Q Consensus 1031 PsNILLDedg~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk-~PFd~s~ 1109 (1299)
|+||||++++.+||+|||+|+...............||..|+|||++.++.++.++|||||||++|||++|. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf 31065779982898457520011356652224751667210203686468899663221367899999868899998999
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 975034688431002443455211048889999913599999999971696968999989999999999965
Q 000757 1110 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1110 ~~~~~nLv~wa~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
... .+..... ...+...+.....++.+++.+||+.||++||++.||+++|+.+++.
T Consensus 242 ~~~--~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE--EFCRRLK--------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH--HHHHHHH--------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHH--------------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 899--9999996--------------3898888865789999999997677966791999999999799867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.98 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=211.6
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCC--EEEEEEEECC-CCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710473689999953-897--8999992113-433225789988875512-446611354144303635899
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~-dG~--~VAVK~Lk~~-~~~~~keflrEIeILsrL-rHPNIVrLlGv~~e~~~~~LV 974 (1299)
++|++.+.||+|+||.||+|.+. ++. .||||+++.. .....++|.+|+++|+++ +|+|||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHCCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCC
Q ss_conf 96348998100023565------------678888756899999999999987652499953530134567243168750
Q 000757 975 YELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1042 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~------------~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~V 1042 (1299)
|||+++|+|.++|+... .....++|.++++++.|++.||.|||+.+ |+|||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHH
Q ss_conf 3527775211233335442122136556667520014978721100416999999971999-999999975034688431
Q 000757 1043 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK-PVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1043 KLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~-PFd~s~~~~~~nLv~wa~ 1121 (1299)
||+|||+++....... .....|+..|+|||.+.++.++.++|||||||++|||++|.. ||...+. ..+...+.
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG
T ss_pred EECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH
T ss_conf 8743443224442234---55301377555538752699996221531388999998368999999999---99999998
Q ss_pred CCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 0024434552110488899999135999999999716969689999899999999999651
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1122 plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
. ..+...+.....++.+|+.+||+.+|++||+|.||++.|+.+.++.
T Consensus 241 ~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 Q--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp G--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H--------------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 2--------------6888887667899999999976789668949999999999998618
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=369.60 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=206.3
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 8099215467710473689999953-89789999921134-332257899888755124466113541443036358999
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
..+.|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++|++++|+|||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCCEECCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431---687503527775211
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARS 1052 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLD---edg~VKLsDFGLAr~ 1052 (1299)
|||+||+|.+++.. ...+++.++..|+.|++.||.|||+.+ |+||||||+|||+. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 52689848886530----367887899999999999987524130---55687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCE
Q ss_conf 23333544212213655666752001497872110041699999997199999999997503468843100244345521
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1053 ~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~e 1132 (1299)
.... ......+||..|||||++.+..|+.++|||||||+||||++|+.||...... .+..... ...
T Consensus 160 ~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~---~~~----- 225 (307)
T d1a06a_ 160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQIL---KAE----- 225 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH---TTC-----
T ss_pred CCCC---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---CCC-----
T ss_conf 2589---7044003284225918873799980787345159999998597999998999---9999986---168-----
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 104888999991359999999997169696899998999999
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 IiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
..+......+....+.+|+.+||+.||++||++.|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---777876666789999999999760897579189998629
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.26 Aligned_cols=245 Identities=27% Similarity=0.343 Sum_probs=199.6
Q ss_pred CCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 921546771047368999995-3897899999211343---322578998887551244661135414430363589996
Q 000757 901 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 901 ~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~---~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmE 976 (1299)
.|+..+.||+|+||.||+|+. .+++.||||++..... ...+++.+|++++++++|+|||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 34899810002356567888875689999999999998765249995353013456724316875035277752112333
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
||.+|+|..++. ....+++.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 069994578997----3799999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 35442122136556667520014---978721100416999999971999999999975034688431002443455211
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1057 ~~~~~st~vvGT~gYmAPEvl~~---~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eI 1133 (1299)
....+||+.|||||++.+ +.|+.++|||||||+||||++|+.||....... .+..- ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~~i----~~-------- 228 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI----AQ-------- 228 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH----HH--------
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH----HH--------
T ss_conf -----873134766368899834678886721454558999999987889999979999--99999----82--------
Q ss_pred ECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04888999991359999999997169696899998999999
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 iDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
..............+.+|+.+||+.||++||++.|+++.
T Consensus 229 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 229 --NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --899988878889999999999773796579189999719
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.95 Aligned_cols=266 Identities=26% Similarity=0.403 Sum_probs=215.8
Q ss_pred HHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECCC-CCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 88099215467710473689999953------89789999921134-33225789988875512-446611354144303
Q 000757 897 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 897 ~aT~~Fsi~eiLGkGaFGtVYkA~l~------dG~~VAVK~Lk~~~-~~~~keflrEIeILsrL-rHPNIVrLlGv~~e~ 968 (1299)
.-.++|++.+.||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|+|||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CCEEEEEEECCCCCHHHCCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCE
Q ss_conf 635899963489981000235656--------------788887568999999999999876524999535301345672
Q 000757 969 QARCLVYELIPNGSVESHLHGVDK--------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1034 (1299)
Q Consensus 969 ~~~~LVmEYi~gGSL~d~L~~~~~--------------~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNI 1034 (1299)
...++|||||++|+|.++|+.... ....+++.++++|+.|++.||+|||+++ |+|||||++||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCC
T ss_conf 978999973799879999985356654444453322233458899999999999999999887579---26662410210
Q ss_pred EECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCH
Q ss_conf 4316875035277752112333354421221365566675200149787211004169999999719-999999999750
Q 000757 1035 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQ 1113 (1299)
Q Consensus 1035 LLDedg~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTG-k~PFd~s~~~~~ 1113 (1299)
|++.++.+||+|||+++...............|+..|+|||++.++.++.++|||||||+||||+|+ ..+|........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 00025752102340102336788615862013596876778861799997400102589999998589988778998999
Q ss_pred HHHHHHHHCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 34688431002443455211048889999913599999999971696968999989999999999965
Q 000757 1114 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1114 ~nLv~wa~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
+. ++++...+...+......+.+|+.+||+.||++||+|.||+++|+.+..+
T Consensus 257 --~~--------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 --FY--------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --HH--------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HH--------------HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf --99--------------99866898898543659999999997577965792999999999876534
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.98 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=206.1
Q ss_pred EEEEEEECCCEEEEEEEECCC----CEEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCCEEEEEEE
Q ss_conf 546771047368999995389----78999992113-43322578998887551244661135414430-3635899963
Q 000757 904 ASRILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYEL 977 (1299)
Q Consensus 904 i~eiLGkGaFGtVYkA~l~dG----~~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e-~~~~~LVmEY 977 (1299)
..++||+|+||+||+|++.++ ..||||+++.. +....++|.+|++++++++|+||++++|+|.+ +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 48998100023565678888756899999999999987652499953530134567243168750352777521123333
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
|++|+|.++++. ....+.+..+++++.|++.||.|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 406741442101---3454048999999999887652003367---6257766875767799988991065232255665
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 54--4212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1058 SR--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1058 ~~--~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
.. .......|+..|+|||++..+.++.++||||||++||||++|+.||...... ..+..+.. ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~---~g--------- 250 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL---QG--------- 250 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TT---------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---CC---------
T ss_conf 55310025655564556768874379997457466199999999789999888999--99999998---08---------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 88899999135999999999716969689999899999999999651
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.+...+..+...+.+|+.+||+.||++||+|.||++.|+.+....
T Consensus 251 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 251 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf --988996447599999999976889768939999999999999752
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.56 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=196.0
Q ss_pred CCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE----CCCEEEE
Q ss_conf 215467710473689999953-8978999992113--43322578998887551244661135414430----3635899
Q 000757 902 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQARCLV 974 (1299)
Q Consensus 902 Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e----~~~~~LV 974 (1299)
|++.+.||+|+||+||+|.+. +++.||+|++... .....+.|.+|+++|++++|+|||++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC-CCCCCEECCCCCCCCC
Q ss_conf 963489981000235656788887568999999999999876524999535301345672431-6875035277752112
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLD-edg~VKLsDFGLAr~~ 1053 (1299)
|||+++|+|.+++.. ...+++.+++.|+.|++.||+|||+++ .+|+||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 957898948999751----355469999999999999999999789-979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 33335442122136556667520014978721100416999999971999999999975034688431002443455211
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1133 (1299)
Q Consensus 1054 ~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eI 1133 (1299)
.. ......+||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+.........
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~~~~-------- 230 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVK-------- 230 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCC--------
T ss_pred CC----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHCCCC--------
T ss_conf 68----76677553813008988478-9998671100799999998788999876559--999999973899--------
Q ss_pred ECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04888999991359999999997169696899998999999
Q 000757 1134 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 iDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
..........++.+|+.+||+.+|++||++.|+++.
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----865675578999999999763797589299999677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.36 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=210.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECC----CCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 0992154677104736899999538----9789999921134-3322578998887551244661135414430363589
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~d----G~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~L 973 (1299)
.++|++.+.||+|+||.||+|++.. +..||||.++... ....+.|.+|++++++++|+|||+++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953-74799
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 99634899810002356567888875689999999999998765249995353013456724316875035277752112
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 974 VmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~ 1053 (1299)
||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 9984069807765422---4789999999999999987752302267---441410265532067896787650342133
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCE
Q ss_conf 33335442122136556667520014978721100416999999971-99999999997503468843100244345521
Q 000757 1054 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1132 (1299)
Q Consensus 1054 ~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~e 1132 (1299)
... .........||..|+|||++.+..++.++|||||||+||||++ |+.||....... +...+.. .
T Consensus 159 ~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~----~----- 225 (273)
T d1mp8a_ 159 EDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN----G----- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----T-----
T ss_pred CCC-CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHHC----C-----
T ss_conf 677-62330540058310326675169988745244424789999826999988899999---9999981----8-----
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 10488899999135999999999716969689999899999999999651
Q 000757 1133 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1133 IiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.+...+......+.+|+.+||..||++||++.||++.|+.+.++.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf -----999898777999999999976879768929999999999997786
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.20 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=204.5
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC------CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 09921546771047368999995-389789999921134------33225789988875512446611354144303635
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~------~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~ 971 (1299)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+|||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC----CCEECCC
Q ss_conf 899963489981000235656788887568999999999999876524999535301345672431687----5035277
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSDF 1047 (1299)
Q Consensus 972 ~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg----~VKLsDF 1047 (1299)
|+|||||++|+|.+++.. ...+++.+++.|+.|++.||+|||+.+ |+|||||++|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 999986778643100103----564215578999999999987666254---2211333012798258986664696433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 75211233335442122136556667520014978721100416999999971999999999975034688431002443
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1127 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~ 1127 (1299)
|+++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||...+... ...... ...
T Consensus 162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~---~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS---AVN 232 (293)
T ss_dssp TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---TTC
T ss_pred HHHHHCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH---HCC
T ss_conf 442105777---63122477774309999818999976652214099999970889988999999---999998---168
Q ss_pred CCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 45521104888999991359999999997169696899998999999
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1128 e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.... ..........+.+|+.+||+.||++||++.|+++.
T Consensus 233 ~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 YEFE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCC--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCC--------CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8887--------01047889999999999863896689199999619
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.68 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=215.2
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECC--------CCEEEEEEEECCC-CCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 0992154677104736899999538--------9789999921134-33225789988875512-446611354144303
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 968 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~d--------G~~VAVK~Lk~~~-~~~~keflrEIeILsrL-rHPNIVrLlGv~~e~ 968 (1299)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCEEEEEEECCCCCHHHCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEE
Q ss_conf 635899963489981000235656------------78888756899999999999987652499953530134567243
Q 000757 969 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1036 (1299)
Q Consensus 969 ~~~~LVmEYi~gGSL~d~L~~~~~------------~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILL 1036 (1299)
+..++||||+++|+|.+++..... ....+++.++++++.|++.||.|||+.+ |+|||||++|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHH
Q ss_conf 1687503527775211233335442122136556667520014978721100416999999971-999999999975034
Q 000757 1037 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1115 (1299)
Q Consensus 1037 Dedg~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~n 1115 (1299)
+.++.+||+|||+++...............|+..|+|||++.++.|+.++|||||||+||||++ |+.||..... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH---HH
T ss_conf 478976762211101135555543146678884663266751798882555477588888740179898999999---99
Q ss_pred HHHHHHCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 68843100244345521104888999991359999999997169696899998999999999996
Q 000757 1116 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1116 Lv~wa~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~ 1180 (1299)
+..+.. ...+...+......+.+|+.+||+.+|++||++.||++.|+.+..
T Consensus 246 ~~~~i~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH--------------CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999997--------------288889874352999999999766797679399999999988860
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=358.93 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=200.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC---CCCCHHHHHHH---HHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 099215467710473689999953-8978999992113---43322578998---8875512446611354144303635
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAE---VEMLSRLHHRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~---~~~~~keflrE---IeILsrLrHPNIVrLlGv~~e~~~~ 971 (1299)
.++|++.++||+|+||.||+|+.. +|+.||||++... .......+.+| +.+++.++|+|||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCC
Q ss_conf 89996348998100023565678888756899999999999987652499953530134567243168750352777521
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
|+||||+++|+|.++|.. ...+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf 999991489838999873----255327899999999999999999779---6220444221678588967982201023
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 1233335442122136556667520014-978721100416999999971999999999975034688431002443455
Q 000757 1052 SAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1052 ~~~~~~~~~~st~vvGT~gYmAPEvl~~-~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L 1130 (1299)
...... ....+||..|+|||++.. ..|+.++|||||||+||||++|+.||..........+..... ..
T Consensus 156 ~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---~~---- 224 (364)
T d1omwa3 156 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM---- 224 (364)
T ss_dssp ECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS---SC----
T ss_pred ECCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC---CC----
T ss_conf 337886----4331134554216876038999844104677899999985999888899899999998604---68----
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 2110488899999135999999999716969689999-----8999999
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1131 ~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPS-----MsEVLq~ 1174 (1299)
....+.....++.+|+.+||..||++|++ +.|+++.
T Consensus 225 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf --------88788778999999999985669888088743579999749
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.36 Aligned_cols=252 Identities=30% Similarity=0.475 Sum_probs=209.2
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCCEEEEEEE
Q ss_conf 099215467710473689999953897899999211343322578998887551244661135414430-3635899963
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYEL 977 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e-~~~~~LVmEY 977 (1299)
.++|++.+.||+|+||.||+|+++ |+.||||+++. ....+.|.+|++++++++|+||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-90999999885--777999999999998678989854987887238928999963
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 48998100023565678888756899999999999987652499953530134567243168750352777521123333
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+++|+|.++|+.. ....++|.++++|+.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 6999899998745--7888899999999999985232113376---553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEECC
Q ss_conf 5442122136556667520014978721100416999999971-999999999975034688431002443455211048
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1136 (1299)
Q Consensus 1058 ~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiDp 1136 (1299)
.....++..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..++. .
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~--------------~ 215 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE--------------K 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT--------------T
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH--------------C
T ss_conf ----76556664677817872798885887775799999999789999999999---99999998--------------0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 88999991359999999997169696899998999999999996
Q 000757 1137 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1180 (1299)
Q Consensus 1137 ~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~ 1180 (1299)
..+...+.....++.+|+.+||+.||++||+|.++++.|+.+..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89999976579999999999756697689399999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.15 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=206.5
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 09921546771047368999995-38978999992113---433225789988875512446611354144303635899
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LV 974 (1299)
.++|++.+.||+|+||.||+|+. .+|+.||+|++++. .....+.+.+|+++|++++|+||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 96348998100023565678888756899999999999987652499953530134567243168750352777521123
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
||||.+|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 003579860555532----567759999999999965211343159---6224647778476589988882056520035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEE
Q ss_conf 33354421221365566675200149787211004169999999719999999999750346884310024434552110
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIi 1134 (1299)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.. .+.... ....
T Consensus 157 ~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i---~~~~------- 221 (337)
T d1o6la_ 157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI---LMEE------- 221 (337)
T ss_dssp CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHCC-------
T ss_pred CCC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HCCC-------
T ss_conf 678--6205510088996666504898883331022306788998789999996999---999998---5289-------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 488899999135999999999716969689999-----8999999
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPS-----MsEVLq~ 1174 (1299)
..++.....++.+|+.+||+.||++|++ +.|+++.
T Consensus 222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -----9898668999999998666389344225652349999729
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.15 Aligned_cols=267 Identities=27% Similarity=0.455 Sum_probs=214.6
Q ss_pred HHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf 9988099215467710473689999953------8978999992113-43322578998887551244661135414430
Q 000757 895 IEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 967 (1299)
Q Consensus 895 Le~aT~~Fsi~eiLGkGaFGtVYkA~l~------dG~~VAVK~Lk~~-~~~~~keflrEIeILsrLrHPNIVrLlGv~~e 967 (1299)
++...++|++.+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++|+|||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 04268991883598207881899999878644778968999998701286899999999999997699988412547842
Q ss_pred CCCEEEEEEECCCCCHHHCCCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCC
Q ss_conf 363589996348998100023565------67888875689999999999998765249995353013456724316875
Q 000757 968 EQARCLVYELIPNGSVESHLHGVD------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1041 (1299)
Q Consensus 968 ~~~~~LVmEYi~gGSL~d~L~~~~------~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~ 1041 (1299)
+...++||||+.+|+|.++++... .....+++..+++|+.|+++||.|||+.+ |+|||||++|||||++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCE
T ss_conf 88106777604899889998750332113444688799999999999999999876479---654328677540359964
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 0352777521123333544212213655666752001497872110041699999997199-999999997503468843
Q 000757 1042 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAWA 1120 (1299)
Q Consensus 1042 VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk-~PFd~s~~~~~~nLv~wa 1120 (1299)
+||+|||+++...............|+..|+|||.+.++.++.++||||||++||||+||+ .||..... ......+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV 248 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH
T ss_pred EEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH---HHHHHHH
T ss_conf 9994245420235776303134023163237888873699883334443789999999689999999899---9999999
Q ss_pred HCCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 1002443455211048889999913599999999971696968999989999999999965
Q 000757 1121 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1121 ~plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
.+.. +...+..+...+.+|+.+||+.+|++||+|.+|++.|+...+.
T Consensus 249 -------------~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 249 -------------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -------------HHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf -------------8088-8888633539999999997577965893999999997876177
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.81 Aligned_cols=276 Identities=22% Similarity=0.286 Sum_probs=204.5
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CEEEE
Q ss_conf 09921546771047368999995389789999921134332257899888755124466113541443036----35899
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----ARCLV 974 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~----~~~LV 974 (1299)
.++|.+.+.||+|+||.||+|++. |+.||||+++... .....+++|+..+.+++|+|||+++|+|.+.+ ..|+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 868999889820788199999999-9899999987200-46799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEECCCCCCEEECCCCCCEECCCCC
Q ss_conf 963489981000235656788887568999999999999876524-----999535301345672431687503527775
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-----SSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~-----gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
|||+.+|+|.++|+. ..++|..+++++.|++.||.|||.. .+.+|+|||||++||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 964669898999865-----899989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 2112333354--4212213655666752001497------8721100416999999971999999999975034688431
Q 000757 1050 ARSAMDEESR--HISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1050 Ar~~~~~~~~--~~st~vvGT~gYmAPEvl~~~~------~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~ 1121 (1299)
++........ ......+||..|+|||++.+.. ++.++|||||||+||||+||..++......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSC
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC-HHHCCC
T ss_conf 6234677762001355250354767822105654546777675012201599999996289988766311241-012255
Q ss_pred CCCCCCCCCCEEECCCCCCCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 002443455211048889999-----9135999999999716969689999899999999999651
Q 000757 1122 PLLTSREGLERIIDPSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1122 plls~~e~L~eIiDp~L~~~~-----~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
...........+.+..++... ..+....+.+|+.+||+.||++||+|.||++.|+++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 643099999987502468887765577689999999999976069858959999999999888865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=356.82 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771047368999995-38978999992113---4332257899888755124466113541443036358999
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|+|||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687503527775211233
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.||+|..++. ....+.+..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 5037863223432----2221110079999999987655412476---77055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
. ....+||..|||||++.+..|+.++|||||||+||||++|+.||...+... +... .....
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~---i~~~~-------- 217 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEK---ILNAE-------- 217 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHCC--------
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH---HHHH---HHCCC--------
T ss_conf 5-----643457634359999838999804304653336899975989999969999---9999---97089--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 8889999913599999999971696968999-----98999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRP-----SMsEVLq~ 1174 (1299)
..++......+.+++.+||..+|.+|+ +++++++.
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ----8899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.65 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=204.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771047368999995-38978999992113---4332257899888755124466113541443036358999
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 975 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVm 975 (1299)
++|++.+.||+|+||.||+|+. .+|+.||||++... +....+.+++|+++|++++|+|||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687503527775211233
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1055 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~ 1055 (1299)
||+.+|+|.+++.. ...+++.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 23346622666751----589899999999999999899998599---86176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEEC
Q ss_conf 33544212213655666752001497872110041699999997199999999997503468843100244345521104
Q 000757 1056 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1135 (1299)
Q Consensus 1056 ~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIiD 1135 (1299)
. .....||..|||||++.+..++.++|||||||+||||++|+.||...+.. .+.... ..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i---~~---------- 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKI---VS---------- 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH----------
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HC----------
T ss_conf 6-----64336763567889971799885331145007899997588998995999---999998---61----------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 8889999913599999999971696968999-----98999999
Q 000757 1136 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1174 (1299)
Q Consensus 1136 p~L~~~~~~ee~~eL~~LI~~CL~~dPseRP-----SMsEVLq~ 1174 (1299)
... ..+......+.+++.+||..||.+|+ ++.++++.
T Consensus 253 ~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 GKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC--CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 798--897668999999999983409986065534549999719
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.20 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=207.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEECC--C--CEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 992154677104736899999538--9--78999992113---4332257899888755124466113541443036358
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDD--G--TKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 972 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~d--G--~~VAVK~Lk~~---~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~ 972 (1299)
++|++.+.||+|+||.||+|++.. + ..||||+++.. +....++|.+|++++++++|+||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf 99963489981000235656788887568999999999999876524999535301345672431687503527775211
Q 000757 973 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 973 LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
+||||+++|+|.+++.. ....+++..+++++.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 14654238612544421---2689999999999999999998752178---75205668881565565433256115553
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 23333544-2122136556667520014978721100416999999971-999999999975034688431002443455
Q 000757 1053 AMDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1130 (1299)
Q Consensus 1053 ~~~~~~~~-~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLT-Gk~PFd~s~~~~~~nLv~wa~plls~~e~L 1130 (1299)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...+. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~-------- 229 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDK-------- 229 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT--------
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHH--------
T ss_conf 035887526547632573107999983799994215661489999999689999999699---999999984--------
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 211048889999913599999999971696968999989999999999
Q 000757 1131 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1178 (1299)
Q Consensus 1131 ~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I 1178 (1299)
...+..........+.+|+.+||+.||++||+|.||++.|++.
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf -----7999998544539999999997688966792999999999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=354.02 Aligned_cols=261 Identities=26% Similarity=0.327 Sum_probs=209.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----C
Q ss_conf 09921546771047368999995-389789999921134---332257899888755124466113541443036----3
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----A 970 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~---~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~----~ 970 (1299)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....++|.+|++++++++|+||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCC
Q ss_conf 58999634899810002356567888875689999999999998765249995353013456724316875035277752
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.|+||||++||+|.+++.. ...+++.+++.|+.|++.||.|||+.+ |+||||||+||||+.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 9999977889871011203----589999999999999999999998579---527634675566575432010034443
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 11233335-44212213655666752001497872110041699999997199999999997503468843100244345
Q 000757 1051 RSAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1051 r~~~~~~~-~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~ 1129 (1299)
+....... .......+||..|+|||++.+..++.++|||||||+||||++|+.||...+... .+... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~~----~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VAYQH----VREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH----HHCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH--HHHHH----HHCCCC
T ss_conf 221235443333464257624369999839999966320265289999976979989969999--99999----846999
Q ss_pred CCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 5211048889999913599999999971696968999-98999999999996
Q 000757 1130 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCN 1180 (1299)
Q Consensus 1130 L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRP-SMsEVLq~Lk~I~~ 1180 (1299)
. ......+....+.+++.+||..||++|| +++++.+.|.++.+
T Consensus 233 ~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 P--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp C--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred C--------CCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 9--------7100347899999999998667976777399999999999758
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.09 Aligned_cols=255 Identities=19% Similarity=0.233 Sum_probs=205.7
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 8099215467710473689999953-897899999211343322578998887551244661135414430363589996
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmE 976 (1299)
..++|++.+.||+|+||+||+|... +++.||+|+++.. ......+.+|+++|++++|+|||++++++.+++..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC--CCCEECCCCCCCCCC
Q ss_conf 348998100023565678888756899999999999987652499953530134567243168--750352777521123
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD--FTPKVSDFGLARSAM 1054 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDed--g~VKLsDFGLAr~~~ 1054 (1299)
||.||+|.+++.. ....+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC
T ss_conf 3899808899875---3899999999999999999999998769---975135544434437885189976441110034
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEE
Q ss_conf 33354421221365566675200149787211004169999999719999999999750346884310024434552110
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIi 1134 (1299)
.. .......|+..|+|||.+.+..++.++|||||||+||||++|+.||...+... +.... ......+..
T Consensus 156 ~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i---~~~~~~~~~-- 224 (321)
T d1tkia_ 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAEYTFDE-- 224 (321)
T ss_dssp TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTCCCCCH--
T ss_pred CC---CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HHCCCCCCH--
T ss_conf 67---75321223322234021048777840113027999999982899999989999---99999---838999880--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 488899999135999999999716969689999899999999
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1176 (1299)
Q Consensus 1135 Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk 1176 (1299)
....+...++.+|+.+||..||++|+++.|+++.-+
T Consensus 225 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 225 ------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf ------223678999999999986699668909999963996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.19 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=198.9
Q ss_pred HCCCCEE-EEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEE----CCCE
Q ss_conf 0992154-6771047368999995-38978999992113433225789988875512-44661135414430----3635
Q 000757 899 TGNFDAS-RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE----EQAR 971 (1299)
Q Consensus 899 T~~Fsi~-eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrL-rHPNIVrLlGv~~e----~~~~ 971 (1299)
.++|++. ++||+|+||.||+|.. .+++.||||+++.. +.+.+|++++.++ +|+|||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCCEECCCC
Q ss_conf 8999634899810002356567888875689999999999998765249995353013456724316---8750352777
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFG 1048 (1299)
Q Consensus 972 ~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDe---dg~VKLsDFG 1048 (1299)
|+|||||+||+|.++|... ....+++.++..|+.|++.||+|||+.+ |+|||||++|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9999778998499999862--7877579999999999999999999769---8644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 52112333354421221365566675200149787211004169999999719999999999750346884310024434
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e 1128 (1299)
+++...... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+...... ..
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~-------- 225 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GM-------- 225 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred EEEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HH--------
T ss_conf 123336888---6432267756379277748988888888764516778865889988988778899---99--------
Q ss_pred CCCEEECCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 552110488--89999913599999999971696968999989999999
Q 000757 1129 GLERIIDPS--LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1129 ~L~eIiDp~--L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~L 1175 (1299)
...+.... +...........+.+|+.+||+.||++|+++.|+++.-
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred -HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf -999853888889854346999999999997569965790999997098
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.90 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=202.6
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC---CCCCHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710473689999953-8978999992113---4332257899888755-12446611354144303635899
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLS-RLHHRNLVKLIGICIEEQARCLV 974 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~---~~~~~keflrEIeILs-rLrHPNIVrLlGv~~e~~~~~LV 974 (1299)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++. .++|+|||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCC
Q ss_conf 96348998100023565678888756899999999999987652499953530134567243168750352777521123
Q 000757 975 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1054 (1299)
Q Consensus 975 mEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~ 1054 (1299)
|||+++|+|.+++.. ...+++.+++.++.|++.||.|||+++ |+|||||++|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 750379808998640----478999999999999999999998689---3403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCEEE
Q ss_conf 33354421221365566675200149787211004169999999719999999999750346884310024434552110
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1134 (1299)
Q Consensus 1055 ~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~L~eIi 1134 (1299)
... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+... +..... ..
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~---~~-------- 218 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR---MD-------- 218 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HC--------
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---CC--------
T ss_conf 665--33454578777689999827998832320112278989873889999989999---999997---18--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH
Q ss_conf 48889999913599999999971696968999989-99999
Q 000757 1135 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQA 1174 (1299)
Q Consensus 1135 Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMs-EVLq~ 1174 (1299)
.. .++......+.+|+.+||..||++|+++. ++++.
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CC----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf 99----89756799999999996544898783889999809
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.58 Aligned_cols=262 Identities=22% Similarity=0.223 Sum_probs=197.7
Q ss_pred EEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 546771047368999995-3897899999211343-----3225789988875512446611354144303635899963
Q 000757 904 ASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ-----QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 904 i~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~-----~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEY 977 (1299)
..++||+|+||+||+|++ .+|+.||||+++.... ...+.+++|++++++++|+|||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 48998100023565678888756899999999999987652499953530134567243168750352777521123333
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.++++...+. .+..+++.++..|+.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 34507765541----2667789999999999999998863163---5503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH-HHHHC----CCCCCCCCC
Q ss_conf 5442122136556667520014-97872110041699999997199999999997503468-84310----024434552
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARP----LLTSREGLE 1131 (1299)
Q Consensus 1058 ~~~~st~vvGT~gYmAPEvl~~-~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv-~wa~p----lls~~e~L~ 1131 (1299)
. .....+||..|+|||++.. ..|+.++|||||||++|||++|+.||......+....+ ..... .+.......
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred C--CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCC
T ss_conf 5--43302047333639997267788805643630428999985969999999999999999851899725452100021
Q ss_pred EEECCCCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 110488899999-----1359999999997169696899998999999
Q 000757 1132 RIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1132 eIiDp~L~~~~~-----~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
............ ......+.+|+.+||+.||++|+|+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 344303478988678565689999999999763894569089999679
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=347.15 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=203.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC---------CCHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 09921546771047368999995-3897899999211343---------32257899888755124-4661135414430
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---------QGGREFLAEVEMLSRLH-HRNLVKLIGICIE 967 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~---------~~~keflrEIeILsrLr-HPNIVrLlGv~~e 967 (1299)
.++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+++|+.++++++ |+||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCC
Q ss_conf 36358999634899810002356567888875689999999999998765249995353013456724316875035277
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
.+..|+||||+++|+|.++|.. ...+++.+++.++.|++.||.|||+.+ |+|||||++||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986----599999999999999999999998759---943234625489868998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 75211233335442122136556667520014------978721100416999999971999999999975034688431
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1121 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~------~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~ 1121 (1299)
|+++...... .....+||..|+|||++.+ ..++.++||||+||+||||++|+.||...+.... ....
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~~~i- 227 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMI- 227 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-
T ss_pred HHEEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH---HHHH-
T ss_conf 0316726887---21345246788898886053445678899233185656023103228889889999999---9999-
Q ss_pred CCCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 00244345521104888999991359999999997169696899998999999
Q 000757 1122 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1122 plls~~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
..... .+..........++.+|+.+||+.+|++||++.|+++.
T Consensus 228 --~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 --MSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHCCC--------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --81898--------88985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.79 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=200.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 9921546771047368999995-389789999921134--3322578998887551244661135414430363589996
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~--~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmE 976 (1299)
++|++.+.||+|+||+||+|.. .+++.||||+++... ....+++.+|++++++++|+|||++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 34899810002356567888875689999999999998765249995353013456724316875035277752112333
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
|+.+ .+.+++.. .....+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCC-CHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 2377-44555442--02568888999999999999999865288---992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH-HHH-HCCCCCCCCCCEE
Q ss_conf 3544212213655666752001497-872110041699999997199999999997503468-843-1002443455211
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWA-RPLLTSREGLERI 1133 (1299)
Q Consensus 1057 ~~~~~st~vvGT~gYmAPEvl~~~~-~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv-~wa-~plls~~e~L~eI 1133 (1299)
. .......|+..|+|||++.... ++.++|||||||++|||++|+.||...+..+..... ... .............
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred C--CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCC
T ss_conf 6--41001036521541122136657774221033331342796687998988999999999983289833314442224
Q ss_pred EC--CCC----CCC---CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04--888----999---991359999999997169696899998999999
Q 000757 1134 ID--PSL----GND---VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1134 iD--p~L----~~~---~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.+ ... ... ........+.+|+.+||..||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21243454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.99 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=199.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CC-CCEEEEEEEECC--CCCCHHHHHHHHHHHHHC---CCCCCEEEEEEEEE----
Q ss_conf 09921546771047368999995-38-978999992113--433225789988875512---44661135414430----
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DD-GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL---HHRNLVKLIGICIE---- 967 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~d-G~~VAVK~Lk~~--~~~~~keflrEIeILsrL---rHPNIVrLlGv~~e---- 967 (1299)
.++|++.+.||+|+||+||+|++ .+ ++.||||+++.. .......+.+|+.+++.| +|+||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECC
Q ss_conf -3635899963489981000235656788887568999999999999876524999535301345672431687503527
Q 000757 968 -EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1046 (1299)
Q Consensus 968 -~~~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsD 1046 (1299)
....+++|||+.+|.+..... .....+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCEEEEEEEECCCCCHHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 6746999997405871444443---03789998999999999999999997588---98357986278985899754210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHC----
Q ss_conf 7752112333354421221365566675200149787211004169999999719999999999750346884310----
Q 000757 1047 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP---- 1122 (1299)
Q Consensus 1047 FGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~p---- 1122 (1299)
||+++..... .......||..|+|||++.+..|+.++|||||||+||||++|+.||...+..+..........
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred HHHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCH
T ss_conf 0010110023---4577765485114831001798881110003289999998787998998989999999984079961
Q ss_pred -CCCCCCCCCE-EEC---CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -0244345521-104---888999991359999999997169696899998999999
Q 000757 1123 -LLTSREGLER-IID---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 -lls~~e~L~e-IiD---p~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.+........ .+. ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 105321111033302234564544044589999999999874896679189999669
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=337.54 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=204.5
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 992154677104736899999538978999992113--433225789988875512446611354144303635899963
Q 000757 900 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 977 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmEY 977 (1299)
++|++.+.||+|+||+||+|++.+|+.||||+++.. +....+++.+|+.+|++++|+||+++++++......++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCCC
Q ss_conf 48998100023565678888756899999999999987652499953530134567243168750352777521123333
Q 000757 978 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1057 (1299)
Q Consensus 978 i~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~~ 1057 (1299)
+.++.+..+.. ....+++.+++.|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 00456789986----0477514456899999999999860574---8826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH--C---CCCCCCCCC
Q ss_conf 5442122136556667520014-978721100416999999971999999999975034688431--0---024434552
Q 000757 1058 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR--P---LLTSREGLE 1131 (1299)
Q Consensus 1058 ~~~~st~vvGT~gYmAPEvl~~-~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~--p---lls~~e~L~ 1131 (1299)
. ......|+..|++||.+.. ..++.++|||||||++|||++|+.||...+..+....+.... . .+.....+.
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred C--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5--41010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred EEE------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 110------4888999991359999999997169696899998999999
Q 000757 1132 RII------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1132 eIi------Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
+.. ...............+.+++.+||+.||++|+++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2143333356764666512589999999999866896689099998569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.88 Aligned_cols=263 Identities=23% Similarity=0.261 Sum_probs=194.1
Q ss_pred CCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------CCEEE
Q ss_conf 9215467710473689999953-8978999992113433225789988875512446611354144303------63589
Q 000757 901 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QARCL 973 (1299)
Q Consensus 901 ~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~------~~~~L 973 (1299)
+|+..++||+|+||+||+|++. +|+.||||+++... +.+.+|+++|++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 7675169821768399999999999799999988160----689999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CCEECCCCCCCC
Q ss_conf 9963489981000235656788887568999999999999876524999535301345672431687-503527775211
Q 000757 974 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1052 (1299)
Q Consensus 974 VmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~ 1052 (1299)
||||+++|. .+.+.........+++.++..|+.|++.||+|||+.+ |+|||||++||||+.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCC-HHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 984168860-7888863103689999999999999999999998668---764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH---------HHC
Q ss_conf 233335442122136556667520014-9787211004169999999719999999999750346884---------310
Q 000757 1053 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW---------ARP 1122 (1299)
Q Consensus 1053 ~~~~~~~~~st~vvGT~gYmAPEvl~~-~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~w---------a~p 1122 (1299)
..... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....... ...
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 04776---532002555556827764046888210002465277855028799898799999999999748981776543
Q ss_pred CCCC--CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 0244--345521104888999991359999999997169696899998999999
Q 000757 1123 LLTS--REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 lls~--~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.... ...+.......+...........+.+|+.+||..||++|+|+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 062101103554456744443156899999999999765895579299999669
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.89 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=195.8
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC------CCHHHHHHHHHHHHHCC--CCCCEEEEEEEEECC
Q ss_conf 09921546771047368999995-3897899999211343------32257899888755124--466113541443036
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ------QGGREFLAEVEMLSRLH--HRNLVKLIGICIEEQ 969 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~------~~~keflrEIeILsrLr--HPNIVrLlGv~~e~~ 969 (1299)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+++.+|+.++++++ |+|||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEEECCC-CCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCC-CCCEECCC
Q ss_conf 35899963489-98100023565678888756899999999999987652499953530134567243168-75035277
Q 000757 970 ARCLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 1047 (1299)
Q Consensus 970 ~~~LVmEYi~g-GSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDed-g~VKLsDF 1047 (1299)
..++||||+.+ +++.+++. ....+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 68999983368622899986----1589999999999999999999998779---7556676111477447884897754
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 75211233335442122136556667520014978-72110041699999997199999999997503468843100244
Q 000757 1048 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1048 GLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~-T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~ 1126 (1299)
|+++..... ......||..|+|||++.+..+ +.++|||||||+||||++|+.||...+ .....
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~------- 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRG------- 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHC-------
T ss_pred CCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----HHHHC-------
T ss_conf 653532444----55665658774799998489978865332554034536756889988736-----77615-------
Q ss_pred CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 345521104888999991359999999997169696899998999999
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 ~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
. . .+......++.+|+.+||..||++|||+.|+++.
T Consensus 220 ~--------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C--------C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4--------4----7787799999999999760897589399998539
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.98 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=200.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE--------
Q ss_conf 09921546771047368999995-38978999992113--43322578998887551244661135414430--------
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-------- 967 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e-------- 967 (1299)
.++|++.+.||+|+||+||+|++ .+|+.||||++... .....+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCC
Q ss_conf 36358999634899810002356567888875689999999999998765249995353013456724316875035277
Q 000757 968 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1047 (1299)
Q Consensus 968 ~~~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDF 1047 (1299)
....|+||||+.++.+..... ....+.+..+..|+.|++.||.|||+.+ |+|||||++||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEEC
T ss_conf 763899985357874101222----0344330899999999999998852299---885676722203668996876313
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 752112333354--421221365566675200149-78721100416999999971999999999975034688431002
Q 000757 1048 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1124 (1299)
Q Consensus 1048 GLAr~~~~~~~~--~~st~vvGT~gYmAPEvl~~~-~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~pll 1124 (1299)
|+++........ ......+||..|+|||++.+. .++.++|||||||++|||++|+.||+..................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCC-------CCCCEEECCCCCCCCCH-------HHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 443-------45521104888999991-------359999999997169696899998999999
Q 000757 1125 TSR-------EGLERIIDPSLGNDVPF-------DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1125 s~~-------e~L~eIiDp~L~~~~~~-------ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
... ......+.......... .....+.+|+.+||+.||++|+|+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8255344320344433201334455503340444599899999999873896589099999749
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.70 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CE
Q ss_conf 809921546771047368999995-389789999921134-332257899888755124466113541443036----35
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----AR 971 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~-~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~----~~ 971 (1299)
.+.+|++.+.||+|+||+||+|.. .+|+.||||+++... ....+++++|+++|++++|+||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCC
Q ss_conf 89996348998100023565678888756899999999999987652499953530134567243168750352777521
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 972 ~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
+++++|+.+|+|.+++.. ..+++..+..|+.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 999996259865664405-----89999999999999999999999789---8677787643788799977875457056
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 12333354-4212213655666752001-497872110041699999997199999999997503468843100244345
Q 000757 1052 SAMDEESR-HISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1129 (1299)
Q Consensus 1052 ~~~~~~~~-~~st~vvGT~gYmAPEvl~-~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e~ 1129 (1299)
........ ......+|+..|+|||++. ...++.++||||+||++|||++|+.||......+.................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred -------CCEEECCC-CCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -------52110488-899999-----1359999999997169696899998999999
Q 000757 1130 -------LERIIDPS-LGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1130 -------L~eIiDp~-L~~~~~-----~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
........ ...... .....++.+|+.+||..||++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.25 Aligned_cols=263 Identities=19% Similarity=0.253 Sum_probs=201.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCEEEEEE-EEECCCEEEEEE
Q ss_conf 09921546771047368999995-3897899999211343322578998887551244661135414-430363589996
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI-CIEEQARCLVYE 976 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIVrLlGv-~~e~~~~~LVmE 976 (1299)
.++|++.+.||+|+||.||+|++ .+++.||||++... ...+++.+|++++++++|.+++.+++. ..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHH--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 88899968985078809999999889989999997210--0588899999999970389960179999951987789998
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCCEECCCCCCCCC
Q ss_conf 3489981000235656788887568999999999999876524999535301345672431---6875035277752112
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSA 1053 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLD---edg~VKLsDFGLAr~~ 1053 (1299)
|+ +|+|.+.+.. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EC-CCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 73-8713332443---0688768999999999999999999799---442667876606433577761565046751342
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH-HHHHCCCCCC
Q ss_conf 333354-----4212213655666752001497872110041699999997199999999997503468-8431002443
Q 000757 1054 MDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARPLLTSR 1127 (1299)
Q Consensus 1054 ~~~~~~-----~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv-~wa~plls~~ 1127 (1299)
...... .......||..|+|||++.+..++.++|||||||++|||++|+.||............ .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC--
T ss_conf 554455410001357767873532999991899898321886177899998498766553057799999985235678--
Q ss_pred CCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 455211048889999913599999999971696968999989999999999965
Q 000757 1128 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1181 (1299)
Q Consensus 1128 e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e 1181 (1299)
..... .......++.+++..||..+|++||++.++.+.|+.+...
T Consensus 235 ~~~~~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 TPIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCHHH---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCHHH---------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 98357---------5347889999999998439955791999999999999997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.35 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=199.0
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-----
Q ss_conf 809921546771047368999995-38978999992113--4332257899888755124466113541443036-----
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 969 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~----- 969 (1299)
..++|++.+.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+++|++++|+|||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -CEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCC
Q ss_conf -3589996348998100023565678888756899999999999987652499953530134567243168750352777
Q 000757 970 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1048 (1299)
Q Consensus 970 -~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFG 1048 (1299)
..|+||||+ +++|..+++ ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-521899987-----402269999999999999999987378---7645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC----
Q ss_conf 5211233335442122136556667520014-97872110041699999997199999999997503468843100----
Q 000757 1049 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL---- 1123 (1299)
Q Consensus 1049 LAr~~~~~~~~~~st~vvGT~gYmAPEvl~~-~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~pl---- 1123 (1299)
+++.... ..+...|+..|+|||++.+ ..++.++||||+||+||||++|+.||...+..............
T Consensus 167 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf 0220687-----63102455333588998178789965010300389999997869988897689999998503788488
Q ss_pred ----CCC------CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----244------345521104888999991359999999997169696899998999999
Q 000757 1124 ----LTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1124 ----ls~------~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
... ...+.+.....+. .........+.+|+.+||..||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88653000344331157866655667-7556899999999999772995579299999639
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=323.72 Aligned_cols=259 Identities=18% Similarity=0.278 Sum_probs=197.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCEEEEEEEEE--CCCEEEEE
Q ss_conf 9921546771047368999995-389789999921134332257899888755124-4661135414430--36358999
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIE--EQARCLVY 975 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLr-HPNIVrLlGv~~e--~~~~~LVm 975 (1299)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|+.++ |+||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CCEECCCCCCCCCC
Q ss_conf 63489981000235656788887568999999999999876524999535301345672431687-50352777521123
Q 000757 976 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAM 1054 (1299)
Q Consensus 976 EYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg-~VKLsDFGLAr~~~ 1054 (1299)
||+.+|+|..+. ..+++.++..|+.|++.||.|||+++ |+|||||++||||+.++ .+||+|||+++...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 631798589974-------68999999999999999998876433---44345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHH--H---------HHHHHC
Q ss_conf 33354421221365566675200149-78721100416999999971999999999975034--6---------884310
Q 000757 1055 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN--L---------VAWARP 1122 (1299)
Q Consensus 1055 ~~~~~~~st~vvGT~gYmAPEvl~~~-~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~n--L---------v~wa~p 1122 (1299)
... ......||..|+|||.+.+. .++.++||||+||++|||++|+.||.......... + ..|...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 887---44432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred C-CCCCCCCCEEE--------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 0-24434552110--------4888999991359999999997169696899998999999
Q 000757 1123 L-LTSREGLERII--------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1123 l-ls~~e~L~eIi--------Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
. .........+. ..............++.+|+.+||..||++|+|+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2544474300000333433112115521124489999999999866995689089999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.79 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=201.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC----CCCEEEEEEEECC----CCCCHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCC
Q ss_conf 99215467710473689999953----8978999992113----43322578998887551244-661135414430363
Q 000757 900 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV----DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQA 970 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l~----dG~~VAVK~Lk~~----~~~~~keflrEIeILsrLrH-PNIVrLlGv~~e~~~ 970 (1299)
++|++.+.||+|+||+||+|... +|+.||||.++.. +....+.+.+|++++++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCC
Q ss_conf 58999634899810002356567888875689999999999998765249995353013456724316875035277752
Q 000757 971 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1050 (1299)
Q Consensus 971 ~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLA 1050 (1299)
.++||||+.+|+|.+++.. ...+.+...+.++.|++.||.|||+.+ |+|||||++||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 0012312341179999873----045437888888999999998851499---896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 112333354421221365566675200149--787211004169999999719999999999750346884310024434
Q 000757 1051 RSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1128 (1299)
Q Consensus 1051 r~~~~~~~~~~st~vvGT~gYmAPEvl~~~--~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~~e 1128 (1299)
+....... .......|+..|++||.+.+. .++.++|||||||+||||++|+.||...+............ ..
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~--- 250 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK--- 250 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH---
T ss_pred HHHCCCCC-CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC--CC---
T ss_conf 22034444-3221222333331068760577688713251777799999976899988887777999999833--56---
Q ss_pred CCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 552110488899999135999999999716969689999-----8999999
Q 000757 1129 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1174 (1299)
Q Consensus 1129 ~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPS-----MsEVLq~ 1174 (1299)
. ...++.....++.+++.+||+.||++|++ ++|+++.
T Consensus 251 -------~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 -------S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------C--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -------8--99886547999999999974458988199974509999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=322.94 Aligned_cols=265 Identities=17% Similarity=0.196 Sum_probs=208.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCEEEEEE
Q ss_conf 09921546771047368999995-3897899999211343322578998887551244-661135414430363589996
Q 000757 899 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrH-PNIVrLlGv~~e~~~~~LVmE 976 (1299)
.++|++.+.||+|+||.||+|++ .+|+.||||++... ...+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 98069979984178829999999889979999997502--5829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-----CCCCEECCCCCCC
Q ss_conf 34899810002356567888875689999999999998765249995353013456724316-----8750352777521
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 1051 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDe-----dg~VKLsDFGLAr 1051 (1299)
|+ +|+|.+++... ...+++.++..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EC-CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 64-88879999752---031106899999999999999999779---662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 12333354-----4212213655666752001497872110041699999997199999999997503468843100244
Q 000757 1052 SAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1126 (1299)
Q Consensus 1052 ~~~~~~~~-----~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~ 1126 (1299)
........ ......+||..|||||++.+..++.++|||||||++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC-
T ss_conf 7146766541110246762775102679896488888699989831999999869876788530219999999970567-
Q ss_pred CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 34552110488899999135999999999716969689999899999999999651
Q 000757 1127 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1182 (1299)
Q Consensus 1127 ~e~L~eIiDp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~Lk~I~~e~ 1182 (1299)
.....++ . .....++.+++..|+..++++||++..+.+.|+.+++..
T Consensus 234 ~~~~~~l-----~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 STPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HSCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCHHHH-----C----CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 9995896-----5----799899999999984399300859999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.04 Aligned_cols=266 Identities=19% Similarity=0.234 Sum_probs=202.4
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 9921546771047368999995-389789999921134--3322578998887551244661135414430363589996
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 976 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~--~~~~keflrEIeILsrLrHPNIVrLlGv~~e~~~~~LVmE 976 (1299)
++|++.+.||+|+||+||+|++ .+++.||||+++... ....+++.+|+.++++++|+||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCCCCCCCCC
Q ss_conf 34899810002356567888875689999999999998765249995353013456724316875035277752112333
Q 000757 977 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1056 (1299)
Q Consensus 977 Yi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr~~~~~ 1056 (1299)
++.+++|..++. ....+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 023322211212----3565403678999999999987743399---860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCH-HHHH-HHHHCCC-CCCCCCCE
Q ss_conf 3544212213655666752001497-87211004169999999719999999999750-3468-8431002-44345521
Q 000757 1057 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLV-AWARPLL-TSREGLER 1132 (1299)
Q Consensus 1057 ~~~~~st~vvGT~gYmAPEvl~~~~-~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~-~nLv-~wa~pll-s~~e~L~e 1132 (1299)
.. ......++..|++||++.... ++.++|||||||++|||++|+.||........ .... ....... ........
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CC--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 75--1001034431014667506988880444026541889985189999889999999999986118997355134432
Q ss_pred EE---------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 10---------4888999991359999999997169696899998999999
Q 000757 1133 II---------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1133 Ii---------Dp~L~~~~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
.. ...............+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 221133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.86 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=199.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------C
Q ss_conf 099215467710473689999953-8978999992113--433225789988875512446611354144303------6
Q 000757 899 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------Q 969 (1299)
Q Consensus 899 T~~Fsi~eiLGkGaFGtVYkA~l~-dG~~VAVK~Lk~~--~~~~~keflrEIeILsrLrHPNIVrLlGv~~e~------~ 969 (1299)
.++|++.+.||+|+||+||+|.+. +|+.||||++... +....+++.+|+.++++++|+||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCC
Q ss_conf 35899963489981000235656788887568999999999999876524999535301345672431687503527775
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..|+||||+.++ +.+.++ ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEEEECCCHH-HHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHH
T ss_conf 269998414467-787650------38999999999999999998865221---12456776321136544313201023
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH---------HHH
Q ss_conf 21123333544212213655666752001497872110041699999997199999999997503468---------843
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------AWA 1120 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv---------~wa 1120 (1299)
++..... ......+||..|+|||++.+..++.++||||+||++|||++|+.||...+........ ++.
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred HHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 2114666---5533221465555813314777787743335662578986598998889778899999972058987999
Q ss_pred HCCC-------CCC-----CCCCEEECCCCCCC---CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 1002-------443-----45521104888999---9913599999999971696968999989999999
Q 000757 1121 RPLL-------TSR-----EGLERIIDPSLGND---VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1175 (1299)
Q Consensus 1121 ~pll-------s~~-----e~L~eIiDp~L~~~---~~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~L 1175 (1299)
.... ... .....++....... ........+.+|+.+||..||++|||++|+++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 8765667777641754356664212643335432101333799999999998769945790899996694
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.28 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=198.3
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE-----CC
Q ss_conf 809921546771047368999995-389789999921134--3322578998887551244661135414430-----36
Q 000757 898 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIE-----EQ 969 (1299)
Q Consensus 898 aT~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~--~~~~keflrEIeILsrLrHPNIVrLlGv~~e-----~~ 969 (1299)
..++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|+|||++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred CEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCEECCCCC
Q ss_conf 35899963489981000235656788887568999999999999876524999535301345672431687503527775
Q 000757 970 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1049 (1299)
Q Consensus 970 ~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VKLsDFGL 1049 (1299)
..+++++|+.+|+|.+++.. ..+++.++..|+.|++.||+|||+.+ |+|||||++|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 64999996258862320022-----45309999999999999999997388---76516677633455432200132100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCC--
Q ss_conf 2112333354421221365566675200149-7872110041699999997199999999997503468843100244--
Q 000757 1050 ARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-- 1126 (1299)
Q Consensus 1050 Ar~~~~~~~~~~st~vvGT~gYmAPEvl~~~-~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~nLv~wa~plls~-- 1126 (1299)
+..... ......|+..|+|||+..+. .++.++|||||||++|||++|+.||...+.......+.........
T Consensus 168 a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 012575-----444434543555835533775678551243205899999768899788988999999997307997577
Q ss_pred -----CCCCCEEECCCC-CCCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----345521104888-9999-----91359999999997169696899998999999
Q 000757 1127 -----REGLERIIDPSL-GNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1174 (1299)
Q Consensus 1127 -----~e~L~eIiDp~L-~~~~-----~~ee~~eL~~LI~~CL~~dPseRPSMsEVLq~ 1174 (1299)
............ .... .......+.+|+.+||..||.+|+|+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 32001024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=292.12 Aligned_cols=265 Identities=21% Similarity=0.220 Sum_probs=191.7
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 9921546771047368999995-389789999921134332257899888755124-----------4661135414430
Q 000757 900 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----------HRNLVKLIGICIE 967 (1299)
Q Consensus 900 ~~Fsi~eiLGkGaFGtVYkA~l-~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLr-----------HPNIVrLlGv~~e 967 (1299)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCC----
Q ss_conf 3--63589996348998100023565678888756899999999999987652-4999535301345672431687----
Q 000757 968 E--QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDF---- 1040 (1299)
Q Consensus 968 ~--~~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs-~gsp~IVHRDIKPsNILLDedg---- 1040 (1299)
. ...+++++++..+........ ......+.+..+..++.|++.||.|||+ .+ |+|||||++||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCC
T ss_conf 256520234320003542000001-2234678689999999999999888764058---646567705705630576564
Q ss_pred --CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHH----
Q ss_conf --50352777521123333544212213655666752001497872110041699999997199999999997503----
Q 000757 1041 --TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE---- 1114 (1299)
Q Consensus 1041 --~VKLsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILlELLTGk~PFd~s~~~~~~---- 1114 (1299)
.+|++|||.+..... .....+|+..|+|||++....++.++||||+||+++||++|+.||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 43056753144212344-----5422366521057132146677764320123789999987889989875543210268
Q ss_pred HHHHHHHCC-----------------CCCCCCCCEEECCC---------CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 468843100-----------------24434552110488---------8999991359999999997169696899998
Q 000757 1115 NLVAWARPL-----------------LTSREGLERIIDPS---------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1168 (1299)
Q Consensus 1115 nLv~wa~pl-----------------ls~~e~L~eIiDp~---------L~~~~~~ee~~eL~~LI~~CL~~dPseRPSM 1168 (1299)
.+......+ +........+.... ............+.+|+.+|+..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHHH
Q ss_conf 999999
Q 000757 1169 GEVVQA 1174 (1299)
Q Consensus 1169 sEVLq~ 1174 (1299)
.|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHHCC
T ss_conf 999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.1e-26 Score=176.41 Aligned_cols=171 Identities=18% Similarity=0.170 Sum_probs=120.0
Q ss_pred CCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC------------------CCHHHHHHHHHHHHHCCCCCCEEEEE
Q ss_conf 215467710473689999953897899999211343------------------32257899888755124466113541
Q 000757 902 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ------------------QGGREFLAEVEMLSRLHHRNLVKLIG 963 (1299)
Q Consensus 902 Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~------------------~~~keflrEIeILsrLrHPNIVrLlG 963 (1299)
+.+++.||+|+||.||+|.+.+|+.||||+++.... .....+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCCE
Q ss_conf 44303635899963489981000235656788887568999999999999876524999535301345672431687503
Q 000757 964 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1043 (1299)
Q Consensus 964 v~~e~~~~~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~gsp~IVHRDIKPsNILLDedg~VK 1043 (1299)
+. ..+++|||+.++.+.+ +.+.....++.|++.+|+|||+.+ |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred EC----CCEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEE
T ss_conf 62----8889999504565420-----------015789999999999999982688---8983689036114289-899
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 52777521123333544212213655666752001497872110041699999
Q 000757 1044 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVIL 1096 (1299)
Q Consensus 1044 LsDFGLAr~~~~~~~~~~st~vvGT~gYmAPEvl~~~~~T~KSDVWSLGVILl 1096 (1299)
|+|||+|+............+.+. .+ -|+ -.+.|..++|+||..--++
T Consensus 143 liDFG~a~~~~~~~~~~~l~rd~~---~~-~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILERDVR---NI-ITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHHHHH---HH-HHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHHHHHHHHH---HH-HHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 987788430899870999987799---99-999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.20 E-value=2.5e-10 Score=76.84 Aligned_cols=150 Identities=15% Similarity=0.093 Sum_probs=101.7
Q ss_pred HHHHHHHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCE
Q ss_conf 89998809921546771047368999995389789999921134332257899888755124-46611354144303635
Q 000757 893 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 971 (1299)
Q Consensus 893 ~ELe~aT~~Fsi~eiLGkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLr-HPNIVrLlGv~~e~~~~ 971 (1299)
.++......|+..+..+.+..+.||+...+ +..+++|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999975135279976789987718999908-9869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf 8999634899810002356567888875689999999999998765249-------------------------------
Q 000757 972 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS------------------------------- 1020 (1299)
Q Consensus 972 ~LVmEYi~gGSL~d~L~~~~~~~~~Lsw~~rlkIalQIA~ALaYLHs~g------------------------------- 1020 (1299)
++||++++|..+.+.... ......++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEECCCCCCCCCCCC---------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 999986043343543344---------02699999989999999855684214357644656555778998776555543
Q ss_pred -------------------------CCCEEEECCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf -------------------------99535301345672431687503527775211
Q 000757 1021 -------------------------SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1021 -------------------------sp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
...++|+|+.+.|||++++..+-|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.80 E-value=3.2e-08 Score=64.04 Aligned_cols=143 Identities=21% Similarity=0.175 Sum_probs=85.2
Q ss_pred EEEECCC-EEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCC--CCEEEEEEEEECCCEEEEEEECCCCCH
Q ss_conf 7710473-6899999538978999992113433225789988875512446--611354144303635899963489981
Q 000757 907 ILGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR--NLVKLIGICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 907 iLGkGaF-GtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHP--NIVrLlGv~~e~~~~~LVmEYi~gGSL 983 (1299)
.+..|.. +.||+....++..+++|..... ....+.+|...++.|... .+.++++++.+.+..++||++++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966---77689999999999986599988613222456615999874413554
Q ss_pred HHCC-----------------CCCCCCCCCCCHHH--HHHHHH--------------------HHHHHHHHHHHC----C
Q ss_conf 0002-----------------35656788887568--999999--------------------999999876524----9
Q 000757 984 ESHL-----------------HGVDKESAPLGWDA--RLKIAL--------------------GAARALAYLHED----S 1020 (1299)
Q Consensus 984 ~d~L-----------------~~~~~~~~~Lsw~~--rlkIal--------------------QIA~ALaYLHs~----g 1020 (1299)
.+.. |........+.+.. ...... .....+..+.+. .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCEEEECCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf 99535301345672431687503527775211
Q 000757 1021 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1021 sp~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
...++|+|+.+.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=1.5e-06 Score=53.82 Aligned_cols=77 Identities=14% Similarity=0.141 Sum_probs=49.9
Q ss_pred EEEEEECCCEEEEEEEECC-CCEEEEEEEEC----CC---CCCHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCCEEE
Q ss_conf 4677104736899999538-97899999211----34---332257899888755124-4--661135414430363589
Q 000757 905 SRILGEGGFGLVYSGVLDD-GTKVAVKVLKR----VD---QQGGREFLAEVEMLSRLH-H--RNLVKLIGICIEEQARCL 973 (1299)
Q Consensus 905 ~eiLGkGaFGtVYkA~l~d-G~~VAVK~Lk~----~~---~~~~keflrEIeILsrLr-H--PNIVrLlGv~~e~~~~~L 973 (1299)
.+.||.|....||+....+ ++.+++|.-.. .. .....+..+|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9963489981
Q 000757 974 VYELIPNGSV 983 (1299)
Q Consensus 974 VmEYi~gGSL 983 (1299)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.36 E-value=9.2e-09 Score=67.33 Aligned_cols=53 Identities=8% Similarity=-0.023 Sum_probs=41.9
Q ss_pred CCCCCCCHHHHHHHHH-CCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCC
Q ss_conf 4632357256896420-0137501255568777139995389999999999987
Q 000757 721 PLGEKFDNTTAFLTYQ-RFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 773 (1299)
Q Consensus 721 P~~~sF~~~EaldLs~-N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIPs~ls~ 773 (1299)
+--..+..++.|+|+. |.++|+||..++.|.+|+.|++++|++.+.++..+..
T Consensus 70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~ 123 (313)
T d1ogqa_ 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123 (313)
T ss_dssp GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 478467533520202654333002431145420011020356434433222220
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.15 E-value=3.7e-05 Score=45.45 Aligned_cols=159 Identities=12% Similarity=0.061 Sum_probs=87.8
Q ss_pred CCHHHHHHHHCCCCEEEEE-----EECCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCE-----
Q ss_conf 7978999880992154677-----104736899999538978999992113433225789988875512446611-----
Q 000757 890 FSASEIEKATGNFDASRIL-----GEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV----- 959 (1299)
Q Consensus 890 Fs~~ELe~aT~~Fsi~eiL-----GkGaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIV----- 959 (1299)
.+.++++....+|.++++. ..|--.+.|+....+|+ +++|+.... ...+++..|++++..|...++.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 89999999998679998568523788852673899978972-899980789--998899999999875430255545564
Q ss_pred EEE-E--EEEECCCEEEEEEECCCCCHHHCCC--------------C----C--CCCCCC-----------------CCH
Q ss_conf 354-1--4430363589996348998100023--------------5----6--567888-----------------875
Q 000757 960 KLI-G--ICIEEQARCLVYELIPNGSVESHLH--------------G----V--DKESAP-----------------LGW 999 (1299)
Q Consensus 960 rLl-G--v~~e~~~~~LVmEYi~gGSL~d~L~--------------~----~--~~~~~~-----------------Lsw 999 (1299)
... | +.........++.++.+........ . . ...... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHHC-CCCCEEEECCCCCCEEECCCCCCEECCCCCCC
Q ss_conf 68999999999999876524-99953530134567243168750352777521
Q 000757 1000 DARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1051 (1299)
Q Consensus 1000 ~~rlkIalQIA~ALaYLHs~-gsp~IVHRDIKPsNILLDedg~VKLsDFGLAr 1051 (1299)
......+..+...+...... -..++||+|+..+|||++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 12799999998764204855454503337863656402045412674222123
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.09 E-value=2.3e-05 Score=46.67 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=78.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCE--EEEE-----EEEECCCEEEEEEECCCCCH
Q ss_conf 4736899999538978999992113433225789988875512446611--3541-----44303635899963489981
Q 000757 911 GGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLIG-----ICIEEQARCLVYELIPNGSV 983 (1299)
Q Consensus 911 GaFGtVYkA~l~dG~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNIV--rLlG-----v~~e~~~~~LVmEYi~gGSL 983 (1299)
+....||++..++|+.+++|+.+.. ....+++..|...+..|....+. ..+. .....+..+.+++++.|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 6120269998389997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred HHC--------------CCC----CC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHH----CCC
Q ss_conf 000--------------235----65-678888756-------------------899999999999987652----499
Q 000757 984 ESH--------------LHG----VD-KESAPLGWD-------------------ARLKIALGAARALAYLHE----DSS 1021 (1299)
Q Consensus 984 ~d~--------------L~~----~~-~~~~~Lsw~-------------------~rlkIalQIA~ALaYLHs----~gs 1021 (1299)
... +|. .. .....+++. .+-.+...+.+.+..+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEEECCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf 9535301345672431687503527775211
Q 000757 1022 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1052 (1299)
Q Consensus 1022 p~IVHRDIKPsNILLDedg~VKLsDFGLAr~ 1052 (1299)
..++|+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.07 E-value=4.6e-05 Score=44.82 Aligned_cols=77 Identities=22% Similarity=0.297 Sum_probs=50.8
Q ss_pred CCCEEEEEEECCCEEEEEEEECCC--------CEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCC-EEEEEEEEECCCE
Q ss_conf 921546771047368999995389--------7899999211343322578998887551244661-1354144303635
Q 000757 901 NFDASRILGEGGFGLVYSGVLDDG--------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQAR 971 (1299)
Q Consensus 901 ~Fsi~eiLGkGaFGtVYkA~l~dG--------~~VAVK~Lk~~~~~~~keflrEIeILsrLrHPNI-VrLlGv~~e~~~~ 971 (1299)
++++ +.|+.|-.-.+|++...++ ..|.+++... ........+|..+++.+.-.++ .++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----
T ss_conf 1699-9917853343489996887754457898179996599--61165899999999999757999808998189----
Q ss_pred EEEEEECCCCCHH
Q ss_conf 8999634899810
Q 000757 972 CLVYELIPNGSVE 984 (1299)
Q Consensus 972 ~LVmEYi~gGSL~ 984 (1299)
.+|+||++|..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred CEEEEEECCCCCC
T ss_conf 5699973455488
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=94.19 E-value=0.002 Score=34.85 Aligned_cols=41 Identities=12% Similarity=-0.006 Sum_probs=15.0
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCC
Q ss_conf 25689642001375012555687771399953899999999
Q 000757 728 NTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPP 768 (1299)
Q Consensus 728 ~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIP 768 (1299)
+++.|+|++|.+.+.++..+..+..|..+++++|++.+.+|
T Consensus 102 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p 142 (313)
T d1ogqa_ 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142 (313)
T ss_dssp TCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCC
T ss_pred CCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 00110203564344332222201110011112245555685
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.25 E-value=0.021 Score=28.70 Aligned_cols=38 Identities=11% Similarity=0.037 Sum_probs=23.4
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCC
Q ss_conf 72568964200137501255568777139995389999
Q 000757 727 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLP 764 (1299)
Q Consensus 727 ~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LS 764 (1299)
.+++.|+|++|.+++--+..+..+.+|+.|++++|+|+
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~ 68 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 68898988499289859778634565522135665444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=92.39 E-value=0.016 Score=29.44 Aligned_cols=48 Identities=4% Similarity=-0.145 Sum_probs=23.8
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCC
Q ss_conf 572568964200137501255568777139995389999999999987
Q 000757 726 FDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 773 (1299)
Q Consensus 726 F~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIPs~ls~ 773 (1299)
+..++.++|+.|.+++-.+..|..|..|+.|++++|+|++-.+..|..
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~ 124 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTT
T ss_pred CCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCC
T ss_conf 222210100355344349799807974655245774535359778568
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.63 E-value=0.095 Score=24.67 Aligned_cols=49 Identities=4% Similarity=-0.086 Sum_probs=40.1
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCC
Q ss_conf 3572568964200137501255568777139995389999999999987
Q 000757 725 KFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 773 (1299)
Q Consensus 725 sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIPs~ls~ 773 (1299)
.+.+++.|+|++|.++.--+..+..+.+|+.|++++|+|..-.+..++.
T Consensus 54 ~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 102 (156)
T d2ifga3 54 GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102 (156)
T ss_dssp SCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCC
T ss_conf 6666672162021247742011124554333322678785157456335
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=87.87 E-value=0.074 Score=25.32 Aligned_cols=49 Identities=2% Similarity=-0.192 Sum_probs=41.7
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCC
Q ss_conf 3572568964200137501255568777139995389999999999987
Q 000757 725 KFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 773 (1299)
Q Consensus 725 sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIPs~ls~ 773 (1299)
.+.+++.|+|+.|.+.+-++..+..+..|+.|++++|++..-.+..|..
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~ 100 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLG 100 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTT
T ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHC
T ss_conf 8762721301363221212122211222210100355344349799807
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=84.12 E-value=0.12 Score=24.07 Aligned_cols=42 Identities=14% Similarity=-0.047 Sum_probs=31.1
Q ss_pred CCCCHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 2357256896420013750125556877713999538999999
Q 000757 724 EKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPS 766 (1299)
Q Consensus 724 ~sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGp 766 (1299)
..+..++.++|++|.++ +||..++.+..|+.|++++|+++.-
T Consensus 17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l 58 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV 58 (124)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 05898898979787168-6521565543135453243211235
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.64 E-value=0.049 Score=26.45 Aligned_cols=53 Identities=11% Similarity=0.055 Sum_probs=38.0
Q ss_pred ECCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 034632357256896420013750125556877713999538999999999998
Q 000757 719 LVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASS 772 (1299)
Q Consensus 719 i~P~~~sF~~~EaldLs~N~LsGeIP~~ls~LgrL~~LNVS~N~LSGpIPs~ls 772 (1299)
-+|.++ +.+++.|+|++|.++.--+..+..+..|+.|++++|++..-.+..+.
T Consensus 25 ~iP~~i-p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~ 77 (284)
T d1ozna_ 25 AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77 (284)
T ss_dssp SCCTTC-CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred CCCCCC-CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 449788-99988897748817987977864142130000134454332111212
|